DB00001	Lepirudin	Direct thrombin inhibitors	approved	Prothrombin	P00734	339641	inhibitor	yes
DB00002	Cetuximab	Monoclonal antibodies	approved	Epidermal growth factor receptor	P00533	757924	antagonist	yes
DB00002	Cetuximab	Monoclonal antibodies	approved	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00002	Cetuximab	Monoclonal antibodies	approved	Complement C1r subcomponent	P00736	29539	None	unknown
DB00002	Cetuximab	Monoclonal antibodies	approved	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00002	Cetuximab	Monoclonal antibodies	approved	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00002	Cetuximab	Monoclonal antibodies	approved	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00002	Cetuximab	Monoclonal antibodies	approved	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00002	Cetuximab	Monoclonal antibodies	approved	Complement C1s subcomponent	P09871	763110	None	unknown
DB00002	Cetuximab	Monoclonal antibodies	approved	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00002	Cetuximab	Monoclonal antibodies	approved	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00002	Cetuximab	Monoclonal antibodies	approved	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00002	Cetuximab	Monoclonal antibodies	approved	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00003	Dornase alfa	Mucolytics	approved	DNA	None	None	None	yes
DB00004	Denileukin diftitox	Other antineoplastic agents	approved;investigational	Interleukin-2 receptor subunit alpha	P01589	33813	binder	yes
DB00004	Denileukin diftitox	Other antineoplastic agents	approved;investigational	Interleukin-2 receptor subunit beta	P14784	307048	agonist	yes
DB00004	Denileukin diftitox	Other antineoplastic agents	approved;investigational	Cytokine receptor common subunit gamma	P31785	219890	None	unknown
DB00006	Bivalirudin	Direct thrombin inhibitors	approved;investigational	Prothrombin	P00734	339641	inhibitor	yes
DB00007	Leuprolide	Gonadotropin releasing hormone analogues	approved;investigational	Gonadotropin-releasing hormone receptor	P30968	183422	agonist	yes
DB00008	Peginterferon alfa-2a	Interferons	approved;investigational	Interferon alpha/beta receptor 2	P48551	995300	agonist	yes
DB00008	Peginterferon alfa-2a	Interferons	approved;investigational	Interferon alpha/beta receptor 1	P17181	306914	agonist	yes
DB00009	Alteplase	Other ophthalmologicals	approved	Plasminogen	P00747	387026	activator	yes
DB00009	Alteplase	Other ophthalmologicals	approved	Fibrinogen alpha chain	P02671	13591824	None	yes
DB00009	Alteplase	Other ophthalmologicals	approved	Urokinase plasminogen activator surface receptor	Q03405	37605	None	unknown
DB00009	Alteplase	Other ophthalmologicals	approved	Plasminogen activator inhibitor 1	P05121	35272	None	unknown
DB00010	Sermorelin	Tests for pituitary function	approved;withdrawn	Growth hormone-releasing hormone receptor	Q02643	183173	agonist	yes
DB00011	Interferon alfa-n1	Interferons	approved;investigational	Interferon alpha/beta receptor 2	P48551	995300	agonist	yes
DB00011	Interferon alfa-n1	Interferons	approved;investigational	Interferon alpha/beta receptor 1	P17181	306914	agonist	yes
DB00012	Darbepoetin alfa	Other antianemic preparations	approved;investigational	Erythropoietin receptor	P19235	182245	agonist	yes
DB00013	Urokinase	Enzymes	approved;investigational;withdrawn	Plasminogen	P00747	387026	activator	yes
DB00013	Urokinase	Enzymes	approved;investigational;withdrawn	Urokinase plasminogen activator surface receptor	Q03405	37605	None	yes
DB00013	Urokinase	Enzymes	approved;investigational;withdrawn	Urokinase-type plasminogen activator	P00749	1834524	None	yes
DB00013	Urokinase	Enzymes	approved;investigational;withdrawn	Tissue-type plasminogen activator	P00750	339834	None	yes
DB00013	Urokinase	Enzymes	approved;investigational;withdrawn	Plasminogen activator inhibitor 1	P05121	35272	None	yes
DB00013	Urokinase	Enzymes	approved;investigational;withdrawn	Plasminogen activator inhibitor 2	P05120	189545	None	yes
DB00013	Urokinase	Enzymes	approved;investigational;withdrawn	Plasma serine protease inhibitor	P05154	180550	None	unknown
DB00013	Urokinase	Enzymes	approved;investigational;withdrawn	Low-density lipoprotein receptor-related protein 2	P98164	1809240	None	unknown
DB00013	Urokinase	Enzymes	approved;investigational;withdrawn	Suppressor of tumorigenicity 14 protein	Q9Y5Y6	6647302	None	unknown
DB00013	Urokinase	Enzymes	approved;investigational;withdrawn	Nidogen-1	P14543	189209	None	unknown
DB00014	Goserelin	Gonadotropin releasing hormone analogues	approved	Lutropin-choriogonadotropic hormone receptor	P22888	903746	agonist	yes
DB00014	Goserelin	Gonadotropin releasing hormone analogues	approved	Gonadotropin-releasing hormone receptor	P30968	183422	agonist	yes
DB00015	Reteplase	Enzymes	approved;investigational	Plasminogen	P00747	387026	activator	yes
DB00015	Reteplase	Enzymes	approved;investigational	Fibrinogen alpha chain	P02671	13591824	None	yes
DB00015	Reteplase	Enzymes	approved;investigational	Urokinase plasminogen activator surface receptor	Q03405	37605	None	unknown
DB00015	Reteplase	Enzymes	approved;investigational	Plasminogen activator inhibitor 1	P05121	35272	None	unknown
DB00016	Erythropoietin	Other antianemic preparations	approved	Erythropoietin receptor	P19235	182245	agonist	yes
DB00017	Salmon Calcitonin	Calcitonin preparations	approved;investigational	Calcitonin receptor	P30988	179880	agonist	unknown
DB00018	Interferon alfa-n3	N/A	approved;investigational	Interferon alpha/beta receptor 1	P17181	306914	agonist	yes
DB00018	Interferon alfa-n3	N/A	approved;investigational	Interferon alpha/beta receptor 2	P48551	995300	agonist	yes
DB00019	Pegfilgrastim	Colony stimulating factors	approved	Granulocyte colony-stimulating factor receptor	Q99062	31697	agonist	yes
DB00019	Pegfilgrastim	Colony stimulating factors	approved	Neutrophil elastase	P08246	296665	None	unknown
DB00020	Sargramostim	Colony stimulating factors	approved;investigational	Granulocyte-macrophage colony-stimulating factor receptor subunit alpha	P15509	32089	agonist	yes
DB00020	Sargramostim	Colony stimulating factors	approved;investigational	Interleukin-3 receptor subunit alpha	P26951	186331	agonist	yes
DB00020	Sargramostim	Colony stimulating factors	approved;investigational	Cytokine receptor common subunit beta	P32927	487425	agonist	yes
DB00020	Sargramostim	Colony stimulating factors	approved;investigational	Syndecan-2	P34741	386787	agonist	unknown
DB00020	Sargramostim	Colony stimulating factors	approved;investigational	Bone marrow proteoglycan	P13727	34476	None	unknown
DB00021	Secretin	Tests for pancreatic function	approved;investigational	Secretin receptor	P47872	662796	agonist	yes
DB00022	Peginterferon alfa-2b	Interferons	approved	Interferon alpha/beta receptor 1	P17181	306914	agonist	yes
DB00022	Peginterferon alfa-2b	Interferons	approved	Interferon alpha/beta receptor 2	P48551	995300	agonist	yes
DB00023	Asparaginase Escherichia coli	Other antineoplastic agents	approved;investigational	L-asparagine	None	None	other/unknown	yes
DB00024	Thyrotropin Alfa	Thyrotropin	approved;vet_approved	Thyrotropin receptor	P16473	903760	agonist	yes
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	Coagulation factor X	P00742	182841	activator	yes
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	Coagulation factor IX	P00740	182609	cofactor	yes
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	von Willebrand factor	P04275	37947	binder	yes
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	Phytanoyl-CoA dioxygenase, peroxisomal	O14832	2564671	antagonist	unknown
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	Asialoglycoprotein receptor 2	P07307	179081	binder	unknown
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	78 kDa glucose-regulated protein	P11021	386758	chaperone	unknown
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	Calreticulin	P27797	337487	chaperone	unknown
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	Calnexin	P27824	186523	chaperone	unknown
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	Protein ERGIC-53	P49257	433938	chaperone	unknown
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	Prolow-density lipoprotein receptor-related protein 1	Q07954	34339	modulator	unknown
DB00025	Antihemophilic factor, human recombinant	Blood coagulation factors	approved;investigational	Multiple coagulation factor deficiency protein 2	Q8NI22	20799383	modulator	unknown
DB00026	Anakinra	Interleukin inhibitors	approved	Interleukin-1 receptor type 1	P14778	33801	antagonist	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	antagonist	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	High affinity immunoglobulin gamma Fc receptor IB	Q92637	None	antagonist	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	antagonist	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	antagonist	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	antagonist	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	antagonist	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	antagonist	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	Complement C3	P01024	None	binder	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	Complement C4-A	P0C0L4	None	binder	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	Complement C4-B	P0C0L5	None	binder	yes
DB00028	Immune Globulin Human	N/A	approved;investigational	Complement C5	P01031	179983	binder	yes
DB00029	Anistreplase	Enzymes	approved	Plasminogen	P00747	387026	activator	yes
DB00029	Anistreplase	Enzymes	approved	Fibrinogen alpha chain	P02671	13591824	None	yes
DB00029	Anistreplase	Enzymes	approved	Urokinase plasminogen activator surface receptor	Q03405	37605	None	unknown
DB00029	Anistreplase	Enzymes	approved	Plasminogen activator inhibitor 1	P05121	35272	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Insulin receptor	P06213	307070	agonist	yes
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Insulin-like growth factor 1 receptor	P08069	804990	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Retinoblastoma-associated protein	P06400	190959	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Cathepsin D	P07339	181180	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Insulin-degrading enzyme	P14735	184556	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Neuroendocrine convertase 2	P16519	189652	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Carboxypeptidase E	P16870	29667	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Neuroendocrine convertase 1	P29120	35318	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Protein NOV homolog	P48745	825696	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Low-density lipoprotein receptor-related protein 2	P98164	1809240	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Insulin-like growth factor-binding protein 7	Q16270	307151	None	unknown
DB00030	Insulin Human	Insulins and analogues for injection, intermediate-acting	approved;investigational	Synaptotagmin-like protein 4	Q96C24	21753104	None	unknown
DB00031	Tenecteplase	Enzymes	approved	Plasminogen	P00747	387026	activator	yes
DB00031	Tenecteplase	Enzymes	approved	Fibrinogen alpha chain	P02671	13591824	None	yes
DB00031	Tenecteplase	Enzymes	approved	Urokinase plasminogen activator surface receptor	Q03405	37605	None	unknown
DB00031	Tenecteplase	Enzymes	approved	Plasminogen activator inhibitor 1	P05121	35272	None	unknown
DB00031	Tenecteplase	Enzymes	approved	Plasminogen activator inhibitor 2	P05120	189545	None	unknown
DB00031	Tenecteplase	Enzymes	approved	Tetranectin	P05452	37409	None	unknown
DB00031	Tenecteplase	Enzymes	approved	Keratin, type II cytoskeletal 8	P05787	181573	None	unknown
DB00031	Tenecteplase	Enzymes	approved	Annexin A2	P07355	219910	None	unknown
DB00031	Tenecteplase	Enzymes	approved	Calreticulin	P27797	337487	None	unknown
DB00031	Tenecteplase	Enzymes	approved	Calnexin	P27824	186523	None	unknown
DB00031	Tenecteplase	Enzymes	approved	Prolow-density lipoprotein receptor-related protein 1	Q07954	34339	None	unknown
DB00032	Menotropins	Gonadotropins	approved	Follicle-stimulating hormone receptor	P23945	182771	binder	yes
DB00032	Menotropins	Gonadotropins	approved	Lutropin-choriogonadotropic hormone receptor	P22888	903746	None	yes
DB00033	Interferon gamma-1b	N/A	approved;investigational	Interferon gamma receptor 1	P15260	306915	binder	yes
DB00033	Interferon gamma-1b	N/A	approved;investigational	Interferon gamma receptor 2	P38484	463550	binder	yes
DB00034	Interferon Alfa-2a, Recombinant	Interferons	approved;investigational	Interferon alpha/beta receptor 1	P17181	306914	None	yes
DB00034	Interferon Alfa-2a, Recombinant	Interferons	approved;investigational	Interferon alpha/beta receptor 2	P48551	995300	None	yes
DB00035	Desmopressin	Vasopressin and analogues	approved	Vasopressin V2 receptor	P30518	28418	agonist	yes
DB00035	Desmopressin	Vasopressin and analogues	approved	Vasopressin V1a receptor	P37288	667068	None	yes
DB00035	Desmopressin	Vasopressin and analogues	approved	Vasopressin V1b receptor	P47901	563982	None	yes
DB00036	Coagulation factor VIIa Recombinant Human	Blood coagulation factors	approved	Coagulation factor X	P00742	182841	None	unknown
DB00036	Coagulation factor VIIa Recombinant Human	Blood coagulation factors	approved	Serine protease hepsin	P05981	306886	None	unknown
DB00036	Coagulation factor VIIa Recombinant Human	Blood coagulation factors	approved	Tissue factor pathway inhibitor	P10646	180546	None	unknown
DB00036	Coagulation factor VIIa Recombinant Human	Blood coagulation factors	approved	Vitamin K-dependent gamma-carboxylase	P38435	184028	None	unknown
DB00036	Coagulation factor VIIa Recombinant Human	Blood coagulation factors	approved	Coagulation factor VII	P08709	182801	None	unknown
DB00036	Coagulation factor VIIa Recombinant Human	Blood coagulation factors	approved	Tissue factor	P13726	339504	None	unknown
DB00038	Oprelvekin	Interleukins	approved;investigational	Interleukin-11 receptor subunit alpha	Q14626	995654	agonist	yes
DB00039	Palifermin	Detoxifying agents for antineoplastic treatment	approved	Fibroblast growth factor receptor 2	P21802	31374	binder	yes
DB00039	Palifermin	Detoxifying agents for antineoplastic treatment	approved	Neuropilin-1	O14786	2407641	None	unknown
DB00039	Palifermin	Detoxifying agents for antineoplastic treatment	approved	Fibroblast growth factor receptor 1	P11362	31368	None	unknown
DB00039	Palifermin	Detoxifying agents for antineoplastic treatment	approved	Fibroblast growth factor receptor 4	P22455	31372	None	unknown
DB00039	Palifermin	Detoxifying agents for antineoplastic treatment	approved	Fibroblast growth factor receptor 3	P22607	182569	None	unknown
DB00039	Palifermin	Detoxifying agents for antineoplastic treatment	approved	Basement membrane-specific heparan sulfate proteoglycan core protein	P98160	29470	None	unknown
DB00040	Glucagon recombinant	Glycogenolytic hormones	approved	Glucagon receptor	P47871	439690	agonist	yes
DB00040	Glucagon recombinant	Glycogenolytic hormones	approved	Glucagon-like peptide 2 receptor	O95838	4324491	None	unknown
DB00040	Glucagon recombinant	Glycogenolytic hormones	approved	Glucagon-like peptide 1 receptor	P43220	405082	None	unknown
DB00041	Aldesleukin	Interleukins	approved	Interleukin-2 receptor subunit beta	P14784	307048	agonist	yes
DB00041	Aldesleukin	Interleukins	approved	Interleukin-2 receptor subunit alpha	P01589	33813	agonist	yes
DB00041	Aldesleukin	Interleukins	approved	Cytokine receptor common subunit gamma	P31785	219890	agonist	yes
DB00042	Botulinum Toxin Type B	Other muscle relaxants, peripherally acting agents	approved;investigational	Vesicle-associated membrane protein 2	P63027	338632	binder	yes
DB00042	Botulinum Toxin Type B	Other muscle relaxants, peripherally acting agents	approved;investigational	Vesicle-associated membrane protein 1	P23763	338625	binder	yes
DB00042	Botulinum Toxin Type B	Other muscle relaxants, peripherally acting agents	approved;investigational	Synaptotagmin-2	Q8N9I0	21748879	None	yes
DB00043	Omalizumab	Other systemic drugs for obstructive airway diseases	approved;investigational	High affinity immunoglobulin epsilon receptor subunit alpha	P12319	31318	None	yes
DB00043	Omalizumab	Other systemic drugs for obstructive airway diseases	approved;investigational	High affinity immunoglobulin epsilon receptor subunit beta	Q01362	219882	antagonist	yes
DB00044	Lutropin alfa	Gonadotropins	approved	Lutropin-choriogonadotropic hormone receptor	P22888	903746	agonist	yes
DB00045	Lyme disease vaccine (recombinant OspA)	N/A	approved;withdrawn	Toll-like receptor 2	O60603	3132528	other/unknown	yes
DB00046	Insulin Lispro	Insulins and analogues for injection, intermediate-acting	approved	Insulin receptor	P06213	307070	agonist	yes
DB00046	Insulin Lispro	Insulins and analogues for injection, intermediate-acting	approved	Insulin-like growth factor 1 receptor	P08069	804990	None	unknown
DB00047	Insulin Glargine	Insulins and analogues for injection, long-acting	approved	Insulin receptor	P06213	307070	agonist	yes
DB00047	Insulin Glargine	Insulins and analogues for injection, long-acting	approved	Insulin-like growth factor 1 receptor	P08069	804990	agonist	unknown
DB00048	Collagenase clostridium histolyticum	Enzymes	approved;investigational	Collagen alpha-1(I) chain	P02452	1418928	None	unknown
DB00048	Collagenase clostridium histolyticum	Enzymes	approved;investigational	Collagen alpha-1(II) chain	P02458	29516	None	unknown
DB00048	Collagenase clostridium histolyticum	Enzymes	approved;investigational	Collagen alpha-1(III) chain	P02461	30058	None	unknown
DB00048	Collagenase clostridium histolyticum	Enzymes	approved;investigational	Collagen alpha-2(I) chain	P08123	179596	None	unknown
DB00049	Rasburicase	Detoxifying agents for antineoplastic treatment	approved;investigational	Uric acid	None	None	metabolizer	yes
DB00050	Cetrorelix	Anti-gonadotropin-releasing hormones	approved;investigational	Gonadotropin-releasing hormone receptor	P30968	183422	antagonist	yes
DB00050	Cetrorelix	Anti-gonadotropin-releasing hormones	approved;investigational	Lutropin-choriogonadotropic hormone receptor	P22888	903746	None	unknown
DB00052	Somatotropin	Somatropin and somatropin agonists	approved;investigational	Growth hormone receptor	P10912	31738	binder	yes
DB00052	Somatotropin	Somatropin and somatropin agonists	approved;investigational	Prolactin receptor	P16471	190362	None	yes
DB00053	Imiglucerase	Enzymes	approved	Glucocerebroside	None	None	other/unknown	yes
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Integrin beta-3	P05106	306786	antagonist	yes
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Integrin alpha-IIb	P08514	190068	antagonist	yes
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Complement C1r subcomponent	P00736	29539	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Complement C1s subcomponent	P09871	763110	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00054	Abciximab	Platelet aggregation inhibitors excl. heparin	approved	Vitronectin	P04004	36575	None	unknown
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Coagulation factor VIII	P00451	182818	multitarget	yes
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Coagulation factor V	P12259	182412	multitarget	yes
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Plasminogen activator inhibitor 1	P05121	35272	None	unknown
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Thrombomodulin	P07204	736251	None	unknown
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Vitamin K-dependent protein S	P07225	190289	None	unknown
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Ceruloplasmin	P00450	180256	None	unknown
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Prothrombin	P00734	339641	None	unknown
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Platelet factor 4	P02776	189851	None	unknown
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Plasma serine protease inhibitor	P05154	180550	None	unknown
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Serpin B6	P35237	297412	None	unknown
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Vitamin K-dependent gamma-carboxylase	P38435	184028	None	unknown
DB00055	Drotrecogin alfa	Enzymes	approved;investigational;withdrawn	Endothelial protein C receptor	Q9UNN8	565268	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Myeloid cell surface antigen CD33	P20138	180098	antibody	yes
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Complement C1s subcomponent	P09871	763110	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00056	Gemtuzumab ozogamicin	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00057	Indium In-111 satumomab pendetide	Indium (111In) compounds	approved;withdrawn	Tumor-associated glycoprotein 72 (TAG-72)	None	None	other/unknown	yes
DB00058	Alpha-1-proteinase inhibitor	Proteinase inhibitors	approved	Neutrophil elastase	P08246	296665	inhibitor	yes
DB00059	Pegaspargase	Other antineoplastic agents	approved;investigational	L-asparagine	None	None	other/unknown	yes
DB00060	Interferon beta-1a	Interferons	approved;investigational	Interferon alpha/beta receptor 1	P17181	306914	agonist	yes
DB00060	Interferon beta-1a	Interferons	approved;investigational	Interferon alpha/beta receptor 2	P48551	995300	None	yes
DB00061	Pegademase bovine	N/A	approved	Adenosine	None	None	metabolizer	yes
DB00061	Pegademase bovine	N/A	approved	Growth factor receptor-bound protein 2	P62993	181976	binder	unknown
DB00063	Eptifibatide	Platelet aggregation inhibitors excl. heparin	approved;investigational	Integrin beta-3	P05106	306786	None	yes
DB00066	Follitropin	Gonadotropins	approved	Follicle-stimulating hormone receptor	P23945	182771	agonist	yes
DB00067	Vasopressin	Vasopressin and analogues	approved	Vasopressin V2 receptor	P30518	28418	agonist	yes
DB00067	Vasopressin	Vasopressin and analogues	approved	Vasopressin V1a receptor	P37288	667068	None	yes
DB00067	Vasopressin	Vasopressin and analogues	approved	Vasopressin V1b receptor	P47901	563982	None	yes
DB00068	Interferon beta-1b	Interferons	approved	Interferon alpha/beta receptor 1	P17181	306914	agonist	yes
DB00068	Interferon beta-1b	Interferons	approved	Interferon alpha/beta receptor 2	P48551	995300	agonist	yes
DB00069	Interferon alfacon-1	Interferons	approved;investigational	Interferon alpha/beta receptor 1	P17181	306914	binder	yes
DB00069	Interferon alfacon-1	Interferons	approved;investigational	Interferon alpha/beta receptor 2	P48551	995300	binder	yes
DB00070	Hyaluronidase	Enzymes	approved;investigational	Hyaluronan	None	None	other	yes
DB00070	Hyaluronidase	Enzymes	approved;investigational	Transforming growth factor beta-1	P01137	1212989	inhibitor	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Insulin receptor	P06213	307070	binder	yes
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Insulin-like growth factor 1 receptor	P08069	804990	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Insulin-degrading enzyme	P14735	184556	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	HLA class II histocompatibility antigen, DQ alpha 2 chain	P01906	493166	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	HLA class II histocompatibility antigen, DQ beta 1 chain	P01920	None	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Retinoblastoma-associated protein	P06400	190959	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Cathepsin D	P07339	181180	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Carboxypeptidase E	P16870	29667	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Neuroendocrine convertase 2	P16519	189652	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Neuroendocrine convertase 1	P29120	35318	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Protein NOV homolog	P48745	825696	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Low-density lipoprotein receptor-related protein 2	P98164	1809240	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Insulin-like growth factor-binding protein 7	Q16270	307151	None	unknown
DB00071	Insulin Pork	Insulins and analogues for injection, intermediate-acting	approved	Synaptotagmin-like protein 4	Q96C24	21753104	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Receptor tyrosine-protein kinase erbB-2	P04626	553282	antibody	yes
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Epidermal growth factor receptor	P00533	757924	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Complement C1s subcomponent	P09871	763110	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00072	Trastuzumab	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	B-lymphocyte antigen CD20	P11836	29774	antibody	yes
DB00073	Rituximab	Monoclonal antibodies	approved	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	Complement C1r subcomponent	P00736	29539	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	Complement C1s subcomponent	P09871	763110	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00073	Rituximab	Monoclonal antibodies	approved	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Interleukin-2 receptor subunit alpha	P01589	33813	antibody	yes
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Interleukin-2 receptor subunit beta	P14784	307048	antibody	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Complement C1s subcomponent	P09871	763110	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00074	Basiliximab	Interleukin inhibitors	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	T-cell surface glycoprotein CD3 delta chain	P04234	None	None	yes
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	T-cell surface glycoprotein CD3 epsilon chain	P07766	469945	binder	yes
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	T-cell surface glycoprotein CD3 gamma chain	P09693	None	None	yes
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	T-cell surface glycoprotein CD3 zeta chain	P20963	None	None	yes
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	Complement C1s subcomponent	P09871	763110	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00075	Muromonab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00076	Digoxin Immune Fab (Ovine)	Antidotes	approved	Digoxin	None	None	other/unknown	yes
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	B-lymphocyte antigen CD20	P11836	29774	antibody	yes
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	Complement C1s subcomponent	P09871	763110	None	unknown
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00078	Ibritumomab tiuxetan	Various therapeutic radiopharmaceuticals	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00080	Daptomycin	Other antibacterials	approved;investigational	Bacterial outer membrane	None	None	incorporation into and destabilization	yes
DB00080	Daptomycin	Other antibacterials	approved;investigational	Lipoteichoic acid synthesis	None	None	inhibitor	unknown
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	B-lymphocyte antigen CD20	P11836	29774	antibody	yes
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00081	Tositumomab	Iodine (131I) compounds	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00082	Pegvisomant	Other anterior pituitary lobe hormones and analogues	approved	Growth hormone receptor	P10912	31738	antagonist	yes
DB00083	Botulinum Toxin Type A	Other muscle relaxants, peripherally acting agents	approved;investigational	Synaptosomal-associated protein 25	P60880	307426	inhibitor	yes
DB00083	Botulinum Toxin Type A	Other muscle relaxants, peripherally acting agents	approved;investigational	Rho-related GTP-binding protein RhoB	P62745	36032	None	unknown
DB00085	Pancrelipase	Enzyme preparations	approved;investigational	Dietary fat	None	None	cleavage	yes
DB00085	Pancrelipase	Enzyme preparations	approved;investigational	Dietary protein	None	None	cleavage	yes
DB00085	Pancrelipase	Enzyme preparations	approved;investigational	Dietary starch	None	None	cleavage	yes
DB00086	Streptokinase	Enzymes	approved;investigational	Plasminogen	P00747	387026	activator	yes
DB00086	Streptokinase	Enzymes	approved;investigational	Proteinase-activated receptor 1	P25116	339677	cleavage	unknown
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	CAMPATH-1 antigen	P31358	29646	antibody	yes
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00087	Alemtuzumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00088	Alglucerase	Enzymes	approved;investigational	Glucocerebroside	None	None	other/unknown	yes
DB00089	Capromab pendetide	Indium (111In) compounds	approved	Glutamate carboxypeptidase 2	Q04609	190664	other/unknown	yes
DB00090	Laronidase	Enzymes	approved	Iduronic acid	None	None	other/unknown	yes
DB00091	Cyclosporine	Other ophthalmologicals	approved;investigational;vet_approved	Calcium signal-modulating cyclophilin ligand	P49069	619670	binder	yes
DB00091	Cyclosporine	Other ophthalmologicals	approved;investigational;vet_approved	Calcineurin subunit B type 2	Q96LZ3	33150800	inhibitor	yes
DB00091	Cyclosporine	Other ophthalmologicals	approved;investigational;vet_approved	Peptidyl-prolyl cis-trans isomerase A	P62937	30309	None	unknown
DB00091	Cyclosporine	Other ophthalmologicals	approved;investigational;vet_approved	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	P30405	181274	binder	unknown
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	T-cell surface antigen CD2	P06729	180081	inhibitor	yes
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	Complement C1r subcomponent	P00736	29539	None	unknown
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00092	Alefacept	Selective immunosuppressants	approved;investigational;withdrawn	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00093	Felypressin	N/A	approved	Vasopressin V1a receptor	P37288	667068	agonist	yes
DB00094	Urofollitropin	Gonadotropins	approved;vet_approved	Follicle-stimulating hormone receptor	P23945	182771	agonist	yes
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	Integrin alpha-L	P20701	31422	antibody	yes
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00095	Efalizumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00097	Choriogonadotropin alfa	Gonadotropins	approved	Lutropin-choriogonadotropic hormone receptor	P22888	903746	None	yes
DB00097	Choriogonadotropin alfa	Gonadotropins	approved	Follicle-stimulating hormone receptor	P23945	182771	binder	yes
DB00098	Antithymocyte immunoglobulin (rabbit)	Selective immunosuppressants	approved	T-cell surface glycoprotein CD1a	P06126	180036	inhibitor	unknown
DB00098	Antithymocyte immunoglobulin (rabbit)	Selective immunosuppressants	approved	Major histocompatibility complex class I-related gene protein	Q95460	940354	antagonist	yes
DB00098	Antithymocyte immunoglobulin (rabbit)	Selective immunosuppressants	approved	Integrin alpha-L	P20701	31422	None	yes
DB00098	Antithymocyte immunoglobulin (rabbit)	Selective immunosuppressants	approved	T-lymphocyte activation antigen CD86	P42081	439839	None	yes
DB00098	Antithymocyte immunoglobulin (rabbit)	Selective immunosuppressants	approved	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	yes
DB00098	Antithymocyte immunoglobulin (rabbit)	Selective immunosuppressants	approved	T-cell surface glycoprotein CD4	P01730	None	None	yes
DB00098	Antithymocyte immunoglobulin (rabbit)	Selective immunosuppressants	approved	Integrin beta-1	P05556	31442	None	yes
DB00098	Antithymocyte immunoglobulin (rabbit)	Selective immunosuppressants	approved	Integrin alpha-V	P06756	340307	None	yes
DB00098	Antithymocyte immunoglobulin (rabbit)	Selective immunosuppressants	approved	Integrin beta-3	P05106	306786	None	yes
DB00099	Filgrastim	Colony stimulating factors	approved	Granulocyte colony-stimulating factor receptor	Q99062	31697	stimulator	yes
DB00099	Filgrastim	Colony stimulating factors	approved	Neutrophil elastase	P08246	296665	other/unknown	unknown
DB00100	Coagulation Factor IX (Recombinant)	Blood coagulation factors	approved;investigational	Coagulation factor X	P00742	182841	activator	yes
DB00100	Coagulation Factor IX (Recombinant)	Blood coagulation factors	approved;investigational	Coagulation factor XI	P03951	182833	ligand	yes
DB00100	Coagulation Factor IX (Recombinant)	Blood coagulation factors	approved;investigational	Coagulation factor VII	P08709	182801	ligand	yes
DB00100	Coagulation Factor IX (Recombinant)	Blood coagulation factors	approved;investigational	Coagulation factor VIII	P00451	182818	cofactor	yes
DB00100	Coagulation Factor IX (Recombinant)	Blood coagulation factors	approved;investigational	Prothrombin	P00734	339641	None	unknown
DB00100	Coagulation Factor IX (Recombinant)	Blood coagulation factors	approved;investigational	Prolow-density lipoprotein receptor-related protein 1	Q07954	34339	None	unknown
DB00100	Coagulation Factor IX (Recombinant)	Blood coagulation factors	approved;investigational	Vitamin K-dependent gamma-carboxylase	P38435	184028	None	unknown
DB00102	Becaplermin	Other agents for local oral treatment	approved;investigational	Platelet-derived growth factor receptor beta	P09619	189732	None	yes
DB00102	Becaplermin	Other agents for local oral treatment	approved;investigational	Platelet-derived growth factor receptor alpha	P16234	189734	None	unknown
DB00102	Becaplermin	Other agents for local oral treatment	approved;investigational	Alpha-2-macroglobulin	P01023	177870	None	unknown
DB00103	Agalsidase beta	Enzymes	approved;investigational	Globotriaosylceramide	None	None	ligand	yes
DB00104	Octreotide	Somatostatin and analogues	approved;investigational	Somatostatin receptor type 1	P30872	307434	None	yes
DB00104	Octreotide	Somatostatin and analogues	approved;investigational	Somatostatin receptor type 5	P35346	431095	None	yes
DB00104	Octreotide	Somatostatin and analogues	approved;investigational	Somatostatin receptor type 2	P30874	None	binder	yes
DB00105	Interferon Alfa-2b, Recombinant	Interferons	approved	Interferon alpha/beta receptor 2	P48551	995300	binder	yes
DB00105	Interferon Alfa-2b, Recombinant	Interferons	approved	Interferon alpha/beta receptor 1	P17181	306914	binder	yes
DB00106	Abarelix	Other hormone antagonists and related agents	approved;investigational;withdrawn	Gonadotropin-releasing hormone receptor	P30968	183422	antagonist	yes
DB00107	Oxytocin	Oxytocin and analogues	approved;vet_approved	Oxytocin receptor	P30559	34765	agonist	yes
DB00107	Oxytocin	Oxytocin and analogues	approved;vet_approved	Oxytocin-neurophysin 1	P01178	189411	binder	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Integrin alpha-4	P13612	33946	antibody	yes
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00108	Natalizumab	Selective immunosuppressants	approved;investigational	Intercellular adhesion molecule 1	P05362	758074	None	unknown
DB00109	Enfuvirtide	Other antivirals	approved;investigational	Envelope glycoprotein	Q53I07	62732120	None	yes
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	Fusion glycoprotein F0	P13843	222565	None	yes
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00110	Palivizumab	Specific immunoglobulins	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	Vascular endothelial growth factor A	P15692	181971	None	yes
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	None	unknown
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	Complement C1q subcomponent subunit A	P02745	4894854	None	unknown
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	None	unknown
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	None	unknown
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	None	unknown
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	None	unknown
DB00112	Bevacizumab	Monoclonal antibodies	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-c	P31995	32074	None	unknown
DB00113	Technetium Tc-99m arcitumomab	Technetium (99mTc) compounds	approved;investigational	Carcinoembryonic antigen-related cell adhesion molecule 1	P13688	179440	other/unknown	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Alanine--glyoxylate aminotransferase 2, mitochondrial	Q9BYV1	12406973	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Glutamate decarboxylase 1	Q99259	182936	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Cystathionine beta-synthase	P35520	388716	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Kynureninase	Q16719	1323715	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Serine hydroxymethyltransferase, cytosolic	P34896	307422	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Cysteine desulfurase, mitochondrial	Q9Y697	24042327	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Aspartate aminotransferase, cytoplasmic	P17174	179067	activator	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Ornithine aminotransferase, mitochondrial	P04181	189329	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Ornithine decarboxylase	P11926	29893806	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	Q8N5Z0	6165634	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	4-aminobutyrate aminotransferase, mitochondrial	P80404	602705	inhibitor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Pyridoxine-5'-phosphate oxidase	Q9NVS9	21728336	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Sphingosine-1-phosphate lyase 1	O95470	10129683	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Tyrosine aminotransferase	P17735	36713	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Kynurenine--oxoglutarate transaminase 1	Q16773	758591	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Threonine synthase-like 1	Q8IYQ7	23243453	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Glycogen phosphorylase, liver form	P06737	183353	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Serine palmitoyltransferase 2	O15270	2564249	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Cysteine sulfinic acid decarboxylase	Q9Y600	4894558	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Histidine decarboxylase	P19113	32109	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Arginine decarboxylase	Q96A70	15858863	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	L-serine dehydratase/L-threonine deaminase	P20132	338030	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial	O75600	3342906	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Glycine dehydrogenase [decarboxylating], mitochondrial	P23378	190287	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Alanine aminotransferase 1	P24298	1763096	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Phosphoserine aminotransferase	Q9Y617	5326802	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	5-aminolevulinate synthase, nonspecific, mitochondrial	P13196	28583	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Serine--pyruvate aminotransferase	P21549	36582	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Pyridoxal phosphate phosphatase	Q96GD0	37545684	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Serine palmitoyltransferase 1	O15269	2564247	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Cystathionine gamma-lyase	P32929	262476	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Branched-chain-amino-acid aminotransferase, cytosolic	P54687	1036780	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Branched-chain-amino-acid aminotransferase, mitochondrial	O15382	2342862	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Proline synthase co-transcribed bacterial homolog protein	O94903	4126978	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Formimidoyltransferase-cyclodeaminase	O95954	6537208	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Aspartate aminotransferase, mitochondrial	P00505	179104	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Glycogen phosphorylase, brain form	P11216	307200	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Glycogen phosphorylase, muscle form	P11217	190784	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Aromatic-L-amino-acid decarboxylase	P20711	181521	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Aspartate aminotransferase	Q2TU84	46981967	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	GAD1 protein	Q99259	182936	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Serine hydroxymethyltransferase	Q53ET4	62898842	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Selenocysteine lyase variant	Q59FK2	62088496	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Phosphorylase	Q59GM9	62087740	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Ornithine aminotransferase variant	Q59HE2	62087214	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	5-aminolevulinate synthase	Q5JAM2	33112016	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Glutamate decarboxylase 2 (Pancreatic islets and brain, 65kDa)	Q5VZ30	55662653	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	DDC protein	Q6IBS8	48145565	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Pyridoxal-dependent decarboxylase domain-containing protein 1	Q6P996	38174269	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Kynurenine--oxoglutarate transaminase 3	Q6YP21	37542047	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Glutamate decarboxylase-like protein 1	Q6ZQY3	34536121	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Selenocysteine lyase	Q96I15	None	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Immunoglobulin superfamily member 10	Q6WRI0	None	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	5-phosphohydroxy-L-lysine phospho-lyase	Q8IUZ5	18027842	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Glutamate decarboxylase 1 (Brain, 67kDa)	Q8IVA8	23138819	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Serine hydroxymethyltransferase, mitochondrial	P34897	746436	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	5-aminolevulinate synthase, erythroid-specific, mitochondrial	P22557	28586	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Alanine aminotransferase 2	Q8TD30	19046894	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Molybdenum cofactor sulfurase	Q96EN8	7021017	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Serine dehydratase-like	Q96GA7	33150744	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	P-selectin cytoplasmic tail-associated protein (PCAP)	Q96JQ3	14495153	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Hepatic peroxysomal alanine:glyoxylate aminotransferase	Q9BXA1	13560684	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Serine racemase	Q9GZT4	11034785	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	O-phosphoseryl-tRNA(Sec) selenium transferase	Q9HD40	7652498	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Serine palmitoyltransferase 3	Q9NUV7	7023574	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Glutamic acid decarboxylase	Q9UGI5	6562440	cofactor	unknown
DB00114	Pyridoxal Phosphate	Other plain vitamin preparations	approved;investigational;nutraceutical	Alanine-glyoxylate aminotransferase homolog	Q9UJX1	6176530	cofactor	unknown
DB00115	Cyanocobalamin	Iron in other combinations	approved;nutraceutical	Methionine synthase	Q99707	1923221	cofactor	yes
DB00115	Cyanocobalamin	Iron in other combinations	approved;nutraceutical	Methylmalonyl-CoA mutase, mitochondrial	P22033	187452	cofactor	yes
DB00115	Cyanocobalamin	Iron in other combinations	approved;nutraceutical	Methionine synthase reductase	Q9UBK8	6572540	cofactor	unknown
DB00115	Cyanocobalamin	Iron in other combinations	approved;nutraceutical	Methylmalonic aciduria type A protein, mitochondrial	Q8IVH4	26006421	cofactor	unknown
DB00115	Cyanocobalamin	Iron in other combinations	approved;nutraceutical	Methylmalonic aciduria and homocystinuria type C protein	Q9Y4U1	52545527	cofactor	unknown
DB00115	Cyanocobalamin	Iron in other combinations	approved;nutraceutical	Methylenetetrahydrofolate reductase	P42898	6139053	cofactor	unknown
DB00117	Histidine	N/A	approved;nutraceutical	Histidine decarboxylase	P19113	32109	None	unknown
DB00117	Histidine	N/A	approved;nutraceutical	Histidine--tRNA ligase, cytoplasmic	P12081	32460	None	unknown
DB00117	Histidine	N/A	approved;nutraceutical	Sodium-coupled neutral amino acid transporter 3	Q99624	10242111	None	unknown
DB00117	Histidine	N/A	approved;nutraceutical	Histidine ammonia-lyase	P42357	451210	None	unknown
DB00118	Ademetionine	Amino acids and derivatives	approved;investigational;nutraceutical	Glycine N-methyltransferase	Q14749	8671584	cofactor	unknown
DB00118	Ademetionine	Amino acids and derivatives	approved;investigational;nutraceutical	S-adenosylmethionine decarboxylase proenzyme	P17707	178518	cofactor	unknown
DB00118	Ademetionine	Amino acids and derivatives	approved;investigational;nutraceutical	S-adenosylmethionine synthase isoform type-2	P31153	36327	cofactor	unknown
DB00118	Ademetionine	Amino acids and derivatives	approved;investigational;nutraceutical	Cystathionine beta-synthase	P35520	388716	activator	unknown
DB00118	Ademetionine	Amino acids and derivatives	approved;investigational;nutraceutical	S-adenosylmethionine synthase isoform type-1	Q00266	220066	cofactor	unknown
DB00118	Ademetionine	Amino acids and derivatives	approved;investigational;nutraceutical	Catechol O-methyltransferase	P21964	180920	cofactor	unknown
DB00118	Ademetionine	Amino acids and derivatives	approved;investigational;nutraceutical	Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1	Q8N1G2	None	None	unknown
DB00118	Ademetionine	Amino acids and derivatives	approved;investigational;nutraceutical	Arsenite methyltransferase	Q9HBK9	None	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Monocarboxylate transporter 4	O15427	2463634	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Monocarboxylate transporter 8	P36021	458255	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Alanine--glyoxylate aminotransferase 2, mitochondrial	Q9BYV1	12406973	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Monocarboxylate transporter 6	O15375	2463630	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Pyruvate kinase PKLR	P30613	3327365	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Monocarboxylate transporter 7	O15403	2463632	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Monocarboxylate transporter 2	O60669	3047402	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	P11177	189760	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Pyruvate kinase PKM	P14618	189998	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	4-aminobutyrate aminotransferase, mitochondrial	P80404	602705	inhibitor	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Monocarboxylate transporter 5	O15374	2463628	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Monocarboxylate transporter 3	O95907	6103363	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Monocarboxylate transporter 1	P53985	561722	None	unknown
DB00119	Pyruvic acid	N/A	approved;investigational;nutraceutical	Pyruvate carboxylase, mitochondrial	P11498	458236	None	unknown
DB00120	L-Phenylalanine	N/A	approved;investigational;nutraceutical	Tyrosine aminotransferase	P17735	36713	None	unknown
DB00120	L-Phenylalanine	N/A	approved;investigational;nutraceutical	Large neutral amino acids transporter small subunit 2	Q9UHI5	6642960	None	unknown
DB00120	L-Phenylalanine	N/A	approved;investigational;nutraceutical	Phenylalanine--tRNA ligase alpha subunit	Q9Y285	2102679	None	unknown
DB00120	L-Phenylalanine	N/A	approved;investigational;nutraceutical	Phenylalanine-4-hydroxylase	P00439	189937	None	unknown
DB00120	L-Phenylalanine	N/A	approved;investigational;nutraceutical	Phenylalanine--tRNA ligase, mitochondrial	O95363	3983103	None	unknown
DB00120	L-Phenylalanine	N/A	approved;investigational;nutraceutical	Phenylalanine--tRNA ligase beta subunit	Q9NSD9	7768938	None	unknown
DB00120	L-Phenylalanine	N/A	approved;investigational;nutraceutical	Tyrosine 3-monooxygenase	P07101	37127	binder	unknown
DB00121	Biotin	Other plain vitamin preparations	approved;investigational;nutraceutical	Propionyl-CoA carboxylase beta chain, mitochondrial	P05166	312812	None	unknown
DB00121	Biotin	Other plain vitamin preparations	approved;investigational;nutraceutical	Biotin--protein ligase	P50747	577625	None	unknown
DB00121	Biotin	Other plain vitamin preparations	approved;investigational;nutraceutical	Sodium-dependent multivitamin transporter	Q9Y289	5006439	None	unknown
DB00121	Biotin	Other plain vitamin preparations	approved;investigational;nutraceutical	Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial	Q9HCC0	10934059	None	unknown
DB00121	Biotin	Other plain vitamin preparations	approved;investigational;nutraceutical	Acetyl-CoA carboxylase 2	O00763	2138330	None	unknown
DB00121	Biotin	Other plain vitamin preparations	approved;investigational;nutraceutical	Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial	Q96RQ3	12382296	None	unknown
DB00121	Biotin	Other plain vitamin preparations	approved;investigational;nutraceutical	Pyruvate carboxylase, mitochondrial	P11498	458236	None	unknown
DB00121	Biotin	Other plain vitamin preparations	approved;investigational;nutraceutical	Propionyl-CoA carboxylase alpha chain, mitochondrial	P05165	296366	None	unknown
DB00121	Biotin	Other plain vitamin preparations	approved;investigational;nutraceutical	Acetyl-CoA carboxylase 1	Q13085	849083	None	unknown
DB00122	Choline	N/A	approved;nutraceutical	Choline-phosphate cytidylyltransferase B	Q9Y5K3	3153239	product of	unknown
DB00122	Choline	N/A	approved;nutraceutical	Acetylcholinesterase	P22303	177975	product of	unknown
DB00122	Choline	N/A	approved;nutraceutical	Choline-phosphate cytidylyltransferase A	P49585	575486	product of	unknown
DB00122	Choline	N/A	approved;nutraceutical	Phospholipase D2	O14939	2645858	product of	unknown
DB00122	Choline	N/A	approved;nutraceutical	Cholinesterase	P06276	1311630	product of	unknown
DB00122	Choline	N/A	approved;nutraceutical	Phospholipase D1	Q13393	1185463	product of	unknown
DB00122	Choline	N/A	approved;nutraceutical	Phosphoethanolamine/phosphocholine phosphatase	Q8TCT1	20196839	product of	unknown
DB00122	Choline	N/A	approved;nutraceutical	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	None	unknown
DB00123	L-Lysine	Amino acids	approved;nutraceutical	High affinity cationic amino acid transporter 1	P30825	36161	None	unknown
DB00123	L-Lysine	Amino acids	approved;nutraceutical	Cationic amino acid transporter 4	O43246	4378940	None	unknown
DB00123	L-Lysine	Amino acids	approved;nutraceutical	Cationic amino acid transporter 3	Q8WY07	17224957	None	unknown
DB00123	L-Lysine	Amino acids	approved;nutraceutical	Low affinity cationic amino acid transporter 2	P52569	849051	None	unknown
DB00123	L-Lysine	Amino acids	approved;nutraceutical	Lysine--tRNA ligase	Q15046	505108	None	unknown
DB00125	L-Arginine	Amino acids	approved;nutraceutical	Nitric oxide synthase, endothelial	P29474	189212	None	unknown
DB00125	L-Arginine	Amino acids	approved;nutraceutical	Cationic amino acid transporter 3	Q8WY07	17224957	None	unknown
DB00125	L-Arginine	Amino acids	approved;nutraceutical	Arginine decarboxylase	Q96A70	15858863	None	unknown
DB00125	L-Arginine	Amino acids	approved;nutraceutical	Argininosuccinate lyase	P04424	28878	None	unknown
DB00125	L-Arginine	Amino acids	approved;nutraceutical	Nitric oxide synthase, inducible	P35228	292242	None	unknown
DB00125	L-Arginine	Amino acids	approved;nutraceutical	High affinity cationic amino acid transporter 1	P30825	36161	None	unknown
DB00125	L-Arginine	Amino acids	approved;nutraceutical	Arginase-2, mitochondrial	P78540	1694633	None	unknown
DB00125	L-Arginine	Amino acids	approved;nutraceutical	Cationic amino acid transporter 4	O43246	4378940	None	unknown
DB00125	L-Arginine	Amino acids	approved;nutraceutical	Argininosuccinate synthase	P00966	28872	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Lactase-phlorizin hydrolase	P09848	34400	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Hyaluronate lyase	Q54873	14971788	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	DNA	None	None	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Xylose isomerase	P24300	153534	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2	O00469	2138314	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Phytanoyl-CoA dioxygenase, peroxisomal	O14832	2564671	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	O60568	3153235	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Gamma-butyrobetaine dioxygenase	O75936	3746805	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Dopamine beta-hydroxylase	P09172	30474	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Peptidyl-glycine alpha-amidating monooxygenase	P19021	189595	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Prolyl 4-hydroxylase subunit alpha-1	P13674	190786	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Prolyl 3-hydroxylase 1	Q32P28	11127636	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2	Q6N063	34364724	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2	Q6NS38	53988530	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Prolyl 3-hydroxylase 2	Q8IVL5	27526730	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Prolyl 3-hydroxylase 3	Q8IVL6	1200503	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1	Q8N543	21410525	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Egl nine homolog 2	Q96KS0	14547148	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3	Q96Q83	16326129	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Lysine-specific demethylase 5D	Q9BY66	1661016	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Egl nine homolog 1	Q9GZT9	11345052	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Solute carrier family 23 member 1	Q9UHI7	3789785	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	Q02809	190074	activator	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Egl nine homolog 3	Q9H6Z9	14547150	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Trimethyllysine dioxygenase, mitochondrial	Q9NVH6	15553435	None	unknown
DB00126	Vitamin C	Ascorbic acid (vitamin C), combinations	approved;nutraceutical	Transmembrane prolyl 4-hydroxylase	Q9NXG6	28566186	None	unknown
DB00127	Spermine	N/A	approved;nutraceutical	Spermine synthase	P52788	791051	ligand	yes
DB00127	Spermine	N/A	approved;nutraceutical	Spermine oxidase	Q9NWM0	14860862	ligand	yes
DB00127	Spermine	N/A	approved;nutraceutical	DNA	None	None	binder	yes
DB00127	Spermine	N/A	approved;nutraceutical	Ornithine decarboxylase	P11926	29893806	product of	unknown
DB00127	Spermine	N/A	approved;nutraceutical	Extracellular calcium-sensing receptor	P41180	599820	None	unknown
DB00127	Spermine	N/A	approved;nutraceutical	Beta-1 adrenergic receptor	P08588	178200	None	unknown
DB00127	Spermine	N/A	approved;nutraceutical	Beta-2 adrenergic receptor	P07550	29371	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Ribonuclease pancreatic	P07998	None	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Lysozyme C	P61626	None	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Calcium-binding mitochondrial carrier protein Aralar2	Q9UJS0	22002963	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Aspartate aminotransferase, cytoplasmic	P17174	179067	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Aspartoacylase	P45381	455834	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Asparagine synthetase [glutamine-hydrolyzing]	P08243	179100	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Argininosuccinate synthase	P00966	28872	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Aminoacylase-1	Q03154	178071	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Aspartate aminotransferase, mitochondrial	P00505	179104	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Aspartate--tRNA ligase, cytoplasmic	P14868	179102	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Calcium-binding mitochondrial carrier protein Aralar1	O75746	3559910	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Aspartyl/asparaginyl beta-hydroxylase	Q12797	458032	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Multifunctional protein ADE2	P22234	28384	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	CAD protein	P27708	1228049	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Adenylosuccinate synthetase isozyme 2	P30520	415849	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Excitatory amino acid transporter 3	P43005	507898	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Aspartate aminotransferase	Q2TU84	46981967	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Argininosuccinate synthetase, isoform CRA_a	Q5T6L4	55958410	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Aspartate--tRNA ligase, mitochondrial	Q6PI48	56203852	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Isoaspartyl peptidase/L-asparaginase	Q7L266	127798426	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Adenylosuccinate synthetase isozyme 1	Q8N142	21303413	None	unknown
DB00128	L-Aspartic Acid	N/A	approved;nutraceutical	Aspartoacylase-2	Q96HD9	21654856	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Ornithine aminotransferase, mitochondrial	P04181	189329	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Ornithine carbamoyltransferase, mitochondrial	P00480	189407	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Arginase-1	P05089	178995	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Ornithine decarboxylase antizyme 1	P54368	852429	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Low affinity cationic amino acid transporter 2	P52569	849051	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Mitochondrial ornithine transporter 2	Q9BXI2	13445628	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Cationic amino acid transporter 4	O43246	4378940	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	High affinity cationic amino acid transporter 1	P30825	36161	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Arginase-2, mitochondrial	P78540	1694633	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Mitochondrial ornithine transporter 1	Q9Y619	5565862	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Cationic amino acid transporter 3	Q8WY07	17224957	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Ornithine decarboxylase antizyme 2	O95190	3766170	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Glycine amidinotransferase, mitochondrial	P50440	545385	None	unknown
DB00129	Ornithine	N/A	approved;nutraceutical	Ornithine decarboxylase antizyme 3	Q9UMX2	5802609	None	unknown
DB00130	L-Glutamine	Amino acids and derivatives	approved;investigational;nutraceutical	CTP synthase 1	P17812	30293	antagonist	unknown
DB00130	L-Glutamine	Amino acids and derivatives	approved;investigational;nutraceutical	Amidophosphoribosyltransferase	Q06203	219459	product of	unknown
DB00130	L-Glutamine	Amino acids and derivatives	approved;investigational;nutraceutical	Glutamine synthetase	P15104	31833	product of	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	Cyclic AMP-responsive element-binding protein 1	P16220	240429	activator	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	DNA	None	None	component of	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	Serine/threonine-protein kinase pim-1	P11309	387022	product of	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	product of	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	Glycogen phosphorylase, liver form	P06737	183353	activator	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	5'-AMP-activated protein kinase subunit beta-1	Q9Y478	2916800	activator	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	Histidine triad nucleotide-binding protein 1	P49773	862933	product of	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Q08499	347130	product of	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	Acetyl-coenzyme A synthetase 2-like, mitochondrial	Q9NUB1	56203090	product of	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	Acetyl-coenzyme A synthetase, cytoplasmic	Q9NR19	8439651	product of	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	5'-AMP-activated protein kinase catalytic subunit alpha-1	Q13131	4115829	activator	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	5'-AMP-activated protein kinase subunit beta-2	O43741	2916802	activator	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	Adenylate cyclase type 1	Q08828	41472630	product of	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	Long-chain-fatty-acid--CoA ligase 1	P33121	219900	product of	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	Fructose-1,6-bisphosphatase 1	P09467	None	antagonist	unknown
DB00131	Adenosine monophosphate	N/A	approved;investigational;nutraceutical	Adenosine kinase	P55263	1224125	product of	unknown
DB00132	Alpha-Linolenic Acid	N/A	approved;nutraceutical	Fatty acid desaturase 1	O60427	3169158	ligand	yes
DB00132	Alpha-Linolenic Acid	N/A	approved;nutraceutical	Fatty acid desaturase 2	O95864	4406528	ligand	yes
DB00132	Alpha-Linolenic Acid	N/A	approved;nutraceutical	Sodium/calcium exchanger 1	P32418	180673	None	unknown
DB00132	Alpha-Linolenic Acid	N/A	approved;nutraceutical	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	None	unknown
DB00132	Alpha-Linolenic Acid	N/A	approved;nutraceutical	Elongation of very long chain fatty acids protein 4	Q9GZR5	12044051	None	unknown
DB00132	Alpha-Linolenic Acid	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB00132	Alpha-Linolenic Acid	N/A	approved;nutraceutical	Bile acid receptor	Q96RI1	1546084	agonist	unknown
DB00132	Alpha-Linolenic Acid	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor delta	Q03181	190230	None	unknown
DB00132	Alpha-Linolenic Acid	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB00132	Alpha-Linolenic Acid	N/A	approved;nutraceutical	Retinoic acid receptor RXR-alpha	P19793	35885	None	unknown
DB00133	Serine	N/A	approved;nutraceutical	Cystathionine beta-synthase	P35520	388716	None	unknown
DB00133	Serine	N/A	approved;nutraceutical	L-serine dehydratase/L-threonine deaminase	P20132	338030	None	unknown
DB00133	Serine	N/A	approved;nutraceutical	Serine racemase	Q9GZT4	11034785	None	unknown
DB00133	Serine	N/A	approved;nutraceutical	Serine palmitoyltransferase 2	O15270	2564249	None	unknown
DB00133	Serine	N/A	approved;nutraceutical	Serine palmitoyltransferase 1	O15269	2564247	None	unknown
DB00133	Serine	N/A	approved;nutraceutical	Serine--tRNA ligase, cytoplasmic	P49591	1050527	None	unknown
DB00133	Serine	N/A	approved;nutraceutical	Serine--pyruvate aminotransferase	P21549	36582	None	unknown
DB00134	Methionine	Antidotes	approved;nutraceutical	Methionine synthase reductase	Q9UBK8	6572540	product of	unknown
DB00134	Methionine	Antidotes	approved;nutraceutical	Methionine synthase	Q99707	1923221	product of	unknown
DB00134	Methionine	Antidotes	approved;nutraceutical	Methionine aminopeptidase 2	P50579	903982	product of	unknown
DB00134	Methionine	Antidotes	approved;nutraceutical	Betaine--homocysteine S-methyltransferase 1	Q93088	1522683	product of	unknown
DB00134	Methionine	Antidotes	approved;nutraceutical	S-methylmethionine--homocysteine S-methyltransferase BHMT2	Q9H2M3	11907831	product of	unknown
DB00135	L-Tyrosine	N/A	approved;investigational;nutraceutical	Tyrosine 3-monooxygenase	P07101	37127	binder	unknown
DB00135	L-Tyrosine	N/A	approved;investigational;nutraceutical	Tyrosine--tRNA ligase, mitochondrial	Q9Y2Z4	4680649	None	unknown
DB00135	L-Tyrosine	N/A	approved;investigational;nutraceutical	Tyrosine--tRNA ligase, cytoplasmic	P54577	1184699	None	unknown
DB00135	L-Tyrosine	N/A	approved;investigational;nutraceutical	Tyrosine aminotransferase	P17735	36713	None	unknown
DB00136	Calcitriol	Vitamin D and analogues	approved;nutraceutical	Vitamin D3 receptor	P11473	340203	antagonist	yes
DB00136	Calcitriol	Vitamin D and analogues	approved;nutraceutical	Homeobox protein Hox-A10	P31260	None	None	unknown
DB00136	Calcitriol	Vitamin D and analogues	approved;nutraceutical	Vitamin D-binding protein	P02774	639896	None	unknown
DB00138	Cystine	N/A	approved;nutraceutical	Cystine/glutamate transporter	Q9UPY5	5668545	None	unknown
DB00138	Cystine	N/A	approved;nutraceutical	Cystinosin	O60931	3036851	None	unknown
DB00138	Cystine	N/A	approved;nutraceutical	B(0,+)-type amino acid transporter 1	P82251	5916108	None	unknown
DB00138	Cystine	N/A	approved;nutraceutical	Neutral and basic amino acid transport protein rBAT	Q07837	306442	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinate dehydrogenase cytochrome b560 subunit, mitochondrial	Q99643	1814226	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinate receptor 1	Q9BXA5	13517983	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial	Q9BYC2	13548673	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Trimethyllysine dioxygenase, mitochondrial	Q9NVH6	15553435	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial	Q9P2R7	7328935	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Mitochondrial dicarboxylate carrier	Q9UBX3	6224534	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	P31040	506338	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	17-beta-hydroxysteroid dehydrogenase type 6	O14756	2338748	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Solute carrier family 13 member 3	Q8WWT9	8132324	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Solute carrier family 13 member 2	Q13183	1098557	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Solute carrier family 13 member 1	Q9BZW2	12620132	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial	Q96I99	133777003	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	O14521	2351037	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Prolyl 4-hydroxylase subunit alpha-2	O15460	2439985	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3	O60568	3153235	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Gamma-butyrobetaine dioxygenase	O75936	3746805	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Prolyl 4-hydroxylase subunit alpha-1	P13674	190786	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial	P21912	665925	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinate-semialdehyde dehydrogenase, mitochondrial	P51649	3766467	inhibitor	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial	P53597	9409794	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial	P55809	1519052	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1	Q02809	190074	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Aspartyl/asparaginyl beta-hydroxylase	Q12797	458032	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Prolyl 3-hydroxylase 1	Q32P28	11127636	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Prolyl 3-hydroxylase 2	Q8IVL5	27526730	None	unknown
DB00139	Succinic acid	N/A	approved;nutraceutical	Prolyl 3-hydroxylase 3	Q8IVL6	1200503	None	unknown
DB00140	Riboflavin	Other plain vitamin preparations	approved;investigational;nutraceutical;vet_approved	Riboflavin kinase	Q969G6	7023634	ligand	yes
DB00140	Riboflavin	Other plain vitamin preparations	approved;investigational;nutraceutical;vet_approved	Riboflavin synthase	P0AFU8	None	other	yes
DB00140	Riboflavin	Other plain vitamin preparations	approved;investigational;nutraceutical;vet_approved	Flavin reductase (NADPH)	P30043	1384068	product of	yes
DB00141	N-Acetylglucosamine	N/A	approved;investigational;nutraceutical	Beta-1,4-galactosyltransferase 3	O60512	2982510	None	unknown
DB00141	N-Acetylglucosamine	N/A	approved;investigational;nutraceutical	Beta-1,4-galactosyltransferase 4	O60513	3132900	None	unknown
DB00141	N-Acetylglucosamine	N/A	approved;investigational;nutraceutical	Beta-1,4-galactosyltransferase 2	O60909	2995442	None	unknown
DB00141	N-Acetylglucosamine	N/A	approved;investigational;nutraceutical	N-acetyl-D-glucosamine kinase	Q9UJ70	6491737	None	unknown
DB00141	N-Acetylglucosamine	N/A	approved;investigational;nutraceutical	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	Q9UK23	6425040	None	unknown
DB00141	N-Acetylglucosamine	N/A	approved;investigational;nutraceutical	Alpha-N-acetylglucosaminidase	P54802	1171229	activator	unknown
DB00141	N-Acetylglucosamine	N/A	approved;investigational;nutraceutical	N-acylglucosamine 2-epimerase	P51606	220053	None	unknown
DB00141	N-Acetylglucosamine	N/A	approved;investigational;nutraceutical	Beta-1,4-galactosyltransferase 1	P15291	29424	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Metabotropic glutamate receptor 1	Q13255	945097	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Metabotropic glutamate receptor 4	Q14833	1160183	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, kainate 4	Q16099	544590	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, kainate 5	Q16478	251840	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Metabotropic glutamate receptor 7	Q14831	1370111	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Metabotropic glutamate receptor 8	O00222	1935043	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Excitatory amino acid transporter 5	O00341	2076762	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	5-oxoprolinase	O14841	46020040	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Phosphoribosylformylglycinamidine synthase	O15067	2224663	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Branched-chain-amino-acid aminotransferase, mitochondrial	O15382	2342862	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, NMDA 2D	O15399	2444026	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, delta-2	O43424	2853315	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, NMDA 3B	O60391	3025446	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial	O75879	3599964	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutaminase kidney isoform, mitochondrial	O94925	5690372	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Aspartate aminotransferase, mitochondrial	P00505	179104	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Bifunctional glutamate/proline--tRNA ligase	P07814	31958	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Asparagine synthetase [glutamine-hydrolyzing]	P08243	179100	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamine synthetase	P15104	31833	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Aspartate aminotransferase, cytoplasmic	P17174	179067	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Tyrosine aminotransferase	P17735	36713	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Alanine aminotransferase 1	P24298	1763096	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Vitamin K-dependent gamma-carboxylase	P38435	184028	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Excitatory amino acid transporter 1	P43003	None	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Excitatory amino acid transporter 2	P43004	487341	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Excitatory amino acid transporter 3	P43005	507898	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate--cysteine ligase catalytic subunit	P48506	183039	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Excitatory amino acid transporter 4	P48664	930337	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate dehydrogenase 2, mitochondrial	P49448	31815	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	GMP synthase [glutamine-hydrolyzing]	P49915	595410	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Branched-chain-amino-acid aminotransferase, cytosolic	P54687	1036780	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	4-aminobutyrate aminotransferase, mitochondrial	P80404	602705	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, NMDA 1	Q05586	219920	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Folylpolyglutamate synthase, mitochondrial	Q05932	292029	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamyl aminopeptidase	Q07075	291854	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, NMDA 2A	Q12879	558749	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, NMDA 2B	Q13224	1899202	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, NMDA 2C	Q14957	1196449	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Aspartate aminotransferase	Q2TU84	46981967	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Probable glutamate--tRNA ligase, mitochondrial	Q5JPH6	57997136	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Lengsin	Q5TDP6	7341339	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamine-dependent NAD(+) synthetase	Q6IA69	28849201	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Kynurenine--oxoglutarate transaminase 3	Q6YP21	37542047	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	N-acetylglutamate synthase, mitochondrial	Q8N159	22651769	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial	Q8N5Z0	6165634	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Alanine aminotransferase 2	Q8TD30	19046894	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Mitochondrial glutamate carrier 2	Q9H1K4	21322707	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Mitochondrial glutamate carrier 1	Q9H936	21322705	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Alpha-aminoadipic semialdehyde synthase, mitochondrial	Q9UDR5	7264724	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutaminase liver isoform, mitochondrial	Q9UI32	6650606	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Aspartyl aminopeptidase	Q9ULA0	5902181	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, delta-1	Q9ULK0	24657795	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Cystine/glutamate transporter	Q9UPY5	5668545	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Carboxypeptidase Q	Q9Y646	None	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Phosphoserine aminotransferase	Q9Y617	5326802	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate dehydrogenase 1, mitochondrial	P00367	31707	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, kainate 1	P39086	455448	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor 1	P42261	183281	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate--cysteine ligase regulatory subunit	P48507	530137	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate carboxypeptidase 2	Q04609	190664	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate decarboxylase 2	Q05329	182934	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate decarboxylase 1	Q99259	182936	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Formimidoyltransferase-cyclodeaminase	O95954	6537208	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor 2	P42262	493134	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor 3	P42263	507829	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor 4	P48058	790538	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Delta-1-pyrroline-5-carboxylate synthase	P54886	1304314	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, kainate 2	Q13002	790532	None	unknown
DB00142	Glutamic Acid	Acid preparations	approved;nutraceutical	Glutamate receptor ionotropic, kainate 3	Q13003	790534	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Microsomal glutathione S-transferase 3	O14880	2583081	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Hematopoietic prostaglandin D synthase	O60760	3046817	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Thioredoxin domain-containing protein 12	O95881	23477616	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase A1	P08263	306809	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase A2	P09210	306811	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Microsomal glutathione S-transferase 1	P10620	306808	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	S-formylglutathione hydrolase	P10768	182265	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Gamma-glutamyltranspeptidase 1	P19440	183138	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase Mu 2	P28161	183301	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutaredoxin-1	P35754	643695	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Phospholipid hydroperoxide glutathione peroxidase, mitochondrial	P36969	825667	cofactor	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase Mu 5	P46439	468260	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione peroxidase 6	P59796	32492913	cofactor	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Hydroxyacylglutathione hydrolase, mitochondrial	Q16775	1237213	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione peroxidase	Q6NSD4	47124246	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Probable glutathione peroxidase 8	Q8TED1	18676757	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione peroxidase 7	Q96SL4	25990366	cofactor	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Microsomal glutathione S-transferase 2	Q99735	1747521	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase omega-2	Q9H4Y5	37777744	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutaredoxin-2, mitochondrial	Q9NS18	9507250	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Lactoylglutathione lyase	Q04760	219664	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Leukotriene C4 synthase	Q16873	520485	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione reductase, mitochondrial	P00390	31825	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione synthetase	P48637	886284	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase Mu 1	P09488	31924	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase kappa 1	Q9Y2Q3	41351794	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase A3	Q16772	951352	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase Mu 3	P21266	306820	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase A4	O15217	2597924	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase Mu 4	Q03013	306819	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase A5	Q7RTV2	23197582	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase P	P09211	31946	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase omega-1	P78417	2393722	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione peroxidase 1	P07203	577777	cofactor	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione peroxidase 2	P18283	4902773	cofactor	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione S-transferase theta-1	P30711	510905	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Maleylacetoacetate isomerase	O43708	2832731	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Epididymal secretory glutathione peroxidase	O75715	3288455	cofactor	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Glutathione peroxidase 3	P22352	2160390	cofactor	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Aldose reductase	P15121	178487	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Matrix metalloproteinase-9	P14780	177205	None	unknown
DB00143	Glutathione	Antidotes	approved;investigational;nutraceutical	Cytochrome P450 3A4	P08684	None	None	unknown
DB00144	Phosphatidyl serine	N/A	approved;investigational;nutraceutical	Diacylglycerol kinase gamma	P49619	516758	None	unknown
DB00144	Phosphatidyl serine	N/A	approved;investigational;nutraceutical	Diacylglycerol kinase delta	Q16760	22773821	None	unknown
DB00144	Phosphatidyl serine	N/A	approved;investigational;nutraceutical	Phosphatidylserine synthase 2	Q9BVG9	21740008	None	unknown
DB00144	Phosphatidyl serine	N/A	approved;investigational;nutraceutical	Sphingomyelin phosphodiesterase 4	Q9NXE4	7243217	None	unknown
DB00144	Phosphatidyl serine	N/A	approved;investigational;nutraceutical	Sphingomyelin phosphodiesterase 3	Q9NY59	8247250	None	unknown
DB00144	Phosphatidyl serine	N/A	approved;investigational;nutraceutical	Probable phospholipid-transporting ATPase IA	Q9Y2Q0	4972583	None	unknown
DB00144	Phosphatidyl serine	N/A	approved;investigational;nutraceutical	Protein kinase C alpha type	P17252	35483	None	unknown
DB00144	Phosphatidyl serine	N/A	approved;investigational;nutraceutical	Phosphatidylserine synthase 1	P48651	603802	None	unknown
DB00144	Phosphatidyl serine	N/A	approved;investigational;nutraceutical	Phosphatidylserine decarboxylase proenzyme	Q9UG56	57997016	None	unknown
DB00144	Phosphatidyl serine	N/A	approved;investigational;nutraceutical	Scavenger receptor class B member 1	Q8WTV0	397607	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial	O75600	3342906	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	5-aminolevulinate synthase, nonspecific, mitochondrial	P13196	28583	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	5-aminolevulinate synthase, erythroid-specific, mitochondrial	P22557	28586	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine cleavage system H protein, mitochondrial	P23434	184348	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine--tRNA ligase	P41250	1311463	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glutamate receptor ionotropic, NMDA 2A	Q12879	558749	antagonist	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Bile acid-CoA:amino acid N-acyltransferase	Q14032	532505	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	N-arachidonyl glycine receptor	Q14330	1066731	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glutathione synthetase	P48637	886284	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glutamate receptor ionotropic, NMDA 2C	Q14957	1196449	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Serine hydroxymethyltransferase	Q53ET4	62898842	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine N-acyltransferase	Q6IB77	2554941	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Proton-coupled amino acid transporter 1	Q7Z2H8	31324239	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Serine hydroxymethyltransferase, mitochondrial	P34897	746436	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine N-acyltransferase-like protein 2	Q8WU03	29243559	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine N-acyltransferase-like protein 1	Q969I3	71384826	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Alanine--glyoxylate aminotransferase 2, mitochondrial	Q9BYV1	12406973	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Vesicular inhibitory amino acid transporter	Q9H598	17975777	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Peroxisomal sarcosine oxidase	Q9P0Z9	7157903	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Sodium- and chloride-dependent glycine transporter 2	Q9Y345	4003525	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glutamate receptor ionotropic, NMDA 3B	O60391	3025446	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine dehydrogenase [decarboxylating], mitochondrial	P23378	190287	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Sodium- and chloride-dependent glycine transporter 1	P48067	546769	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine receptor subunit alpha-1	P23415	31851	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Serine--pyruvate aminotransferase	P21549	36582	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine receptor subunit beta	P48167	992687	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Serine hydroxymethyltransferase, cytosolic	P34896	307422	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine receptor subunit alpha-3	O75311	3342792	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine receptor subunit alpha-2	P23416	31849	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine N-methyltransferase	Q14749	8671584	None	unknown
DB00145	Glycine	Other irrigating solutions	approved;nutraceutical;vet_approved	Glycine amidinotransferase, mitochondrial	P50440	545385	None	unknown
DB00146	Calcidiol	Vitamin D and analogues	approved;nutraceutical	Vitamin D3 receptor	P11473	340203	agonist	yes
DB00147	Pyridoxal	N/A	approved;nutraceutical	Pyridoxal kinase	O00764	1946349	None	yes
DB00148	Creatine	N/A	approved;investigational;nutraceutical	Creatine kinase M-type	P06732	180576	ligand	yes
DB00148	Creatine	N/A	approved;investigational;nutraceutical	Creatine kinase U-type, mitochondrial	P12532	180590	ligand	yes
DB00148	Creatine	N/A	approved;investigational;nutraceutical	Creatine kinase B-type	P12277	180572	ligand	yes
DB00148	Creatine	N/A	approved;investigational;nutraceutical	Creatine kinase S-type, mitochondrial	P17540	338237	ligand	yes
DB00148	Creatine	N/A	approved;investigational;nutraceutical	Sodium- and chloride-dependent creatine transporter 1	P48029	493132	None	yes
DB00148	Creatine	N/A	approved;investigational;nutraceutical	Guanidinoacetate N-methyltransferase	Q14353	1212946	product of	yes
DB00149	L-Leucine	N/A	approved;nutraceutical	Probable leucine--tRNA ligase, mitochondrial	Q15031	40788954	None	unknown
DB00149	L-Leucine	N/A	approved;nutraceutical	Branched-chain-amino-acid aminotransferase, mitochondrial	O15382	2342862	None	unknown
DB00149	L-Leucine	N/A	approved;nutraceutical	Branched-chain-amino-acid aminotransferase, cytosolic	P54687	1036780	None	unknown
DB00149	L-Leucine	N/A	approved;nutraceutical	Leucine carboxyl methyltransferase 2	O60294	40788285	None	unknown
DB00149	L-Leucine	N/A	approved;nutraceutical	Leucine carboxyl methyltransferase 1	Q9UIC8	6580758	None	unknown
DB00149	L-Leucine	N/A	approved;nutraceutical	Leucine--tRNA ligase, cytoplasmic	Q9P2J5	7804450	None	unknown
DB00150	L-Tryptophan	Other antidepressants	approved;nutraceutical;withdrawn	Tryptophan--tRNA ligase, mitochondrial	Q9UGM6	6572289	inhibitor	unknown
DB00150	L-Tryptophan	Other antidepressants	approved;nutraceutical;withdrawn	Tryptophan--tRNA ligase	P00953	143784	inhibitor	unknown
DB00150	L-Tryptophan	Other antidepressants	approved;nutraceutical;withdrawn	Tryptophan--tRNA ligase, cytoplasmic	P23381	184657	inhibitor	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Glutamate--cysteine ligase regulatory subunit	P48507	530137	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Glutamate--cysteine ligase catalytic subunit	P48506	183039	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Aspartate aminotransferase, cytoplasmic	P17174	179067	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Cystathionine gamma-lyase	P32929	262476	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Cystathionine beta-synthase	P35520	388716	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Cysteine--tRNA ligase, cytoplasmic	P49589	927229	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Methylated-DNA--protein-cysteine methyltransferase	P16455	34559	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Glutathione synthetase	P48637	886284	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Thiamine transporter 2	Q9BZV2	12483888	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Probable cysteine--tRNA ligase, mitochondrial	Q9HA77	10433519	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Cysteine sulfinic acid decarboxylase	Q9Y600	4894558	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Cysteine desulfurase, mitochondrial	Q9Y697	24042327	None	unknown
DB00151	L-Cysteine	N/A	approved;nutraceutical	Cysteine dioxygenase type 1	Q16878	467561	None	unknown
DB00152	Thiamine	Vitamin B1, plain	approved;investigational;nutraceutical;vet_approved	Thiamin pyrophosphokinase 1	Q9H3S4	12248915	ligand	yes
DB00152	Thiamine	Vitamin B1, plain	approved;investigational;nutraceutical;vet_approved	Thiamine transporter 1	O60779	6524689	binder	unknown
DB00153	Ergocalciferol	Vitamin D and analogues	approved;nutraceutical	Vitamin D3 receptor	P11473	340203	agonist	yes
DB00154	Dihomo-gamma-linolenic acid	N/A	approved;investigational;nutraceutical	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00154	Dihomo-gamma-linolenic acid	N/A	approved;investigational;nutraceutical	Prostaglandin G/H synthase 2	P35354	291988	None	yes
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Argininosuccinate synthase	P00966	28872	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	N(G),N(G)-dimethylarginine dimethylaminohydrolase 2	O95865	4454710	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Argininosuccinate synthetase, isoform CRA_a	Q5T6L4	55958410	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	O94760	4160666	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Ornithine carbamoyltransferase, mitochondrial	P00480	189407	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Nitric oxide synthase, brain	P29475	642526	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Nitric oxide synthase, inducible	P35228	292242	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Nitric oxide synthase, endothelial	P29474	189212	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Protein-arginine deiminase type-6	Q6TGC4	40068449	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Protein-arginine deiminase type-1	Q9ULC6	6116899	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Protein-arginine deiminase type-3	Q9ULW8	6172379	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Protein-arginine deiminase type-2	Q9Y2J8	5572747	None	unknown
DB00155	L-Citrulline	N/A	approved;investigational;nutraceutical	Protein-arginine deiminase type-4	Q9UM07	5913971	None	unknown
DB00156	L-Threonine	N/A	approved;nutraceutical	Threonine synthase-like 1	Q8IYQ7	23243453	None	unknown
DB00156	L-Threonine	N/A	approved;nutraceutical	Threonine--tRNA ligase, cytoplasmic	P26639	1464742	None	unknown
DB00156	L-Threonine	N/A	approved;nutraceutical	Threonine--tRNA ligase, mitochondrial	Q9BW92	62897187	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	UDP-glucose 6-dehydrogenase	O60701	3127127	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Alcohol dehydrogenase 1A	P07327	178092	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Sorbitol dehydrogenase	Q00796	520450	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Alcohol dehydrogenase 4	P08319	178121	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Alcohol dehydrogenase 1C	P00326	28404	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Alcohol dehydrogenase 1B	P00325	178098	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Alcohol dehydrogenase class 4 mu/sigma chain	P40394	516618	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic	P21695	508487	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	L-lactate dehydrogenase A-like 6A	Q6ZMR3	46405145	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Alcohol dehydrogenase class-3	P11766	178134	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldose reductase	P15121	178487	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	3-hydroxyacyl-CoA dehydrogenase type-2	Q99714	2558754	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Malate dehydrogenase, mitochondrial	P40926	2906146	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	L-lactate dehydrogenase A chain	P00338	34313	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NAD-dependent malic enzyme, mitochondrial	P23368	187300	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Peroxisomal multifunctional enzyme type 2	P51659	1050517	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	L-lactate dehydrogenase A-like 6B	Q9BYZ2	12331000	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	L-lactate dehydrogenase C chain	P07864	307120	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	L-lactate dehydrogenase B chain	P07195	1200083	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Peroxisomal bifunctional enzyme	Q08426	452045	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	Q16836	1483511	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADP-dependent malic enzyme, mitochondrial	Q16798	535012	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	D-beta-hydroxybutyrate dehydrogenase, mitochondrial	Q02338	177198	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Malate dehydrogenase, cytoplasmic	P40925	1255604	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	3-hydroxyisobutyrate dehydrogenase, mitochondrial	P31937	None	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Testosterone 17-beta-dehydrogenase 3	P37058	531162	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	3-hydroxy-3-methylglutaryl-coenzyme A reductase	P04035	306865	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADP-dependent malic enzyme	P48163	495123	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	D-3-phosphoglycerate dehydrogenase	O43175	2674062	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	3-keto-steroid reductase	P56937	6721095	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	P51553	1167849	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial	O43837	2737886	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	P50213	706839	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Estradiol 17-beta-dehydrogenase 1	P14061	23365	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Estradiol 17-beta-dehydrogenase 2	P37059	306462	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	11-cis retinol dehydrogenase	Q92781	1616654	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	GDH/6PGL endoplasmic bifunctional protein	O95479	4186038	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Estradiol 17-beta-dehydrogenase 8	Q92506	30583317	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldo-keto reductase family 1 member C4	P17516	4261710	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Inosine-5'-monophosphate dehydrogenase 2	P12268	307066	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldo-keto reductase family 1 member C3	P42330	4261711	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	15-hydroxyprostaglandin dehydrogenase [NAD(+)]	P15428	1203984	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	GDP-L-fucose synthase	Q13630	1381179	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldo-keto reductase family 1 member C1	Q04828	181549	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Corticosteroid 11-beta-dehydrogenase isozyme 1	P28845	179475	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	P26439	184401	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	P14060	306889	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Inosine-5'-monophosphate dehydrogenase 1	P20839	307067	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Trifunctional enzyme subunit alpha, mitochondrial	P40939	862457	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldehyde dehydrogenase, mitochondrial	P05091	28606	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Corticosteroid 11-beta-dehydrogenase isozyme 2	P80365	565082	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldo-keto reductase family 1 member C2	P52895	531160	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating	Q15738	4457237	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldehyde dehydrogenase family 3 member B2	P48448	1051281	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial	Q02252	7160985	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldehyde dehydrogenase, dimeric NADP-preferring	P30838	178402	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Retinal dehydrogenase 1	P00352	178372	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	O14556	3046742	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	4-trimethylaminobutyraldehyde dehydrogenase	P49189	1049219	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldehyde dehydrogenase family 1 member A3	P47895	544482	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldehyde dehydrogenase X, mitochondrial	P30837	1263008	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aldehyde dehydrogenase family 3 member B1	P43353	601780	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Glyceraldehyde-3-phosphate dehydrogenase	P04406	31645	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Retinal dehydrogenase 2	O94788	3970842	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Fatty aldehyde dehydrogenase	P51648	1082036	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Succinate-semialdehyde dehydrogenase, mitochondrial	P51649	3766467	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Alpha-aminoadipic semialdehyde dehydrogenase	P49419	797410	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Flavin reductase (NADPH)	P30043	1384068	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Pyrroline-5-carboxylate reductase 2	Q96C36	33150582	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Pyrroline-5-carboxylate reductase 1, mitochondrial	P32322	189498	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Glutamate dehydrogenase 1, mitochondrial	P00367	31707	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Pyruvate dehydrogenase E1 component subunit beta, mitochondrial	P11177	189760	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial	P29803	190790	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial	P08559	387009	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Biliverdin reductase A	P53004	1246749	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	P16219	337928	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Dihydrofolate reductase	P00374	182724	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	2-oxoglutarate dehydrogenase, mitochondrial	Q02218	531241	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Glutamate dehydrogenase 2, mitochondrial	P49448	31815	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	7-dehydrocholesterol reductase	Q9UBM7	4191398	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Ribosyldihydronicotinamide dehydrogenase [quinone]	P16083	190818	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH-ubiquinone oxidoreductase chain 2	P03891	2052363	binder	unknown
DB00157	NADH	N/A	approved;nutraceutical	Alpha-aminoadipic semialdehyde synthase, mitochondrial	Q9UDR5	7264724	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH-ubiquinone oxidoreductase chain 3	P03897	506832	binder	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial	O75251	3342734	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	C-1-tetrahydrofolate synthase, cytoplasmic	P11586	307178	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial	P13995	35071	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial	P30038	1353250	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH-cytochrome b5 reductase 3	P00387	553600	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11	Q86Y39	28170654	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH-ubiquinone oxidoreductase chain 4	P03905	None	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Dihydropteridine reductase	P09417	30819	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH-ubiquinone oxidoreductase chain 1	P03886	13004	binder	unknown
DB00157	NADH	N/A	approved;nutraceutical	NAD(P) transhydrogenase, mitochondrial	Q13423	1110520	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5	Q16718	1373173	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	Q16795	5326823	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH-ubiquinone oxidoreductase chain 4L	P03901	337197	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	O95299	4191348	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7	O95182	4164452	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1	O15239	2274974	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH-ubiquinone oxidoreductase chain 6	P03923	2052367	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH-ubiquinone oxidoreductase chain 5	P03915	2052366	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4	O00483	1946692	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6	P56556	2909856	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Acyl carrier protein, mitochondrial	O14561	4567042	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2	O43678	2909862	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8	P51970	5326825	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3	O95167	4164444	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial	O95169	4164448	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 subunit C2	O95298	4191346	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1	O75438	5326820	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	P28331	38079	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10	O96000	4164442	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4	O95168	4164446	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3	O43676	2909858	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial	O95178	4164454	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7	P17568	180233	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9	Q9Y6M9	5326828	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	O75306	3540239	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial	O43674	2909854	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial	O43677	2909860	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6	O95139	3800740	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial	P56181	6002197	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Dihydrolipoyl dehydrogenase, mitochondrial	P09622	307137	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	O75489	3337441	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Glutathione reductase, mitochondrial	P00390	31825	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12	Q9UI09	9651637	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] iron-sulfur protein 5	O43920	2911482	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial	O43181	2655053	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	P49821	3184148	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial	P19404	188852	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Q9P0J0	11055599	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Cysteine dioxygenase type 1	Q16878	467561	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial	O75380	3348137	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2	Q9NRX3	8895095	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial	O00217	1935056	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Cytochrome P450 4A11	Q02928	181397	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial	P10515	35360	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Aminomethyltransferase, mitochondrial	P48728	391721	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Methylsterol monooxygenase 1	Q15800	1408206	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Heme oxygenase 1	P09601	35173	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Heme oxygenase 2	P30519	443771	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Steroid 17-alpha-hydroxylase/17,20 lyase	P05093	181342	None	unknown
DB00157	NADH	N/A	approved;nutraceutical	Tyrosinase	P14679	340037	None	unknown
DB00158	Folic Acid	Iron in other combinations	approved;nutraceutical;vet_approved	Folate receptor beta	P14207	1655592	binder	unknown
DB00158	Folic Acid	Iron in other combinations	approved;nutraceutical;vet_approved	Folate receptor gamma	P41439	473236	binder	unknown
DB00158	Folic Acid	Iron in other combinations	approved;nutraceutical;vet_approved	Folate receptor alpha	P15328	None	None	unknown
DB00159	Icosapent	N/A	approved;nutraceutical	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00159	Icosapent	N/A	approved;nutraceutical	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00159	Icosapent	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	yes
DB00159	Icosapent	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor delta	Q03181	190230	agonist	yes
DB00159	Icosapent	N/A	approved;nutraceutical	Fatty acid desaturase 1	O60427	3169158	agonist	unknown
DB00159	Icosapent	N/A	approved;nutraceutical	Long-chain-fatty-acid--CoA ligase 4	O60488	3158351	inducer	unknown
DB00159	Icosapent	N/A	approved;nutraceutical	Long-chain-fatty-acid--CoA ligase 3	O95573	4165018	inducer	unknown
DB00159	Icosapent	N/A	approved;nutraceutical	Free fatty acid receptor 1	O14842	2612946	agonist	yes
DB00159	Icosapent	N/A	approved;nutraceutical	Sodium/calcium exchanger 1	P32418	180673	inhibitor	yes
DB00159	Icosapent	N/A	approved;nutraceutical	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	inducer	unknown
DB00159	Icosapent	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Serine--pyruvate aminotransferase	P21549	36582	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	4-aminobutyrate aminotransferase, mitochondrial	P80404	602705	inhibitor	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Kynureninase	Q16719	1323715	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Alanine--tRNA ligase, mitochondrial	Q5JTZ9	6331226	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	5-phosphohydroxy-L-lysine phospho-lyase	Q8IUZ5	18027842	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Alanine aminotransferase 2	Q8TD30	19046894	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Alanine aminotransferase 1	P24298	1763096	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Cysteine desulfurase, mitochondrial	Q9Y697	24042327	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Proton-coupled amino acid transporter 1	Q7Z2H8	31324239	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Large neutral amino acids transporter small subunit 2	Q9UHI5	6642960	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Alanine--glyoxylate aminotransferase 2, mitochondrial	Q9BYV1	12406973	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Alanine--tRNA ligase, cytoplasmic	P49588	1015321	None	unknown
DB00160	L-Alanine	N/A	approved;nutraceutical	Neutral amino acid transporter A	P43007	348012	None	unknown
DB00161	L-Valine	N/A	approved;nutraceutical	Propionyl-CoA carboxylase beta chain, mitochondrial	P05166	312812	None	unknown
DB00161	L-Valine	N/A	approved;nutraceutical	Branched-chain-amino-acid aminotransferase, cytosolic	P54687	1036780	None	unknown
DB00161	L-Valine	N/A	approved;nutraceutical	Valine--tRNA ligase	P26640	31545	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Retinol dehydrogenase 12	Q96NR8	16549449	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Short-chain dehydrogenase/reductase 3	O75911	3450828	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Aldehyde dehydrogenase family 1 member A3	P47895	544482	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	All-trans-retinol 13,14-reductase	Q6NUM9	37182258	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Retinol dehydrogenase 11	Q8TC12	9622124	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Dehydrogenase/reductase SDR family member 4	Q9BTZ2	4105190	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Retinol dehydrogenase 14	Q9HBH5	10039619	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Retinol dehydrogenase 8	Q9NYR8	7527474	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Lecithin retinol acyltransferase	O95237	4240391	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Retinol-binding protein 1	P09455	190948	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	11-cis retinol dehydrogenase	Q92781	1616654	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Retinol dehydrogenase 13	Q8NBN7	22761451	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Retinol-binding protein 3	P10745	186541	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Retinal dehydrogenase 2	O94788	3970842	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Retinal dehydrogenase 1	P00352	178372	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Retinaldehyde-binding protein 1	P12271	190854	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Apolipoprotein D	P05090	None	None	unknown
DB00162	Vitamin A	Other nasal preparations	approved;nutraceutical;vet_approved	Hematopoietic prostaglandin D synthase	O60760	3046817	None	unknown
DB00163	Vitamin E	N/A	approved;nutraceutical;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00163	Vitamin E	N/A	approved;nutraceutical;vet_approved	Protein kinase C beta type	P05771	189969	None	unknown
DB00163	Vitamin E	N/A	approved;nutraceutical;vet_approved	Arachidonate 5-lipoxygenase	P09917	187193	None	unknown
DB00163	Vitamin E	N/A	approved;nutraceutical;vet_approved	Protein kinase C alpha type	P17252	35483	None	unknown
DB00163	Vitamin E	N/A	approved;nutraceutical;vet_approved	Diacylglycerol kinase alpha	P23743	30823	None	unknown
DB00163	Vitamin E	N/A	approved;nutraceutical;vet_approved	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	P62714	35581	None	unknown
DB00163	Vitamin E	N/A	approved;nutraceutical;vet_approved	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	P67775	36120	None	unknown
DB00163	Vitamin E	N/A	approved;nutraceutical;vet_approved	SEC14-like protein 4	Q9UDX3	27803380	None	unknown
DB00163	Vitamin E	N/A	approved;nutraceutical;vet_approved	SEC14-like protein 3	Q9UDX4	27803382	None	unknown
DB00163	Vitamin E	N/A	approved;nutraceutical;vet_approved	SEC14-like protein 2	O76054	5596693	None	unknown
DB00165	Pyridoxine	Other plain vitamin preparations	approved;investigational;nutraceutical;vet_approved	Pyridoxal kinase	O00764	1946349	ligand	yes
DB00166	Lipoic Acid	Various alimentary tract and metabolism products	approved;investigational;nutraceutical	Lipoyltransferase 1, mitochondrial	Q9Y234	4586380	None	unknown
DB00166	Lipoic Acid	Various alimentary tract and metabolism products	approved;investigational;nutraceutical	Lipoyl synthase, mitochondrial	O43766	23958222	None	unknown
DB00166	Lipoic Acid	Various alimentary tract and metabolism products	approved;investigational;nutraceutical	Sodium-dependent multivitamin transporter	Q9Y289	5006439	None	unknown
DB00167	L-Isoleucine	N/A	approved;investigational;nutraceutical	Isoleucine--tRNA ligase, mitochondrial	Q9NSE4	None	None	unknown
DB00167	L-Isoleucine	N/A	approved;investigational;nutraceutical	Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial	P45954	531391	None	unknown
DB00167	L-Isoleucine	N/A	approved;investigational;nutraceutical	Branched-chain-amino-acid aminotransferase, cytosolic	P54687	1036780	None	unknown
DB00167	L-Isoleucine	N/A	approved;investigational;nutraceutical	Branched-chain-amino-acid aminotransferase, mitochondrial	O15382	2342862	None	unknown
DB00167	L-Isoleucine	N/A	approved;investigational;nutraceutical	Isoleucine--tRNA ligase, cytoplasmic	P41252	551622	None	unknown
DB00168	Aspartame	N/A	approved;nutraceutical	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	inducer	unknown
DB00168	Aspartame	N/A	approved;nutraceutical	Taste receptor type 1 member 2	Q8TE23	20142333	agonist	unknown
DB00168	Aspartame	N/A	approved;nutraceutical	Taste receptor type 1 member 3	Q7RTX0	21928569	None	unknown
DB00169	Cholecalciferol	Bisphosphonates, combinations	approved;nutraceutical	Vitamin D3 receptor	P11473	340203	agonist	yes
DB00170	Menadione	Vitamin K	approved;nutraceutical	Vitamin K-dependent gamma-carboxylase	P38435	184028	cofactor	yes
DB00170	Menadione	Vitamin K	approved;nutraceutical	Vitamin K epoxide reductase complex subunit 1	Q9BQB6	40217983	cofactor	yes
DB00170	Menadione	Vitamin K	approved;nutraceutical	Vitamin K epoxide reductase complex subunit 1-like protein 1	Q8N0U8	40217985	cofactor	yes
DB00170	Menadione	Vitamin K	approved;nutraceutical	Prothrombin	P00734	339641	activator	unknown
DB00170	Menadione	Vitamin K	approved;nutraceutical	Coagulation factor VII	P08709	182801	activator	unknown
DB00170	Menadione	Vitamin K	approved;nutraceutical	Coagulation factor IX	P00740	182609	activator	unknown
DB00170	Menadione	Vitamin K	approved;nutraceutical	Coagulation factor X	P00742	182841	activator	unknown
DB00170	Menadione	Vitamin K	approved;nutraceutical	Vitamin K-dependent protein C	P04070	190334	activator	unknown
DB00170	Menadione	Vitamin K	approved;nutraceutical	Vitamin K-dependent protein S	P07225	190289	activator	unknown
DB00170	Menadione	Vitamin K	approved;nutraceutical	Vitamin K-dependent protein Z	P22891	190464	activator	unknown
DB00170	Menadione	Vitamin K	approved;nutraceutical	Ribosyldihydronicotinamide dehydrogenase [quinone]	P16083	190818	None	unknown
DB00170	Menadione	Vitamin K	approved;nutraceutical	NAD(P)H dehydrogenase [quinone] 1	P15559	189246	None	unknown
DB00170	Menadione	Vitamin K	approved;nutraceutical	Osteocalcin	P02818	36093	agonist	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Prolyl 4-hydroxylase subunit alpha-2	O15460	2439985	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Proline dehydrogenase 1, mitochondrial	O43272	2677802	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Peptidyl-prolyl cis-trans isomerase H	O43447	2708309	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Proline synthase co-transcribed bacterial homolog protein	O94903	4126978	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Prolyl 4-hydroxylase subunit alpha-1	P13674	190786	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Peptidyl-prolyl cis-trans isomerase B	P23284	181335	binder	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Peptidyl-prolyl cis-trans isomerase F, mitochondrial	P30405	181274	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Peptidyl-prolyl cis-trans isomerase C	P45877	547304	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Peptidyl-prolyl cis-trans isomerase A	P62937	30309	binder	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Peptidyl-prolyl cis-trans isomerase G	Q13427	1117968	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Prolyl 3-hydroxylase 1	Q32P28	11127636	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Pyrroline-5-carboxylate reductase	Q4W8W1	4960118	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Probable proline--tRNA ligase, mitochondrial	Q7L3T8	39644604	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Prolyl 3-hydroxylase 2	Q8IVL5	27526730	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Prolyl 3-hydroxylase 3	Q8IVL6	1200503	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Pyrroline-5-carboxylate reductase 3	Q53H96	None	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Trans-L-3-hydroxyproline dehydratase	Q96EM0	15082426	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Pyrroline-5-carboxylate reductase 1, mitochondrial	P32322	189498	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Bifunctional glutamate/proline--tRNA ligase	P07814	31958	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+)	Q9UN76	5732680	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Sodium-dependent proline transporter	Q99884	8176779	None	unknown
DB00172	L-Proline	N/A	approved;nutraceutical	Pyrroline-5-carboxylate reductase 2	Q96C36	33150582	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	Adenine phosphoribosyltransferase	P07741	28819	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase	P0AF12	2981267	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	Acetyl-CoA carboxylase 2	O00763	2138330	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	Low molecular weight phosphotyrosine protein phosphatase	P24666	179636	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	Peroxisomal trans-2-enoyl-CoA reductase	Q9BY49	None	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	A/G-specific adenine glycosylase	P17802	None	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	Nucleoside deoxyribosyltransferase-I	Q8RLY5	None	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	SRSF protein kinase 2	P78362	1857944	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	Holliday junction ATP-dependent DNA helicase RuvB	Q5SL87	None	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	DNA	None	None	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	S-methyl-5'-thioadenosine phosphorylase	Q13126	847724	None	unknown
DB00173	Adenine	N/A	approved;nutraceutical	Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase	Q05603	535767	None	unknown
DB00174	L-Asparagine	N/A	approved;investigational;nutraceutical	Neutral amino acid transporter B(0)	Q15758	1478281	None	unknown
DB00174	L-Asparagine	N/A	approved;investigational;nutraceutical	Isoaspartyl peptidase/L-asparaginase	Q7L266	127798426	None	unknown
DB00174	L-Asparagine	N/A	approved;investigational;nutraceutical	Probable asparagine--tRNA ligase, mitochondrial	Q96I59	39644781	None	unknown
DB00174	L-Asparagine	N/A	approved;investigational;nutraceutical	Sodium-coupled neutral amino acid transporter 3	Q99624	10242111	None	unknown
DB00174	L-Asparagine	N/A	approved;investigational;nutraceutical	Asparagine synthetase [glutamine-hydrolyzing]	P08243	179100	None	unknown
DB00174	L-Asparagine	N/A	approved;investigational;nutraceutical	Asparagine--tRNA ligase, cytoplasmic	O43776	2764505	None	unknown
DB00175	Pravastatin	HMG CoA reductase inhibitors	approved	3-hydroxy-3-methylglutaryl-coenzyme A reductase	P04035	306865	inhibitor	yes
DB00176	Fluvoxamine	Selective serotonin reuptake inhibitors	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00176	Fluvoxamine	Selective serotonin reuptake inhibitors	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	None	unknown
DB00177	Valsartan	Angiotensin II antagonists, other combinations	approved;investigational	Type-1 angiotensin II receptor	P30556	179122	antagonist	yes
DB00178	Ramipril	HMG CoA reductase inhibitors, other combinations	approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB00178	Ramipril	HMG CoA reductase inhibitors, other combinations	approved	B1 bradykinin receptor	P46663	None	None	unknown
DB00179	Masoprocol	Other antineoplastic agents	approved;investigational	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	yes
DB00179	Masoprocol	Other antineoplastic agents	approved;investigational	Sex hormone-binding globulin	P04278	296673	None	unknown
DB00180	Flunisolide	Corticosteroids	approved;investigational	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00181	Baclofen	Other centrally acting agents	approved	Gamma-aminobutyric acid type B receptor subunit 1	Q9UBS5	3892594	agonist	yes
DB00181	Baclofen	Other centrally acting agents	approved	Gamma-aminobutyric acid type B receptor subunit 2	O75899	3776098	agonist	yes
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	Synaptic vesicular amine transporter	Q05940	292335	inhibitor	yes
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	Sodium-dependent dopamine transporter	Q01959	553260	negative modulator	yes
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	Cocaine- and amphetamine-regulated transcript protein	Q16568	609306	agonist	yes
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	Trace amine-associated receptor 1	Q96RJ0	14600074	agonist	yes
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	stimulator	unknown
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	Alpha adrenergic receptor	P18825	178194	agonist	unknown
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	Beta adrenergic receptor	P13945	178896	agonist	unknown
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	D(2) dopamine receptor	P14416	181432	binder	unknown
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	Amine oxidase [flavin-containing] B	P27338	398415	inhibitor	unknown
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	Sodium-dependent serotonin transporter	P31645	36433	binder	unknown
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	Monoamine oxidase	P27338	398415	inhibitor	yes
DB00182	Amphetamine	Centrally acting sympathomimetics	approved;illicit;investigational	vesicular monoamine transporter 2 (VMAT2)	Q99870	None	None	yes
DB00183	Pentagastrin	Tests for gastric secretion	approved	Gastrin/cholecystokinin type B receptor	P32239	306489	agonist	yes
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	agonist	yes
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	agonist	yes
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	agonist	yes
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	agonist	unknown
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	agonist	unknown
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit alpha-5	P30532	177926	agonist	unknown
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit alpha-6	Q15825	1458118	agonist	unknown
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit alpha-9	Q9UGM1	6688136	agonist	unknown
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit alpha-10	Q9GZZ6	12053839	agonist	unknown
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit beta-3	Q05901	1458124	agonist	unknown
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Neuronal acetylcholine receptor subunit beta-4	P30926	1458126	agonist	unknown
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Cytochrome P450 19A1	P11511	179002	inhibitor	unknown
DB00184	Nicotine	Drugs used in nicotine dependence	approved	Choline O-acetyltransferase	P28329	301096	inhibitor	unknown
DB00185	Cevimeline	Other parasympathomimetics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	agonist	yes
DB00185	Cevimeline	Other parasympathomimetics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	agonist	yes
DB00186	Lorazepam	Benzodiazepine derivatives	approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00186	Lorazepam	Benzodiazepine derivatives	approved	Translocator protein	P30536	306883	other	unknown
DB00187	Esmolol	Beta blocking agents, selective	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB00188	Bortezomib	Other antineoplastic agents	approved;investigational	Proteasome subunit beta type-5	P28074	558526	inhibitor	yes
DB00188	Bortezomib	Other antineoplastic agents	approved;investigational	Proteasome subunit beta type-1	P20618	220026	inhibitor	yes
DB00189	Ethchlorvynol	Other hypnotics and sedatives	approved;illicit;withdrawn	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00190	Carbidopa	N/A	approved	Aromatic-L-amino-acid decarboxylase	P20711	181521	inhibitor	yes
DB00191	Phentermine	Centrally acting antiobesity products	approved;illicit	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00191	Phentermine	Centrally acting antiobesity products	approved;illicit	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00191	Phentermine	Centrally acting antiobesity products	approved;illicit	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB00191	Phentermine	Centrally acting antiobesity products	approved;illicit	Amine oxidase [flavin-containing] A	P21397	187353	antagonist	yes
DB00191	Phentermine	Centrally acting antiobesity products	approved;illicit	Amine oxidase [flavin-containing] B	P27338	398415	antagonist	yes
DB00192	Indecainide	N/A	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00193	Tramadol	Other opioids	approved;investigational	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00193	Tramadol	Other opioids	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00193	Tramadol	Other opioids	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00193	Tramadol	Other opioids	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00193	Tramadol	Other opioids	approved;investigational	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB00193	Tramadol	Other opioids	approved;investigational	Delta-type opioid receptor	P41143	27545517	agonist	no
DB00193	Tramadol	Other opioids	approved;investigational	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	unknown
DB00193	Tramadol	Other opioids	approved;investigational	Alpha-7 nicotinic cholinergic receptor subunit	Q693P7	None	antagonist	unknown
DB00193	Tramadol	Other opioids	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00193	Tramadol	Other opioids	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00194	Vidarabine	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved;investigational	DNA polymerase catalytic subunit	P03198	1334913	inhibitor	yes
DB00194	Vidarabine	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved;investigational	DNA	None	None	incorporation into and destabilization	yes
DB00194	Vidarabine	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved;investigational	Thymidine kinase	P09250	None	inducer	yes
DB00194	Vidarabine	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved;investigational	Thymidine kinase	Q9QNF7	8100965	inducer	yes
DB00195	Betaxolol	Beta blocking agents, selective	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB00195	Betaxolol	Beta blocking agents, selective	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB00196	Fluconazole	Triazole derivatives	approved;investigational	Lanosterol 14-alpha demethylase	P10613	578119	inhibitor	yes
DB00198	Oseltamivir	Neuraminidase inhibitors	approved	Neuraminidase	P11485	60811	inhibitor	yes
DB00198	Oseltamivir	Neuraminidase inhibitors	approved	Liver carboxylesterase 1	P23141	None	other	yes
DB00198	Oseltamivir	Neuraminidase inhibitors	approved	Sialidase-1	Q99519	2773339	inhibitor	unknown
DB00198	Oseltamivir	Neuraminidase inhibitors	approved	Sialidase-2	Q9Y3R4	None	inhibitor	unknown
DB00199	Erythromycin	Antiinfectives for treatment of acne	approved;investigational;vet_approved	23S rRNA	None	None	inhibitor	yes
DB00199	Erythromycin	Antiinfectives for treatment of acne	approved;investigational;vet_approved	Motilin receptor	O43193	None	agonist	no
DB00199	Erythromycin	Antiinfectives for treatment of acne	approved;investigational;vet_approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	no
DB00199	Erythromycin	Antiinfectives for treatment of acne	approved;investigational;vet_approved	Serum albumin	P02768	28590	binder	no
DB00200	Hydroxocobalamin	Antidotes	approved	Methionine synthase	Q99707	1923221	cofactor	yes
DB00200	Hydroxocobalamin	Antidotes	approved	Methylmalonyl-CoA mutase, mitochondrial	P22033	187452	cofactor	yes
DB00200	Hydroxocobalamin	Antidotes	approved	Methionine synthase reductase	Q9UBK8	6572540	other	unknown
DB00200	Hydroxocobalamin	Antidotes	approved	Methylmalonic aciduria type A protein, mitochondrial	Q8IVH4	26006421	other/unknown	unknown
DB00200	Hydroxocobalamin	Antidotes	approved	Transcobalamin-1	P20061	307479	other	unknown
DB00200	Hydroxocobalamin	Antidotes	approved	Protein amnionless	Q9BXJ7	13507259	other	unknown
DB00200	Hydroxocobalamin	Antidotes	approved	Cubilin	O60494	3929529	other	unknown
DB00200	Hydroxocobalamin	Antidotes	approved	Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial	Q96EY8	26284726	other	unknown
DB00200	Hydroxocobalamin	Antidotes	approved	Methylmalonic aciduria and homocystinuria type C protein	Q9Y4U1	52545527	other/unknown	unknown
DB00201	Caffeine	Tests for gastric secretion	approved	Adenosine receptor A1	P30542	256155	antagonist	yes
DB00201	Caffeine	Tests for gastric secretion	approved	Adenosine receptor A2a	P29274	177892	antagonist	yes
DB00201	Caffeine	Tests for gastric secretion	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	unknown
DB00201	Caffeine	Tests for gastric secretion	approved	Ryanodine receptor 1	P21817	337722	None	unknown
DB00201	Caffeine	Tests for gastric secretion	approved	Cyclic nucleotide phosphodiesterase	P35913	32261241	inhibitor	unknown
DB00201	Caffeine	Tests for gastric secretion	approved	DNA-dependent protein kinase catalytic subunit	P78527	None	inhibitor	unknown
DB00201	Caffeine	Tests for gastric secretion	approved	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	O00329	None	inhibitor	unknown
DB00201	Caffeine	Tests for gastric secretion	approved	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	P42336	None	inhibitor	unknown
DB00201	Caffeine	Tests for gastric secretion	approved	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform	P42338	None	inhibitor	unknown
DB00201	Caffeine	Tests for gastric secretion	approved	Inositol 1,4,5-trisphosphate receptor	Q14573	None	inhibitor	unknown
DB00201	Caffeine	Tests for gastric secretion	approved	Serine-protein kinase ATM	Q13315	None	inhibitor	unknown
DB00202	Succinylcholine	Choline derivatives	approved	Neuronal acetylcholine receptor subunit alpha-10	Q9GZZ6	12053839	agonist	yes
DB00202	Succinylcholine	Choline derivatives	approved	Alpha-7 nicotinic cholinergic receptor subunit	Q693P7	None	agonist	yes
DB00202	Succinylcholine	Choline derivatives	approved	Muscarinic acetylcholine receptor M1	P11229	34451	agonist	yes
DB00202	Succinylcholine	Choline derivatives	approved	Muscarinic acetylcholine receptor M2	P08172	177990	agonist	unknown
DB00202	Succinylcholine	Choline derivatives	approved	Muscarinic acetylcholine receptor M3	P20309	32324	agonist	unknown
DB00203	Sildenafil	Drugs used in erectile dysfunction	approved;investigational	cGMP-specific 3',5'-cyclic phosphodiesterase	O76074	3420185	inhibitor	yes
DB00203	Sildenafil	Drugs used in erectile dysfunction	approved;investigational	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	P18545	189703	inhibitor	no
DB00203	Sildenafil	Drugs used in erectile dysfunction	approved;investigational	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	Q13956	1311544	inhibitor	no
DB00204	Dofetilide	Antiarrhythmics, class III	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	yes
DB00204	Dofetilide	Antiarrhythmics, class III	approved;investigational	Potassium channel subfamily K member 2	O95069	5712621	inhibitor	yes
DB00204	Dofetilide	Antiarrhythmics, class III	approved;investigational	ATP-sensitive inward rectifier potassium channel 12	Q14500	567019	inhibitor	yes
DB00205	Pyrimethamine	Artemisinin and derivatives, combinations	approved;investigational;vet_approved	Dihydrofolate reductase	P00374	182724	inhibitor	yes
DB00205	Pyrimethamine	Artemisinin and derivatives, combinations	approved;investigational;vet_approved	Bifunctional dihydrofolate reductase-thymidylate synthase	P13922	160260	inhibitor	yes
DB00205	Pyrimethamine	Artemisinin and derivatives, combinations	approved;investigational;vet_approved	Beta-hexosaminidase subunit beta	P07686	179462	None	unknown
DB00206	Reserpine	Rauwolfia alkaloids and diuretics in combination	approved;investigational	Synaptic vesicular amine transporter	Q05940	292335	inhibitor	yes
DB00206	Reserpine	Rauwolfia alkaloids and diuretics in combination	approved;investigational	Chromaffin granule amine transporter	P54219	None	inhibitor	unknown
DB00206	Reserpine	Rauwolfia alkaloids and diuretics in combination	approved;investigational	Baculoviral IAP repeat-containing protein 5	O15392	None	None	unknown
DB00207	Azithromycin	Macrolides	approved	23S rRNA	None	None	inhibitor	yes
DB00207	Azithromycin	Macrolides	approved	50S ribosomal protein L4	P60725	None	inhibitor	yes
DB00207	Azithromycin	Macrolides	approved	50S ribosomal protein L22	P61177	None	inhibitor	yes
DB00207	Azithromycin	Macrolides	approved	Protein-arginine deiminase type-4	Q9UM07	5913971	None	unknown
DB00208	Ticlopidine	Platelet aggregation inhibitors excl. heparin	approved	P2Y purinoceptor 12	Q9H244	12083902	antagonist	yes
DB00209	Trospium	Synthetic anticholinergic agents in combination with analgesics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00210	Adapalene	Retinoids for topical use in acne	approved	Retinoic acid receptor gamma	P13631	306887	agonist	yes
DB00210	Adapalene	Retinoids for topical use in acne	approved	Retinoic acid receptor beta	P10826	35883	agonist	yes
DB00210	Adapalene	Retinoids for topical use in acne	approved	Retinoic acid receptor RXR-gamma	P48443	1053069	agonist	yes
DB00210	Adapalene	Retinoids for topical use in acne	approved	Retinoic acid receptor RXR-beta	P28702	30448	agonist	yes
DB00210	Adapalene	Retinoids for topical use in acne	approved	Retinoic acid receptor alpha	P10276	36157	agonist	unknown
DB00210	Adapalene	Retinoids for topical use in acne	approved	Retinoic acid receptor RXR-alpha	P19793	35885	other/unknown	no
DB00210	Adapalene	Retinoids for topical use in acne	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00211	Midodrine	Adrenergic and dopaminergic agents	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB00211	Midodrine	Adrenergic and dopaminergic agents	approved	Alpha-1B adrenergic receptor	P35368	None	agonist	yes
DB00211	Midodrine	Adrenergic and dopaminergic agents	approved	Alpha-1D adrenergic receptor	P25100	177807	agonist	unknown
DB00212	Remikiren	Renin-inhibitors	approved	Renin	P00797	190994	inhibitor	yes
DB00213	Pantoprazole	Proton pump inhibitors	approved	Potassium-transporting ATPase alpha chain 1	P20648	561634	inhibitor	yes
DB00214	Torasemide	Sulfonamides, plain	approved	Solute carrier family 12 member 1	Q13621	1373425	inhibitor	yes
DB00215	Citalopram	Selective serotonin reuptake inhibitors	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00215	Citalopram	Selective serotonin reuptake inhibitors	approved	Histamine H1 receptor	P35367	510296	binder	unknown
DB00215	Citalopram	Selective serotonin reuptake inhibitors	approved	Alpha-1A adrenergic receptor	P35348	433201	binder	unknown
DB00215	Citalopram	Selective serotonin reuptake inhibitors	approved	Muscarinic acetylcholine receptor M1	P11229	34451	binder	unknown
DB00215	Citalopram	Selective serotonin reuptake inhibitors	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00216	Eletriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	yes
DB00216	Eletriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	yes
DB00216	Eletriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1F	P30939	307420	agonist	yes
DB00216	Eletriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB00216	Eletriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1E	P28566	177774	agonist	unknown
DB00216	Eletriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	agonist	unknown
DB00216	Eletriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	agonist	unknown
DB00217	Bethanidine	Guanidine derivatives	approved	Alpha-2 adrenergic receptors	P18825	178194	agonist	yes
DB00217	Bethanidine	Guanidine derivatives	approved	ATP-sensitive inward rectifier potassium channel 1	P48048	529313	inhibitor	yes
DB00217	Bethanidine	Guanidine derivatives	approved	Beta adrenergic receptor	P13945	178896	antagonist	unknown
DB00218	Moxifloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB00218	Moxifloxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB00218	Moxifloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	unknown
DB00219	Oxyphenonium	Synthetic anticholinergics, quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00220	Nelfinavir	Protease inhibitors	approved	HIV-1 protease	O90777	4377614	inhibitor	yes
DB00221	Isoetarine	Selective beta-2-adrenoreceptor agonists	approved	Beta-1 adrenergic receptor	P08588	178200	agonist	yes
DB00221	Isoetarine	Selective beta-2-adrenoreceptor agonists	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	unknown
DB00222	Glimepiride	Sulfonylureas	approved	ATP-sensitive inward rectifier potassium channel 11	Q14654	1088445	inhibitor	yes
DB00222	Glimepiride	Sulfonylureas	approved	ATP-sensitive inward rectifier potassium channel 1	P48048	529313	inhibitor	yes
DB00222	Glimepiride	Sulfonylureas	approved	ATP-binding cassette sub-family C member 8	Q09428	1374919	inducer	yes
DB00223	Diflorasone	Corticosteroids, potent (group III)	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00224	Indinavir	Protease inhibitors	approved	Human immunodeficiency virus type 1 protease	Q72874	None	inhibitor	yes
DB00226	Guanadrel	N/A	approved	Sodium-dependent noradrenaline transporter	P23975	189258	partial agonist	yes
DB00227	Lovastatin	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved;investigational	3-hydroxy-3-methylglutaryl-coenzyme A reductase	P04035	306865	inhibitor	yes
DB00227	Lovastatin	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved;investigational	Integrin alpha-L	P20701	31422	other/unknown	no
DB00227	Lovastatin	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved;investigational	Histone deacetylase 2	Q92769	1667394	other	no
DB00228	Enflurane	Halogenated hydrocarbons	approved;investigational;vet_approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00228	Enflurane	Halogenated hydrocarbons	approved;investigational;vet_approved	Glycine receptor (alpha-1/beta)	P48167	992687	agonist	yes
DB00228	Enflurane	Halogenated hydrocarbons	approved;investigational;vet_approved	Intermediate conductance calcium-activated potassium channel protein 4	O15554	2584866	inhibitor	unknown
DB00228	Enflurane	Halogenated hydrocarbons	approved;investigational;vet_approved	Potassium voltage-gated channel subfamily A member 1	Q09470	186663	inducer	yes
DB00228	Enflurane	Halogenated hydrocarbons	approved;investigational;vet_approved	Calcium-transporting ATPase type 2C member 1	P98194	6715131	inhibitor	yes
DB00228	Enflurane	Halogenated hydrocarbons	approved;investigational;vet_approved	Glutamate receptor 1	P42261	183281	antagonist	yes
DB00228	Enflurane	Halogenated hydrocarbons	approved;investigational;vet_approved	ATP synthase subunit delta, mitochondrial	P30049	12586	other/unknown	unknown
DB00229	Cefotiam	Second-generation cephalosporins	approved;investigational	Penicillin-binding protein 1A	Q8XJ01	18145626	inducer	yes
DB00230	Pregabalin	Other antiepileptics	approved;illicit;investigational	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	O00555	2213913	inhibitor	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit theta	Q9UN88	7861736	potentiator	yes
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	Translocator protein	P30536	306883	other	unknown
DB00231	Temazepam	Benzodiazepine derivatives	approved;investigational	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00232	Methyclothiazide	Thiazides, plain	approved	Solute carrier family 12 member 1	Q13621	1373425	inhibitor	yes
DB00232	Methyclothiazide	Thiazides, plain	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB00232	Methyclothiazide	Thiazides, plain	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB00232	Methyclothiazide	Thiazides, plain	approved	Carbonic anhydrase 4	P22748	179791	inhibitor	unknown
DB00233	Aminosalicylic Acid	Aminosalicylic acid and derivatives	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	unknown
DB00233	Aminosalicylic Acid	Aminosalicylic acid and derivatives	approved	Inhibitor of nuclear factor kappa-B kinase subunit alpha	O15111	None	inhibitor	unknown
DB00233	Aminosalicylic Acid	Aminosalicylic acid and derivatives	approved	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	unknown
DB00233	Aminosalicylic Acid	Aminosalicylic acid and derivatives	approved	Group IIE secretory phospholipase A2	Q9NZK7	7108923	unknown	unknown
DB00233	Aminosalicylic Acid	Aminosalicylic acid and derivatives	approved	2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase	P9WNC7	None	unknown	unknown
DB00234	Reboxetine	Other antidepressants	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00235	Milrinone	Phosphodiesterase inhibitors	approved	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	yes
DB00236	Pipobroman	Other alkylating agents	approved	DNA	None	None	cross-linking/alkylation	yes
DB00237	Butabarbital	N/A	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00237	Butabarbital	N/A	approved;illicit	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00237	Butabarbital	N/A	approved;illicit	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB00237	Butabarbital	N/A	approved;illicit	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB00237	Butabarbital	N/A	approved;illicit	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB00238	Nevirapine	Non-nucleoside reverse transcriptase inhibitors	approved	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB00239	Oxiconazole	Imidazole and triazole derivatives	approved	Lanosterol 14-alpha demethylase	P10613	578119	inhibitor	yes
DB00239	Oxiconazole	Imidazole and triazole derivatives	approved	Lanosterol synthase	Q04782	None	inhibitor	yes
DB00239	Oxiconazole	Imidazole and triazole derivatives	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	partial agonist	unknown
DB00240	Alclometasone	Corticosteroids, plain	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00241	Butalbital	N/A	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00241	Butalbital	N/A	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00241	Butalbital	N/A	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00241	Butalbital	N/A	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00241	Butalbital	N/A	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00241	Butalbital	N/A	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00241	Butalbital	N/A	approved;illicit	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00241	Butalbital	N/A	approved;illicit	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB00241	Butalbital	N/A	approved;illicit	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB00241	Butalbital	N/A	approved;illicit	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB00241	Butalbital	N/A	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00242	Cladribine	Purine analogues	approved;investigational	Ribonucleoside-diphosphate reductase large subunit	P23921	36065	inhibitor	yes
DB00242	Cladribine	Purine analogues	approved;investigational	Ribonucleoside-diphosphate reductase subunit M2	P31350	None	inhibitor	yes
DB00242	Cladribine	Purine analogues	approved;investigational	Ribonucleoside-diphosphate reductase subunit M2 B	Q7LG56	7229086	inhibitor	yes
DB00242	Cladribine	Purine analogues	approved;investigational	DNA	None	None	other/unknown	yes
DB00242	Cladribine	Purine analogues	approved;investigational	DNA polymerase alpha catalytic subunit	P09884	35568	inhibitor	yes
DB00242	Cladribine	Purine analogues	approved;investigational	DNA polymerase epsilon catalytic subunit A	Q07864	3192938	inhibitor	yes
DB00242	Cladribine	Purine analogues	approved;investigational	DNA polymerase epsilon subunit 2	P56282	2697123	inhibitor	yes
DB00242	Cladribine	Purine analogues	approved;investigational	DNA polymerase epsilon subunit 3	Q9NRF9	8100806	inhibitor	yes
DB00242	Cladribine	Purine analogues	approved;investigational	DNA polymerase epsilon subunit 4	Q9NR33	21411517	inhibitor	yes
DB00242	Cladribine	Purine analogues	approved;investigational	Purine nucleoside phosphorylase	P00491	35565	inducer	yes
DB00243	Ranolazine	Other cardiac preparations	approved;investigational	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00243	Ranolazine	Other cardiac preparations	approved;investigational	Sodium channel protein type 9 subunit alpha	Q15858	758110	inhibitor	unknown
DB00244	Mesalazine	Aminosalicylic acid and similar agents	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00244	Mesalazine	Aminosalicylic acid and similar agents	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00244	Mesalazine	Aminosalicylic acid and similar agents	approved	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	yes
DB00244	Mesalazine	Aminosalicylic acid and similar agents	approved	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	yes
DB00244	Mesalazine	Aminosalicylic acid and similar agents	approved	Inhibitor of nuclear factor kappa-B kinase subunit alpha	O15111	None	inhibitor	unknown
DB00244	Mesalazine	Aminosalicylic acid and similar agents	approved	Inhibitor of nuclear factor kappa-B kinase subunit beta	O14920	2599558	inhibitor	unknown
DB00244	Mesalazine	Aminosalicylic acid and similar agents	approved	Myeloperoxidase	P05164	189040	None	unknown
DB00244	Mesalazine	Aminosalicylic acid and similar agents	approved	Arylamine N-acetyltransferase	P9WJI5	None	None	unknown
DB00245	Benzatropine	Ethers of tropine or tropine derivatives	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00245	Benzatropine	Ethers of tropine or tropine derivatives	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB00245	Benzatropine	Ethers of tropine or tropine derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00246	Ziprasidone	Indole derivatives	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00246	Ziprasidone	Indole derivatives	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	D(1B) dopamine receptor	P21918	32049	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	5-hydroxytryptamine receptor 1B	P28222	219679	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	5-hydroxytryptamine receptor 1D	P28221	177772	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	5-hydroxytryptamine receptor 1E	P28566	177774	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	5-hydroxytryptamine receptor 6	P50406	1162924	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB00246	Ziprasidone	Indole derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	no
DB00246	Ziprasidone	Indole derivatives	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	no
DB00246	Ziprasidone	Indole derivatives	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	no
DB00246	Ziprasidone	Indole derivatives	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	no
DB00246	Ziprasidone	Indole derivatives	approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	no
DB00246	Ziprasidone	Indole derivatives	approved	Alpha-2C adrenergic receptor	P18825	178194	antagonist	no
DB00246	Ziprasidone	Indole derivatives	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB00246	Ziprasidone	Indole derivatives	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB00246	Ziprasidone	Indole derivatives	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB00246	Ziprasidone	Indole derivatives	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB00246	Ziprasidone	Indole derivatives	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB00247	Methysergide	Ergot alkaloids	approved	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	yes
DB00247	Methysergide	Ergot alkaloids	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB00247	Methysergide	Ergot alkaloids	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00247	Methysergide	Ergot alkaloids	approved	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	yes
DB00247	Methysergide	Ergot alkaloids	approved	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	yes
DB00247	Methysergide	Ergot alkaloids	approved	5-hydroxytryptamine receptor 1B	P28222	219679	binder	unknown
DB00247	Methysergide	Ergot alkaloids	approved	5-hydroxytryptamine receptor 1F	P30939	307420	binder	unknown
DB00247	Methysergide	Ergot alkaloids	approved	5-hydroxytryptamine receptor 1E	P28566	177774	binder	unknown
DB00248	Cabergoline	Dopamine agonists	approved	D(2) dopamine receptor	P14416	181432	agonist	yes
DB00248	Cabergoline	Dopamine agonists	approved	5-hydroxytryptamine receptor 2B	P41595	475198	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	D(3) dopamine receptor	P35462	927342	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	D(4) dopamine receptor	P21917	291946	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	D(1B) dopamine receptor	P21918	32049	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	D(1A) dopamine receptor	P21728	30397	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	Alpha-1A adrenergic receptor	P35348	433201	binder	unknown
DB00248	Cabergoline	Dopamine agonists	approved	Alpha-1B adrenergic receptor	P35368	None	binder	unknown
DB00248	Cabergoline	Dopamine agonists	approved	Alpha-1D adrenergic receptor	P25100	177807	binder	unknown
DB00248	Cabergoline	Dopamine agonists	approved	Beta-1 adrenergic receptor	P08588	178200	binder	unknown
DB00248	Cabergoline	Dopamine agonists	approved	Beta-2 adrenergic receptor	P07550	29371	binder	unknown
DB00248	Cabergoline	Dopamine agonists	approved	D(1) dopamine receptor	P21918	32049	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	D(2S) dopamine receptor	None	None	agonist	unknown
DB00248	Cabergoline	Dopamine agonists	approved	D(2L) dopamine receptor	None	None	agonist	unknown
DB00249	Idoxuridine	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved;investigational	DNA	None	None	other	yes
DB00249	Idoxuridine	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved;investigational	Thymidine kinase	Q9QNF7	8100965	unknown	unknown
DB00250	Dapsone	Other anti-acne preparations for topical use	approved;investigational	Inactive dihydropteroate synthase 2	P0C0X2	699152	inhibitor	yes
DB00250	Dapsone	Other anti-acne preparations for topical use	approved;investigational	Dihydropteroate synthase 1	P0C0X1	5832717	inhibitor	yes
DB00251	Terconazole	Triazole derivatives	approved	Lanosterol 14-alpha demethylase	P10613	578119	antagonist	yes
DB00252	Phenytoin	Hydantoin derivatives	approved;vet_approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00252	Phenytoin	Hydantoin derivatives	approved;vet_approved	Sodium channel protein type 1 subunit alpha	P35498	12642270	inhibitor	yes
DB00252	Phenytoin	Hydantoin derivatives	approved;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00252	Phenytoin	Hydantoin derivatives	approved;vet_approved	Sodium channel subunit beta-1	Q07699	307415	None	unknown
DB00252	Phenytoin	Hydantoin derivatives	approved;vet_approved	Sodium channel protein type 3 subunit alpha	Q9NY46	7414320	None	unknown
DB00253	Medrysone	Corticosteroids, plain	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00254	Doxycycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	30S ribosomal protein S9	P0A7X3	535073	inhibitor	yes
DB00254	Doxycycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	30S ribosomal protein S4	P0A7V8	42798	inhibitor	yes
DB00254	Doxycycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	16S rRNA	None	None	inhibitor	yes
DB00254	Doxycycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Protein-arginine deiminase type-4	Q9UM07	5913971	None	unknown
DB00254	Doxycycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Beta-2-microglobulin	P61769	27763813	None	unknown
DB00255	Diethylstilbestrol	Estrogens	approved;investigational	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00255	Diethylstilbestrol	Estrogens	approved;investigational	Estrogen-related receptor gamma	P62508	4092075	agonist	yes
DB00255	Diethylstilbestrol	Estrogens	approved;investigational	Estrogen receptor beta	Q92731	2911152	agonist	yes
DB00255	Diethylstilbestrol	Estrogens	approved;investigational	Steroid hormone receptor ERR1	P11474	36609	None	unknown
DB00255	Diethylstilbestrol	Estrogens	approved;investigational	Steroid hormone receptor ERR2	O95718	None	None	unknown
DB00255	Diethylstilbestrol	Estrogens	approved;investigational	Nuclear receptor coactivator 2	Q15596	1877215	None	unknown
DB00255	Diethylstilbestrol	Estrogens	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00255	Diethylstilbestrol	Estrogens	approved;investigational	Androgen receptor	P10275	178628	antagonist	unknown
DB00255	Diethylstilbestrol	Estrogens	approved;investigational	Sex hormone-binding globulin	P04278	296673	None	unknown
DB00256	Lymecycline	Tetracyclines	approved;investigational	30S ribosomal protein S9	P0A7X3	535073	inhibitor	unknown
DB00256	Lymecycline	Tetracyclines	approved;investigational	30S ribosomal protein S4	P0A7V8	42798	inhibitor	unknown
DB00257	Clotrimazole	Imidazole and triazole derivatives	approved;vet_approved	Lanosterol 14-alpha demethylase	P10613	578119	antagonist	yes
DB00257	Clotrimazole	Imidazole and triazole derivatives	approved;vet_approved	Intermediate conductance calcium-activated potassium channel protein 4	O15554	2584866	inhibitor	yes
DB00257	Clotrimazole	Imidazole and triazole derivatives	approved;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	activator	unknown
DB00257	Clotrimazole	Imidazole and triazole derivatives	approved;vet_approved	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	partial agonist	unknown
DB00258	Calcium Acetate	Ascorbic acid (vitamin C), combinations	approved;investigational	Phosphate	None	None	binder	yes
DB00259	Sulfanilamide	Short-acting sulfonamides	approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB00260	Cycloserine	Antibiotics	approved	D-alanine--D-alanine ligase A	P0A6J8	145722	inhibitor	yes
DB00260	Cycloserine	Antibiotics	approved	Alanine racemase	Q9L888	6708455	inhibitor	yes
DB00261	Anagrelide	Other antineoplastic agents	approved	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	yes
DB00262	Carmustine	Nitrosoureas	approved;investigational	DNA	None	None	other/unknown	yes
DB00262	Carmustine	Nitrosoureas	approved;investigational	Glutathione reductase, mitochondrial	P00390	31825	inhibitor	yes
DB00262	Carmustine	Nitrosoureas	approved;investigational	RNA	None	None	other/unknown	yes
DB00263	Sulfisoxazole	Short-acting sulfonamides	approved;vet_approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB00264	Metoprolol	Beta blocking agents, selective, and thiazides	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB00264	Metoprolol	Beta blocking agents, selective, and thiazides	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB00266	Dicoumarol	Vitamin K antagonists	approved	Vitamin K epoxide reductase complex subunit 1	Q9BQB6	40217983	inhibitor	yes
DB00266	Dicoumarol	Vitamin K antagonists	approved	NAD(P)H dehydrogenase [quinone] 1	P15559	189246	inhibitor	unknown
DB00266	Dicoumarol	Vitamin K antagonists	approved	Quinone oxidoreductase	Q08257	292415	inhibitor	unknown
DB00267	Cefmenoxime	Third-generation cephalosporins	approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB00267	Cefmenoxime	Third-generation cephalosporins	approved	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB00268	Ropinirole	Dopamine agonists	approved;investigational	D(3) dopamine receptor	P35462	927342	agonist	yes
DB00268	Ropinirole	Dopamine agonists	approved;investigational	D(2) dopamine receptor	P14416	181432	agonist	yes
DB00268	Ropinirole	Dopamine agonists	approved;investigational	D(4) dopamine receptor	P21917	291946	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	D(1A) dopamine receptor	P21728	30397	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	D(1B) dopamine receptor	P21918	32049	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	agonist	unknown
DB00268	Ropinirole	Dopamine agonists	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	agonist	unknown
DB00270	Isradipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB00270	Isradipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	inhibitor	yes
DB00270	Isradipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	inhibitor	yes
DB00270	Isradipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	inhibitor	yes
DB00270	Isradipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-2	Q9NY47	None	inhibitor	yes
DB00270	Isradipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	yes
DB00270	Isradipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	inhibitor	yes
DB00272	Betazole	Tests for gastric secretion	approved	Histamine H2 receptor	P25021	184088	agonist	yes
DB00273	Topiramate	Other antiepileptics	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB00273	Topiramate	Other antiepileptics	approved	Sodium channel protein type 1 subunit alpha	P35498	12642270	inhibitor	yes
DB00273	Topiramate	Other antiepileptics	approved	Glutamate receptor ionotropic, kainate 1	P39086	455448	antagonist	yes
DB00273	Topiramate	Other antiepileptics	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB00273	Topiramate	Other antiepileptics	approved	Carbonic anhydrase 4	P22748	179791	inhibitor	yes
DB00273	Topiramate	Other antiepileptics	approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00273	Topiramate	Other antiepileptics	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB00273	Topiramate	Other antiepileptics	approved	Carbonic anhydrase 3	P07451	189053812	inhibitor	unknown
DB00274	Cefmetazole	Second-generation cephalosporins	approved;investigational	Penicillin binding protein 2a	C1KC03	None	inhibitor	yes
DB00274	Cefmetazole	Second-generation cephalosporins	approved;investigational	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB00274	Cefmetazole	Second-generation cephalosporins	approved;investigational	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB00274	Cefmetazole	Second-generation cephalosporins	approved;investigational	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB00274	Cefmetazole	Second-generation cephalosporins	approved;investigational	D-alanyl-D-alanine carboxypeptidase DacA	P0AEB2	None	inhibitor	yes
DB00274	Cefmetazole	Second-generation cephalosporins	approved;investigational	D-alanyl-D-alanine carboxypeptidase DacC	P08506	41218	inhibitor	yes
DB00275	Olmesartan	Angiotensin II antagonists and diuretics	approved;investigational	Type-1 angiotensin II receptor	P30556	179122	antagonist	yes
DB00276	Amsacrine	Other antineoplastic agents	approved;investigational	DNA	None	None	intercalation	yes
DB00276	Amsacrine	Other antineoplastic agents	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB00276	Amsacrine	Other antineoplastic agents	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00276	Amsacrine	Other antineoplastic agents	approved;investigational	Alpha-1-acid glycoprotein 1	P02763	757907	None	unknown
DB00276	Amsacrine	Other antineoplastic agents	approved;investigational	Serum albumin	P02768	28590	None	unknown
DB00277	Theophylline	Xanthines	approved	Adenosine receptor A1	P30542	256155	antagonist	yes
DB00277	Theophylline	Xanthines	approved	Adenosine receptor A2a	P29274	177892	antagonist	yes
DB00277	Theophylline	Xanthines	approved	Adenosine receptor A2b	P29275	178150	antagonist	yes
DB00277	Theophylline	Xanthines	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	yes
DB00277	Theophylline	Xanthines	approved	cGMP-specific 3',5'-cyclic phosphodiesterase	O76074	3420185	inhibitor	yes
DB00277	Theophylline	Xanthines	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	yes
DB00277	Theophylline	Xanthines	approved	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	yes
DB00277	Theophylline	Xanthines	approved	Histone deacetylase 2	Q92769	1667394	activator	yes
DB00277	Theophylline	Xanthines	approved	Copine-1	Q99829	None	None	unknown
DB00277	Theophylline	Xanthines	approved	Minor histocompatibility antigen H13	Q8TCT9	None	None	unknown
DB00277	Theophylline	Xanthines	approved	Nodal modulator 1	Q15155	None	None	unknown
DB00277	Theophylline	Xanthines	approved	Poly [ADP-ribose] polymerase 1	P09874	1017423	None	unknown
DB00277	Theophylline	Xanthines	approved	Protein RIC-3	Q7Z5B4	None	None	unknown
DB00277	Theophylline	Xanthines	approved	Tubulin monoglycylase TTLL3	Q9Y4R7	None	None	unknown
DB00278	Argatroban	Direct thrombin inhibitors	approved;investigational	Prothrombin	P00734	339641	inhibitor	yes
DB00279	Liothyronine	Thyroid hormones	approved;vet_approved	Thyroid hormone receptor alpha	P10827	825639	agonist	yes
DB00279	Liothyronine	Thyroid hormones	approved;vet_approved	Thyroid hormone receptor beta	P10828	31207	agonist	yes
DB00279	Liothyronine	Thyroid hormones	approved;vet_approved	Proliferating cell nuclear antigen	P12004	None	None	unknown
DB00280	Disopyramide	Antiarrhythmics, class Ia	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00280	Disopyramide	Antiarrhythmics, class Ia	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00280	Disopyramide	Antiarrhythmics, class Ia	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00280	Disopyramide	Antiarrhythmics, class Ia	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00280	Disopyramide	Antiarrhythmics, class Ia	approved	Potassium voltage-gated channel subfamily D member 2	Q9NZV8	4530478	inhibitor	unknown
DB00280	Disopyramide	Antiarrhythmics, class Ia	approved	Potassium voltage-gated channel subfamily D member 3	Q9UK17	2935434	inhibitor	unknown
DB00280	Disopyramide	Antiarrhythmics, class Ia	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00280	Disopyramide	Antiarrhythmics, class Ia	approved	Alpha-1-acid glycoprotein 2	P19652	16359000	None	unknown
DB00281	Lidocaine	Antiarrhythmics, class Ib	approved;vet_approved	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB00281	Lidocaine	Antiarrhythmics, class Ib	approved;vet_approved	Sodium channel protein type 9 subunit alpha	Q15858	758110	inhibitor	yes
DB00281	Lidocaine	Antiarrhythmics, class Ib	approved;vet_approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00281	Lidocaine	Antiarrhythmics, class Ib	approved;vet_approved	Epidermal growth factor receptor	P00533	757924	antagonist	unknown
DB00281	Lidocaine	Antiarrhythmics, class Ib	approved;vet_approved	Sodium channel protein type 4 subunit alpha	P35499	338213	None	unknown
DB00281	Lidocaine	Antiarrhythmics, class Ib	approved;vet_approved	Alpha-1-acid glycoprotein 1	P02763	757907	None	unknown
DB00281	Lidocaine	Antiarrhythmics, class Ib	approved;vet_approved	Alpha-1-acid glycoprotein 2	P19652	16359000	None	unknown
DB00282	Pamidronate	Bisphosphonates	approved	Farnesyl pyrophosphate synthase	P14324	182399	inhibitor	yes
DB00282	Pamidronate	Bisphosphonates	approved	Hydroxylapatite	None	None	antagonist	yes
DB00283	Clemastine	Antihistamines for topical use	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00284	Acarbose	Alpha glucosidase inhibitors	approved;investigational	Maltase-glucoamylase, intestinal	O43451	17648144	inhibitor	yes
DB00284	Acarbose	Alpha glucosidase inhibitors	approved;investigational	Pancreatic alpha-amylase	P04746	None	inhibitor	yes
DB00284	Acarbose	Alpha glucosidase inhibitors	approved;investigational	Lysosomal alpha-glucosidase	P10253	31608	inhibitor	yes
DB00284	Acarbose	Alpha glucosidase inhibitors	approved;investigational	Sucrase-isomaltase, intestinal	P14410	36645	inhibitor	yes
DB00285	Venlafaxine	Other antidepressants	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00285	Venlafaxine	Other antidepressants	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00285	Venlafaxine	Other antidepressants	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB00286	Conjugated estrogens	Estrogens, combinations with other drugs	approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00287	Travoprost	Prostaglandin analogues	approved	Prostaglandin F2-alpha receptor	P43088	456564	agonist	yes
DB00288	Amcinonide	Corticosteroids, potent (group III)	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00288	Amcinonide	Corticosteroids, potent (group III)	approved	Annexin A1	P04083	12654863	agonist	unknown
DB00289	Atomoxetine	Centrally acting sympathomimetics	approved	Sodium-dependent noradrenaline transporter	P23975	189258	None	yes
DB00289	Atomoxetine	Centrally acting sympathomimetics	approved	Sodium-dependent serotonin transporter	P31645	36433	None	unknown
DB00289	Atomoxetine	Centrally acting sympathomimetics	approved	Sodium-dependent dopamine transporter	Q01959	553260	binder	unknown
DB00289	Atomoxetine	Centrally acting sympathomimetics	approved	NMDA receptor	O60391	3025446	blocker	unknown
DB00290	Bleomycin	Other cytotoxic antibiotics	approved;investigational	DNA ligase 1	P18858	187143	inhibitor	unknown
DB00290	Bleomycin	Other cytotoxic antibiotics	approved;investigational	DNA	None	None	cleavage	yes
DB00290	Bleomycin	Other cytotoxic antibiotics	approved;investigational	DNA ligase 3	P49916	860963	inhibitor	unknown
DB00291	Chlorambucil	Nitrogen mustard analogues	approved	DNA	None	None	cross-linking/alkylation	unknown
DB00292	Etomidate	Other general anesthetics	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB00292	Etomidate	Other general anesthetics	approved	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB00292	Etomidate	Other general anesthetics	approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00293	Raltitrexed	Folic acid analogues	approved;investigational	Thymidylate synthase	P04818	37479	inhibitor	yes
DB00293	Raltitrexed	Folic acid analogues	approved;investigational	Folylpolyglutamate synthase, mitochondrial	Q05932	292029	antagonist	unknown
DB00294	Etonogestrel	Progestogens	approved;investigational	Progesterone receptor	P06401	35652	agonist	yes
DB00294	Etonogestrel	Progestogens	approved;investigational	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00295	Morphine	Natural opium alkaloids	approved;investigational	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00295	Morphine	Natural opium alkaloids	approved;investigational	Kappa-type opioid receptor	P41145	532060	agonist	yes
DB00295	Morphine	Natural opium alkaloids	approved;investigational	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB00295	Morphine	Natural opium alkaloids	approved;investigational	Lymphocyte antigen 96	Q9Y6Y9	5051740	None	unknown
DB00296	Ropivacaine	Amides	approved	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB00297	Bupivacaine	Amides	approved;investigational	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB00297	Bupivacaine	Amides	approved;investigational	Prostaglandin E2 receptor EP1 subtype	P34995	410209	other/unknown	unknown
DB00298	Dapiprazole	Other antiglaucoma preparations	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00298	Dapiprazole	Other antiglaucoma preparations	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	yes
DB00298	Dapiprazole	Other antiglaucoma preparations	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	yes
DB00299	Penciclovir	Antivirals	approved	DNA polymerase catalytic subunit	P04293	59530	inhibitor	yes
DB00299	Penciclovir	Antivirals	approved	Thymidine kinase	P06478	330210	inducer	yes
DB00300	Tenofovir disoproxil	Antivirals for treatment of HIV infections, combinations	approved;investigational	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB00301	Flucloxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB00302	Tranexamic Acid	Amino acids	approved	Plasminogen	P00747	387026	inhibitor	yes
DB00303	Ertapenem	Carbapenems	approved;investigational	Penicillin-binding protein 2	P44469	1572976	inhibitor	yes
DB00303	Ertapenem	Carbapenems	approved;investigational	Penicillin-binding protein 2	P0AD65	42314	inhibitor	yes
DB00303	Ertapenem	Carbapenems	approved;investigational	Peptidoglycan synthase FtsI	P45059	1574687	inhibitor	yes
DB00303	Ertapenem	Carbapenems	approved;investigational	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB00303	Ertapenem	Carbapenems	approved;investigational	D-alanyl-D-alanine carboxypeptidase DacB	P24228	41216	inhibitor	yes
DB00303	Ertapenem	Carbapenems	approved;investigational	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB00303	Ertapenem	Carbapenems	approved;investigational	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB00303	Ertapenem	Carbapenems	approved;investigational	D-alanyl-D-alanine carboxypeptidase DacC	P08506	41218	inhibitor	yes
DB00304	Desogestrel	Progestogens	approved	Progesterone receptor	P06401	35652	agonist	yes
DB00304	Desogestrel	Progestogens	approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00305	Mitomycin	Other cytotoxic antibiotics	approved	DNA	None	None	antagonist	yes
DB00306	Talbutal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00306	Talbutal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00306	Talbutal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00306	Talbutal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00306	Talbutal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00306	Talbutal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00306	Talbutal	Barbiturates, plain	approved;illicit	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00306	Talbutal	Barbiturates, plain	approved;illicit	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB00306	Talbutal	Barbiturates, plain	approved;illicit	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB00306	Talbutal	Barbiturates, plain	approved;illicit	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB00306	Talbutal	Barbiturates, plain	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00307	Bexarotene	Other antineoplastic agents	approved;investigational	Retinoic acid receptor RXR-alpha	P19793	35885	agonist	yes
DB00307	Bexarotene	Other antineoplastic agents	approved;investigational	Retinoic acid receptor RXR-beta	P28702	30448	agonist	yes
DB00307	Bexarotene	Other antineoplastic agents	approved;investigational	Retinoic acid receptor RXR-gamma	P48443	1053069	agonist	yes
DB00308	Ibutilide	Antiarrhythmics, class III	approved	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	activator	yes
DB00308	Ibutilide	Antiarrhythmics, class III	approved	Voltage-dependent L-type calcium channel subunit beta-1	Q02641	179806	activator	yes
DB00308	Ibutilide	Antiarrhythmics, class III	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	yes
DB00308	Ibutilide	Antiarrhythmics, class III	approved	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	activator	unknown
DB00308	Ibutilide	Antiarrhythmics, class III	approved	Voltage-dependent calcium channel gamma-1 subunit	Q06432	306473	activator	unknown
DB00308	Ibutilide	Antiarrhythmics, class III	approved	Potassium channel subfamily K member 1	O00180	1086491	inhibitor	unknown
DB00308	Ibutilide	Antiarrhythmics, class III	approved	Potassium channel subfamily K member 6	Q9Y257	4559312	inhibitor	unknown
DB00308	Ibutilide	Antiarrhythmics, class III	approved	Potassium voltage-gated channel subfamily H member 6	Q9H252	11878259	inhibitor	unknown
DB00308	Ibutilide	Antiarrhythmics, class III	approved	Potassium voltage-gated channel subfamily H member 7	Q9NS40	4104136	inhibitor	unknown
DB00308	Ibutilide	Antiarrhythmics, class III	approved	ATP-sensitive inward rectifier potassium channel 11	Q14654	1088445	inhibitor	unknown
DB00309	Vindesine	Vinca alkaloids and analogues	approved;investigational	Tubulin beta-1 chain	Q9H4B7	11230445	inhibitor	yes
DB00310	Chlorthalidone	Sulfonamides, plain	approved	Solute carrier family 12 member 1	Q13621	1373425	inhibitor	yes
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	NMDA receptor	O60391	3025446	antagonist	unknown
DB00312	Pentobarbital	Barbiturates, plain	approved;investigational;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	activator	unknown
DB00313	Valproic Acid	Fatty acid derivatives	approved;investigational	Histone deacetylase 9	Q9UKV0	15590680	inhibitor	yes
DB00313	Valproic Acid	Fatty acid derivatives	approved;investigational	4-aminobutyrate aminotransferase, mitochondrial	P80404	602705	inhibitor	yes
DB00313	Valproic Acid	Fatty acid derivatives	approved;investigational	Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial	P45954	531391	inhibitor	unknown
DB00313	Valproic Acid	Fatty acid derivatives	approved;investigational	2-oxoglutarate dehydrogenase, mitochondrial	Q02218	531241	inhibitor	unknown
DB00313	Valproic Acid	Fatty acid derivatives	approved;investigational	Succinate-semialdehyde dehydrogenase, mitochondrial	P51649	3766467	inhibitor	unknown
DB00313	Valproic Acid	Fatty acid derivatives	approved;investigational	Sodium channel protein	Q8IWT1	27465047	inhibitor	unknown
DB00313	Valproic Acid	Fatty acid derivatives	approved;investigational	Histone deacetylase 2	Q92769	1667394	inhibitor	unknown
DB00313	Valproic Acid	Fatty acid derivatives	approved;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB00313	Valproic Acid	Fatty acid derivatives	approved;investigational	Peroxisome proliferator-activated receptor delta	Q03181	190230	None	unknown
DB00313	Valproic Acid	Fatty acid derivatives	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB00314	Capreomycin	Antibiotics	approved	70S ribosome	None	None	inhibitor	yes
DB00315	Zolmitriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	yes
DB00315	Zolmitriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	yes
DB00315	Zolmitriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1F	P30939	307420	agonist	yes
DB00315	Zolmitriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	yes
DB00316	Acetaminophen	Anilides	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00316	Acetaminophen	Anilides	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00316	Acetaminophen	Anilides	approved	Prostaglandin G/H synthase 3	None	None	inhibitor	unknown
DB00316	Acetaminophen	Anilides	approved	Fatty-acid amide hydrolase 1	O00519	2149156	inhibitor	unknown
DB00316	Acetaminophen	Anilides	approved	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	None	unknown
DB00316	Acetaminophen	Anilides	approved	Glutathione S-transferase P	P09211	31946	None	unknown
DB00317	Gefitinib	Protein kinase inhibitors	approved;investigational	Epidermal growth factor receptor	P00533	757924	antagonist	yes
DB00318	Codeine	Natural opium alkaloids	approved;illicit	Mu-type opioid receptor	P35372	452073	partial agonist	yes
DB00318	Codeine	Natural opium alkaloids	approved;illicit	Kappa-type opioid receptor	P41145	532060	partial agonist	yes
DB00318	Codeine	Natural opium alkaloids	approved;illicit	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB00319	Piperacillin	Penicillins with extended spectrum	approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00319	Piperacillin	Penicillins with extended spectrum	approved	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB00319	Piperacillin	Penicillins with extended spectrum	approved	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB00319	Piperacillin	Penicillins with extended spectrum	approved	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB00320	Dihydroergotamine	Ergot alkaloids	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	yes
DB00320	Dihydroergotamine	Ergot alkaloids	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	yes
DB00320	Dihydroergotamine	Ergot alkaloids	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	unknown
DB00320	Dihydroergotamine	Ergot alkaloids	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	agonist	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	5-hydroxytryptamine receptor 1A	P08908	189928	inhibitor	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Delta-type opioid receptor	P41143	27545517	agonist	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	High affinity nerve growth factor receptor	P04629	339918	agonist	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	BDNF/NT-3 growth factors receptor	Q16620	530791	agonist	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Histamine H1 receptor	P35367	510296	antagonist	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Potassium voltage-gated channel subfamily KQT member 2	O43526	1841342	inhibitor	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Potassium voltage-gated channel subfamily A member 1	Q09470	186663	inhibitor	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Potassium voltage-gated channel subfamily D member 2	Q9NZV8	4530478	inhibitor	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Potassium voltage-gated channel subfamily D member 3	Q9UK17	2935434	inhibitor	no
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Histamine H2 receptor	P25021	184088	blocker	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Histamine H4 receptor	Q9H3N8	10241847	binder	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Sigma non-opioid intracellular receptor 1	Q99720	1783387	agonist	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	5-hydroxytryptamine receptor 2C	P28335	338028	binder	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	5-hydroxytryptamine receptor 1D	P28221	177772	binder	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Mu-type opioid receptor	P35372	452073	binder	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	5-hydroxytryptamine receptor 1B	P28222	219679	binder	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	5-hydroxytryptamine receptor 6	P50406	1162924	antagonist	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Potassium voltage-gated channel subfamily KQT member 3	O43525	None	inhibitor	unknown
DB00321	Amitriptyline	Antidepressants in combination with psycholeptics	approved	Beta adrenergic receptor	P13945	178896	binder	unknown
DB00322	Floxuridine	N/A	approved	Thymidylate synthase	P04818	37479	None	yes
DB00323	Tolcapone	Other dopaminergic agents	approved;withdrawn	Catechol O-methyltransferase	P21964	180920	inhibitor	yes
DB00324	Fluorometholone	Corticosteroids, combinations for treatment of acne	approved;investigational	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00325	Nitroprusside	Nitroferricyanide derivatives	approved;investigational	Atrial natriuretic peptide receptor 1	P16066	28230	agonist	yes
DB00327	Hydromorphone	Opioids in combination with antispasmodics	approved;illicit	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00327	Hydromorphone	Opioids in combination with antispasmodics	approved;illicit	Delta-type opioid receptor	P41143	27545517	partial agonist	yes
DB00327	Hydromorphone	Opioids in combination with antispasmodics	approved;illicit	Kappa-type opioid receptor	P41145	532060	agonist	yes
DB00328	Indomethacin	Antiinflammatory agents, non-steroids and antiinfectives in combination	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00328	Indomethacin	Antiinflammatory agents, non-steroids and antiinfectives in combination	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00328	Indomethacin	Antiinflammatory agents, non-steroids and antiinfectives in combination	approved;investigational	Phospholipase A2, membrane associated	P14555	190889	inhibitor	yes
DB00328	Indomethacin	Antiinflammatory agents, non-steroids and antiinfectives in combination	approved;investigational	Prostaglandin reductase 2	Q8N8N7	37912002	inhibitor	unknown
DB00328	Indomethacin	Antiinflammatory agents, non-steroids and antiinfectives in combination	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	activator	unknown
DB00328	Indomethacin	Antiinflammatory agents, non-steroids and antiinfectives in combination	approved;investigational	Lactoylglutathione lyase	Q04760	219664	inhibitor	unknown
DB00328	Indomethacin	Antiinflammatory agents, non-steroids and antiinfectives in combination	approved;investigational	Prostaglandin D2 receptor 2	Q9Y5Y4	4204216	other/unknown	unknown
DB00328	Indomethacin	Antiinflammatory agents, non-steroids and antiinfectives in combination	approved;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	agonist	unknown
DB00328	Indomethacin	Antiinflammatory agents, non-steroids and antiinfectives in combination	approved;investigational	Aldo-keto reductase family 1 member C3	P42330	4261711	inhibitor	unknown
DB00330	Ethambutol	Combinations of drugs for treatment of tuberculosis	approved	Probable arabinosyltransferase C	P9WNL5	None	inhibitor	yes
DB00330	Ethambutol	Combinations of drugs for treatment of tuberculosis	approved	Probable arabinosyltransferase B	P9WNL7	None	inhibitor	yes
DB00330	Ethambutol	Combinations of drugs for treatment of tuberculosis	approved	Probable arabinosyltransferase A	P9WNL9	None	inhibitor	yes
DB00331	Metformin	Biguanides	approved	5'-AMP-activated protein kinase subunit beta-1	Q9Y478	2916800	inducer	yes
DB00332	Ipratropium	Anticholinergics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00332	Ipratropium	Anticholinergics	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00332	Ipratropium	Anticholinergics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB00333	Methadone	Drugs used in opioid dependence	approved	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00333	Methadone	Drugs used in opioid dependence	approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	yes
DB00333	Methadone	Drugs used in opioid dependence	approved	Neuronal acetylcholine receptor subunit alpha-10	Q9GZZ6	12053839	antagonist	yes
DB00333	Methadone	Drugs used in opioid dependence	approved	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB00333	Methadone	Drugs used in opioid dependence	approved	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB00333	Methadone	Drugs used in opioid dependence	approved	Lymphocyte antigen 96	Q9Y6Y9	5051740	None	unknown
DB00333	Methadone	Drugs used in opioid dependence	approved	Alpha-1-acid glycoprotein 2	P19652	16359000	None	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	D(1B) dopamine receptor	P21918	32049	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 1E	P28566	177774	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 6	P50406	1162924	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	5-hydroxytryptamine receptor 5A	P47898	None	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	D(1) dopamine receptor	P21918	32049	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Histamine H2 receptor	P25021	184088	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Histamine H4 receptor	Q9H3N8	10241847	antagonist	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	GABA-A receptor (anion channel)	Q9UN88	7861736	inhibitor	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	Beta adrenergic receptor	P13945	178896	inhibitor	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	D(2L) dopamine receptor	None	None	inhibitor	unknown
DB00334	Olanzapine	Diazepines, oxazepines, thiazepines and oxepines	approved;investigational	D(2S) dopamine receptor	None	None	inhibitor	unknown
DB00335	Atenolol	Beta blocking agents, selective, and other diuretics	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB00335	Atenolol	Beta blocking agents, selective, and other diuretics	approved	Beta-2 adrenergic receptor	P07550	29371	inhibitor	unknown
DB00336	Nitrofural	Nitrofuran derivatives	approved;investigational;vet_approved	Pyruvate dehydrogenase [ubiquinone]	P07003	42473	inhibitor	yes
DB00336	Nitrofural	Nitrofuran derivatives	approved;investigational;vet_approved	Glutathione reductase	P06715	146248	inhibitor	yes
DB00336	Nitrofural	Nitrofuran derivatives	approved;investigational;vet_approved	Malate dehydrogenase	P61889	41989	inhibitor	yes
DB00336	Nitrofural	Nitrofuran derivatives	approved;investigational;vet_approved	[Citrate [pro-3S]-lyase] ligase	P77390	1778535	inhibitor	yes
DB00337	Pimecrolimus	Agents for dermatitis, excluding corticosteroids	approved;investigational	Serine/threonine-protein kinase mTOR	P42345	None	potentiator	yes
DB00337	Pimecrolimus	Agents for dermatitis, excluding corticosteroids	approved;investigational	Peptidyl-prolyl cis-trans isomerase FKBP1A	P62942	182628	potentiator	unknown
DB00338	Omeprazole	Proton pump inhibitors	approved;investigational;vet_approved	Potassium-transporting ATPase alpha chain 1	P20648	561634	inhibitor	yes
DB00338	Omeprazole	Proton pump inhibitors	approved;investigational;vet_approved	Aryl hydrocarbon receptor	P35869	533324	agonist	unknown
DB00339	Pyrazinamide	Combinations of drugs for treatment of tuberculosis	approved;investigational	Fatty acid synthetase I (FASI)	None	None	inhibitor	yes
DB00340	Metixene	Tertiary amines	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00340	Metixene	Tertiary amines	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB00340	Metixene	Tertiary amines	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	yes
DB00340	Metixene	Tertiary amines	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00340	Metixene	Tertiary amines	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00341	Cetirizine	Piperazine derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00342	Terfenadine	Other antihistamines for systemic use	approved;withdrawn	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00342	Terfenadine	Other antihistamines for systemic use	approved;withdrawn	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00342	Terfenadine	Other antihistamines for systemic use	approved;withdrawn	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00342	Terfenadine	Other antihistamines for systemic use	approved;withdrawn	Muscarinic acetylcholine receptor M1	P11229	34451	binder	unknown
DB00342	Terfenadine	Other antihistamines for systemic use	approved;withdrawn	Muscarinic acetylcholine receptor M5	P08912	177988	binder	unknown
DB00342	Terfenadine	Other antihistamines for systemic use	approved;withdrawn	Muscarinic acetylcholine receptor M4	P08173	61970253	binder	unknown
DB00342	Terfenadine	Other antihistamines for systemic use	approved;withdrawn	Muscarinic acetylcholine receptor M2	P08172	177990	binder	unknown
DB00343	Diltiazem	Muscle relaxants	approved;investigational	Voltage-dependent calcium channel gamma-1 subunit	Q06432	306473	inhibitor	yes
DB00344	Protriptyline	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00344	Protriptyline	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00346	Alfuzosin	Alpha-adrenoreceptor antagonists	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00346	Alfuzosin	Alpha-adrenoreceptor antagonists	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	yes
DB00346	Alfuzosin	Alpha-adrenoreceptor antagonists	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	antagonist	yes
DB00346	Alfuzosin	Alpha-adrenoreceptor antagonists	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00347	Trimethadione	Oxazolidine derivatives	approved	Voltage-dependent T-type calcium channel subunit alpha-1G	O43497	6625659	inhibitor	yes
DB00348	Nitisinone	Various alimentary tract and metabolism products	approved;investigational	4-hydroxyphenylpyruvate dioxygenase	P32754	3860238	inhibitor	yes
DB00349	Clobazam	Benzodiazepine derivatives	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00350	Minoxidil	Other dermatologicals	approved;investigational	ATP-sensitive inward rectifier potassium channel 1	P48048	529313	inducer	yes
DB00350	Minoxidil	Other dermatologicals	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inducer	unknown
DB00350	Minoxidil	Other dermatologicals	approved;investigational	Renin	P00797	190994	None	unknown
DB00351	Megestrol acetate	Progestogens	approved;investigational;vet_approved	Progesterone receptor	P06401	35652	agonist	yes
DB00351	Megestrol acetate	Progestogens	approved;investigational;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	unknown
DB00352	Tioguanine	Purine analogues	approved	DNA	None	None	intercalation	yes
DB00353	Methylergometrine	Ergot alkaloids and oxytocin incl. analogues, in combination	approved	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB00353	Methylergometrine	Ergot alkaloids and oxytocin incl. analogues, in combination	approved	5-hydroxytryptamine receptor 2B	P41595	475198	None	unknown
DB00354	Buclizine	Piperazine derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00354	Buclizine	Piperazine derivatives	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00355	Aztreonam	Monobactams	approved	Penicillin-binding protein 3	P42971	790944	inhibitor	yes
DB00355	Aztreonam	Monobactams	approved	Beta-lactamase	P05193	40452	potentiator	yes
DB00356	Chlorzoxazone	Oxazol, thiazine, and triazine derivatives	approved	Calcium-activated potassium channel subunit alpha-1	Q12791	537439	None	yes
DB00357	Aminoglutethimide	Aromatase inhibitors	approved;investigational	Cytochrome P450 19A1	P11511	179002	inhibitor	yes
DB00357	Aminoglutethimide	Aromatase inhibitors	approved;investigational	Cholesterol side-chain cleavage enzyme, mitochondrial	P05108	181376	inhibitor	yes
DB00358	Mefloquine	Artemisinin and derivatives, combinations	approved;investigational	Fe(II)-protoporphyrin IX	None	None	antagonist	yes
DB00358	Mefloquine	Artemisinin and derivatives, combinations	approved;investigational	Hemoglobin subunit alpha	P69905	386764	antagonist	yes
DB00358	Mefloquine	Artemisinin and derivatives, combinations	approved;investigational	Adenosine receptor A2a	P29274	177892	antagonist	unknown
DB00359	Sulfadiazine	Combinations of sulfonamides and trimethoprim, incl. derivatives	approved;investigational;vet_approved	Dihydropteroate synthetase	Q27738	505177	inhibitor	yes
DB00360	Sapropterin	Various alimentary tract and metabolism products	approved;investigational	Phenylalanine-4-hydroxylase	P00439	189937	cofactor	yes
DB00360	Sapropterin	Various alimentary tract and metabolism products	approved;investigational	Nitric oxide synthase, endothelial	P29474	189212	cofactor	yes
DB00360	Sapropterin	Various alimentary tract and metabolism products	approved;investigational	Tyrosine 3-monooxygenase	P07101	37127	cofactor	yes
DB00360	Sapropterin	Various alimentary tract and metabolism products	approved;investigational	Tryptophan 5-hydroxylase 1	P17752	37955	cofactor	yes
DB00361	Vinorelbine	Vinca alkaloids and analogues	approved;investigational	Tubulin beta chain	P07437	338695	antagonist	yes
DB00362	Anidulafungin	Other antimycotics for systemic use	approved;investigational	1,3-beta-glucan synthase component FKS1	A2QLK4	None	inhibitor	yes
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1B	P28222	219679	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1D	P28221	177772	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1E	P28566	177774	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 6	P50406	1162924	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Histamine H1 receptor	P35367	510296	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Histamine H4 receptor	Q9H3N8	10241847	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2C adrenergic receptor	P18825	178194	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Neuron-specific vesicular protein calcyon	Q9NYX4	6980076	unknown	unknown
DB00363	Clozapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Glutathione S-transferase P	P09211	31946	None	unknown
DB00364	Sucralfate	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	approved	Pepsin	None	None	inhibitor	yes
DB00364	Sucralfate	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	approved	Fibroblast growth factor 2	P09038	31362	agonist	yes
DB00364	Sucralfate	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	approved	Pro-epidermal growth factor	P01133	31121	inducer	yes
DB00364	Sucralfate	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	approved	Fibrinogen alpha chain	P02671	13591824	antagonist	unknown
DB00364	Sucralfate	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	approved	Fibrinogen beta chain	P02675	182430	antagonist	unknown
DB00364	Sucralfate	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	approved	Fibrinogen gamma chain	P02679	182439	antagonist	unknown
DB00365	Grepafloxacin	Fluoroquinolones	approved;investigational;withdrawn	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB00365	Grepafloxacin	Fluoroquinolones	approved;investigational;withdrawn	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB00366	Doxylamine	Aminoalkyl ethers	approved;vet_approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00366	Doxylamine	Aminoalkyl ethers	approved;vet_approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00366	Doxylamine	Aminoalkyl ethers	approved;vet_approved	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	None	unknown
DB00367	Levonorgestrel	Progestogens and estrogens, fixed combinations	approved;investigational	Progesterone receptor	P06401	35652	binder	yes
DB00367	Levonorgestrel	Progestogens and estrogens, fixed combinations	approved;investigational	3-oxo-5-alpha-steroid 4-dehydrogenase 1	P18405	177767	inhibitor	yes
DB00367	Levonorgestrel	Progestogens and estrogens, fixed combinations	approved;investigational	Estrogen receptor alpha	P03372	31234	other	yes
DB00367	Levonorgestrel	Progestogens and estrogens, fixed combinations	approved;investigational	Androgen receptor	P10275	178628	agonist	unknown
DB00367	Levonorgestrel	Progestogens and estrogens, fixed combinations	approved;investigational	Sex hormone-binding globulin	P04278	296673	None	unknown
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Alpha-1B adrenergic receptor	P35368	None	agonist	yes
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Alpha-1D adrenergic receptor	P25100	177807	agonist	yes
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Alpha-2C adrenergic receptor	P18825	178194	agonist	yes
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Beta-1 adrenergic receptor	P08588	178200	agonist	yes
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Beta-3 adrenergic receptor	P13945	178896	agonist	yes
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Phenylalanine-4-hydroxylase	P00439	189937	inhibitor	no
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Synaptic vesicular amine transporter	Q05940	292335	binder	unknown
DB00368	Norepinephrine	Adrenergic and dopaminergic agents	approved	Chromaffin granule amine transporter	P54219	None	binder	unknown
DB00369	Cidofovir	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved	DNA polymerase catalytic subunit	P08546	1780831	inhibitor	yes
DB00370	Mirtazapine	Other antidepressants	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00370	Mirtazapine	Other antidepressants	approved	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	yes
DB00370	Mirtazapine	Other antidepressants	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	yes
DB00370	Mirtazapine	Other antidepressants	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00370	Mirtazapine	Other antidepressants	approved	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB00370	Mirtazapine	Other antidepressants	approved	Histamine H1 receptor	P35367	510296	antagonist	no
DB00370	Mirtazapine	Other antidepressants	approved	Alpha-2C adrenergic receptor	P18825	178194	binder	unknown
DB00370	Mirtazapine	Other antidepressants	approved	5-hydroxytryptamine receptor 7	P34969	1857143	inhibitor	unknown
DB00370	Mirtazapine	Other antidepressants	approved	Alpha-1 adrenergic receptors	P25100	177807	binder	unknown
DB00370	Mirtazapine	Other antidepressants	approved	D(2) dopamine receptor	P14416	181432	inhibitor	unknown
DB00370	Mirtazapine	Other antidepressants	approved	D(3) dopamine receptor	P35462	927342	inhibitor	unknown
DB00370	Mirtazapine	Other antidepressants	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB00370	Mirtazapine	Other antidepressants	approved	Sodium-dependent serotonin transporter	P31645	36433	binder	unknown
DB00370	Mirtazapine	Other antidepressants	approved	Sodium-dependent dopamine transporter	Q01959	553260	binder	unknown
DB00370	Mirtazapine	Other antidepressants	approved	5-hydroxytryptamine receptor 2B	P41595	475198	binder	unknown
DB00370	Mirtazapine	Other antidepressants	approved	D(1) dopamine receptor	P21918	32049	inhibitor	unknown
DB00370	Mirtazapine	Other antidepressants	approved	Histamine H3 receptor	Q9Y5N1	5031291	antagonist	unknown
DB00370	Mirtazapine	Other antidepressants	approved	Alpha-1A adrenergic receptor	P35348	433201	binder	unknown
DB00370	Mirtazapine	Other antidepressants	approved	Beta-1 adrenergic receptor	P08588	178200	binder	unknown
DB00370	Mirtazapine	Other antidepressants	approved	Beta-2 adrenergic receptor	P07550	29371	binder	unknown
DB00371	Meprobamate	Carbamates	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB00371	Meprobamate	Carbamates	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	agonist	yes
DB00371	Meprobamate	Carbamates	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	agonist	yes
DB00371	Meprobamate	Carbamates	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	agonist	yes
DB00371	Meprobamate	Carbamates	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	agonist	yes
DB00371	Meprobamate	Carbamates	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	agonist	yes
DB00371	Meprobamate	Carbamates	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00373	Timolol	Beta blocking agents, non-selective, thiazides and other diuretics	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB00373	Timolol	Beta blocking agents, non-selective, thiazides and other diuretics	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	yes
DB00373	Timolol	Beta blocking agents, non-selective, thiazides and other diuretics	approved	Lysozyme	P00720	15261	None	unknown
DB00374	Treprostinil	Platelet aggregation inhibitors excl. heparin	approved;investigational	Prostacyclin receptor	P43119	495043	agonist	yes
DB00374	Treprostinil	Platelet aggregation inhibitors excl. heparin	approved;investigational	Peroxisome proliferator-activated receptor delta	Q03181	190230	agonist	yes
DB00374	Treprostinil	Platelet aggregation inhibitors excl. heparin	approved;investigational	P2Y purinoceptor 12	Q9H244	12083902	agonist	yes
DB00375	Colestipol	Bile acid sequestrants	approved	Bile acids	None	None	binder	yes
DB00376	Trihexyphenidyl	Tertiary amines	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00376	Trihexyphenidyl	Tertiary amines	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00376	Trihexyphenidyl	Tertiary amines	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00376	Trihexyphenidyl	Tertiary amines	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB00376	Trihexyphenidyl	Tertiary amines	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB00377	Palonosetron	Serotonin (5HT3) antagonists	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	yes
DB00378	Dydrogesterone	Progestogens and estrogens, fixed combinations	approved;investigational;withdrawn	Progesterone receptor	P06401	35652	agonist	yes
DB00379	Mexiletine	Antiarrhythmics, class Ib	approved;investigational	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00379	Mexiletine	Antiarrhythmics, class Ib	approved;investigational	Aryl hydrocarbon receptor	P35869	533324	agonist	unknown
DB00380	Dexrazoxane	Detoxifying agents for antineoplastic treatment	approved;withdrawn	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB00380	Dexrazoxane	Detoxifying agents for antineoplastic treatment	approved;withdrawn	DNA topoisomerase 2-beta	Q02880	None	None	unknown
DB00381	Amlodipine	Angiotensin II antagonists, other combinations	approved	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB00381	Amlodipine	Angiotensin II antagonists, other combinations	approved	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	inhibitor	yes
DB00381	Amlodipine	Angiotensin II antagonists, other combinations	approved	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	inhibitor	yes
DB00381	Amlodipine	Angiotensin II antagonists, other combinations	approved	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	yes
DB00381	Amlodipine	Angiotensin II antagonists, other combinations	approved	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	inhibitor	yes
DB00381	Amlodipine	Angiotensin II antagonists, other combinations	approved	Voltage-dependent N-type calcium channel subunit alpha-1B	Q00975	179758	inhibitor	unknown
DB00381	Amlodipine	Angiotensin II antagonists, other combinations	approved	Voltage-dependent calcium channel subunit alpha-2/delta-3	Q8IZS8	7105926	inhibitor	unknown
DB00381	Amlodipine	Angiotensin II antagonists, other combinations	approved	Voltage-gated calcium channel beta 1 subunit splice variant CavB1d	Q6TME4	37678114	inhibitor	unknown
DB00381	Amlodipine	Angiotensin II antagonists, other combinations	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB00381	Amlodipine	Angiotensin II antagonists, other combinations	approved	Sphingomyelin phosphodiesterase	P17405	179095	inhibitor	unknown
DB00383	Oxyphencyclimine	Synthetic anticholinergic agents in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB00383	Oxyphencyclimine	Synthetic anticholinergic agents in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00383	Oxyphencyclimine	Synthetic anticholinergic agents in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00384	Triamterene	Other potassium-sparing agents	approved	Amiloride-sensitive sodium channel subunit gamma	P51170	1004273	inhibitor	yes
DB00384	Triamterene	Other potassium-sparing agents	approved	Amiloride-sensitive sodium channel subunit alpha	P37088	452650	inhibitor	yes
DB00384	Triamterene	Other potassium-sparing agents	approved	Amiloride-sensitive sodium channel subunit beta	P51168	1004271	inhibitor	yes
DB00384	Triamterene	Other potassium-sparing agents	approved	Amiloride-sensitive sodium channel subunit delta	P51172	1066457	inhibitor	unknown
DB00385	Valrubicin	Anthracyclines and related substances	approved	DNA	None	None	intercalation	yes
DB00385	Valrubicin	Anthracyclines and related substances	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB00387	Procyclidine	Tertiary amines	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00387	Procyclidine	Tertiary amines	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00387	Procyclidine	Tertiary amines	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB00387	Procyclidine	Tertiary amines	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB00388	Phenylephrine	Sympathomimetics excl. antiglaucoma preparations	approved	Alpha-1A adrenergic receptor	P35348	433201	None	yes
DB00388	Phenylephrine	Sympathomimetics excl. antiglaucoma preparations	approved	Alpha-1B adrenergic receptor	P35368	None	None	yes
DB00388	Phenylephrine	Sympathomimetics excl. antiglaucoma preparations	approved	Alpha-1D adrenergic receptor	P25100	177807	None	yes
DB00389	Carbimazole	Sulfur-containing imidazole derivatives	approved;investigational	Thyroid peroxidase	P07202	339867	inhibitor	yes
DB00390	Digoxin	Digitalis glycosides	approved	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	None	yes
DB00391	Sulpiride	Benzamides	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00391	Sulpiride	Benzamides	approved;investigational	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB00391	Sulpiride	Benzamides	approved;investigational	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB00391	Sulpiride	Benzamides	approved;investigational	Carbonic anhydrase 3	P07451	189053812	inhibitor	unknown
DB00392	Ethopropazine	Tertiary amines	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00392	Ethopropazine	Tertiary amines	approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	yes
DB00392	Ethopropazine	Tertiary amines	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00393	Nimodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB00393	Nimodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	yes
DB00393	Nimodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1F	O60840	3183953	inhibitor	yes
DB00393	Nimodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	inhibitor	yes
DB00393	Nimodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit beta-1	Q02641	179806	inhibitor	yes
DB00393	Nimodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	inhibitor	yes
DB00393	Nimodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit beta-3	P54284	435135	inhibitor	yes
DB00393	Nimodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit beta-4	O00305	2058727	inhibitor	yes
DB00393	Nimodipine	Dihydropyridine derivatives	approved;investigational	Mineralocorticoid receptor	P08235	307166	antagonist	unknown
DB00393	Nimodipine	Dihydropyridine derivatives	approved;investigational	Aryl hydrocarbon receptor	P35869	533324	agonist	unknown
DB00394	Beclomethasone dipropionate	Glucocorticoids	approved;investigational	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00395	Carisoprodol	Carbamic acid esters	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	None	unknown
DB00395	Carisoprodol	Carbamic acid esters	approved	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	None	unknown
DB00395	Carisoprodol	Carbamic acid esters	approved	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	None	unknown
DB00396	Progesterone	Pregnen (4) derivatives	approved;vet_approved	Progesterone receptor	P06401	35652	agonist	yes
DB00396	Progesterone	Pregnen (4) derivatives	approved;vet_approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00396	Progesterone	Pregnen (4) derivatives	approved;vet_approved	Mineralocorticoid receptor	P08235	307166	antagonist	yes
DB00396	Progesterone	Pregnen (4) derivatives	approved;vet_approved	Steroid 17-alpha-hydroxylase/17,20 lyase	P05093	181342	inhibitor	unknown
DB00396	Progesterone	Pregnen (4) derivatives	approved;vet_approved	Kappa-type opioid receptor	P41145	532060	activator	unknown
DB00396	Progesterone	Pregnen (4) derivatives	approved;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00396	Progesterone	Pregnen (4) derivatives	approved;vet_approved	Alpha-1-acid glycoprotein 1	P02763	757907	None	unknown
DB00396	Progesterone	Pregnen (4) derivatives	approved;vet_approved	Glucocorticoid receptor	P04150	31680	partial agonist	unknown
DB00396	Progesterone	Pregnen (4) derivatives	approved;vet_approved	Androgen receptor	P10275	178628	None	unknown
DB00396	Progesterone	Pregnen (4) derivatives	approved;vet_approved	Sex hormone-binding globulin	P04278	296673	None	unknown
DB00397	Phenylpropanolamine	Sympathomimetics	approved;vet_approved;withdrawn	D(1A) dopamine receptor	P21728	30397	partial agonist	unknown
DB00397	Phenylpropanolamine	Sympathomimetics	approved;vet_approved;withdrawn	Beta-1 adrenergic receptor	P08588	178200	agonist	unknown
DB00397	Phenylpropanolamine	Sympathomimetics	approved;vet_approved;withdrawn	Beta-2 adrenergic receptor	P07550	29371	agonist	unknown
DB00397	Phenylpropanolamine	Sympathomimetics	approved;vet_approved;withdrawn	Alpha-2 adrenergic receptors	P18825	178194	None	unknown
DB00398	Sorafenib	Protein kinase inhibitors	approved;investigational	Serine/threonine-protein kinase B-raf	P15056	41387220	inhibitor	yes
DB00398	Sorafenib	Protein kinase inhibitors	approved;investigational	RAF proto-oncogene serine/threonine-protein kinase	P04049	35842	inhibitor	yes
DB00398	Sorafenib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 3	P35916	297050	antagonist	yes
DB00398	Sorafenib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 2	P35968	2655412	antagonist	yes
DB00398	Sorafenib	Protein kinase inhibitors	approved;investigational	Receptor-type tyrosine-protein kinase FLT3	P36888	409573	antagonist	yes
DB00398	Sorafenib	Protein kinase inhibitors	approved;investigational	Platelet-derived growth factor receptor beta	P09619	189732	antagonist	yes
DB00398	Sorafenib	Protein kinase inhibitors	approved;investigational	Mast/stem cell growth factor receptor Kit	P10721	34085	antagonist	yes
DB00398	Sorafenib	Protein kinase inhibitors	approved;investigational	Fibroblast growth factor receptor 1	P11362	31368	inhibitor	yes
DB00398	Sorafenib	Protein kinase inhibitors	approved;investigational	Proto-oncogene tyrosine-protein kinase receptor Ret	P07949	None	inhibitor	yes
DB00398	Sorafenib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 1	P17948	31432	inhibitor	yes
DB00399	Zoledronic acid	Bisphosphonates, combinations	approved	Farnesyl pyrophosphate synthase	P14324	182399	inhibitor	yes
DB00399	Zoledronic acid	Bisphosphonates, combinations	approved	Geranylgeranyl pyrophosphate synthase	O95749	4520350	inhibitor	yes
DB00399	Zoledronic acid	Bisphosphonates, combinations	approved	Hydroxylapatite	None	None	antagonist	yes
DB00400	Griseofulvin	Antibiotics	approved;investigational;vet_approved	Tubulin beta chain	P10875	170938	inhibitor	yes
DB00400	Griseofulvin	Antibiotics	approved;investigational;vet_approved	Tubulin alpha chain	P87066	2055378	inhibitor	yes
DB00400	Griseofulvin	Antibiotics	approved;investigational;vet_approved	Keratin, type I cytoskeletal 12	Q99456	None	other/unknown	unknown
DB00401	Nisoldipine	Dihydropyridine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB00401	Nisoldipine	Dihydropyridine derivatives	approved	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	inhibitor	yes
DB00401	Nisoldipine	Dihydropyridine derivatives	approved	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	inhibitor	yes
DB00401	Nisoldipine	Dihydropyridine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	yes
DB00401	Nisoldipine	Dihydropyridine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	inhibitor	yes
DB00402	Eszopiclone	Benzodiazepine related drugs	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00402	Eszopiclone	Benzodiazepine related drugs	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	agonist	unknown
DB00402	Eszopiclone	Benzodiazepine related drugs	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	agonist	unknown
DB00402	Eszopiclone	Benzodiazepine related drugs	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	agonist	unknown
DB00402	Eszopiclone	Benzodiazepine related drugs	approved;investigational	Translocator protein	P30536	306883	agonist	yes
DB00402	Eszopiclone	Benzodiazepine related drugs	approved;investigational	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00403	Ceruletide	Tests for bile duct patency	approved	Cholecystokinin receptor type A	P32238	306491	inducer	yes
DB00404	Alprazolam	Benzodiazepine derivatives	approved;illicit;investigational	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00405	Dexbrompheniramine	Substituted alkylamines	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00406	Gentian Violet	Other antifungals for topical use	approved	DNA	None	None	intercalation	yes
DB00407	Ardeparin	N/A	approved;investigational;withdrawn	Antithrombin-III	P01008	179161	potentiator	yes
DB00407	Ardeparin	N/A	approved;investigational;withdrawn	Heparin cofactor 2	P05546	183910	agonist	yes
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1A	P08908	189928	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1B	P28222	219679	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1D	P28221	177772	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1E	P28566	177774	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 3A	P46098	681914	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 5A	P47898	None	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 6	P50406	1162924	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 7	P34969	1857143	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-1A adrenergic receptor	P35348	433201	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-1B adrenergic receptor	P35368	None	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2A adrenergic receptor	P08913	178196	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2B adrenergic receptor	P18089	178198	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2C adrenergic receptor	P18825	178194	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Beta-1 adrenergic receptor	P08588	178200	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M1	P11229	34451	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M2	P08172	177990	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M3	P20309	32324	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M5	P08912	177988	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(1) dopamine receptor	P21918	32049	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(3) dopamine receptor	P35462	927342	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(4) dopamine receptor	P21917	291946	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(1B) dopamine receptor	P21918	32049	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Histamine H1 receptor	P35367	510296	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Histamine H2 receptor	P25021	184088	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Histamine H4 receptor	Q9H3N8	10241847	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Sodium-dependent serotonin transporter	P31645	36433	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Sodium-dependent noradrenaline transporter	P23975	189258	binder	unknown
DB00408	Loxapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Sodium-dependent dopamine transporter	Q01959	553260	binder	unknown
DB00409	Remoxipride	Benzamides	approved;withdrawn	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00409	Remoxipride	Benzamides	approved;withdrawn	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB00409	Remoxipride	Benzamides	approved;withdrawn	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB00409	Remoxipride	Benzamides	approved;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	other/unknown	unknown
DB00409	Remoxipride	Benzamides	approved;withdrawn	Sigma non-opioid intracellular receptor 1	Q99720	1783387	antagonist	unknown
DB00410	Mupirocin	Other nasal preparations	approved;investigational;vet_approved	Isoleucine--tRNA ligase	P41972	437916	inhibitor	yes
DB00411	Carbachol	Choline esters	approved	Muscarinic acetylcholine receptor M1	P11229	34451	agonist	yes
DB00411	Carbachol	Choline esters	approved	Muscarinic acetylcholine receptor M2	P08172	177990	agonist	yes
DB00411	Carbachol	Choline esters	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	agonist	yes
DB00411	Carbachol	Choline esters	approved	Acetylcholinesterase	P22303	177975	None	unknown
DB00411	Carbachol	Choline esters	approved	Muscarinic acetylcholine receptor M3	P20309	32324	None	unknown
DB00411	Carbachol	Choline esters	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	None	unknown
DB00412	Rosiglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	yes
DB00412	Rosiglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Long-chain-fatty-acid--CoA ligase 4	O60488	3158351	inhibitor	unknown
DB00412	Rosiglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB00412	Rosiglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Peroxisome proliferator-activated receptor delta	Q03181	190230	None	unknown
DB00412	Rosiglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Retinoic acid receptor RXR-alpha	P19793	35885	None	unknown
DB00412	Rosiglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Retinoic acid receptor RXR-beta	P28702	30448	None	unknown
DB00412	Rosiglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Retinoic acid receptor RXR-gamma	P48443	1053069	None	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	D(3) dopamine receptor	P35462	927342	agonist	yes
DB00413	Pramipexole	Dopamine agonists	approved;investigational	D(2) dopamine receptor	P14416	181432	agonist	yes
DB00413	Pramipexole	Dopamine agonists	approved;investigational	D(4) dopamine receptor	P21917	291946	agonist	yes
DB00413	Pramipexole	Dopamine agonists	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	unknown	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	unknown	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	unknown	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	partial agonist	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	unknown	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	unknown	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	unknown	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	unknown	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	unknown	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	D(1A) dopamine receptor	P21728	30397	unknown	unknown
DB00413	Pramipexole	Dopamine agonists	approved;investigational	D(1B) dopamine receptor	P21918	32049	unknown	unknown
DB00414	Acetohexamide	Sulfonylureas	approved;investigational;withdrawn	ATP-sensitive inward rectifier potassium channel 1	P48048	529313	inhibitor	yes
DB00415	Ampicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB00415	Ampicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB00415	Ampicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00415	Ampicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB00415	Ampicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB00415	Ampicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Solute carrier family 15 member 1	P46059	773588	None	unknown
DB00415	Ampicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Solute carrier family 15 member 2	Q16348	999213	None	unknown
DB00415	Ampicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Angiopoietin-1 receptor	Q02763	None	None	unknown
DB00416	Metocurine Iodide	N/A	approved;withdrawn	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB00417	Phenoxymethylpenicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Penicillin-binding protein 1A	Q8XJ01	18145626	None	yes
DB00417	Phenoxymethylpenicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	MecA PBP2' (penicillin binding protein 2')	Q53707	46611	inhibitor	yes
DB00417	Phenoxymethylpenicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	D-alanyl-D-alanine carboxypeptidase DacB	P24228	41216	None	unknown
DB00417	Phenoxymethylpenicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Penicillin acylase	P12256	143306	None	unknown
DB00417	Phenoxymethylpenicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Solute carrier family 15 member 1	P46059	773588	None	unknown
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB00418	Secobarbital	Barbiturates, plain	approved;vet_approved	NMDA receptor	O60391	3025446	antagonist	unknown
DB00419	Miglustat	Various alimentary tract and metabolism products	approved	Ceramide glucosyltransferase	Q16739	1325917	inhibitor	yes
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB00420	Promazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	Mineralocorticoid receptor	P08235	307166	antagonist	yes
DB00421	Spironolactone	Aldosterone antagonists	approved	Androgen receptor	P10275	178628	antagonist	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	Progesterone receptor	P06401	35652	agonist	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	Glucocorticoid receptor	P04150	31680	antagonist	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	Cytochrome P450 11B2, mitochondrial	P19099	35200	antagonist	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	17alpha-hydroxylase	None	None	antagonist	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	17,20-desmolase	None	None	antagonist	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	3-oxo-5-alpha-steroid 4-dehydrogenase	Q9H8P0	338469	antagonist	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	Sex hormone-binding globulin	P04278	296673	binder	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	Voltage-dependent calcium channel	Q9P0X4	5565888	inhibitor	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	Dihydrotestosterone receptor	None	None	inhibitor	unknown
DB00421	Spironolactone	Aldosterone antagonists	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00422	Methylphenidate	Centrally acting sympathomimetics	approved;investigational	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB00422	Methylphenidate	Centrally acting sympathomimetics	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB00422	Methylphenidate	Centrally acting sympathomimetics	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	unknown
DB00423	Methocarbamol	Carbamic acid esters	approved;vet_approved	Carbonic anhydrase 1	P00915	29600	inhibitor	no
DB00424	Hyoscyamine	Belladonna and derivatives in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00424	Hyoscyamine	Belladonna and derivatives in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00424	Hyoscyamine	Belladonna and derivatives in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00424	Hyoscyamine	Belladonna and derivatives in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB00425	Zolpidem	Benzodiazepine related drugs	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00425	Zolpidem	Benzodiazepine related drugs	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	agonist	unknown
DB00425	Zolpidem	Benzodiazepine related drugs	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	agonist	unknown
DB00425	Zolpidem	Benzodiazepine related drugs	approved	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	agonist	unknown
DB00425	Zolpidem	Benzodiazepine related drugs	approved	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	agonist	unknown
DB00426	Famciclovir	Antivirals	approved;investigational	DNA polymerase catalytic subunit	P04293	59530	inhibitor	yes
DB00426	Famciclovir	Antivirals	approved;investigational	DNA polymerase catalytic subunit	P09252	60016	inhibitor	yes
DB00427	Triprolidine	Other antihistamines for systemic use	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00428	Streptozocin	Nitrosoureas	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB00428	Streptozocin	Nitrosoureas	approved;investigational	Solute carrier family 2, facilitated glucose transporter member 2	P11168	307125	ligand	unknown
DB00428	Streptozocin	Nitrosoureas	approved;investigational	O-GlcNAcase BT_4395	Q89ZI2	29337303	antagonist	yes
DB00428	Streptozocin	Nitrosoureas	approved;investigational	Bifunctional protein NCOAT	O60502	None	None	unknown
DB00429	Carboprost Tromethamine	Prostaglandins	approved	Prostaglandin E2 receptor EP1 subtype	P34995	410209	agonist	yes
DB00430	Cefpiramide	Third-generation cephalosporins	approved	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB00430	Cefpiramide	Third-generation cephalosporins	approved	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB00430	Cefpiramide	Third-generation cephalosporins	approved	Penicillin-binding protein 1A	Q07806	1763284	inhibitor	yes
DB00430	Cefpiramide	Third-generation cephalosporins	approved	Penicillin-binding protein 1B	Q9X6W0	4887211	inhibitor	yes
DB00430	Cefpiramide	Third-generation cephalosporins	approved	D-alanyl-D-alanine carboxypeptidase DacC	P08506	41218	inhibitor	yes
DB00430	Cefpiramide	Third-generation cephalosporins	approved	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB00430	Cefpiramide	Third-generation cephalosporins	approved	Penicillin binding protein 2a	C1KC03	None	inhibitor	no
DB00431	Lindane	Chlorine containing products	approved;withdrawn	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	antagonist	yes
DB00431	Lindane	Chlorine containing products	approved;withdrawn	Glycine receptor subunit alpha-1	P23415	31851	antagonist	unknown
DB00431	Lindane	Chlorine containing products	approved;withdrawn	Glycine receptor subunit alpha-2	P23416	31849	antagonist	unknown
DB00431	Lindane	Chlorine containing products	approved;withdrawn	Glycine receptor subunit alpha-3	O75311	3342792	antagonist	unknown
DB00431	Lindane	Chlorine containing products	approved;withdrawn	Glycine receptor subunit beta	P48167	992687	antagonist	unknown
DB00431	Lindane	Chlorine containing products	approved;withdrawn	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	None	unknown
DB00431	Lindane	Chlorine containing products	approved;withdrawn	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	None	unknown
DB00431	Lindane	Chlorine containing products	approved;withdrawn	Progesterone receptor	P06401	35652	None	unknown
DB00431	Lindane	Chlorine containing products	approved;withdrawn	Estrogen receptor alpha	P03372	31234	None	unknown
DB00431	Lindane	Chlorine containing products	approved;withdrawn	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00432	Trifluridine	Antivirals	approved;investigational	Thymidylate synthase	P04818	37479	inhibitor	yes
DB00432	Trifluridine	Antivirals	approved;investigational	DNA	None	None	other/unknown	yes
DB00433	Prochlorperazine	Phenothiazines with piperazine structure	approved;vet_approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00434	Cyproheptadine	Other antihistamines for systemic use	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00434	Cyproheptadine	Other antihistamines for systemic use	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00434	Cyproheptadine	Other antihistamines for systemic use	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB00434	Cyproheptadine	Other antihistamines for systemic use	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00434	Cyproheptadine	Other antihistamines for systemic use	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00434	Cyproheptadine	Other antihistamines for systemic use	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00434	Cyproheptadine	Other antihistamines for systemic use	approved	5-hydroxytryptamine receptor 7	P34969	1857143	None	unknown
DB00435	Nitric Oxide	Other respiratory system products	approved	Guanylate cyclase soluble subunit alpha-2	P33402	31671	inducer	yes
DB00435	Nitric Oxide	Other respiratory system products	approved	Metallothionein-1A	P04731	None	None	unknown
DB00435	Nitric Oxide	Other respiratory system products	approved	Indoleamine 2,3-dioxygenase 1	P14902	306956	None	unknown
DB00436	Bendroflumethiazide	Low-ceiling diuretics and potassium-sparing agents	approved	Solute carrier family 12 member 3	P55017	1172161	inhibitor	yes
DB00436	Bendroflumethiazide	Low-ceiling diuretics and potassium-sparing agents	approved	Calcium-activated potassium channel subunit alpha-1	Q12791	537439	inducer	yes
DB00436	Bendroflumethiazide	Low-ceiling diuretics and potassium-sparing agents	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB00436	Bendroflumethiazide	Low-ceiling diuretics and potassium-sparing agents	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB00436	Bendroflumethiazide	Low-ceiling diuretics and potassium-sparing agents	approved	Carbonic anhydrase 4	P22748	179791	inhibitor	unknown
DB00437	Allopurinol	Preparations inhibiting uric acid production	approved	Xanthine dehydrogenase/oxidase	P47989	10336525	inhibitor	yes
DB00438	Ceftazidime	Third-generation cephalosporins	approved	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB00438	Ceftazidime	Third-generation cephalosporins	approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00438	Ceftazidime	Third-generation cephalosporins	approved	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB00438	Ceftazidime	Third-generation cephalosporins	approved	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB00438	Ceftazidime	Third-generation cephalosporins	approved	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB00438	Ceftazidime	Third-generation cephalosporins	approved	Penicillin-binding protein 1B	Q9X6W0	4887211	inhibitor	yes
DB00438	Ceftazidime	Third-generation cephalosporins	approved	Penicillin-binding protein 2	Q9X6V3	None	inhibitor	yes
DB00438	Ceftazidime	Third-generation cephalosporins	approved	Penicillin-binding protein 2	P0AD65	42314	inhibitor	yes
DB00438	Ceftazidime	Third-generation cephalosporins	approved	D-alanyl-D-alanine endopeptidase	P72161	None	inhibitor	no
DB00439	Cerivastatin	HMG CoA reductase inhibitors	approved;withdrawn	3-hydroxy-3-methylglutaryl-coenzyme A reductase	P04035	306865	inhibitor	yes
DB00440	Trimethoprim	Combinations of sulfonamides and trimethoprim, incl. derivatives	approved;vet_approved	Thymidylate synthase	P04818	37479	inhibitor	yes
DB00440	Trimethoprim	Combinations of sulfonamides and trimethoprim, incl. derivatives	approved;vet_approved	Dihydrofolate reductase	P00374	182724	inhibitor	no
DB00441	Gemcitabine	Pyrimidine analogues	approved	DNA	None	None	cross-linking/alkylation	yes
DB00441	Gemcitabine	Pyrimidine analogues	approved	Ribonucleoside-diphosphate reductase large subunit	P23921	36065	inhibitor	yes
DB00441	Gemcitabine	Pyrimidine analogues	approved	Thymidylate synthase	P04818	37479	inhibitor	unknown
DB00441	Gemcitabine	Pyrimidine analogues	approved	UMP-CMP kinase	P30085	6578133	inhibitor	unknown
DB00442	Entecavir	Nucleoside and nucleotide reverse transcriptase inhibitors	approved;investigational	DNA	None	None	other	yes
DB00443	Betamethasone	Corticosteroids and mydriatics in combination	approved;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00444	Teniposide	Podophyllotoxin derivatives	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB00445	Epirubicin	Anthracyclines and related substances	approved	Chromodomain-helicase-DNA-binding protein 1	O14646	2645429	antagonist	yes
DB00445	Epirubicin	Anthracyclines and related substances	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	unknown
DB00445	Epirubicin	Anthracyclines and related substances	approved	DNA	None	None	intercalation	unknown
DB00446	Chloramphenicol	Antibiotics	approved;vet_approved	50S ribosomal protein L16	P0ADY7	None	inhibitor	unknown
DB00446	Chloramphenicol	Antibiotics	approved;vet_approved	Dr hemagglutinin structural subunit	P24093	145801	antagonist	unknown
DB00446	Chloramphenicol	Antibiotics	approved;vet_approved	Complement decay-accelerating factor	P08174	181468	other	unknown
DB00448	Lansoprazole	Proton pump inhibitors	approved;investigational	Potassium-transporting ATPase alpha chain 1	P20648	561634	inhibitor	yes
DB00448	Lansoprazole	Proton pump inhibitors	approved;investigational	Microtubule-associated protein tau	P10636	None	None	unknown
DB00449	Dipivefrin	Sympathomimetics in glaucoma therapy	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB00449	Dipivefrin	Sympathomimetics in glaucoma therapy	approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00449	Dipivefrin	Sympathomimetics in glaucoma therapy	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB00449	Dipivefrin	Sympathomimetics in glaucoma therapy	approved	Cholinesterase	P06276	1311630	substrate	yes
DB00449	Dipivefrin	Sympathomimetics in glaucoma therapy	approved	Acetylcholinesterase	P22303	177975	inhibitor	unknown
DB00450	Droperidol	Butyrophenone derivatives	approved;vet_approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00450	Droperidol	Butyrophenone derivatives	approved;vet_approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00451	Levothyroxine	Thyroid hormones	approved	Thyroid hormone receptor alpha	P10827	825639	agonist	yes
DB00451	Levothyroxine	Thyroid hormones	approved	Thyroid hormone receptor beta	P10828	31207	agonist	yes
DB00452	Framycetin	Other nasal preparations	approved	16S rRNA	None	None	inhibitor	yes
DB00452	Framycetin	Other nasal preparations	approved	30S ribosomal protein S12	P0A7S3	43010	inhibitor	yes
DB00452	Framycetin	Other nasal preparations	approved	C-X-C chemokine receptor type 4	P61073	189314	antagonist	unknown
DB00453	Clomocycline	Tetracyclines	approved	30S ribosomal protein S4	P0A7V8	42798	inhibitor	yes
DB00453	Clomocycline	Tetracyclines	approved	30S ribosomal protein S9	P0A7X3	535073	inhibitor	unknown
DB00453	Clomocycline	Tetracyclines	approved	16S rRNA	None	None	inhibitor	no
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Kappa-type opioid receptor	P41145	532060	None	yes
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Glutamate receptor ionotropic, NMDA 1	Q05586	219920	antagonist	unknown
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Glutamate receptor ionotropic, NMDA 2B	Q13224	1899202	antagonist	unknown
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Glutamate receptor ionotropic, NMDA 2A	Q12879	558749	antagonist	unknown
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Glutamate receptor ionotropic, NMDA 2C	Q14957	1196449	antagonist	unknown
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Glutamate receptor ionotropic, NMDA 2D	O15399	2444026	antagonist	unknown
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Muscarinic acetylcholine receptor	P08912	177988	binder	unknown
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Mu-type opioid receptor	P35372	452073	agonist	unknown
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Sodium-dependent serotonin transporter	P31645	36433	binding	unknown
DB00454	Pethidine	Phenylpiperidine derivatives	approved	Liver carboxylesterase 1	P23141	None	None	unknown
DB00455	Loratadine	Other antihistamines for systemic use	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00455	Loratadine	Other antihistamines for systemic use	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	None	unknown
DB00456	Cefalotin	First-generation cephalosporins	approved;investigational;vet_approved	D-alanyl-D-alanine carboxypeptidase	P15555	515050	inhibitor	yes
DB00456	Cefalotin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB00456	Cefalotin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB00456	Cefalotin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00456	Cefalotin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB00456	Cefalotin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB00456	Cefalotin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB00456	Cefalotin	First-generation cephalosporins	approved;investigational;vet_approved	Beta-lactamase	P00811	145267	potentiator	yes
DB00457	Prazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00457	Prazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	yes
DB00457	Prazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	yes
DB00457	Prazosin	Alpha-adrenoreceptor antagonists	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00457	Prazosin	Alpha-adrenoreceptor antagonists	approved	Potassium voltage-gated channel subfamily H member 6	Q9H252	11878259	inhibitor	unknown
DB00457	Prazosin	Alpha-adrenoreceptor antagonists	approved	Potassium voltage-gated channel subfamily H member 7	Q9NS40	4104136	inhibitor	unknown
DB00457	Prazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-2A adrenergic receptor	P08913	178196	binder	unknown
DB00457	Prazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-2B adrenergic receptor	P18089	178198	binder	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Histamine H1 receptor	P35367	510296	antagonist	no
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	no
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	no
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Potassium voltage-gated channel subfamily D member 2	Q9NZV8	4530478	inhibitor	no
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Potassium voltage-gated channel subfamily D member 3	Q9UK17	2935434	inhibitor	no
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	D(1) dopamine receptor	P21918	32049	binder	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	D(2) dopamine receptor	P14416	181432	binder	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 1A	P08908	189928	activator	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 6	P50406	1162924	binder	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Potassium voltage-gated channel subfamily H member 1	O95259	None	None	unknown
DB00458	Imipramine	Non-selective monoamine reuptake inhibitors	approved	Alpha-1-acid glycoprotein 2	P19652	16359000	None	unknown
DB00459	Acitretin	Retinoids for treatment of psoriasis	approved	Retinoic acid receptor RXR-alpha	P19793	35885	agonist	yes
DB00459	Acitretin	Retinoids for treatment of psoriasis	approved	Retinoic acid receptor alpha	P10276	36157	agonist	yes
DB00459	Acitretin	Retinoids for treatment of psoriasis	approved	Retinoic acid receptor beta	P10826	35883	agonist	yes
DB00459	Acitretin	Retinoids for treatment of psoriasis	approved	Retinoic acid receptor gamma	P13631	306887	agonist	yes
DB00459	Acitretin	Retinoids for treatment of psoriasis	approved	Retinoic acid receptor RXR-beta	P28702	30448	agonist	yes
DB00459	Acitretin	Retinoids for treatment of psoriasis	approved	Retinoic acid receptor RXR-gamma	P48443	1053069	agonist	yes
DB00459	Acitretin	Retinoids for treatment of psoriasis	approved	Retinol-binding protein 1	P09455	190948	agonist	unknown
DB00461	Nabumetone	Other antiinflammatory and antirheumatic agents, non-steroids	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00461	Nabumetone	Other antiinflammatory and antirheumatic agents, non-steroids	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00462	Methylscopolamine bromide	N/A	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00462	Methylscopolamine bromide	N/A	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00462	Methylscopolamine bromide	N/A	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00464	Sodium Tetradecyl Sulfate	Sclerosing agents for local injection	approved;investigational	Vitamin K-dependent protein C	P04070	190334	inhibitor	yes
DB00464	Sodium Tetradecyl Sulfate	Sclerosing agents for local injection	approved;investigational	Vitamin K-dependent protein S	P07225	190289	inhibitor	yes
DB00465	Ketorolac	Acetic acid derivatives and related substances	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00465	Ketorolac	Acetic acid derivatives and related substances	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00467	Enoxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB00467	Enoxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB00467	Enoxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	no
DB00468	Quinine	Quinine and derivatives	approved	Fe(II)-protoporphyrin IX	None	None	antagonist	yes
DB00468	Quinine	Quinine and derivatives	approved	Platelet glycoprotein IX	P14770	2160046	other	unknown
DB00468	Quinine	Quinine and derivatives	approved	Intermediate conductance calcium-activated potassium channel protein 4	O15554	2584866	inhibitor	unknown
DB00469	Tenoxicam	Oxicams	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00469	Tenoxicam	Oxicams	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00470	Dronabinol	Other antiemetics	approved;illicit	Cannabinoid receptor 1	P21554	29915	agonist	yes
DB00470	Dronabinol	Other antiemetics	approved;illicit	Cannabinoid receptor 2	P34972	407807	agonist	unknown
DB00471	Montelukast	Leukotriene receptor antagonists	approved	Cysteinyl leukotriene receptor 1	Q9Y271	5353887	antagonist	yes
DB00471	Montelukast	Leukotriene receptor antagonists	approved	Arachidonate 5-lipoxygenase	P09917	187193	other/unknown	unknown
DB00472	Fluoxetine	Antidepressants in combination with psycholeptics	approved;vet_approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00472	Fluoxetine	Antidepressants in combination with psycholeptics	approved;vet_approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00472	Fluoxetine	Antidepressants in combination with psycholeptics	approved;vet_approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00472	Fluoxetine	Antidepressants in combination with psycholeptics	approved;vet_approved	Cyclin-dependent kinases regulatory subunit 1	P61024	None	None	unknown
DB00472	Fluoxetine	Antidepressants in combination with psycholeptics	approved;vet_approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	unknown
DB00472	Fluoxetine	Antidepressants in combination with psycholeptics	approved;vet_approved	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	antagonist	unknown
DB00472	Fluoxetine	Antidepressants in combination with psycholeptics	approved;vet_approved	Neuronal acetylcholine receptor subunit beta-4	P30926	1458126	antagonist	unknown
DB00473	Hexylcaine	N/A	approved;withdrawn	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00473	Hexylcaine	N/A	approved;withdrawn	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	unknown
DB00474	Methohexital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	antagonist	yes
DB00475	Chlordiazepoxide	Benzodiazepine derivatives	approved;illicit;investigational	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00476	Duloxetine	Other antidepressants	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00476	Duloxetine	Other antidepressants	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00476	Duloxetine	Other antidepressants	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	yes
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	yes
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	D(1) dopamine receptor	P21918	32049	inhibitor	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	D(3) dopamine receptor	P35462	927342	inhibitor	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	D(4) dopamine receptor	P21917	291946	binder	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	D(1B) dopamine receptor	P21918	32049	inhibitor	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	5-hydroxytryptamine receptor 2C	P28335	338028	binder	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	5-hydroxytryptamine 2 receptor	P28335	338028	binder	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Alpha-1 adrenergic receptors	P25100	177807	inhibitor	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Alpha-2 adrenergic receptors	P18825	178194	inhibitor	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Sphingomyelin phosphodiesterase	P17405	179095	inhibitor	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Calmodulin	P0DP23	179888	inhibitor	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	alpha1-acid glycoprotein	P19652	16359000	binder	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	5-hydroxytryptamine receptor 6	P50406	1162924	binder	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	5-hydroxytryptamine receptor 7	P34969	1857143	binder	unknown
DB00477	Chlorpromazine	Phenothiazines with aliphatic side-chain	approved;investigational;vet_approved	Histamine H4 receptor	Q9H3N8	10241847	binder	unknown
DB00478	Rimantadine	Cyclic amines	approved;investigational	Matrix protein 2	P21430	324265	other/unknown	yes
DB00479	Amikacin	Antibiotics	approved;investigational;vet_approved	30S ribosomal protein S12	P0A7S3	43010	inhibitor	yes
DB00479	Amikacin	Antibiotics	approved;investigational;vet_approved	16S rRNA	None	None	inhibitor	unknown
DB00480	Lenalidomide	Other immunosuppressants	approved	Protein cereblon	Q96SW2	None	inhibitor	yes
DB00480	Lenalidomide	Other immunosuppressants	approved	Tumor necrosis factor ligand superfamily member 11	O14788	None	inhibitor	yes
DB00480	Lenalidomide	Other immunosuppressants	approved	Cadherin-5	P33151	None	antagonist	unknown
DB00480	Lenalidomide	Other immunosuppressants	approved	Prostaglandin G/H synthase 2	P35354	291988	negative modulator	unknown
DB00481	Raloxifene	Selective estrogen receptor modulators	approved;investigational	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00481	Raloxifene	Selective estrogen receptor modulators	approved;investigational	Estrogen receptor beta	Q92731	2911152	agonist	yes
DB00481	Raloxifene	Selective estrogen receptor modulators	approved;investigational	Serpin B9	P50453	None	None	unknown
DB00481	Raloxifene	Selective estrogen receptor modulators	approved;investigational	Trefoil factor 1	P04155	None	None	unknown
DB00482	Celecoxib	Other antineoplastic agents	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00482	Celecoxib	Other antineoplastic agents	approved;investigational	3-phosphoinositide-dependent protein kinase 1	O15530	2407613	inhibitor	unknown
DB00482	Celecoxib	Other antineoplastic agents	approved;investigational	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB00482	Celecoxib	Other antineoplastic agents	approved;investigational	Carbonic anhydrase 3	P07451	189053812	inhibitor	unknown
DB00482	Celecoxib	Other antineoplastic agents	approved;investigational	ATP-binding cassette sub-family B member 5	Q2M3G0	None	substrate	unknown
DB00482	Celecoxib	Other antineoplastic agents	approved;investigational	ATP-binding cassette sub-family G member 2	Q9UNQ0	4185796	None	unknown
DB00482	Celecoxib	Other antineoplastic agents	approved;investigational	Multidrug resistance protein 1	P08183	307180	None	unknown
DB00483	Gallamine Triethiodide	N/A	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00483	Gallamine Triethiodide	N/A	approved	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB00483	Gallamine Triethiodide	N/A	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	unknown
DB00483	Gallamine Triethiodide	N/A	approved	Muscarinic acetylcholine receptor M1	P11229	34451	None	unknown
DB00483	Gallamine Triethiodide	N/A	approved	Muscarinic acetylcholine receptor M5	P08912	177988	None	unknown
DB00484	Brimonidine	Other dermatologicals	approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00484	Brimonidine	Other dermatologicals	approved	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB00484	Brimonidine	Other dermatologicals	approved	Alpha-2C adrenergic receptor	P18825	178194	agonist	yes
DB00485	Dicloxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational;vet_approved	Penicillin-binding protein 3	A0A0E1R3H3	None	inhibitor	yes
DB00485	Dicloxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational;vet_approved	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB00485	Dicloxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational;vet_approved	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB00485	Dicloxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational;vet_approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00485	Dicloxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational;vet_approved	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB00485	Dicloxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational;vet_approved	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB00486	Nabilone	Other antiemetics	approved;investigational	Cannabinoid receptor 2	P34972	407807	partial agonist	yes
DB00486	Nabilone	Other antiemetics	approved;investigational	Cannabinoid receptor 1	P21554	29915	partial agonist	yes
DB00487	Pefloxacin	Fluoroquinolones	approved	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB00487	Pefloxacin	Fluoroquinolones	approved	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB00487	Pefloxacin	Fluoroquinolones	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	unknown
DB00487	Pefloxacin	Fluoroquinolones	approved	DNA topoisomerase 1	Q06AK7	None	inhibitor	unknown
DB00488	Altretamine	Other antineoplastic agents	approved	DNA	None	None	other/unknown	yes
DB00489	Sotalol	Beta blocking agents, non-selective	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	yes
DB00489	Sotalol	Beta blocking agents, non-selective	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB00489	Sotalol	Beta blocking agents, non-selective	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	yes
DB00490	Buspirone	Azaspirodecanedione derivatives	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	partial agonist	yes
DB00490	Buspirone	Azaspirodecanedione derivatives	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00491	Miglitol	Alpha glucosidase inhibitors	approved	Maltase-glucoamylase, intestinal	O43451	17648144	antagonist	yes
DB00491	Miglitol	Alpha glucosidase inhibitors	approved	Lysosomal alpha-glucosidase	P10253	31608	antagonist	yes
DB00491	Miglitol	Alpha glucosidase inhibitors	approved	Neutral alpha-glucosidase AB	Q14697	None	antagonist	yes
DB00491	Miglitol	Alpha glucosidase inhibitors	approved	Neutral alpha-glucosidase C	Q8TET4	None	antagonist	yes
DB00492	Fosinopril	ACE inhibitors, plain	approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Penicillin-binding protein 3	P42971	790944	inhibitor	yes
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Solute carrier family 22 member 6	Q4U2R8	3831566	None	unknown
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Solute carrier family 22 member 8	Q8TCC7	4378059	None	unknown
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Solute carrier family 22 member 11	Q9NSA0	7707622	None	unknown
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Solute carrier family 22 member 7	Q9Y694	5001689	None	unknown
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Solute carrier family 15 member 1	P46059	773588	None	unknown
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Serum albumin	P02768	28590	None	unknown
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Beta-lactamase	B2ZTR6	None	None	unknown
DB00493	Cefotaxime	Third-generation cephalosporins	approved	Solute carrier family 15 member 2	Q16348	999213	None	unknown
DB00494	Entacapone	Other dopaminergic agents	approved;investigational	Catechol O-methyltransferase	P21964	180920	inhibitor	yes
DB00495	Zidovudine	Antivirals for treatment of HIV infections, combinations	approved	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB00495	Zidovudine	Antivirals for treatment of HIV infections, combinations	approved	Telomerase reverse transcriptase	O14746	None	inhibitor	unknown
DB00496	Darifenacin	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB00496	Darifenacin	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00496	Darifenacin	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00496	Darifenacin	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB00496	Darifenacin	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB00497	Oxycodone	Natural opium alkaloids	approved;illicit;investigational	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00497	Oxycodone	Natural opium alkaloids	approved;illicit;investigational	Kappa-type opioid receptor	P41145	532060	agonist	yes
DB00497	Oxycodone	Natural opium alkaloids	approved;illicit;investigational	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB00497	Oxycodone	Natural opium alkaloids	approved;illicit;investigational	Kappa-type opioid receptor 2b	None	None	agonist	unknown
DB00497	Oxycodone	Natural opium alkaloids	approved;illicit;investigational	alpha1-acid glycoprotein	P19652	16359000	binder	unknown
DB00498	Phenindione	Vitamin K antagonists	approved;investigational	Vitamin K epoxide reductase complex subunit 1	Q9BQB6	40217983	inhibitor	yes
DB00499	Flutamide	Anti-androgens	approved;investigational	Androgen receptor	P10275	178628	antagonist	yes
DB00499	Flutamide	Anti-androgens	approved;investigational	Aryl hydrocarbon receptor	P35869	533324	agonist	unknown
DB00499	Flutamide	Anti-androgens	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00500	Tolmetin	Acetic acid derivatives and related substances	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00500	Tolmetin	Acetic acid derivatives and related substances	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00501	Cimetidine	H2-receptor antagonists	approved;investigational	Histamine H2 receptor	P25021	184088	antagonist	yes
DB00502	Haloperidol	Butyrophenone derivatives	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00502	Haloperidol	Butyrophenone derivatives	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB00502	Haloperidol	Butyrophenone derivatives	approved	Glutamate receptor ionotropic, NMDA 2B	Q13224	1899202	antagonist	unknown
DB00502	Haloperidol	Butyrophenone derivatives	approved	5-hydroxytryptamine receptor 2A	P28223	36431	other/unknown	unknown
DB00502	Haloperidol	Butyrophenone derivatives	approved	D(3) dopamine receptor	P35462	927342	inverse agonist	unknown
DB00502	Haloperidol	Butyrophenone derivatives	approved	Melanin-concentrating hormone receptor 1	Q99705	None	None	unknown
DB00502	Haloperidol	Butyrophenone derivatives	approved	Synaptic vesicular amine transporter	Q05940	292335	None	unknown
DB00503	Ritonavir	Antivirals for treatment of HIV infections, combinations	approved;investigational	Human immunodeficiency virus type 1 protease	Q72874	None	inhibitor	yes
DB00503	Ritonavir	Antivirals for treatment of HIV infections, combinations	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	activator	unknown
DB00504	Levallorphan	N/A	approved	Mu-type opioid receptor	P35372	452073	partial agonist	yes
DB00507	Nitazoxanide	Other agents against amoebiasis and other protozoal diseases	approved;investigational;vet_approved	Pyruvate-flavodoxin oxidoreductase	P94692	None	antagonist	yes
DB00508	Triflupromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB00508	Triflupromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00508	Triflupromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	yes
DB00508	Triflupromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00508	Triflupromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00509	Dextrothyroxine	Other lipid modifying agents	approved;investigational	Thyroid hormone receptor alpha	P10827	825639	agonist	yes
DB00509	Dextrothyroxine	Other lipid modifying agents	approved;investigational	Thyroid hormone receptor beta	P10828	31207	agonist	yes
DB00509	Dextrothyroxine	Other lipid modifying agents	approved;investigational	Thyroid peroxidase	P07202	339867	None	unknown
DB00511	Acetyldigitoxin	Digitalis glycosides	approved	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	inhibitor	yes
DB00512	Vancomycin	Antibiotics	approved	D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan	None	None	ligand	yes
DB00513	Aminocaproic Acid	Amino acids	approved;investigational	Plasminogen	P00747	387026	inhibitor	yes
DB00513	Aminocaproic Acid	Amino acids	approved;investigational	Tissue-type plasminogen activator	P00750	339834	antagonist	yes
DB00513	Aminocaproic Acid	Amino acids	approved;investigational	Apolipoprotein(a)	P08519	28620	other	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Sigma non-opioid intracellular receptor 1	Q99720	1783387	agonist	yes
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	HCG20471, isoform CRA_c	Q5T1J1	123231939	agonist	yes
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	yes
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Membrane-associated progesterone receptor component 1	O00264	None	binder	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	antagonist	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Neuronal acetylcholine receptor subunit beta-4	P30926	1458126	antagonist	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	antagonist	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Mu-type opioid receptor	P35372	452073	agonist	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Delta-type opioid receptor	P41143	27545517	agonist	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	NADPH oxidase	P15153	190824	inhibitor	unknown
DB00514	Dextromethorphan	Opium alkaloids and derivatives	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB00515	Cisplatin	Platinum compounds	approved	DNA	None	None	cross-linking/alkylation	yes
DB00515	Cisplatin	Platinum compounds	approved	DNA-3-methyladenine glycosylase	P29372	None	None	unknown
DB00515	Cisplatin	Platinum compounds	approved	Alpha-2-macroglobulin	P01023	177870	None	unknown
DB00515	Cisplatin	Platinum compounds	approved	Serotransferrin	P02787	339453	None	unknown
DB00515	Cisplatin	Platinum compounds	approved	Copper transport protein ATOX1	O00244	None	None	unknown
DB00517	Anisotropine Methylbromide	N/A	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00517	Anisotropine Methylbromide	N/A	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00517	Anisotropine Methylbromide	N/A	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB00518	Albendazole	Benzimidazole derivatives	approved;vet_approved	Tubulin beta-2 chain	F1L7U3	None	inhibitor	yes
DB00518	Albendazole	Benzimidazole derivatives	approved;vet_approved	Tubulin alpha-1A chain	Q71U36	37492	inhibitor	no
DB00518	Albendazole	Benzimidazole derivatives	approved;vet_approved	Tubulin beta-4B chain	P68371	37494	inhibitor	no
DB00518	Albendazole	Benzimidazole derivatives	approved;vet_approved	Fumarate reductase flavoprotein subunit	P83223	24346572	inhibitor	unknown
DB00519	Trandolapril	ACE inhibitors, plain	approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB00520	Caspofungin	Other antimycotics for systemic use	approved	1,3-beta-glucan synthase component FKS1	A2QLK4	None	inhibitor	yes
DB00521	Carteolol	Beta blocking agents	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	yes
DB00521	Carteolol	Beta blocking agents	approved	Beta-1 adrenergic receptor	P08588	178200	partial agonist	yes
DB00523	Alitretinoin	Agents for dermatitis, excluding corticosteroids	approved;investigational	Retinoic acid receptor alpha	P10276	36157	agonist	yes
DB00523	Alitretinoin	Agents for dermatitis, excluding corticosteroids	approved;investigational	Retinoic acid receptor RXR-alpha	P19793	35885	agonist	yes
DB00523	Alitretinoin	Agents for dermatitis, excluding corticosteroids	approved;investigational	Retinoic acid receptor beta	P10826	35883	agonist	yes
DB00523	Alitretinoin	Agents for dermatitis, excluding corticosteroids	approved;investigational	Retinoic acid receptor RXR-beta	P28702	30448	agonist	yes
DB00523	Alitretinoin	Agents for dermatitis, excluding corticosteroids	approved;investigational	Retinoic acid receptor gamma	P13631	306887	agonist	yes
DB00523	Alitretinoin	Agents for dermatitis, excluding corticosteroids	approved;investigational	Retinoic acid receptor RXR-gamma	P48443	1053069	agonist	yes
DB00523	Alitretinoin	Agents for dermatitis, excluding corticosteroids	approved;investigational	Insulin-like growth factor-binding protein 3	P17936	183116	None	unknown
DB00523	Alitretinoin	Agents for dermatitis, excluding corticosteroids	approved;investigational	Pregnancy-specific beta-1-glycoprotein 5	Q15238	None	None	unknown
DB00523	Alitretinoin	Agents for dermatitis, excluding corticosteroids	approved;investigational	Cytochrome P450 26C1	Q6V0L0	None	None	unknown
DB00524	Metolazone	Sulfonamides, plain	approved	Solute carrier family 12 member 3	P55017	1172161	inhibitor	yes
DB00525	Tolnaftate	Other antifungals for topical use	approved;investigational;vet_approved	Squalene monooxygenase	Q92206	None	inhibitor	yes
DB00526	Oxaliplatin	Platinum compounds	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB00527	Cinchocaine	Analgesics and anesthetics	approved;vet_approved	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB00527	Cinchocaine	Analgesics and anesthetics	approved;vet_approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00527	Cinchocaine	Analgesics and anesthetics	approved;vet_approved	Calmodulin	P0DP23	179888	inhibitor	unknown
DB00528	Lercanidipine	Angiotensin II antagonists and calcium channel blockers	approved;investigational	Voltage-dependent calcium channel gamma-1 subunit	Q06432	306473	inhibitor	yes
DB00529	Foscarnet	Phosphonic acid derivatives	approved	DNA polymerase catalytic subunit	P08546	1780831	inhibitor	yes
DB00529	Foscarnet	Phosphonic acid derivatives	approved	DNA polymerase catalytic subunit	P04293	59530	inhibitor	yes
DB00530	Erlotinib	Protein kinase inhibitors	approved;investigational	Epidermal growth factor receptor	P00533	757924	antagonist	yes
DB00530	Erlotinib	Protein kinase inhibitors	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	agonist	yes
DB00531	Cyclophosphamide	Nitrogen mustard analogues	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB00531	Cyclophosphamide	Nitrogen mustard analogues	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00533	Rofecoxib	Coxibs	approved;investigational;withdrawn	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00533	Rofecoxib	Coxibs	approved;investigational;withdrawn	Elastin	P15502	182021	other/unknown	unknown
DB00534	Chlormerodrin	N/A	approved;withdrawn	Solute carrier family 12 member 1	Q13621	1373425	inducer	yes
DB00534	Chlormerodrin	N/A	approved;withdrawn	Succinate-semialdehyde dehydrogenase, mitochondrial	P51649	3766467	inhibitor	unknown
DB00535	Cefdinir	Third-generation cephalosporins	approved	Penicillin-binding protein 2	P08149	150279	inhibitor	yes
DB00535	Cefdinir	Third-generation cephalosporins	approved	PBP3	Q60FT7	None	inhibitor	yes
DB00535	Cefdinir	Third-generation cephalosporins	approved	Myeloperoxidase	P05164	189040	inhibitor	no
DB00536	Guanidine	N/A	approved	Argininosuccinate synthase	P0A6E4	145342	None	unknown
DB00536	Guanidine	N/A	approved	Guanidinoacetate N-methyltransferase	Q14353	1212946	None	unknown
DB00536	Guanidine	N/A	approved	Ribonuclease pancreatic	P07998	None	None	unknown
DB00536	Guanidine	N/A	approved	DNA	None	None	None	unknown
DB00536	Guanidine	N/A	approved	Disks large homolog 4	P78352	None	None	unknown
DB00536	Guanidine	N/A	approved	Lysozyme	P00720	15261	None	unknown
DB00536	Guanidine	N/A	approved	Aldehyde dehydrogenase, mitochondrial	P05091	28606	None	unknown
DB00536	Guanidine	N/A	approved	Arginase	P53608	None	None	unknown
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	unknown
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	None	unknown
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit A	P0AES4	None	None	unknown
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 4 subunit A	P0C1U9	None	None	unknown
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 4 subunit B	Q59192	None	None	unknown
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit A	P05653	None	None	unknown
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	Multidrug resistance protein MdtK	C3T8E2	None	None	unknown
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	Gyrase A	B4YQT9	None	None	unknown
DB00537	Ciprofloxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit A	P20831	None	None	unknown
DB00539	Toremifene	Anti-estrogens	approved;investigational	Estrogen receptor alpha	P03372	31234	modulator	yes
DB00539	Toremifene	Anti-estrogens	approved;investigational	Sex hormone-binding globulin	P04278	296673	None	unknown
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Histamine H1 receptor	P35367	510296	antagonist	no
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	no
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	no
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 6	P50406	1162924	binder	unknown
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Alpha-2 adrenergic receptors	P18825	178194	antagonist	unknown
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Beta adrenergic receptor	P13945	178896	antagonist	unknown
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	D(2) dopamine receptor	P14416	181432	antagonist	unknown
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	Sigma receptor	Q99720	1783387	binder	unknown
DB00540	Nortriptyline	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 1C	P08909	None	antagonist	unknown
DB00541	Vincristine	Vinca alkaloids and analogues	approved;investigational	Tubulin beta chain	P07437	338695	inhibitor	yes
DB00541	Vincristine	Vinca alkaloids and analogues	approved;investigational	Tubulin alpha-4A chain	P68366	32015	inhibitor	unknown
DB00542	Benazepril	ACE inhibitors, plain	approved;investigational	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	D(2) dopamine receptor	P14416	181432	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 6	P50406	1162924	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Alpha-1 adrenergic receptors	P25100	177807	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor	P08912	177988	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 1B	P28222	219679	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Alpha-2 adrenergic receptors	P18825	178194	antagonist	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Histamine H4 receptor	Q9H3N8	10241847	binder	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	GABA-A receptor (anion channel)	Q9UN88	7861736	binder	unknown
DB00543	Amoxapine	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent dopamine transporter	Q01959	553260	binder	unknown
DB00544	Fluorouracil	Pyrimidine analogues	approved	Thymidylate synthase	P04818	37479	other/unknown	yes
DB00544	Fluorouracil	Pyrimidine analogues	approved	DNA	None	None	incorporation into and destabilization	yes
DB00544	Fluorouracil	Pyrimidine analogues	approved	RNA	None	None	incorporation into and destabilization	yes
DB00545	Pyridostigmine	Anticholinesterases	approved;investigational	Acetylcholinesterase	P22303	177975	antagonist	yes
DB00545	Pyridostigmine	Anticholinesterases	approved;investigational	Cholinesterase	P06276	1311630	antagonist	yes
DB00545	Pyridostigmine	Anticholinesterases	approved;investigational	Serum albumin	P02768	28590	None	unknown
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB00546	Adinazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB00547	Desoximetasone	Corticosteroids, potent, other combinations	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00548	Azelaic Acid	Other anti-acne preparations for topical use	approved	Thioredoxin reductase	P66010	14246533	inhibitor	yes
DB00548	Azelaic Acid	Other anti-acne preparations for topical use	approved	3-oxo-5-beta-steroid 4-dehydrogenase	P51857	431857	inhibitor	yes
DB00548	Azelaic Acid	Other anti-acne preparations for topical use	approved	3-oxo-5-alpha-steroid 4-dehydrogenase 2	P31213	338469	inhibitor	yes
DB00548	Azelaic Acid	Other anti-acne preparations for topical use	approved	Tyrosinase	P14679	340037	inhibitor	yes
DB00548	Azelaic Acid	Other anti-acne preparations for topical use	approved	DNA polymerase I	P00582	42461	inhibitor	yes
DB00549	Zafirlukast	Leukotriene receptor antagonists	approved;investigational	Cysteinyl leukotriene receptor 1	Q9Y271	5353887	antagonist	yes
DB00550	Propylthiouracil	Thiouracils	approved;investigational	Thyroid peroxidase	P07202	339867	inhibitor	yes
DB00551	Acetohydroxamic Acid	Other urologicals	approved	Urease subunit alpha	P18314	149337	inhibitor	yes
DB00551	Acetohydroxamic Acid	Other urologicals	approved	Macrophage metalloelastase	P39900	435970	inhibitor	unknown
DB00552	Pentostatin	Other antineoplastic agents	approved;investigational	Adenosine deaminase	P00813	28380	inhibitor	yes
DB00553	Methoxsalen	Psoralens for topical use	approved	DNA	None	None	intercalation	yes
DB00554	Piroxicam	Antiinflammatory agents, non-steroids	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00554	Piroxicam	Antiinflammatory agents, non-steroids	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	Voltage-dependent R-type calcium channel subunit alpha-1E	Q15878	None	inhibitor	yes
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	Sodium channel protein type 2 subunit alpha	Q99250	457879	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	Adenosine receptor A1	P30542	256155	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	Adenosine receptor A2a	P29274	177892	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	D(1) dopamine receptor	P21918	32049	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	D(2) dopamine receptor	P14416	181432	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	GABA-A receptor (anion channel)	Q9UN88	7861736	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	GABA-A receptor (benzodiazepine site)	Q99928	1754749	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	Histamine H1 receptor	P35367	510296	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	Kappa-type opioid receptor	P41145	532060	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	Muscarinic acetylcholine receptor	P08912	177988	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	inhibitor	unknown
DB00555	Lamotrigine	Other antiepileptics	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	inhibitor	unknown
DB00557	Hydroxyzine	Diphenylmethane derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00558	Zanamivir	Neuraminidase inhibitors	approved;investigational	Neuraminidase	P06818	324460	inhibitor	yes
DB00558	Zanamivir	Neuraminidase inhibitors	approved;investigational	Neuraminidase	P27907	None	inhibitor	yes
DB00558	Zanamivir	Neuraminidase inhibitors	approved;investigational	Sialidase-2	Q9Y3R4	None	inhibitor	unknown
DB00559	Bosentan	Antihypertensives for pulmonary arterial hypertension	approved;investigational	Endothelin-1 receptor	P25101	238636	antagonist	yes
DB00559	Bosentan	Antihypertensives for pulmonary arterial hypertension	approved;investigational	Endothelin B receptor	P24530	182276	antagonist	yes
DB00560	Tigecycline	Tetracyclines	approved	16S rRNA	None	None	adduct	yes
DB00560	Tigecycline	Tetracyclines	approved	30S ribosomal protein S9	P0A7X3	535073	adduct	yes
DB00560	Tigecycline	Tetracyclines	approved	30S ribosomal protein S12	P0A7S3	43010	adduct	yes
DB00560	Tigecycline	Tetracyclines	approved	30S ribosomal protein S13	P0A7S9	581217	adduct	yes
DB00560	Tigecycline	Tetracyclines	approved	30S ribosomal protein S14	P0AG59	809690	adduct	yes
DB00560	Tigecycline	Tetracyclines	approved	30S ribosomal protein S19	P0A7U3	42826	adduct	yes
DB00561	Doxapram	Respiratory stimulants	approved;vet_approved	Potassium channel subfamily K member 3	O14649	2465542	inhibitor	yes
DB00561	Doxapram	Respiratory stimulants	approved;vet_approved	Potassium channel subfamily K member 9	Q9NPC2	7546843	inhibitor	yes
DB00562	Benzthiazide	Sulfonamides	approved	Solute carrier family 12 member 3	P55017	1172161	inhibitor	yes
DB00562	Benzthiazide	Sulfonamides	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB00562	Benzthiazide	Sulfonamides	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB00562	Benzthiazide	Sulfonamides	approved	Carbonic anhydrase 4	P22748	179791	inhibitor	unknown
DB00562	Benzthiazide	Sulfonamides	approved	Carbonic anhydrase 9	Q16790	None	inhibitor	unknown
DB00562	Benzthiazide	Sulfonamides	approved	Carbonic anhydrase 12	O43570	2984693	inhibitor	unknown
DB00563	Methotrexate	Other immunosuppressants	approved	Dihydrofolate reductase	P00374	182724	inhibitor	yes
DB00564	Carbamazepine	Carboxamide derivatives	approved;investigational	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00564	Carbamazepine	Carboxamide derivatives	approved;investigational	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB00564	Carbamazepine	Carboxamide derivatives	approved;investigational	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	None	unknown
DB00564	Carbamazepine	Carboxamide derivatives	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00565	Cisatracurium	Other quaternary ammonium compounds	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB00566	Succimer	N/A	approved	Lead	None	None	chelator	yes
DB00566	Succimer	N/A	approved	Mercury	None	None	chelator	yes
DB00566	Succimer	N/A	approved	Cadmium	None	None	chelator	yes
DB00566	Succimer	N/A	approved	Arsenic	None	None	chelator	yes
DB00567	Cephalexin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00567	Cephalexin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB00567	Cephalexin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB00567	Cephalexin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB00567	Cephalexin	First-generation cephalosporins	approved;investigational;vet_approved	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	yes
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1F	O60840	3183953	inhibitor	yes
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	inhibitor	yes
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1G	O43497	6625659	inhibitor	yes
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	inhibitor	yes
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1I	Q9P0X4	5565888	inhibitor	yes
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	D(2) dopamine receptor	P14416	181432	other/unknown	no
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	D(1) dopamine receptor	P21918	32049	binder	unknown
DB00568	Cinnarizine	Antivertigo preparations	approved;investigational	Muscarinic acetylcholine receptor	P08912	177988	binder	unknown
DB00569	Fondaparinux	Other antithrombotic agents	approved;investigational	Antithrombin-III	P01008	179161	potentiator	yes
DB00569	Fondaparinux	Other antithrombotic agents	approved;investigational	Coagulation factor X	P00742	182841	inhibitor	yes
DB00570	Vinblastine	Vinca alkaloids and analogues	approved	Tubulin alpha-1A chain	Q71U36	37492	adduct	yes
DB00570	Vinblastine	Vinca alkaloids and analogues	approved	Tubulin beta chain	P07437	338695	adduct	yes
DB00570	Vinblastine	Vinca alkaloids and analogues	approved	Tubulin delta chain	Q9UJT1	6457580	adduct	yes
DB00570	Vinblastine	Vinca alkaloids and analogues	approved	Tubulin gamma-1 chain	P23258	183703	adduct	yes
DB00570	Vinblastine	Vinca alkaloids and analogues	approved	Tubulin epsilon chain	Q9UJT0	6457582	adduct	yes
DB00570	Vinblastine	Vinca alkaloids and analogues	approved	Transcription factor AP-1	P05412	386839	other/unknown	no
DB00571	Propranolol	Beta blocking agents, non-selective, and thiazides	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB00571	Propranolol	Beta blocking agents, non-selective, and thiazides	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB00571	Propranolol	Beta blocking agents, non-selective, and thiazides	approved;investigational	Beta-3 adrenergic receptor	P13945	178896	antagonist	unknown
DB00571	Propranolol	Beta blocking agents, non-selective, and thiazides	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	other/unknown	unknown
DB00571	Propranolol	Beta blocking agents, non-selective, and thiazides	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	other/unknown	unknown
DB00572	Atropine	Anticholinergics	approved;vet_approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00572	Atropine	Anticholinergics	approved;vet_approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00572	Atropine	Anticholinergics	approved;vet_approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB00572	Atropine	Anticholinergics	approved;vet_approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB00572	Atropine	Anticholinergics	approved;vet_approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	yes
DB00572	Atropine	Anticholinergics	approved;vet_approved	Glycine receptor subunit alpha-1	P23415	31851	antagonist	unknown
DB00572	Atropine	Anticholinergics	approved;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB00572	Atropine	Anticholinergics	approved;vet_approved	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	None	unknown
DB00573	Fenoprofen	Propionic acid derivatives	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00573	Fenoprofen	Propionic acid derivatives	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00573	Fenoprofen	Propionic acid derivatives	approved	Peroxisome proliferator-activated receptor alpha	Q07869	307341	activator	unknown
DB00573	Fenoprofen	Propionic acid derivatives	approved	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB00574	Fenfluramine	Centrally acting antiobesity products	approved;illicit;investigational;withdrawn	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00574	Fenfluramine	Centrally acting antiobesity products	approved;illicit;investigational;withdrawn	5-hydroxytryptamine receptor 2B	P41595	475198	agonist	yes
DB00574	Fenfluramine	Centrally acting antiobesity products	approved;illicit;investigational;withdrawn	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	yes
DB00574	Fenfluramine	Centrally acting antiobesity products	approved;illicit;investigational;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	None	unknown
DB00575	Clonidine	Sympathomimetics in glaucoma therapy	approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00575	Clonidine	Sympathomimetics in glaucoma therapy	approved	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB00575	Clonidine	Sympathomimetics in glaucoma therapy	approved	Alpha-2C adrenergic receptor	P18825	178194	agonist	yes
DB00575	Clonidine	Sympathomimetics in glaucoma therapy	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	unknown
DB00575	Clonidine	Sympathomimetics in glaucoma therapy	approved	Alpha-1B adrenergic receptor	P35368	None	agonist	unknown
DB00575	Clonidine	Sympathomimetics in glaucoma therapy	approved	Alpha-1D adrenergic receptor	P25100	177807	agonist	unknown
DB00576	Sulfamethizole	Antiinfectives	approved;investigational;vet_approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB00577	Valaciclovir	Xanthines	approved;investigational	DNA polymerase catalytic subunit	P04293	59530	inhibitor	yes
DB00577	Valaciclovir	Xanthines	approved;investigational	Thymidine kinase	Q9QNF7	8100965	inducer	yes
DB00578	Carbenicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 	None	None	inhibitor	yes
DB00579	Mazindol	Centrally acting antiobesity products	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00579	Mazindol	Centrally acting antiobesity products	approved;investigational	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB00579	Mazindol	Centrally acting antiobesity products	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00579	Mazindol	Centrally acting antiobesity products	approved;investigational	Synaptic vesicular amine transporter	Q05940	292335	None	unknown
DB00580	Valdecoxib	Coxibs	approved;investigational;withdrawn	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00580	Valdecoxib	Coxibs	approved;investigational;withdrawn	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB00580	Valdecoxib	Coxibs	approved;investigational;withdrawn	Carbonic anhydrase 3	P07451	189053812	inhibitor	unknown
DB00581	Lactulose	Osmotically acting laxatives	approved	Evolved beta-galactosidase subunit alpha	P06864	145821	other	yes
DB00582	Voriconazole	Triazole derivatives	approved;investigational	Lanosterol 14-alpha demethylase	P10613	578119	antagonist	yes
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Solute carrier family 22 member 4	Q9H015	2605501	None	unknown
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Solute carrier family 22 member 5	O76082	3273741	None	unknown
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Carnitine O-acetyltransferase	P43155	927415	None	unknown
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Mitochondrial carnitine/acylcarnitine carrier protein CACL	Q8N8R3	28193150	None	unknown
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Mitochondrial carnitine/acylcarnitine carrier protein	O43772	2765075	None	unknown
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Peroxisomal carnitine O-octanoyltransferase	Q9UKG9	6066280	None	unknown
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Carnitine O-palmitoyltransferase 2, mitochondrial	P23786	1041195	None	unknown
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Carnitine O-palmitoyltransferase 1, liver isoform	P50416	755646	activator	unknown
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Xanthine dehydrogenase/oxidase	P47989	10336525	None	unknown
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Liver carboxylesterase 1	P23141	None	None	unknown
DB00583	L-Carnitine	Amino acids and derivatives	approved;investigational	Myeloperoxidase	P05164	189040	None	unknown
DB00584	Enalapril	ACE inhibitors and calcium channel blockers	approved;vet_approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB00585	Nizatidine	H2-receptor antagonists	approved	Histamine H2 receptor	P25021	184088	antagonist	yes
DB00586	Diclofenac	Acetic acid derivatives and related substances	approved;vet_approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00586	Diclofenac	Acetic acid derivatives and related substances	approved;vet_approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00586	Diclofenac	Acetic acid derivatives and related substances	approved;vet_approved	Arachidonate 5-lipoxygenase	P09917	187193	potentiator	yes
DB00586	Diclofenac	Acetic acid derivatives and related substances	approved;vet_approved	Sodium channel protein type 4 subunit alpha	P35499	338213	inhibitor	yes
DB00586	Diclofenac	Acetic acid derivatives and related substances	approved;vet_approved	Acid-sensing ion channel 1	P78348	1871168	inhibitor	yes
DB00586	Diclofenac	Acetic acid derivatives and related substances	approved;vet_approved	Potassium voltage-gated channel subfamily KQT member 2	O43526	1841342	other	yes
DB00586	Diclofenac	Acetic acid derivatives and related substances	approved;vet_approved	Potassium voltage-gated channel subfamily KQT member 3	O43525	None	other	yes
DB00586	Diclofenac	Acetic acid derivatives and related substances	approved;vet_approved	Phospholipase A2, membrane associated	P14555	190889	inhibitor	unknown
DB00587	Cinalukast	N/A	approved	Cysteinyl leukotriene receptor 1	Q9Y271	5353887	antagonist	yes
DB00588	Fluticasone propionate	N/A	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00588	Fluticasone propionate	N/A	approved	Progesterone receptor	P06401	35652	agonist	unknown
DB00588	Fluticasone propionate	N/A	approved	Cytosolic phospholipase A2	P47712	190007	inhibitor	unknown
DB00588	Fluticasone propionate	N/A	approved	Mineralocorticoid receptor	P08235	307166	antagonist	unknown
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	D(2) dopamine receptor	P14416	181432	agonist	yes
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	D(3) dopamine receptor	P35462	927342	agonist	yes
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	D(4) dopamine receptor	P21917	291946	agonist	yes
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	D(1B) dopamine receptor	P21918	32049	antagonist	unknown
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	unknown
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	unknown
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	yes
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	yes
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	unknown
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	other/unknown	unknown
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	other/unknown	unknown
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	other/unknown	unknown
DB00589	Lisuride	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	None	unknown
DB00590	Doxazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00590	Doxazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	yes
DB00590	Doxazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	yes
DB00590	Doxazosin	Alpha-adrenoreceptor antagonists	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00590	Doxazosin	Alpha-adrenoreceptor antagonists	approved	Potassium voltage-gated channel subfamily H member 6	Q9H252	11878259	inhibitor	unknown
DB00590	Doxazosin	Alpha-adrenoreceptor antagonists	approved	Potassium voltage-gated channel subfamily H member 7	Q9NS40	4104136	inhibitor	unknown
DB00591	Fluocinolone Acetonide	Corticosteroids	approved;investigational;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00592	Piperazine	Piperazine and derivatives	approved;vet_approved	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	agonist	yes
DB00593	Ethosuximide	Succinimide derivatives	approved	Voltage-dependent T-type calcium channel subunit alpha-1G	O43497	6625659	inhibitor	yes
DB00594	Amiloride	Other potassium-sparing agents	approved	Amiloride-sensitive sodium channel subunit alpha	P37088	452650	inhibitor	yes
DB00594	Amiloride	Other potassium-sparing agents	approved	Amiloride-sensitive sodium channel subunit beta	P51168	1004271	inhibitor	yes
DB00594	Amiloride	Other potassium-sparing agents	approved	Amiloride-sensitive sodium channel subunit gamma	P51170	1004273	inhibitor	yes
DB00594	Amiloride	Other potassium-sparing agents	approved	Amiloride-sensitive sodium channel subunit delta	P51172	1066457	inhibitor	yes
DB00594	Amiloride	Other potassium-sparing agents	approved	Amiloride-sensitive amine oxidase [copper-containing]	P19801	177960	inhibitor	unknown
DB00594	Amiloride	Other potassium-sparing agents	approved	Acid-sensing ion channel 2	Q16515	1256017	inhibitor	unknown
DB00594	Amiloride	Other potassium-sparing agents	approved	Acid-sensing ion channel 1	P78348	1871168	inhibitor	unknown
DB00594	Amiloride	Other potassium-sparing agents	approved	Sodium/hydrogen exchanger 1	P19634	178753	inhibitor	unknown
DB00594	Amiloride	Other potassium-sparing agents	approved	Urokinase-type plasminogen activator	P00749	1834524	inhibitor	unknown
DB00595	Oxytetracycline	Tetracyclines	approved;investigational;vet_approved	30S ribosomal protein S9	P0A7X3	535073	inhibitor	yes
DB00595	Oxytetracycline	Tetracyclines	approved;investigational;vet_approved	30S ribosomal protein S4	P0A7V8	42798	inhibitor	yes
DB00595	Oxytetracycline	Tetracyclines	approved;investigational;vet_approved	16S rRNA	None	None	inhibitor	unknown
DB00596	Ulobetasol	Corticosteroids, potent (group III)	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00598	Labetalol	Alpha and beta blocking agents and thiazides	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB00598	Labetalol	Alpha and beta blocking agents and thiazides	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	yes
DB00598	Labetalol	Alpha and beta blocking agents and thiazides	approved	Alpha-1 adrenergic receptors	P25100	177807	antagonist	yes
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Fatty-acid amide hydrolase 1	O00519	2149156	inhibitor	unknown
DB00599	Thiopental	Barbiturates, plain	approved;vet_approved	Muscarinic acetylcholine receptor M3	P20309	32324	None	unknown
DB00600	Monobenzone	Other dermatologicals	approved	Tyrosinase	P14679	340037	inhibitor	unknown
DB00601	Linezolid	Other antibacterials	approved;investigational	23S rRNA	None	None	inhibitor	yes
DB00602	Ivermectin	Avermectines	approved;investigational;vet_approved	Glycine receptor subunit alpha-3	O75311	3342792	agonist	yes
DB00602	Ivermectin	Avermectines	approved;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	agonist	unknown
DB00603	Medroxyprogesterone acetate	Progestogens and estrogens, fixed combinations	approved;investigational	Progesterone receptor	P06401	35652	agonist	yes
DB00603	Medroxyprogesterone acetate	Progestogens and estrogens, fixed combinations	approved;investigational	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00604	Cisapride	Propulsives	approved;investigational;withdrawn	5-hydroxytryptamine receptor 4	Q13639	2661757	agonist	yes
DB00604	Cisapride	Propulsives	approved;investigational;withdrawn	5-hydroxytryptamine receptor 3A	P46098	681914	agonist	yes
DB00604	Cisapride	Propulsives	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	yes
DB00604	Cisapride	Propulsives	approved;investigational;withdrawn	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00605	Sulindac	Acetic acid derivatives and related substances	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00605	Sulindac	Acetic acid derivatives and related substances	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00605	Sulindac	Acetic acid derivatives and related substances	approved;investigational	Aldose reductase	P15121	178487	inhibitor	unknown
DB00605	Sulindac	Acetic acid derivatives and related substances	approved;investigational	Mitogen-activated protein kinase 3	P27361	31221	inhibitor	unknown
DB00605	Sulindac	Acetic acid derivatives and related substances	approved;investigational	Peroxisome proliferator-activated receptor delta	Q03181	190230	negative modulator	unknown
DB00605	Sulindac	Acetic acid derivatives and related substances	approved;investigational	Prostaglandin D2 receptor 2	Q9Y5Y4	4204216	antagonist	unknown
DB00605	Sulindac	Acetic acid derivatives and related substances	approved;investigational	Aldo-keto reductase family 1 member B10	O60218	3150035	inhibitor	unknown
DB00606	Cyclothiazide	Thiazides, plain	approved	Sodium/potassium-transporting ATPase subunit gamma	P54710	1575004	inhibitor	yes
DB00606	Cyclothiazide	Thiazides, plain	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB00606	Cyclothiazide	Thiazides, plain	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB00606	Cyclothiazide	Thiazides, plain	approved	Carbonic anhydrase 4	P22748	179791	inhibitor	unknown
DB00606	Cyclothiazide	Thiazides, plain	approved	Secreted frizzled-related protein 4	Q6FHJ7	None	inhibitor	unknown
DB00607	Nafcillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB00607	Nafcillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB00607	Nafcillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB00607	Nafcillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00607	Nafcillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB00608	Chloroquine	Aminoquinolines	approved;investigational;vet_approved	Glutathione S-transferase A2	P09210	306811	None	unknown
DB00608	Chloroquine	Aminoquinolines	approved;investigational;vet_approved	Fe(II)-protoporphyrin IX	None	None	antagonist	yes
DB00608	Chloroquine	Aminoquinolines	approved;investigational;vet_approved	Tumor necrosis factor	P01375	339741	None	unknown
DB00608	Chloroquine	Aminoquinolines	approved;investigational;vet_approved	Toll-like receptor 9	Q9NR96	8099652	None	unknown
DB00608	Chloroquine	Aminoquinolines	approved;investigational;vet_approved	Glutathione S-transferase	Q8MU52	None	inhibitor	unknown
DB00609	Ethionamide	Thiocarbamide derivatives	approved	Enoyl-[acyl-carrier-protein] reductase [NADH]	P9WGR1	None	adduct	yes
DB00609	Ethionamide	Thiocarbamide derivatives	approved	Catalase-peroxidase	P9WIE5	None	other/unknown	unknown
DB00610	Metaraminol	Adrenergic and dopaminergic agents	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB00611	Butorphanol	Morphinan derivatives	approved;illicit;vet_approved	Kappa-type opioid receptor	P41145	532060	agonist	yes
DB00611	Butorphanol	Morphinan derivatives	approved;illicit;vet_approved	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB00611	Butorphanol	Morphinan derivatives	approved;illicit;vet_approved	Mu-type opioid receptor	P35372	452073	partial antagonist	yes
DB00612	Bisoprolol	Beta blocking agents, selective, and thiazides	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB00612	Bisoprolol	Beta blocking agents, selective, and thiazides	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	no
DB00613	Amodiaquine	Artemisinin and derivatives, combinations	approved;investigational	Fe(II)-protoporphyrin IX	None	None	adduct	yes
DB00613	Amodiaquine	Artemisinin and derivatives, combinations	approved;investigational	Histamine N-methyltransferase	P50135	None	inhibitor	unknown
DB00614	Furazolidone	Other antiinfectives and antiseptics	approved;investigational;vet_approved	DNA	None	None	cross-linking/alkylation	yes
DB00615	Rifabutin	Antibiotics	approved;investigational	DNA-directed RNA polymerase subunit alpha	P0A7Z4	147715	inhibitor	yes
DB00615	Rifabutin	Antibiotics	approved;investigational	DNA-directed RNA polymerase subunit beta	P0A8V2	42818	inhibitor	yes
DB00615	Rifabutin	Antibiotics	approved;investigational	DNA-directed RNA polymerase subunit beta'	P0A8T7	42814	inhibitor	yes
DB00615	Rifabutin	Antibiotics	approved;investigational	Heat shock protein HSP 90-alpha	P07900	32488	other/unknown	no
DB00615	Rifabutin	Antibiotics	approved;investigational	Endoplasmin	P14625	553797	other/unknown	no
DB00617	Paramethadione	Oxazolidine derivatives	approved	Voltage-dependent T-type calcium channel subunit alpha-1I	Q9P0X4	5565888	suppressor	yes
DB00618	Demeclocycline	Tetracyclines	approved	30S ribosomal protein S9	P0A7X3	535073	inhibitor	yes
DB00618	Demeclocycline	Tetracyclines	approved	30S ribosomal protein S4	P0A7V8	42798	inhibitor	yes
DB00619	Imatinib	Protein kinase inhibitors	approved	BCR/ABL fusion protein isoform X9	A9UF02	162135198	inhibitor	yes
DB00619	Imatinib	Protein kinase inhibitors	approved	Mast/stem cell growth factor receptor Kit	P10721	34085	antagonist	yes
DB00619	Imatinib	Protein kinase inhibitors	approved	RET proto-oncogene	O43519	2795880	inhibitor	yes
DB00619	Imatinib	Protein kinase inhibitors	approved	High affinity nerve growth factor receptor	P04629	339918	antagonist	unknown
DB00619	Imatinib	Protein kinase inhibitors	approved	Macrophage colony-stimulating factor 1 receptor	P07333	553224	antagonist	unknown
DB00619	Imatinib	Protein kinase inhibitors	approved	Platelet-derived growth factor receptor alpha	P16234	189734	antagonist	unknown
DB00619	Imatinib	Protein kinase inhibitors	approved	Epithelial discoidin domain-containing receptor 1	Q08345	306475	antagonist	unknown
DB00619	Imatinib	Protein kinase inhibitors	approved	Tyrosine-protein kinase ABL1	P00519	28237	inhibitor	unknown
DB00619	Imatinib	Protein kinase inhibitors	approved	Platelet-derived growth factor receptor beta	P09619	189732	antagonist	unknown
DB00620	Triamcinolone	Corticosteroids	approved;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00621	Oxandrolone	Androstan derivatives	approved;investigational	Androgen receptor	P10275	178628	agonist	yes
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	inhibitor	yes
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	yes
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	inhibitor	yes
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	P54750	1151109	inhibitor	unknown
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	Q01064	None	inhibitor	unknown
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB00622	Nicardipine	Dihydropyridine derivatives	approved;investigational	Calmodulin	P0DP23	179888	other/unknown	unknown
DB00623	Fluphenazine	Phenothiazines with piperazine structure	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00623	Fluphenazine	Phenothiazines with piperazine structure	approved	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB00623	Fluphenazine	Phenothiazines with piperazine structure	approved	Calmodulin	P0DP23	179888	inhibitor	unknown
DB00623	Fluphenazine	Phenothiazines with piperazine structure	approved	Androgen receptor	P10275	178628	None	unknown
DB00623	Fluphenazine	Phenothiazines with piperazine structure	approved	5-hydroxytryptamine receptor 2A	P28223	36431	None	unknown
DB00623	Fluphenazine	Phenothiazines with piperazine structure	approved	5-hydroxytryptamine receptor 2C	P28335	338028	None	unknown
DB00624	Testosterone	Androgens and estrogens	approved;investigational	Androgen receptor	P10275	178628	agonist	yes
DB00624	Testosterone	Androgens and estrogens	approved;investigational	Estrogen receptor alpha	P03372	31234	None	unknown
DB00624	Testosterone	Androgens and estrogens	approved;investigational	Mineralocorticoid receptor	P08235	307166	None	unknown
DB00625	Efavirenz	Antivirals for treatment of HIV infections, combinations	approved;investigational	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB00626	Bacitracin	Other antibiotics for topical use	approved;vet_approved	C55-isoprenyl pyrophosphate	None	None	antagonist	yes
DB00626	Bacitracin	Other antibiotics for topical use	approved;vet_approved	Insulin-degrading enzyme	P14735	184556	inhibitor	yes
DB00626	Bacitracin	Other antibiotics for topical use	approved;vet_approved	Alpha-2-macroglobulin	P01023	177870	inhibitor	unknown
DB00627	Niacin	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved;investigational;nutraceutical	Hydroxycarboxylic acid receptor 3	P49019	219867	agonist	yes
DB00627	Niacin	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved;investigational;nutraceutical	Hydroxycarboxylic acid receptor 2	Q8TDS4	28975188	agonist	yes
DB00627	Niacin	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved;investigational;nutraceutical	Nicotinate-nucleotide pyrophosphorylase [carboxylating]	Q15274	1060907	binder	yes
DB00627	Niacin	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved;investigational;nutraceutical	Nicotinamide N-methyltransferase	P40261	494989	binder	yes
DB00628	Clorazepate	N/A	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00628	Clorazepate	N/A	approved;illicit	Translocator protein	P30536	306883	agonist	unknown
DB00629	Guanabenz	N/A	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00629	Guanabenz	N/A	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	binder	unknown
DB00630	Alendronic acid	Bisphosphonates	approved	Farnesyl pyrophosphate synthase	P14324	182399	inhibitor	yes
DB00630	Alendronic acid	Bisphosphonates	approved	Hydroxylapatite	None	None	antagonist	yes
DB00630	Alendronic acid	Bisphosphonates	approved	Tyrosine-protein phosphatase non-receptor type 4	P29074	190748	inhibitor	unknown
DB00630	Alendronic acid	Bisphosphonates	approved	Receptor-type tyrosine-protein phosphatase S	Q13332	1109792	inhibitor	unknown
DB00630	Alendronic acid	Bisphosphonates	approved	Receptor-type tyrosine-protein phosphatase epsilon	P23469	35792	inhibitor	unknown
DB00630	Alendronic acid	Bisphosphonates	approved	V-type proton ATPase catalytic subunit A	P38606	291868	inhibitor	unknown
DB00631	Clofarabine	Purine analogues	approved;investigational	DNA polymerase alpha catalytic subunit	P09884	35568	inhibitor	yes
DB00631	Clofarabine	Purine analogues	approved;investigational	Ribonucleoside-diphosphate reductase large subunit	P23921	36065	inhibitor	yes
DB00631	Clofarabine	Purine analogues	approved;investigational	DNA	None	None	other/unknown	yes
DB00632	Docosanol	Antivirals	approved;investigational	Envelope glycoprotein GP350	P03200	1334868	intercalation	yes
DB00632	Docosanol	Antivirals	approved;investigational	Envelope glycoprotein GP340	P68344	291520	intercalation	unknown
DB00633	Dexmedetomidine	Other hypnotics and sedatives	approved;vet_approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00634	Sulfacetamide	Sulfonamides	approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB00634	Sulfacetamide	Sulfonamides	approved	Dihydropteroate synthase type-1	P0C002	None	inhibitor	yes
DB00634	Sulfacetamide	Sulfonamides	approved	Folic acid synthesis protein FOL1	P53848	None	inhibitor	yes
DB00635	Prednisone	Glucocorticoids	approved;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00635	Prednisone	Glucocorticoids	approved;vet_approved	Corticosteroid 11-beta-dehydrogenase isozyme 1	P28845	179475	ligand	unknown
DB00636	Clofibrate	Fibrates	approved;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	agonist	yes
DB00637	Astemizole	Other antihistamines for systemic use	approved;withdrawn	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00637	Astemizole	Other antihistamines for systemic use	approved;withdrawn	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00637	Astemizole	Other antihistamines for systemic use	approved;withdrawn	Potassium voltage-gated channel subfamily H member 1	O95259	None	None	unknown
DB00637	Astemizole	Other antihistamines for systemic use	approved;withdrawn	Microtubule-associated protein tau	P10636	None	None	unknown
DB00638	Inulin	Tests for renal function and ureteral injuries	approved;investigational;nutraceutical	Cycloinulo-oligosaccharide fructanotransferase	Q9F0I5	12056574	binder	no
DB00639	Butoconazole	Imidazole derivatives	approved	Ergosterol	None	None	other	yes
DB00640	Adenosine	Other cardiac preparations	approved;investigational	Adenosine receptor A2a	P29274	177892	agonist	yes
DB00640	Adenosine	Other cardiac preparations	approved;investigational	Adenosine receptor A2b	P29275	178150	agonist	yes
DB00640	Adenosine	Other cardiac preparations	approved;investigational	Adenosine receptor A3	P0DMS8	349449	agonist	yes
DB00640	Adenosine	Other cardiac preparations	approved;investigational	Adenosine receptor A1	P30542	256155	agonist	yes
DB00641	Simvastatin	HMG CoA reductase inhibitors, other combinations	approved	3-hydroxy-3-methylglutaryl-coenzyme A reductase	P04035	306865	inhibitor	yes
DB00641	Simvastatin	HMG CoA reductase inhibitors, other combinations	approved	Integrin beta-2	P05107	307113	other	no
DB00641	Simvastatin	HMG CoA reductase inhibitors, other combinations	approved	Integrin alpha-L	P20701	31422	inhibitor	unknown
DB00642	Pemetrexed	Xanthines	approved;investigational	Thymidylate synthase	P04818	37479	inhibitor	yes
DB00642	Pemetrexed	Xanthines	approved;investigational	Bifunctional purine biosynthesis protein PURH	P31939	1263196	inhibitor	yes
DB00642	Pemetrexed	Xanthines	approved;investigational	Dihydrofolate reductase	P00374	182724	inhibitor	yes
DB00642	Pemetrexed	Xanthines	approved;investigational	Trifunctional purine biosynthetic protein adenosine-3	P22102	31642	inhibitor	yes
DB00643	Mebendazole	Benzimidazole derivatives	approved;vet_approved	Tubulin alpha-1A chain	Q71U36	37492	inhibitor	yes
DB00643	Mebendazole	Benzimidazole derivatives	approved;vet_approved	Tubulin beta-4B chain	P68371	37494	inhibitor	yes
DB00644	Gonadorelin	Tests for fertility disturbances	approved;investigational;vet_approved	Gonadotropin-releasing hormone receptor	P30968	183422	agonist	yes
DB00644	Gonadorelin	Tests for fertility disturbances	approved;investigational;vet_approved	Putative gonadotropin-releasing hormone II receptor	Q96P88	16589056	agonist	yes
DB00645	Dyclonine	Other local anesthetics	approved	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB00646	Nystatin	Antibiotics	approved;vet_approved	Ergosterol	None	None	binder	yes
DB00647	Dextropropoxyphene	Diphenylpropylamine derivatives	approved;illicit;investigational;withdrawn	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00647	Dextropropoxyphene	Diphenylpropylamine derivatives	approved;illicit;investigational;withdrawn	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB00647	Dextropropoxyphene	Diphenylpropylamine derivatives	approved;illicit;investigational;withdrawn	Kappa-type opioid receptor	P41145	532060	antagonist	yes
DB00647	Dextropropoxyphene	Diphenylpropylamine derivatives	approved;illicit;investigational;withdrawn	Liver carboxylesterase 1	P23141	None	None	unknown
DB00648	Mitotane	Other antineoplastic agents	approved	Cytochrome P450 11B1, mitochondrial	P15538	181333	inducer	yes
DB00648	Mitotane	Other antineoplastic agents	approved	Adrenodoxin, mitochondrial	P10109	557734	unknown	unknown
DB00648	Mitotane	Other antineoplastic agents	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB00648	Mitotane	Other antineoplastic agents	approved	Progesterone receptor	P06401	35652	None	unknown
DB00648	Mitotane	Other antineoplastic agents	approved	Androgen receptor	P10275	178628	antagonist	unknown
DB00649	Stavudine	Nucleoside and nucleotide reverse transcriptase inhibitors	approved;investigational	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB00651	Dyphylline	Xanthines	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	yes
DB00651	Dyphylline	Xanthines	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	yes
DB00651	Dyphylline	Xanthines	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Q08493	727223	inhibitor	yes
DB00651	Dyphylline	Xanthines	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Q08499	347130	inhibitor	yes
DB00651	Dyphylline	Xanthines	approved	Adenosine receptor A1	P30542	256155	antagonist	yes
DB00651	Dyphylline	Xanthines	approved	Adenosine receptor A2a	P29274	177892	antagonist	yes
DB00651	Dyphylline	Xanthines	approved	High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	Q13946	5566609	inhibitor	yes
DB00651	Dyphylline	Xanthines	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 7B	Q9NP56	8439497	inhibitor	yes
DB00652	Pentazocine	Benzomorphan derivatives	approved;vet_approved	Mu-type opioid receptor	P35372	452073	antagonist	yes
DB00652	Pentazocine	Benzomorphan derivatives	approved;vet_approved	Kappa-type opioid receptor	P41145	532060	agonist	yes
DB00652	Pentazocine	Benzomorphan derivatives	approved;vet_approved	Sigma non-opioid intracellular receptor 1	Q99720	1783387	agonist	yes
DB00653	Magnesium sulfate	Tests for bile duct patency	approved;investigational;vet_approved	Voltage-dependent calcium channel gamma-1 subunit	Q06432	306473	None	unknown
DB00653	Magnesium sulfate	Tests for bile duct patency	approved;investigational;vet_approved	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	None	unknown
DB00653	Magnesium sulfate	Tests for bile duct patency	approved;investigational;vet_approved	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	None	unknown
DB00653	Magnesium sulfate	Tests for bile duct patency	approved;investigational;vet_approved	Voltage-dependent L-type calcium channel subunit beta-1	Q02641	179806	None	unknown
DB00653	Magnesium sulfate	Tests for bile duct patency	approved;investigational;vet_approved	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	None	unknown
DB00653	Magnesium sulfate	Tests for bile duct patency	approved;investigational;vet_approved	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	None	unknown
DB00654	Latanoprost	Prostaglandin analogues	approved;investigational	Prostaglandin F2-alpha receptor	P43088	456564	agonist	yes
DB00655	Estrone	Natural and semisynthetic estrogens, plain	approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00655	Estrone	Natural and semisynthetic estrogens, plain	approved	Estrogen receptor beta	Q92731	2911152	None	unknown
DB00655	Estrone	Natural and semisynthetic estrogens, plain	approved	Androgen receptor	P10275	178628	None	unknown
DB00655	Estrone	Natural and semisynthetic estrogens, plain	approved	Cytochrome P450 19A1	P11511	179002	None	unknown
DB00655	Estrone	Natural and semisynthetic estrogens, plain	approved	Sex hormone-binding globulin	P04278	296673	None	unknown
DB00656	Trazodone	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00656	Trazodone	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	yes
DB00656	Trazodone	Other antidepressants	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00656	Trazodone	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	partial agonist	yes
DB00656	Trazodone	Other antidepressants	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB00656	Trazodone	Other antidepressants	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	no
DB00656	Trazodone	Other antidepressants	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	no
DB00657	Mecamylamine	Secondary and tertiary amines	approved;investigational	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB00657	Mecamylamine	Secondary and tertiary amines	approved;investigational	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	None	unknown
DB00657	Mecamylamine	Secondary and tertiary amines	approved;investigational	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB00657	Mecamylamine	Secondary and tertiary amines	approved;investigational	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	None	unknown
DB00658	Sevelamer	Drugs for treatment of hyperkalemia and hyperphosphatemia	approved	Phosphate	None	None	binder	yes
DB00659	Acamprosate	Drugs used in alcohol dependence	approved;investigational	GABA-A receptor (anion channel)	Q9UN88	7861736	positive modulator	yes
DB00659	Acamprosate	Drugs used in alcohol dependence	approved;investigational	Glutamate (NMDA) receptor	O60391	3025446	antagonist	yes
DB00659	Acamprosate	Drugs used in alcohol dependence	approved;investigational	Metabotropic glutamate receptor 5	P41594	1408052	antagonist	yes
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	yes
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1F	O60840	3183953	inhibitor	yes
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	inhibitor	yes
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent L-type calcium channel subunit beta-1	Q02641	179806	inhibitor	yes
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	inhibitor	yes
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent L-type calcium channel subunit beta-3	P54284	435135	inhibitor	yes
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent L-type calcium channel subunit beta-4	O00305	2058727	inhibitor	yes
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent T-type calcium channel subunit alpha-1I	Q9P0X4	5565888	inhibitor	unknown
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent T-type calcium channel subunit alpha-1G	O43497	6625659	inhibitor	unknown
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent N-type calcium channel subunit alpha-1B	Q00975	179758	inhibitor	unknown
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	O00555	2213913	inhibitor	unknown
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	other	unknown
DB00661	Verapamil	Phenylalkylamine derivatives	approved	ATP-sensitive inward rectifier potassium channel 11	Q14654	1088445	inhibitor	unknown
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Sodium-dependent serotonin transporter	P31645	36433	other/unknown	unknown
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00661	Verapamil	Phenylalkylamine derivatives	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB00663	Flumethasone	Corticosteroids, moderately potent, other combinations	approved;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00664	Sulfametopyrazine	Long-acting sulfonamides	approved;withdrawn	Dihydropteroate synthetase	Q27738	505177	inhibitor	yes
DB00665	Nilutamide	Anti-androgens	approved;investigational	Androgen receptor	P10275	178628	antagonist	yes
DB00666	Nafarelin	Gonadotropin-releasing hormones	approved	Gonadotropin-releasing hormone receptor	P30968	183422	agonist	yes
DB00666	Nafarelin	Gonadotropin-releasing hormones	approved	Putative gonadotropin-releasing hormone II receptor	Q96P88	16589056	agonist	yes
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Alpha-1B adrenergic receptor	P35368	None	agonist	yes
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Beta-1 adrenergic receptor	P08588	178200	agonist	yes
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Phenylalanine-4-hydroxylase	P00439	189937	antagonist	no
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Alpha-2C adrenergic receptor	P18825	178194	agonist	unknown
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Beta-3 adrenergic receptor	P13945	178896	agonist	unknown
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Tumor necrosis factor	P01375	339741	antagonist	unknown
DB00668	Epinephrine	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;vet_approved	Superoxide dismutase [Cu-Zn]	P00441	None	None	unknown
DB00669	Sumatriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	yes
DB00669	Sumatriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	yes
DB00669	Sumatriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1F	P30939	307420	agonist	yes
DB00669	Sumatriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	yes
DB00670	Pirenzepine	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00671	Cefixime	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 2	P44469	1572976	inhibitor	yes
DB00672	Chlorpropamide	Sulfonylureas	approved;investigational	ATP-binding cassette sub-family C member 8	Q09428	1374919	inhibitor	yes
DB00673	Aprepitant	Other antiemetics	approved;investigational	Substance-P receptor	P25103	8176544	antagonist	yes
DB00674	Galantamine	Anticholinesterases	approved	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB00674	Galantamine	Anticholinesterases	approved	Acetylcholine receptor subunit alpha	P02708	None	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Acetylcholine receptor subunit beta	P11230	None	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Acetylcholine receptor subunit delta	Q07001	None	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Acetylcholine receptor subunit gamma	P07510	None	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Acetylcholine receptor subunit epsilon	Q04844	None	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit alpha-5	P30532	177926	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit alpha-6	Q15825	1458118	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit alpha-9	Q9UGM1	6688136	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit alpha-10	Q9GZZ6	12053839	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit beta-3	Q05901	1458124	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Neuronal acetylcholine receptor subunit beta-4	P30926	1458126	allosteric modulator	unknown
DB00674	Galantamine	Anticholinesterases	approved	Cholinesterase	P06276	1311630	inhibitor	unknown
DB00675	Tamoxifen	Anti-estrogens	approved	Estrogen receptor alpha	P03372	31234	antagonist	yes
DB00675	Tamoxifen	Anti-estrogens	approved	Estrogen receptor beta	Q92731	2911152	antagonist	yes
DB00675	Tamoxifen	Anti-estrogens	approved	3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	Q15125	None	inhibitor	unknown
DB00675	Tamoxifen	Anti-estrogens	approved	Protein kinase C	Q05513	558099	inhibitor	unknown
DB00675	Tamoxifen	Anti-estrogens	approved	Androgen receptor	P10275	178628	None	unknown
DB00675	Tamoxifen	Anti-estrogens	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00675	Tamoxifen	Anti-estrogens	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00675	Tamoxifen	Anti-estrogens	approved	Estrogen-related receptor gamma	P62508	4092075	None	unknown
DB00675	Tamoxifen	Anti-estrogens	approved	Sex hormone-binding globulin	P04278	296673	None	unknown
DB00677	Isoflurophate	N/A	approved;investigational;withdrawn	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB00677	Isoflurophate	N/A	approved;investigational;withdrawn	Cholinesterase	P06276	1311630	inhibitor	yes
DB00677	Isoflurophate	N/A	approved;investigational;withdrawn	Serotransferrin	P02787	339453	None	unknown
DB00678	Losartan	Angiotensin II antagonists and diuretics	approved	Type-1 angiotensin II receptor	P30556	179122	antagonist	yes
DB00679	Thioridazine	Phenothiazines with piperidine structure	approved;withdrawn	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00679	Thioridazine	Phenothiazines with piperidine structure	approved;withdrawn	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB00679	Thioridazine	Phenothiazines with piperidine structure	approved;withdrawn	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00679	Thioridazine	Phenothiazines with piperidine structure	approved;withdrawn	Alpha-1B adrenergic receptor	P35368	None	antagonist	yes
DB00679	Thioridazine	Phenothiazines with piperidine structure	approved;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00679	Thioridazine	Phenothiazines with piperidine structure	approved;withdrawn	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00680	Moricizine	Other antiarrhythmics, class I and III	approved;investigational;withdrawn	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00681	Amphotericin B	Antibiotics	approved;investigational	Ergosterol	None	None	binder	yes
DB00682	Warfarin	Vitamin K antagonists	approved	Vitamin K epoxide reductase complex subunit 1	Q9BQB6	40217983	inhibitor	yes
DB00682	Warfarin	Vitamin K antagonists	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB00683	Midazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit theta	Q9UN88	7861736	potentiator	yes
DB00684	Tobramycin	Antibiotics	approved;investigational	30S ribosomal protein S12	P0A7S3	43010	inhibitor	yes
DB00684	Tobramycin	Antibiotics	approved;investigational	16S rRNA	None	None	inhibitor	unknown
DB00685	Trovafloxacin	Fluoroquinolones	approved;investigational;withdrawn	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB00685	Trovafloxacin	Fluoroquinolones	approved;investigational;withdrawn	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB00685	Trovafloxacin	Fluoroquinolones	approved;investigational;withdrawn	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	unknown
DB00686	Pentosan Polysulfate	Heparins or heparinoids for topical use	approved	Fibroblast growth factor 2	P09038	31362	antagonist	yes
DB00686	Pentosan Polysulfate	Heparins or heparinoids for topical use	approved	Fibroblast growth factor 1	P05230	181942	antagonist	yes
DB00686	Pentosan Polysulfate	Heparins or heparinoids for topical use	approved	Fibroblast growth factor 4	P08620	386788	inhibitor	unknown
DB00687	Fludrocortisone	Corticosteroids and antiinfectives in combination	approved;investigational	Mineralocorticoid receptor	P08235	307166	agonist	yes
DB00687	Fludrocortisone	Corticosteroids and antiinfectives in combination	approved;investigational	Glucocorticoid receptor	P04150	31680	agonist	unknown
DB00687	Fludrocortisone	Corticosteroids and antiinfectives in combination	approved;investigational	Androgen receptor	P10275	178628	agonist	unknown
DB00688	Mycophenolate mofetil	N/A	approved;investigational	Inosine-5'-monophosphate dehydrogenase 1	P20839	307067	inhibitor	yes
DB00688	Mycophenolate mofetil	N/A	approved;investigational	Inosine-5'-monophosphate dehydrogenase 2	P12268	307066	inhibitor	yes
DB00689	Cephaloglycin	N/A	approved	Penicillin-binding protein 1 (PBP1)	A0A1Q8GFY7	None	antagonist	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB00690	Flurazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit theta	Q9UN88	7861736	potentiator	yes
DB00691	Moexipril	ACE inhibitors, plain	approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB00691	Moexipril	ACE inhibitors, plain	approved	Angiotensin-converting enzyme 2	Q9BYF1	9802433	inhibitor	yes
DB00692	Phentolamine	Antidotes	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	yes
DB00692	Phentolamine	Antidotes	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00692	Phentolamine	Antidotes	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00692	Phentolamine	Antidotes	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB00693	Fluorescein	Colouring agents	approved	Ig kappa chain V-II region RPMI 6410	P06310	296655	other	no
DB00693	Fluorescein	Colouring agents	approved	DNA	None	None	other	no
DB00694	Daunorubicin	Anthracyclines and related substances	approved	DNA	None	None	intercalation	yes
DB00694	Daunorubicin	Anthracyclines and related substances	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB00694	Daunorubicin	Anthracyclines and related substances	approved	DNA topoisomerase 2-beta	Q02880	None	inhibitor	yes
DB00695	Furosemide	High-ceiling diuretics and potassium-sparing agents	approved;vet_approved	Solute carrier family 12 member 1	Q13621	1373425	inhibitor	yes
DB00695	Furosemide	High-ceiling diuretics and potassium-sparing agents	approved;vet_approved	Carbonic anhydrase 2	P00918	179780	None	unknown
DB00696	Ergotamine	Ergot alkaloids	approved	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	yes
DB00696	Ergotamine	Ergot alkaloids	approved	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	yes
DB00696	Ergotamine	Ergot alkaloids	approved	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	yes
DB00696	Ergotamine	Ergot alkaloids	approved	D(2) dopamine receptor	P14416	181432	agonist	unknown
DB00696	Ergotamine	Ergot alkaloids	approved	Alpha-1A adrenergic receptor	P35348	433201	partial agonist	yes
DB00696	Ergotamine	Ergot alkaloids	approved	Alpha-1B adrenergic receptor	P35368	None	partial agonist	yes
DB00696	Ergotamine	Ergot alkaloids	approved	Alpha-1D adrenergic receptor	P25100	177807	partial agonist	yes
DB00696	Ergotamine	Ergot alkaloids	approved	Alpha-2A adrenergic receptor	P08913	178196	partial agonist	unknown
DB00696	Ergotamine	Ergot alkaloids	approved	Alpha-2B adrenergic receptor	P18089	178198	agonist	unknown
DB00696	Ergotamine	Ergot alkaloids	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB00696	Ergotamine	Ergot alkaloids	approved	D(1) dopamine receptor	P21918	32049	agonist	unknown
DB00696	Ergotamine	Ergot alkaloids	approved	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB00696	Ergotamine	Ergot alkaloids	approved	5-hydroxytryptamine receptor 1F	P30939	307420	agonist	unknown
DB00696	Ergotamine	Ergot alkaloids	approved	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	unknown
DB00696	Ergotamine	Ergot alkaloids	approved	5-hydroxytryptamine receptor 2B	P41595	475198	None	unknown
DB00697	Tizanidine	Other centrally acting agents	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	unknown
DB00697	Tizanidine	Other centrally acting agents	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB00697	Tizanidine	Other centrally acting agents	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	agonist	yes
DB00697	Tizanidine	Other centrally acting agents	approved;investigational	Nischarin	Q9Y2I1	3462807	agonist	no
DB00698	Nitrofurantoin	Nitrofuran derivatives	approved;vet_approved	Probable pyruvate-flavodoxin oxidoreductase	P52647	1787642	potentiator	yes
DB00698	Nitrofurantoin	Nitrofuran derivatives	approved;vet_approved	Oxygen-insensitive NADPH nitroreductase	P17117	609324	potentiator	yes
DB00698	Nitrofurantoin	Nitrofuran derivatives	approved;vet_approved	30S ribosomal protein S10	P0A7R5	42857	None	unknown
DB00699	Nicergoline	Ergot alkaloids	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00700	Eplerenone	Aldosterone antagonists	approved	Mineralocorticoid receptor	P08235	307166	antagonist	yes
DB00701	Amprenavir	Protease inhibitors	approved;investigational	Human immunodeficiency virus type 1 protease	Q72874	None	inhibitor	yes
DB00703	Methazolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	yes
DB00703	Methazolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB00703	Methazolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 4	P22748	179791	inhibitor	yes
DB00703	Methazolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 7	P43166	28192445	inhibitor	yes
DB00703	Methazolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 3	P07451	189053812	inhibitor	unknown
DB00704	Naltrexone	Centrally acting antiobesity products	approved;investigational;vet_approved	Delta-type opioid receptor	P41143	27545517	antagonist	yes
DB00704	Naltrexone	Centrally acting antiobesity products	approved;investigational;vet_approved	Mu-type opioid receptor	P35372	452073	antagonist	yes
DB00704	Naltrexone	Centrally acting antiobesity products	approved;investigational;vet_approved	Kappa-type opioid receptor	P41145	532060	antagonist	yes
DB00704	Naltrexone	Centrally acting antiobesity products	approved;investigational;vet_approved	HCG20471, isoform CRA_c	Q5T1J1	123231939	antagonist	yes
DB00705	Delavirdine	Non-nucleoside reverse transcriptase inhibitors	approved	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB00706	Tamsulosin	Alpha-adrenoreceptor antagonists	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00706	Tamsulosin	Alpha-adrenoreceptor antagonists	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB00706	Tamsulosin	Alpha-adrenoreceptor antagonists	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00707	Porfimer sodium	Sensitizers used in photodynamic/radiation therapy	approved;investigational	Low-density lipoprotein receptor	P01130	307121	other/unknown	unknown
DB00707	Porfimer sodium	Sensitizers used in photodynamic/radiation therapy	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	antagonist	unknown
DB00708	Sufentanil	Opioid anesthetics	approved;investigational	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00708	Sufentanil	Opioid anesthetics	approved;investigational	Delta-type opioid receptor	P41143	27545517	agonist	unknown
DB00708	Sufentanil	Opioid anesthetics	approved;investigational	Kappa-type opioid receptor	P41145	532060	other	unknown
DB00709	Lamivudine	Antivirals for treatment of HIV infections, combinations	approved;investigational	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB00709	Lamivudine	Antivirals for treatment of HIV infections, combinations	approved;investigational	DNA	None	None	adduct	yes
DB00709	Lamivudine	Antivirals for treatment of HIV infections, combinations	approved;investigational	Protein P	Q05486	59427	inhibitor	yes
DB00710	Ibandronate	Bisphosphonates	approved;investigational	Farnesyl pyrophosphate synthase	P14324	182399	inhibitor	yes
DB00710	Ibandronate	Bisphosphonates	approved;investigational	Hydroxylapatite	None	None	antagonist	yes
DB00711	Diethylcarbamazine	Piperazine and derivatives	approved;investigational;vet_approved	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	yes
DB00711	Diethylcarbamazine	Piperazine and derivatives	approved;investigational;vet_approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00712	Flurbiprofen	Propionic acid derivatives	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00712	Flurbiprofen	Propionic acid derivatives	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00713	Oxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00713	Oxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB00713	Oxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB00713	Oxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB00713	Oxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB00713	Oxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB00713	Oxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Solute carrier family 15 member 1	P46059	773588	None	unknown
DB00713	Oxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 2	D6R448	None	None	unknown
DB00713	Oxacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Solute carrier family 15 member 2	Q16348	999213	None	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	D(3) dopamine receptor	P35462	927342	agonist	yes
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	D(4) dopamine receptor	P21917	291946	agonist	yes
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	D(2) dopamine receptor	P14416	181432	agonist	yes
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	D(1B) dopamine receptor	P21918	32049	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	D(1A) dopamine receptor	P21728	30397	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	unknown
DB00714	Apomorphine	Drugs used in erectile dysfunction	approved;investigational	Neuron-specific vesicular protein calcyon	Q9NYX4	6980076	agonist	unknown
DB00715	Paroxetine	Selective serotonin reuptake inhibitors	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00715	Paroxetine	Selective serotonin reuptake inhibitors	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB00715	Paroxetine	Selective serotonin reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	other/unknown	unknown
DB00715	Paroxetine	Selective serotonin reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB00715	Paroxetine	Selective serotonin reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB00715	Paroxetine	Selective serotonin reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB00715	Paroxetine	Selective serotonin reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB00715	Paroxetine	Selective serotonin reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB00716	Nedocromil	Antiallergic agents, excl. corticosteroids	approved;investigational	Cysteinyl leukotriene receptor 1	Q9Y271	5353887	suppressor	yes
DB00716	Nedocromil	Antiallergic agents, excl. corticosteroids	approved;investigational	Cysteinyl leukotriene receptor 2	Q9NS75	9663958	antagonist	yes
DB00716	Nedocromil	Antiallergic agents, excl. corticosteroids	approved;investigational	fMet-Leu-Phe receptor	P21462	189184	antagonist	unknown
DB00716	Nedocromil	Antiallergic agents, excl. corticosteroids	approved;investigational	Prostaglandin D2 receptor	Q13258	940379	unknown	unknown
DB00716	Nedocromil	Antiallergic agents, excl. corticosteroids	approved;investigational	Heat shock protein HSP 90-alpha	P07900	32488	None	unknown
DB00717	Norethisterone	Progestogens and estrogens, sequential preparations	approved	Progesterone receptor	P06401	35652	agonist	unknown
DB00718	Adefovir Dipivoxil	Nucleoside and nucleotide reverse transcriptase inhibitors	approved;investigational	DNA polymerase/reverse transcriptase	P24024	329670	other	yes
DB00719	Azatadine	Other antihistamines for systemic use	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00720	Clodronic Acid	Bisphosphonates	approved;investigational;vet_approved	ADP/ATP translocase 1	P12235	339920	inhibitor	yes
DB00720	Clodronic Acid	Bisphosphonates	approved;investigational;vet_approved	ADP/ATP translocase 2	P05141	178661	inhibitor	yes
DB00720	Clodronic Acid	Bisphosphonates	approved;investigational;vet_approved	ADP/ATP translocase 3	P12236	339723	inhibitor	yes
DB00720	Clodronic Acid	Bisphosphonates	approved;investigational;vet_approved	Hydroxylapatite	None	None	antagonist	yes
DB00721	Procaine	Local anesthetics	approved;investigational;vet_approved	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB00721	Procaine	Local anesthetics	approved;investigational;vet_approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	yes
DB00721	Procaine	Local anesthetics	approved;investigational;vet_approved	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	yes
DB00721	Procaine	Local anesthetics	approved;investigational;vet_approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB00721	Procaine	Local anesthetics	approved;investigational;vet_approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	unknown
DB00721	Procaine	Local anesthetics	approved;investigational;vet_approved	DNA	None	None	binder	unknown
DB00721	Procaine	Local anesthetics	approved;investigational;vet_approved	Calcium-activated potassium channel	Q9UGI6	3309531	binder	unknown
DB00721	Procaine	Local anesthetics	approved;investigational;vet_approved	Phospholipase A2	None	None	inhibitor	unknown
DB00721	Procaine	Local anesthetics	approved;investigational;vet_approved	Lysophospholipase	None	None	inhibitor	unknown
DB00721	Procaine	Local anesthetics	approved;investigational;vet_approved	Monoamine oxidase	P27338	398415	inhibitor	unknown
DB00722	Lisinopril	ACE inhibitors, plain	approved;investigational	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB00723	Methoxamine	Adrenergic and dopaminergic agents	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB00723	Methoxamine	Adrenergic and dopaminergic agents	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	agonist	unknown
DB00723	Methoxamine	Adrenergic and dopaminergic agents	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	binder	unknown
DB00724	Imiquimod	Antivirals	approved;investigational	Toll-like receptor 7	Q9NYK1	7330281	agonist	yes
DB00724	Imiquimod	Antivirals	approved;investigational	Toll-like receptor 8	Q9NR97	None	agonist	unknown
DB00725	Homatropine Methylbromide	Belladonna and derivatives in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00725	Homatropine Methylbromide	Belladonna and derivatives in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00725	Homatropine Methylbromide	Belladonna and derivatives in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB00725	Homatropine Methylbromide	Belladonna and derivatives in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	yes
DB00725	Homatropine Methylbromide	Belladonna and derivatives in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	D(2) dopamine receptor	P14416	181432	other/unknown	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	Alpha-2B adrenergic receptor	P18089	178198	other/unknown	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 3A	P46098	681914	binder	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 1D	P28221	177772	binder	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	Alpha-2A adrenergic receptor	P08913	178196	desensitize the target	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	D(1) dopamine receptor	P21918	32049	binder	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	Beta adrenergic receptor	P13945	178896	binder	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor	P08912	177988	binder	unknown
DB00726	Trimipramine	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 1C	P08909	None	binder	unknown
DB00727	Nitroglycerin	Muscle relaxants	approved;investigational	Atrial natriuretic peptide receptor 1	P16066	28230	agonist	yes
DB00728	Rocuronium	Other quaternary ammonium compounds	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB00728	Rocuronium	Other quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00728	Rocuronium	Other quaternary ammonium compounds	approved	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB00729	Diphemanil Methylsulfate	N/A	approved;vet_approved;withdrawn	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB00730	Thiabendazole	Imidazole and triazole derivatives	approved;vet_approved	Fumarate reductase flavoprotein subunit	P00363	145263	inhibitor	yes
DB00731	Nateglinide	Other blood glucose lowering drugs, excl. insulins	approved;investigational	ATP-binding cassette sub-family C member 8	Q09428	1374919	inhibitor	yes
DB00731	Nateglinide	Other blood glucose lowering drugs, excl. insulins	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	unknown
DB00732	Atracurium besylate	N/A	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB00733	Pralidoxime	Antidotes	approved;vet_approved	Acetylcholinesterase	P22303	177975	activator	yes
DB00733	Pralidoxime	Antidotes	approved;vet_approved	Cholinesterase	P06276	1311630	activator	yes
DB00734	Risperidone	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00734	Risperidone	Other antipsychotics	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00734	Risperidone	Other antipsychotics	approved;investigational	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	agonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB00734	Risperidone	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	None	unknown
DB00735	Naftifine	Other antifungals for topical use	approved	Squalene monooxygenase	Q14534	2443316	inhibitor	yes
DB00736	Esomeprazole	Propionic acid derivatives	approved;investigational	Potassium-transporting ATPase alpha chain 1	P20648	561634	inhibitor	yes
DB00737	Meclizine	Piperazine derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00737	Meclizine	Piperazine derivatives	approved	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	inverse agonist	unknown
DB00738	Pentamidine	Other agents against leishmaniasis and trypanosomiasis	approved;investigational	DNA	None	None	intercalation	unknown
DB00738	Pentamidine	Other agents against leishmaniasis and trypanosomiasis	approved;investigational	tRNA (cytosine(38)-C(5))-methyltransferase	O14717	None	other	unknown
DB00739	Hetacillin	Penicillins with extended spectrum	approved;vet_approved;withdrawn	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB00739	Hetacillin	Penicillins with extended spectrum	approved;vet_approved;withdrawn	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB00739	Hetacillin	Penicillins with extended spectrum	approved;vet_approved;withdrawn	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00739	Hetacillin	Penicillins with extended spectrum	approved;vet_approved;withdrawn	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB00739	Hetacillin	Penicillins with extended spectrum	approved;vet_approved;withdrawn	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB00740	Riluzole	Other nervous system drugs	approved;investigational	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00740	Riluzole	Other nervous system drugs	approved;investigational	Cystine/glutamate transporter	Q9UPY5	5668545	inducer	yes
DB00741	Hydrocortisone	Corticosteroids and antiinfectives in combination	approved;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00741	Hydrocortisone	Corticosteroids and antiinfectives in combination	approved;vet_approved	Annexin A1	P04083	12654863	agonist	yes
DB00741	Hydrocortisone	Corticosteroids and antiinfectives in combination	approved;vet_approved	Corticosteroid 11-beta-dehydrogenase isozyme 2	P80365	565082	None	unknown
DB00741	Hydrocortisone	Corticosteroids and antiinfectives in combination	approved;vet_approved	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	P14060	306889	None	unknown
DB00744	Zileuton	N/A	approved;investigational;withdrawn	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	yes
DB00745	Modafinil	Centrally acting sympathomimetics	approved;investigational	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB00745	Modafinil	Centrally acting sympathomimetics	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	partial agonist	unknown
DB00746	Deferoxamine	Iron chelating agents	approved;investigational	Iron	None	None	chelator	yes
DB00746	Deferoxamine	Iron chelating agents	approved;investigational	Aluminum	None	None	chelator	yes
DB00746	Deferoxamine	Iron chelating agents	approved;investigational	Amyloid beta A4 protein	P05067	None	None	unknown
DB00747	Scopolamine	Anticholinergics	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00747	Scopolamine	Anticholinergics	approved;investigational	Sucrase-isomaltase, intestinal	P14410	36645	inhibitor	unknown
DB00747	Scopolamine	Anticholinergics	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00747	Scopolamine	Anticholinergics	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00747	Scopolamine	Anticholinergics	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB00747	Scopolamine	Anticholinergics	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB00747	Scopolamine	Anticholinergics	approved;investigational	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB00747	Scopolamine	Anticholinergics	approved;investigational	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	None	unknown
DB00748	Carbinoxamine	Aminoalkyl ethers	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00749	Etodolac	Acetic acid derivatives and related substances	approved;investigational;vet_approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00749	Etodolac	Acetic acid derivatives and related substances	approved;investigational;vet_approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00749	Etodolac	Acetic acid derivatives and related substances	approved;investigational;vet_approved	Retinoic acid receptor RXR-alpha	P19793	35885	other	unknown
DB00750	Prilocaine	Amides	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00751	Epinastine	Other antihistamines for systemic use	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00751	Epinastine	Other antihistamines for systemic use	approved;investigational	Histamine H2 receptor	P25021	184088	antagonist	yes
DB00751	Epinastine	Other antihistamines for systemic use	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	unknown	unknown
DB00751	Epinastine	Other antihistamines for systemic use	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	unknown	unknown
DB00751	Epinastine	Other antihistamines for systemic use	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB00751	Epinastine	Other antihistamines for systemic use	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB00752	Tranylcypromine	Monoamine oxidase inhibitors, non-selective	approved;investigational	Amine oxidase [flavin-containing] A	P21397	187353	inhibitor	yes
DB00752	Tranylcypromine	Monoamine oxidase inhibitors, non-selective	approved;investigational	Amine oxidase [flavin-containing] B	P27338	398415	inhibitor	yes
DB00753	Isoflurane	Halogenated hydrocarbons	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB00753	Isoflurane	Halogenated hydrocarbons	approved;vet_approved	Calcium-transporting ATPase type 2C member 1	P98194	6715131	inhibitor	yes
DB00753	Isoflurane	Halogenated hydrocarbons	approved;vet_approved	Glycine receptor subunit alpha-1	P23415	31851	agonist	yes
DB00753	Isoflurane	Halogenated hydrocarbons	approved;vet_approved	Glutamate receptor 1	P42261	183281	antagonist	yes
DB00753	Isoflurane	Halogenated hydrocarbons	approved;vet_approved	Potassium voltage-gated channel subfamily A member 1	Q09470	186663	inducer	yes
DB00753	Isoflurane	Halogenated hydrocarbons	approved;vet_approved	ATP synthase subunit delta, mitochondrial	P30049	12586	unknown	unknown
DB00753	Isoflurane	Halogenated hydrocarbons	approved;vet_approved	Calmodulin	P0DP23	179888	other/unknown	unknown
DB00753	Isoflurane	Halogenated hydrocarbons	approved;vet_approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00753	Isoflurane	Halogenated hydrocarbons	approved;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00753	Isoflurane	Halogenated hydrocarbons	approved;vet_approved	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	antagonist	unknown
DB00754	Ethotoin	Hydantoin derivatives	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00754	Ethotoin	Hydantoin derivatives	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	activator	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinoic acid receptor RXR-beta	P28702	30448	agonist	yes
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinoic acid receptor RXR-gamma	P48443	1053069	agonist	yes
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinoic acid receptor gamma	P13631	306887	agonist	yes
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinal dehydrogenase 1	P00352	178372	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinoic acid-induced protein 3	Q8NFJ5	4063890	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Nuclear receptor subfamily 0 group B member 1	P51843	786532	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinal dehydrogenase 2	O94788	3970842	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinoic acid receptor responder protein 1	P49788	942585	agonist	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinoic acid receptor alpha	P10276	36157	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinoic acid receptor beta	P10826	35883	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Lipocalin-1	P31025	None	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Odorant-binding protein 2a	Q9NY56	None	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinol-binding protein 4	P02753	35897	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial	Q16654	1399197	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Retinoic acid receptor RXR-alpha	P19793	35885	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Cytochrome P450 26A1	O43174	None	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Cytochrome P450 26B1	Q9NR63	None	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Cytochrome P450 26C1	Q6V0L0	None	None	unknown
DB00755	Tretinoin	Other antineoplastic agents	approved;investigational;nutraceutical	Hematopoietic prostaglandin D synthase	O60760	3046817	None	unknown
DB00756	Hexachlorophene	Phenol and derivatives	approved;withdrawn	D-lactate dehydrogenase	P06149	145753	inhibitor	yes
DB00756	Hexachlorophene	Phenol and derivatives	approved;withdrawn	Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial	O14521	2351037	inhibitor	yes
DB00756	Hexachlorophene	Phenol and derivatives	approved;withdrawn	Glutamate dehydrogenase 1, mitochondrial	P00367	31707	inhibitor	unknown
DB00756	Hexachlorophene	Phenol and derivatives	approved;withdrawn	Estrogen receptor alpha	P03372	31234	None	unknown
DB00757	Dolasetron	Serotonin (5HT3) antagonists	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	yes
DB00758	Clopidogrel	Platelet aggregation inhibitors excl. heparin	approved	P2Y purinoceptor 12	Q9H244	12083902	antagonist	yes
DB00759	Tetracycline	Antiinfectives	approved;vet_approved	30S ribosomal protein S7	P02359	None	inhibitor	yes
DB00759	Tetracycline	Antiinfectives	approved;vet_approved	30S ribosomal protein S14	P0AG59	809690	inhibitor	yes
DB00759	Tetracycline	Antiinfectives	approved;vet_approved	30S ribosomal protein S3	P0A7V3	None	inhibitor	yes
DB00759	Tetracycline	Antiinfectives	approved;vet_approved	30S ribosomal protein S8	P0A7W7	None	inhibitor	yes
DB00759	Tetracycline	Antiinfectives	approved;vet_approved	30S ribosomal protein S19	P0A7U3	42826	inhibitor	yes
DB00759	Tetracycline	Antiinfectives	approved;vet_approved	16S rRNA	None	None	inhibitor	yes
DB00759	Tetracycline	Antiinfectives	approved;vet_approved	Major prion protein	P04156	190468	inhibitor	unknown
DB00759	Tetracycline	Antiinfectives	approved;vet_approved	Multidrug translocase MdfA	C9EH48	None	None	unknown
DB00759	Tetracycline	Antiinfectives	approved;vet_approved	Protein-arginine deiminase type-4	Q9UM07	5913971	None	unknown
DB00760	Meropenem	Carbapenems	approved;investigational	D-alanyl-D-alanine carboxypeptidase DacB	P24228	41216	inhibitor	yes
DB00761	Potassium Chloride	Electrolyte solutions	approved;withdrawn	Solute carrier family 12 member 2	P55011	903682	None	unknown
DB00761	Potassium Chloride	Electrolyte solutions	approved;withdrawn	Solute carrier family 12 member 1	Q13621	1373425	binder	unknown
DB00761	Potassium Chloride	Electrolyte solutions	approved;withdrawn	Solute carrier family 12 member 5	Q9H2X9	12003227	None	unknown
DB00761	Potassium Chloride	Electrolyte solutions	approved;withdrawn	Solute carrier family 12 member 6	Q9UHW9	6693798	None	unknown
DB00761	Potassium Chloride	Electrolyte solutions	approved;withdrawn	Solute carrier family 12 member 7	Q9Y666	5106521	None	unknown
DB00761	Potassium Chloride	Electrolyte solutions	approved;withdrawn	Solute carrier family 12 member 4	Q9UP95	1399212	None	unknown
DB00762	Irinotecan	Other antineoplastic agents	approved;investigational	DNA topoisomerase 1	P11387	339806	inhibitor	yes
DB00762	Irinotecan	Other antineoplastic agents	approved;investigational	DNA topoisomerase I, mitochondrial	Q969P6	15919359	inhibitor	yes
DB00763	Methimazole	Sulfur-containing imidazole derivatives	approved	Thyroid peroxidase	P07202	339867	inhibitor	yes
DB00764	Mometasone	Glucocorticoids	approved;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00764	Mometasone	Glucocorticoids	approved;vet_approved	Progesterone receptor	P06401	35652	agonist	unknown
DB00765	Metyrosine	Tyrosine hydroxylase inhibitors	approved	Tyrosine 3-monooxygenase	P07101	37127	binder	yes
DB00766	Clavulanate	N/A	approved;vet_approved	Beta-lactamase	P00807	581568	inhibitor	yes
DB00768	Olopatadine	Other antiallergics	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00768	Olopatadine	Other antiallergics	approved	Protein S100-A1	P23297	36176	antagonist	unknown
DB00768	Olopatadine	Other antiallergics	approved	Protein S100-A12	P80511	1545946	antagonist	unknown
DB00768	Olopatadine	Other antiallergics	approved	Protein S100-B	P04271	337730	other/unknown	unknown
DB00768	Olopatadine	Other antiallergics	approved	Protein S100-A13	Q99584	1694828	other/unknown	unknown
DB00768	Olopatadine	Other antiallergics	approved	Protein S100-A2	P29034	None	antagonist	unknown
DB00769	Hydrocortamate	N/A	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00770	Alprostadil	Prostaglandins	approved;investigational	Prostaglandin E2 receptor EP2 subtype	P43116	632650	agonist	yes
DB00770	Alprostadil	Prostaglandins	approved;investigational	Prostaglandin E2 receptor EP1 subtype	P34995	410209	agonist	yes
DB00770	Alprostadil	Prostaglandins	approved;investigational	Prostaglandin D2 receptor 2	Q9Y5Y4	4204216	agonist	unknown
DB00771	Clidinium	Synthetic anticholinergic agents in combination with psycholeptics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00772	Malathion	Other ectoparasiticides, incl. scabicides	approved;investigational	Cholinesterase	P06276	1311630	inhibitor	yes
DB00773	Etoposide	Podophyllotoxin derivatives	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB00773	Etoposide	Podophyllotoxin derivatives	approved	DNA topoisomerase 2-beta	Q02880	None	inhibitor	no
DB00774	Hydroflumethiazide	Thiazides and potassium in combination	approved;investigational	Solute carrier family 12 member 1	Q13621	1373425	inhibitor	yes
DB00774	Hydroflumethiazide	Thiazides and potassium in combination	approved;investigational	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB00774	Hydroflumethiazide	Thiazides and potassium in combination	approved;investigational	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB00774	Hydroflumethiazide	Thiazides and potassium in combination	approved;investigational	Carbonic anhydrase 4	P22748	179791	inhibitor	unknown
DB00774	Hydroflumethiazide	Thiazides and potassium in combination	approved;investigational	Carbonic anhydrase 9	Q16790	None	inhibitor	unknown
DB00774	Hydroflumethiazide	Thiazides and potassium in combination	approved;investigational	Carbonic anhydrase 12	O43570	2984693	inhibitor	unknown
DB00774	Hydroflumethiazide	Thiazides and potassium in combination	approved;investigational	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	other/unknown	unknown
DB00774	Hydroflumethiazide	Thiazides and potassium in combination	approved;investigational	Calcium-activated potassium channel subunit alpha-1	Q12791	537439	other/unknown	unknown
DB00775	Tirofiban	Platelet aggregation inhibitors excl. heparin	approved	Integrin alpha-IIb	P08514	190068	antagonist	yes
DB00775	Tirofiban	Platelet aggregation inhibitors excl. heparin	approved	Integrin beta-3	P05106	306786	antagonist	yes
DB00776	Oxcarbazepine	Carboxamide derivatives	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00777	Propiomazine	Other hypnotics and sedatives	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00777	Propiomazine	Other hypnotics and sedatives	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	D(2) dopamine receptor	P14416	181432	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB00777	Propiomazine	Other hypnotics and sedatives	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00778	Roxithromycin	Macrolides	approved;investigational;withdrawn	50S ribosomal protein L10	P0A7J6	24054563	inhibitor	yes
DB00778	Roxithromycin	Macrolides	approved;investigational;withdrawn	Multidrug resistance protein 1	P08183	307180	None	unknown
DB00779	Nalidixic Acid	Other quinolones	approved;investigational	DNA	None	None	other	yes
DB00780	Phenelzine	Monoamine oxidase inhibitors, non-selective	approved	Amine oxidase [flavin-containing] A	P21397	187353	antagonist	yes
DB00780	Phenelzine	Monoamine oxidase inhibitors, non-selective	approved	Amine oxidase [flavin-containing] B	P27338	398415	antagonist	yes
DB00780	Phenelzine	Monoamine oxidase inhibitors, non-selective	approved	Membrane primary amine oxidase	Q16853	1399032	inhibitor	unknown
DB00780	Phenelzine	Monoamine oxidase inhibitors, non-selective	approved	4-aminobutyrate aminotransferase, mitochondrial	P80404	602705	inhibitor	unknown
DB00780	Phenelzine	Monoamine oxidase inhibitors, non-selective	approved	Alanine aminotransferase 1	P24298	1763096	inhibitor	unknown
DB00780	Phenelzine	Monoamine oxidase inhibitors, non-selective	approved	Alanine aminotransferase 2	Q8TD30	19046894	inhibitor	unknown
DB00780	Phenelzine	Monoamine oxidase inhibitors, non-selective	approved	Glutamic acid decarboxylase	Q9UGI5	6562440	inhibitor	unknown
DB00781	Polymyxin B Sulfate	Polymyxins	approved;vet_approved	Bacterial outer membrane	None	None	incorporation into and destabilization	yes
DB00782	Propantheline	Synthetic anticholinergics, quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00783	Estradiol	Progestogens and estrogens, fixed combinations	approved;investigational;vet_approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00783	Estradiol	Progestogens and estrogens, fixed combinations	approved;investigational;vet_approved	Estrogen receptor beta	Q92731	2911152	agonist	yes
DB00783	Estradiol	Progestogens and estrogens, fixed combinations	approved;investigational;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00783	Estradiol	Progestogens and estrogens, fixed combinations	approved;investigational;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB00783	Estradiol	Progestogens and estrogens, fixed combinations	approved;investigational;vet_approved	Nuclear receptor coactivator 2	Q15596	1877215	None	unknown
DB00783	Estradiol	Progestogens and estrogens, fixed combinations	approved;investigational;vet_approved	G-protein coupled estrogen receptor 1	Q99527	None	None	unknown
DB00783	Estradiol	Progestogens and estrogens, fixed combinations	approved;investigational;vet_approved	ATP synthase subunit a	P00846	None	None	unknown
DB00783	Estradiol	Progestogens and estrogens, fixed combinations	approved;investigational;vet_approved	Beclin-1	Q14457	None	None	unknown
DB00783	Estradiol	Progestogens and estrogens, fixed combinations	approved;investigational;vet_approved	Estradiol 17-beta-dehydrogenase 2	P37059	306462	None	unknown
DB00783	Estradiol	Progestogens and estrogens, fixed combinations	approved;investigational;vet_approved	Estrogen-related receptor gamma	P62508	4092075	ligand	unknown
DB00784	Mefenamic acid	Fenamates	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00784	Mefenamic acid	Fenamates	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00785	Cryptenamine	N/A	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB00785	Cryptenamine	N/A	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00785	Cryptenamine	N/A	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB00785	Cryptenamine	N/A	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB00785	Cryptenamine	N/A	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	yes
DB00786	Marimastat	N/A	approved;investigational	Interstitial collagenase	P03956	30126	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	72 kDa type IV collagenase	P08253	180671	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Stromelysin-1	P08254	36633	antagonist	yes
DB00786	Marimastat	N/A	approved;investigational	Matrilysin	P09237	35799	antagonist	yes
DB00786	Marimastat	N/A	approved;investigational	Neutrophil collagenase	P22894	180618	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-9	P14780	177205	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Stromelysin-2	P09238	36629	antagonist	yes
DB00786	Marimastat	N/A	approved;investigational	Stromelysin-3	P24347	456257	antagonist	yes
DB00786	Marimastat	N/A	approved;investigational	Macrophage metalloelastase	P39900	435970	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Collagenase 3	P45452	516386	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-14	P50281	793763	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-15	P51511	963056	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-16	P51512	2662306	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-17	Q9ULZ9	18413635	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-19	Q99542	1702930	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-20	O60882	3005946	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-21	Q8N119	22134532	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-23	O75900	3650496	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-24	Q9Y5R2	5381386	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-25	Q9NPA2	8546817	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-26	Q9NRE1	8843950	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-27	Q9H306	11066090	inhibitor	yes
DB00786	Marimastat	N/A	approved;investigational	Matrix metalloproteinase-28	Q9H239	11935132	inhibitor	yes
DB00787	Acyclovir	Antivirals	approved	Thymidine kinase	P03176	59524	potentiator	yes
DB00787	Acyclovir	Antivirals	approved	DNA polymerase catalytic subunit	P04293	59530	inhibitor	yes
DB00787	Acyclovir	Antivirals	approved	DNA polymerase catalytic subunit	P09252	60016	inhibitor	yes
DB00788	Naproxen	Propionic acid derivatives	approved;vet_approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00788	Naproxen	Propionic acid derivatives	approved;vet_approved	Peptostreptococcal albumin-binding protein	Q51911	4388777	None	unknown
DB00788	Naproxen	Propionic acid derivatives	approved;vet_approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00789	Gadopentetate dimeglumine	N/A	approved	6-phosphogluconate dehydrogenase, decarboxylating	P52209	984325	inhibitor	unknown
DB00790	Perindopril	ACE inhibitors, plain	approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB00790	Perindopril	ACE inhibitors, plain	approved	Secreted frizzled-related protein 4	Q6FHJ7	None	inhibitor	unknown
DB00791	Uracil mustard	N/A	approved	DNA	None	None	intercalation	unknown
DB00792	Tripelennamine	Antihistamines for topical use	approved;vet_approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB00794	Primidone	Barbiturates and derivatives	approved;vet_approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00795	Sulfasalazine	Aminosalicylic acid and similar agents	approved	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	yes
DB00795	Sulfasalazine	Aminosalicylic acid and similar agents	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00795	Sulfasalazine	Aminosalicylic acid and similar agents	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00795	Sulfasalazine	Aminosalicylic acid and similar agents	approved	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	yes
DB00795	Sulfasalazine	Aminosalicylic acid and similar agents	approved	Inhibitor of nuclear factor kappa-B kinase subunit alpha	O15111	None	inhibitor	unknown
DB00795	Sulfasalazine	Aminosalicylic acid and similar agents	approved	Inhibitor of nuclear factor kappa-B kinase subunit beta	O14920	2599558	inhibitor	unknown
DB00795	Sulfasalazine	Aminosalicylic acid and similar agents	approved	Cystine/glutamate transporter	Q9UPY5	5668545	inhibitor	unknown
DB00795	Sulfasalazine	Aminosalicylic acid and similar agents	approved	Acetyl-CoA acetyltransferase, mitochondrial	P24752	219918	inhibitor	unknown
DB00795	Sulfasalazine	Aminosalicylic acid and similar agents	approved	Thromboxane-A synthase	P24557	338704	antagonist	unknown
DB00795	Sulfasalazine	Aminosalicylic acid and similar agents	approved	Phospholipase A2	P04054	190013	antagonist	unknown
DB00796	Candesartan cilexetil	N/A	approved	Type-1 angiotensin II receptor	P30556	179122	antagonist	yes
DB00797	Tolazoline	Imidazoline derivatives	approved;vet_approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00797	Tolazoline	Imidazoline derivatives	approved;vet_approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB00797	Tolazoline	Imidazoline derivatives	approved;vet_approved	Histamine H1 receptor	P35367	510296	agonist	unknown
DB00797	Tolazoline	Imidazoline derivatives	approved;vet_approved	Histamine H2 receptor	P25021	184088	agonist	unknown
DB00797	Tolazoline	Imidazoline derivatives	approved;vet_approved	Alpha-2C adrenergic receptor	P18825	178194	binder	unknown
DB00797	Tolazoline	Imidazoline derivatives	approved;vet_approved	Alpha-2B adrenergic receptor	P18089	178198	binder	unknown
DB00798	Gentamicin	Antiinfectives	approved;vet_approved	30S ribosomal protein S12	P0A7S3	43010	adduct	yes
DB00798	Gentamicin	Antiinfectives	approved;vet_approved	16S rRNA	None	None	adduct	yes
DB00798	Gentamicin	Antiinfectives	approved;vet_approved	Low-density lipoprotein receptor-related protein 2	P98164	1809240	other/unknown	no
DB00798	Gentamicin	Antiinfectives	approved;vet_approved	NH(3)-dependent NAD(+) synthetase	P08164	143279	None	unknown
DB00798	Gentamicin	Antiinfectives	approved;vet_approved	Dihydrofolate reductase	P00374	182724	None	unknown
DB00799	Tazarotene	Other antipsoriatics for topical use	approved;investigational	Retinoic acid receptor alpha	P10276	36157	agonist	yes
DB00799	Tazarotene	Other antipsoriatics for topical use	approved;investigational	Retinoic acid receptor RXR-beta	P28702	30448	agonist	yes
DB00799	Tazarotene	Other antipsoriatics for topical use	approved;investigational	Retinoic acid receptor gamma	P13631	306887	agonist	yes
DB00799	Tazarotene	Other antipsoriatics for topical use	approved;investigational	Retinoic acid receptor beta	P10826	35883	agonist	yes
DB00800	Fenoldopam	Adrenergic and dopaminergic agents	approved	D(1B) dopamine receptor	P21918	32049	agonist	yes
DB00800	Fenoldopam	Adrenergic and dopaminergic agents	approved	D(1A) dopamine receptor	P21728	30397	agonist	yes
DB00800	Fenoldopam	Adrenergic and dopaminergic agents	approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB00800	Fenoldopam	Adrenergic and dopaminergic agents	approved	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB00800	Fenoldopam	Adrenergic and dopaminergic agents	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB00800	Fenoldopam	Adrenergic and dopaminergic agents	approved	Alpha-1B adrenergic receptor	P35368	None	inhibitor	unknown
DB00800	Fenoldopam	Adrenergic and dopaminergic agents	approved	Alpha-1D adrenergic receptor	P25100	177807	inhibitor	unknown
DB00800	Fenoldopam	Adrenergic and dopaminergic agents	approved	Alpha-1A adrenergic receptor	P35348	433201	inhibitor	unknown
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB00801	Halazepam	Benzodiazepine derivatives	approved;illicit;withdrawn	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00802	Alfentanil	Opioid anesthetics	approved;illicit	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00803	Colistin	Antibiotics	approved	Bacterial outer membrane	None	None	incorporation into and destabilization	yes
DB00804	Dicyclomine	Synthetic anticholinergics, esters with tertiary amino group	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00804	Dicyclomine	Synthetic anticholinergics, esters with tertiary amino group	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00805	Minaprine	Other antidepressants	approved	Amine oxidase [flavin-containing] A	P21397	187353	inhibitor	yes
DB00805	Minaprine	Other antidepressants	approved	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	yes
DB00805	Minaprine	Other antidepressants	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00805	Minaprine	Other antidepressants	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB00805	Minaprine	Other antidepressants	approved	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB00805	Minaprine	Other antidepressants	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	unknown
DB00805	Minaprine	Other antidepressants	approved	D(1A) dopamine receptor	P21728	30397	agonist	unknown
DB00805	Minaprine	Other antidepressants	approved	D(2) dopamine receptor	P14416	181432	agonist	unknown
DB00805	Minaprine	Other antidepressants	approved	Muscarinic acetylcholine receptor M1	P11229	34451	agonist	unknown
DB00806	Pentoxifylline	Xanthines	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	yes
DB00806	Pentoxifylline	Xanthines	approved;investigational	Adenosine receptor A1	P30542	256155	antagonist	yes
DB00806	Pentoxifylline	Xanthines	approved;investigational	cGMP-specific 3',5'-cyclic phosphodiesterase	O76074	3420185	inhibitor	yes
DB00806	Pentoxifylline	Xanthines	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	yes
DB00806	Pentoxifylline	Xanthines	approved;investigational	Adenosine receptor A2a	P29274	177892	antagonist	yes
DB00806	Pentoxifylline	Xanthines	approved;investigational	5'-nucleotidase	P21589	23897	inhibitor	unknown
DB00807	Proparacaine	Local anesthetics	approved;vet_approved	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB00808	Indapamide	Sulfonamides, plain	approved	Solute carrier family 12 member 3	P55017	1172161	inhibitor	yes
DB00809	Tropicamide	Anticholinergics	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB00809	Tropicamide	Anticholinergics	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00809	Tropicamide	Anticholinergics	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00809	Tropicamide	Anticholinergics	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00810	Biperiden	Tertiary amines	approved;investigational	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB00810	Biperiden	Tertiary amines	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00811	Ribavirin	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved	Inosine-5'-monophosphate dehydrogenase 1	P20839	307067	inhibitor	yes
DB00811	Ribavirin	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved	Adenosine kinase	P55263	1224125	activator	yes
DB00811	Ribavirin	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved	Inosine-5'-monophosphate dehydrogenase 2	P12268	307066	None	unknown
DB00811	Ribavirin	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved	RNA-directed RNA polymerase L	P26676	61991	antagonist	yes
DB00811	Ribavirin	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved	RNA-directed RNA polymerase catalytic subunit	P16502	324960	inhibitor	unknown
DB00811	Ribavirin	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved	Cytosolic purine 5'-nucleotidase	P49902	633071	inducer	unknown
DB00811	Ribavirin	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	P22413	189650	inhibitor	unknown
DB00811	Ribavirin	Nucleosides and nucleotides excl. reverse transcriptase inhibitors	approved	Genome polyprotein	P12823	323655	None	unknown
DB00812	Phenylbutazone	Butylpyrazolidines	approved;vet_approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00812	Phenylbutazone	Butylpyrazolidines	approved;vet_approved	Prostacyclin synthase	Q16647	10944956	inhibitor	yes
DB00812	Phenylbutazone	Butylpyrazolidines	approved;vet_approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00813	Fentanyl	Opioid anesthetics	approved;illicit;investigational;vet_approved	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00813	Fentanyl	Opioid anesthetics	approved;illicit;investigational;vet_approved	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB00813	Fentanyl	Opioid anesthetics	approved;illicit;investigational;vet_approved	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB00813	Fentanyl	Opioid anesthetics	approved;illicit;investigational;vet_approved	Multidrug resistance protein 1	P08183	307180	None	unknown
DB00814	Meloxicam	Oxicams	approved;vet_approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00814	Meloxicam	Oxicams	approved;vet_approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00816	Orciprenaline	Non-selective beta-adrenoreceptor agonists	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB00817	Rosoxacin	Other quinolones	approved;investigational	DNA gyrase subunit B	P0AES6	41646	inhibitor	yes
DB00817	Rosoxacin	Other quinolones	approved;investigational	DNA topoisomerase 4 subunit A	P0AFI2	147106	inhibitor	yes
DB00818	Propofol	Other general anesthetics	approved;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB00818	Propofol	Other general anesthetics	approved;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB00818	Propofol	Other general anesthetics	approved;investigational;vet_approved	Sodium channel protein type 4 subunit alpha	P35499	338213	inhibitor	unknown
DB00818	Propofol	Other general anesthetics	approved;investigational;vet_approved	Sodium channel protein type 2 subunit alpha	Q99250	457879	inhibitor	unknown
DB00818	Propofol	Other general anesthetics	approved;investigational;vet_approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00819	Acetazolamide	Carbonic anhydrase inhibitors	approved;vet_approved	Carbonic anhydrase 1	P00915	29600	inhibitor	yes
DB00819	Acetazolamide	Carbonic anhydrase inhibitors	approved;vet_approved	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB00819	Acetazolamide	Carbonic anhydrase inhibitors	approved;vet_approved	Carbonic anhydrase 4	P22748	179791	inhibitor	yes
DB00819	Acetazolamide	Carbonic anhydrase inhibitors	approved;vet_approved	Carbonic anhydrase 12	O43570	2984693	inhibitor	yes
DB00819	Acetazolamide	Carbonic anhydrase inhibitors	approved;vet_approved	Carbonic anhydrase 14	Q9ULX7	6009640	inhibitor	yes
DB00819	Acetazolamide	Carbonic anhydrase inhibitors	approved;vet_approved	Carbonic anhydrase 3	P07451	189053812	inhibitor	yes
DB00819	Acetazolamide	Carbonic anhydrase inhibitors	approved;vet_approved	Carbonic anhydrase 7	P43166	28192445	inhibitor	yes
DB00819	Acetazolamide	Carbonic anhydrase inhibitors	approved;vet_approved	Aquaporin-1	P29972	180501	inhibitor	unknown
DB00820	Tadalafil	Drugs used in erectile dysfunction	approved;investigational	cGMP-specific 3',5'-cyclic phosphodiesterase	O76074	3420185	inhibitor	yes
DB00820	Tadalafil	Drugs used in erectile dysfunction	approved;investigational	Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	Q9HCR9	10716052	inhibitor	unknown
DB00821	Carprofen	N/A	approved;vet_approved;withdrawn	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00821	Carprofen	N/A	approved;vet_approved;withdrawn	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00822	Disulfiram	Sulfur containing products	approved	Aldehyde dehydrogenase, mitochondrial	P05091	28606	inhibitor	yes
DB00822	Disulfiram	Sulfur containing products	approved	Dopamine beta-hydroxylase	P09172	30474	inhibitor	yes
DB00823	Ethynodiol diacetate	N/A	approved	Progesterone receptor	P06401	35652	agonist	yes
DB00823	Ethynodiol diacetate	N/A	approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00824	Enprofylline	N/A	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	yes
DB00824	Enprofylline	N/A	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	yes
DB00824	Enprofylline	N/A	approved;investigational	Adenosine receptor A2b	P29275	178150	antagonist	yes
DB00824	Enprofylline	N/A	approved;investigational	Adenosine receptor A1	P30542	256155	inhibitor	unknown
DB00824	Enprofylline	N/A	approved;investigational	Adenosine receptor A2a	P29274	177892	inhibitor	unknown
DB00824	Enprofylline	N/A	approved;investigational	Adenosine receptor A3	P0DMS8	349449	inhibitor	unknown
DB00825	Menthol	N/A	approved	Transient receptor potential cation channel subfamily M member 8	Q7Z2W7	20147036	inducer	yes
DB00825	Menthol	N/A	approved	Transient receptor potential cation channel subfamily A member 1	O75762	3287188	inducer	yes
DB00825	Menthol	N/A	approved	Transient receptor potential cation channel subfamily V member 3	Q8NET8	None	inducer	yes
DB00825	Menthol	N/A	approved	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB00825	Menthol	N/A	approved	Voltage dependent L type calcium channel	O00305	2058727	antagonist	yes
DB00826	Natamycin	Antibiotics	approved	Ergosterol	None	None	binder	yes
DB00827	Cinoxacin	Other quinolones	approved;investigational;withdrawn	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB00827	Cinoxacin	Other quinolones	approved;investigational;withdrawn	DNA	None	None	intercalation	unknown
DB00828	Fosfomycin	Other antibacterials	approved	UDP-N-acetylglucosamine 1-carboxyvinyltransferase	P0A749	146902	inhibitor	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit theta	Q9UN88	7861736	potentiator	yes
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	Translocator protein	P30536	306883	potentiator	unknown
DB00829	Diazepam	Benzodiazepine derivatives	approved;illicit;investigational;vet_approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00830	Phenmetrazine	N/A	approved;illicit	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00830	Phenmetrazine	N/A	approved;illicit	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB00831	Trifluoperazine	Phenothiazines with piperazine structure	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00831	Trifluoperazine	Phenothiazines with piperazine structure	approved;investigational	Neuron-specific vesicular protein calcyon	Q9NYX4	6980076	antagonist	yes
DB00831	Trifluoperazine	Phenothiazines with piperazine structure	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00831	Trifluoperazine	Phenothiazines with piperazine structure	approved;investigational	Calmodulin	P0DP23	179888	inhibitor	unknown
DB00831	Trifluoperazine	Phenothiazines with piperazine structure	approved;investigational	Troponin C, slow skeletal and cardiac muscles	P63316	37208	None	unknown
DB00831	Trifluoperazine	Phenothiazines with piperazine structure	approved;investigational	Protein S100-A4	P26447	179917	inhibitor	unknown
DB00833	Cefaclor	Second-generation cephalosporins	approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00833	Cefaclor	Second-generation cephalosporins	approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB00834	Mifepristone	Progesterone receptor modulators	approved;investigational	Progesterone receptor	P06401	35652	antagonist	yes
DB00834	Mifepristone	Progesterone receptor modulators	approved;investigational	Glucocorticoid receptor	P04150	31680	antagonist	yes
DB00834	Mifepristone	Progesterone receptor modulators	approved;investigational	Prostate-specific antigen	P07288	None	None	unknown
DB00834	Mifepristone	Progesterone receptor modulators	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB00835	Brompheniramine	Substituted alkylamines	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00835	Brompheniramine	Substituted alkylamines	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00835	Brompheniramine	Substituted alkylamines	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00835	Brompheniramine	Substituted alkylamines	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00835	Brompheniramine	Substituted alkylamines	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB00835	Brompheniramine	Substituted alkylamines	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB00836	Loperamide	Antipropulsives	approved	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00836	Loperamide	Antipropulsives	approved	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB00836	Loperamide	Antipropulsives	approved	Kappa-type opioid receptor	P41145	532060	agonist	yes
DB00836	Loperamide	Antipropulsives	approved	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	O00555	2213913	inhibitor	unknown
DB00836	Loperamide	Antipropulsives	approved	Pro-opiomelanocortin	P01189	190188	modulator	unknown
DB00836	Loperamide	Antipropulsives	approved	Calmodulin	P0DP23	179888	inhibitor	unknown
DB00836	Loperamide	Antipropulsives	approved	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	None	unknown
DB00837	Progabide	Fatty acid derivatives	approved;investigational	Gamma-aminobutyric acid type B receptor subunit 1	Q9UBS5	3892594	agonist	yes
DB00837	Progabide	Fatty acid derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB00838	Clocortolone	Corticosteroids, moderately potent (group II)	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00839	Tolazamide	Sulfonylureas	approved;investigational	Sulfonylurea receptor 1, Kir6.2	Q14654	1088445	blocker	yes
DB00841	Dobutamine	Adrenergic and dopaminergic agents	approved	Beta-1 adrenergic receptor	P08588	178200	agonist	yes
DB00841	Dobutamine	Adrenergic and dopaminergic agents	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	unknown
DB00841	Dobutamine	Adrenergic and dopaminergic agents	approved	Alpha-1 adrenergic receptors	P25100	177807	agonist	yes
DB00841	Dobutamine	Adrenergic and dopaminergic agents	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit theta	Q9UN88	7861736	potentiator	yes
DB00842	Oxazepam	Benzodiazepine derivatives	approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00843	Donepezil	Anticholinesterases	approved	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB00843	Donepezil	Anticholinesterases	approved	5-hydroxytryptamine receptor 2A	P28223	36431	other/unknown	unknown
DB00844	Nalbuphine	Morphinan derivatives	approved	Kappa-type opioid receptor	P41145	532060	agonist	yes
DB00844	Nalbuphine	Morphinan derivatives	approved	Mu-type opioid receptor	P35372	452073	antagonist	yes
DB00844	Nalbuphine	Morphinan derivatives	approved	Delta-type opioid receptor	P41143	27545517	antagonist	yes
DB00845	Clofazimine	Drugs for treatment of lepra	approved;investigational	DNA	None	None	intercalation	yes
DB00845	Clofazimine	Drugs for treatment of lepra	approved;investigational	Uncharacterized oxidoreductase CzcO-like	Q5L2G3	56378959	inhibitor	yes
DB00845	Clofazimine	Drugs for treatment of lepra	approved;investigational	Bile salt export pump	O95342	3873243	None	unknown
DB00846	Flurandrenolide	Corticosteroids, potent (group III)	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00847	Cysteamine	Other ophthalmologicals	approved;investigational	Cystine	None	None	cleavage	unknown
DB00847	Cysteamine	Other ophthalmologicals	approved;investigational	Somatostatin	P61278	338288	binder	unknown
DB00847	Cysteamine	Other ophthalmologicals	approved;investigational	Neuropeptide Y receptor type 2	P49146	None	other/unknown	unknown
DB00848	Levamisole	Imidazothiazole derivatives	approved;investigational;vet_approved;withdrawn	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	agonist	yes
DB00848	Levamisole	Imidazothiazole derivatives	approved;investigational;vet_approved;withdrawn	Alkaline phosphatase, placental-like	P10696	178428	inhibitor	unknown
DB00848	Levamisole	Imidazothiazole derivatives	approved;investigational;vet_approved;withdrawn	Acetylcholine receptor subunit alpha-type unc-38	Q23022	None	activator	unknown
DB00848	Levamisole	Imidazothiazole derivatives	approved;investigational;vet_approved;withdrawn	Acetylcholine receptor subunit alpha-type unc-63	Q9N587	None	activator	unknown
DB00848	Levamisole	Imidazothiazole derivatives	approved;investigational;vet_approved;withdrawn	Acetylcholine receptor subunit beta-type lev-1	Q27218	None	activator	unknown
DB00848	Levamisole	Imidazothiazole derivatives	approved;investigational;vet_approved;withdrawn	Acetylcholine receptor subunit beta-type unc-29	P48181	None	activator	unknown
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB00849	Methylphenobarbital	Barbiturates and derivatives	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	activator	unknown
DB00850	Perphenazine	Phenothiazines with piperazine structure	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00850	Perphenazine	Phenothiazines with piperazine structure	approved	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB00850	Perphenazine	Phenothiazines with piperazine structure	approved	Calmodulin	P0DP23	179888	inhibitor	unknown
DB00851	Dacarbazine	Other alkylating agents	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB00851	Dacarbazine	Other alkylating agents	approved;investigational	DNA polymerase alpha subunit B	Q14181	439601	other/unknown	unknown
DB00851	Dacarbazine	Other alkylating agents	approved;investigational	6-phosphogluconate dehydrogenase, decarboxylating	P52209	984325	inhibitor	unknown
DB00852	Pseudoephedrine	Sympathomimetics	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00852	Pseudoephedrine	Sympathomimetics	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB00852	Pseudoephedrine	Sympathomimetics	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB00852	Pseudoephedrine	Sympathomimetics	approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00852	Pseudoephedrine	Sympathomimetics	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00852	Pseudoephedrine	Sympathomimetics	approved	Beta-2 adrenergic receptor	P07550	29371	partial agonist	unknown
DB00852	Pseudoephedrine	Sympathomimetics	approved	Beta-1 adrenergic receptor	P08588	178200	agonist	unknown
DB00852	Pseudoephedrine	Sympathomimetics	approved	Nuclear factor of activated T-cells, cytoplasmic 1	O95644	None	inhibitor	unknown
DB00852	Pseudoephedrine	Sympathomimetics	approved	Tumor necrosis factor	P01375	339741	inhibitor	unknown
DB00852	Pseudoephedrine	Sympathomimetics	approved	Nuclear factor kappa-light-chain-enhancer of activated B cells	None	None	inhibitor	unknown
DB00852	Pseudoephedrine	Sympathomimetics	approved	activator protein 1	P05412	386839	inhibitor	unknown
DB00852	Pseudoephedrine	Sympathomimetics	approved	Interleukin-2	P60568	5729676	inhibitor	unknown
DB00853	Temozolomide	Other alkylating agents	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB00854	Levorphanol	N/A	approved	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00854	Levorphanol	N/A	approved	Delta-type opioid receptor	P41143	27545517	agonist	unknown
DB00854	Levorphanol	N/A	approved	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB00855	Aminolevulinic acid	Sensitizers used in photodynamic/radiation therapy	approved	Delta-aminolevulinic acid dehydratase	P13716	178329	inducer	yes
DB00857	Terbinafine	Antifungals for systemic use	approved;investigational;vet_approved	Squalene monooxygenase	Q14534	2443316	inhibitor	yes
DB00858	Drostanolone	N/A	approved;illicit	Androgen receptor	P10275	178628	agonist	yes
DB00859	Penicillamine	Penicillamine and similar agents	approved	Copper	None	None	chelator	yes
DB00860	Prednisolone	Corticosteroids	approved;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00861	Diflunisal	Salicylic acid and derivatives	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00861	Diflunisal	Salicylic acid and derivatives	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00862	Vardenafil	Drugs used in erectile dysfunction	approved	cGMP-specific 3',5'-cyclic phosphodiesterase	O76074	3420185	inhibitor	yes
DB00862	Vardenafil	Drugs used in erectile dysfunction	approved	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	P18545	189703	allosteric modulator	unknown
DB00862	Vardenafil	Drugs used in erectile dysfunction	approved	Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	Q13956	1311544	allosteric modulator	unknown
DB00863	Ranitidine	H2-receptor antagonists	approved	Histamine H2 receptor	P25021	184088	antagonist	yes
DB00863	Ranitidine	H2-receptor antagonists	approved	Acetylcholinesterase	P22303	177975	None	unknown
DB00863	Ranitidine	H2-receptor antagonists	approved	Cholinesterase	P06276	1311630	None	unknown
DB00864	Tacrolimus	Agents for dermatitis, excluding corticosteroids	approved;investigational	Peptidyl-prolyl cis-trans isomerase FKBP1A	P62942	182628	inhibitor	yes
DB00865	Benzphetamine	N/A	approved;illicit	Synaptic vesicular amine transporter	Q05940	292335	inducer	yes
DB00865	Benzphetamine	N/A	approved;illicit	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00865	Benzphetamine	N/A	approved;illicit	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB00865	Benzphetamine	N/A	approved;illicit	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB00866	Alprenolol	Beta blocking agents, non-selective	approved;withdrawn	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB00866	Alprenolol	Beta blocking agents, non-selective	approved;withdrawn	Beta-2 adrenergic receptor	P07550	29371	antagonist	yes
DB00866	Alprenolol	Beta blocking agents, non-selective	approved;withdrawn	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	yes
DB00866	Alprenolol	Beta blocking agents, non-selective	approved;withdrawn	Beta-3 adrenergic receptor	P13945	178896	antagonist	unknown
DB00867	Ritodrine	Sympathomimetics, labour repressants	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB00868	Benzonatate	Other cough suppressants	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	antagonist	unknown
DB00869	Dorzolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB00869	Dorzolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 4	P22748	179791	inhibitor	unknown
DB00869	Dorzolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB00869	Dorzolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 3	P07451	189053812	inhibitor	unknown
DB00870	Suprofen	Propionic acid derivatives	approved;withdrawn	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00870	Suprofen	Propionic acid derivatives	approved;withdrawn	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00871	Terbutaline	Selective beta-2-adrenoreceptor agonists	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB00871	Terbutaline	Selective beta-2-adrenoreceptor agonists	approved	Beta-3 adrenergic receptor	P13945	178896	agonist	unknown
DB00871	Terbutaline	Selective beta-2-adrenoreceptor agonists	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	unknown
DB00872	Conivaptan	Vasopressin antagonists	approved;investigational	Vasopressin V1a receptor	P37288	667068	antagonist	yes
DB00872	Conivaptan	Vasopressin antagonists	approved;investigational	Vasopressin V2 receptor	P30518	28418	antagonist	yes
DB00873	Loteprednol	Corticosteroids, plain	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00875	Flupentixol	Thioxanthene derivatives	approved;investigational;withdrawn	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00875	Flupentixol	Thioxanthene derivatives	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00875	Flupentixol	Thioxanthene derivatives	approved;investigational;withdrawn	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB00875	Flupentixol	Thioxanthene derivatives	approved;investigational;withdrawn	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00875	Flupentixol	Thioxanthene derivatives	approved;investigational;withdrawn	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00876	Eprosartan	Angiotensin II antagonists, plain	approved	Type-1 angiotensin II receptor	P30556	179122	antagonist	yes
DB00877	Sirolimus	Other ophthalmologicals	approved;investigational	Serine/threonine-protein kinase mTOR	P42345	None	inhibitor	yes
DB00877	Sirolimus	Other ophthalmologicals	approved;investigational	Peptidyl-prolyl cis-trans isomerase FKBP1A	P62942	182628	other	yes
DB00877	Sirolimus	Other ophthalmologicals	approved;investigational	Fibroblast growth factor 2	P09038	31362	other/unknown	yes
DB00878	Chlorhexidine	Antiinfectives	approved;vet_approved	Bacterial outer membrane	None	None	incorporation into and destabilization	yes
DB00879	Emtricitabine	Antivirals for treatment of HIV infections, combinations	approved;investigational	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB00880	Chlorothiazide	Thiazides and potassium in combination	approved;vet_approved	Solute carrier family 12 member 3	P55017	1172161	inhibitor	yes
DB00880	Chlorothiazide	Thiazides and potassium in combination	approved;vet_approved	Carbonic anhydrase 1	P00915	29600	inhibitor	yes
DB00880	Chlorothiazide	Thiazides and potassium in combination	approved;vet_approved	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB00881	Quinapril	ACE inhibitors, plain	approved;investigational	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB00882	Clomifene	Ovulation stimulants, synthetic	approved;investigational	Estrogen receptor alpha	P03372	31234	antagonist	yes
DB00882	Clomifene	Ovulation stimulants, synthetic	approved;investigational	Sex hormone-binding globulin	P04278	296673	None	unknown
DB00883	Isosorbide Dinitrate	Organic nitrates	approved;investigational	Atrial natriuretic peptide receptor 1	P16066	28230	agonist	yes
DB00884	Risedronate	Bisphosphonates, combinations	approved;investigational	Farnesyl pyrophosphate synthase	P14324	182399	inhibitor	yes
DB00884	Risedronate	Bisphosphonates, combinations	approved;investigational	Hydroxylapatite	None	None	antagonist	yes
DB00887	Bumetanide	High-ceiling diuretics and potassium-sparing agents	approved	Solute carrier family 12 member 1	Q13621	1373425	inhibitor	yes
DB00887	Bumetanide	High-ceiling diuretics and potassium-sparing agents	approved	Solute carrier family 12 member 2	P55011	903682	inhibitor	yes
DB00887	Bumetanide	High-ceiling diuretics and potassium-sparing agents	approved	Solute carrier family 12 member 4	Q9UP95	1399212	inhibitor	yes
DB00887	Bumetanide	High-ceiling diuretics and potassium-sparing agents	approved	Solute carrier family 12 member 5	Q9H2X9	12003227	inhibitor	yes
DB00887	Bumetanide	High-ceiling diuretics and potassium-sparing agents	approved	Cystic fibrosis transmembrane conductance regulator	P13569	180332	antagonist	unknown
DB00888	Mechlorethamine	Nitrogen mustard analogues	approved;investigational	DNA	None	None	intercalation	yes
DB00889	Granisetron	Serotonin (5HT3) antagonists	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	yes
DB00890	Dienestrol	Synthetic estrogens, plain	approved;investigational	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00890	Dienestrol	Synthetic estrogens, plain	approved;investigational	Sex hormone-binding globulin	P04278	296673	None	unknown
DB00891	Sulfapyridine	Short-acting sulfonamides	approved	Dihydropteroate synthase type-1	Q49184	44284	inhibitor	unknown
DB00892	Oxybuprocaine	Local anesthetics	approved;investigational	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB00893	Iron Dextran	N/A	approved;vet_approved	Hemoglobin subunit beta	P68871	455997	activator	yes
DB00893	Iron Dextran	N/A	approved;vet_approved	Hemoglobin subunit alpha	P69905	386764	activator	yes
DB00893	Iron Dextran	N/A	approved;vet_approved	Ferritin heavy chain	P02794	28435	other	yes
DB00893	Iron Dextran	N/A	approved;vet_approved	Ferritin light chain	P02792	182514	other	yes
DB00894	Testolactone	N/A	approved;investigational	Cytochrome P450 19A1	P11511	179002	inhibitor	yes
DB00895	Benzylpenicilloyl Polylysine	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	High affinity immunoglobulin epsilon receptor subunit gamma	P30273	182488	agonist	yes
DB00895	Benzylpenicilloyl Polylysine	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	High affinity immunoglobulin epsilon receptor subunit alpha	P12319	31318	agonist	yes
DB00896	Rimexolone	Glucocorticoids	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit theta	Q9UN88	7861736	potentiator	yes
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	Translocator protein	P30536	306883	other	unknown
DB00897	Triazolam	Benzodiazepine derivatives	approved;investigational	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB00898	Ethanol	Antidotes	approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	yes
DB00898	Ethanol	Antidotes	approved	Glycine receptor subunit alpha-1	P23415	31851	agonist	yes
DB00898	Ethanol	Antidotes	approved	Glycine receptor subunit alpha-2	P23416	31849	agonist	yes
DB00898	Ethanol	Antidotes	approved	Voltage-dependent L-type calcium channel subunit beta-1	Q02641	179806	None	unknown
DB00898	Ethanol	Antidotes	approved	5-hydroxytryptamine receptor 3A	P46098	681914	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit alpha-10	Q9GZZ6	12053839	None	unknown
DB00898	Ethanol	Antidotes	approved	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	None	unknown
DB00898	Ethanol	Antidotes	approved	Glutamate receptor 1	P42261	183281	None	unknown
DB00898	Ethanol	Antidotes	approved	Voltage-dependent calcium channel gamma-1 subunit	Q06432	306473	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	None	unknown
DB00898	Ethanol	Antidotes	approved	Glutamate receptor 2	P42262	493134	None	unknown
DB00898	Ethanol	Antidotes	approved	Glutamate receptor 4	P48058	790538	None	unknown
DB00898	Ethanol	Antidotes	approved	Glutamate receptor 3	P42263	507829	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	None	unknown
DB00898	Ethanol	Antidotes	approved	G protein-activated inward rectifier potassium channel 1	P48549	1055028	None	unknown
DB00898	Ethanol	Antidotes	approved	G protein-activated inward rectifier potassium channel 2	P48051	1052875	None	unknown
DB00898	Ethanol	Antidotes	approved	Vascular cell adhesion protein 1	P19320	179886	None	unknown
DB00898	Ethanol	Antidotes	approved	Equilibrative nucleoside transporter 1	Q99808	1845345	None	unknown
DB00898	Ethanol	Antidotes	approved	G protein-activated inward rectifier potassium channel 4	P48544	1055026	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit alpha-9	Q9UGM1	6688136	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	None	unknown
DB00898	Ethanol	Antidotes	approved	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	None	unknown
DB00898	Ethanol	Antidotes	approved	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit beta-4	P30926	1458126	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit alpha-5	P30532	177926	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit alpha-6	Q15825	1458118	None	unknown
DB00898	Ethanol	Antidotes	approved	Neuronal acetylcholine receptor subunit beta-3	Q05901	1458124	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit theta	Q9UN88	7861736	None	unknown
DB00898	Ethanol	Antidotes	approved	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	None	unknown
DB00898	Ethanol	Antidotes	approved	Equilibrative nucleoside transporter 2	Q14542	None	None	unknown
DB00898	Ethanol	Antidotes	approved	5-hydroxytryptamine receptor 3E	A5X5Y0	None	None	unknown
DB00898	Ethanol	Antidotes	approved	5-hydroxytryptamine receptor 3B	O95264	None	None	unknown
DB00898	Ethanol	Antidotes	approved	5-hydroxytryptamine receptor 3D	Q70Z44	None	None	unknown
DB00898	Ethanol	Antidotes	approved	5-hydroxytryptamine receptor 3C	Q8WXA8	None	None	unknown
DB00898	Ethanol	Antidotes	approved	Voltage-dependent calcium channel gamma-2 subunit	Q9Y698	None	None	unknown
DB00898	Ethanol	Antidotes	approved	G protein-activated inward rectifier potassium channel 3	Q92806	None	None	unknown
DB00898	Ethanol	Antidotes	approved	Neural cell adhesion molecule L1	P32004	None	None	unknown
DB00899	Remifentanil	Opioid anesthetics	approved	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00899	Remifentanil	Opioid anesthetics	approved	Delta-type opioid receptor	P41143	27545517	agonist	unknown
DB00899	Remifentanil	Opioid anesthetics	approved	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB00900	Didanosine	Nucleoside and nucleotide reverse transcriptase inhibitors	approved	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB00900	Didanosine	Nucleoside and nucleotide reverse transcriptase inhibitors	approved	Purine nucleoside phosphorylase	P00491	35565	None	unknown
DB00902	Methdilazine	Phenothiazine derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00903	Etacrynic acid	Aryloxyacetic acid derivatives	approved;investigational	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	inhibitor	yes
DB00903	Etacrynic acid	Aryloxyacetic acid derivatives	approved;investigational	Solute carrier family 12 member 1	Q13621	1373425	inhibitor	yes
DB00903	Etacrynic acid	Aryloxyacetic acid derivatives	approved;investigational	Lymphoid enhancer-binding factor 1	Q9UJU2	None	None	unknown
DB00903	Etacrynic acid	Aryloxyacetic acid derivatives	approved;investigational	Glutathione S-transferase P	P09211	31946	inhibitor	unknown
DB00904	Ondansetron	Serotonin (5HT3) antagonists	approved	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	yes
DB00904	Ondansetron	Serotonin (5HT3) antagonists	approved	5-hydroxytryptamine receptor 4	Q13639	2661757	agonist	unknown
DB00904	Ondansetron	Serotonin (5HT3) antagonists	approved	Mu-type opioid receptor	P35372	452073	other/unknown	unknown
DB00904	Ondansetron	Serotonin (5HT3) antagonists	approved	5-hydroxytryptamine receptor 1A	P08908	189928	other/unknown	unknown
DB00904	Ondansetron	Serotonin (5HT3) antagonists	approved	5-hydroxytryptamine receptor 1B	P28222	219679	other/unknown	unknown
DB00905	Bimatoprost	Prostaglandin analogues	approved;investigational	Prostaglandin F2-alpha receptor	P43088	456564	agonist	yes
DB00905	Bimatoprost	Prostaglandin analogues	approved;investigational	Prostaglandin E2 receptor EP1 subtype	P34995	410209	agonist	yes
DB00905	Bimatoprost	Prostaglandin analogues	approved;investigational	Prostaglandin E2 receptor EP3 subtype	P43115	None	agonist	yes
DB00905	Bimatoprost	Prostaglandin analogues	approved;investigational	Aldo-keto reductase family 1 member C3	P42330	4261711	None	unknown
DB00906	Tiagabine	Fatty acid derivatives	approved;investigational	Sodium- and chloride-dependent GABA transporter 1	P30531	31658	inhibitor	yes
DB00907	Cocaine	Local anesthetics	approved;illicit	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB00907	Cocaine	Local anesthetics	approved;illicit	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00907	Cocaine	Local anesthetics	approved;illicit	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB00907	Cocaine	Local anesthetics	approved;illicit	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00907	Cocaine	Local anesthetics	approved;illicit	Sodium channel protein type 11 subunit alpha	Q9UI33	6572950	inhibitor	unknown
DB00907	Cocaine	Local anesthetics	approved;illicit	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	unknown
DB00907	Cocaine	Local anesthetics	approved;illicit	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00907	Cocaine	Local anesthetics	approved;illicit	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB00907	Cocaine	Local anesthetics	approved;illicit	Sigma non-opioid intracellular receptor 1	Q99720	1783387	None	unknown
DB00907	Cocaine	Local anesthetics	approved;illicit	Liver carboxylesterase 1	P23141	None	None	unknown
DB00908	Quinidine	Antiarrhythmics, class Ia	approved;investigational	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00908	Quinidine	Antiarrhythmics, class Ia	approved;investigational	Potassium channel subfamily K member 1	O00180	1086491	inhibitor	unknown
DB00908	Quinidine	Antiarrhythmics, class Ia	approved;investigational	Potassium channel subfamily K member 6	Q9Y257	4559312	inhibitor	unknown
DB00908	Quinidine	Antiarrhythmics, class Ia	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB00908	Quinidine	Antiarrhythmics, class Ia	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB00908	Quinidine	Antiarrhythmics, class Ia	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00908	Quinidine	Antiarrhythmics, class Ia	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel protein type 1 subunit alpha	P35498	12642270	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel protein type 2 subunit alpha	Q99250	457879	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel protein type 3 subunit alpha	Q9NY46	7414320	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel protein type 4 subunit alpha	P35499	338213	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel protein type 9 subunit alpha	Q15858	758110	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel protein type 11 subunit alpha	Q9UI33	6572950	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel subunit beta-1	Q07699	307415	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel subunit beta-2	O60939	3309111	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel subunit beta-3	Q9NY72	7160975	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Sodium channel subunit beta-4	Q8IWT1	27465047	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1G	O43497	6625659	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1I	Q9P0X4	5565888	inhibitor	yes
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 3	P07451	189053812	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 4	P22748	179791	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 5A, mitochondrial	P35218	306483	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 5B, mitochondrial	Q9Y2D0	4587223	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 6	P23280	None	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 7	P43166	28192445	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase-related protein	P35219	5069431	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 9	Q16790	None	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase-related protein 10	Q9NS85	9229883	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase-related protein 11	O75493	3283386	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 12	O43570	2984693	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 13	Q8N1Q1	21754549	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Carbonic anhydrase 14	Q9ULX7	6009640	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Amine oxidase [flavin-containing] B	P27338	398415	inhibitor	unknown
DB00909	Zonisamide	Other antiepileptics	approved;investigational	Amine oxidase [flavin-containing] A	P21397	187353	inhibitor	unknown
DB00910	Paricalcitol	Other anti-parathyroid agents	approved;investigational	Vitamin D3 receptor	P11473	340203	agonist	yes
DB00911	Tinidazole	Combinations of antibacterials	approved;investigational	DNA	None	None	binder	yes
DB00912	Repaglinide	Combinations of oral blood glucose lowering drugs	approved;investigational	ATP-binding cassette sub-family C member 8	Q09428	1374919	inhibitor	yes
DB00912	Repaglinide	Combinations of oral blood glucose lowering drugs	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	unknown
DB00913	Anileridine	Opioid anesthetics	approved;illicit	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00914	Phenformin	Biguanides	approved;investigational;withdrawn	5'-AMP-activated protein kinase catalytic subunit alpha-1	Q13131	4115829	activator	yes
DB00914	Phenformin	Biguanides	approved;investigational;withdrawn	ATP-sensitive inward rectifier potassium channel 8	Q15842	None	inhibitor	unknown
DB00915	Amantadine	Adamantane derivatives	approved	Matrix protein 2	P21430	324265	inhibitor	yes
DB00915	Amantadine	Adamantane derivatives	approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	yes
DB00915	Amantadine	Adamantane derivatives	approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB00915	Amantadine	Adamantane derivatives	approved	D(2) dopamine receptor	P14416	181432	agonist	yes
DB00915	Amantadine	Adamantane derivatives	approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB00915	Amantadine	Adamantane derivatives	approved	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	antagonist	unknown
DB00916	Metronidazole	Combinations for eradication of Helicobacter pylori	approved	DNA	None	None	binder	yes
DB00916	Metronidazole	Combinations for eradication of Helicobacter pylori	approved	Oxygen-insensitive NADPH nitroreductase	O25608	None	potentiator	yes
DB00916	Metronidazole	Combinations for eradication of Helicobacter pylori	approved	Iron hydrogenase 1	P29166	144836	inhibitor	unknown
DB00916	Metronidazole	Combinations for eradication of Helicobacter pylori	approved	Lanosterol 14-alpha demethylase	Q16850	1698396	None	unknown
DB00917	Dinoprostone	Prostaglandins	approved	Prostaglandin E2 receptor EP2 subtype	P43116	632650	agonist	yes
DB00917	Dinoprostone	Prostaglandins	approved	Prostaglandin E2 receptor EP1 subtype	P34995	410209	agonist	yes
DB00917	Dinoprostone	Prostaglandins	approved	Prostaglandin E2 receptor EP3 subtype	P43115	None	agonist	yes
DB00917	Dinoprostone	Prostaglandins	approved	Prostaglandin E2 receptor EP4 subtype	P35408	None	agonist	yes
DB00917	Dinoprostone	Prostaglandins	approved	Prostaglandin D2 receptor 2	Q9Y5Y4	4204216	agonist	unknown
DB00918	Almotriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	unknown
DB00918	Almotriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	unknown
DB00919	Spectinomycin	Other antibacterials	approved;investigational;vet_approved	30S ribosomal protein S12	P0A7S3	43010	inhibitor	yes
DB00920	Ketotifen	Other antiallergics	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00920	Ketotifen	Other antiallergics	approved	6-phosphogluconate dehydrogenase, decarboxylating	P52209	984325	inhibitor	unknown
DB00921	Buprenorphine	Oripavine derivatives	approved;illicit;investigational;vet_approved	Mu-type opioid receptor	P35372	452073	partial agonist	yes
DB00921	Buprenorphine	Oripavine derivatives	approved;illicit;investigational;vet_approved	Kappa-type opioid receptor	P41145	532060	antagonist	yes
DB00921	Buprenorphine	Oripavine derivatives	approved;illicit;investigational;vet_approved	Delta-type opioid receptor	P41143	27545517	antagonist	unknown
DB00921	Buprenorphine	Oripavine derivatives	approved;illicit;investigational;vet_approved	Nociceptin receptor	P41146	None	None	unknown
DB00922	Levosimendan	Other cardiac stimulants	approved;investigational	Troponin C, slow skeletal and cardiac muscles	P63316	37208	potentiator	yes
DB00922	Levosimendan	Other cardiac stimulants	approved;investigational	ATP-sensitive inward rectifier potassium channel 11	Q14654	1088445	inducer	yes
DB00922	Levosimendan	Other cardiac stimulants	approved;investigational	ATP-sensitive inward rectifier potassium channel 8	Q15842	None	inducer	yes
DB00922	Levosimendan	Other cardiac stimulants	approved;investigational	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	unknown
DB00923	Ceforanide	Second-generation cephalosporins	approved	Penicillin-binding protein 2	Q70KI2	52214157	inhibitor	yes
DB00924	Cyclobenzaprine	Other centrally acting agents	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00925	Phenoxybenzamine	Other peripheral vasodilators	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB00925	Phenoxybenzamine	Other peripheral vasodilators	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	yes
DB00925	Phenoxybenzamine	Other peripheral vasodilators	approved	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB00925	Phenoxybenzamine	Other peripheral vasodilators	approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB00925	Phenoxybenzamine	Other peripheral vasodilators	approved	Calmodulin	P0DP23	179888	inhibitor	unknown
DB00925	Phenoxybenzamine	Other peripheral vasodilators	approved	Beta-2 adrenergic receptor	P07550	29371	None	unknown
DB00925	Phenoxybenzamine	Other peripheral vasodilators	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB00925	Phenoxybenzamine	Other peripheral vasodilators	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB00927	Famotidine	H2-receptor antagonists	approved	Histamine H2 receptor	P25021	184088	antagonist	yes
DB00928	Azacitidine	Pyrimidine analogues	approved;investigational	DNA (cytosine-5)-methyltransferase 1	P26358	1632819	inhibitor	yes
DB00928	Azacitidine	Pyrimidine analogues	approved;investigational	RNA	None	None	other	yes
DB00928	Azacitidine	Pyrimidine analogues	approved;investigational	DNA	None	None	other	yes
DB00929	Misoprostol	Prostaglandins	approved	Prostaglandin E2 receptor EP3 subtype	P43115	None	agonist	yes
DB00929	Misoprostol	Prostaglandins	approved	Prostaglandin E2 receptor EP2 subtype	P43116	632650	agonist	yes
DB00929	Misoprostol	Prostaglandins	approved	Prostaglandin E2 receptor EP4 subtype	P35408	None	agonist	unknown
DB00930	Colesevelam	Bile acid sequestrants	approved	Bile acids	None	None	binder	yes
DB00931	Methacycline	Tetracyclines	approved;investigational	16S rRNA	None	None	inhibitor	yes
DB00932	Tipranavir	Protease inhibitors	approved;investigational	Human immunodeficiency virus type 1 protease	Q72874	None	inhibitor	yes
DB00933	Mesoridazine	Phenothiazines with piperidine structure	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB00933	Mesoridazine	Phenothiazines with piperidine structure	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	no
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	Alpha-1 adrenergic receptors	P25100	177807	antagonist	no
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	binder	unknown
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	binder	unknown
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	D(2) dopamine receptor	P14416	181432	binder	unknown
DB00934	Maprotiline	Non-selective monoamine reuptake inhibitors	approved;investigational	Alpha-2 adrenergic receptors	P18825	178194	antagonist	unknown
DB00935	Oxymetazoline	Sympathomimetics, plain	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB00935	Oxymetazoline	Sympathomimetics, plain	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00935	Oxymetazoline	Sympathomimetics, plain	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	agonist	unknown
DB00935	Oxymetazoline	Sympathomimetics, plain	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	binder	unknown
DB00935	Oxymetazoline	Sympathomimetics, plain	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	agonist	unknown
DB00935	Oxymetazoline	Sympathomimetics, plain	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	agonist	unknown
DB00936	Salicylic acid	Other antifungals for topical use	approved;investigational;vet_approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00936	Salicylic acid	Other antifungals for topical use	approved;investigational;vet_approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00936	Salicylic acid	Other antifungals for topical use	approved;investigational;vet_approved	Aldo-keto reductase family 1 member C1	Q04828	181549	inhibitor	unknown
DB00937	Diethylpropion	Centrally acting antiobesity products	approved;illicit	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB00937	Diethylpropion	Centrally acting antiobesity products	approved;illicit	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB00938	Salmeterol	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB00938	Salmeterol	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved	Beta-1 adrenergic receptor	P08588	178200	agonist	unknown
DB00938	Salmeterol	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved	Beta-3 adrenergic receptor	P13945	178896	agonist	unknown
DB00939	Meclofenamic acid	Fenamates	approved;vet_approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00939	Meclofenamic acid	Fenamates	approved;vet_approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00939	Meclofenamic acid	Fenamates	approved;vet_approved	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	yes
DB00939	Meclofenamic acid	Fenamates	approved;vet_approved	Potassium voltage-gated channel subfamily KQT member 2	O43526	1841342	other	unknown
DB00939	Meclofenamic acid	Fenamates	approved;vet_approved	Potassium voltage-gated channel subfamily KQT member 3	O43525	None	other	unknown
DB00940	Methantheline	Synthetic anticholinergics, quaternary ammonium compounds	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB00940	Methantheline	Synthetic anticholinergics, quaternary ammonium compounds	approved;investigational	Histamine H2 receptor	P25021	184088	antagonist	yes
DB00941	Hexafluronium	Other quaternary ammonium compounds	approved	Cholinesterase	P06276	1311630	inhibitor	yes
DB00942	Cycrimine	N/A	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00943	Zalcitabine	Nucleoside and nucleotide reverse transcriptase inhibitors	approved;investigational	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB00944	Demecarium	Parasympathomimetics	approved	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB00944	Demecarium	Parasympathomimetics	approved	Cholinesterase	P06276	1311630	inhibitor	unknown
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	Aldo-keto reductase family 1 member C1	Q04828	181549	inhibitor	unknown
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	5'-AMP-activated protein kinase	Q9UGI9	2916802	activator	unknown
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	Endothelin-1 receptor	P25101	238636	inhibitor	unknown
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	Inhibitor of nuclear factor kappa-B kinase subunit beta	O14920	2599558	inhibitor	unknown
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	Cellular tumor antigen p53	P04637	None	acetylation	unknown
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	78 kDa glucose-regulated protein	P11021	386758	binding	unknown
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	Ribosomal protein S6 kinase alpha-3	P51812	None	inhibitor	unknown
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	NF-kappa-B inhibitor alpha	P25963	None	inhibitor	unknown
DB00945	Acetylsalicylic acid	HMG CoA reductase inhibitors, other combinations	approved;vet_approved	Nuclear factor NF-kappa-B	P19838	189180	antagonist	unknown
DB00946	Phenprocoumon	Vitamin K antagonists	approved;investigational	Vitamin K epoxide reductase complex subunit 1	Q9BQB6	40217983	inhibitor	yes
DB00947	Fulvestrant	Anti-estrogens	approved;investigational	Estrogen receptor alpha	P03372	31234	antagonist	yes
DB00948	Mezlocillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB00948	Mezlocillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB00948	Mezlocillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 2	P0AD65	42314	inhibitor	unknown
DB00949	Felbamate	Other antiepileptics	approved	Glutamate receptor ionotropic, NMDA 2B	Q13224	1899202	antagonist	yes
DB00949	Felbamate	Other antiepileptics	approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	yes
DB00949	Felbamate	Other antiepileptics	approved	Glutamate receptor ionotropic, NMDA 2A	Q12879	558749	antagonist	yes
DB00950	Fexofenadine	Other antihistamines for systemic use	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00951	Isoniazid	Combinations of drugs for treatment of tuberculosis	approved;investigational	Catalase-peroxidase	P9WIE5	None	other/unknown	yes
DB00951	Isoniazid	Combinations of drugs for treatment of tuberculosis	approved;investigational	Enoyl-[acyl-carrier-protein] reductase [NADH]	P9WGR1	None	adduct	yes
DB00951	Isoniazid	Combinations of drugs for treatment of tuberculosis	approved;investigational	Cytochrome P450 2C8	P10632	None	None	unknown
DB00951	Isoniazid	Combinations of drugs for treatment of tuberculosis	approved;investigational	Cytochrome P450 1A2	P05177	None	None	unknown
DB00951	Isoniazid	Combinations of drugs for treatment of tuberculosis	approved;investigational	Cytochrome P450 3A4	P08684	None	None	unknown
DB00951	Isoniazid	Combinations of drugs for treatment of tuberculosis	approved;investigational	Cytochrome P450 2C19	P33261	181344	None	unknown
DB00951	Isoniazid	Combinations of drugs for treatment of tuberculosis	approved;investigational	Dihydrofolate reductase	P9WNX1	None	None	unknown
DB00952	Naratriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	yes
DB00952	Naratriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	yes
DB00952	Naratriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1F	P30939	307420	agonist	yes
DB00952	Naratriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	yes
DB00953	Rizatriptan	Selective serotonin (5HT1) agonists	approved	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	yes
DB00953	Rizatriptan	Selective serotonin (5HT1) agonists	approved	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	yes
DB00953	Rizatriptan	Selective serotonin (5HT1) agonists	approved	5-hydroxytryptamine receptor 1F	P30939	307420	agonist	yes
DB00954	Dirithromycin	Macrolides	approved;investigational	23S rRNA	None	None	inhibitor	yes
DB00955	Netilmicin	Antibiotics	approved;investigational	30S ribosomal protein S12	P0A7S3	43010	inhibitor	yes
DB00955	Netilmicin	Antibiotics	approved;investigational	16S rRNA	None	None	inhibitor	yes
DB00956	Hydrocodone	Opium alkaloids and derivatives	approved;illicit	Mu-type opioid receptor	P35372	452073	agonist	yes
DB00956	Hydrocodone	Opium alkaloids and derivatives	approved;illicit	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB00957	Norgestimate	Progestogens and estrogens, fixed combinations	approved;investigational	Progesterone receptor	P06401	35652	agonist	yes
DB00957	Norgestimate	Progestogens and estrogens, fixed combinations	approved;investigational	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00957	Norgestimate	Progestogens and estrogens, fixed combinations	approved;investigational	Androgen receptor	P10275	178628	partial agonist	unknown
DB00958	Carboplatin	Platinum compounds	approved	DNA	None	None	cross-linking/alkylation	yes
DB00959	Methylprednisolone	Corticosteroids, weak, combinations with antibiotics	approved;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB00960	Pindolol	Beta blocking agents, non-selective	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	partial agonist	yes
DB00960	Pindolol	Beta blocking agents, non-selective	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	partial agonist	yes
DB00960	Pindolol	Beta blocking agents, non-selective	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB00960	Pindolol	Beta blocking agents, non-selective	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	other/unknown	unknown
DB00960	Pindolol	Beta blocking agents, non-selective	approved;investigational	Beta-3 adrenergic receptor	P13945	178896	agonist	unknown
DB00961	Mepivacaine	Amides	approved;vet_approved	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB00962	Zaleplon	Benzodiazepine related drugs	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB00962	Zaleplon	Benzodiazepine related drugs	approved;illicit;investigational	Translocator protein	P30536	306883	other	yes
DB00963	Bromfenac	Antiinflammatory agents, non-steroids	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00963	Bromfenac	Antiinflammatory agents, non-steroids	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB00964	Apraclonidine	Sympathomimetics in glaucoma therapy	approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB00964	Apraclonidine	Sympathomimetics in glaucoma therapy	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB00964	Apraclonidine	Sympathomimetics in glaucoma therapy	approved	Alpha-2B adrenergic receptor	P18089	178198	agonist	unknown
DB00966	Telmisartan	Angiotensin II antagonists and calcium channel blockers	approved;investigational	Type-1 angiotensin II receptor	P30556	179122	antagonist	yes
DB00966	Telmisartan	Angiotensin II antagonists and calcium channel blockers	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	partial agonist	yes
DB00967	Desloratadine	Other antihistamines for systemic use	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00968	Methyldopa	N/A	approved	Alpha-2A adrenergic receptor	P08913	178196	None	yes
DB00968	Methyldopa	N/A	approved	Aromatic-L-amino-acid decarboxylase	P20711	181521	inhibitor	unknown
DB00969	Alosetron	Serotonin receptor antagonists	approved;withdrawn	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	yes
DB00970	Dactinomycin	Actinomycines	approved;investigational	DNA	None	None	adduct	yes
DB00970	Dactinomycin	Actinomycines	approved;investigational	DNA topoisomerase 2	Q02880	292830	inhibitor	unknown
DB00972	Azelastine	Antiallergic agents, excl. corticosteroids	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00973	Ezetimibe	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved	Sterol O-acyltransferase 1	P35610	4878022	inhibitor	yes
DB00973	Ezetimibe	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved	Niemann-Pick C1-like protein 1	Q9UHC9	6643036	inhibitor	yes
DB00973	Ezetimibe	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved	Aminopeptidase N	P15144	28678	other	unknown
DB00974	Edetic Acid	N/A	approved;vet_approved	Lead	None	None	chelator	yes
DB00974	Edetic Acid	N/A	approved;vet_approved	Iron	None	None	chelator	unknown
DB00974	Edetic Acid	N/A	approved;vet_approved	Manganese cation	None	None	chelator	unknown
DB00975	Dipyridamole	Platelet aggregation inhibitors excl. heparin	approved	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	Q9Y233	4958858	inhibitor	yes
DB00975	Dipyridamole	Platelet aggregation inhibitors excl. heparin	approved	Adenosine deaminase	P00813	28380	inhibitor	yes
DB00975	Dipyridamole	Platelet aggregation inhibitors excl. heparin	approved	cGMP-specific 3',5'-cyclic phosphodiesterase	O76074	3420185	inhibitor	yes
DB00975	Dipyridamole	Platelet aggregation inhibitors excl. heparin	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	yes
DB00975	Dipyridamole	Platelet aggregation inhibitors excl. heparin	approved	Calcipressin-1	P53805	None	None	unknown
DB00975	Dipyridamole	Platelet aggregation inhibitors excl. heparin	approved	Alpha-1-acid glycoprotein 1	P02763	757907	None	unknown
DB00976	Telithromycin	Macrolides	approved	23S rRNA	None	None	inhibitor	yes
DB00977	Ethinyl Estradiol	Progestogens and estrogens, fixed combinations	approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB00977	Ethinyl Estradiol	Progestogens and estrogens, fixed combinations	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	agonist	unknown
DB00977	Ethinyl Estradiol	Progestogens and estrogens, fixed combinations	approved	Sex hormone-binding globulin	P04278	296673	None	unknown
DB00978	Lomefloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB00978	Lomefloxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB00978	Lomefloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	unknown
DB00979	Cyclopentolate	Anticholinergics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00980	Ramelteon	Melatonin receptor agonists	approved;investigational	Melatonin receptor type 1A	P48039	602130	multitarget	yes
DB00980	Ramelteon	Melatonin receptor agonists	approved;investigational	Melatonin receptor type 1B	P49286	971194	multitarget	yes
DB00981	Physostigmine	Parasympathomimetics	approved;investigational	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB00981	Physostigmine	Parasympathomimetics	approved;investigational	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB00981	Physostigmine	Parasympathomimetics	approved;investigational	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	None	unknown
DB00982	Isotretinoin	Retinoids for topical use in acne	approved	Retinoic acid receptor alpha	P10276	36157	other/unknown	unknown
DB00983	Formoterol	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB00983	Formoterol	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	agonist	unknown
DB00983	Formoterol	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Beta-3 adrenergic receptor	P13945	178896	agonist	unknown
DB00984	Nandrolone phenpropionate	N/A	approved;illicit;investigational	Androgen receptor	P10275	178628	agonist	yes
DB00985	Dimenhydrinate	N/A	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB00986	Glycopyrronium	Adrenergics in combination with anticholinergics	approved;investigational;vet_approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB00986	Glycopyrronium	Adrenergics in combination with anticholinergics	approved;investigational;vet_approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB00986	Glycopyrronium	Adrenergics in combination with anticholinergics	approved;investigational;vet_approved	Muscarinic acetylcholine receptor M2	P08172	177990	binder	unknown
DB00987	Cytarabine	Pyrimidine analogues	approved;investigational	DNA polymerase beta	P06746	292397	inhibitor	yes
DB00987	Cytarabine	Pyrimidine analogues	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	D(2) dopamine receptor	P14416	181432	agonist	yes
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	D(1A) dopamine receptor	P21728	30397	agonist	yes
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	D(1B) dopamine receptor	P21918	32049	agonist	yes
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	D(3) dopamine receptor	P35462	927342	agonist	yes
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	D(4) dopamine receptor	P21917	291946	agonist	yes
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	Sodium-dependent dopamine transporter	Q01959	553260	inducer	yes
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	Dopamine beta-hydroxylase	P09172	30474	ligand	yes
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	5-hydroxytryptamine receptor 1A	P08908	189928	binder	unknown
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	5-hydroxytryptamine receptor 7	P34969	1857143	binder	unknown
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	D(1) dopamine receptor	P21918	32049	agonist	unknown
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	unknown
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	5-hydroxytryptamine receptor 3A	P46098	681914	None	unknown
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	5-hydroxytryptamine receptor 3B	O95264	None	None	unknown
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	Superoxide dismutase [Cu-Zn]	P00441	None	None	unknown
DB00988	Dopamine	Adrenergic and dopaminergic agents	approved	Synaptic vesicular amine transporter	Q05940	292335	None	unknown
DB00989	Rivastigmine	Anticholinesterases	approved;investigational	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB00989	Rivastigmine	Anticholinesterases	approved;investigational	Cholinesterase	P06276	1311630	inhibitor	yes
DB00990	Exemestane	Aromatase inhibitors	approved;investigational	Cytochrome P450 19A1	P11511	179002	inhibitor	yes
DB00991	Oxaprozin	Propionic acid derivatives	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB00991	Oxaprozin	Propionic acid derivatives	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB00992	Methyl aminolevulinate	Sensitizers used in photodynamic/radiation therapy	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	antibody	unknown
DB00993	Azathioprine	Xanthines	approved	Hypoxanthine-guanine phosphoribosyltransferase	P00492	306885	inhibitor	yes
DB00993	Azathioprine	Xanthines	approved	Ras-related C3 botulinum toxin substrate 1	P63000	190824	None	unknown
DB00994	Neomycin	Antibiotics	approved;vet_approved	30S ribosomal protein S12	P0A7S3	43010	inhibitor	yes
DB00994	Neomycin	Antibiotics	approved;vet_approved	16S rRNA	None	None	inhibitor	yes
DB00994	Neomycin	Antibiotics	approved;vet_approved	Extracellular calcium-sensing receptor	P41180	599820	None	unknown
DB00995	Auranofin	Gold preparations	approved;investigational	Peroxiredoxin-5, mitochondrial	P30044	6523289	inhibitor	yes
DB00995	Auranofin	Gold preparations	approved;investigational	Inhibitor of nuclear factor kappa-B kinase subunit beta	O14920	2599558	inhibitor	yes
DB00996	Gabapentin	Other antiepileptics	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	inhibitor	yes
DB00996	Gabapentin	Other antiepileptics	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-2	Q9NY47	None	inhibitor	yes
DB00996	Gabapentin	Other antiepileptics	approved;investigational	Voltage-dependent N-type calcium channel subunit alpha-1B	Q00975	179758	inhibitor	yes
DB00996	Gabapentin	Other antiepileptics	approved;investigational	Adenosine receptor A1	P30542	256155	agonist	unknown
DB00996	Gabapentin	Other antiepileptics	approved;investigational	NMDA receptor	O60391	3025446	inhibitor	unknown
DB00996	Gabapentin	Other antiepileptics	approved;investigational	Gamma-aminobutyric acid type B receptor subunit 1	Q9UBS5	3892594	None	unknown
DB00996	Gabapentin	Other antiepileptics	approved;investigational	Gamma-aminobutyric acid type B receptor subunit 2	O75899	3776098	None	unknown
DB00997	Doxorubicin	Anthracyclines and related substances	approved;investigational	DNA	None	None	intercalation	yes
DB00997	Doxorubicin	Anthracyclines and related substances	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB00997	Doxorubicin	Anthracyclines and related substances	approved;investigational	Nucleolar and coiled-body phosphoprotein 1	Q14978	None	None	unknown
DB00998	Frovatriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	yes
DB00998	Frovatriptan	Selective serotonin (5HT1) agonists	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	yes
DB00999	Hydrochlorothiazide	Thiazides and potassium in combination	approved;vet_approved	Solute carrier family 12 member 3	P55017	1172161	inhibitor	yes
DB00999	Hydrochlorothiazide	Thiazides and potassium in combination	approved;vet_approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB00999	Hydrochlorothiazide	Thiazides and potassium in combination	approved;vet_approved	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB00999	Hydrochlorothiazide	Thiazides and potassium in combination	approved;vet_approved	Calcium-activated potassium channel subunit alpha-1	Q12791	537439	inhibitor	yes
DB01000	Cyclacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB01000	Cyclacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB01000	Cyclacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB01000	Cyclacillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin binding protein 2a	C1KC03	None	inhibitor	yes
DB01001	Salbutamol	Adrenergics in combination with anticholinergics	approved;vet_approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB01001	Salbutamol	Adrenergics in combination with anticholinergics	approved;vet_approved	Beta-1 adrenergic receptor	P08588	178200	agonist	unknown
DB01001	Salbutamol	Adrenergics in combination with anticholinergics	approved;vet_approved	Beta-3 adrenergic receptor	P13945	178896	None	unknown
DB01002	Levobupivacaine	Amides	approved;investigational	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB01003	Cromoglicic acid	Other antiallergics	approved	Calcium-activated potassium channel subunit alpha-1	Q12791	537439	inhibitor	yes
DB01003	Cromoglicic acid	Other antiallergics	approved	Protein S100-P	P25815	36178	antagonist	unknown
DB01004	Ganciclovir	Xanthines	approved;investigational	DNA polymerase catalytic subunit	P04293	59530	inhibitor	yes
DB01004	Ganciclovir	Xanthines	approved;investigational	DNA	None	None	incorporation into and destabilization	yes
DB01004	Ganciclovir	Xanthines	approved;investigational	Thymidine kinase	P03176	59524	inducer	yes
DB01005	Hydroxyurea	Other antineoplastic agents	approved	Ribonucleoside-diphosphate reductase large subunit	P23921	36065	inhibitor	yes
DB01006	Letrozole	Aromatase inhibitors	approved;investigational	Cytochrome P450 19A1	P11511	179002	antagonist	yes
DB01007	Tioconazole	Imidazole derivatives	approved	Lanosterol 14-alpha demethylase	P10613	578119	antagonist	yes
DB01007	Tioconazole	Imidazole derivatives	approved	Lanosterol 14-alpha demethylase	Q16850	1698396	inhibitor	unknown
DB01008	Busulfan	Alkyl sulfonates	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB01009	Ketoprofen	Propionic acid derivatives	approved;vet_approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB01009	Ketoprofen	Propionic acid derivatives	approved;vet_approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB01009	Ketoprofen	Propionic acid derivatives	approved;vet_approved	C-X-C chemokine receptor type 1	P25024	559050	other	unknown
DB01010	Edrophonium	N/A	approved	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB01010	Edrophonium	N/A	approved	Cholinesterase	P06276	1311630	inhibitor	yes
DB01011	Metyrapone	Tests for pituitary function	approved;investigational	Cytochrome P450 11B1, mitochondrial	P15538	181333	inhibitor	yes
DB01011	Metyrapone	Tests for pituitary function	approved;investigational	Camphor 5-monooxygenase	P00183	151115	other/unknown	unknown
DB01012	Cinacalcet	Other anti-parathyroid agents	approved	Extracellular calcium-sensing receptor	P41180	599820	agonist	yes
DB01013	Clobetasol propionate	N/A	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB01014	Balsalazide	Aminosalicylic acid and similar agents	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	yes
DB01014	Balsalazide	Aminosalicylic acid and similar agents	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB01014	Balsalazide	Aminosalicylic acid and similar agents	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB01014	Balsalazide	Aminosalicylic acid and similar agents	approved;investigational	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	yes
DB01015	Sulfamethoxazole	Combinations of sulfonamides and trimethoprim, incl. derivatives	approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB01015	Sulfamethoxazole	Combinations of sulfonamides and trimethoprim, incl. derivatives	approved	Bifunctional protein FolC	P08192	146020	inhibitor	yes
DB01015	Sulfamethoxazole	Combinations of sulfonamides and trimethoprim, incl. derivatives	approved	Glutathione S-transferase P	P09211	31946	None	unknown
DB01016	Glyburide	Sulfonylureas	approved	Sulfonylurea receptor 1, Kir6.2	Q14654	1088445	blocker	yes
DB01016	Glyburide	Sulfonylureas	approved	G protein-activated inward rectifier potassium channel 4	P48544	1055026	inhibitor	unknown
DB01016	Glyburide	Sulfonylureas	approved	ATP-binding cassette sub-family C member 9	O60706	3127176	modulator	unknown
DB01016	Glyburide	Sulfonylureas	approved	Bile salt export pump	O95342	3873243	inhibitor	unknown
DB01016	Glyburide	Sulfonylureas	approved	ATP-binding cassette sub-family A member 1	O95477	9247086	inhibitor	unknown
DB01016	Glyburide	Sulfonylureas	approved	Cystic fibrosis transmembrane conductance regulator	P13569	180332	antagonist	unknown
DB01016	Glyburide	Sulfonylureas	approved	Mitochondrial ATP-sensitive potassium channel	Q15842	1088445	inhibitor	unknown
DB01016	Glyburide	Sulfonylureas	approved	Carnitine O-palmitoyltransferase 1, liver isoform	P50416	755646	inhibitor	unknown
DB01017	Minocycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational	30S ribosomal protein S9	P0A7X3	535073	inhibitor	yes
DB01017	Minocycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational	30S ribosomal protein S4	P0A7V8	42798	inhibitor	yes
DB01017	Minocycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational	16S rRNA	None	None	inhibitor	unknown
DB01017	Minocycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational	Interleukin-1 beta	P01584	307043	modulator	unknown
DB01017	Minocycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	unknown
DB01017	Minocycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational	Matrix metalloproteinase-9	P14780	177205	inhibitor	unknown
DB01017	Minocycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational	Vascular endothelial growth factor A	P15692	181971	inhibitor	unknown
DB01017	Minocycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational	Caspase-1	P29466	33793	negative modulator	unknown
DB01017	Minocycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational	Caspase-3	P42574	561666	negative modulator	unknown
DB01017	Minocycline	Antiinfectives and antiseptics for local oral treatment	approved;investigational	Cytochrome c	P99999	181242	negative modulator	unknown
DB01018	Guanfacine	Imidazoline receptor agonists	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB01018	Guanfacine	Imidazoline receptor agonists	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	binder	unknown
DB01019	Bethanechol	Choline esters	approved	Muscarinic acetylcholine receptor M2	P08172	177990	agonist	yes
DB01019	Bethanechol	Choline esters	approved	Muscarinic acetylcholine receptor M1	P11229	34451	None	unknown
DB01019	Bethanechol	Choline esters	approved	Muscarinic acetylcholine receptor M3	P20309	32324	None	unknown
DB01019	Bethanechol	Choline esters	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	None	unknown
DB01020	Isosorbide Mononitrate	Organic nitrates	approved	Guanylate cyclase soluble subunit alpha-2	P33402	31671	inducer	yes
DB01021	Trichlormethiazide	Thiazides, plain	approved;vet_approved	Solute carrier family 12 member 3	P55017	1172161	inhibitor	yes
DB01021	Trichlormethiazide	Thiazides, plain	approved;vet_approved	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	inhibitor	yes
DB01021	Trichlormethiazide	Thiazides, plain	approved;vet_approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB01021	Trichlormethiazide	Thiazides, plain	approved;vet_approved	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB01021	Trichlormethiazide	Thiazides, plain	approved;vet_approved	Carbonic anhydrase 4	P22748	179791	inhibitor	unknown
DB01022	Phylloquinone	Vitamin K	approved;investigational	Vitamin K-dependent gamma-carboxylase	P38435	184028	inducer	yes
DB01022	Phylloquinone	Vitamin K	approved;investigational	Osteocalcin	P02818	36093	agonist	unknown
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	inhibitor	yes
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	inhibitor	yes
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	yes
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	inhibitor	yes
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	inhibitor	unknown
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-2	Q9NY47	None	inhibitor	unknown
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Calmodulin	P0DP23	179888	other	unknown
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	Q01064	None	inhibitor	unknown
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	P54750	1151109	inhibitor	unknown
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Mineralocorticoid receptor	P08235	307166	antagonist	unknown
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Troponin C, skeletal muscle	P02585	36729	other	unknown
DB01023	Felodipine	Dihydropyridine derivatives	approved;investigational	Troponin C, slow skeletal and cardiac muscles	P63316	37208	other	unknown
DB01024	Mycophenolic acid	Selective immunosuppressants	approved	Inosine-5'-monophosphate dehydrogenase 1	P20839	307067	inhibitor	yes
DB01024	Mycophenolic acid	Selective immunosuppressants	approved	Inosine-5'-monophosphate dehydrogenase 2	P12268	307066	inhibitor	yes
DB01025	Amlexanox	Other agents for local oral treatment	approved;investigational	Protein S100-A12	P80511	1545946	antagonist	unknown
DB01025	Amlexanox	Other agents for local oral treatment	approved;investigational	Protein S100-A13	Q99584	1694828	antagonist	unknown
DB01025	Amlexanox	Other agents for local oral treatment	approved;investigational	Interleukin-3	P08700	307059	antagonist	unknown
DB01025	Amlexanox	Other agents for local oral treatment	approved;investigational	Fibroblast growth factor 1	P05230	181942	inhibitor	unknown
DB01026	Ketoconazole	Imidazole derivatives	approved;investigational	Lanosterol 14-alpha demethylase	P10613	578119	inhibitor	yes
DB01026	Ketoconazole	Imidazole derivatives	approved;investigational	Androgen receptor	P10275	178628	binder	unknown
DB01026	Ketoconazole	Imidazole derivatives	approved;investigational	17-hydroxylase	None	None	inhibitor	unknown
DB01026	Ketoconazole	Imidazole derivatives	approved;investigational	Steroid 21-hydroxylase	P08686	None	inhibitor	unknown
DB01026	Ketoconazole	Imidazole derivatives	approved;investigational	11-hydroxylase	None	None	inhibitor	unknown
DB01026	Ketoconazole	Imidazole derivatives	approved;investigational	Cytochrome P450 19A1	P11511	179002	inhibitor	unknown
DB01026	Ketoconazole	Imidazole derivatives	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB01026	Ketoconazole	Imidazole derivatives	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	antagonist	unknown
DB01026	Ketoconazole	Imidazole derivatives	approved;investigational	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	None	unknown
DB01028	Methoxyflurane	Other analgesics and antipyretics	approved;investigational;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB01028	Methoxyflurane	Other analgesics and antipyretics	approved;investigational;vet_approved	Glutamate receptor 1	P42261	183281	antagonist	yes
DB01028	Methoxyflurane	Other analgesics and antipyretics	approved;investigational;vet_approved	Glycine receptor subunit alpha-1	P23415	31851	agonist	yes
DB01028	Methoxyflurane	Other analgesics and antipyretics	approved;investigational;vet_approved	Calcium-transporting ATPase type 2C member 1	P98194	6715131	inhibitor	unknown
DB01028	Methoxyflurane	Other analgesics and antipyretics	approved;investigational;vet_approved	Potassium voltage-gated channel subfamily A member 1	Q09470	186663	inducer	yes
DB01028	Methoxyflurane	Other analgesics and antipyretics	approved;investigational;vet_approved	ATP synthase subunit delta, mitochondrial	P30049	12586	unknown	unknown
DB01028	Methoxyflurane	Other analgesics and antipyretics	approved;investigational;vet_approved	NADH-ubiquinone oxidoreductase chain 1	P03886	13004	unknown	unknown
DB01028	Methoxyflurane	Other analgesics and antipyretics	approved;investigational;vet_approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01029	Irbesartan	Angiotensin II antagonists and calcium channel blockers	approved;investigational	Type-1 angiotensin II receptor	P30556	179122	antagonist	yes
DB01029	Irbesartan	Angiotensin II antagonists and calcium channel blockers	approved;investigational	Transcription factor AP-1	P05412	386839	other/unknown	unknown
DB01030	Topotecan	Other antineoplastic agents	approved;investigational	DNA topoisomerase 1	P11387	339806	inhibitor	yes
DB01030	Topotecan	Other antineoplastic agents	approved;investigational	DNA topoisomerase I, mitochondrial	Q969P6	15919359	inhibitor	unknown
DB01030	Topotecan	Other antineoplastic agents	approved;investigational	DNA	None	None	intercalation	yes
DB01031	Ethinamate	N/A	approved;illicit;withdrawn	Carbonic anhydrase 1	P00915	29600	inhibitor	yes
DB01031	Ethinamate	N/A	approved;illicit;withdrawn	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB01032	Probenecid	Preparations increasing uric acid excretion	approved;investigational	Solute carrier family 22 member 6	Q4U2R8	3831566	inhibitor	yes
DB01032	Probenecid	Preparations increasing uric acid excretion	approved;investigational	Solute carrier family 22 member 11	Q9NSA0	7707622	inhibitor	yes
DB01032	Probenecid	Preparations increasing uric acid excretion	approved;investigational	Solute carrier family 22 member 8	Q8TCC7	4378059	inhibitor	yes
DB01032	Probenecid	Preparations increasing uric acid excretion	approved;investigational	Pannexin-1	Q96RD7	3661616	antagonist	unknown
DB01032	Probenecid	Preparations increasing uric acid excretion	approved;investigational	Taste receptor type 2 member 16	Q9NYV7	None	None	unknown
DB01033	Mercaptopurine	Purine analogues	approved	Hypoxanthine-guanine phosphoribosyltransferase	P00492	306885	inhibitor	yes
DB01033	Mercaptopurine	Purine analogues	approved	Amidophosphoribosyltransferase	Q06203	219459	inhibitor	unknown
DB01033	Mercaptopurine	Purine analogues	approved	Inosine-5'-monophosphate dehydrogenase	P12268	307066	inhibitor	unknown
DB01034	Cerulenin	N/A	approved	3-oxoacyl-[acyl-carrier-protein] synthase 1	P0A953	145884	inhibitor	yes
DB01034	Cerulenin	N/A	approved	3-oxoacyl-[acyl-carrier-protein] synthase 2	P0AAI5	572680	inhibitor	yes
DB01034	Cerulenin	N/A	approved	3-oxoacyl-[acyl-carrier-protein] synthase 3	P0A6R0	145898	inhibitor	yes
DB01034	Cerulenin	N/A	approved	Fatty acid synthase	P49327	1049053	inhibitor	yes
DB01035	Procainamide	Antiarrhythmics, class Ia	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	unknown
DB01035	Procainamide	Antiarrhythmics, class Ia	approved	DNA (cytosine-5)-methyltransferase 1	P26358	1632819	other	unknown
DB01035	Procainamide	Antiarrhythmics, class Ia	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB01036	Tolterodine	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB01036	Tolterodine	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB01036	Tolterodine	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	yes
DB01036	Tolterodine	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB01036	Tolterodine	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB01037	Selegiline	Monoamine oxidase B inhibitors	approved;investigational;vet_approved	Amine oxidase [flavin-containing] B	P27338	398415	inhibitor	yes
DB01037	Selegiline	Monoamine oxidase B inhibitors	approved;investigational;vet_approved	Amine oxidase [flavin-containing] A	P21397	187353	inhibitor	no
DB01039	Fenofibrate	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved	Peroxisome proliferator-activated receptor alpha	Q07869	307341	agonist	yes
DB01039	Fenofibrate	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved	Metalloproteinase	O43923	2808657	inhibitor	unknown
DB01039	Fenofibrate	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB01039	Fenofibrate	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved	Peroxisome proliferator-activated receptor delta	Q03181	190230	None	unknown
DB01039	Fenofibrate	HMG CoA reductase inhibitors in combination with other lipid modifying agents	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	partial agonist	unknown
DB01040	Hydroxystilbamidine Isethionate	N/A	approved	DNA	None	None	other/unknown	yes
DB01041	Thalidomide	Other immunosuppressants	approved;investigational;withdrawn	Protein cereblon	Q96SW2	None	inhibitor	yes
DB01041	Thalidomide	Other immunosuppressants	approved;investigational;withdrawn	Tumor necrosis factor	P01375	339741	inhibitor	yes
DB01041	Thalidomide	Other immunosuppressants	approved;investigational;withdrawn	Nuclear factor NF-kappa-B p105 subunit	P19838	189180	antagonist	yes
DB01041	Thalidomide	Other immunosuppressants	approved;investigational;withdrawn	DNA	None	None	intercalation	yes
DB01041	Thalidomide	Other immunosuppressants	approved;investigational;withdrawn	Fibroblast growth factor receptor 2	P21802	31374	antagonist	yes
DB01041	Thalidomide	Other immunosuppressants	approved;investigational;withdrawn	Prostaglandin G/H synthase 2	P35354	291988	antagonist	unknown
DB01041	Thalidomide	Other immunosuppressants	approved;investigational;withdrawn	Nuclear factor kappa-light-chain-enhancer of activated B cells	None	None	inhibitor	unknown
DB01041	Thalidomide	Other immunosuppressants	approved;investigational;withdrawn	alpha1-acid glycoprotein	P19652	16359000	binder	unknown
DB01042	Melphalan	Nitrogen mustard analogues	approved	DNA	None	None	cross-linking/alkylation	yes
DB01043	Memantine	Other anti-dementia drugs	approved;investigational	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	yes
DB01043	Memantine	Other anti-dementia drugs	approved;investigational	Glutamate receptor ionotropic, NMDA 2A	Q12879	558749	antagonist	yes
DB01043	Memantine	Other anti-dementia drugs	approved;investigational	Glutamate receptor ionotropic, NMDA 2B	Q13224	1899202	antagonist	yes
DB01043	Memantine	Other anti-dementia drugs	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB01043	Memantine	Other anti-dementia drugs	approved;investigational	Alpha-7 nicotinic cholinergic receptor subunit	Q693P7	None	antagonist	unknown
DB01043	Memantine	Other anti-dementia drugs	approved;investigational	D(2) dopamine receptor	P14416	181432	agonist	unknown
DB01043	Memantine	Other anti-dementia drugs	approved;investigational	Glutamate receptor ionotropic, NMDA 1	Q05586	219920	binder	unknown
DB01044	Gatifloxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit A	P72524	14971465	inhibitor	yes
DB01044	Gatifloxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit B	P0A4L9	1052803	inhibitor	yes
DB01044	Gatifloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 4 subunit A	P72525	1490399	inhibitor	yes
DB01044	Gatifloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 4 subunit B	Q59961	1490399	inhibitor	yes
DB01045	Rifampicin	Combinations of drugs for treatment of tuberculosis	approved	DNA-directed RNA polymerase subunit beta	P0A8V2	42818	inhibitor	yes
DB01045	Rifampicin	Combinations of drugs for treatment of tuberculosis	approved	DNA-directed RNA polymerase subunit beta'	P0A8T7	42814	inhibitor	yes
DB01045	Rifampicin	Combinations of drugs for treatment of tuberculosis	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	agonist	unknown
DB01045	Rifampicin	Combinations of drugs for treatment of tuberculosis	approved	Solute carrier organic anion transporter family member 1B1	Q9Y6L6	5051630	None	unknown
DB01045	Rifampicin	Combinations of drugs for treatment of tuberculosis	approved	Solute carrier organic anion transporter family member 1A2	P46721	885978	None	unknown
DB01045	Rifampicin	Combinations of drugs for treatment of tuberculosis	approved	Solute carrier organic anion transporter family member 1B3	Q9NPD5	9187497	None	unknown
DB01045	Rifampicin	Combinations of drugs for treatment of tuberculosis	approved	Lanosterol 14-alpha demethylase	Q16850	1698396	None	unknown
DB01045	Rifampicin	Combinations of drugs for treatment of tuberculosis	approved	Serum albumin	P02768	28590	None	unknown
DB01045	Rifampicin	Combinations of drugs for treatment of tuberculosis	approved	Solute carrier organic anion transporter family member 2B1	O94956	5006263	None	unknown
DB01046	Lubiprostone	Other drugs for constipation	approved;investigational	Chloride channel protein 2	P51788	2570864	inducer	yes
DB01047	Fluocinonide	Corticosteroids, potent, combinations with antibiotics	approved;investigational	Glucocorticoid receptor	P04150	31680	agonist	yes
DB01047	Fluocinonide	Corticosteroids, potent, combinations with antibiotics	approved;investigational	Smoothened homolog	Q99835	None	agonist	unknown
DB01048	Abacavir	Antivirals for treatment of HIV infections, combinations	approved;investigational	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB01048	Abacavir	Antivirals for treatment of HIV infections, combinations	approved;investigational	HLA class I histocompatibility antigen, B-57 alpha chain	P18465	None	None	unknown
DB01049	Ergoloid mesylate	N/A	approved	Dopamine receptor	P21917	291946	antagonist	yes
DB01049	Ergoloid mesylate	N/A	approved	Alpha adrenergic receptor	P18825	178194	antagonist	yes
DB01049	Ergoloid mesylate	N/A	approved	Beta adrenergic receptor	P13945	178896	antagonist	yes
DB01049	Ergoloid mesylate	N/A	approved	Serotonin Receptors	P34969	1857143	antagonist	yes
DB01050	Ibuprofen	Antiinflammatory preparations, non-steroids for topical use	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB01050	Ibuprofen	Antiinflammatory preparations, non-steroids for topical use	approved	Prostaglandin G/H synthase 1	P23219	387018	None	yes
DB01050	Ibuprofen	Antiinflammatory preparations, non-steroids for topical use	approved	Apoptosis regulator Bcl-2	P10415	179367	modulator	unknown
DB01050	Ibuprofen	Antiinflammatory preparations, non-steroids for topical use	approved	Thrombomodulin	P07204	736251	modulator	unknown
DB01050	Ibuprofen	Antiinflammatory preparations, non-steroids for topical use	approved	Tissue-type plasminogen activator	P00750	339834	negative modulator	unknown
DB01050	Ibuprofen	Antiinflammatory preparations, non-steroids for topical use	approved	Fatty acid-binding protein, intestinal	P12104	46854681	binder	unknown
DB01050	Ibuprofen	Antiinflammatory preparations, non-steroids for topical use	approved	Peroxisome proliferator-activated receptor gamma	P37231	1711117	activator	unknown
DB01050	Ibuprofen	Antiinflammatory preparations, non-steroids for topical use	approved	Cystic fibrosis transmembrane conductance regulator	P13569	180332	inhibitor	unknown
DB01050	Ibuprofen	Antiinflammatory preparations, non-steroids for topical use	approved	Solute carrier family 15 member 1	P46059	773588	None	unknown
DB01050	Ibuprofen	Antiinflammatory preparations, non-steroids for topical use	approved	Peroxisome proliferator-activated receptor alpha	Q07869	307341	activator	unknown
DB01051	Novobiocin	N/A	approved;investigational;vet_approved	DNA gyrase subunit B	P0A0K8	None	inhibitor	yes
DB01051	Novobiocin	N/A	approved;investigational;vet_approved	DNA topoisomerase 1	Q06AK7	None	inhibitor	unknown
DB01053	Benzylpenicillin	Beta-lactamase sensitive penicillins	approved;vet_approved	Penicillin-binding protein 3	A0A0H2XJ39	None	inhibitor	unknown
DB01053	Benzylpenicillin	Beta-lactamase sensitive penicillins	approved;vet_approved	Beta-lactamase TEM	P62593	208959	None	unknown
DB01053	Benzylpenicillin	Beta-lactamase sensitive penicillins	approved;vet_approved	Solute carrier family 22 member 8	Q8TCC7	4378059	None	unknown
DB01053	Benzylpenicillin	Beta-lactamase sensitive penicillins	approved;vet_approved	Solute carrier family 15 member 1	P46059	773588	None	unknown
DB01053	Benzylpenicillin	Beta-lactamase sensitive penicillins	approved;vet_approved	Solute carrier family 15 member 2	Q16348	999213	None	unknown
DB01054	Nitrendipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB01054	Nitrendipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	inhibitor	yes
DB01054	Nitrendipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	inhibitor	yes
DB01054	Nitrendipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent calcium channel gamma-1 subunit	Q06432	306473	inhibitor	yes
DB01054	Nitrendipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	yes
DB01054	Nitrendipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	inhibitor	yes
DB01054	Nitrendipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-2	Q9NY47	None	inhibitor	unknown
DB01054	Nitrendipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	inhibitor	unknown
DB01055	Mimosine	N/A	approved	Serine hydroxymethyltransferase, cytosolic	P34896	307422	inhibitor	yes
DB01055	Mimosine	N/A	approved	C-C motif chemokine 2	P13500	307163	inhibitor	yes
DB01055	Mimosine	N/A	approved	Tyrosinase	P14679	340037	inhibitor	unknown
DB01056	Tocainide	Antiarrhythmics, class Ib	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB01057	Echothiophate	Parasympathomimetics	approved	Cholinesterase	P06276	1311630	inhibitor	yes
DB01058	Praziquantel	Quinoline derivatives and related substances	approved;investigational;vet_approved	Schistosome calcium ion (Ca2+) channels	None	None	other/unknown	yes
DB01059	Norfloxacin	Fluoroquinolones	approved	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB01059	Norfloxacin	Fluoroquinolones	approved	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB01059	Norfloxacin	Fluoroquinolones	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	unknown
DB01060	Amoxicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB01061	Azlocillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB01062	Oxybutynin	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB01062	Oxybutynin	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB01062	Oxybutynin	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB01063	Acetophenazine	Phenothiazines with piperazine structure	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01063	Acetophenazine	Phenothiazines with piperazine structure	approved	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB01063	Acetophenazine	Phenothiazines with piperazine structure	approved	Androgen receptor	P10275	178628	None	unknown
DB01064	Isoprenaline	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	agonist	yes
DB01064	Isoprenaline	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB01064	Isoprenaline	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Beta-3 adrenergic receptor	P13945	178896	agonist	yes
DB01064	Isoprenaline	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Mitogen-activated protein kinase 1	P28482	182191	inducer	unknown
DB01064	Isoprenaline	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Phosphatidylinositol 3-kinase regulatory subunit alpha	P27986	None	agonist	unknown
DB01064	Isoprenaline	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Phosphatidylinositol 3-kinase regulatory subunit beta	O00459	None	agonist	unknown
DB01064	Isoprenaline	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Phosphatidylinositol 3-kinase regulatory subunit gamma	Q92569	None	agonist	unknown
DB01064	Isoprenaline	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	CAMP phosphodiesterase	Q4ZHU6	None	activator	unknown
DB01064	Isoprenaline	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved;investigational	Superoxide dismutase [Cu-Zn]	P00441	None	None	unknown
DB01065	Melatonin	Melatonin receptor agonists	approved;nutraceutical;vet_approved	Melatonin receptor type 1A	P48039	602130	agonist	yes
DB01065	Melatonin	Melatonin receptor agonists	approved;nutraceutical;vet_approved	Melatonin receptor type 1B	P49286	971194	agonist	yes
DB01065	Melatonin	Melatonin receptor agonists	approved;nutraceutical;vet_approved	Estrogen receptor alpha	P03372	31234	antagonist	unknown
DB01065	Melatonin	Melatonin receptor agonists	approved;nutraceutical;vet_approved	Nuclear receptor ROR-beta	Q92753	1619294	agonist	unknown
DB01065	Melatonin	Melatonin receptor agonists	approved;nutraceutical;vet_approved	Calmodulin	P0DP23	179888	None	unknown
DB01065	Melatonin	Melatonin receptor agonists	approved;nutraceutical;vet_approved	Myeloperoxidase	P05164	189040	inhibitor	unknown
DB01065	Melatonin	Melatonin receptor agonists	approved;nutraceutical;vet_approved	Eosinophil peroxidase	P11678	31183	inhibitor	unknown
DB01065	Melatonin	Melatonin receptor agonists	approved;nutraceutical;vet_approved	Calreticulin	P27797	337487	None	unknown
DB01065	Melatonin	Melatonin receptor agonists	approved;nutraceutical;vet_approved	Acetylserotonin O-methyltransferase	P46597	607840	None	unknown
DB01065	Melatonin	Melatonin receptor agonists	approved;nutraceutical;vet_approved	Ribosyldihydronicotinamide dehydrogenase [quinone]	P16083	190818	None	unknown
DB01066	Cefditoren	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB01066	Cefditoren	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB01067	Glipizide	Sulfonylureas	approved;investigational	ATP-binding cassette sub-family C member 8	Q09428	1374919	inhibitor	yes
DB01067	Glipizide	Sulfonylureas	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	unknown
DB01068	Clonazepam	Benzodiazepine derivatives	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01068	Clonazepam	Benzodiazepine derivatives	approved;illicit	Translocator protein	P30536	306883	other/unknown	unknown
DB01068	Clonazepam	Benzodiazepine derivatives	approved;illicit	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	partial agonist	unknown
DB01069	Promethazine	Antidotes	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01069	Promethazine	Antidotes	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	unknown
DB01069	Promethazine	Antidotes	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB01069	Promethazine	Antidotes	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB01069	Promethazine	Antidotes	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB01069	Promethazine	Antidotes	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB01069	Promethazine	Antidotes	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB01069	Promethazine	Antidotes	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	unknown	unknown
DB01069	Promethazine	Antidotes	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB01069	Promethazine	Antidotes	approved;investigational	Calmodulin	P0DP23	179888	inhibitor	unknown
DB01069	Promethazine	Antidotes	approved;investigational	Histamine H2 receptor	P25021	184088	antagonist	unknown
DB01070	Dihydrotachysterol	Vitamin D and analogues	approved	Vitamin D3 receptor	P11473	340203	agonist	yes
DB01071	Mequitazine	Phenothiazine derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01072	Atazanavir	Protease inhibitors	approved;investigational	Human immunodeficiency virus type 1 protease	Q72874	None	inhibitor	yes
DB01073	Fludarabine	Purine analogues	approved	Ribonucleoside-diphosphate reductase large subunit	P23921	36065	inhibitor	yes
DB01073	Fludarabine	Purine analogues	approved	DNA polymerase alpha catalytic subunit	P09884	35568	inhibitor	yes
DB01073	Fludarabine	Purine analogues	approved	DNA	None	None	incorporation into and destabilization	yes
DB01073	Fludarabine	Purine analogues	approved	Deoxycytidine kinase	P27707	None	agonist	yes
DB01074	Perhexiline	Other non-selective calcium channel blockers	approved;investigational	Carnitine O-palmitoyltransferase 1, liver isoform	P50416	755646	inhibitor	yes
DB01074	Perhexiline	Other non-selective calcium channel blockers	approved;investigational	Carnitine O-palmitoyltransferase 2, mitochondrial	P23786	1041195	inhibitor	yes
DB01074	Perhexiline	Other non-selective calcium channel blockers	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	None	unknown
DB01075	Diphenhydramine	Antihistamines for topical use	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01075	Diphenhydramine	Antihistamines for topical use	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB01076	Atorvastatin	HMG CoA reductase inhibitors	approved	3-hydroxy-3-methylglutaryl-coenzyme A reductase	P04035	306865	inhibitor	yes
DB01076	Atorvastatin	HMG CoA reductase inhibitors	approved	Dipeptidyl peptidase 4	P27487	535388	inhibitor	no
DB01076	Atorvastatin	HMG CoA reductase inhibitors	approved	Aryl hydrocarbon receptor	P35869	533324	agonist	unknown
DB01077	Etidronic acid	Bisphosphonates, combinations	approved	Adenosine triphosphate (ATP)	None	None	inhibitor	yes
DB01077	Etidronic acid	Bisphosphonates, combinations	approved	Hydroxylapatite	None	None	antagonist	yes
DB01077	Etidronic acid	Bisphosphonates, combinations	approved	Receptor-type tyrosine-protein phosphatase S	Q13332	1109792	inhibitor	unknown
DB01077	Etidronic acid	Bisphosphonates, combinations	approved	V-type proton ATPase catalytic subunit A	P38606	291868	inhibitor	unknown
DB01078	Deslanoside	Digitalis glycosides	approved	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	inhibitor	yes
DB01079	Tegaserod	Other drugs for constipation	approved;investigational;withdrawn	5-hydroxytryptamine receptor 4	Q13639	2661757	antagonist	yes
DB01079	Tegaserod	Other drugs for constipation	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	unknown
DB01079	Tegaserod	Other drugs for constipation	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB01079	Tegaserod	Other drugs for constipation	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB01080	Vigabatrin	Fatty acid derivatives	approved	Gamma-aminobutyric acid type B receptor subunit 1	Q9UBS5	3892594	agonist	yes
DB01080	Vigabatrin	Fatty acid derivatives	approved	4-aminobutyrate aminotransferase, mitochondrial	P80404	602705	inhibitor	yes
DB01081	Diphenoxylate	Antipropulsives	approved;illicit	Mu-type opioid receptor	P35372	452073	agonist	yes
DB01081	Diphenoxylate	Antipropulsives	approved;illicit	Delta-type opioid receptor	P41143	27545517	agonist	unknown
DB01082	Streptomycin	Streptomycins	approved;vet_approved	30S ribosomal protein S12	P0A7S3	43010	inhibitor	yes
DB01082	Streptomycin	Streptomycins	approved;vet_approved	16S rRNA	None	None	inhibitor	yes
DB01082	Streptomycin	Streptomycins	approved;vet_approved	Protein-arginine deiminase type-4	Q9UM07	5913971	None	unknown
DB01083	Orlistat	Peripherally acting antiobesity products	approved;investigational	Pancreatic triacylglycerol lipase	P16233	339597	inhibitor	yes
DB01083	Orlistat	Peripherally acting antiobesity products	approved;investigational	Gastric triacylglycerol lipase	P07098	758063	inhibitor	yes
DB01083	Orlistat	Peripherally acting antiobesity products	approved;investigational	Fatty acid synthase	P49327	1049053	inhibitor	yes
DB01084	Emedastine	Other antiallergics	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01085	Pilocarpine	Parasympathomimetics	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	agonist	yes
DB01085	Pilocarpine	Parasympathomimetics	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	agonist	yes
DB01085	Pilocarpine	Parasympathomimetics	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	agonist	yes
DB01085	Pilocarpine	Parasympathomimetics	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	partial agonist	unknown
DB01086	Benzocaine	Anesthetics, local	approved;investigational	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB01087	Primaquine	Aminoquinolines	approved	Fe(II)-protoporphyrin IX	None	None	antagonist	yes
DB01087	Primaquine	Aminoquinolines	approved	Keratin, type II cytoskeletal 7	P08729	None	other/unknown	unknown
DB01087	Primaquine	Aminoquinolines	approved	Ribosyldihydronicotinamide dehydrogenase [quinone]	P16083	190818	inhibitor	unknown
DB01088	Iloprost	Platelet aggregation inhibitors excl. heparin	approved;investigational	Prostacyclin receptor	P43119	495043	agonist	yes
DB01088	Iloprost	Platelet aggregation inhibitors excl. heparin	approved;investigational	Prostaglandin E2 receptor EP1 subtype	P34995	410209	agonist	yes
DB01088	Iloprost	Platelet aggregation inhibitors excl. heparin	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inducer	unknown
DB01088	Iloprost	Platelet aggregation inhibitors excl. heparin	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inducer	unknown
DB01088	Iloprost	Platelet aggregation inhibitors excl. heparin	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Q08493	727223	inducer	unknown
DB01088	Iloprost	Platelet aggregation inhibitors excl. heparin	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Q08499	347130	inducer	unknown
DB01088	Iloprost	Platelet aggregation inhibitors excl. heparin	approved;investigational	Tissue-type plasminogen activator	P00750	339834	other/unknown	unknown
DB01088	Iloprost	Platelet aggregation inhibitors excl. heparin	approved;investigational	Prostaglandin D2 receptor 2	Q9Y5Y4	4204216	agonist	unknown
DB01089	Deserpidine	Rauwolfia alkaloids	approved	Synaptic vesicular amine transporter	Q05940	292335	inhibitor	yes
DB01090	Pentolinium	N/A	approved	Neuronal acetylcholine receptor subunit alpha-10	Q9GZZ6	12053839	antagonist	yes
DB01090	Pentolinium	N/A	approved	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	antagonist	yes
DB01090	Pentolinium	N/A	approved	Neuronal acetylcholine receptor subunit beta-4	P30926	1458126	antagonist	yes
DB01091	Butenafine	Other antifungals for topical use	approved	Squalene monooxygenase	Q14534	2443316	inhibitor	yes
DB01092	Ouabain	Strophanthus glycosides	approved	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	inhibitor	yes
DB01092	Ouabain	Strophanthus glycosides	approved	Sodium/potassium-transporting ATPase subunit alpha-2	P50993	None	inhibitor	unknown
DB01092	Ouabain	Strophanthus glycosides	approved	Sodium/potassium-transporting ATPase subunit alpha-3	P13637	None	inhibitor	unknown
DB01094	Hesperetin	N/A	approved	Sterol O-acyltransferase 1	P35610	4878022	inhibitor	yes
DB01094	Hesperetin	N/A	approved	Sterol O-acyltransferase 2	O75908	None	inhibitor	unknown
DB01094	Hesperetin	N/A	approved	Microsomal triglyceride transfer protein large subunit	P55157	414669	antagonist	yes
DB01094	Hesperetin	N/A	approved	Sex hormone-binding globulin	P04278	296673	None	unknown
DB01095	Fluvastatin	HMG CoA reductase inhibitors	approved	3-hydroxy-3-methylglutaryl-coenzyme A reductase	P04035	306865	inhibitor	yes
DB01096	Oxamniquine	Quinoline derivatives and related substances	approved	DNA	None	None	other/unknown	yes
DB01097	Leflunomide	Selective immunosuppressants	approved;investigational	Dihydroorotate dehydrogenase (quinone), mitochondrial	Q02127	555594	inhibitor	yes
DB01097	Leflunomide	Selective immunosuppressants	approved;investigational	Aryl hydrocarbon receptor	P35869	533324	agonist	unknown
DB01097	Leflunomide	Selective immunosuppressants	approved;investigational	Protein-tyrosine kinase 2-beta	Q14289	988305	antagonist	unknown
DB01098	Rosuvastatin	HMG CoA reductase inhibitors, other combinations	approved	3-hydroxy-3-methylglutaryl-coenzyme A reductase	P04035	306865	inhibitor	yes
DB01099	Flucytosine	Other antifungals for topical use	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB01099	Flucytosine	Other antifungals for topical use	approved;investigational	DNA (cytosine-5)-methyltransferase 1	P26358	1632819	other	unknown
DB01099	Flucytosine	Other antifungals for topical use	approved;investigational	Thymidylate synthase	P12461	7537304	inhibitor	unknown
DB01100	Pimozide	Diphenylbutylpiperidine derivatives	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01100	Pimozide	Diphenylbutylpiperidine derivatives	approved	D(3) dopamine receptor	P35462	927342	antagonist	yes
DB01100	Pimozide	Diphenylbutylpiperidine derivatives	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	yes
DB01100	Pimozide	Diphenylbutylpiperidine derivatives	approved	Calmodulin	P0DP23	179888	inhibitor	unknown
DB01101	Capecitabine	Pyrimidine analogues	approved;investigational	Thymidylate synthase	P04818	37479	inhibitor	yes
DB01101	Capecitabine	Pyrimidine analogues	approved;investigational	DNA	None	None	incorporation into and destabilization	yes
DB01101	Capecitabine	Pyrimidine analogues	approved;investigational	RNA	None	None	incorporation into and destabilization	yes
DB01102	Arbutamine	Adrenergic and dopaminergic agents	approved	Beta-1 adrenergic receptor	P08588	178200	agonist	yes
DB01102	Arbutamine	Adrenergic and dopaminergic agents	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	unknown
DB01102	Arbutamine	Adrenergic and dopaminergic agents	approved	Beta-3 adrenergic receptor	P13945	178896	agonist	unknown
DB01103	Quinacrine	Other agents against amoebiasis and other protozoal diseases	approved;investigational	DNA	None	None	intercalation	yes
DB01103	Quinacrine	Other agents against amoebiasis and other protozoal diseases	approved;investigational	85/88 kDa calcium-independent phospholipase A2	O60733	3142700	inhibitor	yes
DB01103	Quinacrine	Other agents against amoebiasis and other protozoal diseases	approved;investigational	Cytosolic phospholipase A2	P47712	190007	inhibitor	yes
DB01103	Quinacrine	Other agents against amoebiasis and other protozoal diseases	approved;investigational	Inactive phospholipase C-like protein 1	Q15111	780122	inhibitor	yes
DB01104	Sertraline	Selective serotonin reuptake inhibitors	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB01104	Sertraline	Selective serotonin reuptake inhibitors	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB01104	Sertraline	Selective serotonin reuptake inhibitors	approved	Sigma receptor	Q99720	1783387	antagonist	unknown
DB01105	Sibutramine	Centrally acting antiobesity products	approved;illicit;investigational;withdrawn	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB01105	Sibutramine	Centrally acting antiobesity products	approved;illicit;investigational;withdrawn	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB01105	Sibutramine	Centrally acting antiobesity products	approved;illicit;investigational;withdrawn	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB01106	Levocabastine	Antiallergic agents, excl. corticosteroids	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01106	Levocabastine	Antiallergic agents, excl. corticosteroids	approved;investigational	Neurotensin receptor type 2	O95665	3901028	partial antagonist	yes
DB01107	Methyprylon	Piperidinedione derivatives	approved;illicit;withdrawn	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB01107	Methyprylon	Piperidinedione derivatives	approved;illicit;withdrawn	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01108	Trilostane	Anticorticosteroids	approved;investigational;vet_approved;withdrawn	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	P14060	306889	inhibitor	yes
DB01108	Trilostane	Anticorticosteroids	approved;investigational;vet_approved;withdrawn	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	P26439	184401	inhibitor	yes
DB01108	Trilostane	Anticorticosteroids	approved;investigational;vet_approved;withdrawn	Estrogen receptor alpha	P03372	31234	allosteric modulator	yes
DB01108	Trilostane	Anticorticosteroids	approved;investigational;vet_approved;withdrawn	Estrogen receptor beta	Q92731	2911152	allosteric modulator	yes
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Antithrombin-III	P01008	179161	potentiator	yes
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Coagulation factor X	P00742	182841	inhibitor	yes
DB01109	Heparin	Other ophthalmologicals	approved;investigational	P-selectin	P16109	183389	inhibitor	unknown
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Fibroblast growth factor receptor 4	P22455	31372	None	unknown
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Fibroblast growth factor 4	P08620	386788	None	unknown
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Fibroblast growth factor 19	O95750	None	None	unknown
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Fibroblast growth factor receptor 1	P11362	31368	None	unknown
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Fibroblast growth factor 1	P05230	181942	None	unknown
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Fibroblast growth factor receptor 2	P21802	31374	None	unknown
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Fibroblast growth factor 2	P09038	31362	None	unknown
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Platelet factor 4	P02776	189851	None	unknown
DB01109	Heparin	Other ophthalmologicals	approved;investigational	Hepatocyte growth factor	P14210	306846	None	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Lanosterol 14-alpha demethylase	P10613	578119	inhibitor	yes
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Nitric oxide synthase, endothelial	P29474	189212	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Nitric oxide synthase, inducible	P35228	292242	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Calcium-activated potassium channel subunit alpha-1	Q12791	537439	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Calcium-activated potassium channel subunit beta-1	Q16558	1326067	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Calcium-activated potassium channel subunit beta-2	Q9Y691	None	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Calcium-activated potassium channel subunit beta-3	Q9NPA1	5880671	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Calcium-activated potassium channel subunit beta-4	Q86W47	7799988	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Intermediate conductance calcium-activated potassium channel protein 4	O15554	2584866	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Small conductance calcium-activated potassium channel protein 1	Q92952	1575661	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Small conductance calcium-activated potassium channel protein 2	Q9H2S1	10334701	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Small conductance calcium-activated potassium channel protein 3	Q9UGI6	3309531	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Potassium voltage-gated channel subfamily H member 6	Q9H252	11878259	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Potassium voltage-gated channel subfamily H member 7	Q9NS40	4104136	inhibitor	unknown
DB01110	Miconazole	Antiinfectives and antiseptics for local oral treatment	approved;investigational;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	partial agonist	unknown
DB01111	Colistimethate	N/A	approved;vet_approved	Bacterial outer membrane	None	None	incorporation into and destabilization	yes
DB01112	Cefuroxime	Antibiotics	approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB01113	Papaverine	Drugs used in erectile dysfunction	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	yes
DB01113	Papaverine	Drugs used in erectile dysfunction	approved;investigational	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	Q9Y233	4958858	inhibitor	unknown
DB01114	Chlorphenamine	Substituted alkylamines	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01114	Chlorphenamine	Substituted alkylamines	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	unknown
DB01114	Chlorphenamine	Substituted alkylamines	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB01114	Chlorphenamine	Substituted alkylamines	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB01115	Nifedipine	Dihydropyridine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB01115	Nifedipine	Dihydropyridine derivatives	approved	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	inhibitor	yes
DB01115	Nifedipine	Dihydropyridine derivatives	approved	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	inhibitor	yes
DB01115	Nifedipine	Dihydropyridine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	yes
DB01115	Nifedipine	Dihydropyridine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	inhibitor	yes
DB01115	Nifedipine	Dihydropyridine derivatives	approved	Calmodulin	P0DP23	179888	inhibitor	unknown
DB01115	Nifedipine	Dihydropyridine derivatives	approved	Potassium voltage-gated channel subfamily A member 1	Q09470	186663	inhibitor	unknown
DB01115	Nifedipine	Dihydropyridine derivatives	approved	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	inhibitor	unknown
DB01115	Nifedipine	Dihydropyridine derivatives	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB01116	Trimethaphan	Sulfonium derivatives	approved;investigational	Neuronal acetylcholine receptor subunit alpha-10	Q9GZZ6	12053839	antagonist	yes
DB01117	Atovaquone	Other agents against amoebiasis and other protozoal diseases	approved	Cytochrome b	Q02768	2978420	inhibitor	yes
DB01117	Atovaquone	Other agents against amoebiasis and other protozoal diseases	approved	Dihydroorotate dehydrogenase (quinone), mitochondrial	Q08210	46362265	inhibitor	yes
DB01117	Atovaquone	Other agents against amoebiasis and other protozoal diseases	approved	Dihydroorotate dehydrogenase (quinone), mitochondrial	Q02127	555594	inhibitor	unknown
DB01118	Amiodarone	Antiarrhythmics, class III	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	yes
DB01118	Amiodarone	Antiarrhythmics, class III	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB01118	Amiodarone	Antiarrhythmics, class III	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	inhibitor	unknown
DB01118	Amiodarone	Antiarrhythmics, class III	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-2	Q9NY47	None	inhibitor	yes
DB01118	Amiodarone	Antiarrhythmics, class III	approved;investigational	Thyroid hormone receptor alpha	P10827	825639	None	unknown
DB01118	Amiodarone	Antiarrhythmics, class III	approved;investigational	Thyroid hormone receptor beta	P10828	31207	None	unknown
DB01118	Amiodarone	Antiarrhythmics, class III	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB01119	Diazoxide	Drugs for treatment of hypoglycemia	approved	ATP-sensitive inward rectifier potassium channel 11	Q14654	1088445	inducer	yes
DB01119	Diazoxide	Drugs for treatment of hypoglycemia	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	yes
DB01119	Diazoxide	Drugs for treatment of hypoglycemia	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB01119	Diazoxide	Drugs for treatment of hypoglycemia	approved	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	other	unknown
DB01119	Diazoxide	Drugs for treatment of hypoglycemia	approved	Calcium-activated potassium channel subunit alpha-1	Q12791	537439	other	unknown
DB01119	Diazoxide	Drugs for treatment of hypoglycemia	approved	Solute carrier family 12 member 3	P55017	1172161	unknown	unknown
DB01120	Gliclazide	Sulfonylureas	approved	ATP-binding cassette sub-family C member 8	Q09428	1374919	binder	yes
DB01120	Gliclazide	Sulfonylureas	approved	Vascular endothelial growth factor A	P15692	181971	other/unknown	unknown
DB01121	Phenacemide	Other antiepileptics	approved	Sodium channel protein type 1 subunit alpha	P35498	12642270	inhibitor	yes
DB01122	Ambenonium	Anticholinesterases	approved	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB01123	Proflavine	N/A	approved	DNA	None	None	intercalation	yes
DB01123	Proflavine	N/A	approved	Prothrombin	P00734	339641	other/unknown	no
DB01123	Proflavine	N/A	approved	HTH-type transcriptional regulator QacR	P0A0N4	46660	None	unknown
DB01123	Proflavine	N/A	approved	TetR family transcriptional repressor LfrR	Q58L87	61104877	None	unknown
DB01124	Tolbutamide	Sulfonylureas	approved;investigational	ATP-binding cassette sub-family C member 8	Q09428	1374919	inhibitor	yes
DB01124	Tolbutamide	Sulfonylureas	approved;investigational	ATP-sensitive inward rectifier potassium channel 1	P48048	529313	inhibitor	unknown
DB01125	Anisindione	N/A	approved	Vitamin K-dependent gamma-carboxylase	P38435	184028	inhibitor	yes
DB01126	Dutasteride	Testosterone-5-alpha reductase inhibitors	approved;investigational	3-oxo-5-alpha-steroid 4-dehydrogenase 2	P31213	338469	inhibitor	yes
DB01126	Dutasteride	Testosterone-5-alpha reductase inhibitors	approved;investigational	3-oxo-5-alpha-steroid 4-dehydrogenase 1	P18405	177767	inhibitor	yes
DB01127	Econazole	Imidazole derivatives	approved	Lanosterol 14-alpha demethylase	P10613	578119	antagonist	yes
DB01127	Econazole	Imidazole derivatives	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	partial agonist	unknown
DB01128	Bicalutamide	Anti-androgens	approved	Androgen receptor	P10275	178628	antagonist	yes
DB01129	Rabeprazole	Proton pump inhibitors	approved;investigational	Potassium-transporting ATPase alpha chain 1	P20648	561634	inhibitor	yes
DB01130	Prednicarbate	Corticosteroids, potent (group III)	approved;investigational	Glucocorticoid receptor	P04150	31680	agonist	yes
DB01131	Proguanil	Biguanides	approved	Dihydrofolate reductase	P00374	182724	inhibitor	yes
DB01131	Proguanil	Biguanides	approved	Bifunctional dihydrofolate reductase-thymidylate synthase	P13922	160260	inhibitor	unknown
DB01132	Pioglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	yes
DB01132	Pioglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Peroxisome proliferator-activated receptor delta	Q03181	190230	None	unknown
DB01132	Pioglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB01132	Pioglitazone	Combinations of oral blood glucose lowering drugs	approved;investigational	Amine oxidase [flavin-containing] B	P27338	398415	None	unknown
DB01133	Tiludronic acid	Bisphosphonates	approved;investigational;vet_approved	Adenosine triphosphate (ATP)	None	None	inhibitor	yes
DB01133	Tiludronic acid	Bisphosphonates	approved;investigational;vet_approved	Hydroxylapatite	None	None	antagonist	yes
DB01133	Tiludronic acid	Bisphosphonates	approved;investigational;vet_approved	V-type proton ATPase catalytic subunit A	P38606	291868	inhibitor	unknown
DB01133	Tiludronic acid	Bisphosphonates	approved;investigational;vet_approved	Tyrosine-protein phosphatase non-receptor type 1	P18031	190742	inhibitor	unknown
DB01135	Doxacurium chloride	Other quaternary ammonium compounds	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB01135	Doxacurium chloride	Other quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	NADH dehydrogenase [ubiquinone] 1 subunit C2	O95298	4191346	inhibitor	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Vascular endothelial growth factor A	P15692	181971	other	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Natriuretic peptides B	P16860	179515	other	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Gap junction alpha-1 protein	P17302	29917	other	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Vascular cell adhesion protein 1	P19320	179886	inhibitor	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	E-selectin	P16581	182048	inhibitor	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Hypoxia-inducible factor 1-alpha	Q16665	None	modulator	unknown
DB01136	Carvedilol	Alpha and beta blocking agents	approved;investigational	Inward rectifier potassium channel 4	P48050	None	None	unknown
DB01137	Levofloxacin	Combinations of antibacterials	approved;investigational	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB01137	Levofloxacin	Combinations of antibacterials	approved;investigational	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB01137	Levofloxacin	Combinations of antibacterials	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB01138	Sulfinpyrazone	Preparations increasing uric acid excretion	approved	Canalicular multispecific organic anion transporter 1	Q92887	1764162	inhibitor	yes
DB01138	Sulfinpyrazone	Preparations increasing uric acid excretion	approved	Multidrug resistance-associated protein 1	P33527	1835659	inhibitor	yes
DB01138	Sulfinpyrazone	Preparations increasing uric acid excretion	approved	Solute carrier family 22 member 12	Q96S37	None	inhibitor	yes
DB01138	Sulfinpyrazone	Preparations increasing uric acid excretion	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	activator	unknown
DB01139	Cefapirin	First-generation cephalosporins	approved;vet_approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB01140	Cefadroxil	First-generation cephalosporins	approved;vet_approved;withdrawn	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB01140	Cefadroxil	First-generation cephalosporins	approved;vet_approved;withdrawn	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB01140	Cefadroxil	First-generation cephalosporins	approved;vet_approved;withdrawn	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB01140	Cefadroxil	First-generation cephalosporins	approved;vet_approved;withdrawn	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB01141	Micafungin	Other antimycotics for systemic use	approved;investigational	1,3-beta-glucan synthase component FKS1	A2QLK4	None	inhibitor	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Histamine H2 receptor	P25021	184088	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	yes
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	unknown
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 6	P50406	1162924	binder	unknown
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Histamine H4 receptor	Q9H3N8	10241847	binder	unknown
DB01142	Doxepin	Non-selective monoamine reuptake inhibitors	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB01143	Amifostine	Detoxifying agents for antineoplastic treatment	approved;investigational	Alkaline phosphatase, placental-like	P10696	178428	inducer	yes
DB01143	Amifostine	Detoxifying agents for antineoplastic treatment	approved;investigational	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	P22413	189650	inducer	unknown
DB01144	Diclofenamide	Carbonic anhydrase inhibitors	approved;investigational	Carbonic anhydrase 1	P00915	29600	inhibitor	yes
DB01144	Diclofenamide	Carbonic anhydrase inhibitors	approved;investigational	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB01144	Diclofenamide	Carbonic anhydrase inhibitors	approved;investigational	Carbonic anhydrase 4	P22748	179791	inhibitor	yes
DB01144	Diclofenamide	Carbonic anhydrase inhibitors	approved;investigational	Carbonic anhydrase 7	P43166	28192445	inhibitor	yes
DB01144	Diclofenamide	Carbonic anhydrase inhibitors	approved;investigational	Carbonic anhydrase 3	P07451	189053812	inhibitor	unknown
DB01145	Sulfoxone	Drugs for treatment of lepra	approved	Dihydropteroate synthetase	Q27738	505177	inhibitor	yes
DB01146	Diphenylpyraline	Aminoalkyl ethers	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01146	Diphenylpyraline	Aminoalkyl ethers	approved;investigational	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB01147	Cloxacillin	Beta-lactamase resistant penicillins	approved;investigational;vet_approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB01147	Cloxacillin	Beta-lactamase resistant penicillins	approved;investigational;vet_approved	Beta-lactamase	P00811	145267	inducer	unknown
DB01147	Cloxacillin	Beta-lactamase resistant penicillins	approved;investigational;vet_approved	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB01147	Cloxacillin	Beta-lactamase resistant penicillins	approved;investigational;vet_approved	Penicillin-binding protein 2B	P0A3M5	14973165	inhibitor	yes
DB01147	Cloxacillin	Beta-lactamase resistant penicillins	approved;investigational;vet_approved	Penicillin-binding protein 3	Q51504	None	inhibitor	yes
DB01147	Cloxacillin	Beta-lactamase resistant penicillins	approved;investigational;vet_approved	D-alanyl-D-alanine carboxypeptidase DacA	P0AEB3	None	inhibitor	unknown
DB01148	Flavoxate	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB01148	Flavoxate	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB01149	Nefazodone	Other antidepressants	approved;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01149	Nefazodone	Other antidepressants	approved;withdrawn	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB01149	Nefazodone	Other antidepressants	approved;withdrawn	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB01149	Nefazodone	Other antidepressants	approved;withdrawn	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	yes
DB01149	Nefazodone	Other antidepressants	approved;withdrawn	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB01149	Nefazodone	Other antidepressants	approved;withdrawn	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB01149	Nefazodone	Other antidepressants	approved;withdrawn	Alpha-1B adrenergic receptor	P35368	None	other/unknown	unknown
DB01149	Nefazodone	Other antidepressants	approved;withdrawn	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB01149	Nefazodone	Other antidepressants	approved;withdrawn	Alpha-1A adrenergic receptor	P35348	433201	antagonist	no
DB01149	Nefazodone	Other antidepressants	approved;withdrawn	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	antagonist	unknown
DB01150	Cefprozil	Second-generation cephalosporins	approved	Penicillin-binding protein 1A	Q04707	None	inhibitor	yes
DB01150	Cefprozil	Second-generation cephalosporins	approved	Penicillin-binding protein 2x	P14677	None	inhibitor	yes
DB01150	Cefprozil	Second-generation cephalosporins	approved	Penicillin-binding protein 2B	P0A3M5	14973165	inhibitor	yes
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	other	unknown
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Sphingomyelin phosphodiesterase	P17405	179095	inhibitor	unknown
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	no
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Alpha-1 adrenergic receptors	P25100	177807	antagonist	no
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	binder	unknown
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	binder	unknown
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	D(2) dopamine receptor	P14416	181432	binder	unknown
DB01151	Desipramine	Non-selective monoamine reuptake inhibitors	approved;investigational	Alpha-2 adrenergic receptors	P18825	178194	binder	unknown
DB01153	Sertaconazole	Imidazole and triazole derivatives	approved;investigational	Lanosterol 14-alpha demethylase	P10613	578119	inhibitor	yes
DB01154	Thiamylal	Barbiturates, combinations	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB01154	Thiamylal	Barbiturates, combinations	approved;vet_approved	ATP-sensitive inward rectifier potassium channel 8	Q15842	None	inhibitor	yes
DB01154	Thiamylal	Barbiturates, combinations	approved;vet_approved	ATP-sensitive inward rectifier potassium channel 11	Q14654	1088445	inhibitor	yes
DB01155	Gemifloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB01155	Gemifloxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB01156	Bupropion	Centrally acting antiobesity products	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB01156	Bupropion	Centrally acting antiobesity products	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB01156	Bupropion	Centrally acting antiobesity products	approved	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	antagonist	unknown
DB01157	Trimetrexate	Other agents against amoebiasis and other protozoal diseases	approved;investigational	Dihydrofolate reductase	P00374	182724	inhibitor	yes
DB01158	Bretylium	N/A	approved	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	inhibitor	yes
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Potassium channel subfamily K member 3	O14649	2465542	binder	yes
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Potassium channel subfamily K member 9	Q9NPC2	7546843	binder	yes
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Calcium-activated potassium channel subunit alpha-1	Q12791	537439	inhibitor	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Glutamate receptor ionotropic, NMDA 3B	O60391	3025446	antagonist	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Glutamate receptor ionotropic, NMDA 2A	Q12879	558749	antagonist	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Glycine receptor subunit alpha-1	P23415	31851	allosteric modulator	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Rhodopsin	P08100	1236137	other	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	G protein-activated inward rectifier potassium channel 2	P48051	1052875	inhibitor	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	G protein-activated inward rectifier potassium channel 1	P48549	1055028	inhibitor	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	NADH-ubiquinone oxidoreductase chain 1	P03886	13004	inhibitor	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Intermediate conductance calcium-activated potassium channel protein 4	O15554	2584866	inhibitor	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	ATP synthase subunit delta, mitochondrial	P30049	12586	other/unknown	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Calcium-transporting ATPase type 2C member 1	P98194	6715131	other/unknown	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	other/unknown	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2	P59768	20147633	other/unknown	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	Neuropeptide S receptor	Q6W5P4	34596864	other/unknown	unknown
DB01159	Halothane	Halogenated hydrocarbons	approved;vet_approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01160	Dinoprost Tromethamine	N/A	approved;vet_approved	Prostaglandin F2-alpha receptor	P43088	456564	agonist	yes
DB01160	Dinoprost Tromethamine	N/A	approved;vet_approved	Prostacyclin receptor	P43119	495043	antagonist	unknown
DB01161	Chloroprocaine	Esters of aminobenzoic acid	approved	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	yes
DB01161	Chloroprocaine	Esters of aminobenzoic acid	approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	unknown
DB01161	Chloroprocaine	Esters of aminobenzoic acid	approved	Neuronal acetylcholine receptor subunit alpha-10	Q9GZZ6	12053839	antagonist	unknown
DB01161	Chloroprocaine	Esters of aminobenzoic acid	approved	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB01161	Chloroprocaine	Esters of aminobenzoic acid	approved	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB01162	Terazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB01162	Terazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	yes
DB01162	Terazosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	yes
DB01162	Terazosin	Alpha-adrenoreceptor antagonists	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB01162	Terazosin	Alpha-adrenoreceptor antagonists	approved	Potassium voltage-gated channel subfamily H member 6	Q9H252	11878259	inhibitor	unknown
DB01162	Terazosin	Alpha-adrenoreceptor antagonists	approved	Potassium voltage-gated channel subfamily H member 7	Q9NS40	4104136	inhibitor	unknown
DB01164	Calcium Chloride	Calcium	approved	Protein S100-A13	Q99584	1694828	None	unknown
DB01165	Ofloxacin	Fluoroquinolones	approved	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB01165	Ofloxacin	Fluoroquinolones	approved	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB01165	Ofloxacin	Fluoroquinolones	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	unknown
DB01166	Cilostazol	Platelet aggregation inhibitors excl. heparin	approved;investigational	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	yes
DB01167	Itraconazole	Triazole derivatives	approved;investigational	Lanosterol 14-alpha demethylase	Q16850	1698396	inhibitor	yes
DB01167	Itraconazole	Triazole derivatives	approved;investigational	Lanosterol 14-alpha demethylase	P50859	755693	inhibitor	yes
DB01168	Procarbazine	Methylhydrazines	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB01168	Procarbazine	Methylhydrazines	approved;investigational	Monoamine oxidase	P27338	398415	inhibitor	yes
DB01169	Arsenic trioxide	Other antineoplastic agents	approved;investigational	Inhibitor of nuclear factor kappa-B kinase subunit beta	O14920	2599558	inducer	yes
DB01169	Arsenic trioxide	Other antineoplastic agents	approved;investigational	Thioredoxin reductase 1, cytoplasmic	Q16881	1237038	inhibitor	yes
DB01169	Arsenic trioxide	Other antineoplastic agents	approved;investigational	Transcription factor AP-1	P05412	386839	inducer	yes
DB01169	Arsenic trioxide	Other antineoplastic agents	approved;investigational	G1/S-specific cyclin-D1	P24385	35632	antagonist	yes
DB01169	Arsenic trioxide	Other antineoplastic agents	approved;investigational	Mitogen-activated protein kinase 3	P27361	31221	inducer	yes
DB01169	Arsenic trioxide	Other antineoplastic agents	approved;investigational	Mitogen-activated protein kinase 1	P28482	182191	inducer	yes
DB01169	Arsenic trioxide	Other antineoplastic agents	approved;investigational	RAC-alpha serine/threonine-protein kinase	P31749	190828	inducer	unknown
DB01169	Arsenic trioxide	Other antineoplastic agents	approved;investigational	Cyclin-dependent kinase inhibitor 1	P38936	None	None	unknown
DB01169	Arsenic trioxide	Other antineoplastic agents	approved;investigational	Histone deacetylase 1	Q13547	1277084	None	unknown
DB01169	Arsenic trioxide	Other antineoplastic agents	approved;investigational	Protein PML	P29590	None	None	unknown
DB01170	Guanethidine	Guanidine derivatives	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inducer	yes
DB01171	Moclobemide	Monoamine oxidase A inhibitors	approved;investigational	Amine oxidase [flavin-containing] A	P21397	187353	antagonist	yes
DB01171	Moclobemide	Monoamine oxidase A inhibitors	approved;investigational	Monoamine oxidase	P27338	398415	antagonist	unknown
DB01171	Moclobemide	Monoamine oxidase A inhibitors	approved;investigational	Amine oxidase [flavin-containing] B	P27338	398415	antagonist	unknown
DB01172	Kanamycin	Antibiotics	approved;investigational;vet_approved	30S ribosomal protein S12	P0A7S3	43010	inhibitor	yes
DB01172	Kanamycin	Antibiotics	approved;investigational;vet_approved	16S rRNA	None	None	inhibitor	yes
DB01173	Orphenadrine	Ethers, chemically close to antihistamines	approved	Glutamate receptor ionotropic, NMDA 2D	O15399	2444026	antagonist	yes
DB01173	Orphenadrine	Ethers, chemically close to antihistamines	approved	Glutamate receptor ionotropic, NMDA 1	Q05586	219920	antagonist	yes
DB01173	Orphenadrine	Ethers, chemically close to antihistamines	approved	Glutamate receptor ionotropic, NMDA 3B	O60391	3025446	antagonist	yes
DB01173	Orphenadrine	Ethers, chemically close to antihistamines	approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	yes
DB01173	Orphenadrine	Ethers, chemically close to antihistamines	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01173	Orphenadrine	Ethers, chemically close to antihistamines	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB01173	Orphenadrine	Ethers, chemically close to antihistamines	approved	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	inhibitor	unknown
DB01174	Phenobarbital	Barbiturates and derivatives	approved;investigational	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01174	Phenobarbital	Barbiturates and derivatives	approved;investigational	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB01174	Phenobarbital	Barbiturates and derivatives	approved;investigational	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB01174	Phenobarbital	Barbiturates and derivatives	approved;investigational	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB01174	Phenobarbital	Barbiturates and derivatives	approved;investigational	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB01174	Phenobarbital	Barbiturates and derivatives	approved;investigational	NMDA receptor	O60391	3025446	antagonist	unknown
DB01174	Phenobarbital	Barbiturates and derivatives	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	activator	unknown
DB01175	Escitalopram	Selective serotonin reuptake inhibitors	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB01175	Escitalopram	Selective serotonin reuptake inhibitors	approved;investigational	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	unknown
DB01175	Escitalopram	Selective serotonin reuptake inhibitors	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB01175	Escitalopram	Selective serotonin reuptake inhibitors	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB01175	Escitalopram	Selective serotonin reuptake inhibitors	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB01175	Escitalopram	Selective serotonin reuptake inhibitors	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB01176	Cyclizine	Piperazine derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01176	Cyclizine	Piperazine derivatives	approved	Estrogen sulfotransferase	P49888	488283	inhibitor	unknown
DB01177	Idarubicin	Anthracyclines and related substances	approved	DNA	None	None	intercalation	yes
DB01177	Idarubicin	Anthracyclines and related substances	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB01178	Chlormezanone	Oxazol, thiazine, and triazine derivatives	approved;investigational;withdrawn	Translocator protein	P30536	306883	agonist	yes
DB01179	Podofilox	Antivirals	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB01179	Podofilox	Antivirals	approved	Tubulin alpha-4A chain	P68366	32015	inhibitor	yes
DB01179	Podofilox	Antivirals	approved	Tubulin beta chain	P07437	338695	inhibitor	yes
DB01180	Rescinnamine	Rauwolfia alkaloids	approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB01181	Ifosfamide	Nitrogen mustard analogues	approved	DNA	None	None	other/unknown	yes
DB01181	Ifosfamide	Nitrogen mustard analogues	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB01182	Propafenone	Antiarrhythmics, class Ic	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB01182	Propafenone	Antiarrhythmics, class Ic	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	yes
DB01182	Propafenone	Antiarrhythmics, class Ic	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	unknown
DB01182	Propafenone	Antiarrhythmics, class Ic	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB01183	Naloxone	Antidotes	approved;vet_approved	Mu-type opioid receptor	P35372	452073	antagonist	yes
DB01183	Naloxone	Antidotes	approved;vet_approved	Delta-type opioid receptor	P41143	27545517	antagonist	yes
DB01183	Naloxone	Antidotes	approved;vet_approved	Kappa-type opioid receptor	P41145	532060	antagonist	yes
DB01183	Naloxone	Antidotes	approved;vet_approved	Cyclic AMP-responsive element-binding protein 1	P16220	240429	other/unknown	no
DB01183	Naloxone	Antidotes	approved;vet_approved	Estrogen receptor alpha	P03372	31234	antagonist	no
DB01183	Naloxone	Antidotes	approved;vet_approved	Toll-like receptor 4	O00206	None	inhibitor	unknown
DB01183	Naloxone	Antidotes	approved;vet_approved	Liver carboxylesterase 1	P23141	None	None	unknown
DB01184	Domperidone	Propulsives	approved;investigational;vet_approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01184	Domperidone	Propulsives	approved;investigational;vet_approved	D(3) dopamine receptor	P35462	927342	antagonist	yes
DB01185	Fluoxymesterone	3-oxoandrosten (4) derivatives	approved;illicit	Androgen receptor	P10275	178628	agonist	yes
DB01185	Fluoxymesterone	3-oxoandrosten (4) derivatives	approved;illicit	Estrogen receptor alpha	P03372	31234	antagonist	yes
DB01185	Fluoxymesterone	3-oxoandrosten (4) derivatives	approved;illicit	Prolactin receptor	P16471	190362	antagonist	yes
DB01185	Fluoxymesterone	3-oxoandrosten (4) derivatives	approved;illicit	Glucocorticoid receptor	P04150	31680	antagonist	unknown
DB01185	Fluoxymesterone	3-oxoandrosten (4) derivatives	approved;illicit	Corticosteroid 11-beta-dehydrogenase isozyme 2	P80365	565082	inhibitor	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	D(2) dopamine receptor	P14416	181432	agonist	yes
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	D(3) dopamine receptor	P35462	927342	agonist	yes
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	D(4) dopamine receptor	P21917	291946	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	5-hydroxytryptamine receptor 2B	P41595	475198	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	Alpha-2B adrenergic receptor	P18089	178198	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	Alpha-2A adrenergic receptor	P08913	178196	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	Alpha-2C adrenergic receptor	P18825	178194	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	D(1B) dopamine receptor	P21918	32049	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	D(1A) dopamine receptor	P21728	30397	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	Alpha-1A adrenergic receptor	P35348	433201	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	Alpha-1B adrenergic receptor	P35368	None	agonist	unknown
DB01186	Pergolide	Dopamine agonists	approved;investigational;vet_approved;withdrawn	Alpha-1D adrenergic receptor	P25100	177807	agonist	unknown
DB01188	Ciclopirox	Other antiinfectives and antiseptics	approved;investigational	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	binder	yes
DB01189	Desflurane	Halogenated hydrocarbons	approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01189	Desflurane	Halogenated hydrocarbons	approved	Glycine receptor subunit alpha-1	P23415	31851	agonist	yes
DB01189	Desflurane	Halogenated hydrocarbons	approved	Glutamate receptor 1	P42261	183281	antagonist	yes
DB01189	Desflurane	Halogenated hydrocarbons	approved	Potassium voltage-gated channel subfamily A member 1	Q09470	186663	inducer	yes
DB01189	Desflurane	Halogenated hydrocarbons	approved	Calcium-transporting ATPase type 2C member 1	P98194	6715131	inhibitor	yes
DB01189	Desflurane	Halogenated hydrocarbons	approved	ATP synthase subunit delta, mitochondrial	P30049	12586	other/unknown	unknown
DB01189	Desflurane	Halogenated hydrocarbons	approved	NADH-ubiquinone oxidoreductase chain 1	P03886	13004	unknown	unknown
DB01190	Clindamycin	Lincosamides	approved;vet_approved	50S ribosomal protein L10	P0A7J6	24054563	inhibitor	yes
DB01190	Clindamycin	Lincosamides	approved;vet_approved	23S rRNA	None	None	inhibitor	yes
DB01191	Dexfenfluramine	Centrally acting antiobesity products	approved;illicit;investigational;withdrawn	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB01191	Dexfenfluramine	Centrally acting antiobesity products	approved;illicit;investigational;withdrawn	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	unknown
DB01192	Oxymorphone	N/A	approved;investigational;vet_approved	Mu-type opioid receptor	P35372	452073	agonist	yes
DB01192	Oxymorphone	N/A	approved;investigational;vet_approved	Delta-type opioid receptor	P41143	27545517	antagonist	unknown
DB01193	Acebutolol	Beta blocking agents, selective	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	partial agonist	yes
DB01193	Acebutolol	Beta blocking agents, selective	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	partial agonist	unknown
DB01194	Brinzolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB01194	Brinzolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB01194	Brinzolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 4	P22748	179791	inhibitor	unknown
DB01194	Brinzolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 5A, mitochondrial	P35218	306483	inhibitor	unknown
DB01194	Brinzolamide	Carbonic anhydrase inhibitors	approved	Carbonic anhydrase 3	P07451	189053812	inhibitor	unknown
DB01195	Flecainide	Antiarrhythmics, class Ic	approved;withdrawn	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB01195	Flecainide	Antiarrhythmics, class Ic	approved;withdrawn	Sodium channel protein type 4 subunit alpha	P35499	338213	inhibitor	yes
DB01195	Flecainide	Antiarrhythmics, class Ic	approved;withdrawn	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB01196	Estramustine	Other antineoplastic agents	approved;investigational	Microtubule-associated protein 2	P11137	409875	antagonist	yes
DB01196	Estramustine	Other antineoplastic agents	approved;investigational	Microtubule-associated protein 1A	P78559	1790878	antagonist	yes
DB01196	Estramustine	Other antineoplastic agents	approved;investigational	Estrogen receptor alpha	P03372	31234	agonist	yes
DB01196	Estramustine	Other antineoplastic agents	approved;investigational	Estrogen receptor beta	Q92731	2911152	other/unknown	yes
DB01197	Captopril	ACE inhibitors, plain	approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB01197	Captopril	ACE inhibitors, plain	approved	72 kDa type IV collagenase	P08253	180671	inhibitor	unknown
DB01197	Captopril	ACE inhibitors, plain	approved	Matrix metalloproteinase-9	P14780	177205	inhibitor	unknown
DB01197	Captopril	ACE inhibitors, plain	approved	Leukotriene A-4 hydrolase	P09960	976396	inhibitor	unknown
DB01197	Captopril	ACE inhibitors, plain	approved	B1 bradykinin receptor	P46663	None	None	unknown
DB01198	Zopiclone	Benzodiazepine related drugs	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01198	Zopiclone	Benzodiazepine related drugs	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01198	Zopiclone	Benzodiazepine related drugs	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01198	Zopiclone	Benzodiazepine related drugs	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01198	Zopiclone	Benzodiazepine related drugs	approved	Translocator protein	P30536	306883	agonist	unknown
DB01199	Tubocurarine	Curare alkaloids	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB01199	Tubocurarine	Curare alkaloids	approved	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	yes
DB01199	Tubocurarine	Curare alkaloids	approved	Acetylcholinesterase	P22303	177975	inhibitor	unknown
DB01199	Tubocurarine	Curare alkaloids	approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	None	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	D(2) dopamine receptor	P14416	181432	agonist	yes
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	D(3) dopamine receptor	P35462	927342	agonist	yes
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	D(1B) dopamine receptor	P21918	32049	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	D(1A) dopamine receptor	P21728	30397	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	agonist	unknown
DB01200	Bromocriptine	Prolactine inhibitors	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB01201	Rifapentine	Antibiotics	approved;investigational	DNA-directed RNA polymerase subunit beta'	P9WGY7	None	inhibitor	yes
DB01202	Levetiracetam	Other antiepileptics	approved;investigational	Synaptic vesicle glycoprotein 2A	Q7L0J3	40788343	agonist	yes
DB01202	Levetiracetam	Other antiepileptics	approved;investigational	Voltage-dependent N-type calcium channel subunit alpha-1B	Q00975	179758	inhibitor	yes
DB01203	Nadolol	Beta blocking agents, non-selective	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB01203	Nadolol	Beta blocking agents, non-selective	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB01204	Mitoxantrone	Anthracyclines and related substances	approved;investigational	DNA	None	None	intercalation	yes
DB01204	Mitoxantrone	Anthracyclines and related substances	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB01205	Flumazenil	Antidotes	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	antagonist	yes
DB01205	Flumazenil	Antidotes	approved	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	antagonist	yes
DB01205	Flumazenil	Antidotes	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	antagonist	yes
DB01205	Flumazenil	Antidotes	approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01206	Lomustine	Nitrosoureas	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB01206	Lomustine	Nitrosoureas	approved;investigational	Stathmin-4	Q9H169	12274941	antagonist	unknown
DB01207	Ridogrel	N/A	approved	Thromboxane A2 receptor	P21731	533326	antagonist	yes
DB01207	Ridogrel	N/A	approved	Thromboxane-A synthase	P24557	338704	inhibitor	yes
DB01208	Sparfloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB01208	Sparfloxacin	Fluoroquinolones	approved;investigational	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB01208	Sparfloxacin	Fluoroquinolones	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB01209	Dezocine	Other opioids	approved;investigational	Mu-type opioid receptor	P35372	452073	agonist	yes
DB01209	Dezocine	Other opioids	approved;investigational	Kappa-type opioid receptor	P41145	532060	antagonist	yes
DB01210	Levobunolol	Beta blocking agents	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	yes
DB01210	Levobunolol	Beta blocking agents	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB01211	Clarithromycin	Combinations for eradication of Helicobacter pylori	approved	50S ribosomal protein L10	P0A7J6	24054563	inhibitor	yes
DB01211	Clarithromycin	Combinations for eradication of Helicobacter pylori	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	None	unknown
DB01211	Clarithromycin	Combinations for eradication of Helicobacter pylori	approved	Solute carrier organic anion transporter family member 1B1	Q9Y6L6	5051630	None	unknown
DB01211	Clarithromycin	Combinations for eradication of Helicobacter pylori	approved	Solute carrier organic anion transporter family member 1B3	Q9NPD5	9187497	None	unknown
DB01212	Ceftriaxone	Third-generation cephalosporins	approved	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB01212	Ceftriaxone	Third-generation cephalosporins	approved	Solute carrier family 22 member 11	Q9NSA0	7707622	None	unknown
DB01212	Ceftriaxone	Third-generation cephalosporins	approved	Solute carrier family 22 member 6	Q4U2R8	3831566	None	unknown
DB01212	Ceftriaxone	Third-generation cephalosporins	approved	Solute carrier family 22 member 8	Q8TCC7	4378059	None	unknown
DB01212	Ceftriaxone	Third-generation cephalosporins	approved	Solute carrier family 15 member 1	P46059	773588	None	unknown
DB01213	Fomepizole	Antidotes	approved;vet_approved	Alcohol dehydrogenase 1A	P07327	178092	inhibitor	yes
DB01213	Fomepizole	Antidotes	approved;vet_approved	Alcohol dehydrogenase 1B	P00325	178098	inhibitor	yes
DB01213	Fomepizole	Antidotes	approved;vet_approved	Alcohol dehydrogenase 1C	P00326	28404	inhibitor	yes
DB01213	Fomepizole	Antidotes	approved;vet_approved	Catalase	P04040	1228085	inhibitor	yes
DB01214	Metipranolol	Beta blocking agents, non-selective, and thiazides	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	yes
DB01214	Metipranolol	Beta blocking agents, non-selective, and thiazides	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB01215	Estazolam	Benzodiazepine derivatives	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01216	Finasteride	Other dermatologicals	approved	3-oxo-5-alpha-steroid 4-dehydrogenase 2	P31213	338469	inhibitor	yes
DB01216	Finasteride	Other dermatologicals	approved	3-oxo-5-alpha-steroid 4-dehydrogenase 1	P18405	177767	inhibitor	unknown
DB01216	Finasteride	Other dermatologicals	approved	3-oxo-5-beta-steroid 4-dehydrogenase	P51857	431857	inhibitor	unknown
DB01217	Anastrozole	Aromatase inhibitors	approved;investigational	Cytochrome P450 19A1	P11511	179002	inhibitor	yes
DB01218	Halofantrine	Other antimalarials	approved	Fe(II)-protoporphyrin IX	None	None	antagonist	yes
DB01218	Halofantrine	Other antimalarials	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	yes
DB01218	Halofantrine	Other antimalarials	approved	Plasmepsin-2	P46925	858754	inhibitor	unknown
DB01219	Dantrolene	Dantrolene and derivatives	approved;investigational	Ryanodine receptor 1	P21817	337722	antagonist	yes
DB01220	Rifaximin	Antibiotics	approved;investigational	DNA-directed RNA polymerase subunit beta	P0A8V2	42818	inhibitor	yes
DB01220	Rifaximin	Antibiotics	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	agonist	no
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	antagonist	yes
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	Substance-P receptor	P25103	8176544	antagonist	unknown
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	D(2) dopamine receptor	P14416	181432	agonist	unknown
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	Delta-type opioid receptor	P41143	27545517	binder	unknown
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	Mu-type opioid receptor	P35372	452073	binder	unknown
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	Muscarinic acetylcholine receptor	P08912	177988	binder	unknown
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	5-hydroxytryptamine receptor 2	P28335	338028	antagonist	unknown
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	5-hydroxytryptamine receptor 1	P30939	307420	antagonist	unknown
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	5-hydroxytryptamine receptor 3A	P46098	681914	potentiator	yes
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	Alpha-7 nicotinic cholinergic receptor subunit	Q693P7	None	antagonist	yes
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	Cholinesterase	P06276	1311630	inhibitor	yes
DB01221	Ketamine	Other general anesthetics	approved;vet_approved	Nitric oxide synthase, brain	P29475	642526	inhibitor	yes
DB01222	Budesonide	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved	Glucocorticoid receptor	P04150	31680	antagonist	yes
DB01223	Aminophylline	Xanthines	approved	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	yes
DB01223	Aminophylline	Xanthines	approved	Adenosine receptor A1	P30542	256155	antagonist	yes
DB01223	Aminophylline	Xanthines	approved	Adenosine receptor A3	P0DMS8	349449	antagonist	yes
DB01223	Aminophylline	Xanthines	approved	Histone deacetylase 2	Q92769	1667394	activator	yes
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1B	P28222	219679	other/unknown	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1D	P28221	177772	other/unknown	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1E	P28566	177774	other/unknown	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 3A	P46098	681914	other/unknown	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 6	P50406	1162924	other/unknown	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(1B) dopamine receptor	P21918	32049	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB01224	Quetiapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB01225	Enoxaparin	Heparin group	approved	Antithrombin-III	P01008	179161	potentiator	yes
DB01225	Enoxaparin	Heparin group	approved	Coagulation factor X	P00742	182841	inhibitor	yes
DB01226	Mivacurium	Other quaternary ammonium compounds	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB01226	Mivacurium	Other quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB01226	Mivacurium	Other quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB01226	Mivacurium	Other quaternary ammonium compounds	approved	Cholinesterase	P06276	1311630	None	unknown
DB01227	Levomethadyl Acetate	Drugs used in opioid dependence	approved;investigational	Mu-type opioid receptor	P35372	452073	agonist	yes
DB01227	Levomethadyl Acetate	Drugs used in opioid dependence	approved;investigational	Neuronal acetylcholine receptor subunit beta-4	P30926	1458126	other/unknown	unknown
DB01227	Levomethadyl Acetate	Drugs used in opioid dependence	approved;investigational	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	antagonist	unknown
DB01228	Encainide	Antiarrhythmics, class Ic	approved;investigational;withdrawn	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB01229	Paclitaxel	Taxanes	approved;vet_approved	Tubulin beta-1 chain	Q9H4B7	11230445	inhibitor	yes
DB01229	Paclitaxel	Taxanes	approved;vet_approved	Apoptosis regulator Bcl-2	P10415	179367	inhibitor	yes
DB01229	Paclitaxel	Taxanes	approved;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	inducer	unknown
DB01229	Paclitaxel	Taxanes	approved;vet_approved	Microtubule-associated protein 4	P27816	None	None	yes
DB01229	Paclitaxel	Taxanes	approved;vet_approved	Microtubule-associated protein 2	P11137	409875	None	yes
DB01229	Paclitaxel	Taxanes	approved;vet_approved	Microtubule-associated protein tau	P10636	None	None	yes
DB01231	Diphenidol	N/A	approved;investigational;withdrawn	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB01231	Diphenidol	N/A	approved;investigational;withdrawn	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB01231	Diphenidol	N/A	approved;investigational;withdrawn	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB01232	Saquinavir	Protease inhibitors	approved;investigational	Human immunodeficiency virus type 1 protease	Q72874	None	inhibitor	yes
DB01233	Metoclopramide	Propulsives	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01233	Metoclopramide	Propulsives	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	agonist	yes
DB01233	Metoclopramide	Propulsives	approved;investigational	5-hydroxytryptamine receptor 4	Q13639	2661757	agonist	unknown
DB01233	Metoclopramide	Propulsives	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	agonist	unknown
DB01233	Metoclopramide	Propulsives	approved;investigational	Acetylcholinesterase	P22303	177975	inhibitor	unknown
DB01234	Dexamethasone	Corticosteroids	approved;investigational;vet_approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB01234	Dexamethasone	Corticosteroids	approved;investigational;vet_approved	Nuclear receptor subfamily 0 group B member 1	P51843	786532	stimulator	unknown
DB01234	Dexamethasone	Corticosteroids	approved;investigational;vet_approved	Annexin A1	P04083	12654863	agonist	unknown
DB01234	Dexamethasone	Corticosteroids	approved;investigational;vet_approved	Nitric oxide synthase, inducible	P35228	292242	negative modulator	unknown
DB01234	Dexamethasone	Corticosteroids	approved;investigational;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB01235	Levodopa	Dopa and dopa derivatives	approved	D(1A) dopamine receptor	P21728	30397	agonist	yes
DB01235	Levodopa	Dopa and dopa derivatives	approved	D(1B) dopamine receptor	P21918	32049	agonist	yes
DB01235	Levodopa	Dopa and dopa derivatives	approved	D(2) dopamine receptor	P14416	181432	agonist	yes
DB01235	Levodopa	Dopa and dopa derivatives	approved	D(3) dopamine receptor	P35462	927342	agonist	yes
DB01235	Levodopa	Dopa and dopa derivatives	approved	D(4) dopamine receptor	P21917	291946	agonist	yes
DB01236	Sevoflurane	Halogenated hydrocarbons	approved;vet_approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB01236	Sevoflurane	Halogenated hydrocarbons	approved;vet_approved	Glycine receptor subunit alpha-1	P23415	31851	agonist	yes
DB01236	Sevoflurane	Halogenated hydrocarbons	approved;vet_approved	Glutamate receptor 1	P42261	183281	antagonist	yes
DB01236	Sevoflurane	Halogenated hydrocarbons	approved;vet_approved	Potassium voltage-gated channel subfamily A member 1	Q09470	186663	inducer	yes
DB01236	Sevoflurane	Halogenated hydrocarbons	approved;vet_approved	Calcium-transporting ATPase type 2C member 1	P98194	6715131	inhibitor	yes
DB01236	Sevoflurane	Halogenated hydrocarbons	approved;vet_approved	ATP synthase subunit delta, mitochondrial	P30049	12586	other/unknown	unknown
DB01236	Sevoflurane	Halogenated hydrocarbons	approved;vet_approved	NADH-ubiquinone oxidoreductase chain 1	P03886	13004	unknown	unknown
DB01236	Sevoflurane	Halogenated hydrocarbons	approved;vet_approved	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01237	Bromodiphenhydramine	Aminoalkyl ethers	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 1E	P28566	177774	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 6	P50406	1162924	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	D(1B) dopamine receptor	P21918	32049	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	no
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	no
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	no
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	no
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	antagonist	no
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	antagonist	no
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB01238	Aripiprazole	Other antipsychotics	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	D(3) dopamine receptor	P35462	927342	antagonist	yes
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	yes
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	no
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	no
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB01239	Chlorprothixene	Thioxanthene derivatives	approved;investigational;withdrawn	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB01240	Epoprostenol	Platelet aggregation inhibitors excl. heparin	approved	P2Y purinoceptor 12	Q9H244	12083902	agonist	yes
DB01240	Epoprostenol	Platelet aggregation inhibitors excl. heparin	approved	Prostacyclin receptor	P43119	495043	agonist	yes
DB01240	Epoprostenol	Platelet aggregation inhibitors excl. heparin	approved	Prostacyclin synthase	Q16647	10944956	inducer	yes
DB01241	Gemfibrozil	Fibrates	approved	Peroxisome proliferator-activated receptor alpha	Q07869	307341	agonist	yes
DB01242	Clomipramine	Non-selective monoamine reuptake inhibitors	approved;investigational;vet_approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB01242	Clomipramine	Non-selective monoamine reuptake inhibitors	approved;investigational;vet_approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01242	Clomipramine	Non-selective monoamine reuptake inhibitors	approved;investigational;vet_approved	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	yes
DB01242	Clomipramine	Non-selective monoamine reuptake inhibitors	approved;investigational;vet_approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB01242	Clomipramine	Non-selective monoamine reuptake inhibitors	approved;investigational;vet_approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB01242	Clomipramine	Non-selective monoamine reuptake inhibitors	approved;investigational;vet_approved	Glutathione S-transferase P	P09211	31946	inhibitor	unknown
DB01244	Bepridil	Phenylalkylamine derivatives	approved;withdrawn	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	O00555	2213913	inhibitor	yes
DB01244	Bepridil	Phenylalkylamine derivatives	approved;withdrawn	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	inhibitor	yes
DB01244	Bepridil	Phenylalkylamine derivatives	approved;withdrawn	Voltage-dependent calcium channel subunit alpha-2/delta-2	Q9NY47	None	inhibitor	yes
DB01244	Bepridil	Phenylalkylamine derivatives	approved;withdrawn	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	inhibitor	unknown
DB01244	Bepridil	Phenylalkylamine derivatives	approved;withdrawn	Potassium voltage-gated channel subfamily KQT member 1	P51787	2465531	inhibitor	unknown
DB01244	Bepridil	Phenylalkylamine derivatives	approved;withdrawn	Troponin C, slow skeletal and cardiac muscles	P63316	37208	other	unknown
DB01244	Bepridil	Phenylalkylamine derivatives	approved;withdrawn	Calmodulin	P0DP23	179888	binder	unknown
DB01244	Bepridil	Phenylalkylamine derivatives	approved;withdrawn	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	Q01064	None	inhibitor	unknown
DB01244	Bepridil	Phenylalkylamine derivatives	approved;withdrawn	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	P54750	1151109	inhibitor	unknown
DB01244	Bepridil	Phenylalkylamine derivatives	approved;withdrawn	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB01245	Decamethonium	N/A	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	partial agonist	yes
DB01245	Decamethonium	N/A	approved	Acetylcholinesterase	P22303	177975	inhibitor	unknown
DB01245	Decamethonium	N/A	approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB01245	Decamethonium	N/A	approved	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	None	unknown
DB01246	Alimemazine	Phenothiazine derivatives	approved;vet_approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01247	Isocarboxazid	Monoamine oxidase inhibitors, non-selective	approved	Amine oxidase [flavin-containing] A	P21397	187353	inhibitor	yes
DB01247	Isocarboxazid	Monoamine oxidase inhibitors, non-selective	approved	Amine oxidase [flavin-containing] B	P27338	398415	inhibitor	yes
DB01248	Docetaxel	Taxanes	approved;investigational	Tubulin beta-1 chain	Q9H4B7	11230445	None	yes
DB01248	Docetaxel	Taxanes	approved;investigational	Apoptosis regulator Bcl-2	P10415	179367	None	unknown
DB01248	Docetaxel	Taxanes	approved;investigational	Microtubule-associated protein 2	P11137	409875	None	yes
DB01248	Docetaxel	Taxanes	approved;investigational	Microtubule-associated protein 4	P27816	None	None	yes
DB01248	Docetaxel	Taxanes	approved;investigational	Microtubule-associated protein tau	P10636	None	None	yes
DB01248	Docetaxel	Taxanes	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	binder	unknown
DB01250	Olsalazine	Aminosalicylic acid and similar agents	approved	Thiopurine S-methyltransferase	P51580	386420	inhibitor	yes
DB01250	Olsalazine	Aminosalicylic acid and similar agents	approved	Interferon gamma	P01579	32692	None	yes
DB01251	Gliquidone	Sulfonylureas	approved;investigational	ATP-binding cassette sub-family C member 8	Q09428	1374919	inhibitor	yes
DB01251	Gliquidone	Sulfonylureas	approved;investigational	ATP-sensitive inward rectifier potassium channel 8	Q15842	None	inhibitor	yes
DB01252	Mitiglinide	Other blood glucose lowering drugs, excl. insulins	approved;investigational	ATP-binding cassette sub-family C member 8	Q09428	1374919	inhibitor	yes
DB01252	Mitiglinide	Other blood glucose lowering drugs, excl. insulins	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	unknown
DB01253	Ergonovine	Ergot alkaloids	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase ABL1	P00519	28237	multitarget	yes
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Proto-oncogene tyrosine-protein kinase Src	P12931	10635153	multitarget	yes
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Ephrin type-A receptor 2	P29317	181944	antagonist	yes
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase Lck	P06239	36808	multitarget	yes
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase Yes	P07947	181268	inhibitor	yes
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Mast/stem cell growth factor receptor Kit	P10721	34085	antagonist	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Platelet-derived growth factor receptor beta	P09619	189732	antagonist	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Signal transducer and activator of transcription 5B	P51692	6981726	inhibitor	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Abelson tyrosine-protein kinase 2	P42684	178993	multitarget	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase Fyn	P06241	338228	multitarget	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase BTK	Q06187	312467	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Nuclear receptor subfamily 4 group A member 3	Q92570	None	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Breakpoint cluster region protein	P11274	None	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase CSK	P41240	30315	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Ephrin type-A receptor 5	P54756	None	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Ephrin type-B receptor 4	P54760	None	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase Fgr	P09769	None	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase FRK	P42685	None	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Heat shock cognate 71 kDa protein	P11142	11526573	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase Lyn	P07948	307144	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Mitogen-activated protein kinase kinase kinase MLT	Q9NYL2	None	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Mitogen-activated protein kinase 14	Q16539	603917	None	unknown
DB01254	Dasatinib	Protein kinase inhibitors	approved;investigational	Amidophosphoribosyltransferase	Q06203	219459	None	unknown
DB01255	Lisdexamfetamine	Centrally acting sympathomimetics	approved;investigational	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB01255	Lisdexamfetamine	Centrally acting sympathomimetics	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB01256	Retapamulin	Other antibiotics for topical use	approved	50S ribosomal protein L3	Q9A1X4	13621367	inhibitor	yes
DB01257	Eculizumab	Selective immunosuppressants	approved;investigational	Complement C5	P01031	179983	antibody	yes
DB01259	Lapatinib	Protein kinase inhibitors	approved;investigational	Epidermal growth factor receptor	P00533	757924	antagonist	yes
DB01259	Lapatinib	Protein kinase inhibitors	approved;investigational	Receptor tyrosine-protein kinase erbB-2	P04626	553282	antagonist	yes
DB01260	Desonide	Corticosteroids, moderately potent, combinations with antiseptics	approved;investigational	Glucocorticoid receptor	P04150	31680	agonist	yes
DB01261	Sitagliptin	Dipeptidyl peptidase 4 (DPP-4) inhibitors	approved;investigational	Dipeptidyl peptidase 4	P27487	535388	inhibitor	yes
DB01262	Decitabine	Pyrimidine analogues	approved;investigational	DNA	None	None	other/unknown	yes
DB01262	Decitabine	Pyrimidine analogues	approved;investigational	DNA (cytosine-5)-methyltransferase 1	P26358	1632819	inhibitor	yes
DB01263	Posaconazole	Triazole derivatives	approved;investigational;vet_approved	Lanosterol 14-alpha demethylase	P10613	578119	antagonist	yes
DB01264	Darunavir	Antivirals for treatment of HIV infections, combinations	approved	Human immunodeficiency virus type 1 protease	Q72874	None	inhibitor	yes
DB01265	Telbivudine	Nucleoside and nucleotide reverse transcriptase inhibitors	approved;investigational	Protein P	Q05486	59427	None	yes
DB01265	Telbivudine	Nucleoside and nucleotide reverse transcriptase inhibitors	approved;investigational	DNA	None	None	None	yes
DB01267	Paliperidone	Other antipsychotics	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01267	Paliperidone	Other antipsychotics	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01267	Paliperidone	Other antipsychotics	approved	Histamine H1 receptor	P35367	510296	agonist	unknown
DB01267	Paliperidone	Other antipsychotics	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB01267	Paliperidone	Other antipsychotics	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB01267	Paliperidone	Other antipsychotics	approved	D(4) dopamine receptor	P21917	291946	antagonist	yes
DB01267	Paliperidone	Other antipsychotics	approved	5-hydroxytryptamine receptor 1D	P28221	177772	antagonist	unknown
DB01267	Paliperidone	Other antipsychotics	approved	D(3) dopamine receptor	P35462	927342	antagonist	yes
DB01267	Paliperidone	Other antipsychotics	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB01267	Paliperidone	Other antipsychotics	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB01267	Paliperidone	Other antipsychotics	approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB01267	Paliperidone	Other antipsychotics	approved	Alpha-2C adrenergic receptor	P18825	178194	agonist	unknown
DB01267	Paliperidone	Other antipsychotics	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB01267	Paliperidone	Other antipsychotics	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB01267	Paliperidone	Other antipsychotics	approved	Cytochrome P450 3A4	P08684	None	None	unknown
DB01267	Paliperidone	Other antipsychotics	approved	Cytochrome P450 2D6	P10635	181350	None	unknown
DB01267	Paliperidone	Other antipsychotics	approved	Cytochrome P450 3A5	P20815	181346	None	unknown
DB01267	Paliperidone	Other antipsychotics	approved	5-hydroxytryptamine receptor 7	P34969	1857143	None	unknown
DB01268	Sunitinib	Protein kinase inhibitors	approved;investigational	Platelet-derived growth factor receptor beta	P09619	189732	inhibitor	yes
DB01268	Sunitinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 1	P17948	31432	inhibitor	yes
DB01268	Sunitinib	Protein kinase inhibitors	approved;investigational	Mast/stem cell growth factor receptor Kit	P10721	34085	inhibitor	yes
DB01268	Sunitinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 2	P35968	2655412	inhibitor	yes
DB01268	Sunitinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 3	P35916	297050	inhibitor	yes
DB01268	Sunitinib	Protein kinase inhibitors	approved;investigational	Receptor-type tyrosine-protein kinase FLT3	P36888	409573	inhibitor	yes
DB01268	Sunitinib	Protein kinase inhibitors	approved;investigational	Macrophage colony-stimulating factor 1 receptor	P07333	553224	inhibitor	yes
DB01268	Sunitinib	Protein kinase inhibitors	approved;investigational	Platelet-derived growth factor receptor alpha	P16234	189734	inhibitor	yes
DB01269	Panitumumab	Monoclonal antibodies	approved;investigational	Epidermal growth factor receptor	P00533	757924	suppressor	yes
DB01270	Ranibizumab	Antineovascularisation agents	approved	Vascular endothelial growth factor A	P15692	181971	None	yes
DB01271	Idursulfase	Enzymes	approved	Dermatan sulfate	None	None	None	yes
DB01271	Idursulfase	Enzymes	approved	Heparan sulfate	None	None	None	yes
DB01271	Idursulfase	Enzymes	approved	Perilipin-3	O60664	3095186	None	no
DB01272	Alglucosidase alfa	Enzymes	approved	Cation-dependent mannose-6-phosphate receptor	P20645	None	binder	yes
DB01272	Alglucosidase alfa	Enzymes	approved	Glycogen	None	None	cleavage	yes
DB01273	Varenicline	Drugs used in nicotine dependence	approved;investigational	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	partial agonist	yes
DB01273	Varenicline	Drugs used in nicotine dependence	approved;investigational	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	agonist	unknown
DB01273	Varenicline	Drugs used in nicotine dependence	approved;investigational	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	partial agonist	unknown
DB01273	Varenicline	Drugs used in nicotine dependence	approved;investigational	Neuronal acetylcholine receptor subunit alpha-6	Q15825	1458118	partial agonist	unknown
DB01273	Varenicline	Drugs used in nicotine dependence	approved;investigational	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	partial agonist	unknown
DB01274	Arformoterol	N/A	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB01275	Hydralazine	Hydrazinophthalazine derivatives	approved	Membrane primary amine oxidase	Q16853	1399032	inhibitor	yes
DB01275	Hydralazine	Hydrazinophthalazine derivatives	approved	Prolyl 4-hydroxylase subunit alpha-1	P13674	190786	inhibitor	unknown
DB01276	Exenatide	Other blood glucose lowering drugs, excl. insulins	approved;investigational	Glucagon-like peptide 1 receptor	P43220	405082	agonist	yes
DB01277	Mecasermin	Somatropin and somatropin agonists	approved;investigational	Insulin-like growth factor 1 receptor	P08069	804990	agonist	yes
DB01277	Mecasermin	Somatropin and somatropin agonists	approved;investigational	Insulin-like growth factor-binding protein 3	P17936	183116	None	unknown
DB01277	Mecasermin	Somatropin and somatropin agonists	approved;investigational	Insulin receptor	P06213	307070	None	unknown
DB01277	Mecasermin	Somatropin and somatropin agonists	approved;investigational	Cation-independent mannose-6-phosphate receptor	P11717	33055	None	unknown
DB01278	Pramlintide	Other blood glucose lowering drugs, excl. insulins	approved;investigational	Calcitonin receptor	P30988	179880	agonist	yes
DB01278	Pramlintide	Other blood glucose lowering drugs, excl. insulins	approved;investigational	Receptor activity-modifying protein 1	O60894	3171910	agonist	yes
DB01278	Pramlintide	Other blood glucose lowering drugs, excl. insulins	approved;investigational	Receptor activity-modifying protein 2	O60895	3171912	agonist	yes
DB01278	Pramlintide	Other blood glucose lowering drugs, excl. insulins	approved;investigational	Receptor activity-modifying protein 3	O60896	3171914	agonist	yes
DB01279	Galsulfase	Enzymes	approved;investigational	Dermatan sulfate	None	None	None	yes
DB01279	Galsulfase	Enzymes	approved;investigational	Perilipin-3	O60664	3095186	None	yes
DB01280	Nelarabine	Purine analogues	approved;investigational	DNA	None	None	incorporation into and destabilization	yes
DB01280	Nelarabine	Purine analogues	approved;investigational	DNA polymerase alpha catalytic subunit	P09884	35568	inhibitor	unknown
DB01281	Abatacept	Selective immunosuppressants	approved	T-lymphocyte activation antigen CD80	P33681	306916	antagonist	yes
DB01281	Abatacept	Selective immunosuppressants	approved	T-lymphocyte activation antigen CD86	P42081	439839	antagonist	yes
DB01282	Carbetocin	Oxytocin and analogues	approved;investigational	Oxytocin receptor	P30559	34765	agonist	yes
DB01283	Lumiracoxib	Coxibs	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB01283	Lumiracoxib	Coxibs	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB01284	Tetracosactide	ACTH	approved	Adrenocorticotropic hormone receptor	Q01718	28344	antagonist	yes
DB01285	Corticotropin	ACTH	approved;investigational;vet_approved	Adrenocorticotropic hormone receptor	Q01718	28344	agonist	yes
DB01285	Corticotropin	ACTH	approved;investigational;vet_approved	Corticoliberin	P06850	35356	agonist	unknown
DB01288	Fenoterol	Adrenergics in combination with anticholinergics	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB01288	Fenoterol	Adrenergics in combination with anticholinergics	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	agonist	unknown
DB01288	Fenoterol	Adrenergics in combination with anticholinergics	approved;investigational	Beta-3 adrenergic receptor	P13945	178896	agonist	unknown
DB01291	Pirbuterol	Selective beta-2-adrenoreceptor agonists	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB01291	Pirbuterol	Selective beta-2-adrenoreceptor agonists	approved	Beta-1 adrenergic receptor	P08588	178200	agonist	unknown
DB01295	Bevantolol	Beta blocking agents, selective	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB01295	Bevantolol	Beta blocking agents, selective	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB01295	Bevantolol	Beta blocking agents, selective	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB01296	Glucosamine	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Matrix metalloproteinase-9	P14780	177205	antagonist	yes
DB01296	Glucosamine	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Nuclear factor NF-kappa-B p100 subunit	Q00653	None	antagonist	unknown
DB01296	Glucosamine	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Tumor necrosis factor	P01375	339741	None	unknown
DB01296	Glucosamine	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Interferon gamma	P01579	32692	None	unknown
DB01296	Glucosamine	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Chitosanase	P33673	23503502	None	unknown
DB01297	Practolol	Beta blocking agents, selective	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB01298	Sulfacytine	Sulfonamides	approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB01299	Sulfadoxine	Sulfonamides	approved;investigational	Dihydropteroate synthetase	Q27738	505177	None	yes
DB01299	Sulfadoxine	Sulfonamides	approved;investigational	Bifunctional dihydrofolate reductase-thymidylate synthase	P13922	160260	inhibitor	unknown
DB01301	Rolitetracycline	Tetracyclines	approved	30S ribosomal protein S9	P0A7X3	535073	inhibitor	yes
DB01301	Rolitetracycline	Tetracyclines	approved	16S rRNA	None	None	inhibitor	yes
DB01303	Oxtriphylline	Xanthines and adrenergics	approved	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	yes
DB01303	Oxtriphylline	Xanthines and adrenergics	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	yes
DB01303	Oxtriphylline	Xanthines and adrenergics	approved	Adenosine receptor A2a	P29274	177892	antagonist	yes
DB01303	Oxtriphylline	Xanthines and adrenergics	approved	Adenosine receptor A1	P30542	256155	antagonist	yes
DB01303	Oxtriphylline	Xanthines and adrenergics	approved	Histone deacetylase 2	Q92769	1667394	activator	yes
DB01306	Insulin Aspart	Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting	approved	Insulin receptor	P06213	307070	agonist	yes
DB01307	Insulin Detemir	Insulins and analogues for injection, long-acting	approved	Insulin receptor	P06213	307070	agonist	yes
DB01309	Insulin Glulisine	Insulins and analogues for injection, fast-acting	approved	Insulin receptor	P06213	307070	agonist	yes
DB01319	Fosamprenavir	Protease inhibitors	approved	Human immunodeficiency virus type 1 protease	Q72874	None	inhibitor	yes
DB01320	Fosphenytoin	Hydantoin derivatives	approved;investigational	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB01321	Josamycin	Macrolides	approved;investigational	50S ribosomal protein L4	P44345	3212176	inhibitor	yes
DB01324	Polythiazide	Thiazides, plain	approved	Solute carrier family 12 member 3	P55017	1172161	inhibitor	yes
DB01325	Quinethazone	Sulfonamides, plain	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	yes
DB01325	Quinethazone	Sulfonamides, plain	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB01325	Quinethazone	Sulfonamides, plain	approved	Solute carrier family 12 member 1	Q13621	1373425	inhibitor	yes
DB01325	Quinethazone	Sulfonamides, plain	approved	Solute carrier family 12 member 2	P55011	903682	inhibitor	yes
DB01325	Quinethazone	Sulfonamides, plain	approved	Solute carrier family 12 member 3	P55017	1172161	inhibitor	yes
DB01326	Cefamandole	Second-generation cephalosporins	approved;investigational	Penicillin-binding protein 2	Q70KI2	52214157	inhibitor	yes
DB01327	Cefazolin	First-generation cephalosporins	approved	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB01327	Cefazolin	First-generation cephalosporins	approved	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB01327	Cefazolin	First-generation cephalosporins	approved	Penicillin-binding protein 1C	P76577	1850613	inhibitor	yes
DB01327	Cefazolin	First-generation cephalosporins	approved	Penicillin-binding protein 2	P0AD65	42314	inhibitor	yes
DB01327	Cefazolin	First-generation cephalosporins	approved	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB01327	Cefazolin	First-generation cephalosporins	approved	Serum paraoxonase/arylesterase 1	P27169	190192	inhibitor	unknown
DB01327	Cefazolin	First-generation cephalosporins	approved	Interleukin-15	P40933	None	inhibitor	unknown
DB01327	Cefazolin	First-generation cephalosporins	approved	Interleukin-2	P60568	5729676	inhibitor	unknown
DB01328	Cefonicid	Second-generation cephalosporins	approved;investigational	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB01328	Cefonicid	Second-generation cephalosporins	approved;investigational	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB01328	Cefonicid	Second-generation cephalosporins	approved;investigational	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB01328	Cefonicid	Second-generation cephalosporins	approved;investigational	D-alanyl-D-alanine carboxypeptidase DacB	P24228	41216	inhibitor	yes
DB01328	Cefonicid	Second-generation cephalosporins	approved;investigational	Penicillin-binding protein 2	P0AD65	42314	inhibitor	yes
DB01329	Cefoperazone	Third-generation cephalosporins	approved;investigational	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB01329	Cefoperazone	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB01329	Cefoperazone	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 2	P0AD65	42314	inhibitor	yes
DB01329	Cefoperazone	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1A	Q07806	1763284	inhibitor	yes
DB01329	Cefoperazone	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1B	Q9X6W0	4887211	inhibitor	yes
DB01329	Cefoperazone	Third-generation cephalosporins	approved;investigational	D-alanyl-D-alanine carboxypeptidase DacC	P08506	41218	inhibitor	yes
DB01329	Cefoperazone	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB01329	Cefoperazone	Third-generation cephalosporins	approved;investigational	D-alanyl-D-alanine carboxypeptidase DacA	P0AEB2	None	inhibitor	yes
DB01329	Cefoperazone	Third-generation cephalosporins	approved;investigational	D-alanyl-D-alanine carboxypeptidase DacB	P24228	41216	inhibitor	yes
DB01330	Cefotetan	Second-generation cephalosporins	approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	D-alanyl-D-alanine carboxypeptidase DacC	P08506	41218	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	D-alanyl-D-alanine carboxypeptidase DacA	P0AEB2	None	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	D-alanyl-D-alanine endopeptidase	P0AFI5	None	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	D-alanyl-D-alanine carboxypeptidase DacB	P24228	41216	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB01331	Cefoxitin	Second-generation cephalosporins	approved	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB01332	Ceftizoxime	Third-generation cephalosporins	approved;investigational	MecA PBP2' (penicillin binding protein 2')	Q53707	46611	inhibitor	yes
DB01332	Ceftizoxime	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB01332	Ceftizoxime	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB01332	Ceftizoxime	Third-generation cephalosporins	approved;investigational	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB01333	Cefradine	First-generation cephalosporins	approved	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB01336	Metocurine	N/A	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB01336	Metocurine	N/A	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB01337	Pancuronium	Other quaternary ammonium compounds	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB01337	Pancuronium	Other quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB01337	Pancuronium	Other quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB01338	Pipecuronium	Other quaternary ammonium compounds	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB01338	Pipecuronium	Other quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB01338	Pipecuronium	Other quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB01339	Vecuronium	Other quaternary ammonium compounds	approved	Neuronal acetylcholine receptor subunit alpha-2	Q15822	1458110	antagonist	yes
DB01340	Cilazapril	ACE inhibitors and diuretics	approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB01344	Tolevamer	Drugs for treatment of hyperkalemia and hyperphosphatemia	approved;investigational	Potassium	None	None	binder	yes
DB01345	Potassium	Thiazides and potassium in combination	approved;investigational	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	None	unknown
DB01346	Quinidine barbiturate	N/A	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01346	Quinidine barbiturate	N/A	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01346	Quinidine barbiturate	N/A	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB01346	Quinidine barbiturate	N/A	approved	Potassium channel subfamily K member 1	O00180	1086491	inhibitor	unknown
DB01346	Quinidine barbiturate	N/A	approved	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB01348	Spirapril	ACE inhibitors, plain	approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB01349	Tasosartan	Angiotensin II antagonists, plain	approved	Type-1 angiotensin II receptor	P30556	179122	antagonist	yes
DB01349	Tasosartan	Angiotensin II antagonists, plain	approved	Type-2 angiotensin II receptor	P50052	None	antagonist	unknown
DB01351	Amobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01351	Amobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01351	Amobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01351	Amobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB01351	Amobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01351	Amobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB01351	Amobarbital	Barbiturates, plain	approved;illicit	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB01351	Amobarbital	Barbiturates, plain	approved;illicit	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB01351	Amobarbital	Barbiturates, plain	approved;illicit	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB01351	Amobarbital	Barbiturates, plain	approved;illicit	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB01352	Aprobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01352	Aprobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01352	Aprobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01352	Aprobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB01352	Aprobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01352	Aprobarbital	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB01352	Aprobarbital	Barbiturates, plain	approved;illicit	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB01352	Aprobarbital	Barbiturates, plain	approved;illicit	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB01352	Aprobarbital	Barbiturates, plain	approved;illicit	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB01352	Aprobarbital	Barbiturates, plain	approved;illicit	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB01353	Butethal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01353	Butethal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01353	Butethal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01353	Butethal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB01353	Butethal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01353	Butethal	Barbiturates, plain	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB01353	Butethal	Barbiturates, plain	approved;illicit	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB01353	Butethal	Barbiturates, plain	approved;illicit	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB01353	Butethal	Barbiturates, plain	approved;illicit	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB01353	Butethal	Barbiturates, plain	approved;illicit	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB01354	Heptabarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01354	Heptabarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01354	Heptabarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01354	Heptabarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB01354	Heptabarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01354	Heptabarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB01354	Heptabarbital	Barbiturates, plain	approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB01354	Heptabarbital	Barbiturates, plain	approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB01354	Heptabarbital	Barbiturates, plain	approved	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB01354	Heptabarbital	Barbiturates, plain	approved	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB01355	Hexobarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01355	Hexobarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01355	Hexobarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01355	Hexobarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB01355	Hexobarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01355	Hexobarbital	Barbiturates, plain	approved	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB01355	Hexobarbital	Barbiturates, plain	approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	antagonist	unknown
DB01355	Hexobarbital	Barbiturates, plain	approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	antagonist	unknown
DB01355	Hexobarbital	Barbiturates, plain	approved	Glutamate receptor 2	P42262	493134	antagonist	unknown
DB01355	Hexobarbital	Barbiturates, plain	approved	Glutamate receptor ionotropic, kainate 2	Q13002	790532	antagonist	unknown
DB01356	Lithium	Other dermatologicals	approved	Glycogen synthase kinase-3 beta	P49841	529237	inhibitor	unknown
DB01356	Lithium	Other dermatologicals	approved	Inositol monophosphatase 1	P29218	395340	inhibitor	unknown
DB01356	Lithium	Other dermatologicals	approved	Inositol monophosphatase 2	O14732	2406666	inhibitor	unknown
DB01356	Lithium	Other dermatologicals	approved	Glutamate receptor 3	P42263	507829	potentiator	unknown
DB01357	Mestranol	N/A	approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB01359	Penbutolol	Beta blocking agents, non-selective, and other diuretics	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB01359	Penbutolol	Beta blocking agents, non-selective, and other diuretics	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	antagonist	yes
DB01359	Penbutolol	Beta blocking agents, non-selective, and other diuretics	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	yes
DB01359	Penbutolol	Beta blocking agents, non-selective, and other diuretics	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	antagonist	unknown
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Sodium-dependent dopamine transporter	Q01959	553260	negative modulator	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Sodium-dependent noradrenaline transporter	P23975	189258	negative modulator	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Alpha-2C adrenergic receptor	P18825	178194	agonist	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Amine oxidase [flavin-containing] A	P21397	187353	inhibitor	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Amine oxidase [flavin-containing] B	P27338	398415	inhibitor	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Beta-1 adrenergic receptor	P08588	178200	agonist	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Beta-3 adrenergic receptor	P13945	178896	agonist	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Sodium-dependent serotonin transporter	P31645	36433	negative modulator	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Synaptic vesicular amine transporter	Q05940	292335	inhibitor	yes
DB01363	Ephedra	N/A	approved;nutraceutical;withdrawn	Chromaffin granule amine transporter	P54219	None	inhibitor	yes
DB01364	Ephedrine	Sympathomimetics, plain	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inverse agonist	unknown
DB01364	Ephedrine	Sympathomimetics, plain	approved	Alpha-1A adrenergic receptor	P35348	433201	None	unknown
DB01364	Ephedrine	Sympathomimetics, plain	approved	Synaptic vesicular amine transporter	Q05940	292335	inhibitor	unknown
DB01364	Ephedrine	Sympathomimetics, plain	approved	Acetylcholinesterase	P22303	177975	None	unknown
DB01365	Mephentermine	Adrenergic and dopaminergic agents	approved	Alpha adrenergic receptor	P18825	178194	agonist	yes
DB01365	Mephentermine	Adrenergic and dopaminergic agents	approved	Beta adrenergic receptor	P13945	178896	agonist	unknown
DB01366	Procaterol	Selective beta-2-adrenoreceptor agonists	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB01367	Rasagiline	Monoamine oxidase B inhibitors	approved	Amine oxidase [flavin-containing] B	P27338	398415	inhibitor	yes
DB01367	Rasagiline	Monoamine oxidase B inhibitors	approved	Apoptosis regulator Bcl-2	P10415	179367	activator	yes
DB01369	Quinupristin	N/A	approved	23S rRNA	None	None	inhibitor	yes
DB01369	Quinupristin	N/A	approved	50S ribosomal protein L10	P0A7J6	24054563	inhibitor	yes
DB01369	Quinupristin	N/A	approved	50S ribosomal protein L22	P61177	None	inhibitor	yes
DB01370	Aluminium	Aluminium compounds	approved;investigational	Serotransferrin	P02787	339453	None	unknown
DB01370	Aluminium	Aluminium compounds	approved;investigational	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	binder	unknown
DB01370	Aluminium	Aluminium compounds	approved;investigational	Kallikrein-1	P06870	186653	inhibitor	unknown
DB01370	Aluminium	Aluminium compounds	approved;investigational	Amyloid beta A4 protein	P05067	None	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	ligand	yes
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Calcium-transporting ATPase type 2C member 1	P98194	6715131	agonist	yes
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Troponin C, skeletal muscle	P02585	36729	agonist	yes
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Troponin C, slow skeletal and cardiac muscles	P63316	37208	agonist	yes
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Spectrin beta chain, non-erythrocytic 1	Q01082	None	agonist	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Protein S100-B	P04271	337730	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Calpastatin	P20810	303599	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Cartilage oligomeric matrix protein	P49747	602450	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Calmodulin	P0DP23	179888	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Amiloride-sensitive amine oxidase [copper-containing]	P19801	177960	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Protein S100-A13	Q99584	1694828	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Alkaline phosphatase, placental type	P05187	178474	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Protein S100-A8	P05109	None	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Protein S100-A9	P06702	None	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Protein S100-A2	P29034	None	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Ceruloplasmin	P00450	180256	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Bone morphogenetic protein 4	P12644	None	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Matrix Gla protein	P08493	None	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Protocadherin-19	Q8TAB3	None	None	unknown
DB01373	Calcium	Bisphosphonates, combinations	approved;nutraceutical	Programmed cell death protein 6	O75340	None	None	unknown
DB01378	Magnesium	Magnesium	approved;nutraceutical	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	None	unknown
DB01380	Cortisone acetate	Glucocorticoids	approved;investigational	Glucocorticoid receptor	P04150	31680	agonist	yes
DB01381	Ginkgo biloba	Anticholinesterases	approved;investigational;nutraceutical	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB01381	Ginkgo biloba	Anticholinesterases	approved;investigational;nutraceutical	Phospholipase A2, membrane associated	P14555	190889	inhibitor	unknown
DB01381	Ginkgo biloba	Anticholinesterases	approved;investigational;nutraceutical	Glycine receptor subunit alpha-1	P23415	31851	antagonist	unknown
DB01381	Ginkgo biloba	Anticholinesterases	approved;investigational;nutraceutical	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	negative modulator	unknown
DB01381	Ginkgo biloba	Anticholinesterases	approved;investigational;nutraceutical	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	negative modulator	unknown
DB01381	Ginkgo biloba	Anticholinesterases	approved;investigational;nutraceutical	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	negative modulator	unknown
DB01382	Glycodiazine	Sulfonamides (heterocyclic)	approved;investigational	ATP-sensitive inward rectifier potassium channel 1	P48048	529313	other/unknown	yes
DB01382	Glycodiazine	Sulfonamides (heterocyclic)	approved;investigational	ATP-binding cassette sub-family C member 8	Q09428	1374919	inducer	unknown
DB01384	Paramethasone	Glucocorticoids	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB01390	Sodium bicarbonate	Electrolyte solutions	approved	Hydrogen ions	None	None	neutralizer	yes
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	yes
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	yes
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	Alpha-2C adrenergic receptor	P18825	178194	antagonist	yes
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	5-hydroxytryptamine receptor 1A	P08908	189928	partial agonist	unknown
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	5-hydroxytryptamine receptor 1B	P28222	219679	antagonist	unknown
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	5-hydroxytryptamine receptor 1D	P28221	177772	antagonist	unknown
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	D(2) dopamine receptor	P14416	181432	antagonist	unknown
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	ATP-sensitive potassium channel	Q15842	567019	inhibitor	unknown
DB01392	Yohimbine	Drugs used in erectile dysfunction	approved;investigational;vet_approved	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	unknown
DB01393	Bezafibrate	Fibrates	approved;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	agonist	yes
DB01393	Bezafibrate	Fibrates	approved;investigational	Peroxisome proliferator-activated receptor delta	Q03181	190230	agonist	yes
DB01393	Bezafibrate	Fibrates	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	yes
DB01393	Bezafibrate	Fibrates	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	partial agonist	unknown
DB01393	Bezafibrate	Fibrates	approved;investigational	Retinoic acid receptor RXR-alpha	P19793	35885	agonist	unknown
DB01393	Bezafibrate	Fibrates	approved;investigational	Retinoic acid receptor RXR-beta	P28702	30448	agonist	unknown
DB01393	Bezafibrate	Fibrates	approved;investigational	Retinoic acid receptor RXR-gamma	P48443	1053069	agonist	unknown
DB01394	Colchicine	Preparations with no effect on uric acid metabolism	approved	Tubulin beta-1 chain	Q9H4B7	11230445	inhibitor	yes
DB01394	Colchicine	Preparations with no effect on uric acid metabolism	approved	Tubulin beta chain	P07437	338695	inhibitor	yes
DB01395	Drospirenone	Progestogens and estrogens, fixed combinations	approved	Progesterone receptor	P06401	35652	agonist	yes
DB01395	Drospirenone	Progestogens and estrogens, fixed combinations	approved	Mineralocorticoid receptor	P08235	307166	antagonist	yes
DB01395	Drospirenone	Progestogens and estrogens, fixed combinations	approved	Androgen receptor	P10275	178628	antagonist	yes
DB01396	Digitoxin	Digitalis glycosides	approved;investigational	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	inhibitor	yes
DB01397	Magnesium salicylate	N/A	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB01397	Magnesium salicylate	N/A	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB01399	Salsalate	Salicylic acid and derivatives	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB01399	Salsalate	Salicylic acid and derivatives	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB01400	Neostigmine	Anticholinesterases	approved;vet_approved	Acetylcholinesterase	P22303	177975	inhibitor	yes
DB01401	Choline magnesium trisalicylate	N/A	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB01401	Choline magnesium trisalicylate	N/A	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	D(1B) dopamine receptor	P21918	32049	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB01403	Methotrimeprazine	Phenothiazines with aliphatic side-chain	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB01404	Ginseng	N/A	approved;investigational;nutraceutical	Interleukin-6	P05231	32674	antagonist	unknown
DB01404	Ginseng	N/A	approved;investigational;nutraceutical	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	unknown
DB01404	Ginseng	N/A	approved;investigational;nutraceutical	Aryl hydrocarbon receptor	P35869	533324	agonist	unknown
DB01406	Danazol	Antigonadotropins and similar agents	approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB01406	Danazol	Antigonadotropins and similar agents	approved	Androgen receptor	P10275	178628	agonist	yes
DB01406	Danazol	Antigonadotropins and similar agents	approved	Progesterone receptor	P06401	35652	agonist	yes
DB01406	Danazol	Antigonadotropins and similar agents	approved	Gonadotropin-releasing hormone receptor	P30968	183422	negative modulator	yes
DB01406	Danazol	Antigonadotropins and similar agents	approved	Putative gonadotropin-releasing hormone II receptor	Q96P88	16589056	negative modulator	yes
DB01406	Danazol	Antigonadotropins and similar agents	approved	C-C motif chemokine 2	P13500	307163	inhibitor	unknown
DB01407	Clenbuterol	Selective beta-2-adrenoreceptor agonists	approved;investigational;vet_approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB01407	Clenbuterol	Selective beta-2-adrenoreceptor agonists	approved;investigational;vet_approved	Beta-1 adrenergic receptor	P08588	178200	agonist	unknown
DB01407	Clenbuterol	Selective beta-2-adrenoreceptor agonists	approved;investigational;vet_approved	Beta-3 adrenergic receptor	P13945	178896	agonist	unknown
DB01407	Clenbuterol	Selective beta-2-adrenoreceptor agonists	approved;investigational;vet_approved	Beta-nerve growth factor	P01138	671883	stimulator	unknown
DB01407	Clenbuterol	Selective beta-2-adrenoreceptor agonists	approved;investigational;vet_approved	Tumor necrosis factor	P01375	339741	other/unknown	unknown
DB01408	Bambuterol	Selective beta-2-adrenoreceptor agonists	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB01409	Tiotropium	Adrenergics in combination with anticholinergics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB01409	Tiotropium	Adrenergics in combination with anticholinergics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB01409	Tiotropium	Adrenergics in combination with anticholinergics	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB01409	Tiotropium	Adrenergics in combination with anticholinergics	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	None	unknown
DB01409	Tiotropium	Adrenergics in combination with anticholinergics	approved	Muscarinic acetylcholine receptor M5	P08912	177988	None	unknown
DB01410	Ciclesonide	Glucocorticoids	approved;investigational	Glucocorticoid receptor	P04150	31680	agonist	yes
DB01411	Pranlukast	Leukotriene receptor antagonists	approved;investigational	Cysteinyl leukotriene receptor 1	Q9Y271	5353887	antagonist	yes
DB01411	Pranlukast	Leukotriene receptor antagonists	approved;investigational	Tumor necrosis factor	P01375	339741	other/unknown	unknown
DB01411	Pranlukast	Leukotriene receptor antagonists	approved;investigational	Interleukin-5	P05113	33836	antagonist	unknown
DB01411	Pranlukast	Leukotriene receptor antagonists	approved;investigational	Eosinophil cationic protein	P12724	31077	other/unknown	unknown
DB01411	Pranlukast	Leukotriene receptor antagonists	approved;investigational	Nuclear factor NF-kappa-B p105 subunit	P19838	189180	other/unknown	unknown
DB01411	Pranlukast	Leukotriene receptor antagonists	approved;investigational	Mucin-2	Q02817	454154	other/unknown	unknown
DB01412	Theobromine	Xanthines	approved;investigational	Adenosine receptor A1	P30542	256155	antagonist	yes
DB01412	Theobromine	Xanthines	approved;investigational	Adenosine receptor A2a	P29274	177892	antagonist	yes
DB01412	Theobromine	Xanthines	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	unknown
DB01413	Cefepime	Combinations of antibacterials	approved;investigational	Penicillin-binding protein 2	P0AD65	42314	inhibitor	yes
DB01413	Cefepime	Combinations of antibacterials	approved;investigational	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB01413	Cefepime	Combinations of antibacterials	approved;investigational	Penicillin-binding protein 3	Q51504	None	inhibitor	yes
DB01413	Cefepime	Combinations of antibacterials	approved;investigational	Penicillin-binding protein 2	Q9X6V3	None	inhibitor	yes
DB01414	Cefacetrile	First-generation cephalosporins	approved	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB01414	Cefacetrile	First-generation cephalosporins	approved	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB01415	Ceftibuten	Third-generation cephalosporins	approved;investigational	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB01415	Ceftibuten	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB01415	Ceftibuten	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB01415	Ceftibuten	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 2	P0AD65	42314	inhibitor	yes
DB01416	Cefpodoxime	Third-generation cephalosporins	approved;vet_approved	Peptidoglycan synthase FtsI	P0AD68	None	inhibitor	yes
DB01418	Acenocoumarol	Vitamin K antagonists	approved;investigational	Vitamin K epoxide reductase complex subunit 1	Q9BQB6	40217983	inhibitor	yes
DB01419	Antrafenine	N/A	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB01419	Antrafenine	N/A	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	unknown
DB01420	Testosterone propionate	N/A	approved;investigational;vet_approved;withdrawn	Androgen receptor	P10275	178628	agonist	yes
DB01421	Paromomycin	Antibiotics	approved;investigational	30S ribosomal protein S10	Q5SHN7	1022792	inhibitor	yes
DB01421	Paromomycin	Antibiotics	approved;investigational	16S rRNA	None	None	inhibitor	yes
DB01422	Nitroxoline	Other antibacterials	approved	Methionine aminopeptidase 2	P50579	903982	inhibitor	yes
DB01422	Nitroxoline	Other antibacterials	approved	Magnesium cation	None	None	chelator	unknown
DB01422	Nitroxoline	Other antibacterials	approved	Manganese cation	None	None	chelator	unknown
DB01425	Alizapride	Propulsives	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01426	Ajmaline	Antiarrhythmics, class Ia	approved;investigational	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB01427	Amrinone	Phosphodiesterase inhibitors	approved	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	yes
DB01427	Amrinone	Phosphodiesterase inhibitors	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	unknown
DB01427	Amrinone	Phosphodiesterase inhibitors	approved	Tumor necrosis factor	P01375	339741	inhibitor	unknown
DB01427	Amrinone	Phosphodiesterase inhibitors	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 3	None	None	inhibitor	unknown
DB01428	Oxybenzone	N/A	approved	Progesterone receptor	P06401	35652	antagonist	unknown
DB01428	Oxybenzone	N/A	approved	Androgen receptor	P10275	178628	antagonist	unknown
DB01428	Oxybenzone	N/A	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB01428	Oxybenzone	N/A	approved	Estrogen receptor beta	Q92731	2911152	None	unknown
DB01429	Aprindine	Antiarrhythmics, class Ib	approved	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	yes
DB01429	Aprindine	Antiarrhythmics, class Ib	approved	Calmodulin	P0DP23	179888	inhibitor	unknown
DB01430	Almitrine	Respiratory stimulants	approved	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	binder	yes
DB01431	Allylestrenol	Estren derivatives	approved	Progesterone receptor	P06401	35652	agonist	yes
DB01431	Allylestrenol	Estren derivatives	approved	Estrogen receptor alpha	P03372	31234	agonist	unknown
DB01432	Cholestyramine	Bile acid sequestrants	approved;investigational	Bile acids	None	None	binder	yes
DB01433	Methadyl Acetate	N/A	approved;illicit	Mu-type opioid receptor	P35372	452073	agonist	yes
DB01435	Antipyrine	Pyrazolones	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	unknown
DB01435	Antipyrine	Pyrazolones	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB01436	Alfacalcidol	Vitamin D and analogues	approved;nutraceutical	Vitamin D3 receptor	P11473	340203	agonist	yes
DB01436	Alfacalcidol	Vitamin D and analogues	approved;nutraceutical	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	O15528	2612976	None	unknown
DB01436	Alfacalcidol	Vitamin D and analogues	approved;nutraceutical	Retinoic acid receptor RXR-alpha	P19793	35885	None	unknown
DB01437	Glutethimide	Piperidinedione derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB01437	Glutethimide	Piperidinedione derivatives	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01438	Phenazopyridine	Other urologicals	approved	Sodium channel protein type 1 subunit alpha	P35498	12642270	inhibitor	yes
DB01440	Gamma Hydroxybutyric Acid	N/A	approved;illicit;investigational	Gamma-hydroxybutyrate (GHB) receptor	Q9HAB3	None	agonist	yes
DB01440	Gamma Hydroxybutyric Acid	N/A	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	agonist	yes
DB01452	Heroin	Drugs used in opioid dependence	approved;illicit;investigational	Mu-type opioid receptor	P35372	452073	agonist	yes
DB01452	Heroin	Drugs used in opioid dependence	approved;illicit;investigational	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB01452	Heroin	Drugs used in opioid dependence	approved;illicit;investigational	Delta-type opioid receptor	P41143	27545517	agonist	unknown
DB01452	Heroin	Drugs used in opioid dependence	approved;illicit;investigational	Liver carboxylesterase 1	P23141	None	None	unknown
DB01463	Fencamfamine	Centrally acting sympathomimetics	approved;illicit;withdrawn	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB01466	Ethylmorphine	Other ophthalmologicals	approved;illicit	Mu-type opioid receptor	P35372	452073	agonist	yes
DB01544	Flunitrazepam	Benzodiazepine derivatives	approved;illicit	Translocator protein	P30536	306883	agonist	yes
DB01544	Flunitrazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01544	Flunitrazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	agonist	yes
DB01544	Flunitrazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01544	Flunitrazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB01544	Flunitrazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01544	Flunitrazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	unknown
DB01544	Flunitrazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	agonist	unknown
DB01544	Flunitrazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	agonist	unknown
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB01558	Bromazepam	Benzodiazepine derivatives	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit theta	Q9UN88	7861736	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB01559	Clotiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB01567	Fludiazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB01576	Dextroamphetamine	Centrally acting sympathomimetics	approved;illicit	Synaptic vesicular amine transporter	Q05940	292335	inducer	yes
DB01576	Dextroamphetamine	Centrally acting sympathomimetics	approved;illicit	Sodium-dependent noradrenaline transporter	P23975	189258	negative modulator	yes
DB01576	Dextroamphetamine	Centrally acting sympathomimetics	approved;illicit	Sodium-dependent dopamine transporter	Q01959	553260	negative modulator	yes
DB01576	Dextroamphetamine	Centrally acting sympathomimetics	approved;illicit	Trace amine-associated receptor 1	Q96RJ0	14600074	agonist	unknown
DB01576	Dextroamphetamine	Centrally acting sympathomimetics	approved;illicit	Alpha-1A adrenergic receptor	P35348	433201	None	unknown
DB01576	Dextroamphetamine	Centrally acting sympathomimetics	approved;illicit	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Sodium-dependent dopamine transporter	Q01959	553260	negative modulator	yes
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Sodium-dependent serotonin transporter	P31645	36433	negative modulator	yes
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Sodium-dependent noradrenaline transporter	P23975	189258	negative modulator	yes
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Synaptic vesicular amine transporter	Q05940	292335	inhibitor	yes
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Chromaffin granule amine transporter	P54219	None	inhibitor	yes
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Trace amine-associated receptor 1	Q96RJ0	14600074	agonist	yes
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Alpha-2C adrenergic receptor	P18825	178194	agonist	yes
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Amine oxidase [flavin-containing] A	P21397	187353	inhibitor	yes
DB01577	Methamphetamine	Centrally acting sympathomimetics	approved;illicit	Amine oxidase [flavin-containing] B	P27338	398415	inhibitor	yes
DB01579	Phendimetrazine	N/A	approved;illicit	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB01579	Phendimetrazine	N/A	approved;illicit	Sodium-dependent noradrenaline transporter	P23975	189258	negative modulator	yes
DB01579	Phendimetrazine	N/A	approved;illicit	Alpha-1B adrenergic receptor	P35368	None	agonist	unknown
DB01580	Oxprenolol	Beta blocking agents, non-selective, and other diuretics	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB01580	Oxprenolol	Beta blocking agents, non-selective, and other diuretics	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB01580	Oxprenolol	Beta blocking agents, non-selective, and other diuretics	approved	Beta-3 adrenergic receptor	P13945	178896	None	unknown
DB01581	Sulfamerazine	Combinations of sulfonamides and trimethoprim, incl. derivatives	approved;vet_approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB01582	Sulfamethazine	Combinations of sulfonamides and trimethoprim, incl. derivatives	approved;investigational;vet_approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB01583	Liotrix	N/A	approved	Thyroid hormone receptor alpha	P10827	825639	agonist	yes
DB01583	Liotrix	N/A	approved	Thyroid hormone receptor beta	P10828	31207	agonist	yes
DB01586	Ursodeoxycholic acid	Bile acid preparations	approved;investigational	Aldo-keto reductase family 1 member C2	P52895	531160	inducer	yes
DB01586	Ursodeoxycholic acid	Bile acid preparations	approved;investigational	Bile acid receptor	Q96RI1	1546084	None	unknown
DB01587	Ketazolam	Benzodiazepine derivatives	approved	Translocator protein	P30536	306883	agonist	yes
DB01587	Ketazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01587	Ketazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB01587	Ketazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB01587	Ketazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB01587	Ketazolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB01588	Prazepam	Benzodiazepine derivatives	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB01589	Quazepam	Benzodiazepine derivatives	approved;illicit	GABA-A receptor (anion channel)	Q9UN88	7861736	positive allosteric modulator	yes
DB01590	Everolimus	Protein kinase inhibitors	approved	Serine/threonine-protein kinase mTOR	P42345	None	inhibitor	yes
DB01591	Solifenacin	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB01591	Solifenacin	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB01591	Solifenacin	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB01591	Solifenacin	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB01591	Solifenacin	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB01592	Iron	Iron in other combinations	approved	Transferrin receptor protein 1	P02786	None	None	unknown
DB01592	Iron	Iron in other combinations	approved	Egl nine homolog 1	Q9GZT9	11345052	None	unknown
DB01592	Iron	Iron in other combinations	approved	Histone deacetylase 8	Q9BY41	8118721	cofactor	unknown
DB01592	Iron	Iron in other combinations	approved	Alpha-hemoglobin-stabilizing protein	Q9NZD4	None	None	unknown
DB01592	Iron	Iron in other combinations	approved	Hemoglobin subunit alpha	P69905	386764	None	unknown
DB01592	Iron	Iron in other combinations	approved	Frataxin, mitochondrial	Q16595	None	None	unknown
DB01592	Iron	Iron in other combinations	approved	Ferritin heavy chain	P02794	28435	None	unknown
DB01592	Iron	Iron in other combinations	approved	Flap endonuclease 1	P39748	None	None	unknown
DB01592	Iron	Iron in other combinations	approved	Endonuclease 8-like 1	Q96FI4	None	None	unknown
DB01592	Iron	Iron in other combinations	approved	Endonuclease 8-like 2	Q969S2	None	None	unknown
DB01592	Iron	Iron in other combinations	approved	DNA polymerase beta	P06746	292397	None	unknown
DB01592	Iron	Iron in other combinations	approved	Ceruloplasmin	P00450	180256	None	unknown
DB01592	Iron	Iron in other combinations	approved	Serotransferrin	P02787	339453	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	B1 bradykinin receptor	P46663	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Methylated-DNA--protein-cysteine methyltransferase	P16455	34559	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Fructose-bisphosphate aldolase A	P04075	178351	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Elongation factor 1-alpha 1	P68104	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Alpha-enolase	P06733	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	O14556	3046742	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Nucleoside diphosphate kinase A	P15531	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Protein disulfide-isomerase	P07237	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Protein disulfide-isomerase A3	P30101	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Peroxiredoxin-1	Q06830	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Phosphoserine phosphatase	P78330	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Triosephosphate isomerase	P60174	339841	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Elongation factor Tu, mitochondrial	P49411	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Estrogen receptor alpha	P03372	31234	cofactor	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Interleukin-3	P08700	307059	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Metallothionein-2	P02795	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Copper chaperone for superoxide dismutase	O14618	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Histone deacetylase 1	Q13547	1277084	cofactor	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Histone deacetylase 4	P56524	None	cofactor	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	DNA-3-methyladenine glycosylase	P29372	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Semenogelin-1	P04279	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Superoxide dismutase [Cu-Zn]	P00441	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Histone deacetylase 8	Q9BY41	8118721	cofactor	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Apoptosis regulatory protein Siva	O15304	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Glycine receptor subunit alpha-1	P23415	31851	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	E3 ubiquitin-protein ligase Mdm2	Q00987	338309	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Insulin	P01308	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Utrophin	P46939	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Aspartoacylase	P45381	455834	cofactor	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Protein S100-A8	P05109	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Protein S100-A9	P06702	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Matrix metalloproteinase-9	P14780	177205	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Tumor protein p73	O15350	None	cofactor	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Protein S100-A2	P29034	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Cellular tumor antigen p53	P04637	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Metallothionein-3	P25713	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Programmed cell death protein 6	O75340	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	DAN domain family member 5	Q8N907	None	cofactor	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Metallothionein-1A	P04731	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Alpha-1B-glycoprotein	P04217	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Alpha-2-macroglobulin	P01023	177870	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Angiotensinogen	P01019	178640	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Alpha-2-HS-glycoprotein	P02765	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Serum amyloid P-component	P02743	220068	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Apolipoprotein A-I	P02647	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Apolipoprotein A-II	P02652	28748	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Apolipoprotein A-IV	P06727	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Apolipoprotein B receptor	Q0VD83	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Apolipoprotein E	P02649	178849	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Apolipoprotein L1	O14791	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement C1q subcomponent subunit B	P02746	573114	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement C1r subcomponent	P00736	29539	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement C1s subcomponent	P09871	763110	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement C3	P01024	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement C4-B	P0C0L5	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	C4b-binding protein alpha chain	P04003	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	C4b-binding protein beta chain	P20851	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement C5	P01031	179983	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Lys-63-specific deubiquitinase BRCC36	P46736	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement component C8 alpha chain	P07357	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement component C8 beta chain	P07358	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement component C8 gamma chain	P07360	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement factor B	P00751	297569	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement factor H	P08603	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Complement factor I	P05156	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Clusterin	P10909	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Ceruloplasmin	P00450	180256	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Carboxypeptidase N catalytic chain	P15169	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Carboxypeptidase N subunit 2	P22792	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Dermcidin	P81605	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Desmoplakin	P15924	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Coagulation factor XII	P00748	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Coagulation factor XIII B chain	P05160	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Prothrombin	P00734	339641	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Ficolin-3	O75636	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Fibrinogen alpha chain	P02671	13591824	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Fibronectin	P02751	12053817	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Gelsolin	P06396	736249	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Hemoglobin subunit alpha	P69905	386764	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Hemoglobin subunit beta	P68871	455997	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Haptoglobin-related protein	P00739	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Hornerin	Q86YZ3	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Insulin-like growth factor-binding protein complex acid labile subunit	P35858	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Ig alpha-1 chain C region	P01876	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Ig mu chain C region	P01871	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Immunoglobulin kappa variable 1-17	P01599	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Ig kappa chain V-III region GOL	P01619	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Immunoglobulin lambda variable 3-21	P80748	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Inter-alpha-trypsin inhibitor heavy chain H1	P19827	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Inter-alpha-trypsin inhibitor heavy chain H2	P19823	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Inter-alpha-trypsin inhibitor heavy chain H3	Q06033	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Inter-alpha-trypsin inhibitor heavy chain H4	Q14624	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Immunoglobulin J chain	P01591	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Junction plakoglobin	P14923	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Plasma kallikrein	P03952	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Kininogen-1	P01042	177890	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Keratin, type II cytoskeletal 1	P04264	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Keratin, type I cytoskeletal 10	P13645	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Keratin, type I cytoskeletal 14	P02533	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Keratin, type I cytoskeletal 16	P08779	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Keratin, type II cytoskeletal 2 epidermal	P35908	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Keratin, type II cytoskeletal 5	P13647	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Keratin, type II cytoskeletal 6A	P02538	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Keratin, type I cytoskeletal 9	P35527	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Alpha-1-acid glycoprotein 2	P19652	16359000	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	N-acetylmuramoyl-L-alanine amidase	Q96PD5	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Serum paraoxonase/arylesterase 1	P27169	190192	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Pregnancy zone protein	P20742	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Protein S100-A7	P31151	190668	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Selenoprotein P	P49908	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Alpha-1-antitrypsin	P01009	177829	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Alpha-1-antichymotrypsin	P01011	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Kallistatin	P29622	None	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Corticosteroid-binding globulin	P08185	179971	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Heparin cofactor 2	P05546	183910	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Sex hormone-binding globulin	P04278	296673	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Serotransferrin	P02787	339453	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Transthyretin	P02766	189582	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Vitronectin	P04004	36575	None	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Amyloid-like protein 1	P51693	None	cofactor	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Amyloid-like protein 2	Q06481	None	cofactor	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Amyloid beta A4 protein	P05067	None	cofactor	unknown
DB01593	Zinc	Other agents for treatment of hemorrhoids and anal fissures for topical use	approved;investigational	Poly [ADP-ribose] polymerase 1	P09874	1017423	None	unknown
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB01594	Cinolazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-4	P48169	905393	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-6	Q16445	1470364	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-1	P18505	31635	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-1	Q8N1C3	193783776	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-3	Q99928	1754749	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit delta	O14764	2388693	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit epsilon	P78334	1857126	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit pi	O00591	2197001	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-1	P24046	182911	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-2	P28476	456428	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit rho-3	A8MPY1	None	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit theta	Q9UN88	7861736	potentiator	yes
DB01595	Nitrazepam	Benzodiazepine derivatives	approved	Sodium channel protein type 1 subunit alpha	P35498	12642270	other/unknown	unknown
DB01597	Cilastatin	N/A	approved;investigational	Dipeptidase 1	P16444	219600	inhibitor	yes
DB01598	Imipenem	Carbapenems	approved	Penicillin-binding protein 2	P0AD65	42314	inhibitor	yes
DB01598	Imipenem	Carbapenems	approved	Penicillin-binding protein 1B	P02919	42468	inhibitor	yes
DB01598	Imipenem	Carbapenems	approved	Penicillin-binding protein 1A	P02918	581194	inhibitor	yes
DB01598	Imipenem	Carbapenems	approved	Penicillin-binding protein 3	P42971	790944	inhibitor	yes
DB01598	Imipenem	Carbapenems	approved	Beta-lactamase	P00807	581568	other/unknown	yes
DB01599	Probucol	Other lipid modifying agents	approved;investigational	ATP-binding cassette sub-family A member 1	O95477	9247086	inhibitor	yes
DB01599	Probucol	Other lipid modifying agents	approved;investigational	Liver carboxylesterase 1	P23141	None	None	unknown
DB01600	Tiaprofenic acid	Propionic acid derivatives	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB01600	Tiaprofenic acid	Propionic acid derivatives	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB01601	Lopinavir	Antivirals for treatment of HIV infections, combinations	approved	Human immunodeficiency virus type 1 protease	Q72874	None	inhibitor	yes
DB01602	Bacampicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB01603	Meticillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	MecA PBP2' (penicillin binding protein 2')	Q53707	46611	inhibitor	yes
DB01603	Meticillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB01603	Meticillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB01603	Meticillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB01603	Meticillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB01603	Meticillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB01604	Pivampicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB01605	Pivmecillinam	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 1A	Q8XJ01	18145626	inhibitor	yes
DB01606	Tazobactam	Beta-lactamase inhibitors	approved	Beta-lactamase SHV-1	P0AD63	5002312	inhibitor	unknown
DB01606	Tazobactam	Beta-lactamase inhibitors	approved	Beta-lactamase TEM	P62594	16505919	inhibitor	yes
DB01607	Ticarcillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational;vet_approved	Penicillin binding protein 2a	C1KC03	None	inhibitor	yes
DB01608	Propericiazine	Phenothiazines with piperidine structure	approved;investigational	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB01608	Propericiazine	Phenothiazines with piperidine structure	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	yes
DB01608	Propericiazine	Phenothiazines with piperidine structure	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB01608	Propericiazine	Phenothiazines with piperidine structure	approved;investigational	Androgen receptor	P10275	178628	None	unknown
DB01609	Deferasirox	Iron chelating agents	approved;investigational	Iron	None	None	chelator	yes
DB01610	Valganciclovir	Xanthines	approved;investigational	DNA	None	None	adduct	yes
DB01611	Hydroxychloroquine	Aminoquinolines	approved	DNA	None	None	cross-linking/alkylation	yes
DB01611	Hydroxychloroquine	Aminoquinolines	approved	Toll-like receptor 7	Q9NYK1	7330281	antagonist	yes
DB01611	Hydroxychloroquine	Aminoquinolines	approved	Toll-like receptor 9	Q9NR96	8099652	antagonist	yes
DB01612	Amyl Nitrite	Antidotes	approved	Atrial natriuretic peptide receptor 1	P16066	28230	agonist	yes
DB01613	Erythrityl Tetranitrate	Organic nitrates	approved;investigational	Atrial natriuretic peptide receptor 1	P16066	28230	agonist	yes
DB01613	Erythrityl Tetranitrate	Organic nitrates	approved;investigational	Atrial natriuretic peptide receptor 2	P20594	5139790	agonist	yes
DB01614	Acepromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01614	Acepromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB01614	Acepromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01614	Acepromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	yes
DB01614	Acepromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB01614	Acepromazine	Phenothiazines with aliphatic side-chain	approved;vet_approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB01615	Aceprometazine	N/A	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01616	Alverine	Other drugs for functional gastrointestinal disorders	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	yes
DB01618	Molindone	Indole derivatives	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01618	Molindone	Indole derivatives	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB01618	Molindone	Indole derivatives	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB01618	Molindone	Indole derivatives	approved	Muscarinic acetylcholine receptor M1	P11229	34451	other/unknown	unknown
DB01619	Phenindamine	Other antihistamines for systemic use	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01620	Pheniramine	Substituted alkylamines	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB01620	Pheniramine	Substituted alkylamines	approved	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	None	unknown
DB01621	Pipotiazine	Phenothiazines with piperidine structure	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01621	Pipotiazine	Phenothiazines with piperidine structure	approved;investigational	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB01621	Pipotiazine	Phenothiazines with piperidine structure	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01621	Pipotiazine	Phenothiazines with piperidine structure	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	yes
DB01622	Thioproperazine	Phenothiazines with piperazine structure	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01622	Thioproperazine	Phenothiazines with piperazine structure	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB01622	Thioproperazine	Phenothiazines with piperazine structure	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01622	Thioproperazine	Phenothiazines with piperazine structure	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	yes
DB01622	Thioproperazine	Phenothiazines with piperazine structure	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB01622	Thioproperazine	Phenothiazines with piperazine structure	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	yes
DB01623	Thiothixene	Thioxanthene derivatives	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01623	Thiothixene	Thioxanthene derivatives	approved	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB01623	Thiothixene	Thioxanthene derivatives	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB01624	Zuclopenthixol	Thioxanthene derivatives	approved;investigational	D(1A) dopamine receptor	P21728	30397	antagonist	yes
DB01624	Zuclopenthixol	Thioxanthene derivatives	approved;investigational	D(1B) dopamine receptor	P21918	32049	antagonist	yes
DB01624	Zuclopenthixol	Thioxanthene derivatives	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB01624	Zuclopenthixol	Thioxanthene derivatives	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB01624	Zuclopenthixol	Thioxanthene derivatives	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB01624	Zuclopenthixol	Thioxanthene derivatives	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB01624	Zuclopenthixol	Thioxanthene derivatives	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB01625	Isopropamide	Synthetic anticholinergic agents in combination with psycholeptics	approved;vet_approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB01625	Isopropamide	Synthetic anticholinergic agents in combination with psycholeptics	approved;vet_approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB01626	Pargyline	MAO inhibitors and diuretics	approved	Amine oxidase [flavin-containing] B	P27338	398415	inhibitor	yes
DB01626	Pargyline	MAO inhibitors and diuretics	approved	Amine oxidase [flavin-containing] A	P21397	187353	inhibitor	unknown
DB01627	Lincomycin	Lincosamides	approved;vet_approved	50S ribosomal protein L10	P0A7J6	24054563	inhibitor	yes
DB01628	Etoricoxib	Coxibs	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB01632	Alpha-Phosphoribosylpyrophosphoric Acid	N/A	approved;experimental;investigational	Hypoxanthine-guanine phosphoribosyltransferase	Q27796	None	None	unknown
DB01632	Alpha-Phosphoribosylpyrophosphoric Acid	N/A	approved;experimental;investigational	Adenine phosphoribosyltransferase	P07741	28819	None	unknown
DB01632	Alpha-Phosphoribosylpyrophosphoric Acid	N/A	approved;experimental;investigational	Anthranilate phosphoribosyltransferase	Q8VP84	None	None	unknown
DB01632	Alpha-Phosphoribosylpyrophosphoric Acid	N/A	approved;experimental;investigational	Hypoxanthine-guanine phosphoribosyltransferase	P00492	306885	None	unknown
DB01632	Alpha-Phosphoribosylpyrophosphoric Acid	N/A	approved;experimental;investigational	Orotate phosphoribosyltransferase	P08870	47812	None	unknown
DB01632	Alpha-Phosphoribosylpyrophosphoric Acid	N/A	approved;experimental;investigational	Uridine-cytidine kinase-like 1	Q9NWZ5	None	None	unknown
DB01638	Sorbitol	Osmotically acting laxatives	approved	Xylose isomerase	P24300	153534	None	unknown
DB01638	Sorbitol	Osmotically acting laxatives	approved	Xylose isomerase	P12851	580713	None	unknown
DB01638	Sorbitol	Osmotically acting laxatives	approved	Xylose isomerase	P12070	39059	None	unknown
DB01638	Sorbitol	Osmotically acting laxatives	approved	Malate synthase G	P37330	517247	None	unknown
DB01656	Roflumilast	Other systemic drugs for obstructive airway diseases	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Q08499	347130	inhibitor	unknown
DB01656	Roflumilast	Other systemic drugs for obstructive airway diseases	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	unknown
DB01656	Roflumilast	Other systemic drugs for obstructive airway diseases	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	unknown
DB01656	Roflumilast	Other systemic drugs for obstructive airway diseases	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Q08493	727223	inhibitor	unknown
DB01685	Topiroxostat	N/A	approved;investigational	Xanthine dehydrogenase/oxidase	P47989	10336525	None	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Estrogen receptor alpha	P03372	31234	binder	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Estrogen receptor beta	Q92731	2911152	activator	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	GABA-A receptor (anion channel)	Q9UN88	7861736	antagonist	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	NMDA receptor	O60391	3025446	agonist	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Androgen receptor	P10275	178628	agonist	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Estradiol 17-beta-dehydrogenase 1	P14061	23365	None	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Bile salt sulfotransferase	Q06520	306702	None	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Sulfotransferase family cytosolic 2B member 1	O00204	1923291	None	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Peroxisome proliferator-activated receptor alpha	Q07869	307341	activator	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Sigma non-opioid intracellular receptor 1	Q99720	1783387	agonist	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	activator	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	activator	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Steroid Delta-isomerase	P07445	309871	None	unknown
DB01708	Prasterone	Androstan derivatives	approved;investigational;nutraceutical	Cholesterol oxidase	P22637	216385	None	unknown
DB01718	Cetrimonium	Medicated shampoos	approved	Cyclopropane mycolic acid synthase MmaA2	Q79FX6	None	None	unknown
DB01718	Cetrimonium	Medicated shampoos	approved	Cyclopropane mycolic acid synthase 1	P9WPB7	None	None	unknown
DB01744	Camphor	Other cardiac preparations	approved	Camphor 5-monooxygenase	P00183	151115	None	unknown
DB01744	Camphor	Other cardiac preparations	approved	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	agonist	yes
DB01744	Camphor	Other cardiac preparations	approved	Transient receptor potential cation channel subfamily V member 3	Q8NET8	None	agonist	yes
DB01744	Camphor	Other cardiac preparations	approved	Transient receptor potential cation channel subfamily A member 1	O75762	3287188	inhibitor	yes
DB01744	Camphor	Other cardiac preparations	approved	Transient receptor potential cation channel subfamily M member 8	Q7Z2W7	20147036	activator	yes
DB01764	Dalfopristin	N/A	approved	Streptogramin A acetyltransferase	P50870	433715	inhibitor	yes
DB01783	Pantothenic acid	Other cicatrizants	approved;nutraceutical;vet_approved	Pantothenate kinase	P0A6I3	147780	None	unknown
DB01839	Propylene glycol	N/A	approved;investigational	Coagulation factor XIII A chain	P00488	182309	None	unknown
DB01839	Propylene glycol	N/A	approved;investigational	Haloalkane dehalogenase	P51698	4521186	None	unknown
DB01839	Propylene glycol	N/A	approved;investigational	Clavaminate synthase 1	Q05581	153220	None	unknown
DB01839	Propylene glycol	N/A	approved;investigational	Lactaldehyde reductase	P0A9S1	None	None	unknown
DB01839	Propylene glycol	N/A	approved;investigational	B12-independent glycerol dehydratase	Q8GEZ8	None	None	unknown
DB01878	Benzophenone	N/A	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB01878	Benzophenone	N/A	approved	Estrogen receptor beta	Q92731	2911152	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Heme oxygenase 1	P09601	35173	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Ribonuclease pancreatic	P07998	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Dihydroorotate dehydrogenase (quinone)	P0A7E1	42609	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	(S)-2-haloacid dehalogenase	Q60099	155350	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Beta-lactamase OXA-2	P0A1V8	154222	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Catalase	P42321	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Signal recognition particle protein	O07347	2149137	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Streptavidin	P22629	46741	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Methylglyoxal synthase	P0A733	24051245	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	C-terminal-binding protein 1	Q13363	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	6-phosphogluconolactonase	Q9X0N8	4981702	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Citrate lyase subunit beta-like protein	P9WPE1	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Peripheral plasma membrane protein CASK	O14936	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Guanylate kinase	P9WKE9	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Probable butyrate kinase 2	Q9X278	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Gamma-glutamylaminecyclotransferase	Q9BVM4	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Parvalbumin alpha	P20472	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Acylphosphatase-2	P14621	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Uncharacterized protein	Q81C15	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Arginine N-succinyltransferase subunit alpha	P80357	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Putative mannose-6-phosphate isomerase YvyI	P39841	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Nitric oxide synthase, brain	P29475	642526	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	ABC-type transporter, periplasmic subunit	Q9X0V0	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Probable phosphatase YcdX	P75914	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Phenazine biosynthesis protein PhzD	Q7DC80	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Oxalate decarboxylase OxdC	O34714	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Putative ketoacyl reductase	P16544	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Gephyrin	Q9NQX3	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Glyoxalase family protein	Q81F54	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Cytohesin-2	Q99418	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Glutaconyl-CoA decarboxylase subunit alpha	Q06700	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Transcriptional regulator, IclR family	Q9WXS0	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Catalase	P77872	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Putative L-rhamnose mutarotase	Q9X0F9	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Glutathione S-transferase	Q8MU52	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Hypoxanthine-guanine phosphoribosyltransferase	Q27796	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Glutaminase 1	O31465	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Glutaminase 1	P77454	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Molybdopterin synthase catalytic subunit	P30749	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Aminotransferase, putative	Q9X0L5	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Iron binding protein FbpA	Q9Z4N6	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	DNA gyrase subunit B	Q5SHZ4	None	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Putative hydroxypyruvate isomerase YgbM	Q46891	882632	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Delta-aminolevulinic acid dehydratase	Q59643	1009431	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	3-phosphoshikimate 1-carboxyvinyltransferase	P0A6D3	40966	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Subtilisin Carlsberg	P00780	5921206	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Fibroblast growth factor 1	P05230	181942	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Peptide deformylase	P0A6K3	471304	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Para-aminobenzoate synthase component 1	P05041	147058	None	unknown
DB01942	Formic Acid	N/A	approved;experimental;investigational	Carbonic anhydrase 2	P00918	179780	None	unknown
DB01956	Taurine	N/A	approved;nutraceutical	Alpha-ketoglutarate-dependent taurine dioxygenase	P37610	1384060	None	unknown
DB01956	Taurine	N/A	approved;nutraceutical	Choloylglycine hydrolase	P54965	882252	None	unknown
DB01956	Taurine	N/A	approved;nutraceutical	Glycine receptor subunit alpha-1	P23415	31851	agonist	unknown
DB01956	Taurine	N/A	approved;nutraceutical	Glutamate receptor ionotropic, NMDA 2B	Q13224	1899202	inhibitor	yes
DB01956	Taurine	N/A	approved;nutraceutical	Glycine receptor subunit alpha-2	P23416	31849	agonist	yes
DB01956	Taurine	N/A	approved;nutraceutical	Glycine receptor subunit alpha-3	O75311	3342792	agonist	yes
DB01956	Taurine	N/A	approved;nutraceutical	GABA-A receptor (anion channel)	Q9UN88	7861736	agonist	yes
DB01956	Taurine	N/A	approved;nutraceutical	Gamma-aminobutyric acid type B receptor subunit 1	Q9UBS5	3892594	agonist	yes
DB01987	Cocarboxylase	N/A	approved;experimental	Benzoylformate decarboxylase	P20906	3093419	None	unknown
DB01987	Cocarboxylase	N/A	approved;experimental	Pyruvate oxidase	P37063	28272737	None	unknown
DB01987	Cocarboxylase	N/A	approved;experimental	DNA	None	None	None	unknown
DB01987	Cocarboxylase	N/A	approved;experimental	Pyruvate dehydrogenase E1 component	P0AFG8	None	None	unknown
DB01987	Cocarboxylase	N/A	approved;experimental	Pyruvate-flavodoxin oxidoreductase	P94692	None	None	unknown
DB01987	Cocarboxylase	N/A	approved;experimental	Indole-3-pyruvate decarboxylase	P23234	None	None	unknown
DB01987	Cocarboxylase	N/A	approved;experimental	Carboxyethylarginine synthase	Q9LCV9	None	None	unknown
DB01987	Cocarboxylase	N/A	approved;experimental	Transketolase 1	P27302	None	None	unknown
DB01987	Cocarboxylase	N/A	approved;experimental	Acetolactate synthase, catabolic	P27696	149211	None	unknown
DB02187	Equilin	N/A	approved	Estradiol 17-beta-dehydrogenase 1	P14061	23365	None	unknown
DB02187	Equilin	N/A	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB02300	Calcipotriol	Other antipsoriatics for topical use	approved	Vitamin D3 receptor	P11473	340203	antagonist	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	mRNA-capping enzyme	O60942	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	FMN-dependent NADH-azoreductase	P41407	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Transcription termination/antitermination protein NusG	O67757	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase	Q9BV57	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	GTP cyclohydrolase 1	P30793	7242659	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Growth/differentiation factor 5	P43026	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Subtilisin BPN'	P00782	142526	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Ig kappa chain V-IV region Len	P06312	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Ribonuclease pancreatic	P07998	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Pectate lyase	Q9X592	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Trypsin-2	P07478	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Gag polyprotein	P05893	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Aldehyde oxidoreductase	Q46509	853817	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Phospholipase A2, membrane associated	P14555	190889	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Ganglioside GM2 activator	P17900	183357	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Thermolysin	P43133	143254	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Scaffolding dockerin binding protein A	P71143	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Chitotriosidase-1	Q13231	1050958	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Alr1529 protein	Q8YWS4	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	L-xylulose reductase	Q7Z4W1	15425623	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Peroxiredoxin-6	P30041	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Hydrolase, TatD family	Q9WZD5	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Tumor necrosis factor	P01375	339741	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Tartrate-resistant acid phosphatase type 5	P13686	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Adenosylhomocysteinase	P23526	178277	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Spliceosome RNA helicase DDX39B	Q13838	None	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	DNA mismatch repair protein MutL	P23367	42067	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Gag-Pro-Pol polyprotein	Q04095	210273	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Lysozyme	P03706	215163	None	unknown
DB02325	Isopropyl Alcohol	Other antiseptics and disinfectants	approved;investigational	Glucarate dehydratase	P0AES2	1786182	None	unknown
DB02362	Aminobenzoic acid	Protectives against UV-radiation for topical use	approved;experimental	p-hydroxybenzoate hydroxylase	P20586	151506	None	unknown
DB02362	Aminobenzoic acid	Protectives against UV-radiation for topical use	approved;experimental	p-hydroxybenzoate hydroxylase	P00438	49145	None	unknown
DB02530	gamma-Aminobutyric acid	N/A	approved;investigational	Glycine amidinotransferase, mitochondrial	P50440	545385	None	unknown
DB02530	gamma-Aminobutyric acid	N/A	approved;investigational	Gamma-aminobutyric acid type B receptor subunit 1	Q9UBS5	3892594	None	unknown
DB02530	gamma-Aminobutyric acid	N/A	approved;investigational	Gamma-aminobutyric acid type B receptor subunit 2	O75899	3776098	None	unknown
DB02546	Vorinostat	Other antineoplastic agents	approved;investigational	Histone deacetylase 1	Q13547	1277084	inhibitor	yes
DB02546	Vorinostat	Other antineoplastic agents	approved;investigational	Histone deacetylase 2	Q92769	1667394	inhibitor	yes
DB02546	Vorinostat	Other antineoplastic agents	approved;investigational	Histone deacetylase 3	O15379	2326173	inhibitor	yes
DB02546	Vorinostat	Other antineoplastic agents	approved;investigational	Histone deacetylase 6	Q9UBN7	4754911	inhibitor	yes
DB02546	Vorinostat	Other antineoplastic agents	approved;investigational	Histone deacetylase 8	Q9BY41	8118721	None	unknown
DB02546	Vorinostat	Other antineoplastic agents	approved;investigational	Acetoin utilization protein	O67135	None	None	unknown
DB02638	Terlipressin	Vasopressin and analogues	approved;investigational	Vasopressin V2 receptor	P30518	28418	agonist	yes
DB02638	Terlipressin	Vasopressin and analogues	approved;investigational	Vasopressin V1b receptor	P47901	563982	None	unknown
DB02638	Terlipressin	Vasopressin and analogues	approved;investigational	Vasopressin V1a receptor	P37288	667068	stimulator	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Ferrochelatase, mitochondrial	P22830	219656	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Alcohol dehydrogenase 1C	P00326	28404	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Estrogen-related receptor gamma	P62508	4092075	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Gastrotropin	P51161	894183	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 4 isoform 1, mitochondrial	P13073	180933	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 1	P00395	13006	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 2	P00403	None	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 3	P00414	337189	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 5A, mitochondrial	P20674	695360	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 5B, mitochondrial	P10606	None	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 6C	P09669	1200057	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 7B, mitochondrial	P24311	30151	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 7C, mitochondrial	P15954	30155	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 8A, mitochondrial	P10176	38614453	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 6A2, mitochondrial	Q02221	180946	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 6B1	P14854	30295	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Cytochrome c oxidase subunit 7A1, mitochondrial	P24310	181405	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Phospholipase A2	P04054	190013	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Liver carboxylesterase 1	P23141	None	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Ferrochelatase	Q7KZA3	33096717	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Choloylglycine hydrolase	P54965	882252	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	Bile acid receptor	Q96RI1	1546084	None	unknown
DB02659	Cholic Acid	Bile acid preparations	approved	G-protein coupled bile acid receptor 1	Q8TDU6	None	None	unknown
DB02701	Nicotinamide	Other plain vitamin preparations	approved;investigational	Exotoxin A	P11439	151216	None	unknown
DB02701	Nicotinamide	Other plain vitamin preparations	approved;investigational	L-lactate dehydrogenase A chain	P00338	34313	None	unknown
DB02701	Nicotinamide	Other plain vitamin preparations	approved;investigational	Poly [ADP-ribose] polymerase 1	P09874	1017423	binder	unknown
DB02701	Nicotinamide	Other plain vitamin preparations	approved;investigational	NAD-dependent protein deacylase sirtuin-5, mitochondrial	Q9NXA8	None	None	unknown
DB02701	Nicotinamide	Other plain vitamin preparations	approved;investigational	ADP-ribosyl cyclase 2	Q10588	999429	None	unknown
DB02703	Fusidic Acid	Steroid antibacterials	approved;investigational	Elongation factor G	P13551	None	inhibitor	yes
DB02703	Fusidic Acid	Steroid antibacterials	approved;investigational	Chloramphenicol acetyltransferase	P62580	16505914	inhibitor	unknown
DB02703	Fusidic Acid	Steroid antibacterials	approved;investigational	Chloramphenicol acetyltransferase 3	P00484	47025	inhibitor	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Ribosyldihydronicotinamide dehydrogenase [quinone]	P16083	190818	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Casein kinase II subunit alpha	P68400	598147	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Arachidonate 15-lipoxygenase	P16050	307135	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Arachidonate 5-lipoxygenase	P09917	187193	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Aryl hydrocarbon receptor	P35869	533324	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Phosphatidylinositol 4-kinase type 2-beta	Q8TCG2	None	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Integrin alpha-5	P08648	None	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Integrin beta-3	P05106	306786	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Amyloid beta A4 protein	P05067	None	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Alpha-synuclein	P37840	437365	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Estrogen receptor alpha	P03372	31234	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Melatonin receptor type 1A	P48039	602130	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Melatonin receptor type 1B	P49286	971194	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	C-type lectin domain family 14 member A	Q86T13	None	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Solute carrier family 2, facilitated glucose transporter member 1	P11166	183303	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Carbonyl reductase [NADPH] 1	P16152	None	inhibitor	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	RAC-alpha serine/threonine-protein kinase	P31749	190828	inhibitor	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Far upstream element-binding protein 2	Q92945	None	None	unknown
DB02709	Resveratrol	N/A	approved;experimental;investigational	Tyrosine--tRNA ligase, cytoplasmic	P54577	1184699	inhibitor	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Beta-glucosidase	Q59976	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Amylosucrase	Q9ZEU2	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Beta-lactamase	Q9L5C8	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Beta-lactamase CTX-M	Q9L5C7	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Heme oxygenase	P71119	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Copper transport protein ATOX1	O00244	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	tRNA-splicing ligase RtcB homolog	Q9Y3I0	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Orange carotenoid-binding protein	P83689	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Sucrose porin	P22340	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Levansucrase	P05655	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Beta-lactamase CTX-M-27	Q840M4	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	GDP-mannose 6-dehydrogenase	P11759	45268	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Actin, alpha skeletal muscle	P68133	178029	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Beta-lactamase	P00811	145267	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Nitric oxide synthase oxygenase	P0A094	21205025	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Lysozyme C	P61626	None	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Septum formation protein Maf	Q02169	143161	None	unknown
DB02772	Sucrose	N/A	approved;experimental;investigational	Taste receptor type 1 member 2	Q8TE23	20142333	None	unknown
DB02789	Pregnenolone	N/A	approved;experimental;investigational	Sulfotransferase family cytosolic 2B member 1	O00204	1923291	None	unknown
DB02789	Pregnenolone	N/A	approved;experimental;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB02893	D-Methionine	N/A	approved;experimental;investigational	Methionine aminopeptidase 2	P50579	903982	None	unknown
DB02893	D-Methionine	N/A	approved;experimental;investigational	Transcriptional regulator, HTH_3 family	Q9KQN0	None	None	unknown
DB02925	Piretanide	Sulfonamides, plain	approved	Solute carrier family 12 member 1	Q13621	1373425	inhibitor	unknown
DB02959	Oxitriptan	Other antidepressants	approved;investigational;nutraceutical	Tryptophan--tRNA ligase 2	Q9RVD6	6458825	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Alcohol dehydrogenase class-3	P11766	178134	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	3-oxoacyl-[acyl-carrier-protein] synthase 1	P0A953	145884	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Ferrichrome-iron receptor	P06971	2226438	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Ganglioside GM2 activator	P17900	183357	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	3-oxoacyl-[acyl-carrier-protein] synthase 3	P9WNG3	None	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Genome polyprotein	Q82122	409464	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Genome polyprotein	P23008	None	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Genome polyprotein	P04936	1617204	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Hepatocyte nuclear factor 4-alpha	P41235	1595752	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Phospholipase A2, membrane associated	P14555	190889	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Very low-density lipoprotein receptor	P98155	409426	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Glycolipid transfer protein	Q9NZD2	6959686	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	3-oxoacyl-[acyl-carrier-protein] synthase 2	P0AAI5	572680	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Lactotransferrin	P02788	34416	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Protein TonB	P02929	148023	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Complement component C8 gamma chain	P07360	None	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Group IID secretory phospholipase A2	Q9UNK4	5771420	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Acyl-homoserine lactone acylase PvdQ	Q9I194	9945819	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Lymphocyte antigen 96	Q9Y6Y9	5051740	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Toll-like receptor 4	O00206	None	None	unknown
DB03017	Lauric Acid	N/A	approved;experimental	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB03085	Glycolic acid	N/A	approved;investigational	Glucose-6-phosphate 1-dehydrogenase	P11413	31543	None	unknown
DB03085	Glycolic acid	N/A	approved;investigational	Glycine oxidase	O31616	2633520	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Vascular endothelial growth factor A	P15692	181971	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Pancreatic alpha-amylase	P04746	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Ig lambda-1 chain C regions	P0CG04	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Ig lambda chain V-II region MGC	P01709	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Trefoil factor 2	Q03403	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Cytochrome c2	P00091	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Disintegrin and metalloproteinase domain-containing protein 28	Q9UKQ2	4583505	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Endo-1,4-beta-xylanase	Q7SIE2	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Dissimilatory copper-containing nitrite reductase	O68601	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Keratin-associated protein 5-2	Q701N4	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Orexin	O43612	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	C-C motif chemokine 8	P80075	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Cytochrome c'	P00138	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Alpha-amylase 2B	P19961	None	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Angiogenin	P03950	178250	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Chondroitinase-B	Q46079	1002527	None	unknown
DB03088	Pidolic Acid	Magnesium	approved;investigational	Alpha-amylase 1	P04745	178585	None	unknown
DB03128	Acetylcholine	Parasympathomimetics	approved	Acetylcholinesterase	P22303	177975	None	unknown
DB03128	Acetylcholine	Parasympathomimetics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	None	unknown
DB03128	Acetylcholine	Parasympathomimetics	approved	Muscarinic acetylcholine receptor M2	P08172	177990	None	unknown
DB03128	Acetylcholine	Parasympathomimetics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	None	unknown
DB03128	Acetylcholine	Parasympathomimetics	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	None	unknown
DB03128	Acetylcholine	Parasympathomimetics	approved	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	UDP-galactopyranose mutase	P37747	510253	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Flavohemoprotein	P39662	460999	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Glycine oxidase	O31616	2633520	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	NADPH--cytochrome P450 reductase	P16435	247307	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Glutaryl-CoA dehydrogenase, mitochondrial	Q92947	1549327	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Medium-chain specific acyl-CoA dehydrogenase, mitochondrial	P11310	187433	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	D-amino-acid oxidase	P14920	30446	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Bifunctional protein PutA	P09546	468875	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Deoxyribodipyrimidine photo-lyase	P61497	15080709	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Amine oxidase [flavin-containing] A	P21397	187353	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Short-chain specific acyl-CoA dehydrogenase, mitochondrial	P16219	337928	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	L-amino-acid oxidase	Q96RQ9	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	2,4-dienoyl-CoA reductase [NADPH]	P42593	2584857	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	2-oxopropyl-CoM reductase, carboxylating	Q56839	929914	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	p-hydroxybenzoate hydroxylase	P20586	151506	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Nitric oxide synthase, brain	P29475	642526	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	NAD(P)H dehydrogenase [quinone] 1	P15559	189246	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	p-hydroxybenzoate hydroxylase	P00438	49145	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Fumarate reductase flavoprotein subunit	P83223	24346572	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	ERO1-like protein beta	Q86YB8	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Glutathione reductase, mitochondrial	P00390	31825	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	NADPH-ferredoxin reductase FprA	P9WIQ3	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	NADH-cytochrome b5 reductase 3	P00387	553600	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Cholesterol oxidase	P12676	153212	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Thymidylate synthase ThyX	Q9WYT0	4980954	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Pyruvate oxidase	P37063	28272737	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Thioredoxin reductase	P0A9P4	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Glutathione reductase	P06715	146248	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	5,10-methylenetetrahydrofolate reductase	P0AEZ1	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Monomeric sarcosine oxidase	P40859	984788	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Trypanothione reductase	P28593	162317	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Ribosyldihydronicotinamide dehydrogenase [quinone]	P16083	190818	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Isovaleryl-CoA dehydrogenase, mitochondrial	P26440	306897	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Xanthine dehydrogenase/oxidase	P47989	10336525	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Cholesterol oxidase	P22637	216385	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	N,N-dimethylglycine oxidase	Q9AGP8	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	NADH peroxidase	P37062	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Dihydropyrimidine dehydrogenase [NADP(+)]	Q12882	558305	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Ferredoxin--NADP reductase	P21890	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	D-lactate dehydrogenase	P06149	145753	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Sulfite reductase [NADPH] flavoprotein alpha-component	P38038	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Thioredoxin reductase 1, cytoplasmic	Q16881	1237038	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Ferredoxin--NADP reductase	Q44532	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Isobutyryl-CoA dehydrogenase, mitochondrial	Q9UKU7	6465955	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Acyl-CoA dehydrogenase, short-chain specific	Q06319	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Apoptosis-inducing factor 1, mitochondrial	O95831	4323587	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Ferredoxin reductase	Q52437	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Dihydrolipoyl dehydrogenase	P18925	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Amine oxidase, flavin-containing protein	Q888A4	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Deoxyribodipyrimidine photo-lyase	P00914	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Deoxyribodipyrimidine photo-lyase	P05327	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	L-aspartate oxidase	P10902	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Cryptochrome DASH	P77967	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Dihydrolipoyl dehydrogenase, mitochondrial	P09622	307137	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Fumarate reductase flavoprotein subunit	Q9Z4P0	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	NADH-cytochrome b5 reductase 1	Q9UHQ9	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Oxidoreductase	Q7SID9	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Amine oxidase [flavin-containing] B	P27338	398415	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	NADPH:adrenodoxin oxidoreductase, mitochondrial	P22570	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Peroxisomal acyl-coenzyme A oxidase 1	Q15067	495475	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	UDP-N-acetylenolpyruvoylglucosamine reductase	P08373	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	FAD-linked sulfhydryl oxidase ALR	P55789	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	UDP-N-acetylenolpyruvoylglucosamine reductase	P61432	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Flavohemoprotein	P24232	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Phenol 2-hydroxylase component B	Q9LAG2	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Methylenetetrahydrofolate reductase	Q9RA47	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Putidaredoxin reductase	P16640	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	NAD(P)H dehydrogenase (quinone)	P9WHH7	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	UDP-galactopyranose mutase	P9WIQ1	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	4-hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA-Delta-isomerase	P55792	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	4-cresol dehydrogenase [hydroxylating] flavoprotein subunit	P09788	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Alkyl hydroperoxide reductase subunit F	P19480	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Outer membrane protein p64k or PM-6	Q51225	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Glutathione reductase	Q94655	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Phenylacetone monooxygenase	Q47PU3	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Benzoate 1,2-dioxygenase electron transfer component	P07771	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Putative acyl-CoA dehydrogenase	Q72JJ3	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	FkbI	Q9KIE5	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Dihydrolipoyl dehydrogenase	P09063	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Dihydrolipoyl dehydrogenase	P14218	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Alkyl hydroperoxide reductase subunit F	P35340	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Ferredoxin--NADP reductase	P58558	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Ferredoxin--NADP reductase	P28861	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Mersacidin decarboxylase	Q9RC23	None	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	Fumarate reductase flavoprotein subunit	P0C278	4539587	None	unknown
DB03147	Flavin adenine dinucleotide	N/A	approved	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial	Q16795	5326823	cofactor	unknown
DB03175	Propyl alcohol	N/A	approved;experimental	Lysozyme C	P61626	None	None	unknown
DB03193	Stearic acid	N/A	approved;experimental	Group IID secretory phospholipase A2	Q9UNK4	5771420	None	unknown
DB03193	Stearic acid	N/A	approved;experimental	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Trimethylamine dehydrogenase	P16099	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Rubredoxin-oxygen oxidoreductase	Q9F0J6	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Riboflavin biosynthesis protein RibF	Q9WZW1	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Morphinone reductase	Q51990	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	NADPH-flavin oxidoreductase	Q56691	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Ribosomal protein S6 kinase alpha-4	O75676	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Phenazine biosynthesis protein PhzG	Q51793	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Hydroxyacid oxidase 2	Q9NYQ3	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	NAD(P)H dehydrogenase (quinone)	Q9RYU4	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Flavodoxin-1	P61949	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Isopentenyl-diphosphate delta-isomerase	P50740	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	NADH dehydrogenase	Q60049	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	FMN-binding protein	Q46604	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Nitroreductase family protein	Q81EW9	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	NADPH--cytochrome P450 reductase	P16435	247307	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Phosphopantothenoylcysteine decarboxylase	Q96CD2	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	PhzG	O69755	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Ferredoxin-dependent glutamate synthase 2	P55038	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Pyridoxine/pyridoxamine 5'-phosphate oxidase	P0AFI7	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Flavodoxin	P00322	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Oxygen-insensitive NAD(P)H nitroreductase	P38489	538227	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Chorismate synthase	P0A2Y7	15458869	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	2,4-dienoyl-CoA reductase [NADPH]	P42593	2584857	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Dihydroorotate dehydrogenase A (fumarate)	Q53ZE5	33302311	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Flavin reductase (NADPH)	P30043	1384068	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Hydroxyacid oxidase 1	Q9UJM8	7530485	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Pyridoxine-5'-phosphate oxidase	Q9NVS9	21728336	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Major NAD(P)H-flavin oxidoreductase	P46072	6539550	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Riboflavin kinase	Q969G6	7023634	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Oxygen-insensitive NADPH nitroreductase	P17117	609324	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Nitric oxide synthase, brain	P29475	642526	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Dihydroorotate dehydrogenase (quinone)	P0A7E1	42609	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Dihydropyrimidine dehydrogenase [NADP(+)]	Q12882	558305	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Dihydroorotate dehydrogenase (quinone), mitochondrial	Q02127	555594	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Pentaerythritol tetranitrate reductase	P71278	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	FMN-dependent NADH-azoreductase	P63462	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Epidermin decarboxylase	P30197	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	FMN-dependent NADH-azoreductase	P41407	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Chorismate synthase	P56122	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Flavodoxin	P0A3D9	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Flavodoxin	P00323	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Flavodoxin	P10340	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Putative uncharacterized protein	Q8DW21	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Putative monooxygenase MoxC	O34974	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	tRNA-dihydrouridine synthase	Q9WXV1	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Protein NrdI	P50618	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Probable aromatic acid decarboxylase	P69772	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	(S)-mandelate dehydrogenase	P20932	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	FMN-dependent NADPH-azoreductase	O07529	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Flavodoxin	Q9ZK53	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Serine/threonine-protein kinase Sgk1	O00141	1834511	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Oxygen-insensitive NAD(P)H nitroreductase	Q01234	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Nitric oxide reductase	Q9FDN7	None	None	unknown
DB03247	Flavin mononucleotide	N/A	approved;investigational	Isopentenyl-diphosphate delta-isomerase	Q746I8	None	None	unknown
DB03255	Phenol	Phenol and derivatives	approved;experimental	Thermolysin	P43133	143254	None	unknown
DB03255	Phenol	Phenol and derivatives	approved;experimental	Lysozyme	P00720	15261	None	unknown
DB03255	Phenol	Phenol and derivatives	approved;experimental	Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase	Q05603	535767	None	unknown
DB03255	Phenol	Phenol and derivatives	approved;experimental	Serum albumin	P02768	28590	None	unknown
DB03310	Glutathione disulfide	N/A	approved;experimental;investigational	Glutathione S-transferase Mu 2	P28161	183301	None	unknown
DB03310	Glutathione disulfide	N/A	approved;experimental;investigational	Glutathione reductase, mitochondrial	P00390	31825	None	unknown
DB03585	Oxyphenbutazone	Antiinflammatory agents, non-steroids	approved;withdrawn	Group IIE secretory phospholipase A2	Q9NZK7	7108923	None	unknown
DB03614	Methylcobalamin	Vitamin B12 (cyanocobalamin and analogues)	approved;experimental;investigational	Methionine synthase	P13009	581135	None	unknown
DB03615	Ribostamycin	Other aminoglycosides	approved;investigational	Aminoglycoside N(6')-acetyltransferase type 1	Q9R381	None	None	unknown
DB03615	Ribostamycin	Other aminoglycosides	approved;investigational	Aminoglycoside 2'-N-acetyltransferase	P9WQG9	None	None	unknown
DB03615	Ribostamycin	Other aminoglycosides	approved;investigational	Protein disulfide-isomerase	P07237	None	None	unknown
DB03615	Ribostamycin	Other aminoglycosides	approved;investigational	30S ribosomal protein S12	P0A7S3	43010	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	Steroid Delta-isomerase	P07445	309871	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	PpcA	Q8GGK7	None	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	Elongation factor Tu GTP-binding domain-containing protein 1	Q7Z2Z2	10434992	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	Choloylglycine hydrolase	P54965	882252	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	Lactaldehyde dehydrogenase	P25553	145222	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	Acriflavine resistance protein B	P31224	290406	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	Cytochrome c oxidase subunit 1	P33517	21955871	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	Cytochrome c oxidase subunit 2	Q03736	15022167	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	Bile acid receptor	Q96RI1	1546084	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	Glutathione S-transferase P	P09211	31946	None	unknown
DB03619	Deoxycholic Acid	N/A	approved	G-protein coupled bile acid receptor 1	Q8TDU6	None	None	unknown
DB03651	Picric acid	N/A	approved;experimental	Pentaerythritol tetranitrate reductase	P71278	None	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	Autolysin	P06653	153695	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	Cytochrome c4	Q52369	516878	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	Soluble calcium-activated nucleotidase 1	Q8WVQ1	22218108	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	Lipoprotein NlpI	P0AFB1	None	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	DNA protection during starvation protein	Q8UCK6	None	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	Putative glucose-6-phosphate 1-epimerase	P44160	None	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	Endonuclease 8-like 1	Q96FI4	None	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	Cholera enterotoxin subunit B	P01556	48348	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	S-adenosylmethionine decarboxylase proenzyme	P17707	178518	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	Biotin synthase	P12996	145425	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	Vascular endothelial growth factor A	P15692	181971	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	6-phosphogluconolactonase	Q9X0N8	4981702	None	unknown
DB03754	Tromethamine	Other i.v. solution additives	approved	Decorin	P07585	None	None	unknown
DB03756	Doconexent	N/A	approved;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	ligand	yes
DB03756	Doconexent	N/A	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	ligand	yes
DB03756	Doconexent	N/A	approved;investigational	Retinoic acid receptor RXR-alpha	P19793	35885	activator	yes
DB03756	Doconexent	N/A	approved;investigational	Retinoic acid receptor RXR-beta	P28702	30448	activator	yes
DB03756	Doconexent	N/A	approved;investigational	Retinoic acid receptor RXR-gamma	P48443	1053069	activator	yes
DB03756	Doconexent	N/A	approved;investigational	Sterol regulatory element-binding protein 1	P36956	None	inhibitor	unknown
DB03766	Propanoic acid	N/A	approved;vet_approved	Non-heme chloroperoxidase	O31158	2623869	None	unknown
DB03766	Propanoic acid	N/A	approved;vet_approved	Gephyrin	Q9NQX3	None	None	unknown
DB03766	Propanoic acid	N/A	approved;vet_approved	2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase	P96965	None	None	unknown
DB03766	Propanoic acid	N/A	approved;vet_approved	Alanine racemase	P10724	142467	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Hydrogen peroxide-inducible genes activator	P0ACQ4	147042	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	HTH-type transcriptional regulator MalT	P06993	146717	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Tautomerase PptA	P31992	4377521	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	D-amino-acid oxidase	P14920	30446	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Ribonuclease UK114	P52758	1177435	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Chlorocatechol 1,2-dioxygenase	O67987	2935033	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Ras-related protein Rab-9A	P51151	1174147	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase	P96965	None	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Non-heme chloroperoxidase	O31168	None	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Oxygen-insensitive NAD(P)H nitroreductase	Q01234	None	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Hydroxyquinol 1,2-dioxygenase	Q5PXQ6	None	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Replication protein	Q52546	None	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Peroxiredoxin-5, mitochondrial	P30044	6523289	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Heat-labile enterotoxin B chain	P32890	145833	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Cocaine esterase	Q9L9D7	7229394	None	unknown
DB03793	Benzoic Acid	Tests for gastric secretion	approved;investigational	Solute carrier family 15 member 1	P46059	773588	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Glycodelin	P09466	190215	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Hepatocyte nuclear factor 4-gamma	Q14541	None	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Lipid binding protein	P83812	None	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Cytochrome P450 2C8	P10632	None	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Trafficking protein particle complex subunit 3	O43617	None	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Fatty acid-binding protein TM_1468	Q9X1H9	None	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Rhodopsin	P08100	1236137	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	SEC14-like protein 2	O76054	5596693	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Palmitoyl-protein thioesterase 1	P50897	None	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Myelin P2 protein	P02689	35186	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Alpha-lactalbumin	P00709	None	None	unknown
DB03796	Palmitic Acid	N/A	approved;experimental	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB03843	Formaldehyde	N/A	approved;vet_approved	D-alanyl-D-alanine carboxypeptidase	P15555	515050	None	unknown
DB03904	Urea	N/A	approved;investigational	Arginase-1	P05089	178995	None	unknown
DB03904	Urea	N/A	approved;investigational	Carbonic anhydrase 2	P00918	179780	None	unknown
DB03904	Urea	N/A	approved;investigational	Structural polyprotein	P09592	323726	None	unknown
DB03904	Urea	N/A	approved;investigational	Catenin beta-1	P35222	860988	None	unknown
DB03904	Urea	N/A	approved;investigational	Sulfoxide reductase catalytic subunit YedY	Q8XB74	12516082	None	unknown
DB03904	Urea	N/A	approved;investigational	Dihydrofolate reductase	P0ABQ4	146006	None	unknown
DB03929	D-Serine	N/A	approved;experimental;investigational	Glycine receptor subunit alpha-1	P23415	31851	None	unknown
DB03929	D-Serine	N/A	approved;experimental;investigational	Glutamate receptor ionotropic, NMDA 1	Q05586	219920	None	unknown
DB03929	D-Serine	N/A	approved;experimental;investigational	Serpin B3	P29508	None	None	unknown
DB03929	D-Serine	N/A	approved;experimental;investigational	Head decoration protein	P36275	None	None	unknown
DB04115	Berberine	N/A	approved;investigational	HTH-type transcriptional regulator QacR	P0A0N5	8574416	None	unknown
DB04115	Berberine	N/A	approved;investigational	Baculoviral IAP repeat-containing protein 5	O15392	None	None	unknown
DB04160	Pyrophosphoric acid	N/A	approved;experimental	Adenylosuccinate synthetase	Q83P33	24054860	None	unknown
DB04160	Pyrophosphoric acid	N/A	approved;experimental	NH(3)-dependent NAD(+) synthetase	P18843	146974	None	unknown
DB04160	Pyrophosphoric acid	N/A	approved;experimental	Thymidylate kinase	P9WKE1	None	None	unknown
DB04160	Pyrophosphoric acid	N/A	approved;experimental	Ferrichrome-iron receptor	P06971	2226438	None	unknown
DB04160	Pyrophosphoric acid	N/A	approved;experimental	Farnesyl diphosphate synthase	P22939	216583	None	unknown
DB04160	Pyrophosphoric acid	N/A	approved;experimental	Isopentenyl-diphosphate Delta-isomerase	Q46822	4633513	None	unknown
DB04173	Fructose	Carbohydrates	approved;experimental	Maltoporin	P02943	None	None	unknown
DB04173	Fructose	Carbohydrates	approved;experimental	Bis(5'-adenosyl)-triphosphatase	P49789	1203836	None	unknown
DB04209	Dequalinium	Antiseptics	approved;investigational	Acriflavine resistance protein B	P31224	290406	None	unknown
DB04209	Dequalinium	Antiseptics	approved;investigational	HTH-type transcriptional regulator QacR	P0A0N5	8574416	None	unknown
DB04209	Dequalinium	Antiseptics	approved;investigational	E3 ubiquitin-protein ligase XIAP	P98170	1184320	antagonist	yes
DB04209	Dequalinium	Antiseptics	approved;investigational	cGMP-gated cation channel alpha-1	P29973	None	blocker	unknown
DB04209	Dequalinium	Antiseptics	approved;investigational	Calcium-activated potassium channel subunit alpha-1	Q12791	537439	inhibitor	unknown
DB04221	Didecyldimethylammonium	N/A	approved;experimental	Cyclopropane mycolic acid synthase 2	P9WPB5	None	None	unknown
DB04224	Oleic Acid	N/A	approved;investigational;vet_approved	Glycolipid transfer protein	Q9NZD2	6959686	None	unknown
DB04224	Oleic Acid	N/A	approved;investigational;vet_approved	14 kDa fatty acid-binding protein	P29498	160984	None	unknown
DB04224	Oleic Acid	N/A	approved;investigational;vet_approved	Myelin P2 protein	P02689	35186	None	unknown
DB04224	Oleic Acid	N/A	approved;investigational;vet_approved	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB04224	Oleic Acid	N/A	approved;investigational;vet_approved	Peroxisome proliferator-activated receptor delta	Q03181	190230	None	unknown
DB04224	Oleic Acid	N/A	approved;investigational;vet_approved	Retinoic acid receptor RXR-alpha	P19793	35885	None	unknown
DB04224	Oleic Acid	N/A	approved;investigational;vet_approved	Peroxisome proliferator-activated receptor gamma	P37231	1711117	ligand	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	KHG/KDPG aldolase	P0A955	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Molybdenum cofactor guanylyltransferase	P32173	304962	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Fumarate hydratase class II	P05042	41513	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	6-phosphogluconolactonase	Q9X0N8	4981702	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Oxygen-insensitive NAD(P)H nitroreductase	P38489	538227	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Gag-Pro-Pol polyprotein	Q04095	210273	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	L-amino-acid oxidase	Q96RQ9	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Macrophage migration inhibitory factor	P14174	188556	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1	Q9GZU7	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	1-deoxy-D-xylulose 5-phosphate reductoisomerase	P45568	3434984	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Tryptophan synthase alpha chain	P16608	155133	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Sialidase	Q02834	216784	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Cytochrome c peroxidase	P83787	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Hepatocyte growth factor-regulated tyrosine kinase substrate	O14964	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Invasin	P11922	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Intron-associated endonuclease 1	P13299	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Short tail fiber protein	P10930	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Malate dehydrogenase, mitochondrial	P40926	2906146	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	N5-carboxyaminoimidazole ribonucleotide mutase	Q2QJL3	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	50S ribosomal protein L4	P38516	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Carboxypeptidase B	P15086	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Hexon protein	P03277	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Riboflavin biosynthesis protein RibF	Q9WZW1	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Beta-fructosidase	O33833	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Putative stringent starvation protein A	Q7CL96	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Citrate synthase	Q9LCX9	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	RNA 3'-terminal phosphate cyclase	P46849	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	U6 snRNA-associated Sm-like protein LSm6	P62312	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Pleckstrin homology domain-containing family A member 1	Q9HB21	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Fe(3+)-binding periplasmic protein	P21408	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Signal recognition particle receptor FtsY	Q9WZ40	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Nicotinate-nucleotide adenylyltransferase	P0A753	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	N utilization substance protein B homolog	Q9X286	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Complement component C8 gamma chain	P07360	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Ribonucleoside-diphosphate reductase subunit beta	Q9CBQ2	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Glutamine synthetase 1	P9WN38	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Citrate synthase	O34002	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Prostaglandin F synthase	Q9GV41	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Cell division protein FtsZ	P9WN95	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Adenine phosphoribosyltransferase	P07741	28819	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Angiogenin	P03950	178250	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Glucose-1-phosphate thymidylyltransferase	Q9HU22	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Beta-lactamase 2	P04190	142604	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Glyoxalase family protein	Q81F54	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Uridine-cytidine kinase 2	Q9BZX2	1655420	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Tumor necrosis factor ligand superfamily member 13B	Q9Y275	4761612	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Laccase domain protein YfiH	P33644	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Betaine--homocysteine S-methyltransferase 1	Q93088	1522683	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Ribose-5-phosphate isomerase A	P44725	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Tryptophan--tRNA ligase	P00953	143784	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	GMP synthase [glutamine-hydrolyzing]	P04079	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Aldose reductase	P15121	178487	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Inosine triphosphate pyrophosphatase	Q9BY32	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Citrate synthase, mitochondrial	O75390	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Lysozyme	Q37875	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Heparan sulfate glucosamine 3-O-sulfotransferase 3A1	Q9Y663	4835723	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Glycerol uptake operon antiterminator regulatory protein	Q9X1F0	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	cGMP-specific 3',5'-cyclic phosphodiesterase	O76074	3420185	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	3-carboxy-cis,cis-muconate cycloisomerase	P32427	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Proto-oncogene tyrosine-protein kinase Src	P12931	10635153	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Pyruvate decarboxylase	P06672	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Ribonuclease pancreatic	P07998	None	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Isocitrate dehydrogenase [NADP]	P39126	487434	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Glycine N-methyltransferase	Q14749	8671584	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Eosinophil cationic protein	P12724	31077	None	unknown
DB04272	Citric Acid	Acid preparations	approved;nutraceutical;vet_approved	Beta-lactamase	P00808	39575	None	unknown
DB04335	Inosine	Other antiinfectives and antiseptics	approved;investigational	IAG-nucleoside hydrolase	Q9GPQ4	None	None	unknown
DB04335	Inosine	Other antiinfectives and antiseptics	approved;investigational	Purine nucleoside phosphorylase	P00491	35565	None	unknown
DB04335	Inosine	Other antiinfectives and antiseptics	approved;investigational	Purine nucleoside phosphorylase DeoD-type	P0ABP8	147309	None	unknown
DB04339	Carbocisteine	Mucolytics	approved;investigational	Glutathione S-transferase P	P09211	31946	None	unknown
DB04398	Lactic Acid	Organic acids	approved;vet_approved	Bifunctional protein PutA	P09546	468875	None	unknown
DB04398	Lactic Acid	Organic acids	approved;vet_approved	NimA-related protein	Q9RW27	None	None	unknown
DB04465	Lactose	N/A	approved;investigational	Glycosyltransferase 6 domain-containing protein 1	Q7Z4J2	None	None	unknown
DB04465	Lactose	N/A	approved;investigational	Glycolipid transfer protein	Q9NZD2	6959686	None	unknown
DB04465	Lactose	N/A	approved;investigational	Enterotoxin type B	P01552	153000	None	unknown
DB04465	Lactose	N/A	approved;investigational	Sialidase	Q02834	216784	None	unknown
DB04465	Lactose	N/A	approved;investigational	Hydrolase	Q7SI98	None	None	unknown
DB04465	Lactose	N/A	approved;investigational	Endo-1,4-beta-xylanase A	P26514	None	None	unknown
DB04465	Lactose	N/A	approved;investigational	Beta-galactosidase	P00722	146577	None	unknown
DB04465	Lactose	N/A	approved;investigational	Tetanus toxin	P04958	40770	None	unknown
DB04465	Lactose	N/A	approved;investigational	Galectin-3	P17931	179531	None	unknown
DB04519	Caprylic acid	N/A	approved;experimental;investigational	3-oxoacyl-[acyl-carrier-protein] synthase 1	P0A953	145884	None	unknown
DB04519	Caprylic acid	N/A	approved;experimental;investigational	Acyl-CoA thioesterase I	P0ADA1	290474	None	unknown
DB04519	Caprylic acid	N/A	approved;experimental;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB04540	Cholesterol	N/A	approved;investigational	Nuclear receptor ROR-alpha	P35398	None	None	unknown
DB04540	Cholesterol	N/A	approved;investigational	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	None	unknown
DB04540	Cholesterol	N/A	approved;investigational	Vitamin D3 receptor	P11473	340203	None	unknown
DB04540	Cholesterol	N/A	approved;investigational	C-type lectin domain family 4 member E	Q9ULY5	None	ligand	unknown
DB04552	Niflumic Acid	Antiinflammatory preparations, non-steroids for topical use	approved	Phospholipase A2	P04054	190013	inhibitor	yes
DB04552	Niflumic Acid	Antiinflammatory preparations, non-steroids for topical use	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB04552	Niflumic Acid	Antiinflammatory preparations, non-steroids for topical use	approved	Chloride channel protein ClC-Ka	P51800	None	inducer	unknown
DB04552	Niflumic Acid	Antiinflammatory preparations, non-steroids for topical use	approved	Prostaglandin G/H synthase 1	P23219	387018	None	unknown
DB04552	Niflumic Acid	Antiinflammatory preparations, non-steroids for topical use	approved	Cytosolic phospholipase A2	P47712	190007	None	unknown
DB04552	Niflumic Acid	Antiinflammatory preparations, non-steroids for topical use	approved	UDP-glucuronosyltransferase 1-9	O60656	7690346	None	unknown
DB04564	Gluconolactone	N/A	approved;experimental	Lactase-phlorizin hydrolase	P09848	34400	None	unknown
DB04570	Latamoxef	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 3	P42971	790944	inhibitor	yes
DB04570	Latamoxef	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1A	P02918	581194	inhibitor	unknown
DB04570	Latamoxef	Third-generation cephalosporins	approved;investigational	Penicillin-binding protein 1B	P02919	42468	inhibitor	unknown
DB04570	Latamoxef	Third-generation cephalosporins	approved;investigational	D-alanyl-D-alanine carboxypeptidase DacB	P24228	41216	inhibitor	unknown
DB04571	Trioxsalen	Psoralens for topical use	approved	DNA	None	None	cross-linking/alkylation	yes
DB04572	Thiotepa	Ethylene imines	approved;investigational	DNA	None	None	cross-linking/alkylation	yes
DB04573	Estriol	Estrogens, combinations with other drugs	approved;investigational;vet_approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB04573	Estriol	Estrogens, combinations with other drugs	approved;investigational;vet_approved	Estrogen receptor beta	Q92731	2911152	agonist	unknown
DB04573	Estriol	Estrogens, combinations with other drugs	approved;investigational;vet_approved	Sex hormone-binding globulin	P04278	296673	None	unknown
DB04574	Estrone sulfate	N/A	approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB04574	Estrone sulfate	N/A	approved	Estrogen receptor beta	Q92731	2911152	agonist	unknown
DB04575	Quinestrol	N/A	approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB04576	Fleroxacin	Fluoroquinolones	approved	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB04576	Fleroxacin	Fluoroquinolones	approved	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB04576	Fleroxacin	Fluoroquinolones	approved	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB04657	Carboxin	N/A	approved;experimental;investigational	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	P31040	506338	None	unknown
DB04743	Nimesulide	Antiinflammatory preparations, non-steroids for topical use	approved;investigational;withdrawn	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB04743	Nimesulide	Antiinflammatory preparations, non-steroids for topical use	approved;investigational;withdrawn	Group IIE secretory phospholipase A2	Q9NZK7	7108923	None	unknown
DB04743	Nimesulide	Antiinflammatory preparations, non-steroids for topical use	approved;investigational;withdrawn	Lactotransferrin	P02788	34416	None	unknown
DB04786	Suramin	Other agents against leishmaniasis and trypanosomiasis	approved;investigational	P2Y purinoceptor 2	P41231	None	antagonist	yes
DB04786	Suramin	Other agents against leishmaniasis and trypanosomiasis	approved;investigational	NAD-dependent protein deacylase sirtuin-5, mitochondrial	Q9NXA8	None	inhibitor	yes
DB04786	Suramin	Other agents against leishmaniasis and trypanosomiasis	approved;investigational	Follicle-stimulating hormone receptor	P23945	182771	antagonist	yes
DB04786	Suramin	Other agents against leishmaniasis and trypanosomiasis	approved;investigational	Ryanodine receptor 1	P21817	337722	agonist	unknown
DB04786	Suramin	Other agents against leishmaniasis and trypanosomiasis	approved;investigational	Prothrombin	P00734	339641	inhibitor	unknown
DB04786	Suramin	Other agents against leishmaniasis and trypanosomiasis	approved;investigational	Phospholipase A2, membrane associated	P14555	190889	inhibitor	unknown
DB04786	Suramin	Other agents against leishmaniasis and trypanosomiasis	approved;investigational	Complement control protein C3	P68638	60691	None	unknown
DB04794	Bifonazole	Imidazole and triazole derivatives	approved;investigational	Lanosterol 14-alpha demethylase	P10613	578119	inhibitor	yes
DB04794	Bifonazole	Imidazole and triazole derivatives	approved;investigational	Cytochrome P450 2B6	P20813	181296	None	unknown
DB04817	Metamizole	Pyrazolones	approved;investigational;withdrawn	Prostaglandin G/H synthase 1	P23219	387018	None	unknown
DB04824	Phenolphthalein	Contact laxatives	approved;withdrawn	UDP-glucuronosyltransferase 1-9	O60656	7690346	None	unknown
DB04824	Phenolphthalein	Contact laxatives	approved;withdrawn	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB04824	Phenolphthalein	Contact laxatives	approved;withdrawn	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	None	unknown
DB04824	Phenolphthalein	Contact laxatives	approved;withdrawn	Estrogen receptor alpha	P03372	31234	agonist	unknown
DB04824	Phenolphthalein	Contact laxatives	approved;withdrawn	Sex hormone-binding globulin	P04278	296673	None	unknown
DB04835	Maraviroc	Other antivirals	approved;investigational	C-C chemokine receptor type 5	P51681	1262811	antagonist	yes
DB04837	Clofedanol	Other cough suppressants	approved;withdrawn	Histamine H1 receptor	P35367	510296	antagonist	yes
DB04838	Cyclandelate	Other peripheral vasodilators	approved	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	inhibitor	unknown
DB04838	Cyclandelate	Other peripheral vasodilators	approved	Liver carboxylesterase 1	P23141	None	None	unknown
DB04839	Cyproterone acetate	Antiandrogens and estrogens	approved;investigational	Androgen receptor	P10275	178628	antagonist	yes
DB04839	Cyproterone acetate	Antiandrogens and estrogens	approved;investigational	Prostate-specific antigen	P07288	None	None	unknown
DB04840	Debrisoquin	Guanidine derivatives	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inducer	yes
DB04841	Flunarizine	Antivertigo preparations	approved	Voltage-dependent T-type calcium channel subunit alpha-1G	O43497	6625659	inhibitor	yes
DB04841	Flunarizine	Antivertigo preparations	approved	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	inhibitor	yes
DB04841	Flunarizine	Antivertigo preparations	approved	Voltage-dependent T-type calcium channel subunit alpha-1I	Q9P0X4	5565888	inhibitor	yes
DB04841	Flunarizine	Antivertigo preparations	approved	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB04841	Flunarizine	Antivertigo preparations	approved	Calmodulin	P0DP23	179888	None	unknown
DB04842	Fluspirilene	Diphenylbutylpiperidine derivatives	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB04842	Fluspirilene	Diphenylbutylpiperidine derivatives	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB04842	Fluspirilene	Diphenylbutylpiperidine derivatives	approved;investigational	Voltage-dependent calcium channel gamma-1 subunit	Q06432	306473	inhibitor	unknown
DB04843	Mepenzolate	Synthetic anticholinergics, quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB04843	Mepenzolate	Synthetic anticholinergics, quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB04844	Tetrabenazine	Other nervous system drugs	approved;investigational	Synaptic vesicular amine transporter	Q05940	292335	inhibitor	yes
DB04844	Tetrabenazine	Other nervous system drugs	approved;investigational	D(2) dopamine receptor	P14416	181432	inhibitor	unknown
DB04845	Ixabepilone	Other cytotoxic antibiotics	approved;investigational	Tubulin beta-3 chain	Q13509	1297274	inhibitor	yes
DB04846	Celiprolol	Beta blocking agents, selective	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB04846	Celiprolol	Beta blocking agents, selective	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB04846	Celiprolol	Beta blocking agents, selective	approved;investigational	Beta-3 adrenergic receptor	P13945	178896	agonist	unknown
DB04846	Celiprolol	Beta blocking agents, selective	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB04846	Celiprolol	Beta blocking agents, selective	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB04846	Celiprolol	Beta blocking agents, selective	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB04854	Febuxostat	Preparations inhibiting uric acid production	approved	Xanthine dehydrogenase/oxidase	P47989	10336525	inhibitor	yes
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Alpha-1D adrenergic receptor	P25100	177807	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Alpha-2A adrenergic receptor	P08913	178196	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Alpha-2B adrenergic receptor	P18089	178198	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Alpha-2C adrenergic receptor	P18825	178194	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Beta-1 adrenergic receptor	P08588	178200	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Voltage-dependent L-type calcium channel subunit alpha-1F	O60840	3183953	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Voltage-dependent L-type calcium channel subunit beta-1	Q02641	179806	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Voltage-dependent L-type calcium channel subunit beta-3	P54284	435135	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Voltage-dependent L-type calcium channel subunit beta-4	O00305	2058727	None	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Sodium channel protein type 1 subunit alpha	P35498	12642270	inhibitor	unknown
DB04855	Dronedarone	Antiarrhythmics, class III	approved	Potassium channel subfamily K member 2	O95069	5712621	inhibitor	unknown
DB04861	Nebivolol	Beta blocking agents, selective, and other antihypertensives	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB04861	Nebivolol	Beta blocking agents, selective, and other antihypertensives	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB04864	Huperzine A	N/A	approved;investigational	Acetylcholinesterase	P22303	177975	None	unknown
DB04865	Omacetaxine mepesuccinate	Other antineoplastic agents	approved;investigational	50S ribosomal protein L2	P20276	None	antagonist	yes
DB04865	Omacetaxine mepesuccinate	Other antineoplastic agents	approved;investigational	60S ribosomal protein L3	P39023	313659	antagonist	yes
DB04868	Nilotinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase ABL1	P00519	28237	inhibitor	yes
DB04868	Nilotinib	Protein kinase inhibitors	approved;investigational	Mast/stem cell growth factor receptor Kit	P10721	34085	antagonist	unknown
DB04871	Lorcaserin	Centrally acting antiobesity products	approved	5-hydroxytryptamine receptor 2C	P28335	338028	None	unknown
DB04876	Vildagliptin	Dipeptidyl peptidase 4 (DPP-4) inhibitors	approved;investigational	Dipeptidyl peptidase 4	P27487	535388	inhibitor	yes
DB04877	Voacamine	N/A	approved;investigational	Multidrug resistance protein 1	P08183	307180	inhibitor	unknown
DB04878	Voglibose	Alpha glucosidase inhibitors	approved;investigational	Maltase-glucoamylase, intestinal	O43451	17648144	inhibitor	yes
DB04880	Enoximone	Phosphodiesterase inhibitors	approved;investigational	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	yes
DB04890	Bepotastine	N/A	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB04894	Vapreotide	Somatostatin and analogues	approved;investigational	Somatostatin receptor type 2	P30874	None	inducer	yes
DB04894	Vapreotide	Somatostatin and analogues	approved;investigational	Somatostatin receptor type 5	P35346	431095	agonist	yes
DB04894	Vapreotide	Somatostatin and analogues	approved;investigational	Substance-P receptor	P25103	8176544	antagonist	unknown
DB04895	Pegaptanib	Antineovascularisation agents	approved;investigational	Neuropilin-1	O14786	2407641	None	unknown
DB04896	Milnacipran	Other antidepressants	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB04896	Milnacipran	Other antidepressants	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB04896	Milnacipran	Other antidepressants	approved;investigational	NMDA receptor	O60391	3025446	inhibitor	unknown
DB04898	Ximelagatran	Direct thrombin inhibitors	approved;investigational;withdrawn	Prothrombin	P00734	339641	inhibitor	yes
DB04899	Nesiritide	Other vasodilators used in cardiac diseases	approved;investigational	Atrial natriuretic peptide receptor 1	P16066	28230	binder	unknown
DB04899	Nesiritide	Other vasodilators used in cardiac diseases	approved;investigational	Atrial natriuretic peptide receptor 2	P20594	5139790	None	unknown
DB04899	Nesiritide	Other vasodilators used in cardiac diseases	approved;investigational	Atrial natriuretic peptide receptor 3	P17342	None	None	unknown
DB04908	Flibanserin	Other gynecologicals	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	yes
DB04908	Flibanserin	Other gynecologicals	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB04908	Flibanserin	Other gynecologicals	approved;investigational	D(4) dopamine receptor	P21917	291946	antagonist	yes
DB04918	Ceftobiprole	Other cephalosporins and penems	approved;investigational	MecA	Q7DHH4	None	None	unknown
DB04918	Ceftobiprole	Other cephalosporins and penems	approved;investigational	Penicillin-binding protein 2x	P14677	None	None	unknown
DB04918	Ceftobiprole	Other cephalosporins and penems	approved;investigational	Peptidoglycan synthase FtsI	P0AD68	None	None	unknown
DB04920	Clevidipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1F	O60840	3183953	None	unknown
DB04920	Clevidipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	None	unknown
DB04920	Clevidipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	None	unknown
DB04920	Clevidipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	None	unknown
DB04930	Permethrin	Pyrethrines, incl. synthetic compounds	approved;investigational	Sodium channel protein type 1 subunit alpha	P35498	12642270	inhibitor	yes
DB04930	Permethrin	Pyrethrines, incl. synthetic compounds	approved;investigational	Estrogen receptor alpha	P03372	31234	None	unknown
DB04930	Permethrin	Pyrethrines, incl. synthetic compounds	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB04931	Afamelanotide	Protectives against UV-radiation for systemic use	approved;investigational	Melanocyte-stimulating hormone receptor	Q01726	None	None	unknown
DB04932	Defibrotide	Other antithrombotic agents	approved;investigational	Adenosine receptor A1	P30542	256155	None	unknown
DB04932	Defibrotide	Other antithrombotic agents	approved;investigational	Adenosine receptor A2a	P29274	177892	None	unknown
DB04932	Defibrotide	Other antithrombotic agents	approved;investigational	Adenosine receptor A2b	P29275	178150	None	unknown
DB04938	Ospemifene	Selective estrogen receptor modulators	approved;investigational	Estrogen receptor alpha	P03372	31234	antagonist	yes
DB04941	Crofelemer	N/A	approved	Cystic fibrosis transmembrane conductance regulator	P13569	180332	antagonist	yes
DB04941	Crofelemer	N/A	approved	Anoctamin-1	Q5XXA6	None	antagonist	yes
DB04942	Tamibarotene	N/A	approved;investigational	Retinoic acid receptor alpha	P10276	36157	agonist	yes
DB04942	Tamibarotene	N/A	approved;investigational	Retinoic acid receptor beta	P10826	35883	agonist	yes
DB04946	Iloperidone	Other antipsychotics	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB04946	Iloperidone	Other antipsychotics	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB04946	Iloperidone	Other antipsychotics	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB04946	Iloperidone	Other antipsychotics	approved	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB04946	Iloperidone	Other antipsychotics	approved	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB04946	Iloperidone	Other antipsychotics	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB04946	Iloperidone	Other antipsychotics	approved	5-hydroxytryptamine receptor 6	P50406	1162924	antagonist	unknown
DB04946	Iloperidone	Other antipsychotics	approved	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB04946	Iloperidone	Other antipsychotics	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB04946	Iloperidone	Other antipsychotics	approved	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB04946	Iloperidone	Other antipsychotics	approved	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB04948	Lofexidine	Drugs used in opioid dependence	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB04948	Lofexidine	Drugs used in opioid dependence	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	agonist	no
DB04948	Lofexidine	Drugs used in opioid dependence	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	no
DB04948	Lofexidine	Drugs used in opioid dependence	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	agonist	no
DB04948	Lofexidine	Drugs used in opioid dependence	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	agonist	no
DB04948	Lofexidine	Drugs used in opioid dependence	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	agonist	no
DB04951	Pirfenidone	Other immunosuppressants	approved;investigational	Furin	P09958	None	None	unknown
DB04953	Ezogabine	Other antiepileptics	approved;investigational	Potassium voltage-gated channel subfamily KQT member 2	O43526	1841342	None	unknown
DB04953	Ezogabine	Other antiepileptics	approved;investigational	Potassium voltage-gated channel subfamily KQT member 3	O43525	None	None	unknown
DB04953	Ezogabine	Other antiepileptics	approved;investigational	Potassium voltage-gated channel subfamily KQT member 4	P56696	None	None	unknown
DB04953	Ezogabine	Other antiepileptics	approved;investigational	Potassium voltage-gated channel subfamily KQT member 5	Q9NR82	None	None	unknown
DB04967	Lucanthone	N/A	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB04967	Lucanthone	N/A	approved;investigational	DNA-(apurinic or apyrimidinic site) lyase	P27695	None	inhibitor	yes
DB04967	Lucanthone	N/A	approved;investigational	DNA	None	None	intercalation	yes
DB04967	Lucanthone	N/A	approved;investigational	DNA topoisomerase 1	P11387	339806	inhibitor	yes
DB05013	Ingenol Mebutate	Other chemotherapeutics	approved	Protein kinase C delta type	Q05655	None	ligand	unknown
DB05013	Ingenol Mebutate	Other chemotherapeutics	approved	Protein kinase C alpha type	P17252	35483	ligand	unknown
DB05015	Belinostat	Other antineoplastic agents	approved;investigational	Histone deacetylase	Q9UKV0	15590680	inhibitor	yes
DB05018	Migalastat	N/A	approved;investigational	Alpha-galactosidase A	P06280	None	None	unknown
DB05039	Indacaterol	Adrenergics in combination with anticholinergics	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB05084	Abaloparatide	N/A	approved;investigational	Parathyroid hormone/parathyroid hormone-related peptide receptor	Q03431	None	ligand	yes
DB05099	Ancrod	Enzymes	approved;investigational	Fibrinogen alpha chain	P02671	13591824	None	unknown
DB05109	Trabectedin	Other plant alkaloids and natural products	approved;investigational	DNA	None	None	binder	yes
DB05219	Crisaborole	N/A	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	unknown
DB05219	Crisaborole	N/A	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	unknown
DB05219	Crisaborole	N/A	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Q08493	727223	inhibitor	unknown
DB05219	Crisaborole	N/A	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Q08499	347130	inhibitor	unknown
DB05239	Cobimetinib	N/A	approved;investigational	Dual specificity mitogen-activated protein kinase kinase 1	Q02750	188569	inhibitor	yes
DB05245	Silver sulfadiazine	Sulfonamides	approved;vet_approved	DNA	None	None	binder	yes
DB05246	Methsuximide	Succinimide derivatives	approved	Voltage-dependent T-type calcium channel subunit alpha-1G	O43497	6625659	inhibitor	yes
DB05258	Natural alpha interferon	N/A	approved;investigational	Interferon alpha/beta receptor 1	P17181	306914	None	unknown
DB05259	Glatiramer	Other immunostimulants	approved;investigational	HLA class II histocompatibility antigen, DRB1-1 beta chain	P04229	None	binder	unknown
DB05260	Gallium nitrate	N/A	approved;investigational	Ribonucleoside-diphosphate reductase subunit M2	P31350	None	inhibitor	yes
DB05260	Gallium nitrate	N/A	approved;investigational	V-type proton ATPase subunit B, brain isoform	P21281	179563	inhibitor	yes
DB05260	Gallium nitrate	N/A	approved;investigational	Osteocalcin	P02818	36093	antagonist	yes
DB05260	Gallium nitrate	N/A	approved;investigational	Hydroxylapatite	None	None	modulator	yes
DB05260	Gallium nitrate	N/A	approved;investigational	Protein-tyrosine-phosphatase	Q9S427	None	inhibitor	unknown
DB05260	Gallium nitrate	N/A	approved;investigational	Interleukin-1 beta	P01584	307043	antagonist	yes
DB05265	Ecabet	N/A	approved;investigational	NADPH oxidase organizer 1	Q8NFA2	25573148	antagonist	yes
DB05265	Ecabet	N/A	approved;investigational	Urease subunit alpha	P18314	149337	inhibitor	yes
DB05266	Ibudilast	Leukotriene receptor antagonists	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	yes
DB05266	Ibudilast	Leukotriene receptor antagonists	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	inhibitor	yes
DB05266	Ibudilast	Leukotriene receptor antagonists	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Q08493	727223	inhibitor	yes
DB05266	Ibudilast	Leukotriene receptor antagonists	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Q08499	347130	inhibitor	unknown
DB05266	Ibudilast	Leukotriene receptor antagonists	approved;investigational	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	unknown
DB05271	Rotigotine	Dopamine agonists	approved	D(3) dopamine receptor	P35462	927342	agonist	yes
DB05271	Rotigotine	Dopamine agonists	approved	D(4) dopamine receptor	P21917	291946	agonist	yes
DB05271	Rotigotine	Dopamine agonists	approved	D(2) dopamine receptor	P14416	181432	agonist	yes
DB05271	Rotigotine	Dopamine agonists	approved	D(1B) dopamine receptor	P21918	32049	agonist	unknown
DB05271	Rotigotine	Dopamine agonists	approved	D(1A) dopamine receptor	P21728	30397	agonist	unknown
DB05271	Rotigotine	Dopamine agonists	approved	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB05271	Rotigotine	Dopamine agonists	approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB05276	Hepatitis B Immune Globulin	N/A	approved;investigational	HBsAg	Q69600	None	None	unknown
DB05294	Vandetanib	Protein kinase inhibitors	approved	Vascular endothelial growth factor A	P15692	181971	inhibitor	unknown
DB05294	Vandetanib	Protein kinase inhibitors	approved	Epidermal growth factor receptor	P00533	757924	inhibitor	unknown
DB05294	Vandetanib	Protein kinase inhibitors	approved	Protein-tyrosine kinase 6	Q13882	None	inhibitor	unknown
DB05294	Vandetanib	Protein kinase inhibitors	approved	Angiopoietin-1 receptor	Q02763	None	inhibitor	unknown
DB05294	Vandetanib	Protein kinase inhibitors	approved	Proto-oncogene tyrosine-protein kinase receptor Ret	P07949	None	None	unknown
DB05299	keyhole limpet hemocyanin	N/A	approved;investigational	Interleukin-2	P60568	5729676	None	unknown
DB05311	Ecallantide	Drugs used in hereditary angioedema	approved;investigational	Plasma kallikrein	P03952	None	inhibitor	yes
DB05316	Pimavanserin	N/A	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	inverse agonist	yes
DB05316	Pimavanserin	N/A	approved;investigational	D(2) dopamine receptor	P14416	181432	None	unknown
DB05332	Romiplostim	Other systemic hemostatics	approved	Thrombopoietin receptor	P40238	None	agonist	yes
DB05351	Dexlansoprazole	Proton pump inhibitors	approved;investigational	Potassium-transporting ATPase alpha chain 1	P20648	561634	inhibitor	yes
DB05351	Dexlansoprazole	Proton pump inhibitors	approved;investigational	Potassium-transporting ATPase subunit beta	P51164	184105	inhibitor	yes
DB05381	Histamine	Other immunostimulants	approved;investigational	Histamine H1 receptor	P35367	510296	agonist	yes
DB05381	Histamine	Other immunostimulants	approved;investigational	Histamine H2 receptor	P25021	184088	agonist	yes
DB05381	Histamine	Other immunostimulants	approved;investigational	Histamine H3 receptor	Q9Y5N1	5031291	agonist	yes
DB05381	Histamine	Other immunostimulants	approved;investigational	Histamine H4 receptor	Q9H3N8	10241847	agonist	unknown
DB05381	Histamine	Other immunostimulants	approved;investigational	Synaptic vesicular amine transporter	Q05940	292335	None	unknown
DB05382	Iodine	Iodine products	approved;investigational	NADH-ubiquinone oxidoreductase chain 5	P03915	2052366	None	unknown
DB05389	Tetrachlorodecaoxide	N/A	approved;investigational	Macrophage erythroblast attacher	Q7L5Y9	None	None	unknown
DB05389	Tetrachlorodecaoxide	N/A	approved;investigational	Scavenger receptor cysteine-rich type 1 protein M130	Q86VB7	None	None	unknown
DB05510	Huperzine-A	N/A	approved;investigational	Acetylcholinesterase	P22303	177975	None	unknown
DB05521	Telaprevir	Protease inhibitors	approved;withdrawn	NS3/4A protein	B0B3C9	None	inhibitor	yes
DB05521	Telaprevir	Protease inhibitors	approved;withdrawn	Solute carrier organic anion transporter family member 1B1	Q9Y6L6	5051630	inhibitor	unknown
DB05521	Telaprevir	Protease inhibitors	approved;withdrawn	Solute carrier organic anion transporter family member 2B1	O94956	5006263	inhibitor	unknown
DB05528	Mipomersen	Other lipid modifying agents	approved;investigational	mRNA of ApoB-100	None	None	binder	yes
DB05541	Brivaracetam	Other antiepileptics	approved;investigational	Synaptic vesicle glycoprotein 2A	Q7L0J3	40788343	unknown	yes
DB05541	Brivaracetam	Other antiepileptics	approved;investigational	Sodium channel protein	Q8IWT1	27465047	inhibitor	yes
DB05578	Ramucirumab	Monoclonal antibodies	approved;investigational	Vascular endothelial growth factor receptor 2	P35968	2655412	antagonist	yes
DB05630	Sodium stibogluconate	Antimony compounds	approved;investigational	DNA topoisomerase 1	P11387	339806	inhibitor	yes
DB05676	Apremilast	Selective immunosuppressants	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Q08499	347130	antagonist	yes
DB05676	Apremilast	Selective immunosuppressants	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	antagonist	yes
DB05676	Apremilast	Selective immunosuppressants	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Q07343	347122	antagonist	yes
DB05676	Apremilast	Selective immunosuppressants	approved;investigational	Tumor necrosis factor	P01375	339741	None	unknown
DB05676	Apremilast	Selective immunosuppressants	approved;investigational	Interleukin-2	P60568	5729676	None	unknown
DB05676	Apremilast	Selective immunosuppressants	approved;investigational	Interferon gamma	P01579	32692	None	unknown
DB05676	Apremilast	Selective immunosuppressants	approved;investigational	Nitric oxide synthase, endothelial	P29474	189212	None	unknown
DB05679	Ustekinumab	Interleukin inhibitors	approved;investigational	Interleukin-12 subunit beta	P29460	180626	antibody	yes
DB05679	Ustekinumab	Interleukin inhibitors	approved;investigational	Interleukin-23	Q9NPF7	180626	None	yes
DB05773	Trastuzumab emtansine	Monoclonal antibodies	approved;investigational	Receptor tyrosine-protein kinase erbB-2	P04626	553282	antibody	yes
DB05777	Thrombomodulin Alfa	N/A	approved;investigational	Prothrombin	P00734	339641	inhibitor	yes
DB05777	Thrombomodulin Alfa	N/A	approved;investigational	Coagulation factor V	P12259	182412	None	unknown
DB05812	Abiraterone	Other hormone antagonists and related agents	approved	Steroid 17-alpha-hydroxylase/17,20 lyase	P05093	181342	inhibitor	yes
DB05829	Parathyroid hormone	Parathyroid hormones and analogues	approved;investigational	Parathyroid hormone/parathyroid hormone-related peptide receptor	Q03431	None	activator	unknown
DB05829	Parathyroid hormone	Parathyroid hormones and analogues	approved;investigational	Parathyroid hormone 2 receptor	P49190	None	activator	yes
DB05889	Inotuzumab ozogamicin	N/A	approved;investigational	B-cell receptor CD22	P20273	36091	antibody	yes
DB05990	Obeticholic acid	Bile acid preparations	approved	Bile acid receptor	Q96RI1	1546084	agonist	yes
DB06014	Eteplirsen	N/A	approved;investigational	DMD-001 gene (exon 51 target site)	None	None	binding	yes
DB06016	Cariprazine	Other antipsychotics	approved;investigational	D(3) dopamine receptor	P35462	927342	agonist	yes
DB06016	Cariprazine	Other antipsychotics	approved;investigational	D(2) dopamine receptor	P14416	181432	agonist	yes
DB06016	Cariprazine	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	yes
DB06016	Cariprazine	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	yes
DB06016	Cariprazine	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB06016	Cariprazine	Other antipsychotics	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB06043	Olaratumab	N/A	approved;investigational	Platelet-derived growth factor receptor alpha	P16234	189734	antagonist	yes
DB06144	Sertindole	Indole derivatives	approved;investigational;withdrawn	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB06144	Sertindole	Indole derivatives	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB06144	Sertindole	Indole derivatives	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB06144	Sertindole	Indole derivatives	approved;investigational;withdrawn	5-hydroxytryptamine receptor 6	P50406	1162924	antagonist	yes
DB06144	Sertindole	Indole derivatives	approved;investigational;withdrawn	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB06144	Sertindole	Indole derivatives	approved;investigational;withdrawn	Alpha-1A adrenergic receptor	P35348	433201	None	unknown
DB06144	Sertindole	Indole derivatives	approved;investigational;withdrawn	Alpha-1B adrenergic receptor	P35368	None	None	unknown
DB06144	Sertindole	Indole derivatives	approved;investigational;withdrawn	Alpha-1D adrenergic receptor	P25100	177807	None	unknown
DB06145	Spiramycin	Macrolides	approved	50S ribosomal protein L3	Q9A1X4	13621367	antagonist	yes
DB06147	Sulfathiazole	Short-acting sulfonamides	approved;vet_approved	Dihydropteroate synthetase	Q27738	505177	inhibitor	yes
DB06148	Mianserin	Other antidepressants	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	Histamine H4 receptor	Q9H3N8	10241847	binder	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	blocker	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	binder	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 1F	P30939	307420	binder	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	D(3) dopamine receptor	P35462	927342	binder	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	Sodium-dependent dopamine transporter	Q01959	553260	binder	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 6	P50406	1162924	binder	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	Alpha-1 adrenergic receptors	P25100	177807	antagonist	unknown
DB06148	Mianserin	Other antidepressants	approved;investigational	D(1) dopamine receptor	P21918	32049	binder	unknown
DB06149	Teicoplanin	Glycopeptide antibacterials	approved;investigational	D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan	None	None	inhibitor	yes
DB06151	Acetylcysteine	Antidotes	approved;investigational	Glutathione synthetase	P48637	886284	stimulator	yes
DB06151	Acetylcysteine	Antidotes	approved;investigational	Cystine/glutamate transporter	Q9UPY5	5668545	activator	yes
DB06151	Acetylcysteine	Antidotes	approved;investigational	NAPQI (N-acetyl-p-benzoquinone imine)	None	None	reducer	unknown
DB06151	Acetylcysteine	Antidotes	approved;investigational	Aminoacylase-1	Q03154	178071	ligand	unknown
DB06151	Acetylcysteine	Antidotes	approved;investigational	Inhibitor of nuclear factor kappa-B kinase subunit beta	O14920	2599558	inhibitor	unknown
DB06151	Acetylcysteine	Antidotes	approved;investigational	Inhibitor of nuclear factor kappa-B kinase subunit alpha	O15111	None	inhibitor	unknown
DB06151	Acetylcysteine	Antidotes	approved;investigational	Glutamate receptor ionotropic, NMDA 2B	Q13224	1899202	activator	unknown
DB06151	Acetylcysteine	Antidotes	approved;investigational	Glutamate receptor ionotropic, NMDA 1	Q05586	219920	activator	unknown
DB06151	Acetylcysteine	Antidotes	approved;investigational	Glutamate receptor ionotropic, NMDA 2A	Q12879	558749	activator	unknown
DB06151	Acetylcysteine	Antidotes	approved;investigational	Glutamate receptor ionotropic, NMDA 2D	O15399	2444026	activator	unknown
DB06151	Acetylcysteine	Antidotes	approved;investigational	Glutamate receptor ionotropic, NMDA 3A	Q8TCU5	20372905	activator	unknown
DB06152	Nylidrin	Sympathomimetics, labour repressants	approved	Voltage-dependent T-type calcium channel subunit alpha-1I	Q9P0X4	5565888	antagonist	unknown
DB06152	Nylidrin	Sympathomimetics, labour repressants	approved	Interferon alpha/beta receptor 2	P48551	995300	agonist	yes
DB06153	Pizotifen	Other antimigraine preparations	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	5-hydroxytryptamine receptor 1B	P28222	219679	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	5-hydroxytryptamine receptor 1D	P28221	177772	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB06153	Pizotifen	Other antimigraine preparations	approved	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB06154	Pentaerythritol Tetranitrate	Organic nitrates	approved	Hemoglobin subunit alpha	P69905	386764	agonist	yes
DB06154	Pentaerythritol Tetranitrate	Organic nitrates	approved	Hemoglobin subunit beta	P68871	455997	agonist	yes
DB06154	Pentaerythritol Tetranitrate	Organic nitrates	approved	Free radicals	None	None	antagonist	no
DB06155	Rimonabant	Other antiobesity drugs	approved;investigational	Cannabinoid receptor 1	P21554	29915	antagonist	yes
DB06155	Rimonabant	Other antiobesity drugs	approved;investigational	G-protein coupled receptor 55	Q9Y2T6	None	None	unknown
DB06168	Canakinumab	Interleukin inhibitors	approved;investigational	Interleukin-1 beta	P01584	307043	binder	yes
DB06176	Romidepsin	Other antineoplastic agents	approved;investigational	Histone deacetylase 1	Q13547	1277084	antagonist	yes
DB06176	Romidepsin	Other antineoplastic agents	approved;investigational	Histone deacetylase 2	Q92769	1667394	antagonist	yes
DB06176	Romidepsin	Other antineoplastic agents	approved;investigational	Histone deacetylase 4	P56524	None	inhibitor	no
DB06176	Romidepsin	Other antineoplastic agents	approved;investigational	Histone deacetylase 6	Q9UBN7	4754911	inhibitor	no
DB06176	Romidepsin	Other antineoplastic agents	approved;investigational	Multidrug resistance-associated protein 1	P33527	1835659	None	unknown
DB06186	Ipilimumab	Monoclonal antibodies	approved	Cytotoxic T-lymphocyte protein 4	P16410	17646228	None	yes
DB06196	Icatibant	Drugs used in hereditary angioedema	approved;investigational	B2 bradykinin receptor	P30411	None	antagonist	yes
DB06196	Icatibant	Drugs used in hereditary angioedema	approved;investigational	Aminopeptidase N	P15144	28678	inhibitor	unknown
DB06201	Rufinamide	Carboxamide derivatives	approved	Metabotropic glutamate receptor 5	P41594	1408052	inhibitor	unknown
DB06201	Rufinamide	Carboxamide derivatives	approved	Sodium channel protein type 9 subunit alpha	Q15858	758110	modulator	unknown
DB06202	Lasofoxifene	Selective estrogen receptor modulators	approved;investigational	Estrogen receptor alpha	P03372	31234	antagonist	yes
DB06202	Lasofoxifene	Selective estrogen receptor modulators	approved;investigational	Estrogen receptor beta	Q92731	2911152	agonist	yes
DB06202	Lasofoxifene	Selective estrogen receptor modulators	approved;investigational	Cannabinoid receptor 2	P34972	407807	inverse agonist	unknown
DB06203	Alogliptin	Combinations of oral blood glucose lowering drugs	approved	Dipeptidyl peptidase 4	P27487	535388	inhibitor	yes
DB06204	Tapentadol	Other opioids	approved	Mu-type opioid receptor	P35372	452073	agonist	yes
DB06204	Tapentadol	Other opioids	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB06204	Tapentadol	Other opioids	approved	Kappa-type opioid receptor	P41145	532060	None	unknown
DB06204	Tapentadol	Other opioids	approved	Delta-type opioid receptor	P41143	27545517	None	unknown
DB06204	Tapentadol	Other opioids	approved	5-hydroxytryptamine receptor 3A	P46098	681914	None	unknown
DB06204	Tapentadol	Other opioids	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	unknown
DB06205	Hyaluronidase (Human Recombinant)	N/A	approved;investigational	Hyaluronan	None	None	None	yes
DB06205	Hyaluronidase (Human Recombinant)	N/A	approved;investigational	Transforming growth factor beta-1	P01137	1212989	inhibitor	unknown
DB06207	Silodosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB06207	Silodosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1B adrenergic receptor	P35368	None	antagonist	unknown
DB06207	Silodosin	Alpha-adrenoreceptor antagonists	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	unknown
DB06209	Prasugrel	Platelet aggregation inhibitors excl. heparin	approved	P2Y purinoceptor 12	Q9H244	12083902	antagonist	yes
DB06210	Eltrombopag	Other systemic hemostatics	approved	Thrombopoietin receptor	P40238	None	agonist	unknown
DB06211	Doripenem	Carbapenems	approved;investigational	Penicillin-binding protein 1A	P02918	581194	antagonist	yes
DB06211	Doripenem	Carbapenems	approved;investigational	Penicillin-binding protein 1B	P02919	42468	antagonist	yes
DB06211	Doripenem	Carbapenems	approved;investigational	Penicillin-binding protein 2	P0AD65	42314	antagonist	yes
DB06211	Doripenem	Carbapenems	approved;investigational	Penicillin-binding protein 3	Q51504	None	antagonist	yes
DB06211	Doripenem	Carbapenems	approved;investigational	Penicillin-binding protein 4	P72355	None	antagonist	yes
DB06212	Tolvaptan	Vasopressin antagonists	approved	Vasopressin V2 receptor	P30518	28418	antagonist	yes
DB06212	Tolvaptan	Vasopressin antagonists	approved	Vasopressin V1a receptor	P37288	667068	antagonist	no
DB06213	Regadenoson	Other cardiac preparations	approved;investigational	Adenosine receptor A2a	P29274	177892	agonist	yes
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 1B	P28222	219679	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 2B	P41595	475198	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 5A	P47898	None	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 6	P50406	1162924	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2B adrenergic receptor	P18089	178198	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Alpha-1A adrenergic receptor	P35348	433201	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Histamine H2 receptor	P25021	184088	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	unknown
DB06216	Asenapine	Diazepines, oxazepines, thiazepines and oxepines	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB06217	Vernakalant	Other antiarrhythmics, class I and III	approved;investigational	Sodium channel protein type 5 subunit alpha	Q14524	184039	blocker	yes
DB06217	Vernakalant	Other antiarrhythmics, class I and III	approved;investigational	Potassium voltage-gated channel subfamily A member 5	P22460	None	blocker	yes
DB06217	Vernakalant	Other antiarrhythmics, class I and III	approved;investigational	Potassium voltage-gated channel subfamily D member 3	Q9UK17	2935434	blocker	yes
DB06217	Vernakalant	Other antiarrhythmics, class I and III	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	blocker	unknown
DB06218	Lacosamide	Other antiepileptics	approved	Sodium channel protein type 9 subunit alpha	Q15858	758110	None	unknown
DB06218	Lacosamide	Other antiepileptics	approved	Sodium channel protein type 3 subunit alpha	Q9NY46	7414320	None	unknown
DB06218	Lacosamide	Other antiepileptics	approved	Sodium channel protein type 10 subunit alpha	Q9Y5Y9	4838145	None	unknown
DB06228	Rivaroxaban	Direct factor Xa inhibitors	approved	Coagulation factor X	P00742	182841	antagonist	yes
DB06230	Nalmefene	Drugs used in alcohol dependence	approved;investigational;withdrawn	Mu-type opioid receptor	P35372	452073	antagonist	yes
DB06230	Nalmefene	Drugs used in alcohol dependence	approved;investigational;withdrawn	Kappa-type opioid receptor	P41145	532060	partial agonist	yes
DB06230	Nalmefene	Drugs used in alcohol dependence	approved;investigational;withdrawn	Delta-type opioid receptor	P41143	27545517	antagonist	yes
DB06237	Avanafil	Drugs used in erectile dysfunction	approved	cGMP-specific 3',5'-cyclic phosphodiesterase	O76074	3420185	inhibitor	yes
DB06243	Eflornithine	Other dermatologicals	approved;withdrawn	Ornithine decarboxylase	P11926	29893806	antagonist	yes
DB06249	Arzoxifene	N/A	approved;investigational	Estrogen receptor alpha	P03372	31234	None	unknown
DB06249	Arzoxifene	N/A	approved;investigational	Estrogen receptor beta	Q92731	2911152	None	unknown
DB06262	Droxidopa	Adrenergic and dopaminergic agents	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB06262	Droxidopa	Adrenergic and dopaminergic agents	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	agonist	yes
DB06262	Droxidopa	Adrenergic and dopaminergic agents	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	agonist	yes
DB06262	Droxidopa	Adrenergic and dopaminergic agents	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB06262	Droxidopa	Adrenergic and dopaminergic agents	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB06262	Droxidopa	Adrenergic and dopaminergic agents	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	agonist	yes
DB06262	Droxidopa	Adrenergic and dopaminergic agents	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	agonist	yes
DB06262	Droxidopa	Adrenergic and dopaminergic agents	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB06262	Droxidopa	Adrenergic and dopaminergic agents	approved;investigational	Beta-3 adrenergic receptor	P13945	178896	agonist	yes
DB06262	Droxidopa	Adrenergic and dopaminergic agents	approved;investigational	Phenylalanine-4-hydroxylase	P00439	189937	inhibitor	no
DB06263	Amrubicin	Anthracyclines and related substances	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	None	unknown
DB06263	Amrubicin	Anthracyclines and related substances	approved;investigational	DNA	None	None	None	unknown
DB06267	Udenafil	Drugs used in erectile dysfunction	approved;investigational	cGMP-specific 3',5'-cyclic phosphodiesterase	O76074	3420185	inhibitor	yes
DB06268	Sitaxentan	Antihypertensives for pulmonary arterial hypertension	approved;investigational;withdrawn	Endothelin-1 receptor	P25101	238636	antagonist	yes
DB06268	Sitaxentan	Antihypertensives for pulmonary arterial hypertension	approved;investigational;withdrawn	Endothelin B receptor	P24530	182276	antagonist	unknown
DB06271	Sulodexide	Heparin group	approved;investigational	Heparin cofactor 2	P05546	183910	agonist	yes
DB06271	Sulodexide	Heparin group	approved;investigational	Antithrombin-III	P01008	179161	potentiator	yes
DB06273	Tocilizumab	Interleukin inhibitors	approved	Interleukin-6 receptor subunit alpha	P08887	None	antibody	yes
DB06274	Alvimopan	Peripheral opioid receptor antagonists	approved;investigational	Mu-type opioid receptor	P35372	452073	antagonist	yes
DB06274	Alvimopan	Peripheral opioid receptor antagonists	approved;investigational	Kappa-type opioid receptor	P41145	532060	antagonist	unknown
DB06274	Alvimopan	Peripheral opioid receptor antagonists	approved;investigational	Delta-type opioid receptor	P41143	27545517	antagonist	unknown
DB06282	Levocetirizine	Piperazine derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB06285	Teriparatide	Parathyroid hormones and analogues	approved;investigational	Parathyroid hormone/parathyroid hormone-related peptide receptor	Q03431	None	binder	unknown
DB06287	Temsirolimus	Protein kinase inhibitors	approved	Serine/threonine-protein kinase mTOR	P42345	None	inhibitor	yes
DB06288	Amisulpride	Benzamides	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB06288	Amisulpride	Benzamides	approved;investigational	D(3) dopamine receptor	P35462	927342	antagonist	unknown
DB06288	Amisulpride	Benzamides	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	yes
DB06288	Amisulpride	Benzamides	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	unknown
DB06290	Simeprevir	Protease inhibitors	approved	NS3 protease	Q91RS4	14150583	inhibitor	yes
DB06292	Dapagliflozin	Other blood glucose lowering drugs, excl. insulins	approved	Sodium/glucose cotransporter 2	P31639	None	antagonist	yes
DB06317	Elotuzumab	N/A	approved	SLAM family member 7	Q9NQ25	None	modulator	yes
DB06335	Saxagliptin	Dipeptidyl peptidase 4 (DPP-4) inhibitors	approved	Dipeptidyl peptidase 4	P27487	535388	inhibitor	yes
DB06366	Pertuzumab	Monoclonal antibodies	approved	Receptor tyrosine-protein kinase erbB-2	P04626	553282	antibody	yes
DB06372	Rilonacept	Interleukin inhibitors	approved;investigational	Interleukin-1 beta	P01584	307043	binder	unknown
DB06372	Rilonacept	Interleukin inhibitors	approved;investigational	Interleukin-1 alpha	P01583	None	binder	unknown
DB06372	Rilonacept	Interleukin inhibitors	approved;investigational	Interleukin-1 receptor antagonist protein	P18510	None	binder	unknown
DB06401	Bazedoxifene	Estrogens, combinations with other drugs	approved;investigational	Estrogen receptor alpha	P03372	31234	antagonist	yes
DB06401	Bazedoxifene	Estrogens, combinations with other drugs	approved;investigational	Estrogen receptor beta	Q92731	2911152	None	unknown
DB06403	Ambrisentan	Antihypertensives for pulmonary arterial hypertension	approved;investigational	Endothelin-1 receptor	P25101	238636	antagonist	yes
DB06403	Ambrisentan	Antihypertensives for pulmonary arterial hypertension	approved;investigational	Endothelin B receptor	P24530	182276	antagonist	no
DB06404	Human C1-esterase inhibitor	Drugs used in hereditary angioedema	approved	Complement C1r subcomponent	P00736	29539	inhibitor	yes
DB06404	Human C1-esterase inhibitor	Drugs used in hereditary angioedema	approved	Complement C1s subcomponent	P09871	763110	inhibitor	yes
DB06404	Human C1-esterase inhibitor	Drugs used in hereditary angioedema	approved	Plasma kallikrein	P03952	None	inhibitor	yes
DB06404	Human C1-esterase inhibitor	Drugs used in hereditary angioedema	approved	Coagulation factor XII	P00748	None	inhibitor	yes
DB06404	Human C1-esterase inhibitor	Drugs used in hereditary angioedema	approved	Prothrombin	P00734	339641	inhibitor	unknown
DB06404	Human C1-esterase inhibitor	Drugs used in hereditary angioedema	approved	Coagulation factor XI	P03951	182833	inhibitor	yes
DB06404	Human C1-esterase inhibitor	Drugs used in hereditary angioedema	approved	Tissue-type plasminogen activator	P00750	339834	inhibitor	yes
DB06410	Doxercalciferol	Other anti-parathyroid agents	approved	Vitamin D3 receptor	P11473	340203	suppressor	unknown
DB06412	Oxymetholone	Androstan derivatives	approved;illicit	Androgen receptor	P10275	178628	agonist	yes
DB06412	Oxymetholone	Androstan derivatives	approved;illicit	Natriuretic peptides B	P16860	179515	None	unknown
DB06413	Armodafinil	Centrally acting sympathomimetics	approved;investigational	Sodium-dependent dopamine transporter	Q01959	553260	antagonist	yes
DB06414	Etravirine	Non-nucleoside reverse transcriptase inhibitors	approved	Gag-Pol polyprotein	P03366	326388	None	unknown
DB06414	Etravirine	Non-nucleoside reverse transcriptase inhibitors	approved	Gag-Pol polyprotein	P04585	1906384	None	unknown
DB06439	Tyloxapol	Expectorants	approved;investigational	Lipoprotein lipase	P06858	307138	inhibitor	yes
DB06441	Cangrelor	Platelet aggregation inhibitors excl. heparin	approved	P2Y purinoceptor 12	Q9H244	12083902	inhibitor	yes
DB06480	Prucalopride	Other drugs for constipation	approved	5-hydroxytryptamine receptor 4	Q13639	2661757	agonist	yes
DB06589	Pazopanib	Protein kinase inhibitors	approved	Vascular endothelial growth factor receptor 1	P17948	31432	inhibitor	yes
DB06589	Pazopanib	Protein kinase inhibitors	approved	Vascular endothelial growth factor receptor 2	P35968	2655412	inhibitor	yes
DB06589	Pazopanib	Protein kinase inhibitors	approved	Vascular endothelial growth factor receptor 3	P35916	297050	None	yes
DB06589	Pazopanib	Protein kinase inhibitors	approved	Platelet-derived growth factor receptor alpha	P16234	189734	inhibitor	yes
DB06589	Pazopanib	Protein kinase inhibitors	approved	Platelet-derived growth factor receptor beta	P09619	189732	inhibitor	yes
DB06589	Pazopanib	Protein kinase inhibitors	approved	Mast/stem cell growth factor receptor Kit	P10721	34085	inhibitor	yes
DB06589	Pazopanib	Protein kinase inhibitors	approved	Fibroblast growth factor receptor 3	P22607	182569	inhibitor	unknown
DB06589	Pazopanib	Protein kinase inhibitors	approved	Tyrosine-protein kinase ITK/TSK	Q08881	399658	inhibitor	unknown
DB06589	Pazopanib	Protein kinase inhibitors	approved	Fibroblast growth factor 1	P05230	181942	inhibitor	unknown
DB06589	Pazopanib	Protein kinase inhibitors	approved	SH2B adapter protein 3	Q9UQQ2	None	inhibitor	unknown
DB06594	Agomelatine	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB06594	Agomelatine	Other antidepressants	approved;investigational	Melatonin receptor type 1A	P48039	602130	agonist	yes
DB06594	Agomelatine	Other antidepressants	approved;investigational	Melatonin receptor type 1B	P49286	971194	agonist	yes
DB06595	Midostaurin	N/A	approved;investigational	Protein kinase C alpha type	P17252	35483	antagonist	yes
DB06595	Midostaurin	N/A	approved;investigational	Vascular endothelial growth factor receptor 2	P35968	2655412	antagonist	yes
DB06595	Midostaurin	N/A	approved;investigational	Mast/stem cell growth factor receptor Kit	P10721	34085	antagonist	unknown
DB06595	Midostaurin	N/A	approved;investigational	Platelet-derived growth factor receptor alpha	P16234	189734	antagonist	yes
DB06595	Midostaurin	N/A	approved;investigational	Platelet-derived growth factor receptor beta	P09619	189732	antagonist	yes
DB06595	Midostaurin	N/A	approved;investigational	Receptor-type tyrosine-protein kinase FLT3	P36888	409573	antagonist	yes
DB06602	Reslizumab	Other systemic drugs for obstructive airway diseases	approved;investigational	Interleukin-5	P05113	33836	antagonist	yes
DB06603	Panobinostat	Other antineoplastic agents	approved;investigational	Histone deacetylase	Q9UKV0	15590680	inhibitor	yes
DB06605	Apixaban	Direct factor Xa inhibitors	approved	Coagulation factor X	P00742	182841	inhibitor	yes
DB06607	Catumaxomab	Monoclonal antibodies	approved;investigational;withdrawn	Epithelial cell adhesion molecule	P16422	None	ligand	no
DB06607	Catumaxomab	Monoclonal antibodies	approved;investigational;withdrawn	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	agonist	yes
DB06607	Catumaxomab	Monoclonal antibodies	approved;investigational;withdrawn	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	agonist	yes
DB06607	Catumaxomab	Monoclonal antibodies	approved;investigational;withdrawn	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	agonist	yes
DB06607	Catumaxomab	Monoclonal antibodies	approved;investigational;withdrawn	T-cell surface glycoprotein CD3 epsilon chain	P07766	469945	agonist	yes
DB06607	Catumaxomab	Monoclonal antibodies	approved;investigational;withdrawn	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	agonist	yes
DB06612	Mepolizumab	Interleukin inhibitors	approved;investigational	Interleukin-5	P05113	33836	antagonist	yes
DB06614	Peramivir	N/A	approved;investigational	Neuraminidase	P03472	324416	None	unknown
DB06614	Peramivir	N/A	approved;investigational	Neuraminidase	P06818	324460	None	unknown
DB06614	Peramivir	N/A	approved;investigational	Neuraminidase	P27907	None	None	unknown
DB06616	Bosutinib	Protein kinase inhibitors	approved	Breakpoint cluster region protein	P11274	None	inhibitor	yes
DB06616	Bosutinib	Protein kinase inhibitors	approved	Tyrosine-protein kinase ABL1	P00519	28237	inhibitor	yes
DB06616	Bosutinib	Protein kinase inhibitors	approved	Tyrosine-protein kinase Lyn	P07948	307144	None	unknown
DB06616	Bosutinib	Protein kinase inhibitors	approved	Tyrosine-protein kinase HCK	P08631	306832	inhibitor	unknown
DB06616	Bosutinib	Protein kinase inhibitors	approved	Proto-oncogene tyrosine-protein kinase Src	P12931	10635153	inhibitor	unknown
DB06616	Bosutinib	Protein kinase inhibitors	approved	Cyclin-dependent kinase 2	P24941	3551191	inhibitor	unknown
DB06616	Bosutinib	Protein kinase inhibitors	approved	Dual specificity mitogen-activated protein kinase kinase 1	Q02750	188569	inhibitor	unknown
DB06616	Bosutinib	Protein kinase inhibitors	approved	Dual specificity mitogen-activated protein kinase kinase 2	P36507	None	inhibitor	unknown
DB06616	Bosutinib	Protein kinase inhibitors	approved	Mitogen-activated protein kinase kinase kinase 2	Q9Y2U5	None	inhibitor	unknown
DB06616	Bosutinib	Protein kinase inhibitors	approved	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Q13555	21707842	inhibitor	unknown
DB06623	Flupirtine	Other analgesics and antipyretics	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	None	unknown
DB06626	Axitinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 1	P17948	31432	inhibitor	yes
DB06626	Axitinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 2	P35968	2655412	inhibitor	yes
DB06626	Axitinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 3	P35916	297050	inhibitor	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily A member 1	Q09470	186663	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily A member 2	P16389	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily A member 3	P22001	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily A member 4	P22459	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily A member 5	P22460	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily A member 6	P17658	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily A member 7	Q96RP8	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily A member 10	Q16322	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily B member 1	Q14721	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily B member 2	Q92953	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily C member 1	P48547	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily C member 2	Q96PR1	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily C member 3	Q14003	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily D member 1	Q9NSA2	None	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily D member 2	Q9NZV8	4530478	antagonist	yes
DB06637	Dalfampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily D member 3	Q9UK17	2935434	antagonist	yes
DB06643	Denosumab	Other drugs affecting bone structure and mineralization	approved	Tumor necrosis factor ligand superfamily member 11	O14788	None	antibody	yes
DB06650	Ofatumumab	Monoclonal antibodies	approved	B-lymphocyte antigen CD20	P11836	29774	inhibitor	yes
DB06654	Safinamide	N/A	approved;investigational	Amine oxidase [flavin-containing] B	P27338	398415	antagonist	yes
DB06655	Liraglutide	Other blood glucose lowering drugs, excl. insulins	approved	Glucagon-like peptide 1 receptor	P43220	405082	agonist	yes
DB06663	Pasireotide	Somatostatin and analogues	approved	Somatostatin receptor type 1	P30872	307434	None	unknown
DB06663	Pasireotide	Somatostatin and analogues	approved	Somatostatin receptor type 2	P30874	None	None	unknown
DB06663	Pasireotide	Somatostatin and analogues	approved	Somatostatin receptor type 3	P32745	None	None	unknown
DB06663	Pasireotide	Somatostatin and analogues	approved	Somatostatin receptor type 5	P35346	431095	None	unknown
DB06681	Belatacept	Selective immunosuppressants	approved;investigational	T-lymphocyte activation antigen CD86	P42081	439839	None	unknown
DB06681	Belatacept	Selective immunosuppressants	approved;investigational	T-lymphocyte activation antigen CD80	P33681	306916	None	unknown
DB06684	Vilazodone	Other antidepressants	approved	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB06688	Sipuleucel-T	Other immunostimulants	approved;investigational	Prostatic acid phosphatase	P15309	189613	antagonist	unknown
DB06689	Ethanolamine Oleate	Sclerosing agents for local injection	approved	Calcium ions	None	None	chelator	unknown
DB06689	Ethanolamine Oleate	Sclerosing agents for local injection	approved	Coagulation factor XII	P00748	None	activator	unknown
DB06691	Mepyramine	Substituted ethylene diamines	approved;vet_approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB06692	Aprotinin	Proteinase inhibitors	approved;investigational;withdrawn	Trypsin-1	P07477	521216	None	unknown
DB06692	Aprotinin	Proteinase inhibitors	approved;investigational;withdrawn	Chymotrypsinogen B	P17538	None	None	unknown
DB06692	Aprotinin	Proteinase inhibitors	approved;investigational;withdrawn	Plasminogen	P00747	387026	None	unknown
DB06692	Aprotinin	Proteinase inhibitors	approved;investigational;withdrawn	Kallikrein-1	P06870	186653	None	unknown
DB06694	Xylometazoline	Sympathomimetics used as decongestants	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB06694	Xylometazoline	Sympathomimetics used as decongestants	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB06694	Xylometazoline	Sympathomimetics used as decongestants	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB06694	Xylometazoline	Sympathomimetics used as decongestants	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	agonist	unknown
DB06694	Xylometazoline	Sympathomimetics used as decongestants	approved;investigational	Alpha-1D adrenergic receptor	P25100	177807	agonist	unknown
DB06694	Xylometazoline	Sympathomimetics used as decongestants	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	agonist	unknown
DB06695	Dabigatran etexilate	Direct thrombin inhibitors	approved	Prothrombin	P00734	339641	inhibitor	yes
DB06696	Arbekacin	Other aminoglycosides	approved;investigational	30S ribosomal protein S12	P0A7S3	43010	inhibitor	yes
DB06698	Betahistine	Antivertigo preparations	approved;investigational	Histamine H1 receptor	P35367	510296	agonist	yes
DB06698	Betahistine	Antivertigo preparations	approved;investigational	Histamine H3 receptor	Q9Y5N1	5031291	antagonist	yes
DB06699	Degarelix	Other hormone antagonists and related agents	approved	Gonadotropin-releasing hormone receptor	P30968	183422	antagonist	yes
DB06700	Desvenlafaxine	Other antidepressants	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB06700	Desvenlafaxine	Other antidepressants	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB06701	Dexmethylphenidate	Centrally acting sympathomimetics	approved;investigational	Sodium-dependent dopamine transporter	Q01959	553260	inhibitor	yes
DB06701	Dexmethylphenidate	Centrally acting sympathomimetics	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB06701	Dexmethylphenidate	Centrally acting sympathomimetics	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	unknown
DB06702	Fesoterodine	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB06702	Fesoterodine	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB06702	Fesoterodine	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB06702	Fesoterodine	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB06702	Fesoterodine	Drugs for urinary frequency and incontinence	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB06706	Isometheptene	Other drugs for functional gastrointestinal disorders	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB06706	Isometheptene	Other drugs for functional gastrointestinal disorders	approved	Synaptic vesicular amine transporter	Q05940	292335	inhibitor	yes
DB06707	Levonordefrin	N/A	approved	Alpha-2 adrenergic receptors	P18825	178194	agonist	yes
DB06709	Methacholine	N/A	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	agonist	yes
DB06710	Methyltestosterone	Androgens and estrogens	approved	Androgen receptor	P10275	178628	agonist	yes
DB06710	Methyltestosterone	Androgens and estrogens	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB06711	Naphazoline	Sympathomimetics, combinations excl. corticosteroids	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB06711	Naphazoline	Sympathomimetics, combinations excl. corticosteroids	approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB06712	Nilvadipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	yes
DB06712	Nilvadipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	inhibitor	yes
DB06712	Nilvadipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit beta-2	Q08289	300417	inhibitor	yes
DB06712	Nilvadipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	inhibitor	unknown
DB06712	Nilvadipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	inhibitor	unknown
DB06712	Nilvadipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-3	Q8IZS8	7105926	inhibitor	unknown
DB06713	Norelgestromin	Progestogens and estrogens, fixed combinations	approved;investigational	Progesterone receptor	P06401	35652	agonist	yes
DB06713	Norelgestromin	Progestogens and estrogens, fixed combinations	approved;investigational	Serum albumin	P02768	28590	None	unknown
DB06713	Norelgestromin	Progestogens and estrogens, fixed combinations	approved;investigational	Androgen receptor	P10275	178628	partial agonist	unknown
DB06714	Propylhexedrine	N/A	approved	Synaptic vesicular amine transporter	Q05940	292335	None	yes
DB06714	Propylhexedrine	N/A	approved	Trace amine-associated receptor 1	Q96RJ0	14600074	agonist	unknown
DB06715	Potassium Iodide	Expectorants	approved	Tyrosine	None	None	binder	unknown
DB06716	Fospropofol	N/A	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit beta-2	P47870	455946	potentiator	yes
DB06716	Fospropofol	N/A	approved;illicit;investigational	Gamma-aminobutyric acid receptor subunit beta-3	P28472	182925	potentiator	yes
DB06718	Stanozolol	Androstan derivatives	approved;vet_approved	 Stanozolol Binding Protein (STBP)	None	None	other	unknown
DB06718	Stanozolol	Androstan derivatives	approved;vet_approved	Low-affinity glucocorticoid-binding protein (LAGS)	None	None	negative modulator	unknown
DB06719	Buserelin	Gonadotropin releasing hormone analogues	approved;investigational	Lutropin-choriogonadotropic hormone receptor	P22888	903746	None	yes
DB06719	Buserelin	Gonadotropin releasing hormone analogues	approved;investigational	Gonadotropin-releasing hormone receptor	P30968	183422	None	yes
DB06720	Velaglucerase alfa	Enzymes	approved;investigational	Glucosylceramidase	P04062	183008	None	unknown
DB06725	Lornoxicam	Oxicams	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB06725	Lornoxicam	Oxicams	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB06729	Sulfaphenazole	Long-acting sulfonamides	approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB06730	Gestodene	Progestogens and estrogens, fixed combinations	approved;investigational	Probable G-protein coupled receptor 133	Q6QNK2	None	None	unknown
DB06736	Aceclofenac	Acetic acid derivatives and related substances	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB06736	Aceclofenac	Acetic acid derivatives and related substances	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB06738	Ketobemidone	Opioids in combination with antispasmodics	approved;investigational	Mu-type opioid receptor	P35372	452073	agonist	yes
DB06738	Ketobemidone	Opioids in combination with antispasmodics	approved;investigational	Kappa-type opioid receptor	P41145	532060	agonist	yes
DB06738	Ketobemidone	Opioids in combination with antispasmodics	approved;investigational	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB06738	Ketobemidone	Opioids in combination with antispasmodics	approved;investigational	NMDA receptor	O60391	3025446	antagonist	unknown
DB06739	Seratrodast	Other systemic drugs for obstructive airway diseases	approved	Thromboxane A2 receptor	P21731	533326	antagonist	unknown
DB06751	Drotaverine	Papaverine and derivatives	approved;investigational	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	yes
DB06751	Drotaverine	Papaverine and derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	unknown
DB06752	Chymopapain	Enzymes	approved;withdrawn	Bone marrow proteoglycan	P13727	34476	degradation	yes
DB06754	Danaparoid	Heparin group	approved;withdrawn	Antithrombin-III	P01008	179161	positive allosteric modulator	yes
DB06755	Beta carotene	Vitamin A, plain	approved;nutraceutical	Free radicals	None	None	binder	yes
DB06756	Glycine betaine	Acid preparations	approved;nutraceutical	Apoptosis regulator Bcl-2	P10415	179367	None	unknown
DB06757	Manganese	N/A	approved;nutraceutical	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	P50213	706839	None	unknown
DB06757	Manganese	N/A	approved;nutraceutical	Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial	P51553	1167849	None	unknown
DB06757	Manganese	N/A	approved;nutraceutical	TGF-beta-activated kinase 1 and MAP3K7-binding protein 1	Q15750	None	None	unknown
DB06757	Manganese	N/A	approved;nutraceutical	Arginase-1	P05089	178995	None	unknown
DB06757	Manganese	N/A	approved;nutraceutical	Serotransferrin	P02787	339453	None	unknown
DB06759	Fomivirsen	Antivirals	approved;investigational;withdrawn	30 kDa immediate-early protein 2	P06434	None	antisense oligonucleotide	yes
DB06759	Fomivirsen	Antivirals	approved;investigational;withdrawn	45 kDa immediate-early protein 2	P06435	None	antisense oligonucleotide	yes
DB06764	Tetryzoline	Sympathomimetics used as decongestants	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB06766	Alcaftadine	Other antiallergics	approved	Histamine H1 receptor	P35367	510296	antagonist	unknown
DB06771	Besifloxacin	Fluoroquinolones	approved	DNA topoisomerase 4 subunit A	P43702	1574370	antagonist	yes
DB06771	Besifloxacin	Fluoroquinolones	approved	DNA topoisomerase 4 subunit A	P72525	1490399	antagonist	yes
DB06771	Besifloxacin	Fluoroquinolones	approved	DNA gyrase subunit A	P43700	1574722	antagonist	yes
DB06771	Besifloxacin	Fluoroquinolones	approved	DNA gyrase subunit A	P72524	14971465	antagonist	yes
DB06772	Cabazitaxel	Taxanes	approved	Tubulin alpha-4A chain	P68366	32015	binder	yes
DB06772	Cabazitaxel	Taxanes	approved	Tubulin beta-1 chain	Q9H4B7	11230445	binder	yes
DB06773	Human calcitonin	Calcitonin preparations	approved;investigational	Alpha-actinin-1	P12814	None	incorporation into and destabilization	yes
DB06774	Capsaicin	Capsaicin and similar agents	approved	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	agonist	yes
DB06774	Capsaicin	Capsaicin and similar agents	approved	Prohibitin-2	Q99623	None	None	unknown
DB06775	Carglumic Acid	Amino acids and derivatives	approved	Carbamoyl-phosphate synthase [ammonia], mitochondrial	P31327	None	allosteric modulator	yes
DB06776	Sodium cellulose phosphate	Drugs for treatment of hypercalcemia	approved	Calcium ions	None	None	binder	yes
DB06777	Chenodeoxycholic acid	Bile acid preparations	approved	Bile acid receptor	Q96RI1	1546084	other	unknown
DB06777	Chenodeoxycholic acid	Bile acid preparations	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB06777	Chenodeoxycholic acid	Bile acid preparations	approved	G-protein coupled bile acid receptor 1	Q8TDU6	None	None	unknown
DB06777	Chenodeoxycholic acid	Bile acid preparations	approved	Aldo-keto reductase family 1 member C2	P52895	531160	substrate	unknown
DB06779	Dalteparin	Heparin group	approved	Antithrombin-III	P01008	179161	potentiator	yes
DB06779	Dalteparin	Heparin group	approved	Vascular endothelial growth factor A	P15692	181971	inhibitor	yes
DB06779	Dalteparin	Heparin group	approved	Tissue factor pathway inhibitor	P10646	180546	inhibitor	yes
DB06779	Dalteparin	Heparin group	approved	P-selectin	P16109	183389	inhibitor	unknown
DB06780	Desoxycorticosterone acetate	N/A	approved	Mineralocorticoid receptor	P08235	307166	agonist	unknown
DB06781	Difluprednate	Corticosteroids, potent (group III)	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB06782	Dimercaprol	Antidotes	approved	Arsenic	None	None	chelator	yes
DB06782	Dimercaprol	Antidotes	approved	Cadmium	None	None	chelator	yes
DB06782	Dimercaprol	Antidotes	approved	Mercury	None	None	chelator	yes
DB06782	Dimercaprol	Antidotes	approved	Amyloid beta A4 protein	P05067	None	None	unknown
DB06785	Ganirelix	Anti-gonadotropin-releasing hormones	approved	Gonadotropin-releasing hormone receptor	P30968	183422	antagonist	yes
DB06786	Halcinonide	Corticosteroids, very potent (group IV)	approved;investigational;withdrawn	Smoothened homolog	Q99835	None	agonist	unknown
DB06787	Hexocyclium	Synthetic anticholinergics, quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB06787	Hexocyclium	Synthetic anticholinergics, quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB06787	Hexocyclium	Synthetic anticholinergics, quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB06787	Hexocyclium	Synthetic anticholinergics, quaternary ammonium compounds	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB06788	Histrelin	Gonadotropin releasing hormone analogues	approved	Gonadotropin-releasing hormone receptor	P30968	183422	agonist	yes
DB06789	Hydroxyprogesterone caproate	Pregnen (4) derivatives	approved;investigational	Progesterone receptor	P06401	35652	agonist	unknown
DB06791	Lanreotide	Somatostatin and analogues	approved	Somatostatin receptor type 2	P30874	None	agonist	unknown
DB06791	Lanreotide	Somatostatin and analogues	approved	Somatostatin receptor type 5	P35346	431095	agonist	unknown
DB06792	Lanthanum carbonate	Drugs for treatment of hyperkalemia and hyperphosphatemia	approved	Phosphate	None	None	binder	yes
DB06795	Mafenide	Sulfonamides	approved;vet_approved	Carbonic anhydrase 6	P23280	None	antagonist	unknown
DB06800	Methylnaltrexone	Peripheral opioid receptor antagonists	approved	Mu-type opioid receptor	P35372	452073	antagonist	yes
DB06800	Methylnaltrexone	Peripheral opioid receptor antagonists	approved	Kappa-type opioid receptor	P41145	532060	antagonist	no
DB06802	Nepafenac	Antiinflammatory agents, non-steroids	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB06802	Nepafenac	Antiinflammatory agents, non-steroids	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	unknown
DB06803	Niclosamide	Salicylic acid derivatives	approved;investigational;vet_approved	DNA	None	None	antagonist	unknown
DB06809	Plerixafor	Other immunostimulants	approved	C-X-C chemokine receptor type 4	P61073	189314	antagonist	yes
DB06810	Plicamycin	Other cytotoxic antibiotics	approved;investigational;withdrawn	DNA	None	None	antagonist	yes
DB06813	Pralatrexate	Folic acid analogues	approved;investigational	Dihydrofolate reductase	P00374	182724	inhibitor	yes
DB06813	Pralatrexate	Folic acid analogues	approved;investigational	Thymidylate synthase	P04818	37479	inhibitor	yes
DB06814	Protokylol	N/A	approved;vet_approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB06817	Raltegravir	Other antivirals	approved	Integrase	Q7ZJM1	None	inhibitor	yes
DB06819	Phenylbutyric acid	Various alimentary tract and metabolism products	approved;investigational	Aromatic-amino-acid aminotransferase	P95468	1806263	None	unknown
DB06819	Phenylbutyric acid	Various alimentary tract and metabolism products	approved;investigational	Thermolysin	P00800	441267	None	unknown
DB06821	Sulfameter	Long-acting sulfonamides	approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB06822	Tinzaparin	Heparin group	approved	Antithrombin-III	P01008	179161	potentiator	yes
DB06822	Tinzaparin	Heparin group	approved	Integrin alpha-4	P13612	33946	inhibitor	unknown
DB06822	Tinzaparin	Heparin group	approved	Stromal cell-derived factor 1	P48061	571508	binder	unknown
DB06825	Triptorelin	Gonadotropin releasing hormone analogues	approved;vet_approved	Gonadotropin-releasing hormone receptor	P30968	183422	agonist	yes
DB06827	Viomycin	N/A	approved	70S ribosome	None	None	None	yes
DB07615	Tranilast	N/A	approved;investigational	Hematopoietic prostaglandin D synthase	O60760	3046817	inhibitor	unknown
DB07776	Flavone	N/A	approved;experimental	Neocarzinostatin	P0A3R9	398596	None	unknown
DB07776	Flavone	N/A	approved;experimental	Steroid hormone receptor ERR1	P11474	36609	agonist	unknown
DB07776	Flavone	N/A	approved;experimental	Steroid hormone receptor ERR2	O95718	None	agonist	unknown
DB07776	Flavone	N/A	approved;experimental	Cytochrome P450 1B1	Q16678	501031	None	unknown
DB08439	Parecoxib	Coxibs	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB08439	Parecoxib	Coxibs	approved	Lactotransferrin	P02788	34416	None	unknown
DB08604	Triclosan	Phenol and derivatives	approved;investigational	Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	P0AEK4	587106	None	unknown
DB08604	Triclosan	Phenol and derivatives	approved;investigational	Enoyl-[acyl-carrier-protein] reductase [NADH]	P9WGR1	None	None	unknown
DB08604	Triclosan	Phenol and derivatives	approved;investigational	Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	O24990	2313282	None	unknown
DB08604	Triclosan	Phenol and derivatives	approved;investigational	Enoyl-[acyl-carrier-protein] reductase [NADH]	Q81JF8	None	None	unknown
DB08604	Triclosan	Phenol and derivatives	approved;investigational	Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI	Q6GI75	49240383	None	unknown
DB08604	Triclosan	Phenol and derivatives	approved;investigational	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB08604	Triclosan	Phenol and derivatives	approved;investigational	Androgen receptor	P10275	178628	None	unknown
DB08604	Triclosan	Phenol and derivatives	approved;investigational	Nuclear receptor subfamily 1 group I member 3	Q14994	458542	inverse agonist	unknown
DB08604	Triclosan	Phenol and derivatives	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB08604	Triclosan	Phenol and derivatives	approved;investigational	Thyroid peroxidase	P07202	339867	weak inhibitor	unknown
DB08795	Azidocillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 2a	Q8DNB6	None	inhibitor	yes
DB08795	Azidocillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 1b	Q7CRA4	15457529	inhibitor	yes
DB08795	Azidocillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 3	Q75Y35	None	inhibitor	yes
DB08795	Azidocillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 1A	Q8DR59	153767	inhibitor	yes
DB08795	Azidocillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved	Penicillin-binding protein 2B	P0A3M6	984233	inhibitor	yes
DB08798	Sulfamoxole	Combinations of sulfonamides and trimethoprim, incl. derivatives	approved	Dihydropteroate synthetase	Q27738	505177	inhibitor	yes
DB08799	Antazoline	Antiallergic agents, excl. corticosteroids	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB08800	Chloropyramine	Antihistamines for topical use	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB08801	Dimetindene	Antihistamines for topical use	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB08801	Dimetindene	Antihistamines for topical use	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB08802	Isothipendyl	Antihistamines for topical use	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB08804	Nandrolone decanoate	N/A	approved;illicit	Androgen receptor	P10275	178628	agonist	yes
DB08806	Roxatidine acetate	H2-receptor antagonists	approved;investigational	Histamine H2 receptor	P25021	184088	antagonist	yes
DB08807	Bopindolol	Beta blocking agents, non-selective, and other diuretics	approved	Beta-1 adrenergic receptor	P08588	178200	partial agonist	yes
DB08807	Bopindolol	Beta blocking agents, non-selective, and other diuretics	approved	Beta-2 adrenergic receptor	P07550	29371	partial agonist	unknown
DB08807	Bopindolol	Beta blocking agents, non-selective, and other diuretics	approved	5-hydroxytryptamine receptor 1A	P08908	189928	None	unknown
DB08807	Bopindolol	Beta blocking agents, non-selective, and other diuretics	approved	5-hydroxytryptamine receptor 1B	P28222	219679	None	unknown
DB08807	Bopindolol	Beta blocking agents, non-selective, and other diuretics	approved	Beta-3 adrenergic receptor	P13945	178896	None	unknown
DB08808	Bupranolol	Beta blocking agents, non-selective	approved	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB08808	Bupranolol	Beta blocking agents, non-selective	approved	Beta-2 adrenergic receptor	P07550	29371	antagonist	unknown
DB08808	Bupranolol	Beta blocking agents, non-selective	approved	Beta-3 adrenergic receptor	P13945	178896	antagonist	unknown
DB08809	Dichloroacetic Acid	N/A	approved;investigational	[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial	Q15118	1088281	inhibitor	yes
DB08809	Dichloroacetic Acid	N/A	approved;investigational	Maleylacetoacetate isomerase	O43708	2832731	None	unknown
DB08810	Cinitapride	N/A	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	yes
DB08810	Cinitapride	N/A	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB08810	Cinitapride	N/A	approved;investigational	5-hydroxytryptamine receptor 4	Q13639	2661757	agonist	unknown
DB08811	Tofisopam	Benzodiazepine derivatives	approved	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	P27815	347120	inhibitor	unknown
DB08811	Tofisopam	Benzodiazepine derivatives	approved	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	Q9Y233	4958858	inhibitor	unknown
DB08811	Tofisopam	Benzodiazepine derivatives	approved	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Q14432	38201493	inhibitor	unknown
DB08811	Tofisopam	Benzodiazepine derivatives	approved	cGMP-dependent 3',5'-cyclic phosphodiesterase	O00408	2108052	inhibitor	unknown
DB08813	Nadroparin	Heparin group	approved;investigational	Antithrombin-III	P01008	179161	potentiator	yes
DB08813	Nadroparin	Heparin group	approved;investigational	P-selectin	P16109	183389	inhibitor	unknown
DB08813	Nadroparin	Heparin group	approved;investigational	Proto-oncogene c-Fos	P01100	29904	inhibitor	unknown
DB08813	Nadroparin	Heparin group	approved;investigational	Myc proto-oncogene protein	P01106	None	inhibitor	unknown
DB08814	Triflusal	Platelet aggregation inhibitors excl. heparin	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	antagonist	yes
DB08814	Triflusal	Platelet aggregation inhibitors excl. heparin	approved;investigational	Nuclear factor NF-kappa-B p105 subunit	P19838	189180	antagonist	yes
DB08814	Triflusal	Platelet aggregation inhibitors excl. heparin	approved;investigational	Nitric oxide synthase, inducible	P35228	292242	agonist	yes
DB08814	Triflusal	Platelet aggregation inhibitors excl. heparin	approved;investigational	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	Q9Y233	4958858	antagonist	yes
DB08815	Lurasidone	Indole derivatives	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB08815	Lurasidone	Indole derivatives	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB08815	Lurasidone	Indole derivatives	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	unknown
DB08815	Lurasidone	Indole derivatives	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB08815	Lurasidone	Indole derivatives	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	antagonist	unknown
DB08815	Lurasidone	Indole derivatives	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	None	unknown
DB08816	Ticagrelor	Platelet aggregation inhibitors excl. heparin	approved	P2Y purinoceptor 12	Q9H244	12083902	inhibitor	yes
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	CD44 antigen	P16070	180197	None	yes
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Intercellular adhesion molecule 1	P05362	758074	None	yes
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Hyaluronan mediated motility receptor	O75330	None	None	yes
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Neurocan core protein	O14594	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Versican core protein	P13611	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Complement component 1 Q subcomponent-binding protein, mitochondrial	Q07021	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Hyaluronan and proteoglycan link protein 1	P10915	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Hyaluronan and proteoglycan link protein 3	Q96S86	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Hyaluronan and proteoglycan link protein 4	Q86UW8	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Hyaluronan-binding protein 2	Q14520	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Layilin	Q6UX15	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Stabilin-2	Q8WWQ8	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Tumor necrosis factor-inducible gene 6 protein	P98066	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Interphotoreceptor matrix proteoglycan 2	Q9BZV3	None	binder	unknown
DB08818	Hyaluronic acid	Viscoelastic substances	approved;vet_approved	Intracellular hyaluronan-binding protein 4	Q5JVS0	None	binder	unknown
DB08819	Tafluprost	Prostaglandin analogues	approved	Prostaglandin F2-alpha receptor	P43088	456564	agonist	yes
DB08820	Ivacaftor	Other respiratory system products	approved	Cystic fibrosis transmembrane conductance regulator	P13569	180332	potentiator	yes
DB08822	Azilsartan medoxomil	Angiotensin II antagonists, plain	approved;investigational	Type-1 angiotensin II receptor	P30556	179122	antagonist	yes
DB08827	Lomitapide	Other lipid modifying agents	approved;investigational	Microsomal triglyceride transfer protein large subunit	P55157	414669	antagonist	yes
DB08828	Vismodegib	Other antineoplastic agents	approved;investigational	Smoothened homolog	Q99835	None	antagonist	yes
DB08835	Spaglumic Acid	Antiallergic agents, excl. corticosteroids	approved	Glutamate carboxypeptidase 2	Q04609	190664	ligand	unknown
DB08860	Pitavastatin	HMG CoA reductase inhibitors	approved	3-hydroxy-3-methylglutaryl-coenzyme A reductase	P04035	306865	inhibitor	yes
DB08862	Cholecystokinin	Tests for pancreatic function	approved;investigational	Cholecystokinin receptor type A	P32238	306491	agonist	unknown
DB08862	Cholecystokinin	Tests for pancreatic function	approved;investigational	RAF proto-oncogene serine/threonine-protein kinase	P04049	35842	agonist	unknown
DB08862	Cholecystokinin	Tests for pancreatic function	approved;investigational	Mitogen-activated protein kinase 3	P27361	31221	None	unknown
DB08862	Cholecystokinin	Tests for pancreatic function	approved;investigational	Pro-epidermal growth factor	P01133	31121	None	unknown
DB08862	Cholecystokinin	Tests for pancreatic function	approved;investigational	Protein kinase C beta type	P05771	189969	agonist	unknown
DB08862	Cholecystokinin	Tests for pancreatic function	approved;investigational	Gastrin/cholecystokinin type B receptor	P32239	306489	agonist	unknown
DB08864	Rilpivirine	Antivirals for treatment of HIV infections, combinations	approved	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB08864	Rilpivirine	Antivirals for treatment of HIV infections, combinations	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	agonist	unknown
DB08865	Crizotinib	Protein kinase inhibitors	approved	ALK tyrosine kinase receptor	Q9UM73	2454168	inhibitor	yes
DB08865	Crizotinib	Protein kinase inhibitors	approved	Hepatocyte growth factor receptor	P08581	307196	inhibitor	yes
DB08867	Ulipristal	Emergency contraceptives	approved	Progesterone receptor	P06401	35652	modulator	yes
DB08867	Ulipristal	Emergency contraceptives	approved	Glucocorticoid receptor	P04150	31680	antagonist	yes
DB08867	Ulipristal	Emergency contraceptives	approved	Androgen receptor	P10275	178628	None	unknown
DB08868	Fingolimod	Selective immunosuppressants	approved;investigational	Sphingosine 1-phosphate receptor 5	Q9H228	None	modulator	yes
DB08868	Fingolimod	Selective immunosuppressants	approved;investigational	Histone deacetylase 1	Q13547	1277084	inhibitor	unknown
DB08869	Tesamorelin	Somatropin and somatropin agonists	approved;investigational	Growth hormone-releasing hormone receptor	Q02643	183173	binder	yes
DB08870	Brentuximab vedotin	Monoclonal antibodies	approved;investigational	Tumor necrosis factor receptor superfamily member 8	P28908	None	binder	yes
DB08871	Eribulin	Other antineoplastic agents	approved;investigational	Apoptosis regulator Bcl-2	P10415	179367	None	unknown
DB08871	Eribulin	Other antineoplastic agents	approved;investigational	Tubulin beta-1 chain	Q9H4B7	11230445	None	unknown
DB08872	Gabapentin Enacarbil	N/A	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-1	P54289	179762	None	unknown
DB08872	Gabapentin Enacarbil	N/A	approved;investigational	Voltage-dependent calcium channel subunit alpha-2/delta-2	Q9NY47	None	None	unknown
DB08873	Boceprevir	Protease inhibitors	approved;withdrawn	NS3/4A protein	B0B3C9	None	inhibitor	yes
DB08874	Fidaxomicin	Antibiotics	approved	RNA polymerase sigma factor	Q18BX5	None	inhibitor	yes
DB08875	Cabozantinib	Protein kinase inhibitors	approved;investigational	Hepatocyte growth factor receptor	P08581	307196	antagonist	yes
DB08875	Cabozantinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 2	P35968	2655412	antagonist	yes
DB08875	Cabozantinib	Protein kinase inhibitors	approved;investigational	Proto-oncogene tyrosine-protein kinase receptor Ret	P07949	None	antagonist	yes
DB08876	Taliglucerase Alfa	Enzymes	approved;investigational	Glucocerebroside	None	None	None	unknown
DB08877	Ruxolitinib	Protein kinase inhibitors	approved	Tyrosine-protein kinase JAK1	P23458	None	inhibitor	yes
DB08877	Ruxolitinib	Protein kinase inhibitors	approved	Tyrosine-protein kinase JAK2	O60674	None	inhibitor	yes
DB08879	Belimumab	Selective immunosuppressants	approved	Tumor necrosis factor ligand superfamily member 13B	Q9Y275	4761612	neutralizer	yes
DB08880	Teriflunomide	Selective immunosuppressants	approved	Dihydroorotate dehydrogenase (quinone), mitochondrial	Q02127	555594	inhibitor	unknown
DB08881	Vemurafenib	Protein kinase inhibitors	approved	Serine/threonine-protein kinase B-raf	P15056	41387220	inhibitor	yes
DB08882	Linagliptin	Dipeptidyl peptidase 4 (DPP-4) inhibitors	approved	Dipeptidyl peptidase 4	P27487	535388	inhibitor	yes
DB08883	Perampanel	Other antiepileptics	approved	Glutamate receptor 1	P42261	183281	antagonist	yes
DB08885	Aflibercept	Other antineoplastic agents	approved	Vascular endothelial growth factor A	P15692	181971	binder	yes
DB08885	Aflibercept	Other antineoplastic agents	approved	Placenta growth factor	P49763	None	binder	yes
DB08885	Aflibercept	Other antineoplastic agents	approved	Vascular endothelial growth factor B	P49765	None	binder	yes
DB08888	Ocriplasmin	Other ophthalmologicals	approved	Fibronectin	P02751	12053817	cleavage	yes
DB08888	Ocriplasmin	Other ophthalmologicals	approved	Alpha-2-macroglobulin	P01023	177870	ligand	no
DB08888	Ocriplasmin	Other ophthalmologicals	approved	Alpha-2-antiplasmin	P08697	219408	ligand	no
DB08889	Carfilzomib	Other antineoplastic agents	approved;investigational	Proteasome subunit beta type-5	P28074	558526	inhibitor	yes
DB08889	Carfilzomib	Other antineoplastic agents	approved;investigational	Proteasome subunit beta type-8	P28062	None	inhibitor	yes
DB08889	Carfilzomib	Other antineoplastic agents	approved;investigational	Proteasome subunit beta type-1	P20618	220026	inhibitor	yes
DB08889	Carfilzomib	Other antineoplastic agents	approved;investigational	Proteasome subunit beta type-9	P28065	None	inhibitor	yes
DB08889	Carfilzomib	Other antineoplastic agents	approved;investigational	Proteasome subunit beta type-2	P49721	565649	inhibitor	yes
DB08889	Carfilzomib	Other antineoplastic agents	approved;investigational	Proteasome subunit beta type-10	P40306	None	inhibitor	yes
DB08890	Linaclotide	Other drugs for constipation	approved	Heat-stable enterotoxin receptor	P25092	None	agonist	yes
DB08893	Mirabegron	Drugs for urinary frequency and incontinence	approved	Beta-3 adrenergic receptor	P13945	178896	agonist	yes
DB08894	Peginesatide	Other antianemic preparations	approved;investigational	Erythropoietin receptor	P19235	182245	stimulator	yes
DB08895	Tofacitinib	Selective immunosuppressants	approved;investigational	Tyrosine-protein kinase JAK1	P23458	None	inhibitor	yes
DB08895	Tofacitinib	Selective immunosuppressants	approved;investigational	Tyrosine-protein kinase JAK2	O60674	None	antagonist	yes
DB08895	Tofacitinib	Selective immunosuppressants	approved;investigational	Tyrosine-protein kinase JAK3	P52333	None	inhibitor	yes
DB08895	Tofacitinib	Selective immunosuppressants	approved;investigational	Non-receptor tyrosine-protein kinase TYK2	P29597	37504	None	unknown
DB08896	Regorafenib	Protein kinase inhibitors	approved	Vascular endothelial growth factor receptor 1	P17948	31432	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Vascular endothelial growth factor receptor 2	P35968	2655412	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Vascular endothelial growth factor receptor 3	P35916	297050	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Mast/stem cell growth factor receptor Kit	P10721	34085	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Platelet-derived growth factor receptor alpha	P16234	189734	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Platelet-derived growth factor receptor beta	P09619	189732	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Fibroblast growth factor receptor 1	P11362	31368	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Fibroblast growth factor receptor 2	P21802	31374	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Angiopoietin-1 receptor	Q02763	None	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Discoidin domain-containing receptor 2	Q16832	None	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	High affinity nerve growth factor receptor	P04629	339918	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Ephrin type-A receptor 2	P29317	181944	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	RAF proto-oncogene serine/threonine-protein kinase	P04049	35842	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Serine/threonine-protein kinase B-raf	P15056	41387220	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Mitogen-activated protein kinase 11	Q15759	None	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Tyrosine-protein kinase FRK	P42685	None	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Tyrosine-protein kinase ABL1	P00519	28237	inhibitor	yes
DB08896	Regorafenib	Protein kinase inhibitors	approved	Proto-oncogene tyrosine-protein kinase receptor Ret	P07949	None	inhibitor	yes
DB08897	Aclidinium	Adrenergics in combination with anticholinergics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB08897	Aclidinium	Adrenergics in combination with anticholinergics	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB08897	Aclidinium	Adrenergics in combination with anticholinergics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB08897	Aclidinium	Adrenergics in combination with anticholinergics	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB08897	Aclidinium	Adrenergics in combination with anticholinergics	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	yes
DB08898	Glucarpidase	Detoxifying agents for antineoplastic treatment	approved;investigational	Methotrexate	None	None	metabolizer	yes
DB08899	Enzalutamide	Anti-androgens	approved	Androgen receptor	P10275	178628	inhibitor	yes
DB08900	Teduglutide	Various alimentary tract and metabolism products	approved	Glucagon-like peptide 2 receptor	O95838	4324491	agonist	yes
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase ABL1	P00519	28237	inhibitor	yes
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Breakpoint cluster region protein	P11274	None	inhibitor	yes
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Mast/stem cell growth factor receptor Kit	P10721	34085	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Proto-oncogene tyrosine-protein kinase receptor Ret	P07949	None	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Angiopoietin-1 receptor	Q02763	None	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Receptor-type tyrosine-protein kinase FLT3	P36888	409573	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Fibroblast growth factor receptor 1	P11362	31368	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Fibroblast growth factor receptor 2	P21802	31374	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Fibroblast growth factor receptor 3	P22607	182569	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Fibroblast growth factor receptor 4	P22455	31372	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase Lck	P06239	36808	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Proto-oncogene tyrosine-protein kinase Src	P12931	10635153	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Tyrosine-protein kinase Lyn	P07948	307144	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 2	P35968	2655412	inhibitor	unknown
DB08901	Ponatinib	Protein kinase inhibitors	approved;investigational	Platelet-derived growth factor receptor alpha	P16234	189734	inhibitor	unknown
DB08902	Raxibacumab	Specific immunoglobulins	approved	Protective antigen	P13423	None	antibody	yes
DB08903	Bedaquiline	Other drugs for treatment of tuberculosis	approved	ATP synthase subunit c	P9WPS1	None	inhibitor	yes
DB08906	Fluticasone furoate	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB08907	Canagliflozin	Other blood glucose lowering drugs, excl. insulins	approved	Sodium/glucose cotransporter 2	P31639	None	inhibitor	yes
DB08907	Canagliflozin	Other blood glucose lowering drugs, excl. insulins	approved	Sodium/glucose cotransporter 1	P13866	None	inhibitor	unknown
DB08908	Dimethyl fumarate	Other nervous system drugs	approved;investigational	Kelch-like ECH-associated protein 1	Q14145	None	binder	yes
DB08908	Dimethyl fumarate	Other nervous system drugs	approved;investigational	Transcription factor p65	Q04206	None	None	unknown
DB08910	Pomalidomide	Other immunosuppressants	approved	Protein cereblon	Q96SW2	None	inhibitor	yes
DB08910	Pomalidomide	Other immunosuppressants	approved	Tumor necrosis factor	P01375	339741	inhibitor	yes
DB08910	Pomalidomide	Other immunosuppressants	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB08911	Trametinib	Protein kinase inhibitors	approved	Dual specificity mitogen-activated protein kinase kinase 1	Q02750	188569	antagonist	yes
DB08911	Trametinib	Protein kinase inhibitors	approved	Dual specificity mitogen-activated protein kinase kinase 2	P36507	None	antagonist	yes
DB08912	Dabrafenib	Protein kinase inhibitors	approved;investigational	Serine/threonine-protein kinase B-raf	P15056	41387220	antagonist	yes
DB08912	Dabrafenib	Protein kinase inhibitors	approved;investigational	RAF proto-oncogene serine/threonine-protein kinase	P04049	35842	antagonist	yes
DB08912	Dabrafenib	Protein kinase inhibitors	approved;investigational	Serine/threonine-protein kinase SIK1	P57059	None	antagonist	unknown
DB08912	Dabrafenib	Protein kinase inhibitors	approved;investigational	Serine/threonine-protein kinase Nek11	Q8NG66	None	antagonist	unknown
DB08912	Dabrafenib	Protein kinase inhibitors	approved;investigational	LIM domain kinase 1	P53667	None	antagonist	unknown
DB08916	Afatinib	Protein kinase inhibitors	approved	Epidermal growth factor receptor	P00533	757924	inhibitor	yes
DB08916	Afatinib	Protein kinase inhibitors	approved	Receptor tyrosine-protein kinase erbB-2	P04626	553282	inhibitor	yes
DB08916	Afatinib	Protein kinase inhibitors	approved	Receptor tyrosine-protein kinase erbB-4	Q15303	None	inhibitor	yes
DB08918	Levomilnacipran	N/A	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB08918	Levomilnacipran	N/A	approved;investigational	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB08922	Perospirone	N/A	approved	5-hydroxytryptamine receptor 2A	P28223	36431	inverse agonist	yes
DB08922	Perospirone	N/A	approved	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB08922	Perospirone	N/A	approved	5-hydroxytryptamine receptor 1A	P08908	189928	partial agonist	yes
DB08922	Perospirone	N/A	approved	Histamine H1 receptor	P35367	510296	inverse agonist	unknown
DB08922	Perospirone	N/A	approved	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB08922	Perospirone	N/A	approved	Alpha-1 adrenergic receptors	P25100	177807	antagonist	unknown
DB08930	Dolutegravir	Antivirals for treatment of HIV infections, combinations	approved	Integrase	Q7ZJM1	None	inhibitor	yes
DB08931	Riociguat	Antihypertensives for pulmonary arterial hypertension	approved	Guanylate cyclase soluble subunit alpha-2	P33402	31671	agonist	yes
DB08932	Macitentan	Antihypertensives for pulmonary arterial hypertension	approved	Endothelin-1 receptor	P25101	238636	antagonist	yes
DB08932	Macitentan	Antihypertensives for pulmonary arterial hypertension	approved	Endothelin B receptor	P24530	182276	antagonist	yes
DB08933	Luliconazole	Imidazole and triazole derivatives	approved	Lanosterol 14-alpha demethylase	P10613	578119	inhibitor	yes
DB08934	Sofosbuvir	Other antivirals	approved	RNA-dependent RNA-polymerase	O39930	None	inhibitor	yes
DB08935	Obinutuzumab	Monoclonal antibodies	approved;investigational	B-lymphocyte antigen CD20	P11836	29774	antibody	yes
DB08936	Chlorcyclizine	Piperazine derivatives	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB08949	Inositol nicotinate	Nicotinic acid and derivatives	approved;withdrawn	Hydroxycarboxylic acid receptor 3	P49019	219867	agonist	yes
DB08949	Inositol nicotinate	Nicotinic acid and derivatives	approved;withdrawn	Hydroxycarboxylic acid receptor 2	Q8TDS4	28975188	agonist	yes
DB08954	Ifenprodil	Other peripheral vasodilators	approved;investigational;withdrawn	Glutamate receptor ionotropic, NMDA 1	Q05586	219920	antagonist	yes
DB08954	Ifenprodil	Other peripheral vasodilators	approved;investigational;withdrawn	Glutamate receptor ionotropic, NMDA 2B	Q13224	1899202	antagonist	yes
DB08964	Gemeprost	Prostaglandins	approved;withdrawn	Prostaglandin E2 receptor EP2 subtype	P43116	632650	agonist	unknown
DB08964	Gemeprost	Prostaglandins	approved;withdrawn	Prostaglandin E2 receptor EP3 subtype	P43115	None	agonist	yes
DB08995	Diosmin	Bioflavonoids	approved;investigational	Aryl hydrocarbon receptor	P35869	533324	agonist	unknown
DB08996	Dimetacrine	Non-selective monoamine reuptake inhibitors	approved;withdrawn	Acetylcholinesterase	P22303	177975	antagonist	yes
DB09006	Clinofibrate	N/A	approved	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB09006	Clinofibrate	N/A	approved	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB09006	Clinofibrate	N/A	approved	Peroxisome proliferator-activated receptor delta	Q03181	190230	None	unknown
DB09014	Captodiame	Diphenylmethane derivatives	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB09014	Captodiame	Diphenylmethane derivatives	approved;investigational	Sigma non-opioid intracellular receptor 1	Q99720	1783387	agonist	yes
DB09014	Captodiame	Diphenylmethane derivatives	approved;investigational	D(3) dopamine receptor	P35462	927342	agonist	yes
DB09016	Butriptyline	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent serotonin transporter	P31645	36433	antagonist	yes
DB09016	Butriptyline	Non-selective monoamine reuptake inhibitors	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB09016	Butriptyline	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB09018	Bromopride	Propulsives	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB09026	Aliskiren	Angiotensin II antagonists, other combinations	approved;investigational	Renin	P00797	190994	inhibitor	yes
DB09027	Ledipasvir	Other antivirals	approved	Nonstructural protein 5A	Q5L478	None	inhibitor	yes
DB09028	Cytisine	N/A	approved;investigational	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	agonist	unknown
DB09028	Cytisine	N/A	approved;investigational	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	agonist	unknown
DB09028	Cytisine	N/A	approved;investigational	Neuronal acetylcholine receptor subunit alpha-3	P32297	177898	agonist	unknown
DB09028	Cytisine	N/A	approved;investigational	Neuronal acetylcholine receptor subunit alpha-6	Q15825	1458118	agonist	unknown
DB09028	Cytisine	N/A	approved;investigational	Neuronal acetylcholine receptor subunit beta-2	P17787	32017	partial agonist	unknown
DB09029	Secukinumab	Interleukin inhibitors	approved	Interleukin-17A	Q16552	None	antagonist	yes
DB09030	Vorapaxar	Platelet aggregation inhibitors excl. heparin	approved	Proteinase-activated receptor 1	P25116	339677	antagonist	yes
DB09031	Miltefosine	Other antineoplastic agents	approved;investigational	Multidrug resistance protein 1	P08183	307180	None	unknown
DB09033	Vedolizumab	Selective immunosuppressants	approved	Integrin alpha-4	P13612	33946	antibody	yes
DB09033	Vedolizumab	Selective immunosuppressants	approved	Integrin beta-7	P26010	None	antibody	yes
DB09034	Suvorexant	N/A	approved;investigational	Orexin receptor type 1	O43613	None	antagonist	yes
DB09034	Suvorexant	N/A	approved;investigational	Orexin receptor type 2	O43614	None	antagonist	yes
DB09035	Nivolumab	Monoclonal antibodies	approved	Programmed cell death protein 1	Q15116	None	antibody	yes
DB09036	Siltuximab	Interleukin inhibitors	approved;investigational	Interleukin-6	P05231	32674	antagonist	yes
DB09037	Pembrolizumab	Monoclonal antibodies	approved	Programmed cell death protein 1	Q15116	None	antagonist	yes
DB09038	Empagliflozin	Combinations of oral blood glucose lowering drugs	approved	Sodium/glucose cotransporter 2	P31639	None	antagonist	unknown
DB09039	Eliglustat	Various alimentary tract and metabolism products	approved	Ceramide glucosyltransferase	Q16739	1325917	antagonist	yes
DB09040	Efinaconazole	Imidazole and triazole derivatives	approved	Lanosterol 14-alpha demethylase	P50859	755693	inhibitor	yes
DB09041	Tavaborole	N/A	approved;investigational	Cytosolic leucyl-tRNA synthetase	Q9HGT2	None	inhibitor	yes
DB09043	Albiglutide	Other blood glucose lowering drugs, excl. insulins	approved	Glucagon-like peptide 1 receptor	P43220	405082	agonist	yes
DB09045	Dulaglutide	Other blood glucose lowering drugs, excl. insulins	approved;investigational	Glucagon-like peptide 1 receptor	P43220	405082	agonist	yes
DB09046	Metreleptin	N/A	approved	Leptin receptor	P48357	None	agonist	yes
DB09047	Finafloxacin	N/A	approved;investigational	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB09047	Finafloxacin	N/A	approved;investigational	DNA topoisomerase 4 subunit A	P43702	1574370	inhibitor	yes
DB09047	Finafloxacin	N/A	approved;investigational	DNA topoisomerase 2-alpha	P11388	292830	inhibitor	yes
DB09048	Netupitant	N/A	approved;investigational	Substance-P receptor	P25103	8176544	antagonist	yes
DB09049	Naloxegol	Peripheral opioid receptor antagonists	approved	Mu-type opioid receptor	P35372	452073	antagonist	yes
DB09050	Ceftolozane	Other cephalosporins and penems	approved;investigational	Penicillin-binding protein 1B	Q9X6W0	4887211	inhibitor	yes
DB09050	Ceftolozane	Other cephalosporins and penems	approved;investigational	Penicillin-binding protein 3	Q51504	None	inhibitor	yes
DB09052	Blinatumomab	Monoclonal antibodies	approved;investigational	B-lymphocyte antigen CD19	P15391	None	activator	yes
DB09052	Blinatumomab	Monoclonal antibodies	approved;investigational	T-cell surface glycoprotein CD3 delta chain	P04234	None	activator	yes
DB09053	Ibrutinib	Protein kinase inhibitors	approved	Tyrosine-protein kinase BTK	Q06187	312467	inhibitor	yes
DB09057	Anthrax immune globulin human	N/A	approved	Protective antigen	P13423	None	antibody	yes
DB09059	Atosiban	Other gynecologicals	approved;investigational	Oxytocin receptor	P30559	34765	antagonist	yes
DB09059	Atosiban	Other gynecologicals	approved;investigational	Vasopressin V1a receptor	P37288	667068	antagonist	unknown
DB09059	Atosiban	Other gynecologicals	approved;investigational	Vasopressin V1b receptor	P47901	563982	antagonist	unknown
DB09059	Atosiban	Other gynecologicals	approved;investigational	Vasopressin V2 receptor	P30518	28418	antagonist	unknown
DB09060	Avibactam	N/A	approved	Beta-lactamase TEM	P62593	208959	inhibitor	yes
DB09060	Avibactam	N/A	approved	Beta-lactamase CTX-M	Q9L5C7	None	inhibitor	yes
DB09060	Avibactam	N/A	approved	Beta-lactamase AmpC	Q93CA2	15705879	inhibitor	yes
DB09060	Avibactam	N/A	approved	Beta-lactamase SHV-1	P0AD63	5002312	inhibitor	yes
DB09060	Avibactam	N/A	approved	Beta-lactamase SHV-2	P0A9Z7	5002314	inhibitor	yes
DB09060	Avibactam	N/A	approved	Beta-lactamase SHV-1	P0AD64	151861	inhibitor	yes
DB09060	Avibactam	N/A	approved	Class D OXA-48 carbapenemase	A0A023W3H0	None	inhibitor	yes
DB09060	Avibactam	N/A	approved	Carbapenem-hydrolyzing beta-lactamase KPC	Q9F663	None	inhibitor	yes
DB09060	Avibactam	N/A	approved	Beta-lactamase CTX-M-15	Q9EXV5	None	inhibitor	yes
DB09060	Avibactam	N/A	approved	Extended-spectrum beta-lactamase PER-1	P37321	None	inhibitor	yes
DB09061	Cannabidiol	N/A	approved;investigational	Cannabinoid receptor 1	P21554	29915	antagonist	yes
DB09061	Cannabidiol	N/A	approved;investigational	Cannabinoid receptor 2	P34972	407807	antagonist	unknown
DB09061	Cannabidiol	N/A	approved;investigational	G-protein coupled receptor 12	P47775	None	inverse agonist	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Glycine receptor subunit alpha-1	P23415	31851	None	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Glycine receptor (alpha-1/beta)	P48167	992687	allosteric modulator	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Glycine receptor subunit alpha-3	O75311	3342792	potentiator	unknown
DB09061	Cannabidiol	N/A	approved;investigational	N-arachidonyl glycine receptor	Q14330	1066731	None	unknown
DB09061	Cannabidiol	N/A	approved;investigational	G-protein coupled receptor 55	Q9Y2T6	None	antagonist	unknown
DB09061	Cannabidiol	N/A	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	unknown
DB09061	Cannabidiol	N/A	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	None	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Delta-type opioid receptor	P41143	27545517	None	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Mu-type opioid receptor	P35372	452073	None	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	activator	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	activator	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1G	O43497	6625659	None	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	None	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1I	Q9P0X4	5565888	None	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Transient receptor potential cation channel subfamily A member 1	O75762	3287188	agonist	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Transient receptor potential cation channel subfamily M member 8	Q7Z2W7	20147036	None	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Transient receptor potential cation channel subfamily V member 2	Q9Y5S1	None	activator	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Transient receptor potential cation channel subfamily V member 3	Q8NET8	None	activator	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Transient receptor potential cation channel subfamily V member 4	Q9HBA0	None	activator	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Voltage-dependent anion-selective channel protein 1	P21796	None	None	unknown
DB09061	Cannabidiol	N/A	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB09061	Cannabidiol	N/A	approved;investigational	Adenosine receptor A1	P30542	256155	activator	unknown
DB09063	Ceritinib	Protein kinase inhibitors	approved	ALK tyrosine kinase receptor	Q9UM73	2454168	antagonist	yes
DB09064	Ciprofibrate	Fibrates	approved;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	None	unknown
DB09066	Corifollitropin alfa	Gonadotropins	approved;investigational	Follicle-stimulating hormone receptor	P23945	182771	agonist	yes
DB09067	Corticorelin ovine triflutate	N/A	approved	Corticotropin-releasing factor receptor 1	P34998	None	ligand	yes
DB09068	Vortioxetine	Other antidepressants	approved;investigational	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB09068	Vortioxetine	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	yes
DB09068	Vortioxetine	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	yes
DB09068	Vortioxetine	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	partial agonist	yes
DB09068	Vortioxetine	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	yes
DB09068	Vortioxetine	Other antidepressants	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	ligand	unknown
DB09068	Vortioxetine	Other antidepressants	approved;investigational	solute carrier family 6 member 2	None	None	blocker	unknown
DB09069	Trimetazidine	Other cardiac preparations	approved;investigational	3-ketoacyl-CoA thiolase, peroxisomal	P09110	None	inhibitor	yes
DB09070	Tibolone	Other estrogens	approved;investigational	Estrogen receptor alpha	P03372	31234	antagonist	yes
DB09071	Tasimelteon	Melatonin receptor agonists	approved;investigational	Melatonin receptor type 1A	P48039	602130	agonist	yes
DB09071	Tasimelteon	Melatonin receptor agonists	approved;investigational	Melatonin receptor type 1B	P49286	971194	agonist	yes
DB09073	Palbociclib	Protein kinase inhibitors	approved;investigational	Cyclin-dependent kinase 4	P11802	456427	inhibitor	yes
DB09073	Palbociclib	Protein kinase inhibitors	approved;investigational	Cyclin-dependent kinase 6	Q00534	36623	inhibitor	yes
DB09074	Olaparib	Other antineoplastic agents	approved	Poly [ADP-ribose] polymerase 1	P09874	1017423	inhibitor	yes
DB09074	Olaparib	Other antineoplastic agents	approved	Poly [ADP-ribose] polymerase 2	Q9UGN5	6688130	inhibitor	yes
DB09074	Olaparib	Other antineoplastic agents	approved	Poly [ADP-ribose] polymerase 3	Q9Y6F1	29788060	inhibitor	yes
DB09075	Edoxaban	N/A	approved	Coagulation factor X	P00742	182841	inhibitor	yes
DB09076	Umeclidinium	Anticholinergics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB09076	Umeclidinium	Anticholinergics	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB09076	Umeclidinium	Anticholinergics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB09076	Umeclidinium	Anticholinergics	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	no
DB09076	Umeclidinium	Anticholinergics	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	no
DB09077	Dinutuximab	Monoclonal antibodies	approved;investigational	Ganglioside GD2	None	None	inhibitor	yes
DB09078	Lenvatinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 1	P17948	31432	inhibitor	yes
DB09078	Lenvatinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 2	P35968	2655412	inhibitor	yes
DB09078	Lenvatinib	Protein kinase inhibitors	approved;investigational	Vascular endothelial growth factor receptor 3	P35916	297050	inhibitor	yes
DB09078	Lenvatinib	Protein kinase inhibitors	approved;investigational	Fibroblast growth factor receptor 1	P11362	31368	inhibitor	yes
DB09078	Lenvatinib	Protein kinase inhibitors	approved;investigational	Fibroblast growth factor receptor 2	P21802	31374	inhibitor	yes
DB09078	Lenvatinib	Protein kinase inhibitors	approved;investigational	Fibroblast growth factor receptor 3	P22607	182569	inhibitor	yes
DB09078	Lenvatinib	Protein kinase inhibitors	approved;investigational	Fibroblast growth factor receptor 4	P22455	31372	inhibitor	yes
DB09078	Lenvatinib	Protein kinase inhibitors	approved;investigational	Platelet derived growth factor receptor alpha	None	None	inhibitor	yes
DB09078	Lenvatinib	Protein kinase inhibitors	approved;investigational	RET 	None	None	inhibitor	yes
DB09078	Lenvatinib	Protein kinase inhibitors	approved;investigational	Mast/stem cell growth factor receptor Kit	P10721	34085	inhibitor	yes
DB09079	Nintedanib	Protein kinase inhibitors	approved	Vascular endothelial growth factor receptor 1	P17948	31432	inhibitor	yes
DB09079	Nintedanib	Protein kinase inhibitors	approved	Vascular endothelial growth factor receptor 2	P35968	2655412	inhibitor	yes
DB09079	Nintedanib	Protein kinase inhibitors	approved	Vascular endothelial growth factor receptor 3	P35916	297050	inhibitor	yes
DB09079	Nintedanib	Protein kinase inhibitors	approved	Platelet derived growth factor receptor alpha	None	None	inhibitor	yes
DB09079	Nintedanib	Protein kinase inhibitors	approved	Platelet derived growth factor receptor beta	None	None	inhibitor	yes
DB09079	Nintedanib	Protein kinase inhibitors	approved	Fibroblast growth factor receptor 1	P11362	31368	inhibitor	yes
DB09079	Nintedanib	Protein kinase inhibitors	approved	Fibroblast growth factor receptor 2	P21802	31374	inhibitor	yes
DB09079	Nintedanib	Protein kinase inhibitors	approved	Fibroblast growth factor receptor 3	P22607	182569	inhibitor	yes
DB09079	Nintedanib	Protein kinase inhibitors	approved	Receptor-type tyrosine-protein kinase FLT3	P36888	409573	inhibitor	unknown
DB09079	Nintedanib	Protein kinase inhibitors	approved	Tyrosine-protein kinase Lck	P06239	36808	inhibitor	unknown
DB09079	Nintedanib	Protein kinase inhibitors	approved	Tyrosine-protein kinase Lyn	P07948	307144	inhibitor	unknown
DB09079	Nintedanib	Protein kinase inhibitors	approved	Proto-oncogene tyrosine-protein kinase Src	P12931	10635153	inhibitor	unknown
DB09080	Olodaterol	Adrenergics in combination with anticholinergics	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB09082	Vilanterol	Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB09083	Ivabradine	Other cardiac preparations	approved	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	Q9UL51	None	inhibitor	unknown
DB09085	Tetracaine	Anesthetics for topical use	approved;vet_approved	Ryanodine receptor 1	P21817	337722	modulator	yes
DB09085	Tetracaine	Anesthetics for topical use	approved;vet_approved	Ryanodine receptor 2	Q92736	None	modulator	yes
DB09085	Tetracaine	Anesthetics for topical use	approved;vet_approved	Voltage gated sodium channel	None	None	antagonist	yes
DB09086	Eugenol	N/A	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB09086	Eugenol	N/A	approved	Estrogen receptor beta	Q92731	2911152	None	unknown
DB09086	Eugenol	N/A	approved	Androgen receptor	P10275	178628	antagonist	unknown
DB09086	Eugenol	N/A	approved	Transient receptor potential cation channel subfamily V member 3	Q8NET8	None	None	unknown
DB09088	Amylocaine	N/A	approved;withdrawn	Voltage gated sodium channel	None	None	antagonist	yes
DB09089	Trimebutine	Synthetic anticholinergics, esters with tertiary amino group	approved	Mu-type opioid receptor	P35372	452073	agonist	yes
DB09089	Trimebutine	Synthetic anticholinergics, esters with tertiary amino group	approved	Voltage dependent L type calcium channel	O00305	2058727	inhibitor	yes
DB09089	Trimebutine	Synthetic anticholinergics, esters with tertiary amino group	approved	Calcium-activated potassium channel	Q9UGI6	3309531	inhibitor	yes
DB09089	Trimebutine	Synthetic anticholinergics, esters with tertiary amino group	approved	Voltage-dependent T-type calcium channel	Q9P0X4	5565888	activator	unknown
DB09089	Trimebutine	Synthetic anticholinergics, esters with tertiary amino group	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB09089	Trimebutine	Synthetic anticholinergics, esters with tertiary amino group	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB09089	Trimebutine	Synthetic anticholinergics, esters with tertiary amino group	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB09089	Trimebutine	Synthetic anticholinergics, esters with tertiary amino group	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB09090	Pinaverium	Other drugs for functional gastrointestinal disorders	approved	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	antagonist	yes
DB09091	Tixocortol	Corticosteroids acting locally	approved;withdrawn	Glucocorticoid receptor	P04150	31680	binder	yes
DB09091	Tixocortol	Corticosteroids acting locally	approved;withdrawn	Histone deacetylase 2	Q92769	1667394	stimulator	yes
DB09092	Xanthinol	Purine derivatives	approved;withdrawn	60S ribosomal protein L3	P39023	313659	binder	no
DB09092	Xanthinol	Purine derivatives	approved;withdrawn	NAD(P) transhydrogenase, mitochondrial	Q13423	1110520	cofactor	yes
DB09092	Xanthinol	Purine derivatives	approved;withdrawn	Glyceraldehyde-3-phosphate dehydrogenase	P04406	31645	cofactor	yes
DB09092	Xanthinol	Purine derivatives	approved;withdrawn	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	P50213	706839	cofactor	yes
DB09092	Xanthinol	Purine derivatives	approved;withdrawn	2-oxoglutarate dehydrogenase, mitochondrial	Q02218	531241	cofactor	yes
DB09092	Xanthinol	Purine derivatives	approved;withdrawn	Malate dehydrogenase, mitochondrial	P40926	2906146	cofactor	yes
DB09093	Chlortetracycline	Antibiotics	approved;investigational;vet_approved	16S rRNA	None	None	inhibitor	yes
DB09093	Chlortetracycline	Antibiotics	approved;investigational;vet_approved	30S ribosomal protein S3	P0A7V3	None	inhibitor	yes
DB09093	Chlortetracycline	Antibiotics	approved;investigational;vet_approved	30S ribosomal protein S8	P0A7W7	None	inhibitor	yes
DB09093	Chlortetracycline	Antibiotics	approved;investigational;vet_approved	30S ribosomal protein S19	P0A7U3	42826	inhibitor	yes
DB09093	Chlortetracycline	Antibiotics	approved;investigational;vet_approved	30S ribosomal protein S14	P0AG59	809690	inhibitor	yes
DB09093	Chlortetracycline	Antibiotics	approved;investigational;vet_approved	30S ribosomal protein S7	P02359	None	inhibitor	yes
DB09095	Difluocortolone	Corticosteroids, potent, other combinations	approved;investigational;withdrawn	Annexin A3	P12429	None	inducer	yes
DB09095	Difluocortolone	Corticosteroids, potent, other combinations	approved;investigational;withdrawn	Glucocorticoid receptor	P04150	31680	binder	yes
DB09097	Quinagolide	Prolactine inhibitors	approved;investigational	D(2) dopamine receptor	P14416	181432	agonist	unknown
DB09097	Quinagolide	Prolactine inhibitors	approved;investigational	D(1) dopamine receptor	P21918	32049	agonist	unknown
DB09098	Somatrem	Somatropin and somatropin agonists	approved;investigational;withdrawn	Growth hormone receptor	P10912	31738	agonist	yes
DB09098	Somatrem	Somatropin and somatropin agonists	approved;investigational;withdrawn	Insulin-like growth factor 1 receptor	P08069	804990	None	yes
DB09099	Somatostatin	Somatostatin and analogues	approved;investigational	Somatostatin receptor type 1	P30872	307434	agonist	yes
DB09099	Somatostatin	Somatostatin and analogues	approved;investigational	Somatostatin receptor type 2	P30874	None	agonist	yes
DB09099	Somatostatin	Somatostatin and analogues	approved;investigational	Somatostatin receptor type 3	P32745	None	agonist	yes
DB09099	Somatostatin	Somatostatin and analogues	approved;investigational	Somatostatin receptor type 4	P31391	None	agonist	yes
DB09099	Somatostatin	Somatostatin and analogues	approved;investigational	Somatostatin receptor type 5	P35346	431095	agonist	yes
DB09101	Elvitegravir	Antivirals for treatment of HIV infections, combinations	approved	Integrase	Q7ZJM1	None	inhibitor	yes
DB09102	Daclatasvir	Other antivirals	approved;investigational	Nonstructural Protein 5A (NS5A)	None	None	inhibitor	unknown
DB09103	Ancestim	Colony stimulating factors	approved;investigational;withdrawn	Mast/stem cell growth factor receptor Kit	P10721	34085	agonist	yes
DB09105	Asfotase Alfa	Enzymes	approved;investigational	Sphingosine 1-phosphate receptor 1	P21453	None	agonist	yes
DB09105	Asfotase Alfa	Enzymes	approved;investigational	Pyrophosphate	None	None	ligand	yes
DB09107	Methoxy polyethylene glycol-epoetin beta	Other antianemic preparations	approved	Erythropoietin receptor	P19235	182245	stimulator	yes
DB09108	Simoctocog Alfa	N/A	approved	von Willebrand factor	P04275	37947	binding	yes
DB09109	Turoctocog alfa	N/A	approved;investigational	Coagulation factor IX	P00740	182609	activator	yes
DB09109	Turoctocog alfa	N/A	approved;investigational	Coagulation factor X	P00742	182841	activator	yes
DB09109	Turoctocog alfa	N/A	approved;investigational	Prothrombin	P00734	339641	binder	yes
DB09112	Nitrous acid	Antidotes	approved;investigational	Hemoglobin subunit alpha	P69905	386764	oxidizer	yes
DB09112	Nitrous acid	Antidotes	approved;investigational	Hemoglobin subunit beta	P68871	455997	oxidizer	yes
DB09112	Nitrous acid	Antidotes	approved;investigational	Myoglobin	P02144	None	oxidizer	unknown
DB09116	Calcium carbimide	Drugs used in alcohol dependence	approved;withdrawn	Aldehyde dehydrogenase family 3 member B2	P48448	1051281	antagonist	yes
DB09118	Stiripentol	Other antiepileptics	approved	GABA-A receptor (anion channel)	Q9UN88	7861736	agonist	yes
DB09118	Stiripentol	Other antiepileptics	approved	L-lactate dehydrogenase A chain	P00338	34313	inhibitor	yes
DB09118	Stiripentol	Other antiepileptics	approved	L-lactate dehydrogenase B chain	P07195	1200083	inhibitor	yes
DB09119	Eslicarbazepine acetate	Carboxamide derivatives	approved	P2X purinoceptor 4	Q99571	None	antagonist	yes
DB09120	Zucapsaicin	Capsaicin and similar agents	approved;investigational	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	agonist	yes
DB09121	Aurothioglucose	Gold preparations	approved;withdrawn	Adenylate cyclase type 1	Q08828	41472630	None	unknown
DB09121	Aurothioglucose	Gold preparations	approved;withdrawn	Adenylate cyclase type 2	Q08462	33150814	None	unknown
DB09121	Aurothioglucose	Gold preparations	approved;withdrawn	Adenylate cyclase type 5	O95622	22212711	None	unknown
DB09123	Dienogest	Progestogens and estrogens, sequential preparations	approved	Progesterone receptor	P06401	35652	agonist	yes
DB09123	Dienogest	Progestogens and estrogens, sequential preparations	approved	Androgen receptor	P10275	178628	antagonist	yes
DB09124	Medrogestone	Progestogens and estrogens, sequential preparations	approved	Progesterone receptor	P06401	35652	ligand	yes
DB09126	Chorionic Gonadotropin (Human)	Gonadotropins	approved;vet_approved	Lutropin-choriogonadotropic hormone receptor	P22888	903746	ligand	yes
DB09128	Brexpiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	agonist	yes
DB09128	Brexpiprazole	Other antipsychotics	approved;investigational	D(2) dopamine receptor	P14416	181432	agonist	yes
DB09128	Brexpiprazole	Other antipsychotics	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB09128	Brexpiprazole	Other antipsychotics	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	antagonist	yes
DB09128	Brexpiprazole	Other antipsychotics	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	antagonist	yes
DB09129	Chromic chloride	N/A	approved	Insulin receptor	P06213	307070	activator	yes
DB09130	Copper	N/A	approved;investigational	Amyloid beta A4 protein	P05067	None	aggregation inhibitor	unknown
DB09130	Copper	N/A	approved;investigational	Adenosylhomocysteinase	P23526	178277	allosteric modulator	unknown
DB09130	Copper	N/A	approved;investigational	Histone H2B type 1-C/E/F/G/I	P62807	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Glyceraldehyde-3-phosphate dehydrogenase	P04406	31645	None	unknown
DB09130	Copper	N/A	approved;investigational	Nucleoside diphosphate kinase A	P15531	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Histone H1.4	P10412	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Peroxiredoxin-1	Q06830	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Protein S100-A8	P05109	None	None	unknown
DB09130	Copper	N/A	approved;investigational	40S ribosomal protein SA	P08865	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Actin, cytoplasmic 2	P63261	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Alpha-enolase	P06733	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Elongation factor 1-alpha 1	P68104	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Keratin, type II cytoskeletal 8	P05787	181573	None	unknown
DB09130	Copper	N/A	approved;investigational	Protein disulfide-isomerase	P07237	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Protein disulfide-isomerase A3	P30101	None	None	unknown
DB09130	Copper	N/A	approved;investigational	60 kDa heat shock protein, mitochondrial	P10809	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Heat shock 70 kDa protein 13	P48723	None	None	unknown
DB09130	Copper	N/A	approved;investigational	78 kDa glucose-regulated protein	P11021	386758	None	unknown
DB09130	Copper	N/A	approved;investigational	Endoplasmin	P14625	553797	None	unknown
DB09130	Copper	N/A	approved;investigational	Serotransferrin	P02787	339453	None	unknown
DB09130	Copper	N/A	approved;investigational	Cell growth-regulating nucleolar protein	Q08288	None	None	unknown
DB09130	Copper	N/A	approved;investigational	40S ribosomal protein S2	P15880	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Serine/arginine-rich splicing factor 1	Q07955	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Heterogeneous nuclear ribonucleoproteins A2/B1	P22626	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Heterogeneous nuclear ribonucleoprotein H	P31943	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Heterogeneous nuclear ribonucleoprotein H3	P31942	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Cobalt-precorrin-5B C(1)-methyltransferase	P61987	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Heterogeneous nuclear ribonucleoprotein L	P14866	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Splicing factor, proline- and glutamine-rich	P23246	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Splicing factor 3A subunit 2	Q15428	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Receptor of activated protein C kinase 1	P63244	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Alpha-actinin-1	P12814	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Aminoacylase-1	Q03154	178071	None	unknown
DB09130	Copper	N/A	approved;investigational	Annexin A4	P09525	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Annexin A5	P08758	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Calreticulin	P27797	337487	None	unknown
DB09130	Copper	N/A	approved;investigational	Pyruvate kinase PKM	P14618	189998	None	unknown
DB09130	Copper	N/A	approved;investigational	Alcohol dehydrogenase [NADP(+)]	P14550	178481	None	unknown
DB09130	Copper	N/A	approved;investigational	NADH-cytochrome b5 reductase 3	P00387	553600	None	unknown
DB09130	Copper	N/A	approved;investigational	Glutathione reductase, mitochondrial	P00390	31825	None	unknown
DB09130	Copper	N/A	approved;investigational	Transketolase	P29401	37267	None	unknown
DB09130	Copper	N/A	approved;investigational	Peroxiredoxin-2	P32119	438069	None	unknown
DB09130	Copper	N/A	approved;investigational	Peroxiredoxin-6	P30041	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Peptidyl-prolyl cis-trans isomerase A	P62937	30309	None	unknown
DB09130	Copper	N/A	approved;investigational	Heat shock cognate 71 kDa protein	P11142	11526573	None	unknown
DB09130	Copper	N/A	approved;investigational	Heat shock protein HSP 90-alpha	P07900	32488	None	unknown
DB09130	Copper	N/A	approved;investigational	Prostaglandin E synthase 3	Q15185	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Stress-induced-phosphoprotein 1	P31948	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Translation elongation factor 1 alpha 1-like 14	Q96RE1	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Eukaryotic translation initiation factor 6	P56537	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Eukaryotic initiation factor 4A-I	P60842	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Glucose-6-phosphate isomerase	P06744	189238	None	unknown
DB09130	Copper	N/A	approved;investigational	L-lactate dehydrogenase A chain	P00338	34313	None	unknown
DB09130	Copper	N/A	approved;investigational	Phosphoglycerate kinase 1	P00558	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Tubulin alpha-3C/D chain	Q13748	2843123	None	unknown
DB09130	Copper	N/A	approved;investigational	Tubulin beta chain	P07437	338695	None	unknown
DB09130	Copper	N/A	approved;investigational	Cofilin-1	P23528	219545	None	unknown
DB09130	Copper	N/A	approved;investigational	14-3-3 protein beta/alpha	P31946	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Aspartate aminotransferase, cytoplasmic	P17174	179067	None	unknown
DB09130	Copper	N/A	approved;investigational	Glutathione synthetase	P48637	886284	None	unknown
DB09130	Copper	N/A	approved;investigational	Hepatoma-derived growth factor	P51858	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial	P50213	706839	None	unknown
DB09130	Copper	N/A	approved;investigational	Chloride intracellular channel protein 1	O00299	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Proteasome activator complex subunit 1	Q06323	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Phosphatidylethanolamine-binding protein 1	P30086	435638	None	unknown
DB09130	Copper	N/A	approved;investigational	Phosphoglycerate mutase 1	P18669	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Ran-specific GTPase-activating protein	P43487	None	None	unknown
DB09130	Copper	N/A	approved;investigational	UDP-glucose 6-dehydrogenase	O60701	3127127	None	unknown
DB09130	Copper	N/A	approved;investigational	Beta-2-microglobulin	P61769	27763813	None	unknown
DB09130	Copper	N/A	approved;investigational	Protein SCO1 homolog, mitochondrial	O75880	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Alternative prion protein	F7VJQ1	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Glycine receptor subunit alpha-1	P23415	31851	None	unknown
DB09130	Copper	N/A	approved;investigational	Huntingtin	P42858	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Endonuclease 8-like 1	Q96FI4	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Endonuclease 8-like 2	Q969S2	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Hephaestin-like protein 1	Q6MZM0	None	cofactor	unknown
DB09130	Copper	N/A	approved;investigational	Plasminogen activator inhibitor 1	P05121	35272	None	unknown
DB09130	Copper	N/A	approved;investigational	Protein S100-A2	P29034	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Protein S100-A4	P26447	179917	None	unknown
DB09130	Copper	N/A	approved;investigational	Alpha-synuclein	P37840	437365	None	unknown
DB09130	Copper	N/A	approved;investigational	Brain-derived neurotrophic factor	P23560	None	cofactor	unknown
DB09130	Copper	N/A	approved;investigational	Protein DJ-1	Q99497	30038760	None	unknown
DB09130	Copper	N/A	approved;investigational	Islet amyloid polypeptide	P10997	457131	None	unknown
DB09130	Copper	N/A	approved;investigational	Tachykinin-3	Q9UHF0	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Alpha-1B-glycoprotein	P04217	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Afamin	P43652	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Angiotensinogen	P01019	178640	None	unknown
DB09130	Copper	N/A	approved;investigational	Alpha-2-HS-glycoprotein	P02765	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Serum amyloid P-component	P02743	220068	None	unknown
DB09130	Copper	N/A	approved;investigational	Apolipoprotein A-I	P02647	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Apolipoprotein A-II	P02652	28748	None	unknown
DB09130	Copper	N/A	approved;investigational	Apolipoprotein A-IV	P06727	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Apolipoprotein B receptor	Q0VD83	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Apolipoprotein C-II	P02655	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Apolipoprotein C-III	P02656	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Apolipoprotein D	P05090	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Apolipoprotein E	P02649	178849	None	unknown
DB09130	Copper	N/A	approved;investigational	Beta-2-glycoprotein 1	P02749	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Zinc-alpha-2-glycoprotein	P25311	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Complement C1q subcomponent subunit C	P02747	33150626	None	unknown
DB09130	Copper	N/A	approved;investigational	Complement C1s subcomponent	P09871	763110	None	unknown
DB09130	Copper	N/A	approved;investigational	Complement C3	P01024	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Complement C4-B	P0C0L5	None	None	unknown
DB09130	Copper	N/A	approved;investigational	C4b-binding protein alpha chain	P04003	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Complement C5	P01031	179983	None	unknown
DB09130	Copper	N/A	approved;investigational	Complement component C8 beta chain	P07358	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Complement component C9	P02748	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Complement factor H	P08603	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Complement factor I	P05156	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Tetranectin	P05452	37409	None	unknown
DB09130	Copper	N/A	approved;investigational	Clusterin	P10909	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Prothrombin	P00734	339641	None	unknown
DB09130	Copper	N/A	approved;investigational	Complement component 1 Q subcomponent-binding protein, mitochondrial	Q07021	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Gelsolin	P06396	736249	None	unknown
DB09130	Copper	N/A	approved;investigational	Hemoglobin subunit alpha	P69905	386764	None	unknown
DB09130	Copper	N/A	approved;investigational	Hemoglobin subunit beta	P68871	455997	None	unknown
DB09130	Copper	N/A	approved;investigational	Chromobox protein homolog 5	P45973	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Haptoglobin-related protein	P00739	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Insulin-like growth factor-binding protein complex acid labile subunit	P35858	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Ig gamma-1 chain C region	P01857	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Ig gamma-4 chain C region	P01861	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Ig kappa chain V-III region GOL	P01619	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Immunoglobulin lambda-like polypeptide 1	P15814	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Inter-alpha-trypsin inhibitor heavy chain H2	P19823	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Kininogen-1	P01042	177890	None	unknown
DB09130	Copper	N/A	approved;investigational	Keratin, type II cytoskeletal 1	P04264	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Keratin, type I cytoskeletal 10	P13645	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Keratin, type II cytoskeletal 2 epidermal	P35908	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Keratin, type I cytoskeletal 9	P35527	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Leucine-rich alpha-2-glycoprotein	P02750	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Lumican	P51884	None	None	unknown
DB09130	Copper	N/A	approved;investigational	N-acetylmuramoyl-L-alanine amidase	Q96PD5	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Plasminogen	P00747	387026	None	unknown
DB09130	Copper	N/A	approved;investigational	Serum paraoxonase/arylesterase 1	P27169	190192	None	unknown
DB09130	Copper	N/A	approved;investigational	Platelet basic protein	P02775	181176	None	unknown
DB09130	Copper	N/A	approved;investigational	Alpha-1-antitrypsin	P01009	177829	None	unknown
DB09130	Copper	N/A	approved;investigational	Kallistatin	P29622	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Corticosteroid-binding globulin	P08185	179971	None	unknown
DB09130	Copper	N/A	approved;investigational	Thyroxine-binding globulin	P05543	338697	None	unknown
DB09130	Copper	N/A	approved;investigational	Antithrombin-III	P01008	179161	None	unknown
DB09130	Copper	N/A	approved;investigational	Heparin cofactor 2	P05546	183910	None	unknown
DB09130	Copper	N/A	approved;investigational	Pigment epithelium-derived factor	P36955	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Alpha-2-antiplasmin	P08697	219408	None	unknown
DB09130	Copper	N/A	approved;investigational	Plasma protease C1 inhibitor	P05155	None	None	unknown
DB09130	Copper	N/A	approved;investigational	Transthyretin	P02766	189582	None	unknown
DB09130	Copper	N/A	approved;investigational	Vitronectin	P04004	36575	None	unknown
DB09130	Copper	N/A	approved;investigational	Amyloid-like protein 1	P51693	None	cofactor	unknown
DB09131	Cupric Chloride	N/A	approved;investigational	Vitamin K-dependent protein C	P04070	190334	None	unknown
DB09131	Cupric Chloride	N/A	approved;investigational	Cystatin-B	P04080	None	None	unknown
DB09140	Oxygen	Medical gases	approved;vet_approved	Cytochrome c oxidase subunit 1	P00395	13006	agonist	unknown
DB09140	Oxygen	Medical gases	approved;vet_approved	NADPH oxidase 1	Q9Y5S8	None	agonist	unknown
DB09140	Oxygen	Medical gases	approved;vet_approved	Hemoglobin subunit alpha	P69905	386764	None	unknown
DB09140	Oxygen	Medical gases	approved;vet_approved	Hemoglobin subunit beta	P68871	455997	None	unknown
DB09143	Sonidegib	Other antineoplastic agents	approved;investigational	Smoothened homolog	Q99835	None	antagonist	unknown
DB09146	Iron saccharate	Iron trivalent, oral preparations	approved	Hemoglobin subunit alpha	P69905	386764	component of	yes
DB09148	Florbetaben (18F)	Other central nervous system diagnostic radiopharmaceuticals	approved	Amyloid beta A4 protein	P05067	None	binder	yes
DB09149	Florbetapir (18F)	Other central nervous system diagnostic radiopharmaceuticals	approved;investigational	Amyloid beta A4 protein	P05067	None	binder	yes
DB09151	Flutemetamol (18F)	Other central nervous system diagnostic radiopharmaceuticals	approved;investigational	Amyloid beta A4 protein	P05067	None	binder	yes
DB09165	Technetium Tc-99m pyrophosphate	Technetium (99mTc) compounds	approved	Hydroxyapatite	None	None	ligand	no
DB09165	Technetium Tc-99m pyrophosphate	Technetium (99mTc) compounds	approved	Amorphous calcium phosphate	None	None	ligand	no
DB09166	Etizolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	agonist	yes
DB09166	Etizolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	agonist	yes
DB09166	Etizolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	agonist	yes
DB09166	Etizolam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	agonist	yes
DB09166	Etizolam	Benzodiazepine derivatives	approved	Platelet-activating factor receptor	P25105	None	antagonist	unknown
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	Alpha-2 adrenergic receptors	P18825	178194	antagonist	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	Alpha-1 adrenergic receptors	P25100	177807	antagonist	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB09167	Dosulepin	Non-selective monoamine reuptake inhibitors	approved	Sodium-dependent serotonin transporter	P31645	36433	inhibitor	yes
DB09183	Dasabuvir	Other antivirals	approved	Nonstructural protein 5B (NS5B)	P87764	None	inhibitor	yes
DB09185	Viloxazine	Other antidepressants	approved;investigational;withdrawn	Sodium-dependent noradrenaline transporter	P23975	189258	inhibitor	yes
DB09195	Lorpiprazole	N/A	approved	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB09195	Lorpiprazole	N/A	approved	5-hydroxytryptamine receptor 2C	P28335	338028	antagonist	yes
DB09195	Lorpiprazole	N/A	approved	Alpha-1 adrenergic receptors	P25100	177807	antagonist	yes
DB09195	Lorpiprazole	N/A	approved	Alpha-2 adrenergic receptors	P18825	178194	antagonist	yes
DB09195	Lorpiprazole	N/A	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB09195	Lorpiprazole	N/A	approved	Sodium-dependent serotonin transporter	P31645	36433	antagonist	yes
DB09198	Lobeglitazone	N/A	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	activator	yes
DB09205	Moxisylyte	Other peripheral vasodilators	approved;investigational	Alpha adrenergic receptor	P18825	178194	antagonist	yes
DB09208	Pegloticase	Other antigout preparations	approved;investigational	Uric acid	None	None	metabolizer	yes
DB09209	Pholcodine	Opium alkaloids and derivatives	approved;illicit	Mu-type opioid receptor	P35372	452073	antagonist	yes
DB09209	Pholcodine	Opium alkaloids and derivatives	approved;illicit	Kappa-type opioid receptor	P41145	532060	antagonist	yes
DB09209	Pholcodine	Opium alkaloids and derivatives	approved;illicit	Delta-type opioid receptor	P41143	27545517	antagonist	unknown
DB09211	Limaprost	N/A	approved;investigational	Prostaglandin E2 receptor EP1 subtype	P34995	410209	agonist	unknown
DB09211	Limaprost	N/A	approved;investigational	Prostaglandin E2 receptor EP2 subtype	P43116	632650	agonist	yes
DB09211	Limaprost	N/A	approved;investigational	Prostaglandin E2 receptor EP3 subtype	P43115	None	agonist	unknown
DB09211	Limaprost	N/A	approved;investigational	Prostaglandin E2 receptor EP4 subtype	P35408	None	None	unknown
DB09212	Loxoprofen	N/A	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	antagonist	yes
DB09212	Loxoprofen	N/A	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	antagonist	yes
DB09213	Dexibuprofen	Propionic acid derivatives	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB09213	Dexibuprofen	Propionic acid derivatives	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	unknown
DB09213	Dexibuprofen	Propionic acid derivatives	approved;investigational	Apoptosis regulator Bcl-2	P10415	179367	negative modulator	unknown
DB09213	Dexibuprofen	Propionic acid derivatives	approved;investigational	Thrombomodulin	P07204	736251	modulator	unknown
DB09213	Dexibuprofen	Propionic acid derivatives	approved;investigational	Tissue-type plasminogen activator	P00750	339834	modulator	unknown
DB09213	Dexibuprofen	Propionic acid derivatives	approved;investigational	Fatty acid-binding protein, intestinal	P12104	46854681	binder	unknown
DB09213	Dexibuprofen	Propionic acid derivatives	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	activator	unknown
DB09213	Dexibuprofen	Propionic acid derivatives	approved;investigational	Cystic fibrosis transmembrane conductance regulator	P13569	180332	inhibitor	unknown
DB09214	Dexketoprofen	Antiinflammatory preparations, non-steroids for topical use	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	antagonist	unknown
DB09214	Dexketoprofen	Antiinflammatory preparations, non-steroids for topical use	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	antagonist	unknown
DB09216	Tolfenamic Acid	Fenamates	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	antagonist	yes
DB09216	Tolfenamic Acid	Fenamates	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	antagonist	yes
DB09220	Nicorandil	Other vasodilators used in cardiac diseases	approved;investigational	ATP-binding cassette sub-family C member 9	O60706	3127176	activator	yes
DB09221	Polaprezinc	N/A	approved;investigational	Tumor necrosis factor	P01375	339741	inhibitor	unknown
DB09221	Polaprezinc	N/A	approved;investigational	Interleukin-6	P05231	32674	inhibitor	unknown
DB09221	Polaprezinc	N/A	approved;investigational	Interleukin-3	P08700	307059	inhibitor	unknown
DB09221	Polaprezinc	N/A	approved;investigational	Vascular endothelial growth factor receptor 1	P17948	31432	agonist	unknown
DB09221	Polaprezinc	N/A	approved;investigational	Beta-nerve growth factor	P01138	671883	agonist	unknown
DB09221	Polaprezinc	N/A	approved;investigational	Platelet-derived growth factor receptor beta	P09619	189732	agonist	unknown
DB09221	Polaprezinc	N/A	approved;investigational	Heat shock protein HSP 90-alpha	P07900	32488	agonist	unknown
DB09221	Polaprezinc	N/A	approved;investigational	Heat shock protein HSP 90-beta	P08238	306891	agonist	unknown
DB09223	Blonanserin	N/A	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB09223	Blonanserin	N/A	approved;investigational	D(3) dopamine receptor	P35462	927342	antagonist	yes
DB09223	Blonanserin	N/A	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB09224	Melperone	Butyrophenone derivatives	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB09225	Zotepine	Other antipsychotics	approved;investigational;withdrawn	D(1) dopamine receptor	P21918	32049	antagonist	yes
DB09225	Zotepine	Other antipsychotics	approved;investigational;withdrawn	D(2) dopamine receptor	P14416	181432	antagonist	yes
DB09225	Zotepine	Other antipsychotics	approved;investigational;withdrawn	5-hydroxytryptamine receptor 2A	P28223	36431	antagonist	yes
DB09225	Zotepine	Other antipsychotics	approved;investigational;withdrawn	5-hydroxytryptamine receptor 6	P50406	1162924	antagonist	unknown
DB09225	Zotepine	Other antipsychotics	approved;investigational;withdrawn	5-hydroxytryptamine receptor 7	P34969	1857143	antagonist	yes
DB09225	Zotepine	Other antipsychotics	approved;investigational;withdrawn	Sodium-dependent noradrenaline transporter	P23975	189258	antagonist	yes
DB09225	Zotepine	Other antipsychotics	approved;investigational;withdrawn	Sodium-dependent serotonin transporter	P31645	36433	antagonist	yes
DB09227	Barnidipine	Dihydropyridine derivatives	approved	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	antagonist	yes
DB09228	Conestat alfa	Drugs used in hereditary angioedema	approved;investigational	Complement C1r subcomponent	P00736	29539	inhibitor	yes
DB09228	Conestat alfa	Drugs used in hereditary angioedema	approved;investigational	Complement C1s subcomponent	P09871	763110	inhibitor	yes
DB09228	Conestat alfa	Drugs used in hereditary angioedema	approved;investigational	Plasma kallikrein	P03952	None	inhibitor	yes
DB09228	Conestat alfa	Drugs used in hereditary angioedema	approved;investigational	Coagulation factor XII	P00748	None	inhibitor	yes
DB09228	Conestat alfa	Drugs used in hereditary angioedema	approved;investigational	Prothrombin	P00734	339641	inhibitor	yes
DB09228	Conestat alfa	Drugs used in hereditary angioedema	approved;investigational	Coagulation factor XI	P03951	182833	inhibitor	yes
DB09228	Conestat alfa	Drugs used in hereditary angioedema	approved;investigational	Tissue-type plasminogen activator	P00750	339834	inhibitor	yes
DB09229	Aranidipine	N/A	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	antagonist	yes
DB09229	Aranidipine	N/A	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1D	Q01668	179764	antagonist	yes
DB09229	Aranidipine	N/A	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1F	O60840	3183953	antagonist	yes
DB09229	Aranidipine	N/A	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1S	Q13698	1698403	antagonist	yes
DB09229	Aranidipine	N/A	approved;investigational	Alpha adrenergic receptor	P18825	178194	agonist	unknown
DB09230	Azelnidipine	N/A	approved;investigational	Voltage-dependent L-type calcium channel subunit beta-1	Q02641	179806	agonist	unknown
DB09231	Benidipine	Dihydropyridine derivatives	approved;investigational	Voltage dependent L type calcium channel	O00305	2058727	antagonist	yes
DB09231	Benidipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent N-type calcium channel subunit alpha-1B	Q00975	179758	antagonist	yes
DB09231	Benidipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent T-type calcium channel	Q9P0X4	5565888	antagonist	yes
DB09232	Cilnidipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent N-type calcium channel subunit alpha-1B	Q00975	179758	antagonist	yes
DB09232	Cilnidipine	Dihydropyridine derivatives	approved;investigational	Voltage dependent L type calcium channel	O00305	2058727	antagonist	yes
DB09235	Efonidipine	N/A	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1I	Q9P0X4	5565888	antagonist	unknown
DB09235	Efonidipine	N/A	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	None	unknown
DB09236	Lacidipine	Dihydropyridine derivatives	approved;investigational	Voltage dependent L type calcium channel	O00305	2058727	antagonist	yes
DB09237	Levamlodipine	N/A	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	antagonist	unknown
DB09237	Levamlodipine	N/A	approved;investigational	Nitric oxide synthase, endothelial	P29474	189212	agonist	unknown
DB09237	Levamlodipine	N/A	approved;investigational	Nitric oxide synthase, inducible	P35228	292242	agonist	unknown
DB09238	Manidipine	Dihydropyridine derivatives	approved;investigational	Voltage dependent L type calcium channel	O00305	2058727	blocker	yes
DB09238	Manidipine	Dihydropyridine derivatives	approved;investigational	Voltage-dependent T-type calcium channel	Q9P0X4	5565888	blocker	yes
DB09241	Methylene blue	Antidotes	approved;investigational	Guanylate cyclase soluble subunit alpha-2	P33402	31671	antagonist	yes
DB09241	Methylene blue	Antidotes	approved;investigational	Nitric oxide synthase, brain	P29475	642526	antagonist	yes
DB09242	Moxonidine	Imidazoline receptor agonists in combination with diuretics	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB09242	Moxonidine	Imidazoline receptor agonists in combination with diuretics	approved;investigational	Nischarin	Q9Y2I1	3462807	agonist	yes
DB09244	Pirlindole	N/A	approved	Amine oxidase [flavin-containing] A	P21397	187353	antagonist	unknown
DB09244	Pirlindole	N/A	approved	5-hydroxytryptamine receptor 1A	P08908	189928	antagonist	unknown
DB09244	Pirlindole	N/A	approved	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB09245	Toloxatone	Monoamine oxidase A inhibitors	approved	Amine oxidase [flavin-containing] A	P21397	187353	antagonist	unknown
DB09256	Tegafur	Pyrimidine analogues	approved;investigational	Thymidylate synthase	P04818	37479	inhibitor	yes
DB09257	Gimeracil	N/A	approved	Dihydropyrimidine dehydrogenase [NADP(+)]	Q12882	558305	inhibitor	no
DB09258	Bemiparin	Heparin group	approved;investigational	Coagulation factor X	P00742	182841	antagonist	yes
DB09258	Bemiparin	Heparin group	approved;investigational	Antithrombin-III	P01008	179161	antagonist	unknown
DB09258	Bemiparin	Heparin group	approved;investigational	Heparin cofactor 2	P05546	183910	antagonist	unknown
DB09262	Imidafenacin	N/A	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB09262	Imidafenacin	N/A	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB09262	Imidafenacin	N/A	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB09263	Patiromer	N/A	approved;investigational	Potassium	None	None	binder	yes
DB09264	Idarucizumab	Antidotes	approved	Dabigatran etexilate	None	None	antibody	yes
DB09265	Lixisenatide	Other blood glucose lowering drugs, excl. insulins	approved	Glucagon-like peptide 1 receptor	P43220	405082	agonist	yes
DB09266	Technetium Tc-99m tilmanocept	Technetium (99mTc) compounds	approved;investigational	Macrophage mannose receptor 1	P22897	None	ligand	yes
DB09270	Ubidecarenone	Other cardiac preparations	approved;investigational;nutraceutical	NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial	P56181	6002197	cofactor	yes
DB09270	Ubidecarenone	Other cardiac preparations	approved;investigational;nutraceutical	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial	P31040	506338	cofactor	yes
DB09272	Eluxadoline	N/A	approved;investigational	Mu-type opioid receptor	P35372	452073	agonist	yes
DB09272	Eluxadoline	N/A	approved;investigational	Delta-type opioid receptor	P41143	27545517	antagonist	yes
DB09272	Eluxadoline	N/A	approved;investigational	Kappa-type opioid receptor	P41145	532060	agonist	yes
DB09273	Doxofylline	Xanthines	approved;investigational	Phosphodiesterase 2A, cGMP-stimulated	Q8IW54	26454702	inhibitor	yes
DB09273	Doxofylline	Xanthines	approved;investigational	Adenosine receptor A2a	P29274	177892	antagonist	unknown
DB09273	Doxofylline	Xanthines	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB09274	Artesunate	Artemisinin and derivatives, combinations	approved;investigational	Malaria protein EXP-1	P04926	None	inhibitor	yes
DB09275	Bismuth Subcitrate	Combinations for eradication of Helicobacter pylori	approved;investigational	ATP-dependent Clp protease ATP-binding subunit ClpX	O25926	None	antagonist	unknown
DB09279	Fimasartan	Angiotensin II antagonists, plain	approved;investigational	Type-1 angiotensin II receptor	P30556	179122	antagonist	yes
DB09280	Lumacaftor	Other respiratory system products	approved	Cystic fibrosis transmembrane conductance regulator	P13569	180332	modulator	yes
DB09282	Molsidomine	Other vasodilators used in cardiac diseases	approved;investigational	Guanylate cyclase soluble subunit alpha-2	P33402	31671	agonist	unknown
DB09283	Trapidil	Other vasodilators used in cardiac diseases	approved	Platelet derived growth factor receptor beta	None	None	antagonist	unknown
DB09283	Trapidil	Other vasodilators used in cardiac diseases	approved	Cyclic nucleotide phosphodiesterase	P35913	32261241	inhibitor	yes
DB09285	Morniflumate	Other antiinflammatory and antirheumatic agents, non-steroids	approved	Arachidonate 5-lipoxygenase	P09917	187193	antagonist	unknown
DB09285	Morniflumate	Other antiinflammatory and antirheumatic agents, non-steroids	approved	Prostaglandin G/H synthase 2	P35354	291988	None	unknown
DB09285	Morniflumate	Other antiinflammatory and antirheumatic agents, non-steroids	approved	Leukotriene B4 receptor 1	Q15722	None	antagonist	unknown
DB09285	Morniflumate	Other antiinflammatory and antirheumatic agents, non-steroids	approved	Thromboxane A2 receptor	P21731	533326	None	unknown
DB09286	Pipamperone	Butyrophenone derivatives	approved;investigational	D(2) dopamine receptor	P14416	181432	antagonist	unknown
DB09286	Pipamperone	Butyrophenone derivatives	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	agonist	unknown
DB09286	Pipamperone	Butyrophenone derivatives	approved;investigational	Alpha-1 adrenergic receptors	P25100	177807	antagonist	unknown
DB09286	Pipamperone	Butyrophenone derivatives	approved;investigational	D(4) dopamine receptor	P21917	291946	antagonist	unknown
DB09286	Pipamperone	Butyrophenone derivatives	approved;investigational	D(1A) dopamine receptor	P21728	30397	antagonist	unknown
DB09286	Pipamperone	Butyrophenone derivatives	approved;investigational	D(3) dopamine receptor	P35462	927342	None	unknown
DB09286	Pipamperone	Butyrophenone derivatives	approved;investigational	5-hydroxytryptamine receptor 2B	P41595	475198	None	unknown
DB09286	Pipamperone	Butyrophenone derivatives	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	antagonist	unknown
DB09288	Propacetamol	Anilides	approved;investigational	Prostaglandin G/H synthase 1	P23219	387018	antagonist	yes
DB09288	Propacetamol	Anilides	approved;investigational	Prostaglandin G/H synthase 2	P35354	291988	antagonist	yes
DB09288	Propacetamol	Anilides	approved;investigational	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	antagonist	yes
DB09288	Propacetamol	Anilides	approved;investigational	Cannabinoid receptor 1	P21554	29915	antagonist	yes
DB09289	Tianeptine	Other antidepressants	approved;investigational	Glutamate receptor 1	P42261	183281	modulator	unknown
DB09289	Tianeptine	Other antidepressants	approved;investigational	Mu-type opioid receptor	P35372	452073	agonist	yes
DB09289	Tianeptine	Other antidepressants	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	inhibitor	unknown
DB09289	Tianeptine	Other antidepressants	approved;investigational	D(3) dopamine receptor	P35462	927342	agonist	unknown
DB09290	Ramosetron	N/A	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	unknown
DB09291	Rolapitant	N/A	approved;investigational	Neurokinin-1 Receptor (NK1R)	None	None	antagonist	yes
DB09292	Sacubitril	Angiotensin II antagonists, other combinations	approved	Neprilysin	P08473	34758	antagonist	yes
DB09295	Talniflumate	N/A	approved	Prostaglandin G/H synthase 1	P23219	387018	antagonist	unknown
DB09295	Talniflumate	N/A	approved	Prostaglandin G/H synthase 2	P35354	291988	antagonist	unknown
DB09295	Talniflumate	N/A	approved	Chloride channel protein ClC-Ka	P51800	None	antagonist	unknown
DB09296	Ombitasvir	Other antivirals	approved;investigational	Nonstructural protein 5A	Q5L478	None	inhibitor	yes
DB09297	Paritaprevir	Other antivirals	approved;investigational	NS3/4A protein	B0B3C9	None	inhibitor	yes
DB09299	Tenofovir alafenamide	Antivirals for treatment of HIV infections, combinations	approved	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	yes
DB09300	Butylscopolamine	Belladonna alkaloids, semisynthetic, quaternary ammonium compounds	approved;investigational;vet_approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB09300	Butylscopolamine	Belladonna alkaloids, semisynthetic, quaternary ammonium compounds	approved;investigational;vet_approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB09301	Chondroitin sulfate	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational;nutraceutical	Brain-derived neurotrophic factor	P23560	None	None	unknown
DB09301	Chondroitin sulfate	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational;nutraceutical	Glial cell line-derived neurotrophic factor	P39905	None	None	unknown
DB09301	Chondroitin sulfate	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational;nutraceutical	Vascular endothelial growth factor A	P15692	181971	None	unknown
DB09301	Chondroitin sulfate	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational;nutraceutical	C-C motif chemokine 2	P13500	307163	None	unknown
DB09302	Alirocumab	N/A	approved	Proprotein convertase subtilisin/kexin type 9	Q8NBP7	None	inhibitor	yes
DB09304	Setiptiline	N/A	approved	Alpha-2 adrenergic receptors	P18825	178194	antagonist	unknown
DB09304	Setiptiline	N/A	approved	Serotonin Receptors	P34969	1857143	antagonist	unknown
DB09310	Coagulation Factor XIII A-Subunit (Recombinant)	Blood coagulation factors	approved	Coagulation factor XIII B chain	P05160	None	None	yes
DB09317	Synthetic Conjugated Estrogens, A	N/A	approved	Estrogen receptor alpha	P03372	31234	ligand	yes
DB09318	Synthetic Conjugated Estrogens, B	N/A	approved	Estrogen receptor alpha	P03372	31234	ligand	yes
DB09319	Carbenicillin indanyl	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;investigational	Penicillin-binding protein 	None	None	inhibitor	yes
DB09323	Benzathine benzylpenicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Penicillin-binding protein 2	P08149	150279	binding	unknown
DB09323	Benzathine benzylpenicillin	Combinations of penicillins, incl. beta-lactamase inhibitors	approved;vet_approved	Beta-lactam-inducible penicillin-binding protein	P07944	46629	binding	unknown
DB09324	Sulbactam	Beta-lactamase inhibitors	approved	Beta-lactamase	P00807	581568	inhibitor	yes
DB09327	Tegafur-uracil	N/A	approved;investigational	Dihydropyrimidine dehydrogenase [NADP(+)]	Q12882	558305	antagonist	yes
DB09327	Tegafur-uracil	N/A	approved;investigational	Thymidylate synthase	P04818	37479	antagonist	yes
DB09327	Tegafur-uracil	N/A	approved;investigational	RNA	None	None	None	yes
DB09327	Tegafur-uracil	N/A	approved;investigational	DNA	None	None	None	yes
DB09329	Antihemophilic Factor (Recombinant), PEGylated	N/A	approved;investigational	von Willebrand factor	P04275	37947	None	unknown
DB09329	Antihemophilic Factor (Recombinant), PEGylated	N/A	approved;investigational	Coagulation factor IX	P00740	182609	None	unknown
DB09329	Antihemophilic Factor (Recombinant), PEGylated	N/A	approved;investigational	Coagulation factor X	P00742	182841	None	unknown
DB09330	Osimertinib	N/A	approved	Epidermal growth factor receptor	P00533	757924	inhibitor	yes
DB09331	Daratumumab	N/A	approved	ADP-ribosyl cyclase 1	P28907	None	antibody	unknown
DB09332	Kappadione	N/A	approved	Prothrombin	P00734	339641	agonist	unknown
DB09332	Kappadione	N/A	approved	Coagulation factor VII	P08709	182801	agonist	unknown
DB09332	Kappadione	N/A	approved	Coagulation factor IX	P00740	182609	agonist	unknown
DB09332	Kappadione	N/A	approved	Coagulation factor X	P00742	182841	agonist	unknown
DB09332	Kappadione	N/A	approved	Vitamin K-dependent protein C	P04070	190334	agonist	unknown
DB09332	Kappadione	N/A	approved	Vitamin K-dependent gamma-carboxylase	P38435	184028	agonist	unknown
DB09332	Kappadione	N/A	approved	Vitamin K-dependent protein S	P07225	190289	agonist	unknown
DB09333	Iopodic acid	Watersoluble, hepatotropic X-ray contrast media	approved;investigational;withdrawn	Thyroxine 5-deiodinase	P55073	None	antagonist	yes
DB09334	Seractide acetate	N/A	approved	Adrenocorticotropic hormone receptor	Q01718	28344	agonist	yes
DB09336	Technetium Tc-99m nofetumomab merpentan	N/A	approved;withdrawn	Epithelial cell adhesion molecule	P16422	None	binder	yes
DB09336	Technetium Tc-99m nofetumomab merpentan	N/A	approved;withdrawn	B-lymphocyte antigen CD20	P11836	29774	binder	yes
DB09338	Mersalyl	Mercurial diuretics	approved	Alkaline phosphatase, tissue-nonspecific isozyme	P05186	28738	antagonist	unknown
DB09338	Mersalyl	Mercurial diuretics	approved	Aquaporin-1	P29972	180501	None	unknown
DB09338	Mersalyl	Mercurial diuretics	approved	Monocarboxylate transporter 1	P53985	561722	antagonist	unknown
DB09342	Propoxycaine	N/A	approved	Voltage gated sodium channel	None	None	antagonist	unknown
DB09343	Tipiracil	N/A	approved;investigational	Thymidine phosphorylase	P19971	189701	inhibitor	yes
DB09345	Pramocaine	Local anesthetics	approved	Voltage gated sodium channel	None	None	antagonist	yes
DB09348	beta-Propiolactone	N/A	approved;withdrawn	DNA	None	None	adduct	yes
DB09351	Levobetaxolol	N/A	approved;investigational	Beta-1 adrenergic receptor	P08588	178200	antagonist	yes
DB09369	Polyestradiol phosphate	Estrogens	approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB09371	Norethynodrel	Progestogens and estrogens, fixed combinations	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB09371	Norethynodrel	Progestogens and estrogens, fixed combinations	approved	Androgen receptor	P10275	178628	None	unknown
DB09371	Norethynodrel	Progestogens and estrogens, fixed combinations	approved	Sex hormone-binding globulin	P04278	296673	None	unknown
DB09379	Sutilain	N/A	approved;withdrawn	Debridement	None	None	None	yes
DB09389	Norgestrel	Progestogens and estrogens, sequential preparations	approved	Progesterone receptor	P06401	35652	binder	yes
DB09389	Norgestrel	Progestogens and estrogens, sequential preparations	approved	3-oxo-5-alpha-steroid 4-dehydrogenase 1	P18405	177767	inhibitor	yes
DB09389	Norgestrel	Progestogens and estrogens, sequential preparations	approved	Androgen receptor	P10275	178628	agonist	unknown
DB09401	Isosorbide	N/A	approved;investigational	Apoptosis regulator Bcl-2	P10415	179367	None	unknown
DB09401	Isosorbide	N/A	approved;investigational	Bcl-2-like protein 1	Q07817	None	None	unknown
DB09401	Isosorbide	N/A	approved;investigational	Induced myeloid leukemia cell differentiation protein Mcl-1	Q07820	None	None	unknown
DB09409	Magnesium acetate tetrahydrate	N/A	approved	Glutamate (NMDA) receptor	O60391	3025446	ligand	unknown
DB09418	Potassium perchlorate	Perchlorates	approved;investigational	Sodium/iodide cotransporter	Q92911	None	inhibitor	yes
DB09421	Protirelin	Tests for thyreoidea function	approved;investigational	Thyrotropin Releasing Hormone Receptor	P34981	None	ligand	yes
DB09422	Soybean oil	N/A	approved	Peroxisome proliferator-activated receptor alpha	Q07869	307341	activator	yes
DB09460	Sodium carbonate	N/A	approved	Carbonic anhydrase 1	P00915	29600	inhibitor	unknown
DB09460	Sodium carbonate	N/A	approved	Carbonic anhydrase 2	P00918	179780	inhibitor	unknown
DB09460	Sodium carbonate	N/A	approved	Carbonic anhydrase 4	P22748	179791	inhibitor	unknown
DB09460	Sodium carbonate	N/A	approved	Carbonic anhydrase 9	Q16790	None	inhibitor	unknown
DB09462	Glycerin	Enemas	approved;investigational	Peroxisome proliferator-activated receptor delta	Q03181	190230	agonist	yes
DB09462	Glycerin	Enemas	approved;investigational	Hematopoietic prostaglandin D synthase	O60760	3046817	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Endoglucanase G	P37700	551774	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Glutathione S-transferase P	P09211	31946	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Group IIE secretory phospholipase A2	Q9NZK7	7108923	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Inositol-3-phosphate synthase 1	Q9NPH2	None	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	C4-dicarboxylate transport transcriptional regulatory protein DctD	P13632	152173	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Alcohol dehydrogenase 1B	P00325	178098	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Inositol 1,4,5-trisphosphate receptor type 1	Q14643	None	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Glycodelin	P09466	190215	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Alpha-N-acetylgalactosaminidase	P17050	None	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Cytochrome c4	Q52369	516878	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Bacterioferritin	Q93PP9	14326006	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	TGF-beta receptor type-2	P37173	339570	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Argininosuccinate synthase	P0A6E4	145342	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Enolase	Q8GR70	22852211	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	ADP-ribosylation factor 1	P84077	178983	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Multidrug resistance protein MexA	P52477	438853	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1	O43252	None	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Histidinol dehydrogenase	P06988	41709	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	DNA mismatch repair protein MutL	P23367	42067	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Glycerol uptake facilitator protein	P0AER0	None	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	Ribonucleoside-diphosphate reductase 1 subunit beta	P69924	None	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	A/G-specific adenine glycosylase	P17802	None	None	unknown
DB09462	Glycerin	Enemas	approved;investigational	tRNA (cytosine(38)-C(5))-methyltransferase	O14717	None	None	unknown
DB09472	Sodium sulfate	Sodium	approved;vet_approved	Carbonic anhydrase 2	P00918	179780	inhibitor	yes
DB09472	Sodium sulfate	Sodium	approved;vet_approved	Carbonic anhydrase 1	P00915	29600	inhibitor	yes
DB09477	Enalaprilat	N/A	approved	Angiotensin-converting enzyme	P12821	178286	inhibitor	yes
DB09477	Enalaprilat	N/A	approved	B1 bradykinin receptor	P46663	None	None	unknown
DB09481	Magnesium carbonate	Magnesium compounds	approved;investigational	Glutamate (NMDA) receptor	O60391	3025446	blocker	unknown
DB09488	Acrivastine	Other antihistamines for systemic use	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB09510	Urea C-13	N/A	approved	Urease	Q8KT33	None	substrate	yes
DB09513	Urea C-14	N/A	approved	Urease	Q8KT33	None	substrate	yes
DB09517	Sodium ferric gluconate complex	N/A	approved	Ferritin light chain	P02792	182514	binding	yes
DB09517	Sodium ferric gluconate complex	N/A	approved	Hemoglobin subunit alpha	P69905	386764	binding	unknown
DB09517	Sodium ferric gluconate complex	N/A	approved	Hemoglobin subunit beta	P68871	455997	binding	yes
DB09526	Hydroquinone	Other dermatologicals	approved;investigational	Tyrosinase	P14679	340037	inhibitor	yes
DB09532	Human secretin	N/A	approved	Secretin receptor	P47872	662796	ligand	yes
DB09535	Octocrylene	N/A	approved;investigational	Estrogen receptor alpha	P03372	31234	None	unknown
DB09535	Octocrylene	N/A	approved;investigational	Estrogen receptor beta	Q92731	2911152	None	unknown
DB09536	Titanium dioxide	N/A	approved	Macrophage receptor MARCO	Q9UEW3	None	None	unknown
DB09552	Thonzonium	N/A	approved	V-type proton ATPase subunit C 1	P21283	None	inhibitor	yes
DB09555	Dexchlorpheniramine maleate	N/A	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB09559	Necitumumab	Monoclonal antibodies	approved;investigational	Epidermal growth factor receptor	P00533	757924	antagonist	yes
DB09564	Insulin Degludec	Insulins and analogues for injection, long-acting	approved	Insulin receptor	P06213	307070	ligand	yes
DB09568	Omega-3-carboxylic acids	N/A	approved;investigational	Diacylglycerol O-acyltransferase 2	Q96PD7	None	antagonist	yes
DB09568	Omega-3-carboxylic acids	N/A	approved;investigational	3-hydroxyacyl-CoA dehydrogenase type-2	Q99714	2558754	potentiator	yes
DB09568	Omega-3-carboxylic acids	N/A	approved;investigational	Enoyl-CoA hydratase, mitochondrial	P30084	None	potentiator	yes
DB09568	Omega-3-carboxylic acids	N/A	approved;investigational	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial	Q16836	1483511	potentiator	yes
DB09568	Omega-3-carboxylic acids	N/A	approved;investigational	Elongation of very long chain fatty acids protein 4	Q9GZR5	12044051	potentiator	yes
DB09568	Omega-3-carboxylic acids	N/A	approved;investigational	Lipoprotein lipase	P06858	307138	stimulator	yes
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	Interleukin-6	P05231	32674	agonist	unknown
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	Vascular endothelial growth factor receptor 1	P17948	31432	agonist	yes
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	Interleukin-1 receptor type 1	P14778	33801	agonist	unknown
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	TGF-beta receptor type-2	P37173	339570	agonist	unknown
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	Fibroblast growth factor 1	P05230	181942	agonist	unknown
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	Interferon gamma	P01579	32692	agonist	unknown
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	Fibroblast growth factor receptor 2	P21802	31374	agonist	unknown
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	Granulocyte-macrophage colony-stimulating factor receptor subunit alpha	P15509	32089	agonist	unknown
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	Platelet-derived growth factor receptor beta	P09619	189732	agonist	unknown
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	Transforming growth factor beta-1	P01137	1212989	agonist	unknown
DB10770	Foreskin fibroblast (neonatal)	N/A	approved	Tumor necrosis factor	P01375	339741	agonist	unknown
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Fibroblast growth factor 1	P05230	181942	agonist	yes
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Epidermal growth factor receptor	P00533	757924	agonist	yes
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Granulocyte-macrophage colony-stimulating factor receptor subunit alpha	P15509	32089	agonist	yes
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Interleukin-1 beta	P01584	307043	agonist	yes
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Interleukin-6	P05231	32674	agonist	yes
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Interferon gamma	P01579	32692	agonist	yes
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Fibroblast growth factor receptor 2	P21802	31374	agonist	unknown
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Platelet-derived growth factor receptor alpha	P16234	189734	agonist	yes
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	TGF-beta receptor type-2	P37173	339570	agonist	yes
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Transforming growth factor beta-1	P01137	1212989	agonist	yes
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Tumor necrosis factor	P01375	339741	agonist	yes
DB10772	Foreskin keratinocyte (neonatal)	N/A	approved	Vascular endothelial growth factor A	P15692	181971	agonist	yes
DB11059	Carboxymethylcellulose	N/A	approved;investigational	Solute carrier family 2, facilitated glucose transporter member 1	P11166	183303	binder	unknown
DB11064	Homosalate	N/A	approved;investigational	Progesterone receptor	P06401	35652	antagonist	unknown
DB11064	Homosalate	N/A	approved;investigational	Androgen receptor	P10275	178628	antagonist	unknown
DB11064	Homosalate	N/A	approved;investigational	Estrogen receptor alpha	P03372	31234	None	unknown
DB11065	Pancrelipase amylase	N/A	approved	Dietary starch	None	None	cleavage	yes
DB11066	Pancrelipase protease	N/A	approved	Dietary protein	None	None	cleavage	yes
DB11071	Phenyl salicylate	Other urologicals	approved	Prostaglandin G/H synthase 1	P23219	387018	antagonist	unknown
DB11071	Phenyl salicylate	Other urologicals	approved	Prostaglandin G/H synthase 2	P35354	291988	antagonist	unknown
DB11075	Hypromellose	Viscoelastic substances	approved	Epithelial cell adhesion molecule	P16422	None	None	unknown
DB11077	Polyethylene glycol 400	N/A	approved	Ectonucleotide pyrophosphatase/phosphodiesterase family member 1	P22413	189650	other	unknown
DB11079	Trolamine salicylate	N/A	approved	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB11079	Trolamine salicylate	N/A	approved	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB11081	Aluminum chloride	Other anti-acne preparations for topical use	approved	Glutamate dehydrogenase 1, mitochondrial	P00367	31707	inactivator	unknown
DB11085	Resorcinol	Other antiinfectives	approved	Thyroid peroxidase	P07202	339867	None	unknown
DB11087	Pyrethrum extract	N/A	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB11090	Potassium nitrate	N/A	approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	agonist	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Extracellular calcium-sensing receptor	P41180	599820	agonist	yes
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calreticulin	P27797	337487	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calcium and integrin-binding protein 1	Q99828	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Programmed cell death protein 6	O75340	None	agonist	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Sorcin	P30626	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calcineurin B homologous protein 1	Q99653	None	agonist	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	SPARC	P09486	29462	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calnexin	P27824	186523	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Fibrillin-2	P35556	None	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Protein S100-B	P04271	337730	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calsequestrin-2	O14958	None	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Regucalcin	Q15493	None	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Peflin	Q9UBV8	None	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Protein S100-A6	P06703	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Translationally-controlled tumor protein	P13693	None	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calcium and integrin-binding family member 2	O75838	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Protein S100-A13	Q99584	1694828	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calsequestrin-1	P31415	None	ligand	no
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Nucleobindin-1	Q02818	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Nucleobindin-2	P80303	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calmodulin	P0DP23	179888	agonist	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Fibrillin-3	Q75N90	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Grancalcin	P28676	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calcium-dependent secretion activator 1	Q9ULU8	None	agonist	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calmodulin-2	P0DP24	None	agonist	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calmodulin-3	P0DP25	None	agonist	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Protein S100-A16	Q96FQ6	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calretinin	P22676	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calcyphosin	Q13938	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calcium-dependent secretion activator 2	Q86UW7	None	agonist	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Calreticulin-3	Q96L12	None	ligand	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Neurexin-1	Q9ULB1	None	agonist	unknown
DB11093	Calcium Citrate	Ascorbic acid (vitamin C), combinations	approved	Neuronal calcium sensor 1	P62166	None	ligand	unknown
DB11094	Vitamin D	N/A	approved;nutraceutical;vet_approved	Vitamin D3 receptor	P11473	340203	None	unknown
DB11094	Vitamin D	N/A	approved;nutraceutical;vet_approved	Vitamin D-binding protein	P02774	639896	None	unknown
DB11098	Potassium bicarbonate	Potassium	approved	Pepsin	None	None	inhibitor	yes
DB11098	Potassium bicarbonate	Potassium	approved	Hydrogen ions	None	None	neutralizer	yes
DB11112	Lanolin	N/A	approved	Skin epithelial cells	None	None	coating agent	yes
DB11113	Castor oil	Contact laxatives	approved;investigational;nutraceutical;vet_approved	Prostaglandin E2 receptor EP3 subtype	P43115	None	agonist	yes
DB11113	Castor oil	Contact laxatives	approved;investigational;nutraceutical;vet_approved	Prostaglandin E2 receptor EP4 subtype	P35408	None	agonist	unknown
DB11120	Turpentine	N/A	approved;experimental	Mitogen-activated protein kinase 1	P28482	182191	None	unknown
DB11124	Racepinephrine	N/A	approved	Alpha-1A adrenergic receptor	P35348	433201	agonist	yes
DB11124	Racepinephrine	N/A	approved	Alpha-1B adrenergic receptor	P35368	None	agonist	yes
DB11124	Racepinephrine	N/A	approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB11124	Racepinephrine	N/A	approved	Alpha-2B adrenergic receptor	P18089	178198	agonist	yes
DB11124	Racepinephrine	N/A	approved	Alpha-2C adrenergic receptor	P18825	178194	agonist	yes
DB11124	Racepinephrine	N/A	approved	Beta-1 adrenergic receptor	P08588	178200	agonist	yes
DB11124	Racepinephrine	N/A	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB11124	Racepinephrine	N/A	approved	Alpha-1D adrenergic receptor	P25100	177807	antagonist	yes
DB11124	Racepinephrine	N/A	approved	Beta-3 adrenergic receptor	P13945	178896	agonist	yes
DB11130	Opium	Natural opium alkaloids	approved;illicit	Delta-type opioid receptor	P41143	27545517	agonist	yes
DB11130	Opium	Natural opium alkaloids	approved;illicit	Kappa-type opioid receptor	P41145	532060	agonist	yes
DB11130	Opium	Natural opium alkaloids	approved;illicit	Mu-type opioid receptor	P35372	452073	agonist	yes
DB11131	Capsicum oleoresin	N/A	approved	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	agonist	yes
DB11132	Silicon dioxide	N/A	approved	Macrophage receptor MARCO	Q9UEW3	None	None	unknown
DB11133	Omega-3 fatty acids	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor gamma	P37231	1711117	ligand	yes
DB11133	Omega-3 fatty acids	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor alpha	Q07869	307341	activator	unknown
DB11133	Omega-3 fatty acids	N/A	approved;nutraceutical	Sterol regulatory element-binding protein 1	P36956	None	inhibitor	unknown
DB11136	Chromium	N/A	approved	Cytochrome b5	P00167	181227	substrate	unknown
DB11148	Butamben	N/A	approved;withdrawn	Voltage-dependent calcium channel	Q9P0X4	5565888	inhibitor	yes
DB11148	Butamben	N/A	approved;withdrawn	Voltage gated sodium channel	None	None	inhibitor	yes
DB11148	Butamben	N/A	approved;withdrawn	ATP-sensitive potassium channel	Q15842	567019	antagonist	yes
DB11155	Triclocarban	N/A	approved	Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI	Q6GI75	49240383	antagonist	yes
DB11156	Pyrantel	Tetrahydropyrimidine derivatives	approved;vet_approved	G-protein coupled receptor 35	Q9HC97	None	None	unknown
DB11156	Pyrantel	Tetrahydropyrimidine derivatives	approved;vet_approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	no
DB11157	Anthralin	Antracen derivatives	approved	Keratin, type II cytoskeletal 2 epidermal	P35908	None	antagonist	yes
DB11157	Anthralin	Antracen derivatives	approved	C-Jun-amino-terminal kinase-interacting protein 1	Q9UQF2	4426597	agonist	unknown
DB11157	Anthralin	Antracen derivatives	approved	Keratin, type I cytoskeletal 12	Q99456	None	antagonist	yes
DB11160	Phenyltoloxamine	N/A	approved	Gamma Globulin	None	None	inverse agonist	yes
DB11166	Antithrombin Alfa	N/A	approved;investigational	Prothrombin	P00734	339641	inhibitor	yes
DB11166	Antithrombin Alfa	N/A	approved;investigational	Coagulation factor X	P00742	182841	inhibitor	yes
DB11181	Homatropine	Anticholinergics	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB11181	Homatropine	Anticholinergics	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB11181	Homatropine	Anticholinergics	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB11181	Homatropine	Anticholinergics	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	yes
DB11181	Homatropine	Anticholinergics	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	yes
DB11185	Sulisobenzone	N/A	approved	Skin epithelial cells	None	None	protector	yes
DB11186	Pentoxyverine	Other cough suppressants	approved;investigational	Sigma non-opioid intracellular receptor 1	Q99720	1783387	agonist	yes
DB11186	Pentoxyverine	Other cough suppressants	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	unknown
DB11186	Pentoxyverine	Other cough suppressants	approved;investigational	Voltage gated sodium channel	None	None	inhibitor	unknown
DB11186	Pentoxyverine	Other cough suppressants	approved;investigational	Kappa-type opioid receptor	P41145	532060	agonist	unknown
DB11186	Pentoxyverine	Other cough suppressants	approved;investigational	Mu-type opioid receptor	P35372	452073	antagonist	unknown
DB11193	Papain	N/A	approved	Toll-like receptor 4	O00206	None	activator	unknown
DB11200	Aluminum zirconium octachlorohydrex gly	N/A	approved	Sweat ducts	None	None	antagonist	yes
DB11201	Menthyl salicylate	N/A	approved	Blood vessels	None	None	antagonist	unknown
DB11201	Menthyl salicylate	N/A	approved	Prostaglandin G/H synthase 1	P23219	387018	antagonist	yes
DB11201	Menthyl salicylate	N/A	approved	Prostaglandin G/H synthase 2	P35354	291988	antagonist	yes
DB11217	Arbutin	N/A	approved	Tyrosinase	P14679	340037	inhibitor	yes
DB11219	Enzacamene	N/A	approved	Progesterone receptor	P06401	35652	antagonist	unknown
DB11219	Enzacamene	N/A	approved	Androgen receptor	P10275	178628	antagonist	unknown
DB11219	Enzacamene	N/A	approved	Estrogen receptor beta	Q92731	2911152	None	unknown
DB11219	Enzacamene	N/A	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB11221	Dioxybenzone	N/A	approved	Sex hormone-binding globulin	P04278	296673	binder	unknown
DB11235	Thonzylamine	Antiallergic agents, excl. corticosteroids	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB11235	Thonzylamine	Antiallergic agents, excl. corticosteroids	approved	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	unknown
DB11235	Thonzylamine	Antiallergic agents, excl. corticosteroids	approved	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	unknown
DB11235	Thonzylamine	Antiallergic agents, excl. corticosteroids	approved	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	unknown
DB11235	Thonzylamine	Antiallergic agents, excl. corticosteroids	approved	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB11235	Thonzylamine	Antiallergic agents, excl. corticosteroids	approved	Muscarinic acetylcholine receptor M5	P08912	177988	antagonist	unknown
DB11251	Tocopherol	Other plain vitamin preparations	approved;investigational	Free radicals	None	None	binder	yes
DB11254	Hexylresorcinol	Antiseptics	approved	DNA topoisomerase 1	P11387	339806	inhibitor	unknown
DB11254	Hexylresorcinol	Antiseptics	approved	Protein-glutamine gamma-glutamyltransferase 2	P21980	339521	inhibitor	unknown
DB11254	Hexylresorcinol	Antiseptics	approved	Tyrosinase	P14679	340037	inhibitor	unknown
DB11273	Dihydroergocornine	N/A	approved	Serotonin Receptors	P34969	1857143	antagonist	yes
DB11273	Dihydroergocornine	N/A	approved	Beta adrenergic receptor	P13945	178896	antagonist	yes
DB11273	Dihydroergocornine	N/A	approved	Alpha adrenergic receptor	P18825	178194	antagonist	yes
DB11274	Dihydro-alpha-ergocryptine	N/A	approved	D(2) dopamine receptor	P14416	181432	agonist	yes
DB11274	Dihydro-alpha-ergocryptine	N/A	approved	D(1) dopamine receptor	P21918	32049	partial agonist	yes
DB11274	Dihydro-alpha-ergocryptine	N/A	approved	D(3) dopamine receptor	P35462	927342	partial agonist	yes
DB11275	Epicriptine	N/A	approved	Dopamine receptor	P21917	291946	agonist	yes
DB11278	DL-Methylephedrine	N/A	approved	Beta-1 adrenergic receptor	P08588	178200	agonist	yes
DB11278	DL-Methylephedrine	N/A	approved	Alpha-2A adrenergic receptor	P08913	178196	agonist	yes
DB11278	DL-Methylephedrine	N/A	approved	Alpha adrenergic receptor	P18825	178194	agonist	yes
DB11278	DL-Methylephedrine	N/A	approved	Beta adrenergic receptor	P13945	178896	agonist	yes
DB11294	Coccidioides immitis spherule	N/A	approved	HLA class I histocompatibility antigen, A-2 alpha chain	P01892	None	binder	unknown
DB11294	Coccidioides immitis spherule	N/A	approved	HLA-DR	None	None	binder	unknown
DB11294	Coccidioides immitis spherule	N/A	approved	HLA class I histocompatibility antigen, A-3 alpha chain	P04439	None	None	unknown
DB11294	Coccidioides immitis spherule	N/A	approved	HLA class I histocompatibility antigen, B-27 alpha chain	P03989	896271	None	unknown
DB11300	Thrombin	Blood coagulation factors	approved;investigational	Proteinase-activated receptor 1	P25116	339677	None	unknown
DB11300	Thrombin	Blood coagulation factors	approved;investigational	Proteinase-activated receptor 4	Q96RI0	None	None	unknown
DB11300	Thrombin	Blood coagulation factors	approved;investigational	Coagulation factor XI	P03951	182833	activator	yes
DB11300	Thrombin	Blood coagulation factors	approved;investigational	Coagulation factor XIII A chain	P00488	182309	activator	yes
DB11300	Thrombin	Blood coagulation factors	approved;investigational	Coagulation factor XIII B chain	P05160	None	activator	yes
DB11300	Thrombin	Blood coagulation factors	approved;investigational	Fibrinogen alpha chain	P02671	13591824	activator	yes
DB11300	Thrombin	Blood coagulation factors	approved;investigational	Fibrinogen beta chain	P02675	182430	activator	yes
DB11300	Thrombin	Blood coagulation factors	approved;investigational	Fibrinogen gamma chain	P02679	182439	activator	yes
DB11300	Thrombin	Blood coagulation factors	approved;investigational	Coagulation factor V	P12259	182412	activator	yes
DB11300	Thrombin	Blood coagulation factors	approved;investigational	Coagulation factor VIII	P00451	182818	activator	yes
DB11311	Prothrombin	N/A	approved	Fibrinogen alpha chain	P02671	13591824	cleavage	yes
DB11311	Prothrombin	N/A	approved	Fibrinogen beta chain	P02675	182430	cleavage	yes
DB11311	Prothrombin	N/A	approved	Coagulation factor XIII A chain	P00488	182309	agonist	yes
DB11311	Prothrombin	N/A	approved	Carboxypeptidase B2	Q96IY4	None	agonist	yes
DB11323	Glycol salicylate	N/A	approved	Prostaglandin G/H synthase 1	P23219	387018	antagonist	yes
DB11323	Glycol salicylate	N/A	approved	Prostaglandin G/H synthase 2	P35354	291988	antagonist	yes
DB11327	Dipyrithione	N/A	approved	Nitric oxide synthase, inducible	P35228	292242	antagonist	unknown
DB11327	Dipyrithione	N/A	approved	Prostaglandin G/H synthase 2	P35354	291988	None	unknown
DB11328	Tetradecyl hydrogen sulfate (ester)	N/A	approved	Endothelial protein C receptor	Q9UNN8	565268	antagonist	yes
DB11332	Sinapultide	N/A	approved	Lung epithelial cells	None	None	agonist	yes
DB11338	Clove oil	N/A	approved;nutraceutical	Vascular cell adhesion protein 1	P19320	179886	antagonist	unknown
DB11338	Clove oil	N/A	approved;nutraceutical	C-X-C motif chemokine 10	P02778	33918	None	unknown
DB11338	Clove oil	N/A	approved;nutraceutical	Collagen alpha-1(I) chain	P02452	1418928	None	unknown
DB11338	Clove oil	N/A	approved;nutraceutical	Granulocyte-macrophage colony-stimulating factor receptor subunit alpha	P15509	32089	None	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Extracellular calcium-sensing receptor	P41180	599820	agonist	yes
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calreticulin	P27797	337487	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calcium and integrin-binding protein 1	Q99828	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Programmed cell death protein 6	O75340	None	agonist	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Sorcin	P30626	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calcineurin B homologous protein 1	Q99653	None	agonist	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	SPARC	P09486	29462	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calnexin	P27824	186523	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Fibrillin-2	P35556	None	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Protein S100-B	P04271	337730	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calsequestrin-2	O14958	None	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Regucalcin	Q15493	None	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Peflin	Q9UBV8	None	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Protein S100-A6	P06703	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Translationally-controlled tumor protein	P13693	None	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calcium and integrin-binding family member 2	O75838	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Protein S100-A13	Q99584	1694828	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calsequestrin-1	P31415	None	ligand	no
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Nucleobindin-1	Q02818	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Nucleobindin-2	P80303	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calmodulin	P0DP23	179888	agonist	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Fibrillin-3	Q75N90	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Grancalcin	P28676	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calcium-dependent secretion activator 1	Q9ULU8	None	agonist	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calmodulin-2	P0DP24	None	agonist	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calmodulin-3	P0DP25	None	agonist	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Protein S100-A16	Q96FQ6	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calretinin	P22676	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calcyphosin	Q13938	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calcium-dependent secretion activator 2	Q86UW7	None	agonist	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Calreticulin-3	Q96L12	None	ligand	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Neurexin-1	Q9ULB1	None	agonist	unknown
DB11348	Calcium Phosphate	Ascorbic acid (vitamin C), combinations	approved	Neuronal calcium sensor 1	P62166	None	ligand	unknown
DB11359	Guaiacol	N/A	approved	Serum albumin	P02768	28590	None	unknown
DB11362	Selexipag	Platelet aggregation inhibitors excl. heparin	approved	Prostacyclin receptor	P43119	495043	agonist	yes
DB11363	Alectinib	N/A	approved;investigational	ALK tyrosine kinase receptor	Q9UM73	2454168	inhibitor	yes
DB11365	Sennosides	Contact laxatives	approved	Reverse transcriptase/RNaseH	Q72547	896047	inhibitor	unknown
DB11386	Chlorobutanol	Other antiemetics	approved;investigational;vet_approved	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	None	unknown
DB11431	Moxidectin	N/A	approved;investigational;vet_approved	Glutamate-gated chloride channel	Q25634	None	binder	yes
DB11431	Moxidectin	N/A	approved;investigational;vet_approved	GABAA gated chloride channel	None	None	binder	yes
DB11431	Moxidectin	N/A	approved;investigational;vet_approved	ABC transporters	None	None	binder	no
DB11560	Lesinurad	Preparations increasing uric acid excretion	approved;investigational	Solute carrier family 22 member 12	Q96S37	None	inhibitor	yes
DB11560	Lesinurad	Preparations increasing uric acid excretion	approved;investigational	Solute carrier family 22 member 11	Q9NSA0	7707622	inhibitor	yes
DB11569	Ixekizumab	N/A	approved;investigational	Interleukin-17A	Q16552	None	antibody	yes
DB11571	Human Thrombin	N/A	approved	Coagulation factor V	P12259	182412	activator	yes
DB11571	Human Thrombin	N/A	approved	Coagulation factor VIII	P00451	182818	activator	yes
DB11571	Human Thrombin	N/A	approved	Coagulation factor XI	P03951	182833	activator	yes
DB11571	Human Thrombin	N/A	approved	Coagulation factor XIII A chain	P00488	182309	activator	yes
DB11571	Human Thrombin	N/A	approved	Coagulation factor XIII B chain	P05160	None	activator	yes
DB11571	Human Thrombin	N/A	approved	Fibrinogen alpha chain	P02671	13591824	activator	yes
DB11571	Human Thrombin	N/A	approved	Fibrinogen beta chain	P02675	182430	activator	yes
DB11571	Human Thrombin	N/A	approved	Fibrinogen gamma chain	P02679	182439	activator	yes
DB11572	Thrombin Alfa	N/A	approved	Coagulation factor XI	P03951	182833	activator	yes
DB11572	Thrombin Alfa	N/A	approved	Coagulation factor VIII	P00451	182818	activator	yes
DB11572	Thrombin Alfa	N/A	approved	Coagulation factor V	P12259	182412	activator	yes
DB11572	Thrombin Alfa	N/A	approved	Coagulation factor XIII A chain	P00488	182309	activator	yes
DB11572	Thrombin Alfa	N/A	approved	Coagulation factor XIII B chain	P05160	None	activator	yes
DB11572	Thrombin Alfa	N/A	approved	Fibrinogen alpha chain	P02671	13591824	activator	yes
DB11572	Thrombin Alfa	N/A	approved	Fibrinogen beta chain	P02675	182430	activator	yes
DB11572	Thrombin Alfa	N/A	approved	Fibrinogen gamma chain	P02679	182439	activator	yes
DB11574	Elbasvir	N/A	approved	Nonstructural Protein 5A (NS5A)	None	None	inhibitor	yes
DB11575	Grazoprevir	N/A	approved	NS3/4A protein	B0B3C9	None	antagonist	yes
DB11577	Indigotindisulfonic Acid	Tests for renal function and ureteral injuries	approved	Aryl hydrocarbon receptor	P35869	533324	None	unknown
DB11577	Indigotindisulfonic Acid	Tests for renal function and ureteral injuries	approved	Alpha adrenergic receptor	P18825	178194	agonist	no
DB11581	Venetoclax	N/A	approved;investigational	Apoptosis regulator Bcl-2	P10415	179367	inhibitor	yes
DB11582	Thiocolchicoside	Other centrally acting agents	approved;investigational	GABA-A receptor (anion channel)	Q9UN88	7861736	antagonist	yes
DB11582	Thiocolchicoside	Other centrally acting agents	approved;investigational	Glycine receptor subunit alpha-1	P23415	31851	antagonist	unknown
DB11582	Thiocolchicoside	Other centrally acting agents	approved;investigational	Tumor necrosis factor ligand superfamily member 11	O14788	None	antagonist	unknown
DB11584	Pipradrol	Other psychostimulants and nootropics	approved	D(1) dopamine receptor	P21918	32049	agonist	unknown
DB11586	Asunaprevir	Protease inhibitors	approved;investigational;withdrawn	Hepatitis C virus NS3 protease/helicase	A3EZI9	None	antagonist	yes
DB11587	Etafedrine	N/A	approved	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB11588	Carbon monoxide	N/A	approved;investigational	Myoglobin	P02144	None	deoxidizer	yes
DB11588	Carbon monoxide	N/A	approved;investigational	Alveolar cells	None	None	diffusing substance	unknown
DB11590	Thimerosal	Mercurial products	approved	Methionine synthase	Q99707	1923221	antagonist	unknown
DB11590	Thimerosal	Mercurial products	approved	Cystine/glutamate transporter	Q9UPY5	5668545	antagonist	unknown
DB11590	Thimerosal	Mercurial products	approved	Sodium/potassium-transporting ATPase subunit gamma	P54710	1575004	antagonist	unknown
DB11591	Bilastine	Other antihistamines for systemic use	approved;investigational	Histamine H1 receptor	P35367	510296	antagonist	yes
DB11595	Atezolizumab	N/A	approved;investigational	Programmed cell death 1 ligand 1	Q9NZQ7	None	antibody	yes
DB11596	Levoleucovorin	Detoxifying agents for antineoplastic treatment	approved;investigational	Serine hydroxymethyltransferase	P0A827	24052975	None	unknown
DB11596	Levoleucovorin	Detoxifying agents for antineoplastic treatment	approved;investigational	Dihydrofolate reductase	P0ABQ4	146006	None	unknown
DB11597	Human Rho(D) immune globulin	N/A	approved;investigational	Rhesus blood group D antigen	A6PZ59	150246790	antibody	yes
DB11598	Antithrombin III human	Heparin group	approved	Antithrombin-III	P01008	179161	agonist	unknown
DB11601	Tuberculin Purified Protein Derivative	N/A	approved	Toll-like receptor 2	O60603	3132528	ligand	yes
DB11603	Human rabies virus immune globulin	N/A	approved	Rabies lyssavirus	None	None	antibody	yes
DB11604	Tetanus Immune Globulin	Specific immunoglobulins	approved	Tetanus toxin	P04958	40770	antibody	yes
DB11605	Myrrh	N/A	approved	Bile acid receptor	Q96RI1	1546084	antagonist	unknown
DB11605	Myrrh	N/A	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	partial agonist	unknown
DB11605	Myrrh	N/A	approved	Peroxisome proliferator-activated receptor alpha	Q07869	307341	agonist	unknown
DB11606	Susoctocog alfa	Blood coagulation factors	approved;investigational	von Willebrand factor	P04275	37947	binding	yes
DB11607	Efmoroctocog alfa	N/A	approved;investigational	von Willebrand factor	P04275	37947	binding	yes
DB11611	Lifitegrast	N/A	approved	Integrin alpha-L	P20701	31422	antagonist	yes
DB11613	Velpatasvir	N/A	approved;investigational	Nonstructural Protein 5A (NS5A)	None	None	inhibitor	yes
DB11614	Rupatadine	Other antihistamines for systemic use	approved	Platelet-activating factor receptor	P25105	None	antagonist	yes
DB11614	Rupatadine	Other antihistamines for systemic use	approved	Histamine H1 receptor	P35367	510296	antagonist	yes
DB11619	Gestrinone	Antigonadotropins and similar agents	approved	Sex hormone-binding globulin	P04278	296673	antagonist	unknown
DB11619	Gestrinone	Antigonadotropins and similar agents	approved	Progesterone receptor	P06401	35652	antagonist	unknown
DB11619	Gestrinone	Antigonadotropins and similar agents	approved	Glucocorticoid receptor	P04150	31680	antagonist	unknown
DB11619	Gestrinone	Antigonadotropins and similar agents	approved	Androgen receptor	P10275	178628	antagonist	unknown
DB11619	Gestrinone	Antigonadotropins and similar agents	approved	Gonadotropin-releasing hormone receptor	P30968	183422	antagonist	unknown
DB11619	Gestrinone	Antigonadotropins and similar agents	approved	Estrogen receptor alpha	P03372	31234	antagonist	unknown
DB11626	Tasonermin	Other immunostimulants	approved	Tumor necrosis factor receptor superfamily member 1A	P19438	37224	agonist	yes
DB11626	Tasonermin	Other immunostimulants	approved	Tumor necrosis factor receptor superfamily member 1B	P20333	189186	agonist	unknown
DB11632	Opicapone	N/A	approved;investigational	Catechol O-methyltransferase	P21964	180920	antagonist	yes
DB11633	Isavuconazole	Triazole derivatives	approved;investigational	Lanosterol 14-alpha demethylase	P50859	755693	inhibitor	yes
DB11633	Isavuconazole	Triazole derivatives	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	inhibitor	no
DB11633	Isavuconazole	Triazole derivatives	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	inhibitor	no
DB11633	Isavuconazole	Triazole derivatives	approved;investigational	G protein-activated inward rectifier potassium channel 2	P48051	1052875	inhibitor	no
DB11633	Isavuconazole	Triazole derivatives	approved;investigational	G protein-activated inward rectifier potassium channel 3	Q92806	None	inhibitor	no
DB11633	Isavuconazole	Triazole derivatives	approved;investigational	ATP-sensitive inward rectifier potassium channel 11	Q14654	1088445	inhibitor	no
DB11633	Isavuconazole	Triazole derivatives	approved;investigational	Potassium voltage-gated channel subfamily A member 5	P22460	None	inhibitor	no
DB11633	Isavuconazole	Triazole derivatives	approved;investigational	Potassium voltage-gated channel subfamily D member 3	Q9UK17	2935434	inhibitor	no
DB11633	Isavuconazole	Triazole derivatives	approved;investigational	Potassium voltage-gated channel subfamily KQT member 1	P51787	2465531	inhibitor	no
DB11633	Isavuconazole	Triazole derivatives	approved;investigational	Sodium channel protein type 5 subunit alpha	Q14524	184039	inhibitor	no
DB11635	Tocofersolan	Other plain vitamin preparations	approved	Multidrug resistance protein 1	P08183	307180	antagonist	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Actin, cytoplasmic 2	P63261	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Alpha-aminoadipic semialdehyde dehydrogenase	P49419	797410	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Annexin A2	P07355	219910	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	ATP synthase subunit alpha, mitochondrial	P25705	28938	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	ATP synthase subunit g, mitochondrial	O75964	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	ATP synthase subunit O, mitochondrial	P48047	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Calpastatin	P20810	303599	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	T-complex protein 1 subunit gamma	P49368	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Cofilin-1	P23528	219545	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Chloride intracellular channel protein 1	O00299	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Cysteine and glycine-rich protein 1	P21291	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Dihydropyrimidinase-related protein 2	Q16555	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Desmoplakin	P15924	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Elongation factor 1-alpha 1	P68104	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Alpha-enolase	P06733	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Filamin-A	P21333	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Alpha-ketoglutarate-dependent dioxygenase FTO	Q9C0B1	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Glucose-6-phosphate 1-dehydrogenase	P11413	31543	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Glyceraldehyde-3-phosphate dehydrogenase, testis-specific	O14556	3046742	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Glucose-6-phosphate isomerase	P06744	189238	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Heterogeneous nuclear ribonucleoproteins A2/B1	P22626	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Heterogeneous nuclear ribonucleoprotein D0	Q14103	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Heterogeneous nuclear ribonucleoprotein K	P61978	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Heterochromatin protein 1-binding protein 3	Q5SSJ5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Heat shock protein beta-1	P04792	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Ras GTPase-activating-like protein IQGAP1	P46940	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Far upstream element-binding protein 2	Q92945	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	L-lactate dehydrogenase A chain	P00338	34313	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	L-lactate dehydrogenase B chain	P07195	1200083	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Galectin-1	P09382	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Microtubule-associated protein 4	P27816	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Malate dehydrogenase, cytoplasmic	P40925	1255604	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Puromycin-sensitive aminopeptidase	P55786	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Profilin-1	P07737	190386	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Phosphoglycerate kinase 1	P00558	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Pyruvate kinase PKM	P14618	189998	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Peptidyl-prolyl cis-trans isomerase A	P62937	30309	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Peroxiredoxin-1	Q06830	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L10	P27635	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L14	P50914	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L18	Q07020	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L23a	P62750	1399086	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L35	P42766	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L4	P36578	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S13	P62277	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S17	P08708	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S18	P62269	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S19	P39019	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S28	P62857	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S5	P46782	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S6	P62753	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S8	P62241	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S9	P46781	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Splicing factor 1	Q15637	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Splicing factor, proline- and glutamine-rich	P23246	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Small nuclear ribonucleoprotein Sm D2	P62316	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Signal recognition particle 14 kDa protein	P37108	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Serine/arginine-rich splicing factor 4	Q08170	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Transgelin	None	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Transgelin-2	P37802	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Triosephosphate isomerase	P60174	339841	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Tropomyosin alpha-1 chain	P09493	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Tubulin alpha-1A chain	Q71U36	37492	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Vimentin	P08670	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Zyxin	Q15942	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Heat shock cognate 71 kDa protein	P11142	11526573	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Tubulin beta-6 chain	Q9BUF5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Tubulin beta-4A chain	P04350	35959	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Tubulin beta chain	P07437	338695	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Fructose-bisphosphate aldolase A	P04075	178351	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Glyceraldehyde-3-phosphate dehydrogenase	P04406	31645	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Cytochrome c	P99999	181242	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Phosphoglycerate mutase 1	P18669	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Myosin-9	P35579	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Protein disulfide-isomerase	P07237	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Probable ATP-dependent RNA helicase DDX5	P17844	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Serine hydroxymethyltransferase, mitochondrial	P34897	746436	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Spliceosome RNA helicase DDX39B	Q13838	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Temporary name for P06748	P06748	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Translationally-controlled tumor protein homolog	Q8I3Z5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	P-type Ca2+-transporting ATPase	Q5R2K6	None	antagonist	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Ornithine aminotransferase	Q6LFH8	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Elongation factor 1-alpha	Q00080	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Multidrug resistance protein	P13568	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Elongation factor 2	Q8IKW5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Actin-1	P86287	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Glyceraldehyde-3-phosphate dehydrogenase	Q8IKK7	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Fructose-bisphosphate aldolase	P14223	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Cell division cycle protein 48 homologue,putative	C6KT34	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Heat shock protein 90	Q8IC05	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Eukaryotic initiation factor 4A	Q8IKF0	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Pyruvate kinase	C6KTA4	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	L-lactate dehydrogenase	Q27743	294165	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Protein disulfide-isomerase	C0H4Y6	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Thioredoxin-related protein, putative	Q8IDH5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Spermidine synthase	Q8II73	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Probable ATP-dependent 6-phosphofructokinase	Q8I2Z8	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Glutamate dehydrogenase	Q8ILF7	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Endoplasmin homolog, putative	Q8I0V4	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Hypoxanthine-guanine-xanthine phosphoribosyltransferase	P20035	9914	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Enolase	Q8IJN7	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S3	Q8IKH8	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Non-SERCA-type Ca2+-transporting P-ATPase	A0A143ZZK9	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Tubulin alpha chain	P14642	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Knob-associated histidine-rich protein	P13817	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	S-adenosylmethionine synthase	Q7K6A4	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	V-type H(+)-translocating pyrophosphatase, putative	Q8IKR1	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L4	Q8I431	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Phosphoethanolamine N-methyltransferase	Q8IDQ9	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S3a	O97313	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Conserved Plasmodium membrane protein	Q8IJT2	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L3	Q8IJC6	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	High molecular weight rhoptry protein 2	C0H571	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Serine repeat antigen 5	T1RTG8	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S19	C0H5C2	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Glycophorin-binding protein	Q8I6U8	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Calcium-transporting ATPase	Q08853	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	V-type proton ATPase catalytic subunit A	Q76NM6	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L2	Q8I3T9	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Acyl-CoA synthetase	Q8I0X2	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Plasmepsin IV	Q8IM16	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Plasmepsin-1	Q7KQM4	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Chloroquine resistance transporter	Q9N623	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	14-3-3 protein	C0H4V6	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Isoleucine--tRNA ligase, putative	Q8I5G6	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Plasmodium exported protein	C6S3C7	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Tubulin beta chain	Q7KQL5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L27	Q8IKM5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Sec62, putative	Q8IL86	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Autophagy-related protein 18, putative	Q8IJR6	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Mature parasite-infected erythrocyte surface antigen	Q8I492	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Importin-7, putative	C0H4L1	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Karyopherin alpha	None	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Peptidyl-prolyl cis-trans isomerase	Q76NN7	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	DnaJ protein, putative	Q8IB72	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Merozoite surface protein 1	P13827	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Glutamate--tRNA ligase	Q8IDD3	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	T-complex protein 1 subunit eta	O77323	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Plasmepsin-2	P46925	858754	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Chaperone, putative	C0H546	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Rhoptry neck protein 3	Q8I4R5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S5, putative	Q8IBN5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Skeleton-binding protein 1	Q8I487	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Purine nucleotide phosphorylase, putative	Q8I3X4	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Adenosylhomocysteinase	P50250	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Adenosine deaminase	Q8IJA9	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Methionine--tRNA ligase	Q8IJ60	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Carbamoyl phosphate synthetase	Q8IEN3	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Aspartate carbamoyltransferase	Q8IDP8	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Signal recognition particle receptor, beta subunit	Q8I4W4	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Parasite-infected erythrocyte surface protein	O77361	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Coatomer alpha subunit, putative	C6KSR5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Hexokinase	Q02155	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Proteasome subunit alpha type	Q8IBI3	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Haloacid dehalogenase-like hydrolase	Q8IJ74	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Insulinase, putative	Q8III5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	40S ribosomal protein S21	Q8IHS5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Ubiquitin-conjugating enzyme E2	Q8IDP1	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Eukaryotic translation initiation factor 3 subunit C	Q8I5Y3	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L24, putative	Q8IEM3	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L23	Q8IE82	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L17, putative	Q8IDI5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	NADP-specific glutamate dehydrogenase	None	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	HAP protein	Q8IM15	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Heat shock protein 110, putative	C0H5H0	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L10, putative	Q8ILV2	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Lysophospholipase, putative	Q8IM74	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Polyadenylate-binding protein	Q8I5H4	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Ubiquitin-60S ribosomal protein L40	Q8ID50	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Phosphoribosylpyrophosphate synthetase	None	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Thioredoxin peroxidase 1	Q8IL80	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Protein transport protein SEC31	O96221	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Dipeptidyl aminopeptidase 1	A0A144A2G5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Ring-infected erythrocyte surface antigen	P13830	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	ATP-dependent RNA helicase UAP56	Q9TY94	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Calcium-dependent protein kinase 4	Q8IBS5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	GTP-binding nuclear protein Ran	P38545	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Nucleoside transporter 2	Q8IB78	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Anamorsin homolog	C0H4X5	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Glutamine synthetase, putative	C0H551	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L30e, putative	Q8IJK8	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Casein kinase 2, alpha subunit	Q8IIR9	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Threonine--tRNA ligase	Q8IIA4	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	cAMP-dependent protein kinase regulatory subunit	Q7KQK0	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Elongation factor 1-gamma, putative	Q8IDV0	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Thioredoxin-like protein	Q8IKL4	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L21	Q8ILK3	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	60S ribosomal protein L14, putative	Q8ILE8	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Inner membrane complex sub-compartment protein 3	Q8IKM6	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	HSP40, subfamily A, putative	Q8IL88	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Pyridoxal 5'-phosphate synthase subunit Pdx1	C6KT50	None	ligand	unknown
DB11638	Artenimol	Artemisinin and derivatives, plain	approved;investigational	Serum albumin	P02768	28590	ligand	unknown
DB11639	Dibotermin alfa	Bone morphogenetic proteins	approved;investigational	Bone morphogenetic protein receptor type-2	Q13873	None	ligand	yes
DB11639	Dibotermin alfa	Bone morphogenetic proteins	approved;investigational	Bone morphogenetic protein receptor type-1A	P36894	None	ligand	yes
DB11640	Amifampridine	Other nervous system drugs	approved	Potassium voltage-gated channel subfamily A member 1	Q09470	186663	blocker	yes
DB11641	Vinflunine	Vinca alkaloids and analogues	approved;investigational	Tubulin beta chain	P07437	338695	inhibitor	yes
DB11642	Pitolisant	Other nervous system drugs	approved;investigational	Histamine H3 receptor	Q9Y5N1	5031291	antagonist	yes
DB11642	Pitolisant	Other nervous system drugs	approved;investigational	Potassium voltage-gated channel subfamily H member 2	Q12809	487738	blocker	no
DB11644	Tafamidis	Other nervous system drugs	approved;investigational	Transthyretin	P02766	189582	chaperone	yes
DB11660	Latanoprostene Bunod	N/A	approved;investigational	Prostaglandin F2-alpha receptor	P43088	456564	agonist	yes
DB11672	Curcumin	N/A	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB11672	Curcumin	N/A	approved;investigational	Vitamin D3 receptor	P11473	340203	None	unknown
DB11672	Curcumin	N/A	approved;investigational	Multidrug resistance-associated protein 5	O15440	4140698	inhibitor	unknown
DB11672	Curcumin	N/A	approved;investigational	Carbonyl reductase [NADPH] 1	P16152	None	None	unknown
DB11672	Curcumin	N/A	approved;investigational	Glutathione S-transferase P	P09211	31946	None	unknown
DB11691	Naldemedine	N/A	approved;investigational	Mu-type opioid receptor	P35372	452073	antagonist	yes
DB11691	Naldemedine	N/A	approved;investigational	Delta-type opioid receptor	P41143	27545517	antagonist	yes
DB11691	Naldemedine	N/A	approved;investigational	Kappa-type opioid receptor	P41145	532060	antagonist	yes
DB11699	Tropisetron	Serotonin (5HT3) antagonists	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	antagonist	yes
DB11703	Acalabrutinib	N/A	approved;investigational	Tyrosine-protein kinase BTK	Q06187	312467	inhibitor	yes
DB11712	Tezacaftor	N/A	approved;investigational	Cystic fibrosis transmembrane conductance regulator	P13569	180332	activator	yes
DB11714	Durvalumab	N/A	approved;investigational	Programmed cell death 1 ligand 1	Q9NZQ7	None	binder	yes
DB11714	Durvalumab	N/A	approved;investigational	T-lymphocyte activation antigen CD80	P33681	306916	binder	yes
DB11730	Ribociclib	N/A	approved;investigational	Cyclin-dependent kinase 4	P11802	456427	antagonist	yes
DB11730	Ribociclib	N/A	approved;investigational	Cyclin-dependent kinase 6	Q00534	36623	antagonist	yes
DB11737	Icotinib	N/A	approved;investigational	Epidermal growth factor receptor	P00533	757924	antagonist	unknown
DB11738	Rilmenidine	Imidazoline receptor agonists	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	None	unknown
DB11767	Sarilumab	N/A	approved;investigational	Interleukin-6 receptor subunit alpha	P08887	None	antagonist	yes
DB11767	Sarilumab	N/A	approved;investigational	High affinity immunoglobulin gamma Fc receptor I	P12314	31332	unknown	unknown
DB11767	Sarilumab	N/A	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-a	P12318	182474	unknown	unknown
DB11767	Sarilumab	N/A	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor II-b	P31994	4099445	unknown	unknown
DB11767	Sarilumab	N/A	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	unknown	unknown
DB11767	Sarilumab	N/A	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-B	O75015	31322	unknown	unknown
DB11793	Niraparib	N/A	approved;investigational	Poly [ADP-ribose] polymerase 1	P09874	1017423	antagonist	yes
DB11793	Niraparib	N/A	approved;investigational	Poly [ADP-ribose] polymerase 2	Q9UGN5	6688130	antagonist	yes
DB11799	Bictegravir	N/A	approved;investigational	Reverse transcriptase/RNaseH	Q72547	896047	antagonist	yes
DB11799	Bictegravir	N/A	approved;investigational	Integrase	Q7ZJM1	None	antagonist	yes
DB11817	Baricitinib	N/A	approved;investigational	Tyrosine-protein kinase JAK1	P23458	None	inhibitor	yes
DB11817	Baricitinib	N/A	approved;investigational	Tyrosine-protein kinase JAK2	O60674	None	inhibitor	yes
DB11817	Baricitinib	N/A	approved;investigational	Protein-tyrosine kinase 2-beta	Q14289	988305	inhibitor	yes
DB11817	Baricitinib	N/A	approved;investigational	Tyrosine-protein kinase JAK3	P52333	None	inhibitor	yes
DB11827	Ertugliflozin	N/A	approved;investigational	Sodium/glucose cotransporter 2	P31639	None	antagonist	yes
DB11828	Neratinib	N/A	approved;investigational	Epidermal growth factor receptor	P00533	757924	inhibitor	yes
DB11834	Guselkumab	N/A	approved;investigational	Interleukin-23 subunit alpha	Q9NPF7	None	blocker	yes
DB11842	Angiotensin II	N/A	approved;investigational	Type-1 angiotensin II receptor	P30556	179122	agonist	yes
DB11901	Apalutamide	N/A	approved;investigational	Androgen receptor	P10275	178628	antagonist	yes
DB11901	Apalutamide	N/A	approved;investigational	GABA-A receptor (anion channel)	Q9UN88	7861736	antagonist	unknown
DB11915	Valbenazine	N/A	approved;investigational	vesicular monoamine transporter 2 (VMAT2)	Q99870	None	antagonist	yes
DB11943	Delafloxacin	N/A	approved;investigational	DNA topoisomerase 4 subunit A	P0AFI2	147106	inhibitor	yes
DB11943	Delafloxacin	N/A	approved;investigational	DNA gyrase subunit A	P0AES4	None	inhibitor	yes
DB11945	Avelumab	N/A	approved;investigational	Programmed cell death 1 ligand 1	Q9NZQ7	None	antagonist	yes
DB11967	Binimetinib	N/A	approved;investigational	Interleukin-6	P05231	32674	None	unknown
DB11967	Binimetinib	N/A	approved;investigational	Tumor necrosis factor	P01375	339741	None	unknown
DB11967	Binimetinib	N/A	approved;investigational	Interleukin-1 beta	P01584	307043	None	unknown
DB11967	Binimetinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 1	Q13233	None	inhibitor	yes
DB11967	Binimetinib	N/A	approved;investigational	Dual specificity mitogen-activated protein kinase kinase 2	P36507	None	inhibitor	yes
DB11988	Ocrelizumab	N/A	approved;investigational	B-lymphocyte antigen CD20	P11836	29774	antagonist	yes
DB11994	Diacerein	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Oxysterols receptor LXR-alpha	Q13133	726513	inhibitor	unknown
DB11994	Diacerein	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Oxysterols receptor LXR-beta	P55055	641962	inhibitor	unknown
DB11994	Diacerein	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Arylamine N-acetyltransferase (Helicobacter pylori)	None	None	inhibitor	unknown
DB11994	Diacerein	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	unknown
DB11994	Diacerein	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Cytochrome P450 1A2	P05177	None	inhibitor	unknown
DB11994	Diacerein	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	CYP3A	P24462	220149	inhibitor	unknown
DB11994	Diacerein	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Cytochrome P450 2E1	P05181	181360	inhibitor	unknown
DB11994	Diacerein	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Cytochrome P450 2C9	P11712	None	inhibitor	unknown
DB11994	Diacerein	Other antiinflammatory and antirheumatic agents, non-steroids	approved;investigational	Cytochrome P450 2D6	P10635	181350	inhibitor	unknown
DB11995	Avatrombopag	N/A	approved;investigational	ATP-binding cassette sub-family G member 2	Q9UNQ0	4185796	inhibitor	unknown
DB11995	Avatrombopag	N/A	approved;investigational	Thrombopoietin receptor	P40238	None	agonist	yes
DB11995	Avatrombopag	N/A	approved;investigational	Solute carrier family 22 member 8	Q8TCC7	4378059	inhibitor	unknown
DB12001	Abemaciclib	N/A	approved;investigational	Cyclin-dependent kinase 4	P11802	456427	inhibitor	yes
DB12001	Abemaciclib	N/A	approved;investigational	Cyclin-dependent kinase 6	Q00534	36623	inhibitor	yes
DB12007	Isoflavone	N/A	approved;investigational	Peroxisome proliferator-activated receptor alpha	Q07869	307341	agonist	unknown
DB12007	Isoflavone	N/A	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	agonist	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase SYK	P43405	496900	inhibitor	yes
DB12010	Fostamatinib	N/A	approved;investigational	Adenosine receptor A3	P0DMS8	349449	antagonist	unknown
DB12010	Fostamatinib	N/A	approved;investigational	vesicular monoamine transporter 2 (VMAT2)	Q99870	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Fatty-acid amide hydrolase 1	O00519	2149156	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Equilibrative nucleoside transporter 1	Q99808	1845345	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	UDP-glucuronosyltransferase 1-1	P22309	184473	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	cGMP-specific 3',5'-cyclic phosphodiesterase	O76074	3420185	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Arachidonate 5-lipoxygenase	P09917	187193	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cathepsin S	P25774	248406	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cathepsin L1	P07711	29715	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase ABL1	P00519	28237	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Calcium-dependent protein kinase 1	P62344	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PknB	P9WI81	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ribosomal protein S6 kinase alpha-6	Q9UK32	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Non-receptor tyrosine-protein kinase TYK2	P29597	37504	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Atypical kinase COQ8A, mitochondrial	Q8NI60	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase JAK1	P23458	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Hepatocyte growth factor receptor	P08581	307196	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase NIM1	Q8IY84	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase MST4	Q9P289	13702675	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	cAMP-dependent protein kinase catalytic subunit alpha	P17612	35479	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 24	Q9Y6E0	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 3	Q13188	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Tec	P42680	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 33	Q9BYT3	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 35	Q8TDR2	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 36	Q9NRP7	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 38	Q15208	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 38-like	Q9Y2H1	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	STE20/SPS1-related proline-alanine-rich protein kinase	Q9UEW8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase TAO1	Q7L7X3	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase TAO2	Q9UL54	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase TAO3	Q9H2K8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase TBK1	Q9UHD2	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Angiopoietin-1 receptor	Q02763	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity testis-specific protein kinase 1	Q15569	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	TGF-beta receptor type-1	P36897	431035	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	TGF-beta receptor type-2	P37173	339570	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase receptor Tie-1	P35590	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase tousled-like 1	Q9UKI8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase tousled-like 2	Q86UE8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	TRAF2 and NCK-interacting protein kinase	Q9UKE5	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Non-receptor tyrosine-protein kinase TNK1	Q13470	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Activated CDC42 kinase 1	Q07912	8850245	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase TNNI3K	Q59H18	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Testis-specific serine/threonine-protein kinase 1	Q9BXA7	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity protein kinase TTK	P33981	340011	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase TXK	P42681	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase receptor TYRO3	Q06418	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase ULK1	O75385	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase ULK2	Q8IYT8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase ULK3	Q6PHR2	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Wee1-like protein kinase	P30291	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Yes	P07947	181268	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 19	Q56UN5	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase MLT	Q9NYL2	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase ZAP-70	P43403	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	AP2-associated protein kinase 1	Q2M2I8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Abelson tyrosine-protein kinase 2	P42684	178993	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Activin receptor type-1	Q04771	338219	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Activin receptor type-1B	P36896	402189	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Atypical kinase COQ8B, mitochondrial	Q96D53	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	ALK tyrosine kinase receptor	Q9UM73	2454168	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ankyrin repeat and protein kinase domain-containing protein 1	Q8NFD2	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Aurora kinase A	O14965	2641948	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Aurora kinase B	Q96GD4	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Aurora kinase C	Q9UQB9	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase receptor UFO	P30530	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Blk	P51451	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	BMP-2-inducible protein kinase	Q9NSY1	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Bone morphogenetic protein receptor type-1B	O00238	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Bone morphogenetic protein receptor type-2	Q13873	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cytoplasmic tyrosine-protein kinase BMX	P51813	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase B-raf	P15056	41387220	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase BTK	Q06187	312467	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Calcium/calmodulin-dependent protein kinase type 1	Q14012	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Calcium/calmodulin-dependent protein kinase type 1D	Q8IU85	23491810	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Calcium/calmodulin-dependent protein kinase type 1G	Q96NX5	16755792	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Calcium/calmodulin-dependent protein kinase type II subunit alpha	Q9UQM7	4836793	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Calcium/calmodulin-dependent protein kinase type II subunit beta	Q13554	5326757	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Calcium/calmodulin-dependent protein kinase type II subunit delta	Q13557	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Calcium/calmodulin-dependent protein kinase type II subunit gamma	Q13555	21707842	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Calcium/calmodulin-dependent protein kinase kinase 1	Q8N5S9	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Calcium/calmodulin-dependent protein kinase kinase 2	Q96RR4	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Peripheral plasma membrane protein CASK	O14936	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Kappa-casein	P07498	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cyclin-dependent kinase 1	P06493	29839	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase MRCK gamma	Q6DT37	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cyclin-dependent kinase 4	P11802	456427	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cyclin-dependent kinase-like 1	Q00532	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cyclin-dependent kinase-like 2	Q92772	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase Chk1	O14757	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase Chk2	O96017	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Citron Rho-interacting kinase	O14578	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity protein kinase CLK1	P49759	632964	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity protein kinase CLK2	P49760	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity protein kinase CLK3	P49761	632970	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity protein kinase CLK4	Q9HAZ1	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Macrophage colony-stimulating factor 1 receptor	P07333	553224	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase CSK	P41240	30315	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Casein kinase I isoform alpha	P48729	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Casein kinase II subunit alpha	P68400	598147	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Casein kinase II subunit alpha'	P19784	177838	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Death-associated protein kinase 1	P53355	2094873	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Death-associated protein kinase 2	Q9UIK4	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Death-associated protein kinase 3	O43293	2911156	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase DCLK1	O15075	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase DCLK2	Q8N568	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase DCLK3	Q9C098	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Epithelial discoidin domain-containing receptor 1	Q08345	306475	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Discoidin domain-containing receptor 2	Q16832	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Q13627	1381156	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity tyrosine-phosphorylation-regulated kinase 1B	Q9Y463	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Epidermal growth factor receptor	P00533	757924	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Eukaryotic translation initiation factor 2-alpha kinase 1	Q9BQI3	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Interferon-induced, double-stranded RNA-activated protein kinase	P19525	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	eIF-2-alpha kinase GCN2	Q9P2K8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-A receptor 1	P21709	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-A receptor 2	P29317	181944	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-A receptor 3	P29320	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-A receptor 4	P54764	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-A receptor 5	P54756	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-A receptor 6	Q9UF33	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-A receptor 7	Q15375	551608	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-A receptor 8	P29322	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-B receptor 1	P54762	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-B receptor 2	P29323	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-B receptor 4	P54760	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ephrin type-B receptor 6	O15197	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Receptor tyrosine-protein kinase erbB-2	P04626	553282	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Receptor tyrosine-protein kinase erbB-4	Q15303	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase/endoribonuclease IRE1	O75460	3300094	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Fer	P16591	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Fes/Fps	P07332	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Fibroblast growth factor receptor 1	P11362	31368	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Fibroblast growth factor receptor 2	P21802	31374	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Fibroblast growth factor receptor 3	P22607	182569	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Fgr	P09769	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Vascular endothelial growth factor receptor 1	P17948	31432	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Receptor-type tyrosine-protein kinase FLT3	P36888	409573	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Vascular endothelial growth factor receptor 3	P35916	297050	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase mTOR	P42345	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase FRK	P42685	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Fyn	P06241	338228	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cyclin-G-associated kinase	O14976	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Glycogen synthase kinase-3 alpha	P49840	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Glycogen synthase kinase-3 beta	P49841	529237	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase HCK	P08631	306832	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Homeodomain-interacting protein kinase 2	Q9H2X6	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Homeodomain-interacting protein kinase 3	Q9H422	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase ICK	Q9UPZ9	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Inhibitor of nuclear factor kappa-B kinase subunit beta	O14920	2599558	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Inhibitor of nuclear factor kappa-B kinase subunit epsilon	Q14164	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Insulin receptor	P06213	307070	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Insulin receptor-related protein	P14616	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Interleukin-1 receptor-associated kinase 1	P51617	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Interleukin-1 receptor-associated kinase 3	Q9Y616	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Interleukin-1 receptor-associated kinase 4	Q9NWZ3	20219010	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase ITK/TSK	Q08881	399658	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase JAK2	O60674	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase JAK3	P52333	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Vascular endothelial growth factor receptor 2	P35968	2655412	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase SIK3	Q9Y2K2	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mast/stem cell growth factor receptor Kit	P10721	34085	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase LATS1	O95835	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Lck	P06239	36808	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	LIM domain kinase 1	P53667	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	LIM domain kinase 2	P53671	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Leucine-rich repeat serine/threonine-protein kinase 2	Q5S007	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Leukocyte tyrosine kinase receptor	P29376	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Lyn	P07948	307144	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity mitogen-activated protein kinase kinase 2	P36507	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity mitogen-activated protein kinase kinase 3	P46734	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity mitogen-activated protein kinase kinase 5	Q13163	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Dual specificity mitogen-activated protein kinase kinase 6	P52564	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 1	Q13233	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 10	Q02779	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 11	Q16584	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 12	Q12852	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 13	O43283	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 15	Q6ZN16	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 2	Q9Y2U5	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 3	Q99759	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 4	Q9Y6R4	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 6	O95382	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase 9	P80192	33591094	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase kinase 1	Q92918	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase kinase 2	Q12851	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase kinase 3	Q8IVH8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase kinase 4	O95819	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase kinase kinase kinase 5	Q9Y4K4	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase 10	P53779	468151	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase 13	O15264	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase 14	Q16539	603917	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase 15	Q8TD08	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase 4	P31152	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase 7	Q13164	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Mitogen-activated protein kinase 9	P45984	598183	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	MAP kinase-activated protein kinase 5	Q8IW41	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase MARK1	Q9P0L2	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase MARK2	Q7KZI7	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	MAP/microtubule affinity-regulating kinase 3	P27448	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	MAP/microtubule affinity-regulating kinase 4	Q96L34	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	CLIP-associating protein 1	Q7Z460	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Microtubule-associated serine/threonine-protein kinase 1	Q9Y2H9	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Megakaryocyte-associated tyrosine-protein kinase	P42679	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Maternal embryonic leucine zipper kinase	Q14680	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Mer	Q12866	505665	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Misshapen-like kinase 1	Q8N4C8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	MAP kinase-interacting serine/threonine-protein kinase 1	Q9BUB5	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	MAP kinase-interacting serine/threonine-protein kinase 2	Q9HBH9	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Macrophage-stimulating protein receptor	Q04912	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Muscle, skeletal receptor tyrosine-protein kinase	O15146	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Myosin light chain kinase, smooth muscle	Q15746	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Myosin light chain kinase 2, skeletal/cardiac muscle	Q9H1R3	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Myosin light chain kinase 3	Q32MK0	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Myosin light chain kinase family member 4	Q86YV6	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Myosin-IIIa	Q8NEV4	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase Nek1	Q96PY6	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase Nek11	Q8NG66	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase Nek2	P51955	479171	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase Nek3	P51956	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase Nek4	P51957	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase Nek5	Q6P3R8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase Nek9	Q8TD19	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	High affinity nerve growth factor receptor	P04629	339918	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	BDNF/NT-3 growth factors receptor	Q16620	530791	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	NT-3 growth factor receptor	Q16288	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	NUAK family SNF1-like kinase 1	O60285	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	NUAK family SNF1-like kinase 2	Q9H093	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase OSR1	O95747	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PAK 1	Q13153	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PAK 2	Q13177	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PAK 3	O75914	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PAK 4	O96013	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PAK 6	Q9NQU5	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PAK 5	Q9P286	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cyclin-dependent kinase 16	Q00536	36619	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cyclin-dependent kinase 17	Q00537	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Platelet-derived growth factor receptor alpha	P16234	189734	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Platelet-derived growth factor receptor beta	P09619	189732	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	3-phosphoinositide-dependent protein kinase 1	O15530	2407613	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Cyclin-dependent kinase 15	Q96Q40	15823642	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform	Q16816	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Phosphatidylinositol 4-kinase beta	Q9UBF8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta	O00750	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma	O75747	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	O00329	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	P48736	1507822	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase pim-1	P11309	387022	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase pim-3	Q86V86	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Phosphatidylinositol 5-phosphate 4-kinase type-2 beta	P78356	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma	Q8TBX8	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase	Q99640	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase N1	Q16512	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase N2	Q16513	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PLK1	P53350	393017	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PLK2	Q9NYY3	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PLK3	Q9H4B4	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PLK4	O00444	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	5'-AMP-activated protein kinase catalytic subunit alpha-1	Q13131	4115829	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	5'-AMP-activated protein kinase	Q9UGI9	2916802	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	cAMP-dependent protein kinase catalytic subunit beta	P22694	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Protein kinase C delta type	Q05655	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Protein kinase C epsilon type	Q02156	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Protein kinase C gamma type	P05129	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Protein kinase C iota type	P41743	432274	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Protein kinase C theta type	Q04759	558099	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase D1	Q15139	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	cGMP-dependent protein kinase 2	Q13237	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase PRP4 homolog	Q13523	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Focal adhesion kinase 1	Q05397	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Protein-tyrosine kinase 2-beta	Q14289	988305	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Protein-tyrosine kinase 6	Q13882	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	RAF proto-oncogene serine/threonine-protein kinase	P04049	35842	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Proto-oncogene tyrosine-protein kinase receptor Ret	P07949	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase RIO1	Q9BRS2	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase RIO2	Q9BVS4	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase RIO3	O14730	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Receptor-interacting serine/threonine-protein kinase 1	Q13546	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Receptor-interacting serine/threonine-protein kinase 2	O43353	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Receptor-interacting serine/threonine-protein kinase 4	P57078	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Rho-associated protein kinase 2	O75116	4520225	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Proto-oncogene tyrosine-protein kinase ROS	P08922	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ribosomal protein S6 kinase alpha-1	Q15418	292457	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Ribosomal protein S6 kinase alpha-3	P51812	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase SBK1	Q52WX2	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Uncharacterized serine/threonine-protein kinase SBK3	P0C264	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase Sgk3	Q96BR1	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase SIK1	P57059	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase SIK2	Q9H0K1	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	STE20-like serine/threonine-protein kinase	Q9H2G2	1944185	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	SNF-related serine/threonine-protein kinase	Q9NRH2	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Proto-oncogene tyrosine-protein kinase Src	P12931	10635153	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Tyrosine-protein kinase Srms	Q9H3Y6	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 10	O94804	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 16	O75716	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 17A	Q9UEE5	None	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 17B	O94768	3834356	inhibitor	unknown
DB12010	Fostamatinib	N/A	approved;investigational	Serine/threonine-protein kinase 32A	Q8WU08	None	inhibitor	unknown
DB12023	Benralizumab	N/A	approved;investigational	Interleukin-5 receptor subunit alpha	Q01344	None	antibody	yes
DB12023	Benralizumab	N/A	approved;investigational	Low affinity immunoglobulin gamma Fc region receptor III-A	P08637	31324	binding	yes
DB12026	Voxilaprevir	N/A	approved;investigational	NS3/4A protein	B0B3C9	None	inhibitor	yes
DB12070	Letermovir	N/A	approved;investigational	Tripartite terminase subunit 1	F5HC79	None	inhibitor	yes
DB12070	Letermovir	N/A	approved;investigational	Tripartite terminase subunit 2	F5HGI9	None	inhibitor	yes
DB12070	Letermovir	N/A	approved;investigational	Tripartite terminase subunit 3	F5HCU8	None	inhibitor	yes
DB12095	Telotristat ethyl	N/A	approved;investigational	Tryptophan 5-hydroxylase 2	Q8IWU9	27497159	antagonist	yes
DB12095	Telotristat ethyl	N/A	approved;investigational	Tryptophan 5-hydroxylase 1	P17752	37955	antagonist	yes
DB12107	Vaborbactam	N/A	approved;investigational	Beta-lactamase	P05364	42261	inhibitor	yes
DB12107	Vaborbactam	N/A	approved;investigational	Carbapenem-hydrolyzing beta-lactamase KPC	Q9F663	None	inhibitor	yes
DB12107	Vaborbactam	N/A	approved;investigational	Beta-lactamase (KPC-2)	Q93LQ9	None	inhibitor	yes
DB12107	Vaborbactam	N/A	approved;investigational	Beta-lactamase CTX-M	Q9L5C7	None	inhibitor	yes
DB12107	Vaborbactam	N/A	approved;investigational	Beta-lactamase (blaSHV)	A8DZJ2	None	inhibitor	yes
DB12107	Vaborbactam	N/A	approved;investigational	Beta-lactamase SHV-1	P0AD64	151861	inhibitor	yes
DB12107	Vaborbactam	N/A	approved;investigational	Beta-lactamase TEM	P62593	208959	inhibitor	yes
DB12107	Vaborbactam	N/A	approved;investigational	Beta-lactamase AmpC	Q93CA2	15705879	inhibitor	yes
DB12107	Vaborbactam	N/A	approved;investigational	Beta-lactamase (MIR-1)	Q9X757	None	inhibitor	yes
DB12107	Vaborbactam	N/A	approved;investigational	Beta-lactamase	Q53IN1	None	inhibitor	yes
DB12159	Dupilumab	N/A	approved;investigational	Interleukin-4 receptor subunit alpha	P24394	None	antagonist	yes
DB12161	Deutetrabenazine	N/A	approved;investigational	Synaptic vesicular amine transporter	Q05940	292335	inhibitor	yes
DB12267	Brigatinib	N/A	approved;investigational	ALK tyrosine kinase receptor	Q9UM73	2454168	inhibitor	yes
DB12267	Brigatinib	N/A	approved;investigational	Epidermal growth factor receptor	P00533	757924	inhibitor	yes
DB12267	Brigatinib	N/A	approved;investigational	Tyrosine-protein kinase ABL1	P00519	28237	inhibitor	unknown
DB12267	Brigatinib	N/A	approved;investigational	Insulin-like growth factor 1 receptor	P08069	804990	inhibitor	unknown
DB12267	Brigatinib	N/A	approved;investigational	Receptor-type tyrosine-protein kinase FLT3	P36888	409573	inhibitor	unknown
DB12267	Brigatinib	N/A	approved;investigational	Insulin receptor	P06213	307070	binding	no
DB12267	Brigatinib	N/A	approved;investigational	Hepatocyte growth factor receptor	P08581	307196	inhibitor	unknown
DB12267	Brigatinib	N/A	approved;investigational	Receptor tyrosine-protein kinase erbB-4	Q15303	None	inhibitor	unknown
DB12267	Brigatinib	N/A	approved;investigational	Receptor tyrosine-protein kinase erbB-2	P04626	553282	inhibitor	unknown
DB12278	Propiverine	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	antagonist	yes
DB12278	Propiverine	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	antagonist	yes
DB12278	Propiverine	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	antagonist	yes
DB12278	Propiverine	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	antagonist	unknown
DB12278	Propiverine	Drugs for urinary frequency and incontinence	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	None	yes
DB12278	Propiverine	Drugs for urinary frequency and incontinence	approved;investigational	Voltage-dependent L-type calcium channel subunit alpha-1C	Q13936	None	antagonist	yes
DB12278	Propiverine	Drugs for urinary frequency and incontinence	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	antagonist	yes
DB12328	Cantharidin	N/A	approved;investigational	Aryl hydrocarbon receptor	P35869	533324	agonist	unknown
DB12328	Cantharidin	N/A	approved;investigational	Skin epithelial cells	None	None	Vesicant	yes
DB12332	Rucaparib	N/A	approved;investigational	Poly [ADP-ribose] polymerase 1	P09874	1017423	antagonist	yes
DB12332	Rucaparib	N/A	approved;investigational	Poly [ADP-ribose] polymerase 2	Q9UGN5	6688130	antagonist	yes
DB12332	Rucaparib	N/A	approved;investigational	Poly [ADP-ribose] polymerase 3	Q9Y6F1	29788060	antagonist	yes
DB12364	Betrixaban	N/A	approved;investigational	Coagulation factor X	P00742	182841	inhibitor	yes
DB12483	Copanlisib	N/A	approved;investigational	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	P42336	None	inhibitor	yes
DB12483	Copanlisib	N/A	approved;investigational	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	O00329	None	inhibitor	yes
DB12532	Oxetacaine	Local anesthetics	approved;investigational	Gastrin	P01350	None	inhibition of synthesis	yes
DB12598	Nafamostat	N/A	approved;investigational	Prothrombin	P00734	339641	inhibitor	yes
DB12598	Nafamostat	N/A	approved;investigational	Coagulation factor X	P00742	182841	inhibitor	yes
DB12598	Nafamostat	N/A	approved;investigational	Coagulation factor XII	P00748	None	inhibitor	yes
DB12598	Nafamostat	N/A	approved;investigational	Trypsin-1	P07477	521216	inhibitor	yes
DB12598	Nafamostat	N/A	approved;investigational	Kallikrein-1	P06870	186653	inhibitor	yes
DB12598	Nafamostat	N/A	approved;investigational	Intercellular adhesion molecule 1	P05362	758074	inhibitor	unknown
DB12615	Plazomicin	N/A	approved;investigational	30S ribosomal protein S14	P0AG59	809690	inhibitor	unknown
DB12615	Plazomicin	N/A	approved;investigational	30S ribosomal protein S11	L0LZJ6	None	inhibitor	yes
DB12698	Ibalizumab	N/A	approved;investigational	T-cell surface glycoprotein CD4	P01730	None	antagonist	unknown
DB12698	Ibalizumab	N/A	approved;investigational	C-C chemokine receptor type 5	P51681	1262811	antagonist	unknown
DB12698	Ibalizumab	N/A	approved;investigational	C-X-C chemokine receptor type 4	P61073	189314	antagonist	unknown
DB12783	Benserazide	N/A	approved;investigational	Aromatic-L-amino-acid decarboxylase	P20711	181521	inhibitor	yes
DB12865	Etelcalcetide	N/A	approved;investigational	Extracellular calcium-sensing receptor	P41180	599820	agonist	yes
DB12872	Vonicog Alfa	N/A	approved;investigational	Coagulation factor VIII	P00451	182818	stabilization	yes
DB12872	Vonicog Alfa	N/A	approved;investigational	Collagen alpha-1(I) chain	P02452	1418928	binder	yes
DB12924	Ozenoxacin	N/A	approved;investigational	DNA gyrase subunit A	P43700	1574722	inhibitor	yes
DB12924	Ozenoxacin	N/A	approved;investigational	DNA topoisomerase 4 subunit A	P0AFI2	147106	inhibitor	yes
DB12965	Silver	Silver compounds	approved;investigational	Metallothionein	Q9Y4I5	None	binder	unknown
DB12965	Silver	Silver compounds	approved;investigational	Ceruloplasmin	P00450	180256	binder	unknown
DB12965	Silver	Silver compounds	approved;investigational	Serum albumin	P02768	28590	binder	unknown
DB12965	Silver	Silver compounds	approved;investigational	Alpha-2-macroglobulin	P01023	177870	binder	unknown
DB13025	Tiapride	Benzamides	approved;investigational	D(2) dopamine receptor	P14416	181432	blocker	yes
DB13025	Tiapride	Benzamides	approved;investigational	D(3) dopamine receptor	P35462	927342	blocker	yes
DB13025	Tiapride	Benzamides	approved;investigational	Serotonin Receptors	P34969	1857143	antagonist	yes
DB13025	Tiapride	Benzamides	approved;investigational	Alpha-1 adrenergic receptors	P25100	177807	antagonist	yes
DB13025	Tiapride	Benzamides	approved;investigational	Alpha-2 adrenergic receptors	P18825	178194	antagonist	yes
DB13074	Macimorelin	Tests for pituitary function	approved;investigational	Growth hormone secretagogue receptor type 1	Q92847	None	agonist	unknown
DB13092	Meclocycline	N/A	approved;investigational	30S ribosomal protein S7	P02359	None	antagonist	yes
DB13133	Von Willebrand Factor Human	Blood coagulation factors	approved;investigational	Coagulation factor VIII	P00451	182818	stabilization	yes
DB13133	Von Willebrand Factor Human	Blood coagulation factors	approved;investigational	Collagen alpha-1(I) chain	P02452	1418928	binder	yes
DB13139	Levosalbutamol	N/A	approved;investigational	Beta-2 adrenergic receptor	P07550	29371	agonist	yes
DB13140	Bezlotoxumab	N/A	approved;investigational	Clostridium difficile Toxin B	P18177	None	antibody	yes
DB13144	Lenograstim	Colony stimulating factors	approved;investigational	Granulocyte colony-stimulating factor receptor	Q99062	31697	agonist	yes
DB13145	Nedaplatin	N/A	approved;investigational	Glutathione	None	None	ligand	unknown
DB13145	Nedaplatin	N/A	approved;investigational	DNA	None	None	ligand	yes
DB13146	Fluciclovine (18F)	N/A	approved	Neutral amino acid transporter B(0)	Q15758	1478281	binder	yes
DB13146	Fluciclovine (18F)	N/A	approved	Y+L amino acid transporter 1	Q9UM01	None	binder	yes
DB13146	Fluciclovine (18F)	N/A	approved	Cationic amino acid transporter 3	Q8WY07	17224957	binder	yes
DB13146	Fluciclovine (18F)	N/A	approved	Glutamate (NMDA) receptor	O60391	3025446	inhibitor	no
DB13146	Fluciclovine (18F)	N/A	approved	Glutamate receptor 1	P42261	183281	inhibitor	no
DB13146	Fluciclovine (18F)	N/A	approved	Glutamate receptor 2	P42262	493134	inhibitor	no
DB13146	Fluciclovine (18F)	N/A	approved	Glutamate receptor 3	P42263	507829	inhibitor	no
DB13146	Fluciclovine (18F)	N/A	approved	Glutamate receptor 4	P48058	790538	inhibitor	no
DB13147	Pancrelipase lipase	N/A	approved	Dietary fat	None	None	cleavage	yes
DB13149	Protein S human	N/A	approved	Coagulation factor V	P12259	182412	antagonist	yes
DB13149	Protein S human	N/A	approved	Coagulation factor X	P00742	182841	antagonist	yes
DB13149	Protein S human	N/A	approved	Vitamin K-dependent protein C	P04070	190334	cofactor	yes
DB13150	Coagulation factor VII human	N/A	approved;investigational	Tissue factor	P13726	339504	activator	yes
DB13150	Coagulation factor VII human	N/A	approved;investigational	Coagulation factor X	P00742	182841	activator	yes
DB13150	Coagulation factor VII human	N/A	approved;investigational	Coagulation factor IX	P00740	182609	activator	yes
DB13151	Anti-inhibitor coagulant complex	Blood coagulation factors	approved;investigational	Coagulation factor X	P00742	182841	agonist	yes
DB13151	Anti-inhibitor coagulant complex	Blood coagulation factors	approved;investigational	Prothrombin	P00734	339641	agonist	yes
DB13151	Anti-inhibitor coagulant complex	Blood coagulation factors	approved;investigational	Fibrinogen alpha chain	P02671	13591824	cleavage	yes
DB13151	Anti-inhibitor coagulant complex	Blood coagulation factors	approved;investigational	Fibrinogen beta chain	P02675	182430	cleavage	yes
DB13151	Anti-inhibitor coagulant complex	Blood coagulation factors	approved;investigational	Coagulation factor XIII A chain	P00488	182309	agonist	yes
DB13151	Anti-inhibitor coagulant complex	Blood coagulation factors	approved;investigational	Coagulation factor V	P12259	182412	agonist	yes
DB13151	Anti-inhibitor coagulant complex	Blood coagulation factors	approved;investigational	Coagulation factor VIII	P00451	182818	agonist	yes
DB13151	Anti-inhibitor coagulant complex	Blood coagulation factors	approved;investigational	Coagulation factor VII	P08709	182801	agonist	yes
DB13152	Coagulation Factor IX Human	N/A	approved	Coagulation factor X	P00742	182841	activator	yes
DB13152	Coagulation Factor IX Human	N/A	approved	Coagulation factor XI	P03951	182833	ligand	yes
DB13152	Coagulation Factor IX Human	N/A	approved	Coagulation factor VII	P08709	182801	ligand	yes
DB13152	Coagulation Factor IX Human	N/A	approved	Coagulation factor VIII	P00451	182818	cofactor	yes
DB13152	Coagulation Factor IX Human	N/A	approved	Prothrombin	P00734	339641	None	unknown
DB13152	Coagulation Factor IX Human	N/A	approved	Prolow-density lipoprotein receptor-related protein 1	Q07954	34339	None	unknown
DB13152	Coagulation Factor IX Human	N/A	approved	Vitamin K-dependent gamma-carboxylase	P38435	184028	None	unknown
DB13154	Parachlorophenol	N/A	approved	Sodium channel protein type 4 subunit alpha	P35499	338213	None	unknown
DB13155	Esculin	N/A	approved	Androgen receptor	P10275	178628	agonist	unknown
DB13158	Clobetasone	Corticosteroids, plain	approved	Glucocorticoid receptor	P04150	31680	agonist	yes
DB13161	Nusinersen	N/A	approved;investigational	Survival motor neuron protein	B4DP61	None	antisense oligonucleotide	yes
DB13164	Olmutinib	N/A	approved;investigational	Epidermal growth factor receptor	P00533	757924	inhibitor	yes
DB13165	Ripasudil	N/A	approved	Rho-associated protein kinase 1	Q13464	1276901	inhibitor	unknown
DB13165	Ripasudil	N/A	approved	Rho-associated protein kinase 2	O75116	4520225	inhibitor	unknown
DB13167	Alclofenac	Acetic acid derivatives and related substances	approved;withdrawn	Prostaglandin G/H synthase 2	P35354	291988	antagonist	yes
DB13170	Plecanatide	N/A	approved;investigational	Guanylate cyclase soluble subunit alpha-2	P33402	31671	agonist	yes
DB13173	Cerliponase alfa	N/A	approved;investigational	Cation-independent mannose-6-phosphate receptor	P11717	33055	ligand	unknown
DB13179	Troleandomycin	Macrolides	approved	50S ribosomal protein L32	P49228	970089	inhibitor	yes
DB13179	Troleandomycin	Macrolides	approved	50S ribosomal protein L4	P60723	42826	inhibitor	yes
DB13179	Troleandomycin	Macrolides	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	activator	unknown
DB13192	Antihemophilic factor human	Blood coagulation factors	approved	Coagulation factor IX	P00740	182609	activator	yes
DB13192	Antihemophilic factor human	Blood coagulation factors	approved	Coagulation factor X	P00742	182841	activator	yes
DB13200	Lipegfilgrastim	Colony stimulating factors	approved;investigational	Granulocyte colony-stimulating factor receptor	Q99062	31697	agonist	yes
DB13257	Ferrous sulfate	Iron in combination with folic acid	approved;experimental	Free radicals	None	None	agonist	unknown
DB13269	Dichlorobenzyl alcohol	Antiseptics	approved	Sodium channel protein	Q8IWT1	27465047	antagonist	yes
DB13345	Dihydroergocristine	Ergot alkaloids	approved;experimental	Serotonin Receptors	P34969	1857143	antagonist	yes
DB13345	Dihydroergocristine	Ergot alkaloids	approved;experimental	Beta adrenergic receptor	P13945	178896	antagonist	yes
DB13345	Dihydroergocristine	Ergot alkaloids	approved;experimental	Alpha adrenergic receptor	P18825	178194	antagonist	yes
DB13345	Dihydroergocristine	Ergot alkaloids	approved;experimental	Dopamine receptor	P21917	291946	antagonist	yes
DB13346	Bufexamac	Antiinflammatory preparations, non-steroids for topical use	approved;experimental	Prostaglandin G/H synthase 1	P23219	387018	inhibitor	yes
DB13346	Bufexamac	Antiinflammatory preparations, non-steroids for topical use	approved;experimental	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB13346	Bufexamac	Antiinflammatory preparations, non-steroids for topical use	approved;experimental	Histone deacetylase 6	Q9UBN7	4754911	inhibitor	unknown
DB13346	Bufexamac	Antiinflammatory preparations, non-steroids for topical use	approved;experimental	Histone deacetylase 10	Q969S8	None	inhibitor	unknown
DB13421	Edoxudine	Antivirals	approved;investigational;withdrawn	DNA polymerase	Q91CQ6	None	inhibitor	yes
DB13503	Tyrothricin	Antibiotics	approved	Acetylcholinesterase	P22303	177975	inhibitor	unknown
DB13503	Tyrothricin	Antibiotics	approved	Beta-galactosidase	P00722	146577	inhibitor	unknown
DB13503	Tyrothricin	Antibiotics	approved	Phospholipid membrane	None	None	disruptor	yes
DB13615	Mifamurtide	Other immunostimulants	approved;experimental	Toll-like receptor 4	O00206	None	ligand	yes
DB13615	Mifamurtide	Other immunostimulants	approved;experimental	Nucleotide-binding oligomerization domain-containing protein 2	Q9HC29	None	ligand	yes
DB13746	Bioallethrin	Pyrethrines, incl. synthetic compounds	approved;experimental	Voltage gated sodium channel	None	None	modulator	unknown
DB13746	Bioallethrin	Pyrethrines, incl. synthetic compounds	approved;experimental	Sodium channel protein	Q86DI9	None	modulator	yes
DB13746	Bioallethrin	Pyrethrines, incl. synthetic compounds	approved;experimental	Voltage-dependent N-type calcium channel	None	None	agonist	unknown
DB13746	Bioallethrin	Pyrethrines, incl. synthetic compounds	approved;experimental	Voltage-dependent T-type calcium channel	Q9P0X4	5565888	blocker	unknown
DB13746	Bioallethrin	Pyrethrines, incl. synthetic compounds	approved;experimental	Voltage-dependent P/Q-type calcium channel	O00555	2213913	blocker	unknown
DB13746	Bioallethrin	Pyrethrines, incl. synthetic compounds	approved;experimental	Voltage dependent L type calcium channel	O00305	2058727	blocker	unknown
DB13751	Glycyrrhizic acid	Liver therapy	approved;experimental	Corticosteroid 11-beta-dehydrogenase isozyme 1	P28845	179475	antagonist	yes
DB13751	Glycyrrhizic acid	Liver therapy	approved;experimental	Tumor necrosis factor	P01375	339741	antagonist	yes
DB13751	Glycyrrhizic acid	Liver therapy	approved;experimental	Caspase-3	P42574	561666	antagonist	yes
DB13751	Glycyrrhizic acid	Liver therapy	approved;experimental	Nuclear factor NF-kappa-B	P19838	189180	translocation inhibitor	yes
DB13751	Glycyrrhizic acid	Liver therapy	approved;experimental	Lipoprotein lipase	P06858	307138	inducer	yes
DB13761	Tilactase	Enzyme preparations	approved;experimental	Lactose	None	None	cleavage	yes
DB13783	Acemetacin	Acetic acid derivatives and related substances	approved;experimental;investigational	Prostaglandin G/H synthase 1	P23219	387018	antagonist	yes
DB13783	Acemetacin	Acetic acid derivatives and related substances	approved;experimental;investigational	Prostaglandin G/H synthase 2	P35354	291988	antagonist	yes
DB13800	Calcium levulinate	Calcium	approved;experimental	Calmodulin	P0DP23	179888	agonist	unknown
DB13800	Calcium levulinate	Calcium	approved;experimental	Calsequestrin-1	P31415	None	agonist	unknown
DB13800	Calcium levulinate	Calcium	approved;experimental	Calretinin	P22676	None	agonist	unknown
DB13857	Demegestone	Pregnadien derivatives	approved	Progesterone receptor	P06401	35652	agonist	yes
DB13872	Lormetazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-2	P47869	386422	positive allosteric modulator	yes
DB13872	Lormetazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit gamma-2	P18507	31637	positive allosteric modulator	yes
DB13872	Lormetazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-3	P34903	386424	positive allosteric modulator	yes
DB13872	Lormetazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-5	P31644	182916	positive allosteric modulator	yes
DB13872	Lormetazepam	Benzodiazepine derivatives	approved	Gamma-aminobutyric acid receptor subunit alpha-1	P14867	31631	positive allosteric modulator	yes
DB13873	Fenofibric acid	Fibrates	approved	Peroxisome proliferator-activated receptor alpha	Q07869	307341	agonist	yes
DB13873	Fenofibric acid	Fibrates	approved	Metalloproteinase	O43923	2808657	unknown	unknown
DB13873	Fenofibric acid	Fibrates	approved	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB13873	Fenofibric acid	Fibrates	approved	Peroxisome proliferator-activated receptor delta	Q03181	190230	unknown	unknown
DB13873	Fenofibric acid	Fibrates	approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	partial agonist	unknown
DB13874	Enasidenib	N/A	approved;investigational	Isocitrate dehydrogenase [NADP], mitochondrial	P48735	None	inhibitor	yes
DB13878	Pibrentasvir	N/A	approved;investigational	Nonstructural Protein 5A (NS5A)	None	None	inhibitor	yes
DB13879	Glecaprevir	N/A	approved;investigational	NS3 protease	Q91RS4	14150583	inhibitor	yes
DB13881	Tisagenlecleucel	N/A	approved;investigational	B-lymphocyte antigen CD19	P15391	None	antibody	yes
DB13884	Albutrepenonacog alfa	N/A	approved	Coagulation factor X	P00742	182841	activator	yes
DB13893	Crotalus adamanteus antivenin	N/A	approved;experimental	Group 10 secretory phospholipase A2	O15496	2289237	antagonist	yes
DB13894	Agkistrodon piscivorus antivenin	N/A	approved;experimental	Group 10 secretory phospholipase A2	O15496	2289237	antagonist	yes
DB13896	Talimogene laherparepvec	N/A	approved;experimental;investigational	Heparan sulfate	None	None	None	yes
DB13896	Talimogene laherparepvec	N/A	approved;experimental;investigational	DNA polymerase catalytic subunit	P04293	59530	activator	yes
DB13896	Talimogene laherparepvec	N/A	approved;experimental;investigational	DNA polymerase catalytic subunit	P09252	60016	activator	yes
DB13897	Equine Botulinum Neurotoxin E Immune FAB2	N/A	approved;experimental;investigational	Botulinum neurotoxin type E	Q00496	None	antibody	yes
DB13898	Equine Botulinum Neurotoxin C Immune FAB2	N/A	approved;experimental;investigational	Botulinum neurotoxin type C1	P18640	None	antibody	yes
DB13899	Equine Botulinum Neurotoxin G Immune FAB2	N/A	approved;experimental;investigational	Botulinum neurotoxin type G	Q60393	None	antibody	yes
DB13900	Equine Botulinum Neurotoxin A Immune FAB2	N/A	approved;experimental;investigational	Botulinum neurotoxin type A	P10845	None	antibody	yes
DB13901	Equine Botulinum Neurotoxin F Immune FAB2	N/A	approved;experimental;investigational	Botulinum neurotoxin type F	P30996	None	antibody	yes
DB13902	Equine Botulinum Neurotoxin D Immune FAB2	N/A	approved;experimental;investigational	Botulinum neurotoxin type D	P19321	None	antibody	yes
DB13903	Equine Botulinum Neurotoxin B Immune FAB2	N/A	approved;experimental;investigational	Botulinum neurotoxin type B	P10844	144735	antibody	yes
DB13906	Aloe Polysaccharide	N/A	approved;experimental	Free radicals	None	None	chelator	yes
DB13908	Amylmetacresol	N/A	approved	Voltage gated sodium channel	None	None	antagonist	unknown
DB13915	Axicabtagene ciloleucel	N/A	approved	B-lymphocyte antigen CD19	P15391	None	antibody	yes
DB13923	Emicizumab	N/A	approved;investigational	Coagulation factor IX	P00740	182609	cofactor	yes
DB13923	Emicizumab	N/A	approved;investigational	Coagulation factor X	P00742	182841	activator	yes
DB13925	Dotatate gallium Ga-68	N/A	approved;investigational	Somatostatin receptor type 2	P30874	None	binder	yes
DB13928	Semaglutide	N/A	approved;investigational	Glucagon-like peptide 1 receptor	P43220	405082	agonist	yes
DB13931	Netarsudil	N/A	approved	Rho-associated protein kinase 1	Q13464	1276901	inhibitor	yes
DB13931	Netarsudil	N/A	approved	Rho-associated protein kinase 2	O75116	4520225	inhibitor	yes
DB13931	Netarsudil	N/A	approved	solute carrier family 6 member 2	None	None	inhibitor	yes
DB13932	Voretigene Neparvovec	N/A	approved	Retinoid isomerohydrolase	Q16518	None	gene replacement	yes
DB13933	Nonacog beta pegol	N/A	approved;investigational	Coagulation factor VII	P08709	182801	cofactor	yes
DB13933	Nonacog beta pegol	N/A	approved;investigational	Coagulation factor VIII	P00451	182818	cofactor	yes
DB13933	Nonacog beta pegol	N/A	approved;investigational	Coagulation factor X	P00742	182841	agonist	yes
DB13943	Testosterone cypionate	N/A	approved	Androgen receptor	P10275	178628	agonist	yes
DB13943	Testosterone cypionate	N/A	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB13943	Testosterone cypionate	N/A	approved	Mineralocorticoid receptor	P08235	307166	None	unknown
DB13944	Testosterone enanthate	N/A	approved	Androgen receptor	P10275	178628	agonist	yes
DB13944	Testosterone enanthate	N/A	approved	Estrogen receptor alpha	P03372	31234	None	unknown
DB13944	Testosterone enanthate	N/A	approved	Mineralocorticoid receptor	P08235	307166	None	unknown
DB13946	Testosterone undecanoate	N/A	approved;investigational	Androgen receptor	P10275	178628	agonist	yes
DB13946	Testosterone undecanoate	N/A	approved;investigational	Estrogen receptor alpha	P03372	31234	None	unknown
DB13946	Testosterone undecanoate	N/A	approved;investigational	Mineralocorticoid receptor	P08235	307166	None	unknown
DB13949	Ferric cation	Drugs for treatment of hyperkalemia and hyperphosphatemia	approved	Iron(3+)-hydroxamate-binding protein FhuD	P07822	41440	binder	unknown
DB13949	Ferric cation	Drugs for treatment of hyperkalemia and hyperphosphatemia	approved	Transferrin receptor protein 1	P02786	None	agonist	yes
DB13952	Estradiol acetate	N/A	approved;investigational;vet_approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB13952	Estradiol acetate	N/A	approved;investigational;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB13952	Estradiol acetate	N/A	approved;investigational;vet_approved	Estrogen receptor beta	Q92731	2911152	agonist	yes
DB13952	Estradiol acetate	N/A	approved;investigational;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB13952	Estradiol acetate	N/A	approved;investigational;vet_approved	Nuclear receptor coactivator 2	Q15596	1877215	None	unknown
DB13952	Estradiol acetate	N/A	approved;investigational;vet_approved	G-protein coupled estrogen receptor 1	Q99527	None	None	unknown
DB13952	Estradiol acetate	N/A	approved;investigational;vet_approved	ATP synthase subunit a	P00846	None	None	unknown
DB13952	Estradiol acetate	N/A	approved;investigational;vet_approved	Beclin-1	Q14457	None	None	unknown
DB13952	Estradiol acetate	N/A	approved;investigational;vet_approved	Estradiol 17-beta-dehydrogenase 2	P37059	306462	None	unknown
DB13952	Estradiol acetate	N/A	approved;investigational;vet_approved	Estrogen-related receptor gamma	P62508	4092075	ligand	unknown
DB13953	Estradiol benzoate	N/A	approved;investigational;vet_approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB13953	Estradiol benzoate	N/A	approved;investigational;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB13953	Estradiol benzoate	N/A	approved;investigational;vet_approved	Estrogen receptor beta	Q92731	2911152	agonist	yes
DB13953	Estradiol benzoate	N/A	approved;investigational;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB13953	Estradiol benzoate	N/A	approved;investigational;vet_approved	Nuclear receptor coactivator 2	Q15596	1877215	None	unknown
DB13953	Estradiol benzoate	N/A	approved;investigational;vet_approved	G-protein coupled estrogen receptor 1	Q99527	None	None	unknown
DB13953	Estradiol benzoate	N/A	approved;investigational;vet_approved	ATP synthase subunit a	P00846	None	None	unknown
DB13953	Estradiol benzoate	N/A	approved;investigational;vet_approved	Beclin-1	Q14457	None	None	unknown
DB13953	Estradiol benzoate	N/A	approved;investigational;vet_approved	Estradiol 17-beta-dehydrogenase 2	P37059	306462	None	unknown
DB13953	Estradiol benzoate	N/A	approved;investigational;vet_approved	Estrogen-related receptor gamma	P62508	4092075	ligand	unknown
DB13954	Estradiol cypionate	N/A	approved;investigational;vet_approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB13954	Estradiol cypionate	N/A	approved;investigational;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB13954	Estradiol cypionate	N/A	approved;investigational;vet_approved	Estrogen receptor beta	Q92731	2911152	agonist	yes
DB13954	Estradiol cypionate	N/A	approved;investigational;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB13954	Estradiol cypionate	N/A	approved;investigational;vet_approved	Nuclear receptor coactivator 2	Q15596	1877215	None	unknown
DB13954	Estradiol cypionate	N/A	approved;investigational;vet_approved	G-protein coupled estrogen receptor 1	Q99527	None	None	unknown
DB13954	Estradiol cypionate	N/A	approved;investigational;vet_approved	ATP synthase subunit a	P00846	None	None	unknown
DB13954	Estradiol cypionate	N/A	approved;investigational;vet_approved	Beclin-1	Q14457	None	None	unknown
DB13954	Estradiol cypionate	N/A	approved;investigational;vet_approved	Estradiol 17-beta-dehydrogenase 2	P37059	306462	None	unknown
DB13954	Estradiol cypionate	N/A	approved;investigational;vet_approved	Estrogen-related receptor gamma	P62508	4092075	ligand	unknown
DB13955	Estradiol dienanthate	N/A	approved;investigational;vet_approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB13955	Estradiol dienanthate	N/A	approved;investigational;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB13955	Estradiol dienanthate	N/A	approved;investigational;vet_approved	Estrogen receptor beta	Q92731	2911152	agonist	yes
DB13955	Estradiol dienanthate	N/A	approved;investigational;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB13955	Estradiol dienanthate	N/A	approved;investigational;vet_approved	Nuclear receptor coactivator 2	Q15596	1877215	None	unknown
DB13955	Estradiol dienanthate	N/A	approved;investigational;vet_approved	G-protein coupled estrogen receptor 1	Q99527	None	None	unknown
DB13955	Estradiol dienanthate	N/A	approved;investigational;vet_approved	ATP synthase subunit a	P00846	None	None	unknown
DB13955	Estradiol dienanthate	N/A	approved;investigational;vet_approved	Beclin-1	Q14457	None	None	unknown
DB13955	Estradiol dienanthate	N/A	approved;investigational;vet_approved	Estradiol 17-beta-dehydrogenase 2	P37059	306462	None	unknown
DB13955	Estradiol dienanthate	N/A	approved;investigational;vet_approved	Estrogen-related receptor gamma	P62508	4092075	ligand	unknown
DB13956	Estradiol valerate	N/A	approved;investigational;vet_approved	Estrogen receptor alpha	P03372	31234	agonist	yes
DB13956	Estradiol valerate	N/A	approved;investigational;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB13956	Estradiol valerate	N/A	approved;investigational;vet_approved	Estrogen receptor beta	Q92731	2911152	agonist	yes
DB13956	Estradiol valerate	N/A	approved;investigational;vet_approved	Neuronal acetylcholine receptor subunit alpha-4	P43681	755648	None	unknown
DB13956	Estradiol valerate	N/A	approved;investigational;vet_approved	Nuclear receptor coactivator 2	Q15596	1877215	None	unknown
DB13956	Estradiol valerate	N/A	approved;investigational;vet_approved	G-protein coupled estrogen receptor 1	Q99527	None	None	unknown
DB13956	Estradiol valerate	N/A	approved;investigational;vet_approved	ATP synthase subunit a	P00846	None	None	unknown
DB13956	Estradiol valerate	N/A	approved;investigational;vet_approved	Beclin-1	Q14457	None	None	unknown
DB13956	Estradiol valerate	N/A	approved;investigational;vet_approved	Estradiol 17-beta-dehydrogenase 2	P37059	306462	None	unknown
DB13956	Estradiol valerate	N/A	approved;investigational;vet_approved	Estrogen-related receptor gamma	P62508	4092075	ligand	unknown
DB13960	Bronopol	N/A	approved	Thiol groups	None	None	oxidizer	yes
DB13961	Fish oil	N/A	approved;nutraceutical	Diacylglycerol O-acyltransferase 2	Q96PD7	None	agonist	yes
DB13961	Fish oil	N/A	approved;nutraceutical	Prostaglandin G/H synthase 2	P35354	291988	inhibitor	yes
DB13961	Fish oil	N/A	approved;nutraceutical	Free fatty acid receptor 4	Q5NUL3	None	agonist	yes
DB13961	Fish oil	N/A	approved;nutraceutical	Voltage dependent L type calcium channel	O00305	2058727	inhibitor	unknown
DB13961	Fish oil	N/A	approved;nutraceutical	Voltage gated sodium channel	None	None	inhibitor	unknown
DB13961	Fish oil	N/A	approved;nutraceutical	Free radicals	None	None	None	unknown
DB13961	Fish oil	N/A	approved;nutraceutical	Nuclear factor NF-kappa-B	P19838	189180	regulator	unknown
DB13961	Fish oil	N/A	approved;nutraceutical	Sterol regulatory element-binding protein 1	P36956	None	regulator	unknown
DB13961	Fish oil	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor alpha	Q07869	307341	regulator	unknown
DB13961	Fish oil	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB13961	Fish oil	N/A	approved;nutraceutical	Peroxisome proliferator-activated receptor delta	Q03181	190230	regulator	unknown
DB13967	Patent Blue	N/A	approved	Serum albumin	P02768	28590	binder	yes
DB13979	Besilesomab	N/A	approved	Carcinoembryonic antigen	Q14081	None	None	no
DB13985	Lutetium Lu 177 dotatate	N/A	approved;investigational	Somatostatin receptor type 2	P30874	None	agonist	yes
DB13985	Lutetium Lu 177 dotatate	N/A	approved;investigational	Somatostatin receptor type 1	P30872	307434	agonist	yes
DB13985	Lutetium Lu 177 dotatate	N/A	approved;investigational	Somatostatin receptor type 3	P32745	None	agonist	yes
DB13985	Lutetium Lu 177 dotatate	N/A	approved;investigational	Somatostatin receptor type 4	P31391	None	agonist	yes
DB13985	Lutetium Lu 177 dotatate	N/A	approved;investigational	Somatostatin receptor type 5	P35346	431095	agonist	yes
DB13995	Ferric pyrophosphate citrate	N/A	approved;investigational	Ferritin light chain	P02792	182514	binder	yes
DB13995	Ferric pyrophosphate citrate	N/A	approved;investigational	Ferritin heavy chain	P02794	28435	binder	yes
DB13995	Ferric pyrophosphate citrate	N/A	approved;investigational	Hemoglobin subunit alpha	P69905	386764	binder	yes
DB13995	Ferric pyrophosphate citrate	N/A	approved;investigational	Hemoglobin subunit beta	P68871	455997	binder	yes
DB13996	Magnesium acetate	N/A	approved	Sodium/potassium-transporting ATPase subunit alpha-1	P05023	219942	None	unknown
DB13998	Lonoctocog alfa	N/A	approved;investigational	Coagulation factor X	P00742	182841	activator	yes
DB13998	Lonoctocog alfa	N/A	approved;investigational	Phytanoyl-CoA dioxygenase, peroxisomal	O14832	2564671	antagonist	unknown
DB13998	Lonoctocog alfa	N/A	approved;investigational	Coagulation factor IX	P00740	182609	cofactor	yes
DB13998	Lonoctocog alfa	N/A	approved;investigational	Asialoglycoprotein receptor 2	P07307	179081	binder	unknown
DB13998	Lonoctocog alfa	N/A	approved;investigational	78 kDa glucose-regulated protein	P11021	386758	chaperone	unknown
DB13998	Lonoctocog alfa	N/A	approved;investigational	Calreticulin	P27797	337487	chaperone	unknown
DB13998	Lonoctocog alfa	N/A	approved;investigational	Calnexin	P27824	186523	chaperone	unknown
DB13998	Lonoctocog alfa	N/A	approved;investigational	Protein ERGIC-53	P49257	433938	chaperone	unknown
DB13998	Lonoctocog alfa	N/A	approved;investigational	Prolow-density lipoprotein receptor-related protein 1	Q07954	34339	modulator	unknown
DB13998	Lonoctocog alfa	N/A	approved;investigational	Multiple coagulation factor deficiency protein 2	Q8NI22	20799383	modulator	unknown
DB13998	Lonoctocog alfa	N/A	approved;investigational	von Willebrand factor	P04275	37947	binder	yes
DB13999	Moroctocog alfa	N/A	approved	Coagulation factor X	P00742	182841	activator	yes
DB13999	Moroctocog alfa	N/A	approved	Phytanoyl-CoA dioxygenase, peroxisomal	O14832	2564671	antagonist	unknown
DB13999	Moroctocog alfa	N/A	approved	Coagulation factor IX	P00740	182609	cofactor	yes
DB13999	Moroctocog alfa	N/A	approved	Asialoglycoprotein receptor 2	P07307	179081	binder	unknown
DB13999	Moroctocog alfa	N/A	approved	78 kDa glucose-regulated protein	P11021	386758	chaperone	unknown
DB13999	Moroctocog alfa	N/A	approved	Calreticulin	P27797	337487	chaperone	unknown
DB13999	Moroctocog alfa	N/A	approved	Calnexin	P27824	186523	chaperone	unknown
DB13999	Moroctocog alfa	N/A	approved	Protein ERGIC-53	P49257	433938	chaperone	unknown
DB13999	Moroctocog alfa	N/A	approved	Prolow-density lipoprotein receptor-related protein 1	Q07954	34339	modulator	unknown
DB13999	Moroctocog alfa	N/A	approved	Multiple coagulation factor deficiency protein 2	Q8NI22	20799383	modulator	unknown
DB13999	Moroctocog alfa	N/A	approved	von Willebrand factor	P04275	37947	binder	yes
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	SEC14-like protein 4	Q9UDX3	27803380	None	unknown
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	SEC14-like protein 3	Q9UDX4	27803382	None	unknown
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	SEC14-like protein 2	O76054	5596693	None	unknown
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	Protein kinase C beta type	P05771	189969	None	unknown
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	Arachidonate 5-lipoxygenase	P09917	187193	None	unknown
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	Protein kinase C alpha type	P17252	35483	None	unknown
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	Diacylglycerol kinase alpha	P23743	30823	None	unknown
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	P62714	35581	None	unknown
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	P67775	36120	None	unknown
DB14001	alpha-Tocopherol succinate	N/A	approved;nutraceutical;vet_approved	Lung epithelial cells	None	None	None	unknown
DB14002	D-alpha-Tocopherol acetate	N/A	approved;nutraceutical;vet_approved	SEC14-like protein 4	Q9UDX3	27803380	None	unknown
DB14002	D-alpha-Tocopherol acetate	N/A	approved;nutraceutical;vet_approved	SEC14-like protein 3	Q9UDX4	27803382	None	unknown
DB14002	D-alpha-Tocopherol acetate	N/A	approved;nutraceutical;vet_approved	SEC14-like protein 2	O76054	5596693	None	unknown
DB14002	D-alpha-Tocopherol acetate	N/A	approved;nutraceutical;vet_approved	Nuclear receptor subfamily 1 group I member 2	O75469	3511138	None	unknown
DB14002	D-alpha-Tocopherol acetate	N/A	approved;nutraceutical;vet_approved	Protein kinase C beta type	P05771	189969	None	unknown
DB14002	D-alpha-Tocopherol acetate	N/A	approved;nutraceutical;vet_approved	Arachidonate 5-lipoxygenase	P09917	187193	None	unknown
DB14002	D-alpha-Tocopherol acetate	N/A	approved;nutraceutical;vet_approved	Protein kinase C alpha type	P17252	35483	None	unknown
DB14002	D-alpha-Tocopherol acetate	N/A	approved;nutraceutical;vet_approved	Diacylglycerol kinase alpha	P23743	30823	None	unknown
DB14002	D-alpha-Tocopherol acetate	N/A	approved;nutraceutical;vet_approved	Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	P62714	35581	None	unknown
DB14002	D-alpha-Tocopherol acetate	N/A	approved;nutraceutical;vet_approved	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	P67775	36120	None	unknown
DB14003	alpha-Tocopherol acetate	N/A	approved	Free radicals	None	None	binder	yes
DB14004	Tildrakizumab	N/A	approved;investigational	Interleukin-23	Q9NPF7	180626	antagonist	yes
DB14006	Choline salicylate	Salicylic acid and derivatives	approved;nutraceutical	Choline-phosphate cytidylyltransferase B	Q9Y5K3	3153239	product of	unknown
DB14006	Choline salicylate	Salicylic acid and derivatives	approved;nutraceutical	Acetylcholinesterase	P22303	177975	product of	unknown
DB14006	Choline salicylate	Salicylic acid and derivatives	approved;nutraceutical	Choline-phosphate cytidylyltransferase A	P49585	575486	product of	unknown
DB14006	Choline salicylate	Salicylic acid and derivatives	approved;nutraceutical	Phospholipase D2	O14939	2645858	product of	unknown
DB14006	Choline salicylate	Salicylic acid and derivatives	approved;nutraceutical	Cholinesterase	P06276	1311630	product of	unknown
DB14006	Choline salicylate	Salicylic acid and derivatives	approved;nutraceutical	Phospholipase D1	Q13393	1185463	product of	unknown
DB14006	Choline salicylate	Salicylic acid and derivatives	approved;nutraceutical	Phosphoethanolamine/phosphocholine phosphatase	Q8TCT1	20196839	product of	unknown
DB14006	Choline salicylate	Salicylic acid and derivatives	approved;nutraceutical	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	None	unknown
DB14007	Pentetic acid	N/A	approved	Transuranium elements	None	None	chelator	yes
DB14011	Nabiximols	N/A	approved;investigational	Cannabinoid receptor 1	P21554	29915	None	yes
DB14011	Nabiximols	N/A	approved;investigational	Cannabinoid receptor 2	P34972	407807	None	yes
DB14011	Nabiximols	N/A	approved;investigational	G-protein coupled receptor 12	P47775	None	inverse agonist	unknown
DB14011	Nabiximols	N/A	approved;investigational	Glycine receptor subunit alpha-1	P23415	31851	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Glycine receptor (alpha-1/beta)	P48167	992687	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Glycine receptor subunit alpha-3	O75311	3342792	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	N-arachidonyl glycine receptor	Q14330	1066731	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	G-protein coupled receptor 55	Q9Y2T6	None	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Neuronal acetylcholine receptor subunit alpha-7	P36544	496607	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Delta-type opioid receptor	P41143	27545517	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Mu-type opioid receptor	P35372	452073	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Peroxisome proliferator-activated receptor gamma	P37231	1711117	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Transient receptor potential cation channel subfamily V member 1	Q8NER1	8977866	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1G	O43497	6625659	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1H	O95180	14670397	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Voltage-dependent T-type calcium channel subunit alpha-1I	Q9P0X4	5565888	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Transient receptor potential cation channel subfamily A member 1	O75762	3287188	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Transient receptor potential cation channel subfamily M member 8	Q7Z2W7	20147036	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Transient receptor potential cation channel subfamily V member 2	Q9Y5S1	None	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Transient receptor potential cation channel subfamily V member 3	Q8NET8	None	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Transient receptor potential cation channel subfamily V member 4	Q9HBA0	None	None	unknown
DB14011	Nabiximols	N/A	approved;investigational	Voltage-dependent anion-selective channel protein 1	P21796	None	None	unknown
DB14012	Burosumab	N/A	approved;investigational	Fibroblast growth factor 23	Q7Z4T2	None	antagonist	yes
DB14019	Fosnetupitant	N/A	approved	Neurokinin-1 Receptor (NK1R)	None	None	antagonist	yes
DB14033	Acetyl sulfisoxazole	Sulfonamides	approved;vet_approved	Dihydropteroate synthase	P0AC13	41273	inhibitor	yes
DB14039	Erenumab	N/A	approved;investigational	Calcitonin gene-related peptide type 1 receptor	Q16602	None	None	unknown
DB14061	Hycanthone	N/A	approved;investigational	Multidrug resistance protein 1	P08183	307180	inhibitor	yes
DB14132	8-chlorotheophylline	Xanthines	approved	Adenosine receptor A2a	P29274	177892	antagonist	yes
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	D(2) dopamine receptor	P14416	181432	None	yes
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	5-hydroxytryptamine receptor 1A	P08908	189928	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	5-hydroxytryptamine receptor 2A	P28223	36431	None	yes
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	5-hydroxytryptamine receptor 1B	P28222	219679	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	5-hydroxytryptamine receptor 1D	P28221	177772	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	5-hydroxytryptamine receptor 1E	P28566	177774	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	D(1A) dopamine receptor	P21728	30397	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	D(1B) dopamine receptor	P21918	32049	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	D(3) dopamine receptor	P35462	927342	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	D(4) dopamine receptor	P21917	291946	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	5-hydroxytryptamine receptor 2C	P28335	338028	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	5-hydroxytryptamine receptor 3A	P46098	681914	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	5-hydroxytryptamine receptor 6	P50406	1162924	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	5-hydroxytryptamine receptor 7	P34969	1857143	None	unknown
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Histamine H1 receptor	P35367	510296	None	no
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Alpha-1A adrenergic receptor	P35348	433201	None	no
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Alpha-1B adrenergic receptor	P35368	None	None	no
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Alpha-2A adrenergic receptor	P08913	178196	None	no
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Alpha-2B adrenergic receptor	P18089	178198	None	no
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Alpha-2C adrenergic receptor	P18825	178194	None	no
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Muscarinic acetylcholine receptor M1	P11229	34451	None	no
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Muscarinic acetylcholine receptor M2	P08172	177990	None	no
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Muscarinic acetylcholine receptor M3	P20309	32324	None	no
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Muscarinic acetylcholine receptor M4	P08173	61970253	None	no
DB14185	Aripiprazole lauroxil	N/A	approved;investigational	Muscarinic acetylcholine receptor M5	P08912	177988	None	no
